Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
CHEMBL100100,P08253,,ZRDGYJAMDSHROJ-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1453246,DTCC00264536,982314,3373
CHEMBL100100,P08253,,ZRDGYJAMDSHROJ-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,19.95,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258334,DTCC00264536,972938,24803
CHEMBL100273,P08253,,CVJMAXDBGIRLPL-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1478676,DTCC00264430,885728,3373
CHEMBL100273,P08253,,CVJMAXDBGIRLPL-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1995.26,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258338,DTCC00264430,876665,24803
CHEMBL100570,P08253,,RNCWXNOSFWYLTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,=,3.8,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,674929,DTCC00106694,970630,18131
CHEMBL100570,P08253,,RNCWXNOSFWYLTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16289878,KI,=,3.8,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334535,DTCT0025094,469043,DTCC00106694,984001,20373
CHEMBL100570,P08253,,RNCWXNOSFWYLTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19095454,KI,=,3.8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495049,DTCT0025094,2594688,DTCC00106694,985007,32093
CHEMBL100584,P08253,,IFHBUYGFCSEHIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,628942,DTCC00269547,161928,4635
CHEMBL100754,P08253,,CMALBPMZEURNBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,=,28.5,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,693863,DTCC00269176,1326745,18131
CHEMBL100805,P08253,,XYVVUCAHUUIYFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,637871,DTCC00269559,582958,4635
CHEMBL101121,P08253,,VVZTYGQJDUUATC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,619915,DTCC00269629,2001205,4635
CHEMBL101789,P08253,,XBJDUGZISLIDRA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,<,3.3,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,678776,DTCC00269210,1968643,18131
CHEMBL10180,P08253,,MOVLHCHTKCWLQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,939250,DTCC00138525,1016783,16645
CHEMBL10193,P08253,,QIKCPSHYSFYKBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,2770,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,956223,DTCC00138519,272574,16645
CHEMBL102415,P08253,,RNMJVOBQCWORLK-GFOWMXPYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,1.64,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1202332,DTCC00273885,226190,16385
CHEMBL102438,P08253,,BSGLIFPGYIIUAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1389494,DTCC00273957,885822,16392
CHEMBL102441,P08253,,AGLYKFTUNLOGBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,1810,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1379266,DTCC00273131,465265,16392
CHEMBL102459,P08253,,YMFBAKCSKQKFMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,650231,DTCC00269592,1326752,4635
CHEMBL102504,P08253,,MEVLEABHOAUFQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,30,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1371785,DTCC00273508,1661708,16392
CHEMBL10257,P08253,,ZOSFRKHRZHSICA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,969085,DTCC00138526,110709,16645
CHEMBL10266,P08253,,DPDQSBRVGYFIHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,33,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,956060,DTCC00138497,919742,16645
CHEMBL102698,P08253,,WYWVSRVZNIIISU-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,15.4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1194613,DTCC00273956,97110,16385
CHEMBL102785,P08253,,PECNGMJVFOGIBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1398096,DTCC00273055,723954,16392
CHEMBL102798,P08253,,MAOGHLYYLNCNCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1399289,DTCC00273086,2077525,16392
CHEMBL10296,P08253,,AWDSUFIHUSMPAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,956231,DTCC00138702,726065,16645
CHEMBL10335,P08253,,XZFOATQBCODVSR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,965338,DTCC00138703,822790,16645
CHEMBL103418,P08253,,QVCXUWWKONKLBL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,=,0.4,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,367650,DTCC00269253,1003161,18131
CHEMBL103418,P08253,,QVCXUWWKONKLBL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,KI,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278522,DTCC00269253,1021673,25112
CHEMBL103442,P08253,,KFTWEWMQNRZZNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,621139,DTCC00269617,1003168,4635
CHEMBL103563,P08253,,QAIMUZSIIGFZOG-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,=,3.2,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,692554,DTCC00269250,324184,18131
CHEMBL104021,P08253,,NKRKWSFHPLAZOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,4.22,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1381855,DTCC00106784,1240704,16392
CHEMBL104022,P08253,,TWQZYQBXMVVVCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1385693,DTCC00273200,433728,16392
CHEMBL104022,P08253,,TWQZYQBXMVVVCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16392792,IC50,=,0.7,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329820,DTCT0025094,1880216,DTCC00273200,423989,20214
CHEMBL10431,P08253,,SBPZKNUSQCPAAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,28,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,954775,DTCC00138456,2015345,16645
CHEMBL104446,P08253,,BMPCLJPYXFVWKY-ARLHGKGLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,441,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1194608,DTCC00273526,1228796,16385
CHEMBL10454,P08253,,UXURFMZZZWZYFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,936724,DTCC00138391,693756,16645
CHEMBL10454,P08253,,UXURFMZZZWZYFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,12.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1321636,DTCC00138391,578578,16328
CHEMBL104599,P08253,,XOOXBIFEOHDRHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,1.6,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1398101,DTCC00273602,1564726,16392
CHEMBL10469,P08253,,TZGXQAYCVFGRLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,175,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,936720,DTCC00138421,1695954,16645
CHEMBL104722,P08253,,CQIQKDQFHVTTKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1385697,DTCC00273620,659487,16392
CHEMBL10492,P08253,,YUOAPDQYFOIVNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,661,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,964047,DTCC00138706,1695957,16645
CHEMBL105142,P08253,,FCYBWLNLMVDLRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,53,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1401769,DTCC00273509,1207889,16392
CHEMBL105279,P08253,,ACXYSVKNGLLDLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,3.78,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1369047,DTCC00273107,1500350,16392
CHEMBL105311,P08253,,SWRNCXLTVBBIMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1402982,DTCC00274052,205240,16392
CHEMBL105422,P08253,,AXBFSSCCVFPFFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1371781,DTCC00273155,1079676,16392
CHEMBL105535,P08253,,SSFOEYVZLXDDTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,6.3,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1384506,DTCC00273105,659486,16392
CHEMBL10590,P08253,,ZSZSGGNFCMWYDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,46,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,950660,DTCC00138558,403686,16645
CHEMBL105962,P08253,,ZPNXAVJYHSAOKF-SJBAFXMYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,16.2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1200049,DTCC00273570,389552,16385
CHEMBL106016,P08253,,MMOBDSFVSOBMOV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,1.2,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1389489,DTCC00273742,335997,16392
CHEMBL10646,P08253,,PTRUGAYWWQMKAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,100,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,956227,DTCC00138654,822791,16645
CHEMBL10655,P08253,,KMBQQDDLWIEVKL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,16,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,947003,DTCC00138617,1949640,16645
CHEMBL10671,P08253,,UMBHCIONUFCHIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,952149,DTCC00138613,403685,16645
CHEMBL10672,P08253,,HSFOMBDSDMOJCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,957552,DTCC00138695,34638,16645
CHEMBL10673,P08253,,ZCJYXMGAZICHPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,953640,DTCC00138696,1695956,16645
CHEMBL10674,P08253,,AXDNELHYOHIRLD-MIHMCVIASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,952153,DTCC00138552,822792,16645
CHEMBL106889,P08253,,HECCDGMGLZRKDV-XWUOBKMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,32000,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,,Bioorg. Med. Chem. Lett.,1997,7,24,,,71649,DTCT0025094,1268921,DTCC00276363,788306,2375
CHEMBL10760,P08253,,XHIUPZBXQZTGTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,1475,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,975193,DTCC00138621,34636,16645
CHEMBL10761,P08253,,FFHXMPKAWWFPSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,964043,DTCC00138622,564527,16645
CHEMBL1077203,P08253,,CNUCYIDHDPTDOD-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20172725,KI,=,1208,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery and SAR of hydantoin TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,6,"Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C, Feltz RJ, Girijavallabhan VM, Kim SH, Kozlowski JA, Lavey BJ, Li D, Lundell D, Niu X, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Sun J, Tong L, Umland S, Wong MK, Yang DY, Zhou G",,615264,DTCT0025094,3227033,DTCC00631173,1104573,38167
CHEMBL1078396,P08253,,PIEMRKVLYXWKFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20172725,KI,=,4599,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery and SAR of hydantoin TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,6,"Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C, Feltz RJ, Girijavallabhan VM, Kim SH, Kozlowski JA, Lavey BJ, Li D, Lundell D, Niu X, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Sun J, Tong L, Umland S, Wong MK, Yang DY, Zhou G",,615264,DTCT0025094,3227032,DTCC00631942,1232705,38167
CHEMBL10792,P08253,,LQLNFJVHRIWFTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,158,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,939389,DTCC00138714,1308274,16645
CHEMBL10806,P08253,,DPNFTGXQMOIHKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,104,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,961569,DTCC00138724,1081840,16645
CHEMBL10809,P08253,,GCCFOYRWIAVTCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,17,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,962732,DTCC00138658,1755790,16645
CHEMBL10822,P08253,,HCOFTHTVAIHKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,1480,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,936716,DTCC00138431,467502,16645
CHEMBL1082314,P08253,,QJQSFVGRKOULTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346144,DTCC00647778,230222,35540
CHEMBL1082317,P08253,,QOWJHUFMPPFELP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346202,DTCC00647799,780673,35540
CHEMBL1082318,P08253,,HWZVYNMATDDRGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,6350,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346203,DTCC00647800,2038151,35540
CHEMBL1082319,P08253,,TWUHFGMOEBVGGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346204,DTCC00647801,878385,35540
CHEMBL1082324,P08253,,ISXZSJVTKFNYSR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346136,DTCC00647701,1330912,35540
CHEMBL1082325,P08253,,XFAVBLSYPFKCGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,7300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346138,DTCC00647703,1654393,35540
CHEMBL1082370,P08253,,XZDDXHHQKBWEQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345316,DTCC00647469,954160,35532
CHEMBL1082371,P08253,,PYJCXRBSZSSHDD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,505,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345317,DTCC00647470,2049561,35532
CHEMBL1082381,P08253,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.33,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14742625,DTCC00031197,2108114,69259
CHEMBL1082381,P08253,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,0.33,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3346097,DTCC00031197,792376,35532
CHEMBL1082381,P08253,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.33,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005931,DTCC00031197,781480,45214
CHEMBL1082381,P08253,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,0.33,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936620,DTCC00031197,799452,44425
CHEMBL1082645,P08253,,LZVLSPCMSRJJKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346155,DTCC00647831,1622137,35540
CHEMBL1082657,P08253,,BBYYDINTRXZVIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346141,DTCC00647775,165828,35540
CHEMBL1082658,P08253,,SOPJLCCBZBCHFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,5500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346142,DTCC00647776,1298263,35540
CHEMBL108275,P08253,,FUWKALSZHXSYKK-DGPALRBDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,,,,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2),Not Determined,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101918,DTCT0025094,1020729,DTCC00283583,237806,1950
CHEMBL1082789,P08253,,CWKUARBGJRTUFB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,1750,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346154,DTCC00646734,230213,35540
CHEMBL1082966,P08253,,NHBOIMAIUCLQKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,21.1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345296,DTCC00647118,1051282,35532
CHEMBL1083007,P08253,,DDSDNLBIGCANQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345312,DTCC00647403,1822511,35532
CHEMBL1083030,P08253,,ZUERCGBCDFBAQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346133,DTCC00647616,1039529,35540
CHEMBL1083290,P08253,,IMRHHKFKEFFZON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346139,DTCC00647704,230221,35540
CHEMBL1083291,P08253,,BKCSZOHESJTBQU-HDICACEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346140,DTCC00647705,619470,35540
CHEMBL1083321,P08253,,DNPNWGZXJBALIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,3100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345313,DTCC00647404,1951711,35532
CHEMBL1083322,P08253,,FSVPEOOPDJVOOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345314,DTCC00647405,112725,35532
CHEMBL1083336,P08253,,KURIXYQCCHLXJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346134,DTCC00647617,1810676,35540
CHEMBL1083337,P08253,,YOEUGEBWOYBNPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,3500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346135,DTCC00647618,1939510,35540
CHEMBL1083584,P08253,,XSEREZCRIQFANN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,4500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346148,DTCC00646651,490568,35540
CHEMBL1083585,P08253,,DGNSDTQNQWONIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346150,DTCC00646653,1622116,35540
CHEMBL1083586,P08253,,FPRHOXXDKHGHSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,5600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346151,DTCC00646654,328385,35540
CHEMBL1083606,P08253,,BTDOGCFKKXBYKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346143,DTCC00647777,554962,35540
CHEMBL1083607,P08253,,PXTTXJDSBQDLQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346145,DTCC00647779,1939513,35540
CHEMBL1083609,P08253,,KWMLNYHZDJEOKG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20478708,INHIBITION,=,7.4,%,,,,,,,,,,,,,,Inhibition of MMP2 at 3 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635094,DTCT0025094,3350474,DTCC00647058,274642,39108
CHEMBL1083609,P08253,,KWMLNYHZDJEOKG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20478708,INHIBITION,=,19.6,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635093,DTCT0025094,3350473,DTCC00647058,274642,39108
CHEMBL1083609,P08253,,KWMLNYHZDJEOKG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20478708,INHIBITION,=,86,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635092,DTCT0025094,3350471,DTCC00647058,274642,39108
CHEMBL1083625,P08253,,HQIAPHYTAVZNQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,82,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345310,DTCC00647325,566621,35532
CHEMBL1083626,P08253,,HCEJOINDKHKFPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345311,DTCC00647326,1790044,35532
CHEMBL1083906,P08253,,HYKTXCHYRXFJMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,88,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345297,DTCC00647119,1665937,35532
CHEMBL1083907,P08253,,XFCISDUWYSMJOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345298,DTCC00647120,534358,35532
CHEMBL1083908,P08253,,INGMGORXRMQEAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,370,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345299,DTCC00647121,2081682,35532
CHEMBL1083918,P08253,,NBVVLRJKURZELV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20478708,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibition of MMP2 at 3 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635094,DTCT0025094,3350475,DTCC00647059,1277543,39108
CHEMBL1083918,P08253,,NBVVLRJKURZELV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20478708,INHIBITION,=,30,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 nM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635096,DTCT0025094,3350478,DTCC00647059,1277543,39108
CHEMBL1083918,P08253,,NBVVLRJKURZELV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20478708,INHIBITION,=,88,%,,,,,,,,,,,,,,Inhibition of MMP2 at 300 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635095,DTCT0025094,3350477,DTCC00647059,1277543,39108
CHEMBL1083931,P08253,,VGQUGXBRZGFKOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,32.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345306,DTCC00647257,824921,35532
CHEMBL1083932,P08253,,BADHAWRYSSJDAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345307,DTCC00647258,1472207,35532
CHEMBL1084024,P08253,,RWVGBBDAACKFOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,3600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346152,DTCC00646732,1717798,35540
CHEMBL1084206,P08253,,RMMYIAVIROFVLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,48.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345300,DTCC00647201,1697970,35532
CHEMBL1084207,P08253,,REXXRRWHIZEEBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345301,DTCC00647202,824919,35532
CHEMBL1084208,P08253,,QQPOIMHFFPBDQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,18.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345302,DTCC00647203,1727327,35532
CHEMBL1084209,P08253,,HBPYDCJRDHWDAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345303,DTCC00647204,1018809,35532
CHEMBL1084217,P08253,,GWRXKVPUXYYCMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345304,DTCC00647255,340233,35532
CHEMBL1084218,P08253,,UWCWCXPWHSKCKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,5.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345305,DTCC00647256,1854573,35532
CHEMBL1084220,P08253,,DPDYQDPIBOABCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345308,DTCC00647323,1886832,35532
CHEMBL1084221,P08253,,FNEPKOHTWFANAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345309,DTCC00647324,598800,35532
CHEMBL1084238,P08253,,UFKFLDDRYBWLPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,12.1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3346094,DTCC00647546,80529,35532
CHEMBL1084298,P08253,,ITQUODOQSFVYAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346153,DTCC00646733,490569,35540
CHEMBL1084509,P08253,,VCKIKUWRRCAZBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3346095,DTCC00647547,1601315,35532
CHEMBL1084510,P08253,,HMVRHAWMVBUIKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,5.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3346096,DTCC00647548,1375495,35532
CHEMBL10848,P08253,,QFUKIOJKDCKUGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,960226,DTCC00138628,1081839,16645
CHEMBL108494,P08253,,MBSMJAHZPVXQCK-HIGJEIRPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,>,15000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1704491,DTCC00282283,1196752,16424
CHEMBL108494,P08253,,MBSMJAHZPVXQCK-HIGJEIRPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,15000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457387,DTCC00282283,1210750,32556
CHEMBL10851,P08253,,GVUFJCREUUFMPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,547,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,936782,DTCC00138737,1146775,16645
CHEMBL1085257,P08253,,WVNVANHURONWTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346220,DTCC00647802,262531,35540
CHEMBL1085263,P08253,,JOMDWNBZLUPPTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,1750,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345318,DTCC00647471,1051285,35532
CHEMBL1085264,P08253,,ATIAZZHHFGJINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345319,DTCC00647472,80527,35532
CHEMBL1085562,P08253,,NJSDEGWKISRFRU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346146,DTCC00646649,878376,35540
CHEMBL1085563,P08253,,FQMDDNHJAAIYKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346147,DTCC00646650,1622115,35540
CHEMBL1085602,P08253,,XFIZGIIZTOASLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,23.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345295,DTCC00647043,1568775,35532
CHEMBL1085725,P08253,,ZAPMQYOCCLDIJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20478708,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of MMP2 at 3 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635094,DTCT0025094,3350476,DTCC00647060,405782,39108
CHEMBL1085725,P08253,,ZAPMQYOCCLDIJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20478708,INHIBITION,=,24,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,12,"Esteves MA, Ortet O, Capelo A, Supuran CT, Marques SM, Santos MA",,635092,DTCT0025094,3350472,DTCC00647060,405782,39108
CHEMBL1085748,P08253,,DNOKLXCRZPAPJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345320,DTCC00647545,112726,35532
CHEMBL1085787,P08253,,JKMQHCXIFJQOMJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346149,DTCC00646652,716359,35540
CHEMBL1085988,P08253,,ODGSTGNVDAZIJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529684,IC50,=,5400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634105,DTCT0025094,3345315,DTCC00647406,1212002,35532
CHEMBL1086379,P08253,,SAXMIJMROZDLCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20529685,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634117,DTCT0025094,3346137,DTCC00647702,911038,35540
CHEMBL10881,P08253,,WYTXTYOLYMMDCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,29,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,939393,DTCC00138674,403684,16645
CHEMBL10885,P08253,,WUKUJFFVJZRRNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,943129,DTCC00138648,34637,16645
CHEMBL1088878,P08253,,WMJKIJLFVOMJDF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3287145,DTCC00635636,2081582,38228
CHEMBL1089842,P08253,,YAYGKNVDBLFWFW-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3287133,DTCC00635634,1211870,38228
CHEMBL1089843,P08253,,MWMRJYLEVAWDDL-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,4.2,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3287139,DTCC00635635,1375373,38228
CHEMBL1090035,P08253,,BBUAWDNXWDAMGY-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,190,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3286029,DTCC00635487,566470,38228
CHEMBL1090283,P08253,,AKOBMMAQXVKOJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3286023,DTCC00635486,760177,38228
CHEMBL1090284,P08253,,KLOYCYLPVRADHA-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3286035,DTCC00635488,824786,38228
CHEMBL1090284,P08253,,KLOYCYLPVRADHA-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59812,DTCC00635488,807189,65811
CHEMBL1090647,P08253,,RLHOCYLKSSHKMW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3286047,DTCC00635564,792230,38228
CHEMBL10908,P08253,,GLFZNNLEMNMSQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,957557,DTCC00138721,1373409,16645
CHEMBL1092104,P08253,,MTDVSXPXWCWOED-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3287127,DTCC00635567,1310213,38228
CHEMBL109214,P08253,,PDKBAEDNMKVROV-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,440,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1718164,DTCC00282259,422410,16424
CHEMBL109239,P08253,,IKIPPVJMYSOQOD-GVAUOCQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,8.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1377684,DTCC00282987,291843,2897
CHEMBL109246,P08253,,IZXYSBTXZXSNBA-MZKRTTBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,110,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1398772,DTCC00282967,226309,2897
CHEMBL10935,P08253,,XFLXFAKGEAQTOI-MIHMCVIASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,31,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,949518,DTCC00138543,1242881,16645
CHEMBL109353,P08253,,JXHAGXRDZALSLG-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,500,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1716614,DTCC00282683,357026,16424
CHEMBL109358,P08253,,WRARKZOMOGNDCB-VWNXMTODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1030626,DTCC00283663,1818474,1950
CHEMBL1093689,P08253,,HOKBADYASDUFAM-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,390,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3287115,DTCC00635565,177119,38228
CHEMBL1093690,P08253,,XXZNXULRAJJTRV-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,190,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3287121,DTCC00635566,340097,38228
CHEMBL109438,P08253,,HXMCVMJQARWQIU-ZUKKLESISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,12,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1028259,DTCC00284144,336105,1950
CHEMBL10952,P08253,,MWPVYUMZDJJEOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,23,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,936778,DTCC00138640,1949638,16645
CHEMBL10953,P08253,,PMHIYNQSFXKIMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,33,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,941796,DTCC00138641,855708,16645
CHEMBL109579,P08253,,LEDMBBYIVRLZAS-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,450,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1713950,DTCC00282314,258563,16424
CHEMBL109596,P08253,,YLXVWRCBKXEQFD-BDTNDASRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,8.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1382741,DTCC00282942,193946,2897
CHEMBL109603,P08253,,JOKZNFFZUNYVMR-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,880,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1693270,DTCC00281761,2034295,16424
CHEMBL109655,P08253,,PDKBAEDNMKVROV-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,410,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1689447,DTCC00281762,2066041,16424
CHEMBL109670,P08253,,LCBDMDPQRIZWHQ-RSXGOPAZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,87,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1020726,DTCC00284035,820715,1950
CHEMBL109671,P08253,,XPMZVZSLPMEDJA-VEEOACQBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,58,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1018146,DTCC00283582,401605,1950
CHEMBL109706,P08253,,YLQBSSFZOXXRNR-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,33,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1397638,DTCC00282928,1456432,2897
CHEMBL109806,P08253,,JJTWETADXAELLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,80,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1709908,DTCC00281760,1871211,16424
CHEMBL109829,P08253,,PWMJELWPVMQEPL-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101916,DTCT0025094,1047960,DTCC00283940,141139,1950
CHEMBL109861,P08253,,BTMGFNYLYGWAKT-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,550,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1703222,DTCC00282336,1003340,16424
CHEMBL109910,P08253,,PPRCMDPOMBHOSF-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,94,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1036516,DTCC00284158,1175856,1950
CHEMBL11005,P08253,,ILNPRELUGQHUMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,297,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,941800,DTCC00138731,1631580,16645
CHEMBL110075,P08253,,VXEAQOOPZOMMSG-UHSQPCAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,60,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1047963,DTCC00283616,982501,1950
CHEMBL110153,P08253,,GCGWPKSFLVGEQR-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease 2 (MMP2) of human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102120,DTCT0025094,1380017,DTCC00282990,1871220,2897
CHEMBL110253,P08253,,BZHYFMBTEMWGNH-MVSFAKPFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,85,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1049335,DTCC00283939,1079791,1950
CHEMBL110527,P08253,,DOECLBQWTWHNID-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,22,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1375228,DTCC00106999,193948,2897
CHEMBL110696,P08253,,SGQBRJNZCHCINW-ARNLJNQMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,23,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1398768,DTCC00282953,583127,2897
CHEMBL110750,P08253,,WOIMZSMDPIJLFO-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,270,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1683056,DTCC00281785,518969,16424
CHEMBL110970,P08253,,WOIMZSMDPIJLFO-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,150,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1713942,DTCC00281754,1035753,16424
CHEMBL110991,P08253,,DTQSORRPTAWCFK-VXMNRCMCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,89,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1015646,DTCC00283637,1014852,1950
CHEMBL110997,P08253,,QQIBFLKIYAKNQM-BHYZAODMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,46,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1036519,DTCC00283545,1144731,1950
CHEMBL111017,P08253,,CVNQIEKSHLAVBX-NHKHRBQYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,578052,DTCC00285102,1935563,1951
CHEMBL111104,P08253,,AALOSJKQIIRSAO-ZRBLBEILSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,3.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1380021,DTCC00282940,1228896,2897
CHEMBL111179,P08253,,GINBTQGVSPUJLE-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,90,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1715089,DTCC00282652,389663,16424
CHEMBL111257,P08253,,JXHAGXRDZALSLG-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,140,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1696857,DTCC00282583,809139,16424
CHEMBL111450,P08253,,IIABJCHWKFZJBK-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,210,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1701964,DTCC00282684,291838,16424
CHEMBL111601,P08253,,PPRNBKQKXZPFHI-JOMNFKBKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,4400,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1016973,DTCC00283604,1723494,1950
CHEMBL111678,P08253,,WJWOJAKOSRCFKB-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,1870,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1688175,DTCC00282653,809140,16424
CHEMBL111736,P08253,,VYGKNAIULXUTGK-GVAUOCQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,3.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1401313,DTCC00282980,744763,2897
CHEMBL111798,P08253,,AAPPTEGQHHRRCP-NJNPRVFISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,1.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1387583,DTCC00282748,809145,2897
CHEMBL111856,P08253,,ZBRHTUMWSDPCMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15177439,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,104555,DTCT0025094,1496217,DTCC00287961,76527,6475
CHEMBL111856,P08253,,ZBRHTUMWSDPCMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317107,DTCC00287961,63119,67557
CHEMBL111856,P08253,,ZBRHTUMWSDPCMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,318169,DTCC00287961,63119,67557
CHEMBL11188,P08253,,NDCGWDYXJPEWRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,29,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,945722,DTCC00138717,1146774,16645
CHEMBL111975,P08253,,DEQRLFQPZJLTBQ-LMERMFHRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,6.1,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1043101,DTCC00283937,1371398,1950
CHEMBL112100,P08253,,ARJINTGTQBBVFK-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,64,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 1 uM.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101932,DTCT0025094,576096,DTCC00285128,357053,1951
CHEMBL112147,P08253,,XCJPWKHINIJNBZ-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,557443,DTCC00285793,938755,1951
CHEMBL112180,P08253,,MTAVQVITWBDOLI-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,86,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,552779,DTCC00285522,1164282,1951
CHEMBL112180,P08253,,MTAVQVITWBDOLI-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,86,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,583438,DTCC00285522,1165199,2023
CHEMBL112508,P08253,,OLFNQERWBAAFKD-DSPMFFIESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,350,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,546663,DTCC00285691,1618288,1951
CHEMBL112803,P08253,,RDCAEKWUGPXPHR-JBOQNHBVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,570,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,552776,DTCC00285368,162108,1951
CHEMBL112864,P08253,,NHZFPZSJJGPCJS-NHKHRBQYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,72,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101912,DTCT0025094,357041,DTCC00285373,1068101,1951
CHEMBL11306,P08253,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3.98,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258322,DTCC00139917,359207,24803
CHEMBL11306,P08253,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17719700,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510904,DTCT0025094,2438449,DTCC00139917,359575,30977
CHEMBL113234,P08253,,DEQRLFQPZJLTBQ-WEAWZCMZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,92,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1049338,DTCC00284348,433823,1950
CHEMBL113322,P08253,,DGFULAROBOKMBD-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,60,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,564680,DTCC00285573,583161,1951
CHEMBL113362,P08253,,DVZGEDWEZGPRNW-ZUKKLESISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.1,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1049332,DTCC00284347,885924,1950
CHEMBL113460,P08253,,SXKYEZPKHTUHRD-UTBBQBIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 1 uM.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101913,DTCT0025094,565724,DTCC00285374,162107,1951
CHEMBL114116,P08253,,PPHAWIZVVUURJO-OXQOHEQNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10052961,KI,=,10,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-2 (MMP-2), gelatinase-A",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104394,DTCT0025094,874374,DTCC00288870,1113109,15577
CHEMBL114116,P08253,,PPHAWIZVVUURJO-OXQOHEQNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104534,DTCT0025094,1084492,DTCC00288870,1100953,16063
CHEMBL114357,P08253,,ZFCJDZRVAOLEGY-ZTNFWEORSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,6600,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1443598,DTCC00287866,433860,16438
CHEMBL114673,P08253,,HZAXNPDJVFUGDS-SCSAIBSYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,KI,=,3000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104534,DTCT0025094,1075030,DTCC00288871,1489116,16063
CHEMBL114804,P08253,,VUKNURXXGDIFMO-ZTNFWEORSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,52,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1413778,DTCC00287203,917654,16438
CHEMBL114815,P08253,,SQQHSADBIVCBBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835701,DTCC00288372,1612260,53820
CHEMBL114878,P08253,,LCWWOMJWYGNKJF-IARZGTGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1322671,DTCC00286952,724080,16439
CHEMBL115082,P08253,,PUKQZUALFZRFQE-KKVAFCGZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,35000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1427166,DTCC00287445,1818512,16438
CHEMBL115189,P08253,,OCSMOTCMPXTDND-JKIOLJMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104374,DTCT0025094,1072592,DTCC00289405,1035817,16063
CHEMBL115263,P08253,,SOPDPCOBVSOXIM-ZDXQCDESSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,=,1867,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1309689,DTCC00287904,433861,16439
CHEMBL115460,P08253,,FOOIUOKCYUZPDW-YCLCTBJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12877590,IC50,=,34200,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 (MMP-2),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104373,DTCT0025094,1548441,DTCC00293174,1871336,17445
CHEMBL115653,P08253,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,KI,=,154,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104534,DTCT0025094,1065648,DTCC00288838,1839322,16063
CHEMBL115653,P08253,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,154,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,527936,DTCC00288838,1850867,13726
CHEMBL115712,P08253,,ZYIMYAJZHPOFQU-IVMMDQJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,1533,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1442405,DTCC00287104,917655,16438
CHEMBL115727,P08253,,MCSWSPNUKWMZHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10535384,DTCC00288787,1591034,48665
CHEMBL115774,P08253,,YQEMFOGNUTYMTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14711305,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,104396,DTCT0025094,1264835,DTCC00287265,336153,17924
CHEMBL115774,P08253,,YQEMFOGNUTYMTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16392792,KI,=,20,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329820,DTCT0025094,1880221,DTCC00287265,325923,20214
CHEMBL1160559,P08253,QUINALDIC ACID,LOAUVZALPPNFOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103901,DTCC00648701,183412,43205
CHEMBL1160685,P08253,CYCLOHEXANAMINIUM HYDROGEN (ISOBUTYLAMINO)CARBONYLPHOSPHONATE,JAOQWUBVSCNFML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1301424,DTCC00648810,401328,17838
CHEMBL1160686,P08253,,SPZJLPXBRLFGFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,30000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1302613,DTCC00648811,1273344,17838
CHEMBL1161012,P08253,,DLGBEGBHXSAQOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103082,DTCC00649095,1057326,43205
CHEMBL1162966,P08253,,YKGQQUOXWATGTB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,112000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266563,DTCC00650352,1231185,24949
CHEMBL1163444,P08253,,MLPHDUQOZKAGHK-KRXBUXKQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.31,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836388,DTCC00652632,1962738,53968
CHEMBL1163454,P08253,,DVEFFLBSEMHSOV-SOFGYWHQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1679.56,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836395,DTCC00652696,480716,53968
CHEMBL1163455,P08253,,MGXQKQSEWXXTPE-YCRREMRBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,3.42,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836394,DTCC00652754,416567,53968
CHEMBL1163867,P08253,,ZBVTYCHAECZWPS-SOFGYWHQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.11,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836387,DTCC00652627,706502,53968
CHEMBL1163869,P08253,,PXFQYERIXZVNLU-FNORWQNLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1820.53,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836389,DTCC00652629,1418673,53968
CHEMBL1164630,P08253,,HQSAGGSYGVYRMT-FNORWQNLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1873.02,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836386,DTCC00652630,803174,53968
CHEMBL1164826,P08253,4-HYDROXY-CINNAMANILIDE,YAGRPHZXEPGAOZ-DHZHZOJOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836365,DTCC00652814,123575,53968
CHEMBL1165106,P08253,,LAIQRLYWSPLUFU-WEVVVXLNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,3.55,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836391,DTCC00652694,1095001,53968
CHEMBL1165150,P08253,,QLFZPAXTWPSTQC-KRXBUXKQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.95,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836385,DTCC00652690,706503,53968
CHEMBL1165152,P08253,,PDBFFXOPMVKXDS-VQHVLOKHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.97,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836393,DTCC00652692,1929600,53968
CHEMBL1165241,P08253,,KFABJEHFICPFBB-SOFGYWHQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1721.82,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836392,DTCC00652693,1255979,53968
CHEMBL1165574,P08253,,OOOVNHOIFALTIZ-SOFGYWHQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.92,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836390,DTCC00652626,318271,53968
CHEMBL1165627,P08253,,AWFUHISUKJQLHQ-VQHVLOKHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.27,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836396,DTCC00652695,220269,53968
CHEMBL1169,P08253,AMINOSALICYLIC ACID,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103015,DTCC00290367,669653,43205
CHEMBL116944,P08253,,BLBHPKKKTVUSPA-ZFWWWQNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12877587,IC50,=,0.65,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (MMP-2),,Development of a water-soluble matrix metalloproteinase inhibitor as an intra-arterial infusion drug for prevention of restenosis after angioplasty.,J. Med. Chem.,2003,46,16,"Masuda T, Nakayama Y",,104371,DTCT0025094,1325409,DTCC00292720,1435874,17442
CHEMBL1169459,P08253,,DJFLQKKXERRBMK-UVMBWLQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,1900,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305105,DTCT0025094,1828970,DTCC00656861,271891,19718
CHEMBL117225,P08253,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,1790,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,573963,DTCC01742560,174043,4692
CHEMBL117225,P08253,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12877590,IC50,=,1790,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 (MMP-2),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104373,DTCT0025094,1551206,DTCC01742560,162203,17445
CHEMBL117225,P08253,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,1790,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457463,DTCC01742560,176034,32556
CHEMBL118497,P08253,,STDLDNSJNOVMBK-RDJZCZTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12877587,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (MMP-2),,Development of a water-soluble matrix metalloproteinase inhibitor as an intra-arterial infusion drug for prevention of restenosis after angioplasty.,J. Med. Chem.,2003,46,16,"Masuda T, Nakayama Y",,104371,DTCT0025094,1331807,DTCC00292723,917731,17442
CHEMBL119083,P08253,,IQXWFHDFTAZGNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103805,DTCC00298384,701897,43205
CHEMBL119647,P08253,,UFVLIVCXTIGACT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104016,DTCC00292472,540481,43205
CHEMBL120049,P08253,,HHJKMUMZRIIHIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,39,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1632995,DTCC00107516,917812,15919
CHEMBL120049,P08253,,HHJKMUMZRIIHIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,38.9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258468,DTCC00107516,909279,24803
CHEMBL1204013,P08253,,RUFCUNSVBIYRLT-CPLNNKCJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,506,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101227,DTCC00681531,910637,36106
CHEMBL120526,P08253,METHANANDAMIDE,SQKRUBZPTNJQEM-FQPARAGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,=,5,%,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 10 nM relative to control,,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494402,DTCT0025094,2595831,DTCC00297313,132088,32132
CHEMBL120526,P08253,METHANANDAMIDE,SQKRUBZPTNJQEM-FQPARAGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,=,10,%,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 10 nM relative to control,,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494408,DTCT0025094,2595838,DTCC00297313,132088,32132
CHEMBL120526,P08253,METHANANDAMIDE,SQKRUBZPTNJQEM-FQPARAGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,=,20,%,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 1 uM relative to control,,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494406,DTCT0025094,2595836,DTCC00297313,132088,32132
CHEMBL120526,P08253,METHANANDAMIDE,SQKRUBZPTNJQEM-FQPARAGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,=,25,%,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 1 uM relative to control,,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494412,DTCT0025094,2595842,DTCC00297313,132088,32132
CHEMBL120526,P08253,METHANANDAMIDE,SQKRUBZPTNJQEM-FQPARAGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,=,28,%,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 100 nM relative to control,,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494404,DTCT0025094,2595834,DTCC00297313,132088,32132
CHEMBL120526,P08253,METHANANDAMIDE,SQKRUBZPTNJQEM-FQPARAGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,=,33,%,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 100 nM relative to control,,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494410,DTCT0025094,2595840,DTCC00297313,132088,32132
CHEMBL120934,P08253,,YNOGLIGOUAHYJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,72000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1636617,DTCC00298635,1468303,15919
CHEMBL121188,P08253,TROPOLONE,MDYOLVRUBBJPFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,146000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096321,DTCC00298736,183415,43205
CHEMBL121188,P08253,TROPOLONE,MDYOLVRUBBJPFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,89,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103863,DTCC00298736,183415,43205
CHEMBL1213668,P08253,,BHVKXGWLKBNZIN-YYWHXJBOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,129000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435353,DTCC00688344,133576,40062
CHEMBL1213669,P08253,,AHKOKCMJYKTRIE-HWBMXIPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,18500,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435354,DTCC00688345,2005457,40062
CHEMBL1213670,P08253,,AASZTKIVNWYIER-HJOGWXRNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,121000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435355,DTCC00688346,1396082,40062
CHEMBL1213671,P08253,,HZMFVVWJWUHNEI-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,127000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435356,DTCC00688347,1717915,40062
CHEMBL1213672,P08253,,OAASGJCKICMUFQ-QKDODKLFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435357,DTCC00688348,555062,40062
CHEMBL1213731,P08253,,AHOYCYYSQHFBHB-AWCRTANDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,272000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435358,DTCC00688399,295854,40062
CHEMBL1213732,P08253,,PMJKBRZXTVTAAY-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,107000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435359,DTCC00688400,1810769,40062
CHEMBL1213733,P08253,,STOPHONVTFVVIO-UBHSHLNASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,155000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435360,DTCC00688401,846093,40062
CHEMBL1213734,P08253,,ZAPYCRBFYVMEME-MPGHIAIKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435361,DTCC00688402,361092,40062
CHEMBL1213735,P08253,,JWCWQSOKEXNPTA-ULQDDVLXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435362,DTCC00688403,2038248,40062
CHEMBL1213795,P08253,,ZWTMDRLIHVMAAH-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,22700,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435363,DTCC00688456,1363725,40062
CHEMBL1213796,P08253,,QUQWNLSXJHOAAX-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,315650,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435364,DTCC00688457,1717920,40062
CHEMBL1213797,P08253,,OCNDCFZDJQQEPE-ILXRZTDVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435366,DTCC00688458,2069991,40062
CHEMBL1213798,P08253,,UYZWRQUCKJSXPB-OLZOCXBDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,141000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435367,DTCC00688459,813128,40062
CHEMBL1214487,P08253,,TXRLXDLBKIZMDM-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,122000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435344,DTCC00689074,1622255,40062
CHEMBL1214541,P08253,,RTQYBLYVTVUTKN-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435345,DTCC00689122,328502,40062
CHEMBL1214542,P08253,,GMWOIXHXLHBKSC-ICSRJNTNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,8270,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435346,DTCC00689123,1939637,40062
CHEMBL1214543,P08253,,JEQZLTRYTKQZEH-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,60400,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435347,DTCC00689124,1654501,40062
CHEMBL1214544,P08253,,QWCXCTYSOQJKRL-WMZOPIPTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,62700,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435348,DTCC00689125,911152,40062
CHEMBL1214590,P08253,,MPJWFQWKCYBJIT-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,71600,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435349,DTCC00125893,1428428,40062
CHEMBL1214591,P08253,,FWHRTJQKPZGSSY-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,131000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435350,DTCC00689167,1939638,40062
CHEMBL1214592,P08253,,XBRDFIWPISFORX-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,46900,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435351,DTCC00689168,1972803,40062
CHEMBL1214593,P08253,,RETPIOCFNJSBIJ-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,454000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435352,DTCC00689169,2038257,40062
CHEMBL121501,P08253,,CDRGZNIXJYUKQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,38000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1610014,DTCC00299141,238022,15919
CHEMBL121557,P08253,E637,YIKYNHJUKRTCJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,33,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103740,DTCC00298041,1445791,43205
CHEMBL121559,P08253,,XMJJPCJUQLGGND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,77000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1620367,DTCC00298606,950358,15919
CHEMBL121592,P08253,,YNYVAXYTOIAEND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,23000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1639318,DTCC00298632,691932,15919
CHEMBL121729,P08253,,UYGXLIUFUDWVHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,21000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1602502,DTCC00298661,1047445,15919
CHEMBL121916,P08253,,SUEBJDNLBVTIQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,82,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1629117,DTCC00299015,1564995,15919
CHEMBL121916,P08253,,SUEBJDNLBVTIQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,81.28,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258435,DTCC00299015,1555532,24803
CHEMBL122109,P08253,,XSOOLQYDISZIKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,14000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1608687,DTCC00298851,1500649,15919
CHEMBL1223007,P08253,,JHADKVOWWKZBNS-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20663669,INH,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651597,DTCT0025094,3456543,DTCC00691756,1310511,40340
CHEMBL1223075,P08253,,HGPPYGXNQCWPLJ-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20663669,INH,=,86,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651597,DTCT0025094,3456560,DTCC00691820,922026,40340
CHEMBL122651,P08253,,LEWMAZXEBPMBSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1630521,DTCC00298572,1435960,15919
CHEMBL122651,P08253,,LEWMAZXEBPMBSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,15.14,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258462,DTCC00298572,1426639,24803
CHEMBL122711,P08253,,ROMGJVVZNVJOPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,1.4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1613749,DTCC00298574,1500650,15919
CHEMBL122711,P08253,,ROMGJVVZNVJOPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,1.41,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258463,DTCC00298574,1491217,24803
CHEMBL122719,P08253,,ZHENEPVPETWBJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,3.7,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1629125,DTCC00299183,270685,15919
CHEMBL122719,P08253,,ZHENEPVPETWBJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,3.72,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258464,DTCC00299183,260720,24803
CHEMBL122831,P08253,,DUCBSHDQTBWWLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,3.7,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1634314,DTCC00299399,173533,15919
CHEMBL122831,P08253,,DUCBSHDQTBWWLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,3.72,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258452,DTCC00299399,164156,24803
CHEMBL122836,P08253,,UGZOJBSDACNWAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,1.4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1599883,DTCC00299434,2077808,15919
CHEMBL122836,P08253,,UGZOJBSDACNWAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,1.41,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258455,DTCC00299434,2068202,24803
CHEMBL122868,P08253,,MBKXTRZDNQFIJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,14000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1627953,DTCC00299111,303682,15919
CHEMBL122925,P08253,,FPJLTHNGOJRXMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,900,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1612447,DTCC00299110,530554,15919
CHEMBL122950,P08253,,LSHFFFVFHVCTTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,11000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1617698,DTCC00298794,465561,15919
CHEMBL1229516,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26871660,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 3 hrs by fluorometric assay,,Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.,Eur. J. Med. Chem.,2016,111,,"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.",,1559055,DTCT0025094,101494,DTCC00046206,581272,66304
CHEMBL1229868,P08253,SC-77774,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005967,DTCC00032045,781475,45214
CHEMBL123041,P08253,,IWTGCCHOUSDKHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,3.2,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1634306,DTCC00299582,38898,15919
CHEMBL123041,P08253,,IWTGCCHOUSDKHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,3.24,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258475,DTCC00299582,1716216,24803
CHEMBL123064,P08253,,RRPKGUUYTHFUPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,21000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1627945,DTCC00298793,595002,15919
CHEMBL123105,P08253,,HBZIAYRTJNOIOI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,15000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1611261,DTCC00299584,31106,15919
CHEMBL123167,P08253,,WWQRPJINVFSPDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,44,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1627913,DTCC00299223,853820,15919
CHEMBL123167,P08253,,WWQRPJINVFSPDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,43.65,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258480,DTCC00299223,844214,24803
CHEMBL12318,P08253,CLODRONIC ACID,ACSIXWWBWUQEHA-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17583333,IC50,=,145000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 1 hr,,"Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.",J. Med. Chem.,2007,50,15,"Sasanelli R, Boccarelli A, Giordano D, Laforgia M, Arnesano F, Natile G, Cardellicchio C, Capozzi MA, Coluccia M",,439902,DTCT0025094,2112262,DTCC00140920,1523158,23003
CHEMBL123233,P08253,,UIBGOVKOYKPDFL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,9000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1631612,DTCC00298759,2013481,15919
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,8.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650748,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,40,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650853,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,47,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650644,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,62,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646215,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,76,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247361,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,183179,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,76,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641792,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,181,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646319,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,565,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646423,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655433,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655549,DTCC00694177,1422152,64498
CHEMBL1232487,P08253,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655537,DTCC00694177,1422152,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,112,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646330,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,119,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650759,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,756,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247372,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,164602,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,756,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641803,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646434,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650655,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650864,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655444,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646226,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655538,DTCC00694178,484290,64498
CHEMBL1232489,P08253,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655550,DTCC00694178,484290,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1.92,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650840,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,144,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650841,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,410,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646410,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,684,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655420,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,872,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650735,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247452,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,166575,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247453,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,163667,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646202,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646203,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646306,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650632,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650736,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655421,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655524,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655554,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646307,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646411,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650631,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655525,DTCC00694179,1680179,64498
CHEMBL1232492,P08253,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655542,DTCC00694179,1680179,64498
CHEMBL1233506,P08253,SC-74020,YJNCFXPJICILOK-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640495,DTCC00032086,1642108,47642
CHEMBL123382,P08253,,CPWMZTRXCCYTDM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,84,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1630512,DTCC00298903,498461,15919
CHEMBL123382,P08253,,CPWMZTRXCCYTDM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,83.18,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258433,DTCC00298903,488945,24803
CHEMBL123404,P08253,,PORUPJYSNWMWCH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,65000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1631620,DTCC00299414,788555,15919
CHEMBL1234326,P08253,3-HYDROXYPICOLINIC ACID,BRARRAHGNDUELT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,58,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103230,DTCC00032094,1607385,43205
CHEMBL1234370,P08253,,CYYCSKFJEOSZTF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,2905,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1371836,DTCC00694384,1883251,15412
CHEMBL123443,P08253,,STWCTQDLUUVJMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,62,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1599875,DTCC00299356,562771,15919
CHEMBL123443,P08253,,STWCTQDLUUVJMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,61.66,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258434,DTCC00299356,553251,24803
CHEMBL123463,P08253,,SNYKGOMEURTYMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,0.9,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1610006,DTCC00299603,36667,15919
CHEMBL123463,P08253,,SNYKGOMEURTYMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,0.891,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258474,DTCC00299603,1716217,24803
CHEMBL123503,P08253,,DZFFLJXATZFATL-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,62,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,515823,DTCC00304831,1371678,13726
CHEMBL1235568,P08253,,XYEPUTZVZYUENX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,84,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103022,DTCC00694512,1283744,43205
CHEMBL123775,P08253,,DJASZHFLBWUJAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,0.7,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1625330,DTCC00299432,950355,15919
CHEMBL123775,P08253,,DJASZHFLBWUJAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,0.692,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258454,DTCC00299432,940925,24803
CHEMBL1241348,P08253,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20823284,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of human MMP-2 at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010,54,11,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724361,DTCT0025094,5125913,DTCC00126282,118904,43507
CHEMBL124237,P08253,,ACUCWGGAKLORQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,>,100000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1605170,DTCC00298788,1597483,15919
CHEMBL125104,P08253,,BHBDAWJEKOCFGP-TUSQITKMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,541126,DTCC00304856,627570,13726
CHEMBL125138,P08253,,UROHLDAMBMAOKL-DPSWKAHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,829,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,514820,DTCC00304556,1468365,13726
CHEMBL125302,P08253,,KZZHUKUOPGQIRQ-YSSFQJQWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,>,8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,514817,DTCC00304565,917876,13726
CHEMBL1255934,P08253,,SWELIMKTDYHAOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103754,DTCC00699570,1672007,43205
CHEMBL125901,P08253,,LAXIFXUCVNKYRQ-TZYHBYERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,176,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,513862,DTCC00304596,270760,13726
CHEMBL126380,P08253,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,541121,DTCC00304598,853893,13726
CHEMBL126380,P08253,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,63,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,536419,DTCC00304598,853891,13726
CHEMBL126380,P08253,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,849,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,518977,DTCC00304598,853892,13726
CHEMBL126461,P08253,,NOCFVGZKPITVEY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,0.06,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,533622,DTCC00304599,108960,13726
CHEMBL126711,P08253,,BOXAYSWQFMJSDX-OEOAZWSVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,514825,DTCC00304242,1500715,13726
CHEMBL126712,P08253,,DRINIAFHXKEERM-VDGAXYAQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,572,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,516917,DTCC00304243,205585,13726
CHEMBL126923,P08253,,UVAFSUYDCCCUTO-HRNNMHKYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,46,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,530744,DTCC00304832,820979,13726
CHEMBL126977,P08253,,CXRYZROMBCZZFO-IGKWTDBASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,537435,DTCC00304833,1241046,13726
CHEMBL127035,P08253,,IHWAKJKUYYZNCF-NDXORKPFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,517912,DTCC00304827,595069,13726
CHEMBL127138,P08253,,XJZZRJAENCZOAK-APTRMMRNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,530749,DTCC00304826,1047499,13726
CHEMBL127168,P08253,,GQVFUZHQNCWOMM-SSPYTLHUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,538390,DTCC00304825,1565048,13726
CHEMBL127559,P08253,,AKWUAHDLDRSRDC-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,76,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,522121,DTCC00304754,724286,13726
CHEMBL127787,P08253,,IYWLZQLIFMUDCK-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,383,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,521080,DTCC00304726,498524,13726
CHEMBL127867,P08253,,SPHCUXPEUQITEV-HARLFGEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,25,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,539253,DTCC00304547,530612,13726
CHEMBL1287851,P08253,,FYZPCUXRTDXRBF-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21106451,IC50,=,431,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel TNF-a converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseases.,Bioorg. Med. Chem. Lett.,2010,20,24,"Girijavallabhan VM, Chen L, Dai C, Feltz RJ, Firmansjah L, Li D, Kim SH, Kozlowski JA, Lavey BJ, Kosinski A, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Tong L, Wong MK, Yang DY, Yang L, Yu W, Zhou G, Guo Z, Orth P, Madison V, Bian H, Lundell D, Niu X, Shah H, Sun J, Umland S",,686065,DTCT0025094,3618669,DTCC00707887,40801,42108
CHEMBL129208,P08253,,ZXLDQJLIBNPEFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215411,DTCC00308105,1248206,33038
CHEMBL1299478,P08253,,SSLFSJSESOYTHY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215359,DTCC00710956,1639330,33038
CHEMBL1299980,P08253,,LKXOPRJGYYWDEI-VOTSOKGWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215481,DTCC00711408,1955127,33038
CHEMBL1302696,P08253,,JSFJGQDDHVRIDM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211246,DTCC00713872,210424,33038
CHEMBL1302889,P08253,,IAGOJVBNJCFBHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215368,DTCC00714048,246757,33038
CHEMBL1303333,P08253,,WSBFTODMEZTVBC-WNQIWMROSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,71200,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215492,DTCC00714453,1728112,33038
CHEMBL1305393,P08253,N-PHENETHYLCINNAMAMIDE,BOSUEWCVNFFBGV-VAWYXSNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.13,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836345,DTCC00032768,1708382,53968
CHEMBL1305574,P08253,,SXRPCRZFBUCPSR-LFPVQMOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219704,DTCC00716497,504810,33038
CHEMBL1306471,P08253,,GBDNDLPRUVYQTN-MUAVYFROSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215416,DTCC00717323,893379,33038
CHEMBL1306521,P08253,,DDCAEUZTHGGZME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215406,DTCC00717369,990156,33038
CHEMBL1306844,P08253,,JIYISGORSRKNKF-CPNJWEJPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215498,DTCC00717657,1956691,33038
CHEMBL1306897,P08253,,ZZNAEKUGXVDZFY-MOSHPQCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215517,DTCC00717704,1955618,33038
CHEMBL1307663,P08253,,IYYVRFBXLKMHJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219773,DTCC00718389,345341,33038
CHEMBL1308055,P08253,,LDXIDWXNUJDJMV-JMPIQFJJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215405,DTCC00718745,1376692,33038
CHEMBL1308195,P08253,,ZPWORYYJRHISSQ-NLRVBDNBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215435,DTCC00718874,2054474,33038
CHEMBL1309895,P08253,,JENMTPUZLVWREN-VMPITWQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,12000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215423,DTCC00720420,569744,33038
CHEMBL1313324,P08253,,LDIHFJPZWBYWJD-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215579,DTCC00723529,761199,33038
CHEMBL1313755,P08253,,JWXFOJJHFNTLGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215353,DTCC00723926,184978,33038
CHEMBL1315298,P08253,,LLWMARJKCJATFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211255,DTCC00725403,1574142,33038
CHEMBL1316089,P08253,,ZZVBYNZAKJETTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215366,DTCC00726183,214643,33038
CHEMBL1316472,P08253,,IMJBROUCGFXWLG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215525,DTCC00726561,1121614,33038
CHEMBL1317897,P08253,,YMZGZLNKZSHIQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215355,DTCC00727961,1121085,33038
CHEMBL1318608,P08253,,VTKAGANTFFZJAF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,23600,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219770,DTCC00728656,1638812,33038
CHEMBL1320535,P08253,,YFGBHHQSAHRQIB-IZZDOVSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215413,DTCC00730431,603340,33038
CHEMBL1320702,P08253,,AZOWITBRVMGBSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,27900,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215530,DTCC00730586,700388,33038
CHEMBL1325757,P08253,,JQGVKCPECJKJFX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215523,DTCC00735299,1508114,33038
CHEMBL1325818,P08253,,OVUKSXMFCJNVRB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,18800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215493,DTCC00735356,1117290,33038
CHEMBL1326271,P08253,,PDYYLYJPZRUTHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219750,DTCC00735771,280102,33038
CHEMBL1326349,P08253,,QFBNCPDZJWRRDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219776,DTCC00735844,1473577,33038
CHEMBL1327091,P08253,,SWSLEYJUZUJRMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215554,DTCC00736537,1505662,33038
CHEMBL1328104,P08253,,OEPSPKUXYVLHDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215479,DTCC00737473,1250386,33038
CHEMBL132928,P08253,,UIQCNEYBEDSLMK-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1038167,DTCC00318186,109128,6011
CHEMBL1329487,P08253,,QKKNIVQCIBWDPQ-JGEPBQDUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,64900,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215399,DTCC00738790,829717,33038
CHEMBL133028,P08253,,RNWQPFKNMGJQAE-OZXSUGGESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1025785,DTCC00318196,1818903,6011
CHEMBL1330588,P08253,METHYLTHIOURACIL,HWGBHCRJGXAGEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,26,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103812,DTCC00739824,896233,43205
CHEMBL133259,P08253,,HMHMTFRLVFSEQY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1024629,DTCC00317771,1630030,6011
CHEMBL1332854,P08253,,SDOFETOHPRCXKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219765,DTCC00741980,1728337,33038
CHEMBL1333181,P08253,,GOXBBIMCZQLBKU-YBEGLDIGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,42100,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215490,DTCC00742290,1344010,33038
CHEMBL1333858,P08253,,IHFNTDQDXPVXQM-QGOAFFKASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215441,DTCC00742932,1702823,33038
CHEMBL1334755,P08253,,YEXMVQCKWPWRLK-UITAMQMPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219758,DTCC00743776,411358,33038
CHEMBL1335064,P08253,,QBNICJNUNTZNOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,57200,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215351,DTCC00744069,1444172,33038
CHEMBL1336784,P08253,,FVSDJTXCXJYFEL-PUOZGBORSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215453,DTCC00745685,731211,33038
CHEMBL1336874,P08253,,VOGWUBKWORXULG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215504,DTCC00745769,148618,33038
CHEMBL1337267,P08253,,LDBAHXNHYNKYMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215581,DTCC00746136,84259,33038
CHEMBL1339485,P08253,,OUGDVSYSNSYHDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215363,DTCC00748200,1669638,33038
CHEMBL1340228,P08253,,KRRROLDQDLWUGG-WOSMYTDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215534,DTCC00748881,1182338,33038
CHEMBL1340766,P08253,,QFKJSQQSGRZHAG-RCCKNPSSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219738,DTCC00749369,113978,33038
CHEMBL1342085,P08253,,QNELIYOULMBGTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215555,DTCC00750548,1961039,33038
CHEMBL1342836,P08253,,RPPZKECJAPWGOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215352,DTCC00751219,698039,33038
CHEMBL1343166,P08253,,SXRPCRZFBUCPSR-KZZDLZNXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215415,DTCC00751520,1411112,33038
CHEMBL1343853,P08253,,VBNNAZYCENJPPE-HKWRFOASSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215571,DTCC00752154,570089,33038
CHEMBL1343966,P08253,,HMNVREUITHREJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219713,DTCC00752255,1212769,33038
CHEMBL1344023,P08253,,QFHWKOBKNPQMBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219714,DTCC00752304,699810,33038
CHEMBL1345800,P08253,,PHPXTASWTZTZAR-LFIBNONCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,45200,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219742,DTCC00753939,861248,33038
CHEMBL1345911,P08253,,HTIXQBYFKXIBJR-NTUHNPAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219717,DTCC00754042,1730329,33038
CHEMBL1346025,P08253,DNDI1417884,SJUNUJVHOPLROK-YBEGLDIGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219769,DTCC00032827,117298,33038
CHEMBL134640,P08253,,DTKRCIBCJDXQMT-FPOVZHCZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1024616,DTCC00318261,1723887,6011
CHEMBL1346724,P08253,,MMGDGLARAHHBQA-GQECEEOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,30900,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215454,DTCC00754783,1603869,33038
CHEMBL1347547,P08253,,YXJCCBPUJNOIPM-VOTSOKGWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219744,DTCC00755524,1412573,33038
CHEMBL1347610,P08253,,FMPMZUAARSQGKI-ATVHPVEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219786,DTCC00755580,1792455,33038
CHEMBL134782,P08253,,WKVGPQBRJBFDSN-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1024636,DTCC00318183,1786352,6011
CHEMBL1348946,P08253,,HOCWESIGOJJCOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,3940,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215598,DTCC00756800,85127,33038
CHEMBL134908,P08253,IM-491,RJSKOAOWDAMMHR-GMAHTHKFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1017093,DTCC01743223,1015228,6011
CHEMBL1350,P08253,TILUDRONIC ACID,DKJJVAGXPKPDRL-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,7200,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629974,DTCC00380285,609949,56259
CHEMBL1350299,P08253,,IZOBYAFWYHXWLU-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215494,DTCC00758052,406560,33038
CHEMBL1350703,P08253,,QPQCKWIATNPHEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215557,DTCC00758416,343708,33038
CHEMBL1351250,P08253,,GUYMXDPEPVWJPW-DHDCSXOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219731,DTCC00758905,1539169,33038
CHEMBL1351704,P08253,,KNCCBDFDBNPWBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219789,DTCC00759314,568924,33038
CHEMBL135177,P08253,,JFZMYYGJKATRJG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,496343,DTCC00318325,939099,6009
CHEMBL1351925,P08253,,GSXYOSZLTHUBLG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215367,DTCC00759506,1504971,33038
CHEMBL1352624,P08253,,OJLSHCIZPDKONY-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,97400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215466,DTCC00760148,1248516,33038
CHEMBL135448,P08253,,NODRUMNZQLWMFX-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1269078,DTCC00318421,141535,12304
CHEMBL1354909,P08253,,VHJWCYAHCSYBEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215436,DTCC00762256,1282888,33038
CHEMBL135499,P08253,,XKFUMWBMSCFOSW-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1044369,DTCC00318657,1662237,6011
CHEMBL135640,P08253,,YLFRNDPMRQUKDD-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,67,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1279221,DTCC00318281,336562,12304
CHEMBL135641,P08253,,XVGNAZNOVPHPDB-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,71,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1269075,DTCC00318282,465784,12304
CHEMBL135696,P08253,,CTQQHSLVVFZJEY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,498818,DTCC00318328,1650827,6009
CHEMBL135696,P08253,,CTQQHSLVVFZJEY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1033003,DTCC00318328,1662236,6011
CHEMBL135766,P08253,,KCZGFJPNYDYQHF-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1022176,DTCC00317823,982926,6011
CHEMBL1360824,P08253,,PSPVKQXDXRMMBG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215537,DTCC00767933,635613,33038
CHEMBL1361742,P08253,,HIZVFUNZHBQMHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215412,DTCC00768796,503301,33038
CHEMBL1361889,P08253,,VLTZONYFQFOYOS-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215473,DTCC00768934,1473751,33038
CHEMBL1362445,P08253,,AQTWMUUOCRXCPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,23000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219774,DTCC00769453,373253,33038
CHEMBL1362650,P08253,,GXEHDKDVKTUCMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215362,DTCC00769639,210828,33038
CHEMBL136353,P08253,,RFVBJRNTFIODDG-GMAHTHKFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1018277,DTCC00318993,1851030,6011
CHEMBL1363662,P08253,,HHQUFEDNFBTNMJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219726,DTCC00770586,893825,33038
CHEMBL1364454,P08253,,JZDNXUHZIKNIPX-SFQUDFHCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215497,DTCC00771331,2083083,33038
CHEMBL1364731,P08253,,QJVAMHASECCPSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219695,DTCC00771596,2018368,33038
CHEMBL1365706,P08253,,UNQIEGNMXFRSSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215514,DTCC00772507,2022656,33038
CHEMBL1366112,P08253,,ZIAHEDPZUGMZMM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219700,DTCC00772881,1985453,33038
CHEMBL1366289,P08253,,NCICBKOUGMFPRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219777,DTCC00773046,538209,33038
CHEMBL1367703,P08253,,UKTOGNNLSYPQFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211256,DTCC00774363,1891458,33038
CHEMBL1368601,P08253,,UHBIKXOBLZWFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,84,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103707,DTCC00775206,734154,43205
CHEMBL1369893,P08253,,DEXNORPUTBBNSC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,5910,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219722,DTCC00776436,1758938,33038
CHEMBL137013,P08253,,ZNCOVHFRMJEGMK-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1039505,DTCC00318972,1371830,6011
CHEMBL137065,P08253,,BPBXDIWULCWTST-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,=,1002,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1027093,DTCC00319115,2045980,6011
CHEMBL1371684,P08253,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22018790,ACTIVITY,=,97.6,%,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799330,DTCT0025094,7596128,DTCC00778134,283182,47025
CHEMBL1371684,P08253,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22018790,INHIBITION,=,19,%,,,,,,,,,,,,,,Inhibition of human MMP2 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799263,DTCT0025094,7596106,DTCC00778134,283182,47025
CHEMBL1371684,P08253,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25330343,INHIBITION,>,10,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using GRIGFL substrate up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435005,DTCT0025094,14018304,DTCC00778134,266421,60192
CHEMBL137297,P08253,,VVYSJNRLNVGHLZ-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1020896,DTCC00318978,109127,6011
CHEMBL137315,P08253,,XXYKPFAJBJFQQP-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1028417,DTCC00318846,141536,6011
CHEMBL137323,P08253,,AOAODEKDRRDLGQ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,=,476,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1031991,DTCC00318979,1145156,6011
CHEMBL137365,P08253,,DQLBBYKDXWLUIC-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,=,642,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1024621,DTCC00318937,854058,6011
CHEMBL137383,P08253,,KVBHIVSGXGLJKE-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,=,771,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1022181,DTCC00319054,369188,6011
CHEMBL137406,P08253,,PYZZBYJLLRVFDM-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,486621,DTCC00318806,1327341,6009
CHEMBL137468,P08253,,OARVSZIEJWIMBW-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1272414,DTCC00318921,205761,12304
CHEMBL1375551,P08253,,BSHOEHGZMWFMPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215491,DTCC00781798,1858585,33038
CHEMBL137646,P08253,,BZSVSBCWCXTKOM-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1029542,DTCC00319385,109126,6011
CHEMBL1376556,P08253,,NWWFZLKJMMYAGJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215522,DTCC00782723,995567,33038
CHEMBL13766,P08253,GUAIACOL,LHGVFZTZFXWLCP-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103167,DTCC00143437,798492,43205
CHEMBL137703,P08253,,QOGHJMHAONXOFF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1030749,DTCC00319034,756588,6011
CHEMBL137732,P08253,,RETDRIUBVHKDAA-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,=,1111,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1029537,DTCC00319086,692161,6011
CHEMBL1378569,P08253,,YMOBNKQXTQKQFD-GHRIWEEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,38700,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219719,DTCC00784587,1572271,33038
CHEMBL1378952,P08253,,YOFLBLOFOVCWEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,14800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215431,DTCC00784954,1541390,33038
CHEMBL1381264,P08253,,FOUCUCMUTILNFC-ZJMWYTODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,4490,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215389,DTCC00787021,1857073,33038
CHEMBL1381406,P08253,,FLRWWDKUWSLDGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,83500,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215437,DTCC00787145,1249754,33038
CHEMBL1381815,P08253,,LBLDMCQURLKTFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215545,DTCC00787523,1444549,33038
CHEMBL13826,P08253,,ZVSMTZWKNHRQHX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104545,DTCT0025094,764374,DTCC00143020,1837727,6676
CHEMBL1383972,P08253,,KIWJGDMDRPTPRV-QNGOZBTKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219745,DTCC00789488,955420,33038
CHEMBL1384373,P08253,,DRXXNHVPDYGFPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211247,DTCC00789849,441653,33038
CHEMBL1384550,P08253,,ITYHSNAOBNKVNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215379,DTCC00790012,1505420,33038
CHEMBL13849,P08253,,GUXHGWLTAOJOHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (No data),Not Determined,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104546,DTCT0025094,757991,DTCC00103659,256946,6676
CHEMBL1385587,P08253,,LAUNGOBYHDZBIA-ZSOIEALJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,81600,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219699,DTCC00790954,149721,33038
CHEMBL138594,P08253,,STALJGVVURZIBK-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1019669,DTCC00319390,1883178,6011
CHEMBL1387744,P08253,,WEZNDFHHRQIFQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211258,DTCC00792917,1477719,33038
CHEMBL1388156,P08253,,JPGIRCRTVGFEJQ-JJIBRWJFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215401,DTCC00793297,1987585,33038
CHEMBL13927,P08253,,SOGUXTBLQCIBBA-MZYLBHOOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104545,DTCT0025094,768327,DTCC00142930,1227361,6676
CHEMBL1393151,P08253,,HBNOSXCFGXWLCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,3680,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215561,DTCC00797787,2086508,33038
CHEMBL13965,P08253,,BDLOAWYPUGHWAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104545,DTCT0025094,750493,DTCC00142990,905349,6676
CHEMBL1396811,P08253,,AXGWJTOVBYCSDE-KSIBEGPGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215461,DTCC00801320,312695,33038
CHEMBL13974,P08253,,PTDAGIOFVRAOTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104545,DTCT0025094,767137,DTCC00142959,1999866,6676
CHEMBL1398357,P08253,,YIJQNOIBCXRURY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215427,DTCC00802827,1217291,33038
CHEMBL139884,P08253,,JGHZXBJPZQXVAB-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1384561,DTCC00325370,1176354,15412
CHEMBL139886,P08253,,YTCCTPYUECNUFO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,24,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1371831,DTCC00325371,821219,15412
CHEMBL140004,P08253,,GAQJSKIBXSLAJK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1385760,DTCC00325534,1145228,15412
CHEMBL140152,P08253,,TVNINFNNQVBJHI-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,1.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1390645,DTCC00326357,1080274,15412
CHEMBL1401522,P08253,,CIPNODLBEYNKGK-JXMROGBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215443,DTCC00805786,1246417,33038
CHEMBL1402117,P08253,,ZTAHCRBSESSJBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,16.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219697,DTCC00806345,1282149,33038
CHEMBL1403497,P08253,,WNSAVOLNDMMVNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1040,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219779,DTCC00807636,1379718,33038
CHEMBL1404120,P08253,,GTCVVJLHMBTZRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215508,DTCC00808222,634810,33038
CHEMBL140511,P08253,,XSWDEIOVOAQSMZ-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,6.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1383309,DTCC00325504,76971,15412
CHEMBL1405120,P08253,,VKWUUXGXNAKUIZ-DNKAYRMDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215422,DTCC00809137,375898,33038
CHEMBL140569,P08253,,PZPOCZWOYXDPDG-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,,,,,,,,,,,,,,,,,Inhibition of gelatinase-A (Matrix metalloprotease-2) (Not determined),Not Determined,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106806,DTCT0025094,1381931,DTCC00325327,31638,15412
CHEMBL1406738,P08253,,KKWMKNOWBWQMAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215564,DTCC00810644,895520,33038
CHEMBL140720,P08253,,BPNDGQNQHSBNOE-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,35,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1378201,DTCC00325470,563043,15412
CHEMBL140970,P08253,,CYYCSKFJEOSZTF-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,2.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1385753,DTCC00325595,692228,15412
CHEMBL1409822,P08253,,RHOVPAIIXAFCFZ-AQTBWJFISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215528,DTCC00813576,828396,33038
CHEMBL141080,P08253,,ULILDPSFFUSXJH-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,1.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1401844,DTCC00108095,821220,15412
CHEMBL1410870,P08253,,ZFRPXZSATDEAOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215529,DTCC00814575,1634734,33038
CHEMBL1410895,P08253,,PXPXXPJORACKKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,9510,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219752,DTCC00814599,2052970,33038
CHEMBL1411168,P08253,,VTWMBGNYXSQTBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215393,DTCC00814856,795991,33038
CHEMBL1411673,P08253,,YWBQLJPBFAEUSW-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,12700,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219732,DTCC00815339,1729014,33038
CHEMBL1412423,P08253,,VLCRZRLOWXCGKH-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,39700,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219778,DTCC00816054,1216498,33038
CHEMBL1414362,P08253,,ODTSUZRODNCQKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219739,DTCC00817901,275341,33038
CHEMBL141451,P08253,,GFDLNQRSUGRRNQ-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,4.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1386977,DTCC00325427,173833,15412
CHEMBL1414513,P08253,,JWYIVJUJWDLXNP-GFULKKFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219743,DTCC00818038,923000,33038
CHEMBL1416348,P08253,,CKEWJSWELSHRNM-ZSOIEALJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,33500,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215503,DTCC00819746,471001,33038
CHEMBL1418430,P08253,,KVFBUGRAAWCNBR-DTQAZKPQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215375,DTCC00821721,41688,33038
CHEMBL1420113,P08253,,BDJBMVCZLQHUDS-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219702,DTCC00823234,1052495,33038
CHEMBL1421745,P08253,,DTJUQPZHTMALSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219707,DTCC00824702,1856041,33038
CHEMBL1422472,P08253,,XUGLAAOALNPRSY-LFIBNONCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215387,DTCC00825363,1440831,33038
CHEMBL1422807,P08253,,PGMDZTMNDOBGFY-ATVHPVEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,9310,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215460,DTCC00825665,9242,33038
CHEMBL1425576,P08253,,PLQXOJCBVIRMCS-PTNGSMBKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211245,DTCC00828173,1569557,33038
CHEMBL1427330,P08253,,QQBRLUFHGDSFAQ-UITAMQMPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,15200,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215374,DTCC00829763,1919966,33038
CHEMBL1427458,P08253,,KUELMQAVLKNHFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21669521,IC50,=,50118.72,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Selective non zinc binding inhibitors of MMP13.,Bioorg. Med. Chem. Lett.,2011,21,14,"De Savi C, Morley AD, Ting A, Nash I, Karabelas K, Wood CM, James M, Norris SJ, Karoutchi G, Rankine N, Hamlin G, Macfaul PA, Ryan D, Baker SV, Hargreaves D, Gerhardt S",,754262,DTCT0025094,5996193,DTCC00829882,605884,45042
CHEMBL1427477,P08253,QUINOLINE-8-CARBOXYLIC ACID,QRDZFPUVLYEQTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103249,DTCC00032919,86518,43205
CHEMBL1427486,P08253,,OUZNLTMTXMVQLL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215394,DTCC00829905,1793465,33038
CHEMBL1427763,P08253,,VOMJABLLAXJBNQ-FXBPSFAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215507,DTCC00830166,1119982,33038
CHEMBL1428264,P08253,,RMOCZAYXRHRQBE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215599,DTCC00830633,1855604,33038
CHEMBL1428997,P08253,,BLSTVPWBRJQJEO-GNPCJPGPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,21200,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215365,DTCC00831300,1180503,33038
CHEMBL1429479,P08253,,SBMGYJWFXRUVER-JYRVWZFOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,3450,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215464,DTCC00831732,1475728,33038
CHEMBL1431851,P08253,,XRRODVCIARZPEN-YERBQUFUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,81600,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215472,DTCC00833907,795006,33038
CHEMBL1431909,P08253,,KVFQQUDPUDVEJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215465,DTCC00833957,41267,33038
CHEMBL1432,P08253,"2,3-DIHYDROXYBENZOIC ACID",GLDQAMYCGOIJDV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103014,DTCC00442073,540482,43205
CHEMBL1433,P08253,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17267227,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441978,DTCT0025094,2144959,DTCC00443319,370710,23207
CHEMBL1433,P08253,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19375915,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP2 gelatinolytic activity in human HT1080 cells at upto 60 ug/ml by gelatin zymography relative to control,Not Active,The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.,Bioorg. Med. Chem. Lett.,2009,19,10,"Mendis E, Kim MM, Rajapakse N, Kim SK",,578143,DTCT0025094,2884710,DTCC00443319,371915,34969
CHEMBL1433546,P08253,,XEUHZOUOUOKIRY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215551,DTCC00835473,959511,33038
CHEMBL1434377,P08253,,VCLWTTYTYNHNFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215421,DTCC00836290,182552,33038
CHEMBL143451,P08253,,FLJLPPYUZKFFLM-CMJOXMDJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,>,3000,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,726189,DTCC00333147,756748,17028
CHEMBL1434555,P08253,,LCYBVSOFHBBEEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,18400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215543,DTCC00836466,1827729,33038
CHEMBL1437190,P08253,,LTEVHNGJROBLSR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219746,DTCC00839050,507496,33038
CHEMBL1438210,P08253,,HFASLYFPYMGHFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215438,DTCC00840010,1923714,33038
CHEMBL1438370,P08253,,BESGEGPRGYRHQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215471,DTCC00840164,1603858,33038
CHEMBL1438503,P08253,,WGVLTEVDNJRKCG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215541,DTCC00840290,1729053,33038
CHEMBL1439933,P08253,,UFXRJYCYGSXGAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215569,DTCC00841629,991216,33038
CHEMBL1440,P08253,TETRACYCLINE,OFVLGDICTFRJMM-WESIUVDSSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17267227,IC50,=,220000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441978,DTCT0025094,2144955,DTCC00445351,34477,23207
CHEMBL144049,P08253,,ADBJQPXZUYOOEQ-VLIAUNLRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,<,2.8,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,699733,DTCC00333594,1176449,17028
CHEMBL144081,P08253,,UGIVRDOCHMXQLW-SZNDQCEHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,35,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,700976,DTCC00333593,1565398,17028
CHEMBL144176,P08253,,HPIJZAVGIHKGTA-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1635519,DTCC00332983,1586176,16049
CHEMBL1443088,P08253,,FRSALIPXDMWDSD-PTNGSMBKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215417,DTCC00844552,891266,33038
CHEMBL144320,P08253,,WTYPBULLPNGNTN-ASSNKEHSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,>,3000,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,722685,DTCC00333146,1786527,17028
CHEMBL1443805,P08253,,CTHWWNOHSNCVQW-DAXSKMNVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219729,DTCC00845200,1021060,33038
CHEMBL144430,P08253,,KUEURUPTKRCKAQ-QFBILLFUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1624030,DTCC00333938,616106,16049
CHEMBL1444386,P08253,,JMHSEWVRMMTIMI-SILNSSARSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215487,DTCC00845746,1311621,33038
CHEMBL144548,P08253,,AHGKFZKBVGBMPT-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,5812,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,723895,DTCC00333182,2046153,17028
CHEMBL1445488,P08253,,WRFNFMUNJVHPGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,821,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215425,DTCC00846772,309653,33038
CHEMBL1446094,P08253,,ONQBWENTOXHISF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219696,DTCC00847339,696559,33038
CHEMBL1447158,P08253,,LIFGQVFZCIHISM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,8140,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211254,DTCC00848332,1149882,33038
CHEMBL1448606,P08253,,XGRLRSQTHCDOKH-GDGARQCUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,94800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215532,DTCC00849708,829816,33038
CHEMBL145,P08253,CAFFEIC ACID,QAIPRVGONGVQAS-DUXPYHPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,24.26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833429,DTCC00163351,2060256,53968
CHEMBL1450813,P08253,,UVFSUSSIXDOCCM-XFXZXTDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215452,DTCC00851804,1991018,33038
CHEMBL1451107,P08253,,SDZMIZUXXRYOBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215572,DTCC00852083,41205,33038
CHEMBL145175,P08253,,ZZEIPXVXVCUKGA-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1607508,DTCC00333707,2034901,16049
CHEMBL1452158,P08253,,QNGVNLMMEQUVQK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211233,DTCC00853091,766052,33038
CHEMBL1452939,P08253,,JXYPJFKLYSPJET-LFIBNONCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,20000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215558,DTCC00853839,1409114,33038
CHEMBL1453126,P08253,DNDI1416969,WRUVTYDQVPMYDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215596,DTCC00032954,1985479,33038
CHEMBL1454680,P08253,,IVIHPZLBUDTFNS-VIZOYTHASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219787,DTCC00855493,1794721,33038
CHEMBL1458593,P08253,,DASSFVQGPUWYCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215538,DTCC00859134,989828,33038
CHEMBL145930,P08253,,ZEDSMYWEJHIELA-JOYOIKCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1606311,DTCC00333806,1257134,16049
CHEMBL1459808,P08253,,AWYFCSUVODLPDD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215420,DTCC00860244,700828,33038
CHEMBL145999,P08253,,CHCOTWNQXXEITG-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1616296,DTCC00333248,1133620,16049
CHEMBL1460470,P08253,,LCOYYIYBAKWSIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,2680,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215586,DTCC00860842,474395,33038
CHEMBL1460857,P08253,,DXYXVWWGEXIRHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219767,DTCC00861195,312424,33038
CHEMBL1460896,P08253,,AFWFDCXCYPHSSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219749,DTCC00861231,1986546,33038
CHEMBL1461,P08253,GENTISIC ACID,WXTMDXOMEHJXQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103760,DTCC00460344,1731965,43205
CHEMBL1461270,P08253,,LVMCWQAASILQEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,12700,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215378,DTCC00861562,212599,33038
CHEMBL1461524,P08253,,GZJBVAQVFHTCAD-QXMHVHEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215403,DTCC00861796,632534,33038
CHEMBL146289,P08253,,NOENPCOHNDAVLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,430,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,891474,DTCC00334082,1371999,6330
CHEMBL1463203,P08253,,VHAZJILCIAUTIA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,32700,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215414,DTCC00863321,2055095,33038
CHEMBL1464805,P08253,,UGICRKWJFNHPOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,8370,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215429,DTCC00864781,1182692,33038
CHEMBL146718,P08253,,RILFWDKQYPJIOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,886399,DTCC00333495,173918,6330
CHEMBL1467881,P08253,,HKRBAHHRDUTPHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211226,DTCC00867581,1441154,33038
CHEMBL1468383,P08253,,RYZZYWRGQJBHQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215426,DTCC00868038,1954067,33038
CHEMBL146896,P08253,,JRSHTLSUFIPCSG-BMIGLBTASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,4.8,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,715587,DTCC00333056,563126,17028
CHEMBL1469245,P08253,,QOKXCAGORAZEFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215588,DTCC00868829,1603580,33038
CHEMBL146951,P08253,,NACPMNMCCDZXLH-AJAMINHISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,49,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1621634,DTCC00333084,1553949,16049
CHEMBL147005,P08253,,JRJPXBUCHQFJHU-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1611278,DTCC00333055,1425118,16049
CHEMBL1470199,P08253,,ROLRTMFEEBDCDD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211241,DTCC00869685,1505494,33038
CHEMBL147107,P08253,,SESDSMKBCYCQSU-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1612505,DTCC00333406,1425117,16049
CHEMBL1471965,P08253,,FXTBDJDNPHEMMV-ZOQHSEBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219703,DTCC00871281,1505487,33038
CHEMBL1471990,P08253,,HLUGXSOUOOYBRE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219711,DTCC00871302,1604618,33038
CHEMBL147261,P08253,,UJUNISWMIDZDSX-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1617734,DTCC00333100,2066648,16049
CHEMBL1473121,P08253,,XYKOOESWACXXHW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,64600,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215385,DTCC00872362,863586,33038
CHEMBL1474528,P08253,,GWLZBXPQTKXSTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211232,DTCC00873749,1542462,33038
CHEMBL147489,P08253,,YVJXBWDNNWDVMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,76,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,881341,DTCC00333722,886509,6330
CHEMBL147489,P08253,,YVJXBWDNNWDVMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,0.076,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835697,DTCC00333722,900923,53820
CHEMBL147494,P08253,,HKQQBEWUPLWAAA-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1603813,DTCC00333020,325018,16049
CHEMBL147604,P08253,,XLTGYQNRFLYPNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,1099,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,885128,DTCC00334132,1436341,6330
CHEMBL147629,P08253,,CPBPQYOAJUZJNL-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1608699,DTCC00333768,1457038,16049
CHEMBL147804,P08253,,PQPJWKCPMXIWMW-HEHGZKQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1603794,DTCC00333935,5899,16049
CHEMBL147844,P08253,,UHNNTTJWQVSHSC-GZMMTYOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1603788,DTCC00333455,809739,16049
CHEMBL147881,P08253,,YVCCTHCWKOIESX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,878653,DTCC00333744,1339403,6330
CHEMBL147882,P08253,,PFIFGQWOKBQYID-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,874872,DTCC00333745,1113042,6330
CHEMBL147910,P08253,,LKSVLIAQUIGTTF-SCLBCKFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1617728,DTCC00333782,1489664,16049
CHEMBL1479139,P08253,,WTJDAIUHHYUASO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215575,DTCC00878157,1922020,33038
CHEMBL1480073,P08253,,HAUUEJYWPQJHCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215506,DTCC00879021,1506951,33038
CHEMBL1480262,P08253,,ICCGULWRUAXLTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215544,DTCC00879195,474387,33038
CHEMBL1480510,P08253,,HTJSHKHRSFPCAW-STZFKDTASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219733,DTCC00879422,1569587,33038
CHEMBL148081,P08253,,YCKAPRALLQTAKS-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1625361,DTCC00333857,1457037,16049
CHEMBL1481077,P08253,,UDLFNRJYXKFBGE-LDADJPATSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,29300,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215373,DTCC00879949,761004,33038
CHEMBL148118,P08253,,NIUYUCAJYPRIRB-ACJLOTCBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,701,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,697250,DTCC00333022,854230,17028
CHEMBL148120,P08253,,PTGMPWHDIULCAR-PMOQBDJRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,0.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1621629,DTCC00333934,1714821,16049
CHEMBL148136,P08253,,YNSHKUPPIHHCNP-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1605192,DTCC00333769,130093,16049
CHEMBL1481605,P08253,,NGVUEBALZWISSV-SCORJZKRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215591,DTCC00880437,891353,33038
CHEMBL1481627,P08253,,DRRLXWOFTBQDAV-ATVHPVEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215587,DTCC00880456,1441918,33038
CHEMBL148169,P08253,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,2050,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,697257,DTCC01743557,205947,17028
CHEMBL148169,P08253,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,2050,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153841,DTCC01743557,195837,23077
CHEMBL148169,P08253,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,=,2050,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101543,DTCC01743557,207226,22885
CHEMBL148169,P08253,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,2050,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457297,DTCC01743557,208203,32556
CHEMBL148171,P08253,,JOGYGVFUVCZABB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,27,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,877390,DTCC00334131,1851209,6330
CHEMBL148214,P08253,,AYFCYVLVRYQGME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,878662,DTCC00334130,1501033,6330
CHEMBL1482670,P08253,,BYQQNBDKRJXLHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215488,DTCC00881415,341360,33038
CHEMBL1482795,P08253,,FISZZIYIDXQPIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215566,DTCC00881537,1024286,33038
CHEMBL1482926,P08253,,DOMCPMYAFKEXJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219709,DTCC00881660,1823817,33038
CHEMBL148406,P08253,,VVZFBVIPGIVQRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,870993,DTCC00333693,1754320,6330
CHEMBL1484595,P08253,,PQAPIBDZDMDUOZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215396,DTCC00883221,1376382,33038
CHEMBL1484632,P08253,,ZHDWXPJAMSZVEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215397,DTCC00883256,1701206,33038
CHEMBL1486214,P08253,,SVAGCAFOMRRHDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215495,DTCC00884739,45777,33038
CHEMBL1486470,P08253,,AVKVIDQMZOSMPL-RIYZIHGNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,31100,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215565,DTCC00884979,2020871,33038
CHEMBL1487024,P08253,,LALCDJCLSWCKCF-UNOMPAQXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219783,DTCC00885503,1606305,33038
CHEMBL1491016,P08253,,OUYFSZNFCWTUFO-MHWRWJLKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215390,DTCC00889299,1826906,33038
CHEMBL1491272,P08253,,UAIHFEJUGDIRJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219723,DTCC00889538,1511523,33038
CHEMBL1492305,P08253,,WVXZZGALNSGPLY-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215584,DTCC00890521,1440658,33038
CHEMBL1492565,P08253,,NXVLUZVMQGFUFA-JLFKZYKSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,6290,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219692,DTCC00890770,957344,33038
CHEMBL1493011,P08253,,WCTMKYSKFWOZEY-YDFGWWAZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,302,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215354,DTCC00891187,957334,33038
CHEMBL149431,P08253,,DQXUWRWXYMJLHB-RIFZZMRRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1616292,DTCC00333949,162627,16049
CHEMBL1497338,P08253,,LOFHAVLBSWQMMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215370,DTCC00895196,1791139,33038
CHEMBL1497731,P08253,,MYOZOPXTSIPVMP-OBGWFSINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215468,DTCC00895557,604634,33038
CHEMBL1498705,P08253,,ZDIMPGUUXPFYAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211222,DTCC00896448,1890774,33038
CHEMBL149977,P08253,,OCZKLINSAMKTBK-PWDRBQJJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,504071,DTCC00340600,983146,15546
CHEMBL150077,P08253,,BKIYUSXBJJEODV-VQCBNXJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,491833,DTCC00340146,1662509,15546
CHEMBL1501577,P08253,,NUBQOILMKZCPGN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,22500,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215563,DTCC00899044,1759957,33038
CHEMBL1501743,P08253,,NXVLUZVMQGFUFA-SCORJZKRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,9070,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215600,DTCC00899199,667057,33038
CHEMBL150242,P08253,,USIBDKCJHKIPNX-VJOZSWGJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,493100,DTCC00340535,1274218,15546
CHEMBL1503793,P08253,,DMQCJSQWRZRAFU-RIYZIHGNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,968,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219766,DTCC00901070,1250141,33038
CHEMBL150386,P08253,,WUAZNNQUKKZSIX-HJNYFJLDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of human gelatinase A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,101922,DTCT0025094,997351,DTCC00340452,97895,1529
CHEMBL1504166,P08253,,LYPRZQFFNFKLBW-JXAWBTAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215402,DTCC00901412,243059,33038
CHEMBL150483,P08253,,YVUNEHSVUBACDW-SDLDRHLBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,483437,DTCC00340471,1694649,15546
CHEMBL1505300,P08253,,LCVNTDGCWYGYIW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,5790,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219747,DTCC00902449,1055179,33038
CHEMBL150628,P08253,,BVLFHPOFMVUZAF-GIVPXCGWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of human gelatinase A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,101922,DTCT0025094,992414,DTCC00340832,1586251,1529
CHEMBL150655,P08253,,SFESNYSPTLYJFZ-JYVXZMADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,482256,DTCC00340890,1915624,15546
CHEMBL150745,P08253,,MKKSGKUWQUXKAQ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,512678,DTCC00340182,304181,15546
CHEMBL1509380,P08253,,MUJZCKSGBHBTSD-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219761,DTCC00906155,506729,33038
CHEMBL1509590,P08253,,AUUPYCHYWBKMAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211239,DTCC00906351,1792463,33038
CHEMBL1509867,P08253,,RZNOUJVZRGPNED-CXUHLZMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215381,DTCC00906598,146526,33038
CHEMBL1509913,P08253,,BBRZYKRLSUTSMP-FXBPSFAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215391,DTCC00906636,1856016,33038
CHEMBL151,P08253,LUTEOLIN,IQPNAANSBPBGFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,3610,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534771,DTCC00171064,458853,48665
CHEMBL151,P08253,LUTEOLIN,IQPNAANSBPBGFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535487,DTCC00171064,458853,48665
CHEMBL151024,P08253,,WGVFUINCAVSVGT-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,500252,DTCC00340793,1694648,15546
CHEMBL151047,P08253,,BJHMYZYTJBIHAQ-PUHATCMVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,500,NM,,,,,,,,,,,,,,Inhibition of human gelatinase A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,101922,DTCT0025094,1003418,DTCC00340658,2002074,1529
CHEMBL1511181,P08253,,UKXAPHVPTGSURU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215595,DTCC00907787,1180753,33038
CHEMBL151133,P08253,,FIAWLFURFKPROF-RHTHQAGFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,502893,DTCC00340745,466055,15546
CHEMBL151235,P08253,,JBWUJRFOXXRXHG-LRHAYUFXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,500258,DTCC00340774,1948200,15546
CHEMBL151249,P08253,,PPHAWIZVVUURJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10052961,KI,=,60,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-2 (MMP-2), gelatinase-A",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104394,DTCT0025094,896421,DTCC00340767,1404525,15577
CHEMBL151539,P08253,,NVNGYUBMJMOHQL-RQNDZEIBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,475398,DTCC00340432,595467,15546
CHEMBL1515648,P08253,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22018790,ACTIVITY,=,84.7,%,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799330,DTCT0025094,7596129,DTCC00912100,185710,47025
CHEMBL1515648,P08253,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22018790,INHIBITION,=,26,%,,,,,,,,,,,,,,Inhibition of human MMP2 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799263,DTCT0025094,7596107,DTCC00912100,185710,47025
CHEMBL1515648,P08253,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25330343,INHIBITION,>,10,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using GRIGFL substrate up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435005,DTCT0025094,13947380,DTCC00912100,169412,60192
CHEMBL151591,P08253,,OJLWCTMBGWSVFC-FFFFSGIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,478971,DTCC00340536,271200,15546
CHEMBL151718,P08253,,WXUQPWYPRTYWIR-JVVDOCDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,476523,DTCC00340145,692419,15546
CHEMBL151741,P08253,,FGDQQAHGMHOQDV-NGXZDTIWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,19,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1382336,DTCC00344136,787756,14854
CHEMBL151741,P08253,,FGDQQAHGMHOQDV-NGXZDTIWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,KI,=,30,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104398,DTCT0025094,1112972,DTCC00344136,789075,4691
CHEMBL1518206,P08253,,NREFQBVXBYJUDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211235,DTCC00914519,1477547,33038
CHEMBL1518982,P08253,,AFXKEZWXXFZJDL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215386,DTCC00915239,1052377,33038
CHEMBL151975,P08253,,QSYNMGQKALWUKE-HJNYFJLDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,340,NM,,,,,,,,,,,,,,Inhibition of human gelatinase A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,101922,DTCT0025094,1008212,DTCC00340679,907736,1529
CHEMBL151996,P08253,,ZTJKUSGWPHJXES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10052961,KI,=,50,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-2 (MMP-2), gelatinase-A",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104394,DTCT0025094,858888,DTCC00340768,174000,15577
CHEMBL1520551,P08253,,AHXNCGUEOCEZLI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215449,DTCC00916705,1889374,33038
CHEMBL152104,P08253,,FGDQQAHGMHOQDV-WVQWTBLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,240,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1369660,DTCC00343439,172749,14854
CHEMBL152104,P08253,,FGDQQAHGMHOQDV-WVQWTBLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,KI,=,100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104398,DTCT0025094,1131338,DTCC00343439,174039,4691
CHEMBL1522018,P08253,,PNFZUCFQPLNPLV-OCFWRVAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215552,DTCC00918082,1506013,33038
CHEMBL152267,P08253,,DJWZYQPRHLAHAP-VAVYLYDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,26,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1110315,DTCC00343245,1436447,4691
CHEMBL152267,P08253,,DJWZYQPRHLAHAP-VAVYLYDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,25.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258378,DTCC00343245,1426642,24803
CHEMBL152277,P08253,,NXBDTIZSKZYBRI-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,335,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,570633,DTCC00344459,369477,4692
CHEMBL152531,P08253,,LYTGQQFBDSMLSD-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,15,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1121179,DTCC00343401,1694700,4691
CHEMBL152531,P08253,,LYTGQQFBDSMLSD-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,15.14,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258382,DTCC00343401,1684867,24803
CHEMBL1525735,P08253,,RWVUMQOYOPSNTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215455,DTCC00921547,279555,33038
CHEMBL152592,P08253,,VHDLIHHMSRFRJB-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,5.8,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1124752,DTCC00343895,206091,4691
CHEMBL152592,P08253,,VHDLIHHMSRFRJB-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,5.75,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258387,DTCC00343895,196123,24803
CHEMBL1526150,P08253,,XRXJJQVVKJZHGL-LICLKQGHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215510,DTCC00921944,341318,33038
CHEMBL152625,P08253,,BZZVTPZKPMXERH-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,30,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1118162,DTCC00343350,789076,4691
CHEMBL152625,P08253,,BZZVTPZKPMXERH-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,30.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258376,DTCC00343350,778989,24803
CHEMBL1526763,P08253,,NRIDPHPNVUPLOD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211257,DTCC00922525,1278753,33038
CHEMBL152769,P08253,,WVUNKWULDOXHJH-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,54,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1105006,DTCC00344238,1948249,4691
CHEMBL152769,P08253,,WVUNKWULDOXHJH-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,53.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258374,DTCC00344238,1937749,24803
CHEMBL152805,P08253,,RPEMCHYEPZNXLW-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,11,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1106407,DTCC00343384,756889,4691
CHEMBL152805,P08253,,RPEMCHYEPZNXLW-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,10.96,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258377,DTCC00343384,746929,24803
CHEMBL1528327,P08253,,JTHXKWOVBNJPJE-YWEYNIOJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211240,DTCC00924008,603207,33038
CHEMBL1528476,P08253,,CMOJFCJULDLNOC-JLHYYAGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219780,DTCC00924145,539404,33038
CHEMBL152855,P08253,,XJTUBPYIIOWNPG-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,3.4,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1102021,DTCC00343406,238524,4691
CHEMBL152855,P08253,,XJTUBPYIIOWNPG-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3.39,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258380,DTCC00343406,228497,24803
CHEMBL1528977,P08253,,PYMWSXIKOYZNSO-FMIVXFBMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215469,DTCC00924623,1087555,33038
CHEMBL1529328,P08253,,MHIZILWBZBKEHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215533,DTCC00924959,1117298,33038
CHEMBL1531824,P08253,,RTUHRLPKTRDLJO-VOTSOKGWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,45000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219691,DTCC00927306,763401,33038
CHEMBL1532025,P08253,,WYDALEWSLMNXDW-WQRHYEAKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,43000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211223,DTCC00927501,1638537,33038
CHEMBL1532097,P08253,DIHYDRODAPHNODORIN B,YXPCHLHMGOFXRA-DHGPJANISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,14110,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534773,DTCC00927565,717882,48665
CHEMBL1532097,P08253,DIHYDRODAPHNODORIN B,YXPCHLHMGOFXRA-DHGPJANISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535489,DTCC00927565,717882,48665
CHEMBL1532956,P08253,,LUNULWSLLIDRKH-LFIBNONCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,23800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215535,DTCC00928374,1376721,33038
CHEMBL1534006,P08253,,BWVQJXWDZCDJJJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,89000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215483,DTCC00929356,441815,33038
CHEMBL153446,P08253,,LYTGQQFBDSMLSD-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,110,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1119572,DTCC00343397,498975,4691
CHEMBL153446,P08253,,LYTGQQFBDSMLSD-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,109.65,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258381,DTCC00343397,488943,24803
CHEMBL153469,P08253,,AFJPLWPNTPTDED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10052961,KI,=,20,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-2 (MMP-2), gelatinase-A",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104394,DTCT0025094,870467,DTCC00340951,141810,15577
CHEMBL1535349,P08253,,GLXNVODYOHCEND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215582,DTCC00930601,473197,33038
CHEMBL1536896,P08253,,WBNVGVTYQBOUQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1040,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215480,DTCC00932034,1021040,33038
CHEMBL1537775,P08253,,MZTBDBIOXZFHSM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219771,DTCC00932833,795806,33038
CHEMBL1537781,P08253,,TZZRBHONFLVZSC-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219760,DTCC00932839,954966,33038
CHEMBL1537847,P08253,,IQHAXELCELAPMH-GHXNOFRVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219784,DTCC00932897,1758877,33038
CHEMBL1538250,P08253,,DXCQBPNWFCQNSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,20600,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215383,DTCC00933259,830727,33038
CHEMBL1538322,P08253,,JMWHBLVQIUCXPI-VRGAHVDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215398,DTCC00933318,503629,33038
CHEMBL153882,P08253,,LOAUOKWVGGODSI-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,1300,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,579453,DTCC00344509,1754436,4692
CHEMBL1538897,P08253,,NIABXQNAUHOSTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215531,DTCC00933837,344738,33038
CHEMBL153914,P08253,,XAHWTAYXASVGFG-BPUDTRNYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,0.38,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1106404,DTCC00343865,109423,4691
CHEMBL153914,P08253,,XAHWTAYXASVGFG-BPUDTRNYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,61.66,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258385,DTCC00343865,99393,24803
CHEMBL154040,P08253,,NKFQHGPGJWLOIN-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,920,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,573959,DTCC00344341,1819216,4692
CHEMBL154040,P08253,,NKFQHGPGJWLOIN-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113937,DTCC00344341,1808688,23023
CHEMBL154040,P08253,,NKFQHGPGJWLOIN-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710432,DTCC00344341,1821146,32223
CHEMBL154044,P08253,,FHLVTPHOAMUXFU-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,1,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,456816,DTCC00344483,918365,4692
CHEMBL1540680,P08253,,KTTGDCQTQWQTSC-IZZDOVSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215560,DTCC00935462,1279793,33038
CHEMBL1541480,P08253,,ITPWUSUCOBCXRZ-VMPITWQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215388,DTCC00936194,41937,33038
CHEMBL154169,P08253,,FCZUABNOVRUEJK-GSVBYQBUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,6800,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,550480,DTCC00344508,1598055,4692
CHEMBL1542128,P08253,,JKRNYSMGLKKINP-ULKQKBTCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,6340,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215542,DTCC00936794,1790645,33038
CHEMBL154215,P08253,,KMQAVDUVVBJBAN-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,38,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1126152,DTCC00344111,304231,4691
CHEMBL154215,P08253,,KMQAVDUVVBJBAN-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,38.02,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258373,DTCC00344111,294022,24803
CHEMBL154317,P08253,,JGLOGDIUSBZLOV-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,1,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1107768,DTCC00343839,1436446,4691
CHEMBL154317,P08253,,JGLOGDIUSBZLOV-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258391,DTCC00343839,1426641,24803
CHEMBL1543841,P08253,,WKXIDLGUGVAHTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215548,DTCC00938338,373734,33038
CHEMBL154440,P08253,,YWZDVYPIFZUSBG-FHPVIJFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,310,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,550477,DTCC00344325,402322,4692
CHEMBL1544407,P08253,,JZRACMMNONVYRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219710,DTCC00938842,1216037,33038
CHEMBL154551,P08253,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,61,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1131335,DTCC00344114,918356,4691
CHEMBL154551,P08253,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,61,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,576228,DTCC00344114,918363,4692
CHEMBL154551,P08253,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,0.38,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258386,DTCC00344114,909282,24803
CHEMBL154551,P08253,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,=,135,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113938,DTCC00344114,909001,23023
CHEMBL154551,P08253,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,=,135,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710430,DTCC00344114,920436,32223
CHEMBL1545689,P08253,,CKTIARXUFCVGMF-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215550,DTCC00940019,246056,33038
CHEMBL1545846,P08253,,QTCWNETWXOJNIB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215597,DTCC00940163,211893,33038
CHEMBL1545927,P08253,,BDDPXUZRHMQXHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219720,DTCC00940239,1920130,33038
CHEMBL1546767,P08253,,HDENPXAEIHEJHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,3260,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215456,DTCC00940996,81631,33038
CHEMBL1548574,P08253,,IKNRTONYGCGHRA-POHAHGRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,21200,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215347,DTCC00942620,1087161,33038
CHEMBL1548704,P08253,,DPBQSCCTZVVUPC-WJDWOHSUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,96000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211248,DTCC00942736,731497,33038
CHEMBL1548770,P08253,,SZESRDLHBLPEJF-LDADJPATSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,62400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215356,DTCC00942795,1118913,33038
CHEMBL1548928,P08253,,RZAYTPMYGDZHGH-LSCVHKIXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215392,DTCC00942940,1572238,33038
CHEMBL1549732,P08253,,CMIYMWHBLLWGMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215520,DTCC00943659,1763626,33038
CHEMBL1550553,P08253,,FHSZDGCXOARJMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219701,DTCC00944399,535663,33038
CHEMBL1552053,P08253,,KAYPYRGLYHVOCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215358,DTCC00945826,1606553,33038
CHEMBL1552672,P08253,,OOCLJYAMEFPTPK-OIQMFWTRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215372,DTCC00946429,117753,33038
CHEMBL1555215,P08253,,DDRGITLVHAAKQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211236,DTCC00948925,1413087,33038
CHEMBL1555317,P08253,,JLJROIXJDZGXLO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219755,DTCC00949025,1316061,33038
CHEMBL1556531,P08253,,PRGIOMDFWSHPTC-QPEQYQDCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,2320,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219759,DTCC00950167,2054521,33038
CHEMBL1556684,P08253,,PWUDMGKYHCIOTE-ZRDIBKRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211234,DTCC00950308,1728429,33038
CHEMBL1556780,P08253,,AQVOTCNNTOHWMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211229,DTCC00950397,1121686,33038
CHEMBL155815,P08253,,FGYWYFYJBJBYQH-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,625214,DTCC00350621,1339618,15057
CHEMBL155848,P08253,,DVIJGAWVVKJCSM-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,649725,DTCC00350492,2014126,15057
CHEMBL155862,P08253,,KJUQRHGKOLRTFD-HMEKMZBJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11266157,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,104385,DTCT0025094,640104,DTCC00349395,1489851,4704
CHEMBL1558644,P08253,,DFLRUMRQZKFKRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215524,DTCC00952142,1729439,33038
CHEMBL155874,P08253,,FUXIPODKBLQFAK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,621900,DTCC00350429,821520,15057
CHEMBL155874,P08253,,FUXIPODKBLQFAK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447066,DTCC00350429,835978,54747
CHEMBL155923,P08253,,QFYHJFQVDPPYCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,629619,DTCC00350500,821519,15057
CHEMBL155959,P08253,,NLDJVWRAKUUGKI-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,654242,DTCC00350758,499059,15057
CHEMBL1560,P08253,CAPTOPRIL,FAKRSMQSSFJEIM-RQJHMYQMSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617810,DTCC00507377,1074765,56109
CHEMBL1560147,P08253,,VLWIVWDZEUGVSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219712,DTCC00953549,796498,33038
CHEMBL1560833,P08253,,FSTMVTJCUXGKFP-AUWJEWJLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215467,DTCC00954184,1922305,33038
CHEMBL1564058,P08253,,ITLSBPKECBERDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211237,DTCC00957174,797414,33038
CHEMBL1564141,P08253,,DBOHWMPKJCJANT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215369,DTCC00957247,1922267,33038
CHEMBL1564638,P08253,,YNRINJTUILGZIP-YWEYNIOJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,20400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215559,DTCC00957710,1020885,33038
CHEMBL156614,P08253,,IHPHOLWJEHZAOF-VAVYLYDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,780,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1119578,DTCC00344237,1533557,4691
CHEMBL156614,P08253,,IHPHOLWJEHZAOF-VAVYLYDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,776.25,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258363,DTCC00344237,1523431,24803
CHEMBL156663,P08253,,FYHSMVNHGKEDAV-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,6200,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1115356,DTCC00344079,1208724,4691
CHEMBL156663,P08253,,FYHSMVNHGKEDAV-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,6165.95,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258367,DTCC00344079,1198920,24803
CHEMBL1566994,P08253,,PPYMPELJQZQIBQ-RMKNXTFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,2150,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219730,DTCC00959952,352490,33038
CHEMBL156830,P08253,,FLMHRETZLINTLJ-PCFFTZKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,11,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,562256,DTCC00344510,1883465,4692
CHEMBL1568373,P08253,,VDAFWRPJYTUQSM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215518,DTCC00961261,2025158,33038
CHEMBL1568803,P08253,,BYYOJQGOODCASN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219706,DTCC00961673,1987892,33038
CHEMBL1569092,P08253,,ZBDUBPPJQMBWPQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219757,DTCC00961948,441844,33038
CHEMBL1569215,P08253,,OJWXVAZPRPROLV-BOPFTXTBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,56700,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219740,DTCC00962066,2019797,33038
CHEMBL1569364,P08253,,HQTNHCWSJFYYHT-CYABFNOHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211244,DTCC00962201,1953031,33038
CHEMBL157048,P08253,,SLWFEUITEJIEHH-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,84,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1121182,DTCC00344073,174038,4691
CHEMBL157048,P08253,,SLWFEUITEJIEHH-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,83.18,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258372,DTCC00344073,164161,24803
CHEMBL1570668,P08253,,LCVZNVJJYXCTLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219735,DTCC00963427,1795876,33038
CHEMBL157112,P08253,,WTMNDZGXJUPIBE-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,1.3,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1098394,DTCC00343840,1241523,4691
CHEMBL157112,P08253,,WTMNDZGXJUPIBE-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1.29,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258388,DTCC00343840,1231165,24803
CHEMBL1571625,P08253,,UFKNVXBWMBITCM-XFFZJAGNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215512,DTCC00964336,1345492,33038
CHEMBL157163,P08253,,URGYPDKRIKINRO-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,62,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1130012,DTCC00343869,174037,4691
CHEMBL157163,P08253,,URGYPDKRIKINRO-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3.31,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258384,DTCC00343869,164160,24803
CHEMBL157243,P08253,,VAHNPPHUNSPFKI-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,647362,DTCC00350826,1819289,15057
CHEMBL157289,P08253,,ZMQMSFHTPLCGRT-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,642999,DTCC00350576,1372168,15057
CHEMBL157363,P08253,,OKLASKXZKFHVBH-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,652061,DTCC00350695,1048039,15057
CHEMBL1573804,P08253,,NSWHSMWSOLLMDJ-SDNWHVSQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215404,DTCC00966382,1509605,33038
CHEMBL1575767,P08253,,XUMNCGLQAXIZJU-MMPACVFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,947,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215478,DTCC00968173,957644,33038
CHEMBL157592,P08253,,ISEJBTOGHVVSRR-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,626301,DTCC00350525,174107,15057
CHEMBL1576310,P08253,BAS03450373,KQAQQNMXXWWOOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215590,DTCC00033082,1343948,33038
CHEMBL157704,P08253,,YLMQYIQDNAUTDZ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,625208,DTCC00350751,1468897,15057
CHEMBL157704,P08253,,YLMQYIQDNAUTDZ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,4.8,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447054,DTCC00350751,1483079,54747
CHEMBL157705,P08253,,JXFQCSDDKGGRKY-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,626303,DTCC00350752,304324,15057
CHEMBL1578629,P08253,,JLNRFAUBBLVMLV-PIIADTLSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215371,DTCC00970773,1730886,33038
CHEMBL1580600,P08253,,ODCLDVLYEJBJDW-MDWZMJQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215445,DTCC00972561,732964,33038
CHEMBL1580664,P08253,,ADZLYWUJKMMMLN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215470,DTCC00972619,538865,33038
CHEMBL1581048,P08253,,JQHGGNXOYQQDBA-NTCAYCPXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215574,DTCC00972968,148804,33038
CHEMBL158265,P08253,,ZXQRCQILIYTPOF-BEHPGTHXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11266157,IC50,=,38,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,104385,DTCT0025094,623450,DTCC00349425,1229760,4704
CHEMBL1583854,P08253,,NXFXYMZBTIUFQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215448,DTCC00975526,2022384,33038
CHEMBL158521,P08253,,XGTBMCGGGJLOPS-IFMALSPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,88000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894225,DTCC00354992,37673,35073
CHEMBL1586269,P08253,,UYEWDPJAFUDTGQ-UDWIEESQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,15600,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215556,DTCC00977718,535517,33038
CHEMBL158674,P08253,,XDOAIHGEJMOGJF-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,646289,DTCC00351214,1274349,15057
CHEMBL1587149,P08253,,HHFTZXSKANTTSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219705,DTCC00978522,185448,33038
CHEMBL1587502,P08253,,GXGGKRHOVUZRQG-JQIJEIRASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215360,DTCC00978819,503583,33038
CHEMBL158798,P08253,,UXRZVXKHVDNOPK-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,636339,DTCC00350948,1724284,15057
CHEMBL159013,P08253,,WUMGWKJNFKXXRX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,<,40,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,632934,DTCC00350734,1015610,15057
CHEMBL1590386,P08253,,PCGVSZRRVBOKJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215475,DTCC00981487,830192,33038
CHEMBL1591174,P08253,,JVECDXYYLCBMHQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,40400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215549,DTCC00982264,1638886,33038
CHEMBL1591691,P08253,,VTVHPFLNMAYJHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215446,DTCC00982772,863110,33038
CHEMBL159229,P08253,,DORIMXJPMPAGRK-VQAHOFKPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,649727,DTCC00351197,1339621,15057
CHEMBL159433,P08253,,BXDRTHBTGNNTEW-NHCUHLMSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,34000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894229,DTCC00354503,1535995,35073
CHEMBL1595376,P08253,,XFTKBXGWKFNSQN-NTCAYCPXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211224,DTCC00986339,535316,33038
CHEMBL1595766,P08253,,DQVJIYPIVMRRFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215419,DTCC00986698,2018486,33038
CHEMBL1596745,P08253,,AXOJXUIKVYEEHL-SKGSMITLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215384,DTCC00987611,244395,33038
CHEMBL1597650,P08253,,SIILNOLGPIOEMP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219748,DTCC00988447,697962,33038
CHEMBL1598236,P08253,,KPFUWROQPLANME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215450,DTCC00988983,146477,33038
CHEMBL1600901,P08253,,BNFAJCDPPMQCGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215521,DTCC00991475,470989,33038
CHEMBL160153,P08253,,CTGTUEAFFDISNJ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,622989,DTCC00350890,1080568,15057
CHEMBL1602055,P08253,,BRGAPCZLCVQROC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215553,DTCC00992551,2054184,33038
CHEMBL160232,P08253,,UYOKHXXMEWHQPZ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,6.7,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,624097,DTCC00350784,1145546,15057
CHEMBL160245,P08253,,KJEQWEFXIVEWJZ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,<,40,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,645183,DTCC00350785,238596,15057
CHEMBL160305,P08253,,LHTMZOJLNGMCKG-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,645177,DTCC00350470,2014127,15057
CHEMBL1604122,P08253,,PRCCJXJXZGPFRK-SDQBBNPISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,54800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219788,DTCC00994486,1023196,33038
CHEMBL1604247,P08253,,IWFRLNKPPPGCTA-FYWRMAATSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211243,DTCC00994605,1052005,33038
CHEMBL160465,P08253,,IQJYLIPOZQSCPF-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,<,40,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,642997,DTCC00351043,1786735,15057
CHEMBL1605425,P08253,,AVKVIDQMZOSMPL-ZSOIEALJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,82100,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219768,DTCC00995722,1700027,33038
CHEMBL160667,P08253,,PUJWEAOLJGFEFS-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,636342,DTCC00351060,1915722,15057
CHEMBL160712,P08253,,PECSXFVCAXHEGF-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,653068,DTCC00351216,174105,15057
CHEMBL160940,P08253,,UVXTZZTWBQFLQL-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,66,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,622986,DTCC00350934,402419,15057
CHEMBL160969,P08253,,ROOYIIGYFULNCM-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,34,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,639676,DTCC00351062,1339619,15057
CHEMBL1609744,P08253,,CARVHGXVWRHSRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211249,DTCC00999820,180447,33038
CHEMBL1610433,P08253,,UMAOLLLRFPHFBM-LGMDPLHJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215546,DTCC01000467,858576,33038
CHEMBL1610506,P08253,,XVPOJLRWFQRPTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,43400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215576,DTCC01000536,828222,33038
CHEMBL1610814,P08253,,YSQSLFIVXOKSGK-NTUHNPAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219763,DTCC01000829,1183064,33038
CHEMBL1612000,P08253,,GUNLMFXHJRNSJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219728,DTCC01001917,46049,33038
CHEMBL1612291,P08253,,JGEBSSTWEFAKAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211259,DTCC01002195,1793367,33038
CHEMBL1613540,P08253,,VQNITLUVCOFHPJ-VKAVYKQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215364,DTCC01003366,1635825,33038
CHEMBL1615187,P08253,,UAGAABCJKYADIR-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,>,6300,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145578,DTCC01003609,1940035,43649
CHEMBL1627009,P08253,LITHIUM ETHYL (CYCLOHEXYLAMINO)CARBONYLPHOSPHONATE,UNVAKRAJEPVVLT-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,30000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1288019,DTCC01014520,627063,17838
CHEMBL1649594,P08253,,PVQRWPNLEMQCSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,76000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096308,DTCC01022968,960351,43205
CHEMBL1649594,P08253,,PVQRWPNLEMQCSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104015,DTCC01022968,960351,43205
CHEMBL1650458,P08253,6-METHYLPICOLINIC ACID,LTUUGSGSUZRPRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-16,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103170,DTCC00033455,604860,43205
CHEMBL1650601,P08253,8-HYDROXYQUINOLINE 1-OXIDE,FJKUOCCQEBLPNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,62,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103887,DTCC00033473,1024885,43205
CHEMBL1650602,P08253,6-HYDROXYPICOLINIC ACID,VRCWSYYXUCKEED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-11,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104052,DTCC00033474,1731964,43205
CHEMBL1650603,P08253,6-BROMOPICOLINIC ACID,XURXQNUIGWHWHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103217,DTCC00033475,442587,43205
CHEMBL1650604,P08253,,PHQBKLKZIXCRIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-17,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103277,DTCC01022962,280902,43205
CHEMBL1650605,P08253,CLOPYRALID,HUBANNPOLNYSAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103072,DTCC01022963,1990718,43205
CHEMBL1650606,P08253,ISOQUINOLINE-1-CARBOXYLIC ACID,XAAKCCMYRKZRAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,42,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103350,DTCC00033476,798490,43205
CHEMBL1650607,P08253,PYRIMIDIN-2-OL,VTGOHKSTWXHQJK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,24,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103300,DTCC00033477,830994,43205
CHEMBL1650608,P08253,2-THIOURACIL,OVONXEQGWXGFJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,121000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096320,DTCC00033478,1860584,43205
CHEMBL1650608,P08253,2-THIOURACIL,OVONXEQGWXGFJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,89,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103949,DTCC00033478,1860584,43205
CHEMBL1650609,P08253,,RAFAYWADRVMWFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,55,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103895,DTCC01022964,1024886,43205
CHEMBL1650610,P08253,,PZVLJGKJIMBYNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103375,DTCC01022965,346294,43205
CHEMBL1650611,P08253,,STUQITWXBMZUGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103909,DTCC01022966,280898,43205
CHEMBL1650612,P08253,,BPSGVKFIQZZFNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103831,DTCC00127529,572604,43205
CHEMBL1650613,P08253,,UQFHLJKWYIJISA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103040,DTCC00127530,1478226,43205
CHEMBL1650614,P08253,,SHVCSCWHWMSGTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-7,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103275,DTCC01022967,1639739,43205
CHEMBL1650615,P08253,,GKLSXUGPECNEMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104014,DTCC01022969,1672008,43205
CHEMBL1650616,P08253,,KKEBDEYRNMMBPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,44,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103899,DTCC01022970,1413986,43205
CHEMBL1650617,P08253,,NFPVFWUVBGEVHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103894,DTCC01022971,378880,43205
CHEMBL1650618,P08253,,LIPRKYKMVQPYPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,66,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103884,DTCC01022972,1574896,43205
CHEMBL1650619,P08253,,YBBJKCMMCRQZMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104035,DTCC01022973,572605,43205
CHEMBL1650620,P08253,,SVOBTPSWHFSTQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104013,DTCC01022974,896235,43205
CHEMBL1650621,P08253,,SQEXIHSVVCJZTQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104012,DTCC01022975,798491,43205
CHEMBL1650622,P08253,,QJEZBSWVHDOAFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,60,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103889,DTCC01022976,572606,43205
CHEMBL1650623,P08253,,HMXGIMVMTIFQHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104011,DTCC01022977,1763873,43205
CHEMBL1650624,P08253,,XTMONGQRZFRDAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104010,DTCC01022978,1381650,43205
CHEMBL1650625,P08253,4-METHYLSALICYLIC ACID,NJESAXZANHETJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-17,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103769,DTCC00033479,1892888,43205
CHEMBL1650626,P08253,,TTZOLDXHOCCNMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-8,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103019,DTCC01022979,766406,43205
CHEMBL1650627,P08253,,KXZQYLBVMZGIKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104009,DTCC01022980,1185923,43205
CHEMBL1650628,P08253,"1,4,7-TRIAZONANE",ITWBWJFEJCHKSN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104008,DTCC00033480,1542780,43205
CHEMBL1650629,P08253,,RRXGRDMHWYLJSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,77,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103713,DTCC01022981,1122425,43205
CHEMBL1650630,P08253,,IQGMRVWUTCYCST-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,389000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096322,DTCC01022982,1445793,43205
CHEMBL1650630,P08253,,IQGMRVWUTCYCST-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103879,DTCC01022982,1445793,43205
CHEMBL1650631,P08253,,GHGZVWOTJDLREY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104047,DTCC01022983,1024888,43205
CHEMBL1650632,P08253,,MVVGSPCXHRFDDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103316,DTCC01022984,1607386,43205
CHEMBL1650633,P08253,,GSOHKPVFCOWKPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103165,DTCC01022985,1763874,43205
CHEMBL1650634,P08253,,GUARKOVVHJSMRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-11,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103687,DTCC01022986,1796211,43205
CHEMBL1650635,P08253,,VLRGXXKFHVJQOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-9,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103845,DTCC01022987,151277,43205
CHEMBL1650636,P08253,,FBDIICHZOKKYPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,8800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096305,DTCC01022988,1218150,43205
CHEMBL1650636,P08253,,FBDIICHZOKKYPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,>,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 25 uM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715240,DTCT0025094,5096324,DTCC01022988,1218150,43205
CHEMBL1650637,P08253,,ZPLJVEYEKBDFPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,7200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096307,DTCC01022989,1413987,43205
CHEMBL1650637,P08253,,ZPLJVEYEKBDFPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,>,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 25 uM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715240,DTCT0025094,5096325,DTCC01022989,1413987,43205
CHEMBL1650638,P08253,,OQFSPTGJLFPDPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,10800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096300,DTCC01022990,1349088,43205
CHEMBL1650638,P08253,,OQFSPTGJLFPDPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,>,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 25 uM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715240,DTCT0025094,5096326,DTCC01022990,1349088,43205
CHEMBL1650639,P08253,,DSEOOTRDYXCBEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,8400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096295,DTCC01022991,1413988,43205
CHEMBL1650639,P08253,,DSEOOTRDYXCBEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,>,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 25 uM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715240,DTCT0025094,5096327,DTCC01022991,1413988,43205
CHEMBL1650640,P08253,,YRWQAAZJYBIVRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,5600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096312,DTCC01022992,1574897,43205
CHEMBL1650640,P08253,,YRWQAAZJYBIVRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,>,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 25 uM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715240,DTCT0025094,5096328,DTCC01022992,1574897,43205
CHEMBL1650641,P08253,,BKXZTMSAOVCSDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096302,DTCC01022993,1763875,43205
CHEMBL1650641,P08253,,BKXZTMSAOVCSDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,>,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 25 uM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715240,DTCT0025094,5096329,DTCC01022993,1763875,43205
CHEMBL1650642,P08253,,MMPMIOYHRSNFRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,3900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096299,DTCC01022994,1990719,43205
CHEMBL1650642,P08253,,MMPMIOYHRSNFRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,>,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 25 uM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715240,DTCT0025094,5096330,DTCC01022994,1990719,43205
CHEMBL1650643,P08253,,MFMOJGSREDPDOD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,4300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5102615,DTCC01022995,1283747,43205
CHEMBL1650643,P08253,,MFMOJGSREDPDOD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,>,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 25 uM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715240,DTCT0025094,5096331,DTCC01022995,1283747,43205
CHEMBL1651842,P08253,,IEHSRERHOYOHOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,1,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066030,DTCC01024067,523282,42713
CHEMBL1651842,P08253,,IEHSRERHOYOHOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,45,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064902,DTCC01024067,523282,42713
CHEMBL1651842,P08253,,IEHSRERHOYOHOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,23,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066063,DTCC01024067,523282,42713
CHEMBL1651842,P08253,,IEHSRERHOYOHOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,23,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566512,DTCC01024067,543746,48923
CHEMBL1651843,P08253,,KPYDTDKHTIUCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,1.3,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066031,DTCC01024068,328820,42713
CHEMBL1651843,P08253,,KPYDTDKHTIUCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,19,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064903,DTCC01024068,328820,42713
CHEMBL1651843,P08253,,KPYDTDKHTIUCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,70,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066064,DTCC01024068,328820,42713
CHEMBL1651844,P08253,,GODQVOUTCHZIOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,1.3,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066032,DTCC01024069,1364047,42713
CHEMBL1651844,P08253,,GODQVOUTCHZIOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,38,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064904,DTCC01024069,1364047,42713
CHEMBL1651844,P08253,,GODQVOUTCHZIOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,34,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066065,DTCC01024069,1364047,42713
CHEMBL1651845,P08253,,IQVPMSHPSMKSIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,1.1,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066033,DTCC01024070,846384,42713
CHEMBL1651845,P08253,,IQVPMSHPSMKSIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,18,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064905,DTCC01024070,846384,42713
CHEMBL1651845,P08253,,IQVPMSHPSMKSIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,61,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066066,DTCC01024070,846384,42713
CHEMBL1651846,P08253,,LWHDLJDNHJFUSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,1.3,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066034,DTCC01024071,716794,42713
CHEMBL1651846,P08253,,LWHDLJDNHJFUSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,3.3,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064906,DTCC01024071,716794,42713
CHEMBL1651846,P08253,,LWHDLJDNHJFUSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,390,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066067,DTCC01024071,716794,42713
CHEMBL1651847,P08253,,BXWKQAHPQICDHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,0.4,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066035,DTCC01024072,198194,42713
CHEMBL1651847,P08253,,BXWKQAHPQICDHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,4.3,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064907,DTCC01024072,198194,42713
CHEMBL1651847,P08253,,BXWKQAHPQICDHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,90,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066068,DTCC01024072,198194,42713
CHEMBL1651848,P08253,,FDPYTWXXVNVJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,0.8,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066036,DTCC01024073,1137429,42713
CHEMBL1651848,P08253,,FDPYTWXXVNVJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,2.9,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064908,DTCC01024073,1137429,42713
CHEMBL1651848,P08253,,FDPYTWXXVNVJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,280,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066069,DTCC01024073,1137429,42713
CHEMBL1651849,P08253,,NMRGHYQXKHANMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,1.1,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066037,DTCC01024074,198195,42713
CHEMBL1651849,P08253,,NMRGHYQXKHANMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,4.5,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064909,DTCC01024074,198195,42713
CHEMBL1651849,P08253,,NMRGHYQXKHANMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066070,DTCC01024074,198195,42713
CHEMBL16520,P08253,RO-319790,QRXOZHSEEGNRFC-ZYHUDNBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,7.4,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,1000673,DTCC00147200,984635,15116
CHEMBL1668626,P08253,,YGGOSFPNPAAKEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23428964,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) up to 50 uM,Not Active,Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.,Bioorg. Med. Chem.,2013,21,7,"Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C",,951227,DTCT0025094,11846964,DTCC01025454,330824,54192
CHEMBL167302,P08253,,HCRZKUHDDTVHQM-GMTSZFNJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,608935,DTCC00362471,357955,2023
CHEMBL167705,P08253,,IEJUQNIPUKZOAL-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,470,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,459349,DTCC00362009,325341,2023
CHEMBL168150,P08253,,QAYDNEIOSCTECQ-QCNZEISBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,5.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,598609,DTCC00362047,1036632,2023
CHEMBL1683449,P08253,,KFGJNQLPIZMSFB-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,170,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145496,DTCC01029435,69400,43649
CHEMBL1683450,P08253,,UDTXDKDGZMYOBK-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,530,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145515,DTCC01029436,1137499,43649
CHEMBL1683451,P08253,,AFXZHRNVMMQHOL-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145520,DTCC01029437,1233395,43649
CHEMBL1683452,P08253,,JAPLGNWCNXCEJT-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145513,DTCC01029438,652502,43649
CHEMBL1683453,P08253,,JGAIDLBSMBNOAG-XDHUDOTRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145521,DTCC01029439,619987,43649
CHEMBL1683454,P08253,,IXKRFERDVUXQLW-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145493,DTCC01029440,1557705,43649
CHEMBL1683455,P08253,,AYZCFZMCYDMFMY-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,350,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145506,DTCC01029441,16131,43649
CHEMBL1683456,P08253,,HUWMGZNULSXXSW-PPHZAIPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,>,9100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145589,DTCC01029442,846445,43649
CHEMBL1683457,P08253,,NYJKRUFCTNREQN-LVXARBLLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,4200,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145537,DTCC01029443,1525647,43649
CHEMBL1683458,P08253,,SOTNGZPOQMJOPI-BVZFJXPGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145545,DTCC01029444,101600,43649
CHEMBL1683459,P08253,,PQEGPXRQOCZFEH-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,35000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145557,DTCC01029445,1746789,43649
CHEMBL1683460,P08253,,YAQNYFRHXMKRGE-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145526,DTCC01029446,684536,43649
CHEMBL1683461,P08253,,ICCQWMPCYVXIPA-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145523,DTCC01029447,328882,43649
CHEMBL1683462,P08253,,WTIUPHRWVGHPRH-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,2800,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145529,DTCC01029448,491087,43649
CHEMBL1683463,P08253,,SVXOKXGEZUGFFS-UUOWRZLLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145527,DTCC01029449,69401,43649
CHEMBL1683464,P08253,,BWHNAQMOABQLDB-BVZFJXPGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145499,DTCC01029450,911513,43649
CHEMBL1683465,P08253,,PDHFGTGPEOIGCF-SBUREZEXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21300546,IC50,=,26000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 assessed as substrate cleavage by measuring increase in fluorescence after 16 hrs,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,5,"De Savi C, Pape A, Cumming JG, Ting A, Smith PD, Burrows JN, Mills M, Davies C, Lamont S, Milne D, Cook C, Moore P, Sawyer Y, Gerhardt S",,726751,DTCT0025094,5145553,DTCC01029451,1718370,43649
CHEMBL1699206,P08253,,RUMPAMJMDBPTGC-MUFRIFMGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215410,DTCC01034140,1925693,33038
CHEMBL1701401,P08253,,RESAZCYZHZRIHJ-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,81800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215602,DTCC01036269,2088468,33038
CHEMBL1702964,P08253,,HQSZFBZWHLZCCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211251,DTCC01037786,281690,33038
CHEMBL1705518,P08253,,HCYYCTWKTBNBOC-WSDLNYQXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215511,DTCC01040273,1991487,33038
CHEMBL1706207,P08253,,RYFFZJHGQCKWMV-YUNKPMOVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,78400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215580,DTCC01040939,1764250,33038
CHEMBL1709846,P08253,,QUKKUCBDZCSTAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215500,DTCC01044448,1797110,33038
CHEMBL1709966,P08253,,DXRWFJPMOVCAIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215505,DTCC01044566,281575,33038
CHEMBL1710601,P08253,,QUDHHWSLEAGDEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215527,DTCC01045182,443416,33038
CHEMBL1711830,P08253,,GTEHDFYFQLMNHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219751,DTCC01046369,638198,33038
CHEMBL1717770,P08253,,QOPNBGVTLMPSKY-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,91800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215350,DTCC01052110,541328,33038
CHEMBL1719956,P08253,,YPQCRZPMQUCSOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215540,DTCC01054225,2088084,33038
CHEMBL1723045,P08253,,HFCWKDLNFWOGDQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215382,DTCC01057220,1414665,33038
CHEMBL1726180,P08253,,KTUSIHJVCYMLRJ-BOPFTXTBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,73800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219721,DTCC01060266,476184,33038
CHEMBL1726773,P08253,,PTZLIJWALDKNDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219734,DTCC01060842,1478899,33038
CHEMBL1727049,P08253,,MADPUBMBWHJZCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211228,DTCC01061108,1218669,33038
CHEMBL1727678,P08253,,OTUQBJVZQSQBAC-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211238,DTCC01061721,897077,33038
CHEMBL1730686,P08253,,TVHASYBZQSLFAU-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,85000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215577,DTCC01064629,961145,33038
CHEMBL173075,P08253,,LWBGXTORWSRDHX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,1300,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,970223,DTCC00372720,174400,4784
CHEMBL1738748,P08253,,FEOIBPWKGPFSTB-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,6309.57,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601160,DTCC01070791,800734,47049
CHEMBL174641,P08253,,FYEUWTVOOOULEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,59,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,959835,DTCC00375021,1404933,4784
CHEMBL175282,P08253,,KYTLMUVGULFASG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,868,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,953314,DTCC00374234,32720,4784
CHEMBL176467,P08253,,RTBMLCLTYAPKIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,81,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,970228,DTCC00374112,1662912,4784
CHEMBL176467,P08253,,RTBMLCLTYAPKIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,=,80,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800058,DTCC00374112,1651773,16433
CHEMBL176517,P08253,,NNRYJLARUIVRRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,9000,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,941523,DTCC00372839,434882,4784
CHEMBL176602,P08253,,KGUVBHLPMGERAT-NIYFSFCBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9888835,IC50,=,13.3,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease 2,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104380,DTCT0025094,1151837,DTCC00373473,2078653,15162
CHEMBL176832,P08253,,CQGUKDZSAPDCJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,21,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,959840,DTCC00374111,1209081,4784
CHEMBL176876,P08253,,RHCPIVUQTCESEP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,13000,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,968888,DTCC00372847,1787020,4784
CHEMBL1770157,P08253,,STMMWXRQAOVQNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,2.5,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936633,DTCC01080448,961249,44425
CHEMBL1770629,P08253,,IIBLNMYMPDUKOQ-HKDUHGGJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20638281,KI,=,43600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Structure and activity relationships of tartrate-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,16,"Li D, Popovici-Muller J, Belanger DB, Caldwell J, Dai C, David M, Girijavallabhan VM, Lavey BJ, Lee JF, Liu Z, Mazzola R, Rizvi R, Rosner KE, Shankar B, Spitler J, Ting PC, Vaccaro H, Yu W, Zhou G, Zhu Z, Niu X, Sun J, Guo Z, Orth P, Chen S, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Shipps GW, Siddiqui MA, Strickland CO",,748388,DTCT0025094,5959017,DTCC01080384,652661,44590
CHEMBL1770629,P08253,,IIBLNMYMPDUKOQ-HKDUHGGJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21458257,KI,=,43660,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744260,DTCT0025094,5930511,DTCC01080384,652615,44403
CHEMBL1770649,P08253,,PRUCBZGVKSTGBL-FPHUIIFBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21458257,KI,=,20500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744260,DTCT0025094,5930512,DTCC01080402,1266399,44403
CHEMBL1770697,P08253,,CLXRDURJLYSMHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,270,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936635,DTCC01080449,799451,44425
CHEMBL1770698,P08253,,RCSWIFOOANTXTQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936621,DTCC01080450,49638,44425
CHEMBL1770699,P08253,,WBIKMXRYXWFRCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936622,DTCC01080451,831943,44425
CHEMBL1770700,P08253,,MASDJPGVHCTFLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,550,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936623,DTCC01080452,1058218,44425
CHEMBL1770700,P08253,,MASDJPGVHCTFLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,550,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937663,DTCC01080452,1040141,44430
CHEMBL1770701,P08253,,OICBVOJTVMMIHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936624,DTCC01080453,314520,44425
CHEMBL1770702,P08253,,JNMYIRAUFFFDQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936625,DTCC01080454,1025844,44425
CHEMBL1770703,P08253,,KLRCKSDGEDNMNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,940,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936626,DTCC01080455,1186873,44425
CHEMBL1770704,P08253,,UKBSDNIYHDAZDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,650,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936627,DTCC01080456,767291,44425
CHEMBL1770705,P08253,,NVZOQOOLHGCJGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936628,DTCC01080457,638469,44425
CHEMBL1770706,P08253,,SJTWWQWUAQAYAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936629,DTCC01080458,87486,44425
CHEMBL1770707,P08253,,CADOQGNFDXDEHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936630,DTCC01080459,1829540,44425
CHEMBL1770708,P08253,,WWVWMBFCEZHXFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936631,DTCC01080460,1349992,44425
CHEMBL1770709,P08253,,PCOMQZCYLOTKTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936634,DTCC01080461,1349993,44425
CHEMBL1770710,P08253,,DZVDZJSJBKHJOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,170,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936636,DTCC01080462,1446682,44425
CHEMBL1770711,P08253,,WNBNYVCTXXPOJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936637,DTCC01080463,1414913,44425
CHEMBL1770712,P08253,,DLMROZSTEBHAOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21493063,IC50,=,6.6,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744869,DTCT0025094,5936638,DTCC01080464,1349994,44425
CHEMBL177077,P08253,,UXMLHHOBOIXMAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,530,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,937708,DTCC00372846,1404932,4784
CHEMBL1770826,P08253,,LOTUNSOIIWVNBG-JUJUEEDWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21458257,KI,>,40000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744260,DTCT0025094,5930513,DTCC01080561,749314,44403
CHEMBL1771212,P08253,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005941,DTCC00033985,1557982,45214
CHEMBL1771212,P08253,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937661,DTCC00033985,1557806,44430
CHEMBL1771213,P08253,,QCRPOQONCVCBFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937662,DTCC01080938,1040140,44430
CHEMBL1771214,P08253,,UIGGXLFLAQCMAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,IC50,=,48,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937664,DTCC01080939,134084,44430
CHEMBL1771215,P08253,,BNPWNBBKUMLEJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,410,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937665,DTCC01080940,361645,44430
CHEMBL1771216,P08253,,MTRATHZFTCSGDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,230,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937666,DTCC01080941,1233526,44430
CHEMBL1771217,P08253,,MMCUCOOPEAHRPL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937667,DTCC01080942,1040142,44430
CHEMBL1771218,P08253,,LIQFLIXIOKMDTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,400,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937668,DTCC01080943,1908020,44430
CHEMBL1771219,P08253,,VCIBNYPUVKINDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,410,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937669,DTCC01080944,975250,44430
CHEMBL1771220,P08253,,NVQGQIYFJRAZLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,410,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937670,DTCC01080945,1590129,44430
CHEMBL1771221,P08253,,JRPLACGAMSWTCU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,530,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937671,DTCC01080946,230822,44430
CHEMBL1771222,P08253,,FVPQYGSYGOKFLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,9200,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937673,DTCC01080947,1105335,44430
CHEMBL1771223,P08253,,UAFRGDNTZQMZFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21507637,KI,=,430,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744950,DTCT0025094,5937674,DTCC01080948,587727,44430
CHEMBL177740,P08253,,DDHOTWKNHXEMKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,19,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,961209,DTCC00374388,1404931,4784
CHEMBL1779630,P08253,,BXLWVAKSQMYQKF-HRUVVLKGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20638281,KI,=,1900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Structure and activity relationships of tartrate-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,16,"Li D, Popovici-Muller J, Belanger DB, Caldwell J, Dai C, David M, Girijavallabhan VM, Lavey BJ, Lee JF, Liu Z, Mazzola R, Rizvi R, Rosner KE, Shankar B, Spitler J, Ting PC, Vaccaro H, Yu W, Zhou G, Zhu Z, Niu X, Sun J, Guo Z, Orth P, Chen S, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Shipps GW, Siddiqui MA, Strickland CO",,748388,DTCT0025094,5959053,DTCC01085211,1875737,44590
CHEMBL178,P08253,DAUNORUBICIN,STQGQHZAVUOBTE-VGBVRHCVSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,780119,DTCC00413150,453026,11463
CHEMBL178163,P08253,,WKXRIMLOWDOHMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15686921,KI,=,1.8,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302479,DTCT0025094,1744904,DTCC00381624,130640,18787
CHEMBL1784338,P08253,,FUEVUWZQRYWTIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,61000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969355,DTCC01087874,1991668,44768
CHEMBL1784339,P08253,,NYSZVCQWENKRKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969356,DTCC01087875,1219147,44768
CHEMBL1784340,P08253,,ISHINUUQDKDNHQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,23000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969357,DTCC01087876,314584,44768
CHEMBL1784341,P08253,,DDRRRYMVRWYNKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970354,DTCC01087877,248843,44768
CHEMBL1784342,P08253,,OGDMRINQXHOSNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970355,DTCC01087878,1991670,44768
CHEMBL1784343,P08253,,XRFARLVFDBABAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970356,DTCC01087879,767362,44768
CHEMBL1784344,P08253,,DTSDNCVLJXFMRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970357,DTCC01087880,1732985,44768
CHEMBL1784345,P08253,,IIJIMCYNCLMHHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970358,DTCC01087881,184445,44768
CHEMBL1784346,P08253,,OUTUIYKUSHWASL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970359,DTCC01087882,1252217,44768
CHEMBL1784347,P08253,,IWRJDNKXMJBFEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970360,DTCC01087883,897249,44768
CHEMBL1784348,P08253,,JHWOJEJVRYYQFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970361,DTCC01087884,541502,44768
CHEMBL1784349,P08253,,CCTJPVSDIZDFJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,3800,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969351,DTCC01087885,1284804,44768
CHEMBL1784350,P08253,,PSAIRTKPKUWNNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970362,DTCC01087886,1284805,44768
CHEMBL1784351,P08253,,IHEWXNWFNBGUFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970363,DTCC01087887,1350068,44768
CHEMBL1784352,P08253,,YIKZSHOVCXXIBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970364,DTCC01087888,1704803,44768
CHEMBL1784353,P08253,,CAFLLFZUWQCIHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5970365,DTCC01087889,735158,44768
CHEMBL1784358,P08253,,VLNVWKDSFQRXHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969344,DTCC01087894,1543800,44768
CHEMBL1784359,P08253,,BZUGNOPIQMYMFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969345,DTCC01087895,184446,44768
CHEMBL1784360,P08253,,VYEJHVQIVKCLHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,3300,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969346,DTCC01087896,509332,44768
CHEMBL1784361,P08253,,STVUCRKRBAWCPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,3500,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969347,DTCC01087897,1186951,44768
CHEMBL1784362,P08253,,AWLKOGZBGNQOBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969348,DTCC01087898,1025922,44768
CHEMBL1784363,P08253,,DVWZDEQXQWWQOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,620,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969349,DTCC01087899,184447,44768
CHEMBL1784364,P08253,,IBSGSCYXBWXQDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969350,DTCC01087900,2024514,44768
CHEMBL1784365,P08253,,OFQBKLDPHHFEPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,=,7600,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969352,DTCC01087901,1861581,44768
CHEMBL1784366,P08253,,BTKROMQYNIJXLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969353,DTCC01087902,1317331,44768
CHEMBL1784367,P08253,,QVHFARCMIMVLSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21536437,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 assessed as substrate cleavage after 20 hrs by fluorescence assay,,Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2011,21,11,"De Savi C, Pape A, Sawyer Y, Milne D, Davies C, Cumming JG, Ting A, Lamont S, Smith PD, Tart J, Page K, Moore P",,751107,DTCT0025094,5969354,DTCC01087903,1446758,44768
CHEMBL178509,P08253,,TVKGACNFKXXAEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15686921,KI,=,1.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302479,DTCT0025094,1744344,DTCC00381771,227480,18787
CHEMBL179288,P08253,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15713379,IC50,=,0.09,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305733,DTCT0025094,1747880,DTCC00381940,1069270,18841
CHEMBL179288,P08253,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044558,DTCC00381940,1071500,35647
CHEMBL179288,P08253,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59813,DTCC00381940,1066000,65811
CHEMBL1795351,P08253,,YZKJTNXYLZWHHJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21514700,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753767,DTCT0025094,6000208,DTCC01091696,1893893,44948
CHEMBL1795857,P08253,,VZNWQFCLBMVARX-SSEXGKCCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21514700,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753767,DTCT0025094,6000215,DTCC01091697,1673074,44948
CHEMBL1795858,P08253,,ABUCHUKPMIVSQV-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21514700,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753767,DTCT0025094,6000222,DTCC01091698,638553,44948
CHEMBL1795859,P08253,,RSAGFYGPXOAVNX-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21514700,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753767,DTCT0025094,6000229,DTCC01091699,119860,44948
CHEMBL1795860,P08253,,YPLZYOZJLNQLST-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21514700,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753767,DTCT0025094,6000236,DTCC01091700,1640794,44948
CHEMBL1795861,P08253,,KGOHHLONXFWMRE-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21514700,IC50,=,2.5,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753767,DTCT0025094,6000243,DTCC01091701,1861595,44948
CHEMBL1795862,P08253,,OTEWYJZEFZRZKI-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21514700,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753767,DTCT0025094,6000250,DTCC01091702,767378,44948
CHEMBL179616,P08253,,DGZZVIWCMGVHGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15713379,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305733,DTCT0025094,1747769,DTCC00381916,487942,18841
CHEMBL1796298,P08253,,YNSKBMXZDCLQIV-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601129,DTCC01092132,1927204,47049
CHEMBL1797983,P08253,,UZZNWMWOBYWIST-SQOVJYTMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21714538,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.,J. Med. Chem.,2011,54,15,"Zhang Y, Fang H, Feng J, Jia Y, Wang X, Xu W",,768035,DTCT0025094,6100955,DTCC01093713,134448,45885
CHEMBL1798007,P08253,,CBAVAZZYVBNYMS-YZYNAAERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21714538,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.,J. Med. Chem.,2011,54,15,"Zhang Y, Fang H, Feng J, Jia Y, Wang X, Xu W",,768035,DTCT0025094,6100956,DTCC01093737,975581,45885
CHEMBL1798008,P08253,,QGRJCELBIMUQGG-BAURHKQJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21714538,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.,J. Med. Chem.,2011,54,15,"Zhang Y, Fang H, Feng J, Jia Y, Wang X, Xu W",,768035,DTCT0025094,6100957,DTCC01093738,620467,45885
CHEMBL1800089,P08253,,VMWGPLRCSWOQJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005946,DTCC01095116,1622971,45214
CHEMBL1801044,P08253,,XQXSQQVRMVVPJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005975,DTCC01094745,1557976,45214
CHEMBL1801045,P08253,,KOPIIXVBCHXDHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005974,DTCC01094746,1747121,45214
CHEMBL1801046,P08253,,HBYRXCFAHCMHAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14743568,DTCC01094747,2108425,69259
CHEMBL1801046,P08253,,HBYRXCFAHCMHAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005973,DTCC01094747,1364426,45214
CHEMBL1801047,P08253,,RDFQXFRQTOWZEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.35,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005972,DTCC01094748,1525962,45214
CHEMBL1801048,P08253,,PKAAOTCIUWGSDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005971,DTCC01094749,1590328,45214
CHEMBL1801049,P08253,,NUTUARVYQWFZAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005970,DTCC01094750,1429088,45214
CHEMBL1801050,P08253,,SPEYRVQKGFNUCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005969,DTCC01094751,2070708,45214
CHEMBL1801051,P08253,,VFDSDRZNXLFCFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005968,DTCC01094752,1811467,45214
CHEMBL1801052,P08253,,QLTNWLFWQKKDEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005966,DTCC01094753,1105534,45214
CHEMBL1801053,P08253,,UZMULMICABXSNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005965,DTCC01094754,1779150,45214
CHEMBL1801054,P08253,,PGEMRSCSFPLCBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005964,DTCC01094755,1940371,45214
CHEMBL1801055,P08253,,BIHFHTLMZBLJAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005963,DTCC01094756,1525963,45214
CHEMBL1801056,P08253,,GXZSIAVJNPWNMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005962,DTCC01094757,1811468,45214
CHEMBL1801057,P08253,,QJNGNVJSSUXWBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005961,DTCC01094758,1687244,45214
CHEMBL1801393,P08253,,JATUSZYMCBLDQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005938,DTCC01095085,1622970,45214
CHEMBL1801394,P08253,,OTKHAYOLIGHFRB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005937,DTCC01095086,1557980,45214
CHEMBL1801395,P08253,,OMFMQXSBXJDRCB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005936,DTCC01095087,749526,45214
CHEMBL1801396,P08253,,QDGVTWBFTFHWOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005935,DTCC01095088,1072789,45214
CHEMBL1801397,P08253,,WVUXCTUJEGJKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005934,DTCC01095089,1299069,45214
CHEMBL1801398,P08253,,QURZZKPWFKUXBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005933,DTCC01095090,555801,45214
CHEMBL1801399,P08253,,HYIVZTPHVNIXFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005932,DTCC01095091,1266628,45214
CHEMBL1801412,P08253,,ASZIRMQBBYBMMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005960,DTCC01095102,523654,45214
CHEMBL1801413,P08253,,SIEIWCDBNIGNIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005959,DTCC01095103,846766,45214
CHEMBL1801414,P08253,,YPRABBTWBDZWGP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005958,DTCC01095104,587925,45214
CHEMBL1801415,P08253,,SXSIQUOYBXOPSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005957,DTCC01095105,1396864,45214
CHEMBL1801416,P08253,,PFIVDCYVKKFLEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005956,DTCC01095106,394582,45214
CHEMBL1801417,P08253,,SFEPJGMZSMIONR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005955,DTCC01095107,263382,45214
CHEMBL1801418,P08253,,JNCKLKQBIMZPBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005954,DTCC01095108,1525968,45214
CHEMBL1801419,P08253,,SYYRIPAKWJBIOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005953,DTCC01095109,1072790,45214
CHEMBL1801420,P08253,,LMIHEFSBOIGKDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005952,DTCC01095110,879231,45214
CHEMBL1801421,P08253,,BDONYXHHXNTUSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.25,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005951,DTCC01095111,1557981,45214
CHEMBL1801422,P08253,,ZHIRJJYNGRGHQQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005950,DTCC01095112,1718593,45214
CHEMBL1801423,P08253,,XFBRPTYLOIFAQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005949,DTCC01095113,1429093,45214
CHEMBL1801424,P08253,,AOPZFYOXZYZEAC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005948,DTCC01095114,101933,45214
CHEMBL1801425,P08253,,DZCGIZPIPKWUIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005947,DTCC01095115,1779153,45214
CHEMBL1801426,P08253,,LTCNKRUYOJZZJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005945,DTCC01095117,1843781,45214
CHEMBL1801427,P08253,,JKRVXAWKSWVVCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005944,DTCC01095118,1169008,45214
CHEMBL1801428,P08253,,ORSWNUGKUNQTLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005943,DTCC01095119,1687248,45214
CHEMBL1801429,P08253,,LCYYUMHWMVOGPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005942,DTCC01095120,717206,45214
CHEMBL1801430,P08253,SC-77964,NBRBWZJMBITNBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005940,DTCC00034383,620315,45214
CHEMBL1801430,P08253,SC-77964,NBRBWZJMBITNBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23999043,IC50,<,1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by fluorescence plate reader analysis,,Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.,Bioorg. Med. Chem. Lett.,2013,23,20,"Freskos JN, Asmelash B, Gaston KR, Karwa A, Marzan TA, Nickols MA, Rogers TE, Schoenstein T, Sympson CJ, Vu B",,985896,DTCT0025094,12592017,DTCC00034383,642622,55953
CHEMBL1801431,P08253,,IXVDOEAUVAJHER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754459,DTCT0025094,6005939,DTCC01095121,263383,45214
CHEMBL180275,P08253,,JGGFVHVZVBWBKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15686921,KI,=,0.23,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302479,DTCT0025094,1744798,DTCC00381599,1360845,18787
CHEMBL180570,P08253,MEDRONIC ACID,MBKDYNNUVRNNRF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,49000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754119,DTCC00382991,72162,59385
CHEMBL180616,P08253,,FKICHBNUXJBKPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15686921,KI,=,0.43,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302479,DTCT0025094,1744362,DTCC00381808,713599,18787
CHEMBL180616,P08253,,FKICHBNUXJBKPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,KI,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278526,DTCC00381808,730979,25112
CHEMBL181244,P08253,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15713379,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305733,DTCT0025094,1747762,DTCC00381891,1586743,18841
CHEMBL181244,P08253,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457477,DTCC00381891,1600108,32556
CHEMBL181244,P08253,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859432,DTCC00381891,1588877,34421
CHEMBL181244,P08253,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859551,DTCC00381891,1588877,34421
CHEMBL181244,P08253,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3285986,DTCC00381891,1601174,38228
CHEMBL181244,P08253,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835709,DTCC00381891,1612259,53820
CHEMBL1812912,P08253,,VYBROWXFFJWNIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,74,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058077,DTCC01100197,1364478,45525
CHEMBL1812913,P08253,,QUSQFIPNDNBHNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,71,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058078,DTCC01100198,684900,45525
CHEMBL1812914,P08253,,ULEKRRIQMQVQCC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058136,DTCC01100199,1875918,45525
CHEMBL1812914,P08253,,ULEKRRIQMQVQCC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,55,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058079,DTCC01100199,1875918,45525
CHEMBL1812915,P08253,,XWFPIEBIPUMISV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,15,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058137,DTCC01100200,231075,45525
CHEMBL1812915,P08253,,XWFPIEBIPUMISV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,76,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058080,DTCC01100200,231075,45525
CHEMBL1812916,P08253,,NTEFOOINKPGXDL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,30,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058081,DTCC01100201,1655191,45525
CHEMBL1812917,P08253,,RXBGONZYRFPJLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,64,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058082,DTCC01100202,1747170,45525
CHEMBL1812918,P08253,,VEWFRRMUFDSOSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,86,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058138,DTCC01100203,911906,45525
CHEMBL1812918,P08253,,VEWFRRMUFDSOSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,52,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058083,DTCC01100203,911906,45525
CHEMBL1812919,P08253,,XMLQRYVULFQRSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,63,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058084,DTCC01100204,1747171,45525
CHEMBL1812920,P08253,,WGLLEESJSUVMDV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,16,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058139,DTCC01100205,1364479,45525
CHEMBL1812920,P08253,,WGLLEESJSUVMDV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,54,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058085,DTCC01100205,1364479,45525
CHEMBL1812921,P08253,,CHCJEQKHZPVJHX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,9.4,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058140,DTCC01100206,101981,45525
CHEMBL1812922,P08253,,WVVVZTYNCILRDX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,1.1,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058141,DTCC01100207,943418,45525
CHEMBL1812923,P08253,,NRMRNHPDYBGTNJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,22,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058142,DTCC01100208,1331812,45525
CHEMBL1812924,P08253,,QFGVLITXAHSQBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,2.9,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058143,DTCC01100209,166647,45525
CHEMBL1812925,P08253,,KTLLOXQGVQXBSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,7.5,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058144,DTCC01100210,134363,45525
CHEMBL1812925,P08253,,KTLLOXQGVQXBSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,INHIBITION,=,49,%,,,,,,,,,,,,,,Inhibition of MMP2 isolated from PMA-stimulated human HT1080 cells at 0.5 uM incubated for 48 hrs by gelatin zymography,,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762825,DTCT0025094,6058086,DTCC01100210,134363,45525
CHEMBL1812926,P08253,,QEINCUZDRZTOOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,73,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058145,DTCC01100211,1493705,45525
CHEMBL1812927,P08253,,QPEQHAHYPSQKRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,45,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058146,DTCC01100212,1875919,45525
CHEMBL1812928,P08253,,YAPNDZAGUYDTAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,54,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058147,DTCC01100213,1137893,45525
CHEMBL1812929,P08253,,LKINTHUDVVLELA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,13,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058148,DTCC01100214,427204,45525
CHEMBL1812930,P08253,,QBHSAKPHKDFXFL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,16,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058149,DTCC01100215,198576,45525
CHEMBL1812931,P08253,,BRWGFVQABBELKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,9.8,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058150,DTCC01100216,394642,45525
CHEMBL1812932,P08253,,LPZDWWQSUZYCFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,104,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058151,DTCC01100217,717253,45525
CHEMBL1812933,P08253,,TUQNORHNSISTNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,13,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058152,DTCC01100218,1461217,45525
CHEMBL1812934,P08253,,SRDYHGFRYLKSRU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,29,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058153,DTCC01100219,1779200,45525
CHEMBL1812935,P08253,,UQMCTVPIBFCEDP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,269,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058154,DTCC01100220,1299130,45525
CHEMBL1812936,P08253,,IXXYMFNUAAIVKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,60,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058155,DTCC01100221,1169053,45525
CHEMBL1812937,P08253,,ZTHKEEDWHVZQDO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,50,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058156,DTCC01100222,1266675,45525
CHEMBL1812938,P08253,,NQGQRKWSZKBYDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,329,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058157,DTCC01100223,523706,45525
CHEMBL1812939,P08253,,YDTMRMDLJOKXKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,86,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058158,DTCC01100224,1875920,45525
CHEMBL1812940,P08253,,ZPEQVNOXLLWMPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,264,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058159,DTCC01100225,231076,45525
CHEMBL1812941,P08253,,AXNVQQUJSUYTRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,2.55,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058160,DTCC01100226,1558035,45525
CHEMBL1812942,P08253,,YVNVOGMCBLDQFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,308,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058161,DTCC01100227,1811513,45525
CHEMBL1812943,P08253,,XYTCENJSUIYBRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,24,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058162,DTCC01100228,846810,45525
CHEMBL1812944,P08253,,UYQVBRVYZIDHBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058163,DTCC01100229,1973545,45525
CHEMBL1812945,P08253,,ARFMWLMOXLXDGE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,47,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058164,DTCC01100230,846811,45525
CHEMBL1812946,P08253,,FUERCCVUUPZPGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,106,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058165,DTCC01100231,1623019,45525
CHEMBL1812947,P08253,,XTZTWPVOIONTJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,264,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058166,DTCC01100232,943419,45525
CHEMBL1812948,P08253,,PIKKDCBNCJTTFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,80,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058167,DTCC01100233,1973546,45525
CHEMBL1812949,P08253,,ZEWXBNFTMNRQJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,268,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058168,DTCC01100234,198577,45525
CHEMBL1812950,P08253,,RSZPITUDITYSGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,23,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058169,DTCC01100235,652844,45525
CHEMBL1812951,P08253,,USAJQJNNFJUVKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,31,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058170,DTCC01100236,813915,45525
CHEMBL1812952,P08253,,RKVSAYKAVLLLNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,95,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058171,DTCC01100237,1875921,45525
CHEMBL1812953,P08253,,DOIOPNJCLRHYSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,100,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058172,DTCC01100238,134364,45525
CHEMBL1812954,P08253,,DMTJHOMQGPRBLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,25,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058173,DTCC01100239,1266676,45525
CHEMBL1812955,P08253,,GJSXROUEXIBCNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,25,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058174,DTCC01100240,943420,45525
CHEMBL1812956,P08253,,GSBYGPBBULKZJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,311,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058175,DTCC01100241,166648,45525
CHEMBL1812957,P08253,,DEHVVEMMIHMAJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,411,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058176,DTCC01100242,394643,45525
CHEMBL1812958,P08253,,DIHUJPNEHNNZDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,24,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058177,DTCC01100243,1655192,45525
CHEMBL1812959,P08253,,BSIHEYODNDRSAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,706,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058178,DTCC01100244,717254,45525
CHEMBL1812960,P08253,,YEXBEMGSRCFPBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,681,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058179,DTCC01100245,1940429,45525
CHEMBL1812961,P08253,,WGBMLJASUBPVSN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058180,DTCC01100246,1137894,45525
CHEMBL1812962,P08253,,CIQLLFNYQWGPMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,83,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058181,DTCC01100247,1590387,45525
CHEMBL1812963,P08253,,OZDWWCLOUIHTHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,54,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058182,DTCC01100248,1072831,45525
CHEMBL1812964,P08253,,FOAPZIUAOJQVMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,142,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058183,DTCC01100249,1266677,45525
CHEMBL1812965,P08253,,GWNUFFZRDMNVCF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21764590,IC50,=,184,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",,N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,2011,19,16,"Wang J, Medina C, Radomski MW, Gilmer JF",,762827,DTCT0025094,6058184,DTCC01100250,1169054,45525
CHEMBL181682,P08253,,VWGKXDUPRHRCAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16002291,IC50,=,26000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,16,"Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A",,305119,DTCT0025094,1742479,DTCC00381375,142259,9478
CHEMBL181707,P08253,,SLZDRBFQRQKNPL-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,>,600000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2,,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,302309,DTCT0025094,1771973,DTCC00389520,402882,17054
CHEMBL181807,P08253,,RLQDDFZTFKMONF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1766884,DTCC00387593,2046737,18194
CHEMBL1819319,P08253,,ZECVRBKNIJWEHF-DCAQKATOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,151600,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072824,DTCC01103474,216646,45627
CHEMBL1819320,P08253,,GUMPWFSDOSPTHO-DCAQKATOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,331100,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072822,DTCC01103475,282012,45627
CHEMBL1819321,P08253,,JOJRHKWYOLSXAA-DCAQKATOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,100100,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072823,DTCC01103476,120000,45627
CHEMBL1819322,P08253,,BMEJTMZRLKJDST-IHRRRGAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,142900,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072825,DTCC01103477,1058423,45627
CHEMBL1819323,P08253,,FZCVQJGVLKLMOT-IHRRRGAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,84300,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072826,DTCC01103478,1154672,45627
CHEMBL1819324,P08253,,YONMWJQXDIKEMB-IKGGRYGDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,67400,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072827,DTCC01103479,1252348,45627
CHEMBL1819325,P08253,,BTXFOEKRWVLAJQ-ULQDDVLXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,61300,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072828,DTCC01103480,865049,45627
CHEMBL1819326,P08253,,CODCOEYSLPEEQS-BZSNNMDCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072829,DTCC01103481,2024662,45627
CHEMBL1819327,P08253,,TYVDYFJOUBAYDR-VGWMRTNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,83900,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072830,DTCC01103482,1543937,45627
CHEMBL1819328,P08253,,KCLFXHIETYMKKM-KJJMTIBFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,173100,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072831,DTCC01103483,2024663,45627
CHEMBL1819329,P08253,,PMHUDQFQCOGSDH-XWSJACJDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,110100,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072832,DTCC01103484,1861710,45627
CHEMBL1819330,P08253,,KLDBPRMCEJJKCB-XWSJACJDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,108900,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072833,DTCC01103485,1894014,45627
CHEMBL1819331,P08253,,XYJODOAAFORUMP-RCTAOEEJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,44100,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072834,DTCC01103486,1640920,45627
CHEMBL1819332,P08253,,TZNFXBZYEMITOS-MLNNCEHLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,105600,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072835,DTCC01103487,767491,45627
CHEMBL1819333,P08253,,UPHDDZFTIUFUGF-RDGPPVDQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,40600,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072836,DTCC01103488,347433,45627
CHEMBL1819334,P08253,,WFUQUNVERNJHPA-IHRRRGAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,119300,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072837,DTCC01103489,1926053,45627
CHEMBL1819335,P08253,,ODLNSQWISYITKL-IHRRRGAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,157400,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072838,DTCC01103490,638672,45627
CHEMBL1819336,P08253,,XUUZEWNVECDJQI-IKGGRYGDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,149200,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072839,DTCC01103491,1797470,45627
CHEMBL1819442,P08253,,VEWBLVNRRJPAAX-ULQDDVLXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,111300,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072840,DTCC01103578,670809,45627
CHEMBL1819443,P08253,,JHFLYAQBLKIOKC-KJJMTIBFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,133800,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072841,DTCC01103579,1608553,45627
CHEMBL1819444,P08253,,ZXANSPAKMHQCNZ-RCTAOEEJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,40400,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072842,DTCC01103580,2088790,45627
CHEMBL1819445,P08253,,NNVVNVWTTVUNPH-MLNNCEHLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,94000,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072843,DTCC01103581,1704925,45627
CHEMBL1819446,P08253,,LMNNIZKYEQCZAB-IHRRRGAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,119500,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072844,DTCC01103582,413029,45627
CHEMBL1819447,P08253,,VJEUKVABBDUJCR-ULQDDVLXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,42200,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072845,DTCC01103583,1317473,45627
CHEMBL1819448,P08253,,CSPUKTBNCMXQLD-KJJMTIBFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,86600,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072846,DTCC01103584,1252349,45627
CHEMBL1819449,P08253,,IIYCHYIEBLWDPC-RCTAOEEJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,107100,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072847,DTCC01103585,443706,45627
CHEMBL1819450,P08253,,IKIUEYKZCHTDJN-MLNNCEHLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,52700,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072848,DTCC01103586,476954,45627
CHEMBL1819451,P08253,,AHVZIVIHAVJBAG-IUCAKERBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072849,DTCC01103587,184580,45627
CHEMBL1821978,P08253,,QDLPFXRBZXAZRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23428964,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) up to 50 uM,Not Active,Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.,Bioorg. Med. Chem.,2013,21,7,"Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C",,951227,DTCT0025094,11846963,DTCC01103969,1107149,54192
CHEMBL182730,P08253,,VMEQJHZAHNCRQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768284,DTCC00387769,337382,18194
CHEMBL182879,P08253,,GNDJOJQVOFQQBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15582436,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 expressed in Sf9 insect cells; NA:Not active,Not Active,"N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.",Bioorg. Med. Chem. Lett.,2005,15,1,"Lee J, Shim JS, Jung SA, Lee ST, Kwon HJ",,306424,DTCT0025094,1757707,DTCC00385215,757396,18428
CHEMBL1828920,P08253,,DMFYWVSGUMHBCM-TVIOGVOPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21714538,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.,J. Med. Chem.,2011,54,15,"Zhang Y, Fang H, Feng J, Jia Y, Wang X, Xu W",,768035,DTCT0025094,6100958,DTCC01107202,458315,45885
CHEMBL1830129,P08253,N-PHENYLCINNAMAMIDE,FIIZQHKGJMRJIL-VAWYXSNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.95,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836347,DTCC01108397,1029669,53968
CHEMBL1830130,P08253,N-M-TOLYLCINNAMAMIDE,DCZZGCCJBFBLOX-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1945.82,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833657,DTCC01108398,56334,53968
CHEMBL1830131,P08253,N-(3-CHLOROPHENYL)CINNAMAMIDE,ZUKRPXSFAZWKHZ-MDZDMXLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1649.92,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833651,DTCC01108399,351093,53968
CHEMBL1830141,P08253,,IZXYYBWPDVJZIX-BQYQJAHWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1937.23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836367,DTCC01108409,1962737,53968
CHEMBL1830143,P08253,,KZKTWYPRMCPYNI-RMKNXTFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1729.19,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836349,DTCC00128735,577251,53968
CHEMBL1830508,P08253,,AUQYMDJPPJGRTJ-QNTKWALQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,Not Active,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093837,DTCC01108744,799709,45986
CHEMBL1830509,P08253,,QEOHNEYAVLMPDE-MERQFXBCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,516830,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093838,DTCC01108745,1704988,45986
CHEMBL1830510,P08253,,IMTSQVHVWGTJOU-YDALLXLXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,251910,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093839,DTCC01108746,1797513,45986
CHEMBL1830511,P08253,,LWQNXAJYLMEUSZ-PPHPATTJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,249240,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093840,DTCC01108747,1608614,45986
CHEMBL1830512,P08253,,DUUZKDIQYNHTQW-RWHJDYSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,463380,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093841,DTCC01108748,2024711,45986
CHEMBL1830648,P08253,,GUXKEEFKMYAXSC-QNTKWALQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,307270,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093842,DTCC01108881,1608618,45986
CHEMBL1830649,P08253,,LVTHSQLZTDLDOC-IODNYQNNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,836490,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093843,DTCC01108882,1091439,45986
CHEMBL1830651,P08253,,JLMYPTXNUWCXIP-MOGJOVFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,393140,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093845,DTCC01108883,1382854,45986
CHEMBL1830652,P08253,,SLKCMCARAPHTEY-QJHJCNPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,939570,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093846,DTCC01108884,993735,45986
CHEMBL1830653,P08253,,YVNFLUFRFLJPLV-QJHJCNPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,540030,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093847,DTCC01108885,282085,45986
CHEMBL1830654,P08253,,MYZRDRSDEKMTIX-QNTKWALQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,166110,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093848,DTCC01108886,1091440,45986
CHEMBL1830655,P08253,,NEFNVBJDJYHLFF-ACMTZBLWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,267730,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093849,DTCC01108887,735360,45986
CHEMBL1830657,P08253,,APGKCDOXZDHOEY-QNTKWALQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,157420,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093851,DTCC01108888,2024714,45986
CHEMBL1830658,P08253,,QXFJUWALOLUEBM-UQGASIHSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,276440,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093852,DTCC01108889,1317515,45986
CHEMBL1830659,P08253,,WYTHILGBISHRTD-FKLPMGAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,Not Active,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093853,DTCC01108890,509505,45986
CHEMBL1830660,P08253,,ZNSRQMMSSQOJME-HLRBRJAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,Not Active,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093854,DTCC01108891,1479451,45986
CHEMBL1830661,P08253,,KGHYSFCUMCJKSO-YOTVLOEGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,Not Active,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093855,DTCC01108892,380117,45986
CHEMBL1830662,P08253,,ATOKAEAGOUWKHM-SGIIKHNDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,656770,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093857,DTCC01108893,1187159,45986
CHEMBL1830663,P08253,,SXGQQSMTMUIECG-SGIIKHNDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,Not Active,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093858,DTCC01108894,50270,45986
CHEMBL1830664,P08253,,YIXKVYWZLHVLLS-NAGNLMCHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,Not Active,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093859,DTCC01108895,1285017,45986
CHEMBL183410,P08253,,ZTJUBPXNBSLSGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15780611,IC50,=,21,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 2,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305081,DTCT0025094,1754255,DTCC00384419,1113613,18917
CHEMBL183410,P08253,,ZTJUBPXNBSLSGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,20.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using (Ac-PLG-[2-mercapto-4-85 methylpentanoyl]-LG-OC2H5) as substrate by microplate photometric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589875,DTCT0025094,318177,DTCC00384419,1099207,67557
CHEMBL183410,P08253,,ZTJUBPXNBSLSGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using (Ac-PLG-[2-mercapto-4-85 methylpentanoyl]-LG-OC2H5) as substrate by microplate photometric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589875,DTCT0025094,318176,DTCC00384419,1099207,67557
CHEMBL183431,P08253,,VTKKCTKODCNOOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1767150,DTCC00387678,109915,18194
CHEMBL1834417,P08253,,SSPSTNTXKUWFJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21866961,KI,=,440,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771288,DTCT0025094,6116347,DTCC01109919,2039082,46049
CHEMBL1834418,P08253,,DJLYTRGAMWVKBZ-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21866961,KI,=,62,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771288,DTCT0025094,6116346,DTCC01109920,1138000,46049
CHEMBL1834419,P08253,,OUATTZIRQSVXDL-DAFXYXGESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21866961,KI,=,69,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771288,DTCT0025094,6116345,DTCC01109921,717366,46049
CHEMBL1834420,P08253,,OWKCGOUEJMBBRA-NNBQYGFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21866961,KI,=,520,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771288,DTCT0025094,6116344,DTCC01109922,198681,46049
CHEMBL1834421,P08253,,DNICZPICBHCWNG-FALYVICWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21866961,KI,=,420,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771288,DTCT0025094,6116343,DTCC01109923,1940556,46049
CHEMBL1834422,P08253,,AGULWCWMDMKUSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21866961,KI,=,24,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771288,DTCT0025094,6116348,DTCC01109924,1072947,46049
CHEMBL1834423,P08253,,FANDWSFYLCHFFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21866961,KI,=,78000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771288,DTCT0025094,6116350,DTCC01109925,166772,46049
CHEMBL1834425,P08253,,FOCZQHBXIUOIJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,=,63.6,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550509,DTCC01109927,1615466,63755
CHEMBL1834425,P08253,,FOCZQHBXIUOIJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550533,DTCC01109927,1615466,63755
CHEMBL183791,P08253,,ZJOWVJCIVPTYBC-UPVQGACJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1770460,DTCC00388720,1981695,18194
CHEMBL183828,P08253,,GZPFSVVEOIXUBD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769764,DTCC00387598,1113642,18194
CHEMBL183868,P08253,,LCIIHDPWZSSNGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768680,DTCC00387868,1663052,18194
CHEMBL184020,P08253,,WRDDVWWWIRVWCJ-YFOSEYIMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770194,DTCC00389257,1048476,17054
CHEMBL184058,P08253,,OPQGJZKLYXEBJB-RYUDHWBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1771856,DTCC00389605,369984,17054
CHEMBL184062,P08253,,QDMJDGKLXWJUSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1766613,DTCC00387550,1948766,18194
CHEMBL184148,P08253,,ZUHYMHIRYGATBX-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770677,DTCC00389446,1274778,17054
CHEMBL184200,P08253,,OOVNTYFKKPGWIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769204,DTCC00387611,2014535,18194
CHEMBL184265,P08253,,ZLXSMXRIMOZSHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1766767,DTCC00387522,174524,18194
CHEMBL184266,P08253,,SUTQJRNQIINAFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769662,DTCC00387523,951382,18194
CHEMBL184302,P08253,,KVMYRTIGLLQRFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,=,1566,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769257,DTCC00387529,1787170,18194
CHEMBL184472,P08253,,HMMHUOOBBQHGHE-WMZOPIPTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770691,DTCC00389494,1405091,17054
CHEMBL184553,P08253,,AENHIDVKFOYIJJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,=,1333,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768814,DTCC00387561,854875,18194
CHEMBL184594,P08253,,NXVZHPLWCQGDFD-RYUDHWBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770165,DTCC00389306,1916149,17054
CHEMBL184603,P08253,,XRUIDIXUYZMASL-WXLQDFAISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770169,DTCC00389262,887129,17054
CHEMBL184731,P08253,,YVZMPLJZOFEXTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769210,DTCC00387551,789551,18194
CHEMBL184782,P08253,,QKSLJJWUWAALHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768688,DTCC00387435,1209204,18194
CHEMBL184885,P08253,,QPQUYVHWOXJEPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769089,DTCC00387860,563749,18194
CHEMBL184889,P08253,,JCNKARFKCMFPMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,=,1333,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768290,DTCC00387709,466623,18194
CHEMBL184942,P08253,,XDBJJTDYSZNDQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1767050,DTCC00387754,271779,18194
CHEMBL184975,P08253,,ZYBZWGUZKUJPEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769216,DTCC00387627,1340070,18194
CHEMBL185159,P08253,,PGTJOSSSBWAALE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1766891,DTCC00387543,1534047,18194
CHEMBL185160,P08253,,PVWTVPDAGBLFIJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769771,DTCC00387544,1015993,18194
CHEMBL1852660,P08253,,XFZZDIHCNHYESF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23428964,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) up to 50 uM,Not Active,Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.,Bioorg. Med. Chem.,2013,21,7,"Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C",,951227,DTCT0025094,11846962,DTCC01113468,1877558,54192
CHEMBL185279,P08253,,NWEMVUGYMZFTLT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1767171,DTCC00387634,32985,18194
CHEMBL185321,P08253,,MBVFAXQWLSRZPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769199,DTCC00387430,1724709,18194
CHEMBL185397,P08253,,KCWUMRBDUUZPAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768157,DTCC00387675,1663050,18194
CHEMBL185459,P08253,,HOLCLOFNVSKQFD-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1771852,DTCC00389596,1242063,17054
CHEMBL185521,P08253,,IFZNBBFLMYGGPO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1767164,DTCC00387708,1630785,18194
CHEMBL185587,P08253,,GQEXSMDDEGSZJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769779,DTCC00387743,109914,18194
CHEMBL1864040,P08253,,NMBZWZAYUOJWRS-ZMOGYAJESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215357,DTCC01114179,1798297,33038
CHEMBL186422,P08253,QUINOLIN-2-OL,LISFMEBWQUVKPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103161,DTCC00000874,1763872,43205
CHEMBL186538,P08253,,FLKISSURPVEJPE-RYUDHWBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,340166,DTCC00389373,1242062,17054
CHEMBL186559,P08253,,JTSGTFRCJJPVQT-SXDPYWSBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770186,DTCC00389314,725291,17054
CHEMBL186648,P08253,,GCUIPMGVKOFNNT-BVAIOKDQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770173,DTCC00389263,1754962,17054
CHEMBL186765,P08253,,HDSODEHQNNGCDW-GMAHTHKFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770698,DTCC00389458,660773,17054
CHEMBL186999,P08253,,ZBGXAQNJQLZZND-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1771966,DTCC00389550,1916152,17054
CHEMBL1870454,P08253,,GSZNPIJCPWBSHQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,92400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215395,DTCC01120424,50450,33038
CHEMBL187079,P08253,,OMKGAAGLEHDNHH-ZUPSLANMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,=,153000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2,,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,302309,DTCT0025094,1770177,DTCC00389368,174548,17054
CHEMBL187092,P08253,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15953722,IC50,=,4,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.,Bioorg. Med. Chem. Lett.,2005,15,14,"Noe MC, Natarajan V, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Otterness I, Bliven MA, Carty TJ, Barberia JT, Sweeney FJ, Liras JL, Vaughn M",,304619,DTCT0025094,1774140,DTCC00390625,681417,18571
CHEMBL187092,P08253,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000059,DTCC00390625,708051,60298
CHEMBL1871747,P08253,,CTRKVMOLJKPTTM-BVSLBCMMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215499,DTCC01121681,1415290,33038
CHEMBL187265,P08253,"1,3,6,7-TETRAHYDROXYXANTONE",ZHTQCPCDXKMMLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534776,DTCC00000833,1779807,48665
CHEMBL1873140,P08253,,SEDGLMOQZHOEJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219694,DTCC01123036,1447087,33038
CHEMBL1873454,P08253,,CAXCSMMWQXAWSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219718,DTCC01123341,477868,33038
CHEMBL1875123,P08253,,RYOLLVLXNYCIPC-WSVATBPTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215346,DTCC01124953,1219374,33038
CHEMBL187523,P08253,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1794809,DTCC00394634,435113,8231
CHEMBL187523,P08253,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860315,DTCC00394634,435259,19837
CHEMBL187523,P08253,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904530,DTCC00394634,425792,35265
CHEMBL187523,P08253,,HJFONKSERLWIGE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19725580,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579098,DTCT0025094,2894854,DTCC00394634,425760,34869
CHEMBL1876111,P08253,,PQVPKSOAEMAHQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215430,DTCC01125911,1285099,33038
CHEMBL187791,P08253,,WDEZDLALUARPAX-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1799278,DTCC00394811,1663114,8231
CHEMBL1881326,P08253,,FUGIXGUQLUYLDT-RNXOBYDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215513,DTCC01130981,347591,33038
CHEMBL1883011,P08253,,VFCMTPJMDJVWMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,4320,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215592,DTCC01132618,1351087,33038
CHEMBL1884200,P08253,,DOYAFDHFPWULLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215515,DTCC01133785,1187976,33038
CHEMBL1884782,P08253,,BWFIOIDJTVTWPS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,85800,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215567,DTCC01134353,768407,33038
CHEMBL188542,P08253,,KJURPZKHCXAZLJ-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1794252,DTCC00394456,206649,8231
CHEMBL1886169,P08253,,PRAFTWYPDIRGEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215345,DTCC01135709,1447862,33038
CHEMBL1886491,P08253,,ABKIYVGPMWZYOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215348,DTCC01136020,736213,33038
CHEMBL188707,P08253,,DCFQDPBZWWAPCG-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,37,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1796530,DTCC00394192,206645,8231
CHEMBL1888496,P08253,,ZKHDVNLPXPOHGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215442,DTCC01137958,961610,33038
CHEMBL188888,P08253,,VEGFRWXANMWHRA-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,3.2,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1798869,DTCC00394466,33093,8231
CHEMBL188894,P08253,,HBBHNZHTEFSNGF-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307790,DTCT0025094,1790619,DTCC00392759,1936804,19089
CHEMBL188894,P08253,,HBBHNZHTEFSNGF-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,15,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307795,DTCT0025094,1790620,DTCC00392759,1936804,19089
CHEMBL189250,P08253,,FQMVAYHQICVINW-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,27.8,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1797685,DTCC00393994,1851891,8231
CHEMBL189591,P08253,,BKBMJVASMYYCKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800088,DTCC00398075,584553,16433
CHEMBL189666,P08253,,BUOFCYNMGVUTSM-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1797553,DTCC00394464,887175,8231
CHEMBL189700,P08253,,GGJDCLDUCIBTBH-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1799706,DTCC00394524,109982,8231
CHEMBL1898074,P08253,,DSYKGVBDZZCIRI-OVCLIPMQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,5410,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215400,DTCC01147262,634514,33038
CHEMBL1899457,P08253,,XEWAWVPHUYHRCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215451,DTCC01148601,865988,33038
CHEMBL189955,P08253,,PXPWUAKZNLIXJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,47,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1795490,DTCC00394485,239105,8231
CHEMBL190215,P08253,,CEGUOXMMRKISPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,=,116,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800242,DTCC00398109,1457816,16433
CHEMBL190871,P08253,,FFOFJMKSEMVOQQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828949,DTCC00399816,951511,19718
CHEMBL190936,P08253,,INGVNDTUNOZHOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800212,DTCC00398012,7206,16433
CHEMBL191076,P08253,,XTJZQNUILYKCRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,=,2530,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800064,DTCC00398004,1361039,16433
CHEMBL191106,P08253,,BRRSHCMZHWWBNJ-KKFPZRRJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,1590,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1798368,DTCC00394741,1630851,8231
CHEMBL191360,P08253,,HEICZDBUMBAABJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800399,DTCC00398432,1328331,16433
CHEMBL1914481,P08253,,ABWKZZSKNBCWLN-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,96,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527187,DTCC01161442,381077,46372
CHEMBL1914483,P08253,,ZTWMNQMJFNKJFV-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527223,DTCC01161638,1027126,46372
CHEMBL1916049,P08253,,GETDIWSMCUZGCD-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,1599,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525307,DTCC01160858,458488,46368
CHEMBL1916050,P08253,,GETDIWSMCUZGCD-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,0.57,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525308,DTCC01160859,685161,46368
CHEMBL1916051,P08253,,SUTULEKUSDXPBW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525309,DTCC01160860,1844049,46368
CHEMBL1916052,P08253,,HVOVPPVRLMOBHI-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525310,DTCC01160861,1779448,46368
CHEMBL1916053,P08253,,RHVLZBAJLKIMQO-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525311,DTCC01160862,394878,46368
CHEMBL1916054,P08253,,XAOJSOMIBKILNZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,0.53,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525312,DTCC01160863,749845,46368
CHEMBL1916055,P08253,,GXKVUIPBWQPVAL-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,2319,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525313,DTCC01160864,1940715,46368
CHEMBL1916056,P08253,,RLGVFNMHAUPJOV-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,85,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525314,DTCC01160865,1332076,46368
CHEMBL1916057,P08253,,QHXQILHKQUVTBK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525315,DTCC01160866,296910,46368
CHEMBL191613,P08253,"2,4-DICHLOROPHENYLAMINOMETHYLENEBISPHOSPHONIC ACID",KASHBTOPZJTDFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629956,DTCC00399306,383982,56259
CHEMBL1916201,P08253,,QOXMDHVVENYQFJ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525316,DTCC01160998,1876213,46368
CHEMBL1916202,P08253,,NPPGCZWIPTWDAM-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525317,DTCC01160999,814212,46368
CHEMBL1916203,P08253,,AFAZTSCLENHGJT-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525318,DTCC01161000,685164,46368
CHEMBL1916204,P08253,,NSMCPQNAHIFGCB-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525319,DTCC01161001,1073094,46368
CHEMBL1916205,P08253,,CUGNLRWAORUYPI-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525320,DTCC01161002,1526277,46368
CHEMBL1916206,P08253,,KTGKATYAFOIELE-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525321,DTCC01161003,2071014,46368
CHEMBL1916207,P08253,,AFHDVSQBDWGAQU-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525322,DTCC01161004,1397221,46368
CHEMBL1916208,P08253,,OXHLNRMJXSJQIA-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525323,DTCC01161005,1073095,46368
CHEMBL1916209,P08253,,TVNIMIJQBWZCGY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525324,DTCC01161006,362159,46368
CHEMBL1916210,P08253,,YBTXAIOMVIXCOD-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,0.39,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525325,DTCC01161007,1655475,46368
CHEMBL1916211,P08253,,SRFKWSJTGCWGBQ-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,0.55,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525326,DTCC01161008,2071015,46368
CHEMBL1916212,P08253,,ZODGWBSBSVHUNW-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,0.49,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525327,DTCC01161009,1299421,46368
CHEMBL1916213,P08253,,XLEZHEBRRDABNS-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525328,DTCC01161010,879542,46368
CHEMBL1916214,P08253,,GLGMQKYHXRSKKD-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525329,DTCC01161011,491719,46368
CHEMBL1916215,P08253,,OQNMPVNWQUKGKU-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21925881,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of full length human MMP2 (amino acids 1 to 660) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787970,DTCT0025094,7525330,DTCC01161012,1008192,46368
CHEMBL191625,P08253,"PENTANE-2,4-DIONE",YRKCREAYFQTBPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103840,DTCC00001048,1957906,43205
CHEMBL1916640,P08253,,IOQOIXCSRBBCDP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,86,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527185,DTCC01161440,930145,46372
CHEMBL1916641,P08253,,NAMZXOAZPHMVHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,163,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527186,DTCC01161441,1609616,46372
CHEMBL1916642,P08253,,JOOOUNMUHMUOJH-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527188,DTCC01161443,1641910,46372
CHEMBL1916643,P08253,,NNUQGANTDABHBL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,308,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527189,DTCC01161444,51704,46372
CHEMBL1916644,P08253,,MRJCPNBIHXIUFQ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,384,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527190,DTCC01161445,1544977,46372
CHEMBL1916645,P08253,,BHCRZOUPEFVWHZ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,706,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527191,DTCC01161446,121036,46372
CHEMBL1916646,P08253,,ZHMDSAFJPANUBJ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527192,DTCC01161447,1609617,46372
CHEMBL1916647,P08253,,BRECBJOQRORDAF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,798,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527193,DTCC01161448,2057692,46372
CHEMBL1916648,P08253,,ICSWIBNMQZLUKX-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527194,DTCC01161449,381078,46372
CHEMBL1916649,P08253,,YTELTZFLAYFFDQ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527195,DTCC01161450,1480418,46372
CHEMBL1916650,P08253,,ZHHIFOMQPDSUIP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,232,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527196,DTCC01161451,1188130,46372
CHEMBL1916651,P08253,,IVBBTZQIKSRCPC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,607,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527197,DTCC01161452,1674210,46372
CHEMBL1916652,P08253,,WHSJFJHSWYAKDM-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,144,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527198,DTCC01161453,1155744,46372
CHEMBL1916653,P08253,,OXLIYFANWBIKMH-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,128,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527199,DTCC01161454,1318507,46372
CHEMBL1916654,P08253,,FUOOTOLTPDFGCS-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,83,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527200,DTCC01161455,866077,46372
CHEMBL1916655,P08253,,PSLXIIKDHBIITK-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,81,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527201,DTCC01161456,51705,46372
CHEMBL1916656,P08253,,QGGLZVYZDFRHHX-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,458,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527202,DTCC01161457,153514,46372
CHEMBL1916657,P08253,,IMCGJWBSANDEHB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,706,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527203,DTCC01161458,962508,46372
CHEMBL1916658,P08253,,PHVICSOQJHYLEW-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527204,DTCC01161459,607032,46372
CHEMBL1916659,P08253,,TXFWBKCCZLIBMU-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,3670,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527205,DTCC01161460,704057,46372
CHEMBL1916660,P08253,,BCNQQPWDHJUQFQ-XPKAQORNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,111,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527206,DTCC01161461,930146,46372
CHEMBL1916661,P08253,,DHCMKRCHROJJHB-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,178,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527207,DTCC01161462,768524,46372
CHEMBL1916662,P08253,,MDDFFAOYZXGICC-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,3286,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527208,DTCC01161463,1092420,46372
CHEMBL1916663,P08253,,URNPXFKEVDQWTO-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527209,DTCC01161464,1609618,46372
CHEMBL1916664,P08253,,UUTDMYYQOAVOHN-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,4370,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527210,DTCC01161465,1577070,46372
CHEMBL1916665,P08253,,NYACXZAKXKSUHM-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,307,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527211,DTCC01161466,1059387,46372
CHEMBL1916666,P08253,,GXINZIOTECAGST-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,9200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527212,DTCC01161467,1188131,46372
CHEMBL1916830,P08253,,PEDLXNUHJRCVGF-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,197,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527213,DTCC01161628,898351,46372
CHEMBL1916831,P08253,,VIWOHIOPIHELRI-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,102,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527214,DTCC01161629,671853,46372
CHEMBL1916832,P08253,,JWGZOXAEXNYYHO-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,931,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527215,DTCC01161630,962509,46372
CHEMBL1916833,P08253,,ZHMXASGBGYZMST-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,1610,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527216,DTCC01161631,704059,46372
CHEMBL1916834,P08253,,UXOSVQFKXFZCKF-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,45,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527217,DTCC01161632,1220339,46372
CHEMBL1916835,P08253,,QGCFRSYWGLGDTC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,2050,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527218,DTCC01161633,1188132,46372
CHEMBL1916836,P08253,,MFBQXIJAOSFCJR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,6913,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527219,DTCC01161634,1830760,46372
CHEMBL1916837,P08253,,XUBGKCSUKRWGIB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,306,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527220,DTCC01161635,1960131,46372
CHEMBL1916838,P08253,,LSURBVCXYPJWOW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527221,DTCC01161636,510370,46372
CHEMBL1916839,P08253,,OOUAVDQEGOBVOR-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527222,DTCC01161637,1734123,46372
CHEMBL1916840,P08253,,RNYCOGRIXBDHFK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,30083,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527224,DTCC01161639,1577071,46372
CHEMBL191986,P08253,,WHDVUUKXFNOVHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,15,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828963,DTCC00399791,563857,19718
CHEMBL192204,P08253,,JXUDAYOKNXBKHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800386,DTCC00398406,7207,16433
CHEMBL192249,P08253,,QZPPOPJGCFXELG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828753,DTCC00399982,370097,19718
CHEMBL192370,P08253,,VQFRAJKJRLAZOI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,85,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828941,DTCC00400311,1884071,19718
CHEMBL1927183,P08253,,URQNIKFTQMJDKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22088955,IC50,=,67000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791979,DTCT0025094,7555520,DTCC01165287,2025754,46745
CHEMBL1927184,P08253,,MXDNHABTSLQECK-VEJZVKIUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22088955,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791979,DTCT0025094,7555521,DTCC01165288,1480457,46745
CHEMBL1927185,P08253,,KKYDQVAGMODEPF-VMPITWQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22088955,IC50,=,61000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791979,DTCT0025094,7555522,DTCC01165289,671878,46745
CHEMBL1927186,P08253,,RMYNLYNJRHVJNU-RIYZIHGNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22088955,IC50,=,350000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791979,DTCT0025094,7555523,DTCC01165290,898397,46745
CHEMBL1927187,P08253,,UEOIUIPMEKCWHI-YJBIHYNGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22088955,IC50,=,120000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791979,DTCT0025094,7555524,DTCC01165291,1351218,46745
CHEMBL192740,P08253,,ZUPKLHSUDRAJGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,,,,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2; I.A.=inactive,Not Active,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305808,DTCT0025094,1828766,DTCC00399933,1242175,19718
CHEMBL192872,P08253,,IOHMRAKHDYVRJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828749,DTCC00399770,110032,19718
CHEMBL193084,P08253,,HNINPFHHNYDBSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800206,DTCC00398196,227645,16433
CHEMBL193316,P08253,,QKXIBRKQCXPSEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1802359,DTCC00398156,1619558,16433
CHEMBL1933865,P08253,,FMGFJOARXWKCIE-XYOKQWHBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22082667,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.,Bioorg. Med. Chem.,2011,19,24,"Li B, Cardinale SC, Butler MM, Pai R, Nuss JE, Peet NP, Bavari S, Bowlin TL",,795997,DTCT0025094,7586731,DTCC01168266,1494036,46860
CHEMBL1933882,P08253,,IAQAYKRJOOBBTO-ZRDIBKRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22082667,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.,Bioorg. Med. Chem.,2011,19,24,"Li B, Cardinale SC, Butler MM, Pai R, Nuss JE, Peet NP, Bavari S, Bowlin TL",,795997,DTCT0025094,7586732,DTCC01168283,1779521,46860
CHEMBL1935291,P08253,,MUMVNZHARHFSLP-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153340,IC50,=,501,NM,,,,,,,,,,,,,,Inhibition of human MMP-2,,Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).,Bioorg. Med. Chem. Lett.,2012,22,1,"Wu Y, Li J, Wu J, Morgan P, Xu X, Rancati F, Vallese S, Raveglia L, Hotchandani R, Fuller N, Bard J, Cunningham K, Fish S, Krykbaev R, Tam S, Goldman SJ, Williams C, Mansour TS, Saiah E, Sypek J, Li W",,796146,DTCT0025094,7576408,DTCC01169633,51895,46933
CHEMBL193945,P08253,,OCBYWAVDKLDIDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,=,83,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800230,DTCC00398285,875794,16433
CHEMBL1939844,P08253,,FTRCUXMVUJZMHT-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017477,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799076,DTCT0025094,7595864,DTCC01171473,2071098,47023
CHEMBL1939845,P08253,,JVBFGGAYMSJQBZ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017477,IC50,=,240,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799076,DTCT0025094,7595865,DTCC01171474,1811871,47023
CHEMBL1939846,P08253,,RQCBSNJRFVZHOS-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017477,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799076,DTCT0025094,7595866,DTCC01171475,1461560,47023
CHEMBL1939861,P08253,,JIKNCQOTMSZCCM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,=,210000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595963,DTCC01171489,1448052,47024
CHEMBL1939862,P08253,,HNSDWMLOQWSYEZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595987,DTCC01171490,1027241,47024
CHEMBL1939863,P08253,,NSMIRZBXLNLXDX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595988,DTCC01171491,1766143,47024
CHEMBL1939864,P08253,,DUIOAVKMTLORSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595989,DTCC01171492,994770,47024
CHEMBL1939865,P08253,,NPIPEGMWIPYGFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595990,DTCC01171493,1480531,47024
CHEMBL1939866,P08253,,BPAGZGRJYMKXTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595991,DTCC01171494,1155846,47024
CHEMBL1939867,P08253,,LGCJHSHDRDEELV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595992,DTCC01171495,1577168,47024
CHEMBL1939868,P08253,,YCALHTWCQXREQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595993,DTCC01171496,1383924,47024
CHEMBL1939869,P08253,,LOJFRPMFTHNIRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595994,DTCC01171497,348592,47024
CHEMBL1939870,P08253,,HESNUJSXTQZPIZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,=,310000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595995,DTCC01171498,1286070,47024
CHEMBL1939871,P08253,,BPFTZTNLEWSFNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595996,DTCC01171499,1092535,47024
CHEMBL1939872,P08253,,FOLNSFQIWULSJC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595997,DTCC01171500,1027242,47024
CHEMBL1939873,P08253,,BUDKKUJVRGJAJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,=,83000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595998,DTCC01171501,51933,47024
CHEMBL1939874,P08253,,XYAPTVNWZXNGOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7595999,DTCC01171502,121152,47024
CHEMBL1939875,P08253,,REANBRVQFZEMPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,24000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7596000,DTCC01171503,994771,47024
CHEMBL1939876,P08253,,MMJPVSDTLGFIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,=,18000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7596001,DTCC01171504,1734238,47024
CHEMBL1939877,P08253,,UHHFYGOUQISNPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,22000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7596002,DTCC01171505,283179,47024
CHEMBL1939878,P08253,,DMKUTALHEIQGEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22017539,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799145,DTCT0025094,7596003,DTCC01171506,1124652,47024
CHEMBL1940277,P08253,,RNUQVLPAAPSKGH-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601159,DTCC01171896,1642036,47049
CHEMBL1940278,P08253,,SYUFFODKYFQNKR-PBBNMVCDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,3981.07,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601158,DTCC01171897,1706025,47049
CHEMBL1940279,P08253,,BLVTYAOGMSRRPZ-YTTGMZPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,1995.26,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601157,DTCC01171898,542752,47049
CHEMBL1940280,P08253,,IUJKVSRFVDSMJK-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601156,DTCC01171899,1059493,47049
CHEMBL1940281,P08253,,FJMHXOYGOGYKAU-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601155,DTCC01171900,510519,47049
CHEMBL1940282,P08253,,IPGBSWJQXVYQBT-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601154,DTCC01171901,1512992,47049
CHEMBL1940283,P08253,,GQZCCXOGTHJTFK-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601153,DTCC01171902,1642037,47049
CHEMBL1940284,P08253,,IFVVAVDCKGJFSK-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601152,DTCC01171903,1383927,47049
CHEMBL1940285,P08253,,BJMJYODXDWMFDH-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601151,DTCC01171904,542753,47049
CHEMBL1940286,P08253,,YQMHKWPHLMVWLN-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601150,DTCC01171905,444802,47049
CHEMBL1940287,P08253,,BDWCIDSXORGMEX-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,1258.93,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601149,DTCC01171906,1927205,47049
CHEMBL1940288,P08253,,DBVCMEXOYUZQJM-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601148,DTCC01171907,51937,47049
CHEMBL1940289,P08253,,WBHJOSGWNQHLCM-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,6309.57,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601147,DTCC01171908,833354,47049
CHEMBL1940290,P08253,,DCRZEJJUPRPPOS-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,6309.57,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601146,DTCC01171909,1480536,47049
CHEMBL1940291,P08253,,HVWVSAVLGKOEBY-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601145,DTCC01171910,2057793,47049
CHEMBL1940292,P08253,,PLYGOFXFDNGSQZ-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,5011.87,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601144,DTCC01171911,704138,47049
CHEMBL1940293,P08253,,OINRDKHSDNWICI-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601143,DTCC01171912,1927206,47049
CHEMBL1940294,P08253,,OPHMVUHOAQVGHE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601142,DTCC01171913,833355,47049
CHEMBL1940295,P08253,,CFEBEGNWVYAYDX-BCHFMIIMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,6309.57,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601141,DTCC01171914,1798571,47049
CHEMBL1940296,P08253,,CWFNNQMBLVACQD-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,19952.62,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601140,DTCC01171915,1124659,47049
CHEMBL1940308,P08253,,RMPYEISUTHEMLW-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7300,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601128,DTCC01171923,574793,47049
CHEMBL1940308,P08253,,RMPYEISUTHEMLW-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601139,DTCC01171923,574793,47049
CHEMBL1940309,P08253,,WHUKRVZMYYJSJL-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601138,DTCC01171924,1448056,47049
CHEMBL1940310,P08253,,IERBLZLEQYZHMU-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,5011.87,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601137,DTCC01171925,1674314,47049
CHEMBL1940311,P08253,,LIYRHLZYJZBQCM-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,6309.57,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601136,DTCC01171926,1416228,47049
CHEMBL1940312,P08253,,QAOWEZMLHINPHR-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,3981.07,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601135,DTCC01171927,1830857,47049
CHEMBL1940313,P08253,,BVTIVQKMMMOOTF-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601134,DTCC01171928,1318627,47049
CHEMBL1940314,P08253,,OMQWCWIEQOEJBD-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601133,DTCC01171929,1286076,47049
CHEMBL1940315,P08253,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,2511.89,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601131,DTCC01171930,1734241,47049
CHEMBL1940315,P08253,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,5011.87,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601132,DTCC01171930,1734240,47049
CHEMBL1940315,P08253,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,5100,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601127,DTCC01171930,1734240,47049
CHEMBL1940316,P08253,,NMPAJDNRYQXHBH-XGCAABAXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22153941,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,798829,DTCT0025094,7601130,DTCC01171931,1830858,47049
CHEMBL194377,P08253,,LRMGKWDRORXPRE-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860392,DTCC00407675,110120,19837
CHEMBL194430,P08253,,FXZROVPZUUATHR-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,3010,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860440,DTCC00407681,596206,19837
CHEMBL1946141,P08253,,BRXGWWVUCIZYMM-VNRZBHCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,23,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619061,DTCC01174040,736427,47195
CHEMBL1946142,P08253,,HSQOMGXZKXTHEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,203,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619062,DTCC01174041,866229,47195
CHEMBL1946143,P08253,,BCOFTFDFNHXYGF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619063,DTCC01174042,1766168,47195
CHEMBL1946144,P08253,,APJIPTNFOKEMIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,64,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619064,DTCC01174043,1124683,47195
CHEMBL1946145,P08253,,LEIFVUOVYOUZFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,29,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619065,DTCC01174044,866230,47195
CHEMBL1946146,P08253,,HSWKOBISGMUSTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,58,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619066,DTCC01174045,704155,47195
CHEMBL1946147,P08253,,GGMOCOYDYRCVAH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,44,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619067,DTCC01174046,185744,47195
CHEMBL1946148,P08253,,LWNWGJXWKYGLPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,202,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619068,DTCC01174047,1706054,47195
CHEMBL1946149,P08253,,SVUOUTRIPGSFHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,22,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619069,DTCC01174048,1513025,47195
CHEMBL1946275,P08253,,RWOLXJOULAGHOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,13,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619070,DTCC01174168,542782,47195
CHEMBL1946276,P08253,,JZIODDCGNMBMLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,12,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619071,DTCC01174169,1830895,47195
CHEMBL1946277,P08253,,PTJXSKQZLWNDNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,52,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619072,DTCC01174170,833388,47195
CHEMBL1956115,P08253,,GDYIQUFNICPYHF-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22175825,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,2012,55,2,"Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG",,806639,DTCT0025094,7652736,DTCC01177834,866270,47510
CHEMBL195743,P08253,,OCQPVQCJWDXDLQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828755,DTCC00399903,1916250,19718
CHEMBL1957575,P08253,,UNZVEKIWWIPTLX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640461,DTCC01179260,444870,47642
CHEMBL1957576,P08253,,VMVUOYMLEJABRL-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,290000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640462,DTCC01179261,2025902,47642
CHEMBL1957577,P08253,,YQCQHFRCABEIDV-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640463,DTCC01179262,962706,47642
CHEMBL1957578,P08253,,DBVRYQPCZBWOIA-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640464,DTCC01179263,348689,47642
CHEMBL1957579,P08253,,KSINVMMDBYSEMQ-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640465,DTCC01179264,1155933,47642
CHEMBL1957580,P08253,,YSFMLQUQUOQGGE-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640466,DTCC01179265,414252,47642
CHEMBL1957581,P08253,,QARPMAYBEMTQCF-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,400000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640467,DTCC01179266,962707,47642
CHEMBL1957582,P08253,,BCZYCMUPDFSLAA-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640468,DTCC01179267,1609805,47642
CHEMBL1957583,P08253,,GWLKAYBSPXJYIE-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640469,DTCC01179268,1480617,47642
CHEMBL1957584,P08253,,UNZVEKIWWIPTLX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,9000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640470,DTCC01179269,962708,47642
CHEMBL1957585,P08253,,VMVUOYMLEJABRL-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,340000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640471,DTCC01179270,510608,47642
CHEMBL1957586,P08253,,YQCQHFRCABEIDV-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640472,DTCC01179271,672048,47642
CHEMBL1957587,P08253,,DBVRYQPCZBWOIA-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640473,DTCC01179272,1253585,47642
CHEMBL1957588,P08253,,YSFMLQUQUOQGGE-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640475,DTCC01179273,1480618,47642
CHEMBL1957589,P08253,,QARPMAYBEMTQCF-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640476,DTCC01179274,1480619,47642
CHEMBL1957590,P08253,,BCZYCMUPDFSLAA-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,383000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640477,DTCC01179275,542835,47642
CHEMBL1957591,P08253,,GWLKAYBSPXJYIE-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640478,DTCC01179276,542836,47642
CHEMBL1957592,P08253,,ZHIUBXZPUVPTOB-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640479,DTCC01179277,962709,47642
CHEMBL1957593,P08253,,HMENVOZJJJXNDF-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,330000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640480,DTCC01179278,315927,47642
CHEMBL1957594,P08253,,LQQBDPSZMPMYFZ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640481,DTCC01179279,1351359,47642
CHEMBL1957595,P08253,,ZNKFBFNCKBPGMH-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,6800,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640482,DTCC01179280,1318696,47642
CHEMBL1957596,P08253,,TZRWLUAWTLLHBS-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640483,DTCC01179281,1384002,47642
CHEMBL1957597,P08253,,XYGPNXMBVTVKDQ-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640484,DTCC01179282,2025903,47642
CHEMBL1957598,P08253,,UNRBDNFPHSIAEP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640485,DTCC01179283,1318697,47642
CHEMBL1957599,P08253,,FEUGLHVWLKFXEV-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,31000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640486,DTCC01179284,1798651,47642
CHEMBL1957600,P08253,,MTFHBXMAOFMWAG-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,710,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640487,DTCC01179285,381267,47642
CHEMBL1957601,P08253,,CYFUZHPFHKFWQX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640488,DTCC01179286,1642107,47642
CHEMBL1957602,P08253,,UCAJNLLYTGJPBY-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640490,DTCC01179287,1798652,47642
CHEMBL1957603,P08253,,WIOGWLUNCZARAP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640491,DTCC01179288,1027325,47642
CHEMBL1957604,P08253,,FYFJMQCWKQDEQR-FZADBTJQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640492,DTCC01179289,1609806,47642
CHEMBL1957605,P08253,,VVEIZVKRPYJCPP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,53,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640493,DTCC01179290,1862951,47642
CHEMBL1957606,P08253,,LXQUQEBAZBLBEJ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640494,DTCC01179291,1513073,47642
CHEMBL19606,P08253,,NUNJVAPBPSWAAF-AATRIKPKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11934591,INHIBITION,=,75,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 at 50 uM,,Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,8,"Pergament I, Reich R, Srebnik M",,104393,DTCT0025094,699187,DTCC00151187,388157,5468
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.39,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1369664,DTCC00151638,1882182,14854
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,1.1,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,997036,DTCC00151638,1884891,15116
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,KI,=,0.57,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104398,DTCT0025094,1102024,DTCC00151638,1883456,4691
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12729664,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.,Bioorg. Med. Chem. Lett.,2003,13,10,"Augé F, Hornebeck W, Decarme M, Laronze JY",,104364,DTCT0025094,1077044,DTCC00151638,1881879,5548
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14611841,IC50,=,0.104,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104382,DTCT0025094,859746,DTCC00151638,1870949,5741
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,877400,DTCC00151638,1883350,6330
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1885379,DTCC00151638,1872716,20234
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17512742,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447905,DTCT0025094,2176033,DTCC00151638,1873251,23716
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17623656,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507872,DTCT0025094,2388620,DTCC00151638,1885151,29282
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791126,DTCC00151638,1873635,31586
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23376997,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948653,DTCT0025094,11842597,DTCC00151638,1877524,53978
CHEMBL19611,P08253,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,=,0.94,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220674,DTCC00151638,1881417,66798
CHEMBL19623,P08253,,KEPYRBFIGNMAQF-MJGOQNOKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,46.3,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,982753,DTCC00151639,1917024,15116
CHEMBL19632,P08253,,VTJNHMOHJUSRNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11934591,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 at 50 uM,,Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,8,"Pergament I, Reich R, Srebnik M",,104393,DTCT0025094,710808,DTCC00151705,969375,5468
CHEMBL1964690,P08253,,AQMVXDKCKLFNEC-PDGQHHTCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211231,DTCC01181886,2050482,33038
CHEMBL1966168,P08253,,HZNIIVLXLZHRBE-AUEPDCJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211250,DTCC01183289,987923,33038
CHEMBL1966202,P08253,,CLJPDYMKWKWPJY-JVWAILMASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211252,DTCC01183321,955522,33038
CHEMBL196647,P08253,,YZYVVJVNDAWVKA-NCRNUEESSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15837315,IC50,=,197,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 in MMPi assay,,A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.,Bioorg. Med. Chem. Lett.,2005,15,9,"Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S, Tuccinardi T, Atkinson SJ, Murphy G, Balsamo A",,305684,DTCT0025094,1841393,DTCC00403116,1916287,18987
CHEMBL1966700,P08253,,NEQNWYSPLFAEHL-MFKUBSTISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215349,DTCC01183790,377790,33038
CHEMBL1968356,P08253,,BIOLJPLPUJUMME-VULFUBBASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215377,DTCC01185370,1212956,33038
CHEMBL1969992,P08253,,XTTLUNFROHAZTJ-REZTVBANSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215409,DTCC01186942,308731,33038
CHEMBL1970785,P08253,,LUAPITYNGREBDV-VYIQYICTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215418,DTCC01187695,1214646,33038
CHEMBL1970867,P08253,,XCUZAOJYLVPYGX-KEBDBYFISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215428,DTCC01187771,1729401,33038
CHEMBL1971033,P08253,,RVYREKHUEYUDRF-AFUMVMLFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,3790,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215424,DTCC01187930,409192,33038
CHEMBL1971051,P08253,,UYUUPJTVOGKWJA-NLRVBDNBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215433,DTCC01187946,1345301,33038
CHEMBL1971127,P08253,,UIZOYKBALIHNJF-MODPYIGGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215434,DTCC01188016,1250423,33038
CHEMBL1972506,P08253,,JYXBPKCFOJNZEJ-VCHYOVAHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215459,DTCC01189313,148769,33038
CHEMBL1972750,P08253,,OBBFYFVKKMVSJX-MRCUWXFGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215463,DTCC01189543,728924,33038
CHEMBL1973435,P08253,,VCWADNDZBILDKZ-OVVQPSECSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215585,DTCC01190193,1924708,33038
CHEMBL19737,P08253,,GJJVFJLMQUWGKA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11934591,INHIBITION,=,50,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 at 50 uM,,Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,8,"Pergament I, Reich R, Srebnik M",,104393,DTCT0025094,730582,DTCC00151716,421018,5468
CHEMBL1974063,P08253,,MVYJADFDXIEEIL-LZYBPNLTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215484,DTCC01190793,1117555,33038
CHEMBL1975054,P08253,,FSEOZQMTYQTNMA-VCHYOVAHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215496,DTCC01191733,1856075,33038
CHEMBL1975801,P08253,,PCDIWWXMGHCGSL-UDWIEESQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215516,DTCC01192449,1443921,33038
CHEMBL197587,P08253,,DCSURGDKZBMZEV-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860294,DTCC00407623,2014748,19837
CHEMBL1976161,P08253,,XVVUWKWSRDRMEN-REZTVBANSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215536,DTCC01192788,893626,33038
CHEMBL1976317,P08253,,XPUVYFAZUFZFKC-PTGBLXJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215539,DTCC01192936,600047,33038
CHEMBL1976677,P08253,,DJSNSDAGFGXYJR-UBKPWBPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,12500,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215547,DTCC01193279,1987930,33038
CHEMBL1976919,P08253,,JUBBARKNNNVDET-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215526,DTCC01193509,1254348,33038
CHEMBL1977596,P08253,,HHBWEIPXSCZNHO-GIJQJNRQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215573,DTCC01194147,44615,33038
CHEMBL197809,P08253,,SKYVAYDFIWVHPU-LJAQVGFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860321,DTCC00407651,983915,19837
CHEMBL197842,P08253,,WHHAEBOHMHRZGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23376997,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948653,DTCT0025094,11842599,DTCC00407684,1656720,53978
CHEMBL197921,P08253,,XQTQPJFARUOTCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16242329,IC50,>,380000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327978,DTCT0025094,1875145,DTCC00410753,1937031,20151
CHEMBL1979539,P08253,,MYJYHWXNINGPAF-BKHCZYBLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215589,DTCC01195995,567809,33038
CHEMBL1979696,P08253,,DAMRJQZZDSXAHP-MSUUIHNZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215594,DTCC01196137,1121860,33038
CHEMBL1980308,P08253,,MPKRSBLEPUYVPU-LPYMAVHISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215583,DTCC01196711,1278701,33038
CHEMBL198039,P08253,,IRPQGYYABIPNQJ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1490,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860348,DTCC00407671,1048682,19837
CHEMBL1980844,P08253,,HPRLWADTNARROR-AAUIGXPGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,76.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219708,DTCC01197225,181779,33038
CHEMBL1981538,P08253,,DSIQURWTWFNELP-CAOOACKPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,10300,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219690,DTCC01197884,439043,33038
CHEMBL1981977,P08253,N-(2-CHLOROPHENYL)CINNAMAMIDE,FKLXMLNUDVRAJG-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833652,DTCC01198303,91233,53968
CHEMBL1982026,P08253,,VWASGXKHHQTKLJ-AFUMVMLFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219737,DTCC01198350,379304,33038
CHEMBL1982195,P08253,,YGRFQTPANYWCIP-WOJGMQOQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,9600,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219724,DTCC01198513,761581,33038
CHEMBL19822,P08253,,SSXSWDUJXWSCEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11934591,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 at 50 uM,,Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,8,"Pergament I, Reich R, Srebnik M",,104393,DTCT0025094,702773,DTCC00151686,1001907,5468
CHEMBL1982202,P08253,,VMWVYUDRQDYCBN-UFFVCSGVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219727,DTCC01198520,44616,33038
CHEMBL1982308,P08253,,SNJJEQAHOQSQCU-FRKPEAEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219741,DTCC01198624,761306,33038
CHEMBL198254,P08253,,QMJIUHKQZQSTQO-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,164,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860328,DTCC00407668,563938,19837
CHEMBL198262,P08253,,HHHAELOQIYTSIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860297,DTCC00407624,1405256,19837
CHEMBL198262,P08253,,HHHAELOQIYTSIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904533,DTCC00407624,1395426,35265
CHEMBL1983001,P08253,,VNSFDHJGNCVNCC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,4500,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219716,DTCC01199276,1642120,33038
CHEMBL1983460,P08253,,SWRRCRBMEGACLH-OEAKJJBVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219715,DTCC01199712,1282309,33038
CHEMBL1983530,P08253,,HSQZGRXVYRTOEB-MDWZMJQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,70300,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219775,DTCC01199779,1344105,33038
CHEMBL198389,P08253,,HAWUDCIVXQTNAF-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1410,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860359,DTCC00407672,304937,19837
CHEMBL19843,P08253,,OFCWIPGKPUJTDP-CFVMTHIKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,7.5,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,1012777,DTCC00151473,305658,15116
CHEMBL1984584,P08253,,SZXLLFMXEKZWSA-LICLKQGHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219756,DTCC01200773,1344034,33038
CHEMBL1984772,P08253,,YZXMSWHOSVYCEE-JFLMPSFJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219753,DTCC01200953,955066,33038
CHEMBL19855,P08253,,RUZDCFCMYATJSO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11354379,IC50,=,59,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,104558,DTCT0025094,711885,DTCC00151144,581757,4814
CHEMBL1985667,P08253,,KPGWLYWSQHXTJI-NGYBGAFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,65400,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211230,DTCC01201790,732339,33038
CHEMBL1985696,P08253,,WBEJUIIUYNERAB-WSDLNYQXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,8150,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219781,DTCC01201818,1347675,33038
CHEMBL1985795,P08253,,QFRBCSHYOSZRPV-YDZHTSKRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219782,DTCC01201914,1791313,33038
CHEMBL1986889,P08253,,WKQHWXDENFKTTR-OGLMXYFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211242,DTCC01202942,1728019,33038
CHEMBL198778,P08253,,YJRJYIQWWPZSTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23376997,IC50,=,0.04,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948653,DTCT0025094,11842602,DTCC00407760,913494,53978
CHEMBL1988376,P08253,,XGOAMKIHJBMTBL-KEBDBYFISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215361,DTCC01204352,1052111,33038
CHEMBL1988686,P08253,,ZXHJBZNJUGTASZ-VULFUBBASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211253,DTCC01204639,148625,33038
CHEMBL199018,P08253,,XTRLBSLKNQZDBD-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,63,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860403,DTCC00407676,822181,19837
CHEMBL1990774,P08253,,WYIWEKXQKQANMX-VYBCSWDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215376,DTCC01206622,407150,33038
CHEMBL1991303,P08253,,OTEMIVSGEDWQNA-GZTJUZNOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215408,DTCC01207120,1119692,33038
CHEMBL199158,P08253,,HHHAELOQIYTSIY-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,688,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860331,DTCC00407669,1916337,19837
CHEMBL199227,P08253,,YHEMJEYZYLVDRO-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,0.91,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860291,DTCC00407618,1566230,19837
CHEMBL1992308,P08253,,BTTUVRKQKPMSRP-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215444,DTCC01208074,995578,33038
CHEMBL1992359,P08253,,XNEPDLOZYPQVLD-KNTRCKAVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215447,DTCC01208122,633962,33038
CHEMBL199241,P08253,,LSKSBHBGNRQEFN-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1370,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860337,DTCC00407670,1787390,19837
CHEMBL1992681,P08253,,ZYZHGKLZZMTSTC-AFUMVMLFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215440,DTCC01208430,276043,33038
CHEMBL199314,P08253,,JIGAPWRVDSTJDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,23100,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1886064,DTCC00412581,98682,20234
CHEMBL1993220,P08253,,HQEMUXOGAHUNIZ-LFVJCYFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215432,DTCC01208937,666067,33038
CHEMBL1993978,P08253,,AHLTZOWYKANEJH-BRJLIKDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215476,DTCC01209651,244985,33038
CHEMBL1994463,P08253,,TVOQBZFDOHZOGA-GIXFXUBFSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,122,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215474,DTCC01210099,862935,33038
CHEMBL1994877,P08253,,FQEQFDVHSZPCQG-NLRVBDNBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215457,DTCC01210488,439821,33038
CHEMBL1994935,P08253,,STMHNEOUYCKQID-RGVLZGJSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215462,DTCC01210544,634923,33038
CHEMBL1995152,P08253,,DLIYPYGOQBSDLZ-BUGNPGDCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,66300,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215458,DTCC01210752,1762360,33038
CHEMBL1996136,P08253,,HRDOEMHGWCTKMW-JTOYJDTJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215485,DTCC01211689,2020720,33038
CHEMBL1996139,P08253,,PQVVWBFGJPIWQJ-YDZHTSKRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215486,DTCC01211692,344889,33038
CHEMBL1996519,P08253,,CCJHUABELYJYIC-QOCHGBHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215489,DTCC01212054,407095,33038
CHEMBL1996548,P08253,,WUBLALSSEJQFKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215482,DTCC01212082,574880,33038
CHEMBL199666,P08253,,UOBFNJXLVSPHNN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,550,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1885375,DTCC00412724,649762,20234
CHEMBL1997413,P08253,,IYUKIXUZPARFBZ-ZJJJPXMSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215519,DTCC01212908,1344422,33038
CHEMBL1997797,P08253,,OTVPLLNEWZULNQ-HJQQBXHUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215509,DTCC01213273,1344399,33038
CHEMBL1997827,P08253,,FXFCRXYCVFVZJQ-OMCISZLKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215502,DTCC01213299,408959,33038
CHEMBL1998061,P08253,,VUVMTYDFRBVXAN-NGYBGAFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215501,DTCC01213511,2050697,33038
CHEMBL1998736,P08253,N-(2-FLUOROPHENYL)CINNAMAMIDE,GFAVMCPSQILRPK-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.66,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833655,DTCC01214148,1158303,53968
CHEMBL199917,P08253,,GJITXIQQHBXCIH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16392792,IC50,=,2.6,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329820,DTCT0025094,1880235,DTCC00412005,1743962,20214
CHEMBL1999908,P08253,,FZCZZABZCQZPPO-QRVIBDJDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,30000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215570,DTCC01215257,829964,33038
CHEMBL20,P08253,ACETAZOLAMIDE,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,Active,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617811,DTCC00133144,21741,56109
CHEMBL2000103,P08253,,GFUYNLWLERBTQA-HFZPWKHCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215578,DTCC01215439,1735037,33038
CHEMBL2000877,P08253,,PJGTWVUBLLWFFY-FOKLQQMPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215568,DTCC01216179,1856795,33038
CHEMBL2001433,P08253,,UEEKFOQRCWCHOR-NHDPSOOVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215601,DTCC01216704,761421,33038
CHEMBL2002565,P08253,,VFHJRRJULULMQH-WSDLNYQXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215593,DTCC01217793,1795216,33038
CHEMBL200274,P08253,,JGRIYRSQHHLUHI-BSOSBYQFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16392792,IC50,=,20,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329820,DTCT0025094,1880236,DTCC00411964,1004812,20214
CHEMBL2003445,P08253,,UFDMBGHPPFXBAX-RCCKNPSSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219698,DTCC01218624,1887250,33038
CHEMBL2003808,P08253,,SSYRQEZOOHPBDK-ZVHZXABRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219693,DTCC01218969,696928,33038
CHEMBL200385,P08253,,DBVIHPVOZIIXAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16242329,IC50,=,685000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327978,DTCT0025094,1875144,DTCC00410754,1970289,20151
CHEMBL200435,P08253,,GVMUNGGWXRKCEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16242329,IC50,=,58000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327978,DTCT0025094,1875146,DTCC00410823,1425968,20151
CHEMBL2004916,P08253,,CPFSCJOSSXSTPW-FEDGQQDLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219736,DTCC01220016,373392,33038
CHEMBL2005518,P08253,,PNOFCMMJWIDROZ-MTJSOVHGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219725,DTCC01220599,1539841,33038
CHEMBL2005671,P08253,,INSCAFMGYGRJSL-IFRROFPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219772,DTCC01220741,1380467,33038
CHEMBL2006338,P08253,,QBUJNSNDZCHEPL-SSDVNMTOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219764,DTCC01221376,41384,33038
CHEMBL2006357,P08253,,OHKQJEGTOCPDIP-YBFXNURJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219754,DTCC01221394,925410,33038
CHEMBL2007227,P08253,,JIMLXYXCMRNIKK-YBFXNURJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219785,DTCC01222220,1669109,33038
CHEMBL201206,P08253,,QTFXITWPRZRHMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,2110,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1885354,DTCC00412719,488239,20234
CHEMBL201298,P08253,3-(4-PHENYLETHYNYLBENZOYL)NONANOIC ACID,RPSYWEPJQQLLJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,1660,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1886061,DTCC00001425,617002,20234
CHEMBL20154,P08253,,LPZWIAVKYXCHGC-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,0.34,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1132704,DTCC00151563,918357,4691
CHEMBL20154,P08253,,LPZWIAVKYXCHGC-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,0.38,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,580582,DTCC00151563,918364,4692
CHEMBL20154,P08253,,LPZWIAVKYXCHGC-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,0.339,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258392,DTCC00151563,909281,24803
CHEMBL202875,P08253,,OQWWYXZJKRAMIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,440,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1886062,DTCC00412620,1037173,20234
CHEMBL202932,P08253,,BZVYQWLRCHLAGK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16451058,KI,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330545,DTCT0025094,1887708,DTCC00413183,1274996,20245
CHEMBL202932,P08253,,BZVYQWLRCHLAGK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,1.5,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061749,DTCC00413183,1263648,22402
CHEMBL203139,P08253,,IIMXFTNJRIHVRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,5740,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1886063,DTCC00412582,1490531,20234
CHEMBL203160,P08253,,XVLVIDNHSWHJBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16289878,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334535,DTCT0025094,469048,DTCC00415520,855174,20373
CHEMBL203199,P08253,,WJAZWFDODWLPHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,15370,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1886051,DTCC00110088,195410,20234
CHEMBL2036146,P08253,,LBKYPJCBYUCLNW-JQWIXIFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22607877,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP2 using succinylated gelatin as substrate incubated for 10 mins prior to substrate addition measured after 1 hr by UV/VIS spectrophotometry,,"Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2012,20,12,"Su L, Jia Y, Zhang L, Xu Y, Fang H, Xu W",,822742,DTCT0025094,10498252,DTCC01237934,1429675,48415
CHEMBL2036147,P08253,,GKMHOQOLPKVIEQ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22607877,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP2 using succinylated gelatin as substrate incubated for 10 mins prior to substrate addition measured after 1 hr by UV/VIS spectrophotometry,,"Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2012,20,12,"Su L, Jia Y, Zhang L, Xu Y, Fang H, Xu W",,822742,DTCT0025094,10498253,DTCC01237935,458796,48415
CHEMBL2036148,P08253,,WCDZXFCWQCZLHJ-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22607877,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP2 using succinylated gelatin as substrate incubated for 10 mins prior to substrate addition measured after 1 hr by UV/VIS spectrophotometry,,"Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2012,20,12,"Su L, Jia Y, Zhang L, Xu Y, Fang H, Xu W",,822742,DTCT0025094,10498254,DTCC01237936,134910,48415
CHEMBL2036152,P08253,,NQSWZMRCVJAUPQ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22607877,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP2 using succinylated gelatin as substrate incubated for 10 mins prior to substrate addition measured after 1 hr by UV/VIS spectrophotometry,,"Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2012,20,12,"Su L, Jia Y, Zhang L, Xu Y, Fang H, Xu W",,822742,DTCT0025094,10498255,DTCC01237940,1747717,48415
CHEMBL2036155,P08253,,YAVDAOYFBAYJLB-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22607877,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP2 using succinylated gelatin as substrate incubated for 10 mins prior to substrate addition measured after 1 hr by UV/VIS spectrophotometry,,"Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2012,20,12,"Su L, Jia Y, Zhang L, Xu Y, Fang H, Xu W",,822742,DTCT0025094,10498256,DTCC01237943,1008520,48415
CHEMBL203972,P08253,,BZIUKEPVFXHVPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16289878,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334535,DTCT0025094,469046,DTCC00415441,1113898,20373
CHEMBL204048,P08253,,CNJHNAILYAGVJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16289878,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334535,DTCT0025094,469050,DTCC00415512,1981982,20373
CHEMBL2043424,P08253,,FATWEDBJJYSZOL-XLDGYAMZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,,MedChemComm,2012,3,11,,,1327984,DTCT0025094,13570931,DTCC01241735,1387287,40045
CHEMBL204357,P08253,SR-973,WICQDDCNCVTFDX-VJGNERBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16473009,KI,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,9,"Thompson LA, Liauw AY, Ramanjulu MM, Kasireddy-Polam P, Mercer SE, Maduskuie TP, Glicksman M, Roach AH, Meredith JE, Liu RQ, Combs AP, Higaki JN, Cordell B, Seiffert D, Zaczek RC, Robertson DW, Olson RE",,350091,DTCT0025094,1920809,DTCC00001675,1949133,20704
CHEMBL204495,P08253,,JHHLVVDASBMHIL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16289878,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334535,DTCT0025094,469051,DTCC00415490,1695445,20373
CHEMBL204543,P08253,"NAPHTHALENE-1,2-DIOL",NXPPAOGUKPJVDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,71,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103782,DTCC00001534,1892886,43205
CHEMBL204549,P08253,,OZLFXWYCUHTSQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16289878,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334535,DTCT0025094,469049,DTCC00415513,855173,20373
CHEMBL204593,P08253,,LUCFRFDOOYLALP-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16338135,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.,Bioorg. Med. Chem. Lett.,2006,16,4,"Xiong Y, Wiltsie J, Woods A, Guo J, Pivnichny JV, Tang W, Bansal A, Cummings RT, Cunningham BR, Friedlander AM, Douglas CM, Salowe SP, Zaller DM, Scolnick EM, Schmatz DM, Bartizal K, Hermes JD, MacCoss M, Chapman KT",,334084,DTCT0025094,1895864,DTCC00415249,1598833,20352
CHEMBL2047536,P08253,,DACARRUBIAXSBX-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22175799,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827021,DTCT0025094,10526931,DTCC01242723,653432,48586
CHEMBL2047537,P08253,,CZRLAOXITNZAJA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22175799,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827021,DTCT0025094,10526929,DTCC01242724,1655819,48586
CHEMBL2048502,P08253,MACRATHOIN F,VEBNYMXKXIIGFX-KBXRYBNXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,3880,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534764,DTCC01243472,1844458,48665
CHEMBL2048502,P08253,MACRATHOIN F,VEBNYMXKXIIGFX-KBXRYBNXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535481,DTCC01243472,1844458,48665
CHEMBL2048503,P08253,,MZNIJRAPCCELQX-HWKANZROSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,64190,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534765,DTCC01243473,492092,48665
CHEMBL2048503,P08253,,MZNIJRAPCCELQX-HWKANZROSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535482,DTCC01243473,492092,48665
CHEMBL2048504,P08253,,FLOHNUCSNZDDJO-DUXPYHPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534766,DTCC01243474,427800,48665
CHEMBL2048505,P08253,DIMETHYL LITHOSPERMATE,YAXTXMBBIHBGPZ-ZBBBDWFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,11650,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534767,DTCC01243475,1494333,48665
CHEMBL2048505,P08253,DIMETHYL LITHOSPERMATE,YAXTXMBBIHBGPZ-ZBBBDWFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535483,DTCC01243475,1494333,48665
CHEMBL2048506,P08253,,QWHMMEKTFNJGTI-GNBMGSNXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,15470,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534768,DTCC01243476,1041021,48665
CHEMBL2048506,P08253,,QWHMMEKTFNJGTI-GNBMGSNXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535484,DTCC01243476,1041021,48665
CHEMBL2048507,P08253,DAPHNODORIN F,KVPJDVHJFGPPAB-XOHQIPOJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,23280,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534772,DTCC01243477,2071373,48665
CHEMBL2048507,P08253,DAPHNODORIN F,KVPJDVHJFGPPAB-XOHQIPOJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535488,DTCC01243477,2071373,48665
CHEMBL2048508,P08253,"(2R,3S)-DIHYDROMYRICETIN",KJXSIXMJHKAJOD-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,11900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534774,DTCC00042059,362498,48665
CHEMBL2048508,P08253,"(2R,3S)-DIHYDROMYRICETIN",KJXSIXMJHKAJOD-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535490,DTCC00042059,362498,48665
CHEMBL2048509,P08253,,FYEZJIXULOZDRT-ARJAWSKDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534778,DTCC01243478,717883,48665
CHEMBL2048510,P08253,,DXXGHDAWCPTRPU-XOSAIJSUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,33260,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534779,DTCC01243479,556512,48665
CHEMBL2048510,P08253,,DXXGHDAWCPTRPU-XOSAIJSUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535492,DTCC01243479,556512,48665
CHEMBL2048511,P08253,ALPHA-ISOVALEROXYISOVALERIC ACID,SOJFCTIYHPWXGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,23320,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10535383,DTCC00042060,264062,48665
CHEMBL2048511,P08253,ALPHA-ISOVALEROXYISOVALERIC ACID,SOJFCTIYHPWXGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535494,DTCC00042060,264062,48665
CHEMBL2048512,P08253,,FQRZOEBSTPAQBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,3.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10535385,DTCC01243480,1812174,48665
CHEMBL2048512,P08253,,FQRZOEBSTPAQBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535495,DTCC01243480,1812174,48665
CHEMBL204987,P08253,,FAMUHUCWJMEIBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936996,DTCC00422957,1165882,20885
CHEMBL205290,P08253,,VRUYZVHIDJWWTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926475,DTCC00421634,617113,20786
CHEMBL205523,P08253,,HBYOIHRPSQTDLO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926495,DTCC00422036,1361292,20786
CHEMBL205900,P08253,,XNQVZVNWVMQCPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926489,DTCC00422242,778397,20786
CHEMBL206045,P08253,,IAFQRNRIALQQBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936988,DTCC00422970,520536,20885
CHEMBL206254,P08253,,DJBJEUJDVZJUDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926478,DTCC00422256,1652037,20786
CHEMBL2062755,P08253,,MZRQRBAXYNSSEV-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14714267,DTCC01247043,2099572,67810
CHEMBL2063270,P08253,,CXKWJJJVWDMSAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,61,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566504,DTCC01247512,186720,48923
CHEMBL2063271,P08253,,LEBLJISYPUWAJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,450,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566505,DTCC01247513,2090921,48923
CHEMBL2063272,P08253,,KUWJZFVZZLSOHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,600,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566506,DTCC01247514,1896167,48923
CHEMBL2063273,P08253,,BGRGANYQQMRQLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,78,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566507,DTCC01247515,316901,48923
CHEMBL2063274,P08253,,AHDPJKYOQXMDIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640801,DTCC01247516,811665,56235
CHEMBL2063274,P08253,,AHDPJKYOQXMDIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,6,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566508,DTCC01247516,834451,48923
CHEMBL2063275,P08253,,GPZUWAHQDYJABE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,300,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566509,DTCC01247517,1546082,48923
CHEMBL2063276,P08253,,STSMSPOAFPZOFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,180,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566510,DTCC01247518,349672,48923
CHEMBL2063277,P08253,,RMRUTHBBMQENKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566513,DTCC01247519,543747,48923
CHEMBL2063424,P08253,,UFSIAJGUBRRIFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,328,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550767,DTCC01247667,931314,48933
CHEMBL2063425,P08253,,RFSACISSBFAKAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,53,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550766,DTCC01247668,705155,48933
CHEMBL2063426,P08253,,GBVUVWPIAISPTQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,149,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550765,DTCC01247669,316905,48933
CHEMBL2063427,P08253,,SOYSLGSCAATJQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,158,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550764,DTCC01247670,1156905,48933
CHEMBL2063428,P08253,,SQFVCIISKZFYEN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,219,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550763,DTCC01247671,575813,48933
CHEMBL2063429,P08253,,BTTWODSMIQJXGA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,179,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550762,DTCC01247672,1578216,48933
CHEMBL2063430,P08253,,NVBXFVBQTBCCGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,3.8,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550761,DTCC01247673,186722,48933
CHEMBL2063431,P08253,,AXYQUZFSLFKHHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,24,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550760,DTCC01247674,1221473,48933
CHEMBL2063432,P08253,,JHWSWPBPMTVCRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,7.3,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550759,DTCC01247675,1643031,48933
CHEMBL2063433,P08253,,RIMRTAIVLQRBJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550758,DTCC01247676,154722,48933
CHEMBL2063517,P08253,,MBENXCXDGKNNSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,66,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550757,DTCC01247745,1449090,48933
CHEMBL2063518,P08253,,GJZJWROSQYQKJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22248361,IC50,=,15,NM,,,,,,,,,,,,,,"Inhibition of p-aminophenylmercuric acetate stimulated human recombinant MMP-2 using (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 as substrate after 45 mins by fluorogenic assay",,Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion.,J. Med. Chem.,2012,55,5,"Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF",,832803,DTCT0025094,10550756,DTCC01247746,1961262,48933
CHEMBL2064540,P08253,,GKLOCXVNLLEZMX-DIPNUNPCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563910,DTCC01248689,284246,48958
CHEMBL2064541,P08253,,GDXZUNJRYLVZAT-WJOKGBTCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563909,DTCC01248690,1254587,48958
CHEMBL2064542,P08253,,YDSGUUACYYBPLW-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,0.35,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563908,DTCC01248691,1028287,48958
CHEMBL2064543,P08253,,HBDUXNUNXGZOCK-VLIRCAPWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563911,DTCC01248692,316917,48958
CHEMBL2064544,P08253,,JZHHNBACJYFNCE-LDLOPFEMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563912,DTCC01248693,543756,48958
CHEMBL2064545,P08253,,JLXRKMSJFVPFIG-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563913,DTCC01248694,1707024,48958
CHEMBL2064546,P08253,,ANZWBBMLNAIBAB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,107,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563914,DTCC01248695,186735,48958
CHEMBL2064547,P08253,,LOPZANGJCBIBLO-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,0.13,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563915,DTCC01248696,382253,48958
CHEMBL2064548,P08253,,FGQWFLDBWZDRJJ-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,0.07,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563916,DTCC01248697,1319659,48958
CHEMBL2064549,P08253,,NRRIJAHIBBGLNH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,0.1,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563917,DTCC01248698,1767171,48958
CHEMBL2064550,P08253,,UMBBJTOZRJURJL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,1.2,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563918,DTCC01248699,1449098,48958
CHEMBL2064551,P08253,,JXMJSOSLBMBYGM-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563919,DTCC01248700,316918,48958
CHEMBL2064552,P08253,,TUYLXABAVZEOSZ-WGVHSKNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,0.2,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563920,DTCC01248701,769661,48958
CHEMBL2064553,P08253,,YWHKQQSHVPCBRN-LQFQNGICSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563921,DTCC01248702,1319660,48958
CHEMBL206694,P08253,,QRNDNIUBUODBRF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,6.8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936998,DTCC00422951,1905161,20885
CHEMBL206944,P08253,,BRPNMBTUBIMOLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,0.84,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937008,DTCC00110339,2035841,20885
CHEMBL206993,P08253,,OVSGONSKJHXDJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926481,DTCC00422065,940295,20786
CHEMBL207018,P08253,,MCNQDQIVWJTIBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926486,DTCC00421714,260143,20786
CHEMBL207026,P08253,,MIBJKVVEWJVVMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936991,DTCC00423331,1522847,20885
CHEMBL207075,P08253,,FAKDVMIECOUVIL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926492,DTCC00422051,1840834,20786
CHEMBL207176,P08253,,WJMUWEBGODGZSG-OXHAUKAOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20970895,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,2-azetidinone--a new profile of various pharmacological activities.,Eur. J. Med. Chem.,2010,45,12,"Mehta PD, Sengar NP, Pathak AK",,696212,DTCT0025094,5021441,DTCC00421644,151219,42247
CHEMBL207180,P08253,,MIUWEXKKKWGHOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926494,DTCC00422044,972339,20786
CHEMBL207242,P08253,,HCCXAZUXAREIQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937000,DTCC00423351,1198385,20885
CHEMBL207305,P08253,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926476,DTCC00421580,552632,20786
CHEMBL207305,P08253,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457281,DTCC00421580,565360,32556
CHEMBL207415,P08253,,ZTSCXJSYCOZWKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926477,DTCC00422266,876063,20786
CHEMBL207468,P08253,,RBUVXLALMRWKQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926497,DTCC00110329,227887,20786
CHEMBL207683,P08253,,NHMWZOLCOOIQJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926479,DTCC00422250,1165868,20786
CHEMBL207709,P08253,,ALAICNBWAOLDPL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926493,DTCC00422046,1295959,20786
CHEMBL207726,P08253,,CBKSKDVWCOUHEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926482,DTCC00421740,2035826,20786
CHEMBL207729,P08253,,CVZIHNYAZLXRRS-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14718605,IC50,=,4.7,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14717448,DTCC00110220,2101028,69108
CHEMBL207729,P08253,,CVZIHNYAZLXRRS-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180873,DTCC00110220,844026,23780
CHEMBL207729,P08253,,CVZIHNYAZLXRRS-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19095454,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495049,DTCT0025094,2594719,DTCC00110220,856184,32093
CHEMBL207999,P08253,,FQARNXJHFBTHOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926480,DTCC00422073,1004906,20786
CHEMBL208009,P08253,,BODLESUVCQEUII-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926499,DTCC00421655,1037257,20786
CHEMBL208022,P08253,,ADROOOBIKREWPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926496,DTCC00421838,260142,20786
CHEMBL208136,P08253,,ORZIBOAGVYKRKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936999,DTCC00423360,714019,20885
CHEMBL208172,P08253,,CTANAKVMPKAIQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926487,DTCC00421845,552631,20786
CHEMBL208287,P08253,,XIADLDSNTKDSQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,8.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937011,DTCC00423345,326038,20885
CHEMBL208548,P08253,,XOZSROHJXDJOTN-NXSKXAQUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 10 nM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494402,DTCT0025094,2595850,DTCC00427081,132090,32132
CHEMBL208548,P08253,,XOZSROHJXDJOTN-NXSKXAQUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 100 nM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494404,DTCT0025094,2595854,DTCC00427081,132090,32132
CHEMBL208548,P08253,,XOZSROHJXDJOTN-NXSKXAQUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 1 uM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494406,DTCT0025094,2595858,DTCC00427081,132090,32132
CHEMBL208548,P08253,,XOZSROHJXDJOTN-NXSKXAQUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 10 nM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494408,DTCT0025094,2595862,DTCC00427081,132090,32132
CHEMBL208548,P08253,,XOZSROHJXDJOTN-NXSKXAQUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 100 nM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494410,DTCT0025094,2595866,DTCC00427081,132090,32132
CHEMBL208548,P08253,,XOZSROHJXDJOTN-NXSKXAQUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 1 uM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494412,DTCT0025094,2595870,DTCC00427081,132090,32132
CHEMBL208548,P08253,,XOZSROHJXDJOTN-NXSKXAQUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity in presence of 1 uM anandamide receptor antagonist O-1918 relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494599,DTCT0025094,2595874,DTCC00427081,132090,32132
CHEMBL208615,P08253,,NJXYRSYNXFYWJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936992,DTCC00423326,1840844,20885
CHEMBL208749,P08253,,NXLDFFHMRBRNMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937002,DTCC00423320,714018,20885
CHEMBL208841,P08253,,BNKOGVVBAYMLMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,113,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969687,DTCC00428615,2067649,21111
CHEMBL2088987,P08253,,UBEZABQQAQIAHU-CXAGYDPISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527165,DTCT0025094,14586897,DTCC01255821,386875,64111
CHEMBL2088987,P08253,,UBEZABQQAQIAHU-CXAGYDPISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14585735,DTCC01255821,386875,64111
CHEMBL2088988,P08253,,UBEZABQQAQIAHU-SUMWQHHRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,45,%,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586878,DTCC01255822,159372,64111
CHEMBL2088989,P08253,,ZQYRDNFYQHYIPA-FZKQIMNGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,39,%,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586874,DTCC01255823,1130243,64111
CHEMBL2088990,P08253,,UCTXPISEYKNHPX-APPDUMDISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527165,DTCT0025094,14586891,DTCC01255824,839224,64111
CHEMBL2088990,P08253,,UCTXPISEYKNHPX-APPDUMDISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586871,DTCC01255824,839224,64111
CHEMBL2088991,P08253,,UCTXPISEYKNHPX-PIGZYNQJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527165,DTCT0025094,14586890,DTCC01255825,321564,64111
CHEMBL2088991,P08253,,UCTXPISEYKNHPX-PIGZYNQJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,80,%,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586870,DTCC01255825,321564,64111
CHEMBL2088991,P08253,,UCTXPISEYKNHPX-PIGZYNQJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of gelatinolytic activity of pro-MMP2 in human endothelial progenitor cells assessed as reduction in active form of protein at 20 uM by gelatin zymography,Active,,MedChemComm,2015,6,2,,,1527284,DTCT0025094,14586917,DTCC01255825,321564,64111
CHEMBL2088991,P08253,,UCTXPISEYKNHPX-PIGZYNQJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of gelatinolytic activity of pro-MMP2 in human A375P cells assessed as reduction in active form of protein at 20 uM by gelatin zymography,Active,,MedChemComm,2015,6,2,,,1527167,DTCT0025094,14586907,DTCC01255825,321564,64111
CHEMBL2088991,P08253,,UCTXPISEYKNHPX-PIGZYNQJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of gelatinolytic activity of pro-MMP2 in human A375P cells assessed as reduction in active form of protein by gelatin zymography,Dose-dependent effect,,MedChemComm,2015,6,2,,,1527169,DTCT0025094,14586911,DTCC01255825,321564,64111
CHEMBL2088992,P08253,,KSMJBRDXKNNSIK-TVQRCGJNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,40,%,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586873,DTCC01255826,839225,64111
CHEMBL2088993,P08253,,KSMJBRDXKNNSIK-NOZJJQNGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,144,NM,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527165,DTCT0025094,14586892,DTCC01255827,255773,64111
CHEMBL2088993,P08253,,KSMJBRDXKNNSIK-NOZJJQNGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,69,%,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586872,DTCC01255827,255773,64111
CHEMBL2088994,P08253,,UAGQDLDHLLZEMM-VNGHWMNVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527165,DTCT0025094,14586896,DTCC01255828,191229,64111
CHEMBL2088994,P08253,,UAGQDLDHLLZEMM-VNGHWMNVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14585686,DTCC01255828,191229,64111
CHEMBL2089002,P08253,DEMETHYLWEDELOLACTONE,LUTYTNLPIUCKBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22926226,INHIBITION,,,,,cell_based,,,,,,,,,,,MDA-MB-231,Inhibition of MMP2 in human MDA-MB-231 cells at 20 uM up to 12 hrs by gelatin-zymogrphy,Active,Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.,Eur. J. Med. Chem.,2012,56,,"Lee YJ, Lin WL, Chen NF, Chuang SK, Tseng TH",,841228,DTCT0025094,10599667,DTCC01255836,1747890,49383
CHEMBL208966,P08253,,NOEGDKHKBSNSLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937007,DTCC00423112,1522846,20885
CHEMBL209077,P08253,,SAPCBLWTLXPCAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,556,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937015,DTCC00423311,876078,20885
CHEMBL209165,P08253,,XQDJISOXSDMORY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,0.74,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937005,DTCC00423120,293433,20885
CHEMBL209289,P08253,,KTYYQUGYTGYWLG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936995,DTCC00423127,810707,20885
CHEMBL209465,P08253,,XROIFKGGWPRMAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936989,DTCC00423391,1102482,20885
CHEMBL209490,P08253,,YLPGDDBCDVVMDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,249,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969724,DTCC00428567,1684282,21111
CHEMBL209930,P08253,,PAMSLXKVBFUENP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,295,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937016,DTCC00423310,260156,20885
CHEMBL209970,P08253,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,355,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969605,DTCC00428551,1426125,21111
CHEMBL209970,P08253,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,355,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153842,DTCC00428551,1426378,23077
CHEMBL209970,P08253,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180816,DTCC00428551,1426485,23780
CHEMBL209970,P08253,,CEVLUPQNDFOYSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,355,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2456491,DTCC00428551,1438568,32556
CHEMBL210084,P08253,,RNHOXGSFKJUDNY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,518,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969618,DTCC00110502,1522899,21111
CHEMBL210133,P08253,,BXOTYZMFPUKYAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969612,DTCC00110503,1619858,21111
CHEMBL210441,P08253,,LOZYBBRAEOAORI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937001,DTCC00423321,778415,20885
CHEMBL210517,P08253,,OIBWGGKYJHWGPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936997,DTCC00422956,1872825,20885
CHEMBL211007,P08253,,GNAOSQHBSOBWJQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937014,DTCC00423315,1295972,20885
CHEMBL211036,P08253,,BOVXSDPQKQCWHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936993,DTCC00422997,1715682,20885
CHEMBL211037,P08253,,WDCDJEJTWPFGEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936987,DTCC00422998,1198386,20885
CHEMBL2111573,P08253,,IHERVMJHCHNTKO-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14611841,IC50,=,19.6,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104382,DTCT0025094,886783,DTCC01263970,808904,5741
CHEMBL2111965,P08253,,KMLOBHZAEFITDB-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,,,,,,,,,,,,,,,,,Inhibition of gelatinase-A (Matrix metalloprotease-2) (Not determined),Not Determined,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106806,DTCT0025094,1366554,DTCC01264342,1208504,15412
CHEMBL211274,P08253,,NILIMKWDWHKQOZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969671,DTCC00428620,227939,21111
CHEMBL2112796,P08253,,KMLOBHZAEFITDB-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,,,,,,,,,,,,,,,,,Inhibition of gelatinase-A (Matrix metalloprotease-2) (Not determined),Not Determined,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106806,DTCT0025094,1401851,DTCC01265121,1241293,15412
CHEMBL2114138,P08253,,IVPPTWCRAFCOFJ-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,6.3,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1581944,DTCC01266112,1423987,16699
CHEMBL2114138,P08253,,IVPPTWCRAFCOFJ-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,260,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1561142,DTCC01266112,1423986,16699
CHEMBL211487,P08253,,MTSOZTJGECJILJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,49,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969710,DTCC00428518,520596,21111
CHEMBL2115165,P08253,ABT-518,IVPPTWCRAFCOFJ-RTBURBONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.78,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1572600,DTCC00045007,550427,16699
CHEMBL2115165,P08253,ABT-518,IVPPTWCRAFCOFJ-RTBURBONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,25,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1576464,DTCC00045007,550426,16699
CHEMBL2115165,P08253,ABT-518,IVPPTWCRAFCOFJ-RTBURBONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.78,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,,MedChemComm,2012,3,11,,,1327984,DTCT0025094,13570930,DTCC00045007,578263,40045
CHEMBL2115236,P08253,,QLXCQCDAJMULKF-ZJZGAYNASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8064799,KI,=,120,NM,,,,,,,,,,,,,,Binding constant containing a pseudophenylalanine residue,,Cyclic peptides with a phosphinic bond as potent inhibitors of a zinc bacterial collagenase.,J. Med. Chem.,1994,37,17,"Yiotakis A, Lecoq A, Vassiliou S, Raynal I, Cuniasse P, Dive V",,49496,DTCT0025094,959884,DTCC01266686,788070,12611
CHEMBL211726,P08253,,LWFCUEQJXZSHMP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969655,DTCC00428523,326079,21111
CHEMBL211770,P08253,,WPYFTDWGMAINBU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969624,DTCC00428541,163652,21111
CHEMBL212205,P08253,,ZUMRSIZQUOZFGG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,553,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969696,DTCC00428527,1134656,21111
CHEMBL212411,P08253,,LNPBBURQSUEIHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969640,DTCC00428532,1652105,21111
CHEMBL212481,P08253,,HNEDFPGSHTUVKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969663,DTCC00428522,1872868,21111
CHEMBL212481,P08253,,HNEDFPGSHTUVKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,62,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832589,DTCC00428522,1885648,33699
CHEMBL2147932,P08253,,JJEQVMCXSWLAFG-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,67500,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344275,DTCC01283929,900065,50678
CHEMBL2147933,P08253,,XLTAUYZYNOXGKZ-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,83700,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344276,DTCC01283930,1320165,50678
CHEMBL2147934,P08253,,AQQXVKQWGGPPHH-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,27600,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344277,DTCC01283931,1675845,50678
CHEMBL2147935,P08253,,PEWMYOGUIVOHOE-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,17800,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344278,DTCC01283932,1578786,50678
CHEMBL2147936,P08253,,CFQFKSCYVRTOCO-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,10700,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344279,DTCC01283933,1126141,50678
CHEMBL2147937,P08253,,BRUMAFXUJDREAI-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,74600,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344280,DTCC01283934,1028839,50678
CHEMBL2147938,P08253,,QMJNWCLUFNKUJE-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,85500,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344266,DTCC01283935,737966,50678
CHEMBL2147939,P08253,,KGVPJOAAWWBOTJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,12500,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344267,DTCC01283936,479797,50678
CHEMBL2147940,P08253,,BXVGHIDPEPREOP-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344268,DTCC01283937,1352878,50678
CHEMBL2147941,P08253,,RDLZRDGONWXGAB-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,6300,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344269,DTCC01283938,673532,50678
CHEMBL2147942,P08253,,GKYAOKWOMSONDW-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,9800,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344265,DTCC01283939,1578787,50678
CHEMBL2147943,P08253,,AHELQCUNRPOHQJ-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,8100,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344264,DTCC01283940,2091496,50678
CHEMBL2147944,P08253,,VCXXRMRBSJAWIA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344263,DTCC01283941,1643561,50678
CHEMBL2147945,P08253,,RCZUFNDVXLBQOV-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344261,DTCC01283942,1189826,50678
CHEMBL2147946,P08253,,MPOZOLBTFHJUBC-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344262,DTCC01283943,1352879,50678
CHEMBL2147947,P08253,,XXLWVDAYISNRTI-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,7600,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344260,DTCC01283944,512125,50678
CHEMBL2147948,P08253,,OOUSNVIOISIYAN-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,4500,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344259,DTCC01283945,1157450,50678
CHEMBL2147949,P08253,,KNBGWMZYQFXBFN-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,750,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344257,DTCC01283946,1189827,50678
CHEMBL2147950,P08253,,WHEVDQNIXVBCRX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344258,DTCC01283947,54425,50678
CHEMBL2147951,P08253,,TVYPKYLSWYFBFL-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,270,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344256,DTCC01283948,382798,50678
CHEMBL2147952,P08253,,KTDVXRMDSWQUCS-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344255,DTCC01283949,1767669,50678
CHEMBL2147953,P08253,,QSKIKACUEIVZAI-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,460,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344253,DTCC01283950,835004,50678
CHEMBL2148008,P08253,,RIZIZKAXSCVVSY-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344254,DTCC01284005,737967,50678
CHEMBL2148009,P08253,,DYKLZYLZOHTNDU-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,67,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344252,DTCC01284006,867775,50678
CHEMBL2148010,P08253,,GIFRIPDQEDWYST-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344251,DTCC01284007,187237,50678
CHEMBL2148011,P08253,,YSWINLJFFQMZJQ-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344250,DTCC01284008,317440,50678
CHEMBL2148012,P08253,,CSMSDQFQJKDBEB-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,3900,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344249,DTCC01284009,1864403,50678
CHEMBL2148013,P08253,,HYLMOGQPCGXZDA-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344274,DTCC01284010,155267,50678
CHEMBL2148014,P08253,,VKIRCTZZWNSTQN-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344248,DTCC01284011,1994634,50678
CHEMBL2148015,P08253,,AOINDPPGFJRJDY-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344233,DTCC01284012,544290,50678
CHEMBL2151348,P08253,,NWWZGWZTAZLVRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate at 10 uM incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854275,DTCT0025094,11370893,DTCC01284445,135194,50870
CHEMBL2151349,P08253,,LXUDTRDQVKIQBB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,39000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370842,DTCC01284446,1106416,50870
CHEMBL2151350,P08253,,NYMLUNFPRGMRNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,21200,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370843,DTCC01284447,297496,50870
CHEMBL2151351,P08253,,LGIWFZRBXLCBCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate at 10 uM incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854275,DTCT0025094,11370894,DTCC01284448,1941376,50870
CHEMBL2151352,P08253,,QYUJNLGEANWSCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,184,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370844,DTCC01284449,1494536,50870
CHEMBL2151353,P08253,,HWKBTEUWFWNXHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370845,DTCC01284450,1494537,50870
CHEMBL2151354,P08253,,PMSYYJDPQTWTTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,8100,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370846,DTCC01284451,1526825,50870
CHEMBL2151355,P08253,,AADOVZDIDBIZSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,301,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370847,DTCC01284452,718092,50870
CHEMBL2151356,P08253,,AHVFZGRDMQDODJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,278,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370848,DTCC01284453,1558882,50870
CHEMBL2151357,P08253,,FHMXFHQIBLHDDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,148,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370849,DTCC01284454,231886,50870
CHEMBL2151358,P08253,,AGAWLHFJRLMKEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,121,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370850,DTCC01284455,2007154,50870
CHEMBL2151359,P08253,,SDXNOQQCPWCNQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,143,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370851,DTCC01284456,814777,50870
CHEMBL2151360,P08253,,NNAGWFHDLZVPJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370852,DTCC01284457,1688074,50870
CHEMBL2151361,P08253,,DUYNKLSOEWBOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,58,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370853,DTCC01284458,1779983,50870
CHEMBL2151362,P08253,,HIPJPXVTDXVQMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370854,DTCC01284459,1397773,50870
CHEMBL2151363,P08253,,OROXFGPUFVFZQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,87,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370855,DTCC01284460,1041255,50870
CHEMBL2151364,P08253,,BHEWROOMWGCNFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,1340,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370856,DTCC00131095,1719403,50870
CHEMBL2151365,P08253,,VGXSIAPPDJZRCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,IC50,=,181,NM,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854272,DTCT0025094,11370857,DTCC00131096,685778,50870
CHEMBL2151366,P08253,,XMDWOYHLYOJZLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate at 100 uM incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854277,DTCT0025094,11370897,DTCC01284461,814778,50870
CHEMBL2151367,P08253,,FJUYBDSGTYSLQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23149299,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate at 100 uM incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854277,DTCT0025094,11370898,DTCC01284462,264295,50870
CHEMBL2153260,P08253,,MJNLEGDDXDONRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,IC50,=,12.4,UG.ML-1,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853829,DTCT0025094,11368662,DTCC01286244,155289,50935
CHEMBL2153261,P08253,,MYOCPUSBKSPROQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,IC50,=,3,UG.ML-1,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853829,DTCT0025094,11368663,DTCC01286245,1482141,50935
CHEMBL2153263,P08253,,VHNMVIBGZONBAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,IC50,=,19,UG.ML-1,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853829,DTCT0025094,11368664,DTCC01286247,187262,50935
CHEMBL2153264,P08253,,JZRNXAPRPJTGOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate at 20 ug/ml preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853830,DTCT0025094,11368665,DTCC01286248,317467,50935
CHEMBL2153265,P08253,,CRSRGBLNXLTDTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate at 20 ug/ml preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853830,DTCT0025094,11368666,DTCC01286249,1896735,50935
CHEMBL2153266,P08253,,IEJOMJUTRBOWNE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,INHIBITION,=,11,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate at 20 ug/ml preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853830,DTCT0025094,11368667,DTCC01286250,317468,50935
CHEMBL2153268,P08253,,DJAYVQDFUAOEKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,INHIBITION,=,21,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate at 20 ug/ml preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853830,DTCT0025094,11368668,DTCC01286252,1126162,50935
CHEMBL2153737,P08253,,LHVGXRIIQBVWQU-JHOVWCEZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21780776,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850719,DTCT0025094,11357592,DTCC01286634,284807,50957
CHEMBL2153738,P08253,,CGPJRIXIBMANTN-PHCUSUGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21780776,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850719,DTCT0025094,11357660,DTCC01286635,705682,50957
CHEMBL2170077,P08253,2-(4-PHENOXYPHENYLSULFONAMIDO)ETHYLCARBAMOYLPHOSPHONIC ACID,AINNCHVLRRGREE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 measured every 5 mins for 3 hrs,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861929,DTCT0025094,11420859,DTCC00045312,556752,51419
CHEMBL2170078,P08253,3-(4-PHENOXYPHENYLSULFONAMIDO)PROPYLCARBAMOYLPHOSPHONIC ACID,WKUTYURYKGUAPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 measured every 5 mins for 3 hrs,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861929,DTCT0025094,11420858,DTCC00045313,944322,51419
CHEMBL2170079,P08253,4-(4-PHENOXYPHENYLSULFONAMIDO)BUTYLCARBAMOYLPHOSPHONIC ACID,GCWNMMYPQYXINB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 measured every 5 mins for 3 hrs,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861929,DTCT0025094,11420857,DTCC00045314,1008873,51419
CHEMBL2170080,P08253,5-(4-PHENOXYPHENYLSULFONAMIDO)PENTYLCARBAMOYLPHOSPHONIC ACID,RSXKZRJAIWEVPD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 measured every 5 mins for 3 hrs,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861929,DTCT0025094,11420856,DTCC00045315,1494617,51419
CHEMBL2172744,P08253,6-(4-PHENOXYPHENYLSULFONAMIDO)HEXYLCARBAMOYLPHOSPHONIC ACID,PHBFNHNDQZJMJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 measured every 5 mins for 3 hrs,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861929,DTCT0025094,11420855,DTCC00045399,1202249,51419
CHEMBL2172745,P08253,2-(4-PHENOXYBENZAMIDO)ETHYLCARBAMOYLPHOSPHONIC ACID,FUJJTYSHSJUEIS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420860,DTCC00045400,1876888,51419
CHEMBL2172746,P08253,(S)-1-CYCLOHEXYLETHYLCARBAMOYLPHOSPHONIC ACID,DFBCBGRDZHMYBK-ZETCQYMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420864,DTCC00045401,199565,51419
CHEMBL2172747,P08253,(R)-1-CYCLOHEXYLETHYLCARBAMOYLPHOSPHONIC ACID,DFBCBGRDZHMYBK-SSDOTTSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420863,DTCC00045402,459218,51419
CHEMBL2172748,P08253,,ZBCBKVJXSTYFMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Determined,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420862,DTCC01293925,1138902,51419
CHEMBL2172749,P08253,,ZRDMGKMQRSWULW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Determined,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420861,DTCC01293926,1365462,51419
CHEMBL217285,P08253,,QUOVSBFFBCDNHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,=,50,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617807,DTCC00435081,1624821,56109
CHEMBL218586,P08253,,KALKLNBLKRHXMI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019765,DTCC00438882,1081562,21880
CHEMBL219104,P08253,,MITLEGOYVUMBJH-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019766,DTCC00438881,661246,21880
CHEMBL219104,P08253,,MITLEGOYVUMBJH-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,446,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276502,DTCC00438881,650433,25086
CHEMBL219105,P08253,,YCCUTKPNUYYNML-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,64,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019757,DTCC00438922,1916656,21880
CHEMBL2204087,P08253,,RTOXIYMJLZFAIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23134659,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of para-amino phenylmercuric acetate-activated MMP2 using Mca-P-L-G-L-Dap(Dnp)-A-R-NH2 as substrate after 1 hr by fluorescence assay,,Design and synthesis of procollagen C-proteinase inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,24,"Turtle E, Chow N, Yang C, Sosa S, Bauer U, Brenner M, Solow-Cordero D, Ho WB",,886677,DTCT0025094,11488701,DTCC01299452,738138,52120
CHEMBL2204802,P08253,,HTYBLKDBXIVZAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23134659,IC50,>,25000,NM,,,,,,,,,,,,,,Inhibition of para-amino phenylmercuric acetate-activated MMP2 using Mca-P-L-G-L-Dap(Dnp)-A-R-NH2 as substrate after 1 hr by fluorescence assay,,Design and synthesis of procollagen C-proteinase inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,24,"Turtle E, Chow N, Yang C, Sosa S, Bauer U, Brenner M, Solow-Cordero D, Ho WB",,886677,DTCT0025094,11488703,DTCC01300083,1514774,52120
CHEMBL2204807,P08253,,CJZYEUWWKSOBJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23134659,IC50,>,6000,NM,,,,,,,,,,,,,,Inhibition of para-amino phenylmercuric acetate-activated MMP2 using Mca-P-L-G-L-Dap(Dnp)-A-R-NH2 as substrate after 1 hr by fluorescence assay,,Design and synthesis of procollagen C-proteinase inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,24,"Turtle E, Chow N, Yang C, Sosa S, Bauer U, Brenner M, Solow-Cordero D, Ho WB",,886677,DTCT0025094,11488702,DTCC01300088,155442,52120
CHEMBL2204943,P08253,,ZBHMNPFLXLENRH-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466038,DTCC01300219,1061223,51793
CHEMBL2204945,P08253,,GULAHLKWSRKKLP-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466037,DTCC01300221,2091644,51793
CHEMBL2204947,P08253,,MDWLLICHHNOYTC-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,573000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466036,DTCC01300223,1514777,51793
CHEMBL2204949,P08253,,OCBWACJAYXFAFO-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466035,DTCC01300225,1896880,51793
CHEMBL2204950,P08253,,VRQZXSUCWGBJIY-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466034,DTCC01300226,1896881,51793
CHEMBL2204951,P08253,,WXFOPRULEBBAOM-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466033,DTCC01300227,1611515,51793
CHEMBL2204952,P08253,,AHEQYFRNVZSMPY-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466032,DTCC01300228,996540,51793
CHEMBL2204953,P08253,,CBAYKXZXONVVTA-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466031,DTCC01300229,1962023,51793
CHEMBL2204954,P08253,,JYQPTCATJPOGGL-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466030,DTCC01300230,1546779,51793
CHEMBL2204959,P08253,,RFGJRKGWQKGXJW-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,545000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466029,DTCC01300235,576533,51793
CHEMBL220501,P08253,,SMNLJWDKCNVQNU-RDJZCZTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019764,DTCC00438889,1852360,21880
CHEMBL2205657,P08253,,XGNIOZCAZTWXMZ-WCHFFXHOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,,,,,,,,,,,,,,,,,Activity at MMP2,Active,,ACS Med. Chem. Lett.,2012,3,8,,,879881,DTCT0025094,11466126,DTCC01300890,738152,51794
CHEMBL220975,P08253,,AXVVLBQLURTOIQ-DVRYWGNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019713,DTCC00438857,110435,21880
CHEMBL221120,P08253,,IWNGNUDBGMCFNB-RDJZCZTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019763,DTCC00438890,110436,21880
CHEMBL221698,P08253,,XKPUKZQRNSFQLM-JYJNAYRXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,960,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019760,DTCC00438914,532136,21880
CHEMBL221698,P08253,,XKPUKZQRNSFQLM-JYJNAYRXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,960,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101212,DTCC00438914,522478,36106
CHEMBL221857,P08253,,GGYBWFRTPPVUAZ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019719,DTCC00438873,1340603,21880
CHEMBL221857,P08253,,GGYBWFRTPPVUAZ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,195,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276419,DTCC00438873,1329203,25086
CHEMBL221857,P08253,,GGYBWFRTPPVUAZ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828320,DTCC00438873,1329994,33677
CHEMBL224857,P08253,,FMMHCRVDJPIDBV-RGEXLXHISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,10300,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215562,DTCC00445116,1382425,33038
CHEMBL225164,P08253,CLOXYQUIN,CTQMJYWDVABFRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,60,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5102598,DTCC00445307,1828598,43205
CHEMBL226149,P08253,,PMVJGZGFFBJYLQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,94000,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079335,DTCC00449747,488621,22603
CHEMBL226345,P08253,ADENINE,GFFGJBXGBJISGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103319,DTCC00449510,86517,43205
CHEMBL226438,P08253,,SDEDFYBPNWGZBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,1060,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079343,DTCC00449739,1037499,22603
CHEMBL226439,P08253,,ICISPHGVMHWYTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,4900,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079341,DTCC00449741,424345,22603
CHEMBL226439,P08253,,ICISPHGVMHWYTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3286004,DTCC00449741,437752,38228
CHEMBL226439,P08253,,ICISPHGVMHWYTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,3600,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835708,DTCC00449741,447228,53820
CHEMBL226630,P08253,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113790,DTCC00002834,1523163,23023
CHEMBL226630,P08253,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440144,DTCT0025094,2113811,DTCC00002834,1523163,23023
CHEMBL226630,P08253,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440150,DTCT0025094,2113839,DTCC00002834,1523163,23023
CHEMBL226630,P08253,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440156,DTCT0025094,2113868,DTCC00002834,1523163,23023
CHEMBL226630,P08253,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,>,60000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710448,DTCC00002834,1535490,32223
CHEMBL226686,P08253,,FRASWKFJOBLAQF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710441,DTCC00452728,1726167,32223
CHEMBL226840,P08253,,QDRXDXOBHKCANX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113783,DTCC00452722,1808687,23023
CHEMBL226840,P08253,,QDRXDXOBHKCANX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440144,DTCT0025094,2113813,DTCC00452722,1808687,23023
CHEMBL226840,P08253,,QDRXDXOBHKCANX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440150,DTCT0025094,2113841,DTCC00452722,1808687,23023
CHEMBL226840,P08253,,QDRXDXOBHKCANX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440156,DTCT0025094,2113870,DTCC00452722,1808687,23023
CHEMBL226852,P08253,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,=,79600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113788,DTCC00452681,1361615,23023
CHEMBL226852,P08253,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440144,DTCT0025094,2113818,DTCC00452681,1361615,23023
CHEMBL226852,P08253,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440150,DTCT0025094,2113846,DTCC00452681,1361615,23023
CHEMBL226852,P08253,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440156,DTCT0025094,2113875,DTCC00452681,1361615,23023
CHEMBL226853,P08253,,BCLDMTLBRZOHBQ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113787,DTCC00452682,1587495,23023
CHEMBL226853,P08253,,BCLDMTLBRZOHBQ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440144,DTCT0025094,2113817,DTCC00452682,1587495,23023
CHEMBL226853,P08253,,BCLDMTLBRZOHBQ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440150,DTCT0025094,2113845,DTCC00452682,1587495,23023
CHEMBL226853,P08253,,BCLDMTLBRZOHBQ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440156,DTCT0025094,2113874,DTCC00452682,1587495,23023
CHEMBL227484,P08253,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,2.3,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061755,DTCC00447716,326283,22402
CHEMBL227484,P08253,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,2.3,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061997,DTCC00447716,326284,22402
CHEMBL227501,P08253,,WNLZTTHHHYZJMB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,24,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061752,DTCC00447830,1426294,22402
CHEMBL227553,P08253,,FHZGYMLWCVBBPM-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,980,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061751,DTCC00447831,1166105,22402
CHEMBL227565,P08253,,HRNIVSOLWXFPBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,30000,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079340,DTCC00449742,1263674,22603
CHEMBL227566,P08253,,DSHAKCWOEUEDGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,137000,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079334,DTCC00449748,1555229,22603
CHEMBL227567,P08253,,FUTYODHCEHIGHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,1980,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079339,DTCC00449743,260406,22603
CHEMBL227598,P08253,,VKFNDAOTTJONML-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,1.8,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061758,DTCC00447803,972589,22402
CHEMBL227824,P08253,,RVKPGECPCLBLDB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,0.39,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061759,DTCC00447798,940549,22402
CHEMBL228141,P08253,,AGSXHHFUSDGSSO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,790,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061750,DTCC00447839,520801,22402
CHEMBL228176,P08253,,PJOVXZAUKZMBRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,2100,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079338,DTCC00449744,293688,22603
CHEMBL228187,P08253,,NZKKRYAESABOSS-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,53,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061754,DTCC00447819,1684493,22402
CHEMBL228188,P08253,,BGBWSADVPWNBME-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,30,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061753,DTCC00447820,1102691,22402
CHEMBL228229,P08253,,JNDVWCINXNIDOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,68000,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079333,DTCC00449749,1263675,22603
CHEMBL228230,P08253,,MTXWGHZYBWXADO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,33700,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079332,DTCC00449750,1523089,22603
CHEMBL228230,P08253,,MTXWGHZYBWXADO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,34000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59798,DTCC00449750,1519347,65811
CHEMBL228231,P08253,,OISVGEVVTLNTBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,151000,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079330,DTCC00449752,1166128,22603
CHEMBL228267,P08253,,HGNMRIKSORWTLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101561,DTCC00455485,1437635,22885
CHEMBL228268,P08253,,GQLPTZZPKXZFQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,=,2472,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101560,DTCC00455487,143032,22885
CHEMBL228318,P08253,,BSAORORNNRENRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101558,DTCC00455489,1884640,22885
CHEMBL228319,P08253,,CLYVYZOSMYXOBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101557,DTCC00455490,984390,22885
CHEMBL228320,P08253,,HVVGLHPJPUUJHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101556,DTCC00455491,467364,22885
CHEMBL228320,P08253,,HVVGLHPJPUUJHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2456514,DTCC00455491,468361,32556
CHEMBL229070,P08253,,BDTGEWQPSASMAZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221431,DTCC00455480,391848,24252
CHEMBL229070,P08253,,BDTGEWQPSASMAZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101564,DTCC00455480,403563,22885
CHEMBL229072,P08253,,IKRKDUGQVRSGJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101562,DTCC00455483,1373275,22885
CHEMBL229239,P08253,5-FLUOROSALICYLIC ACID,JWPRICQKUNODPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103164,DTCC00002746,183414,43205
CHEMBL229375,P08253,,ZPTQFUMRMHOLBG-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,=,5900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113936,DTCC00452790,1873146,23023
CHEMBL229375,P08253,,ZPTQFUMRMHOLBG-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,=,5900,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710433,DTCC00452790,1885412,32223
CHEMBL229844,P08253,N-(4-HYDROXYPHENYL)CINNAMAMIDE,WSRJZGPYPSPGLJ-IZZDOVSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.28,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833662,DTCC00002737,416566,53968
CHEMBL229866,P08253,,AMIZSFRPEJZLFK-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113785,DTCC00452703,746658,23023
CHEMBL229866,P08253,,AMIZSFRPEJZLFK-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440144,DTCT0025094,2113815,DTCC00452703,746658,23023
CHEMBL229866,P08253,,AMIZSFRPEJZLFK-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440150,DTCT0025094,2113843,DTCC00452703,746658,23023
CHEMBL229866,P08253,,AMIZSFRPEJZLFK-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440156,DTCT0025094,2113872,DTCC00452703,746658,23023
CHEMBL230194,P08253,,BPADIXRUNSRDOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,IC50,=,10,UG.ML-1,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853829,DTCT0025094,11368661,DTCC00454330,1578808,50935
CHEMBL230806,P08253,AGELADINE A,QAKGJAQGTQLMFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603499,DTCT0025094,3163458,DTCC00454296,1179428,36845
CHEMBL230806,P08253,AGELADINE A,QAKGJAQGTQLMFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,IC50,=,1.2,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP2,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853824,DTCT0025094,11368655,DTCC00454296,1189861,50935
CHEMBL230806,P08253,AGELADINE A,QAKGJAQGTQLMFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,IC50,=,1.7,UG.ML-1,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853829,DTCT0025094,11368660,DTCC00454296,1189861,50935
CHEMBL2311189,P08253,,ZZEXJLFHXHHYNW-FAUQPBOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,110,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305105,DTCT0025094,1828968,DTCC01335054,1469469,19718
CHEMBL2311765,P08253,,WPGRSZLFNFYSPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,56,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750484,DTCC01335238,770711,53282
CHEMBL2311766,P08253,,XLNFBXKUCFOQRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,69,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750483,DTCC01335239,1897286,53282
CHEMBL2311767,P08253,,DRCOOMXUPYOBBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,145,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750482,DTCC01335240,900591,53282
CHEMBL2311768,P08253,,BZTZPJQXNWROKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,227,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750481,DTCC01335241,674087,53282
CHEMBL2311769,P08253,,BUELAJMDFCPTAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750480,DTCC01335242,1995132,53282
CHEMBL2311770,P08253,,FHCIUVTYGHWJQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,71,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750479,DTCC01335243,996895,53282
CHEMBL2311771,P08253,,UKASSNVNXOWYDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750478,DTCC01335244,416242,53282
CHEMBL2311772,P08253,,VEDBWSBFHMUYOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750477,DTCC01335245,1320712,53282
CHEMBL2311773,P08253,,VPYJEILNNUZOBL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,598,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750476,DTCC01335246,576898,53282
CHEMBL2311774,P08253,,PHKLGXHLOXCURO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,57,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750488,DTCC01335247,1800637,53282
CHEMBL2311775,P08253,,XATUMTIXUAJCSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750489,DTCC01335248,383300,53282
CHEMBL2311776,P08253,,HTUSESRFPXTJLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,149,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750487,DTCC01335249,1768162,53282
CHEMBL2311777,P08253,,LYRSIRCJLISGFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,82,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750486,DTCC01335250,2027994,53282
CHEMBL2311778,P08253,,WDDBBBHPBMFFCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23246356,IC50,=,67,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935678,DTCT0025094,11750485,DTCC01335251,446880,53282
CHEMBL2316256,P08253,,RXBMEHOLQJITJI-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935215,DTCT0025094,11751190,DTCC01339596,71045,53441
CHEMBL2316257,P08253,,LIUMDGLYGBIKBM-SFYKDHMMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935215,DTCT0025094,11751210,DTCC01339597,589403,53441
CHEMBL231665,P08253,,MGIMQKIBRRRYRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,61.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153924,DTCC00461920,778733,23077
CHEMBL231666,P08253,,DUPLEMOAJXTDKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,51,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153923,DTCC00461921,1070027,23077
CHEMBL231667,P08253,,UFEAOVWYWYBIFX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,51,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153922,DTCC00461922,1684599,23077
CHEMBL231877,P08253,,WUVJCBZUUQXYIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153920,DTCC00461924,358923,23077
CHEMBL231878,P08253,,IASRCCATUJITDX-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,58,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153919,DTCC00461925,260453,23077
CHEMBL231879,P08253,,LOOGWNWWNBNMRC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,172,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153918,DTCC00461926,1587506,23077
CHEMBL232086,P08253,,FGPWEPZCTGVLNA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,555,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2154021,DTCC00461927,1037560,23077
CHEMBL2324202,P08253,,BHQDUEIUHBHLON-GXPIJPPGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23437776,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin)-mediated omniMMP degradation up to 10 uM,Not Active,Optimization of Peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity.,J. Med. Chem.,2013,56,6,"Abdul-Hay SO, Lane AL, Caulfield TR, Claussin C, Bertrand J, Masson A, Choudhry S, Fauq AH, Maharvi GM, Leissring MA",,941891,DTCT0025094,11786402,DTCC01342534,1202721,53652
CHEMBL2326363,P08253,,UIVFNXLDHQCJRY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23458498,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940803,DTCT0025094,11795568,DTCC01344669,199799,53669
CHEMBL2326364,P08253,,XXBXRJDBCMCGGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23458498,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940803,DTCT0025094,11795567,DTCC01344670,2040368,53669
CHEMBL2326365,P08253,,CREFCFAJHQSGNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23458498,IC50,=,61,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940803,DTCT0025094,11795566,DTCC01344671,913412,53669
CHEMBL2326366,P08253,,UIVFNXLDHQCJRY-VNRZBHCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23458498,KD,=,15,NM,,,,,,,,,,,,,,Binding affinity to MMP-2 (unknown origin),,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940792,DTCT0025094,11795546,DTCC01344672,1235267,53669
CHEMBL2333287,P08253,,HTYCVVAAKRVDGM-LKCJCFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23353736,IC50,=,3200,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).,Eur. J. Med. Chem.,2013,62,,"Yuan H, Lu W, Wang L, Shan L, Li H, Huang J, Sun Q, Zhang W",,946631,DTCT0025094,11806940,DTCC01346826,868646,53896
CHEMBL2333288,P08253,,HTYCVVAAKRVDGM-IPXXLZSSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23353736,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).,Eur. J. Med. Chem.,2013,62,,"Yuan H, Lu W, Wang L, Shan L, Li H, Huang J, Sun Q, Zhang W",,946631,DTCT0025094,11806939,DTCC01346827,447178,53896
CHEMBL233629,P08253,,YIIFUMKWGPMPET-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169348,DTCC00464768,1070100,23623
CHEMBL2336335,P08253,N-(4-CHLOROPHENYL)CINNAMAMIDE,LSOIYQMAEOVIGQ-IZZDOVSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.72,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833650,DTCC01349758,1321013,53968
CHEMBL2336336,P08253,,WTSJOZDFIVRLTA-RUDMXATFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.11,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836366,DTCC01349759,577250,53968
CHEMBL2336337,P08253,,QQDGGVVFYXVOQK-DHZHZOJOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.32,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836364,DTCC01349760,1255977,53968
CHEMBL2336338,P08253,,XWIGBGGXYQBYPB-JXMROGBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.47,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836362,DTCC01349761,835857,53968
CHEMBL2336339,P08253,,OLGQLHIPIBDKPN-RMKNXTFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1674.23,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836361,DTCC01349762,1708381,53968
CHEMBL2336340,P08253,,MNOXESDMWKOCBB-XCVCLJGOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,3.97,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836360,DTCC01349763,771008,53968
CHEMBL2336341,P08253,,FCQCRGCQYBHIKM-DHZHZOJOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.53,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836359,DTCC01349764,188047,53968
CHEMBL2336342,P08253,,GVKCJQMPJDFTJX-JXMROGBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1764.37,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836358,DTCC01349765,188048,53968
CHEMBL2336343,P08253,,NAWGIDSZZLHVGD-NYYWCZLTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,4.09,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836357,DTCC01349766,512972,53968
CHEMBL2336344,P08253,,HKSVMOLUXTUBKV-DHZHZOJOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.62,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836356,DTCC01349767,609569,53968
CHEMBL2336345,P08253,,JKVBUPKDMBQGAH-JXMROGBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1754.54,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836355,DTCC01349768,416565,53968
CHEMBL2336346,P08253,4-METHYL-(4'-HYDROXY)CINNAMANILIDE,JKPCWPAVEKIDRM-IZZDOVSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,4.19,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836354,DTCC01349769,2028326,53968
CHEMBL2336347,P08253,,MEZDZNCLUJMWCO-JXMROGBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.01,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836353,DTCC01349770,351094,53968
CHEMBL2336348,P08253,,NFRVALKAEKTXJW-RMKNXTFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1578.64,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836352,DTCC01349771,1321014,53968
CHEMBL2336349,P08253,,MMEMOVPZWOUUDC-XCVCLJGOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.39,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836351,DTCC01349772,1579681,53968
CHEMBL2336350,P08253,,SWSHUSNBFAYRJI-JXMROGBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836350,DTCC01349773,2092348,53968
CHEMBL2336351,P08253,,ISQOWKBSJWNQFE-XCVCLJGOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.04,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836348,DTCC01349774,1095000,53968
CHEMBL2336352,P08253,N-BENZYLCINNAMAMIDE,MPWRITRYGLHZBT-VAWYXSNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.02,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836346,DTCC01349775,609570,53968
CHEMBL2336353,P08253,N-(2-HYDROXYPHENYL)CINNAMAMIDE,CYJJBQPBDGQQFZ-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,6.24,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836344,DTCC01349776,351095,53968
CHEMBL2336354,P08253,N-(3-HYDROXYPHENYL)CINNAMAMIDE,IIFFDQOHESPFOL-MDZDMXLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1785.67,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836343,DTCC00045986,1612247,53968
CHEMBL2336355,P08253,N-(2-METHOXYPHENYL)CINNAMAMIDE,RMBQQMJNYKVGEL-VAWYXSNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,6.32,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833661,DTCC01349777,123576,53968
CHEMBL2336356,P08253,N-(3-METHOXYPHENYL)CINNAMAMIDE,GVTLFGJNTIRUEG-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1853.73,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833660,DTCC00045987,1515435,53968
CHEMBL2336357,P08253,N-(4-METHOXYPHENYL)CINNAMAMIDE,WEMJCDDYUBVWRB-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.37,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833659,DTCC01349778,1190743,53968
CHEMBL2336358,P08253,N-O-TOLYLCINNAMAMIDE,VHCQQXKZAMLIPM-VAWYXSNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,6.41,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833658,DTCC01349779,932806,53968
CHEMBL2336359,P08253,N-P-TOLYLCINNAMAMIDE,BZTAHBIRTCNRAW-FMIVXFBMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.46,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833656,DTCC01349780,1929599,53968
CHEMBL2336360,P08253,N-(3-FLUOROPHENYL)CINNAMAMIDE,SQJXVMSLVGLGQR-MDZDMXLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1859.32,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833654,DTCC00045988,1386355,53968
CHEMBL2336361,P08253,N-(4-FLUOROPHENYL)CINNAMAMIDE,FSGUMUYMSDYGOB-IZZDOVSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11833653,DTCC01349781,1450491,53968
CHEMBL2336362,P08253,3-HYDROXY-CINNAMANILIDE,BXDHXEGLUPHJCL-MDZDMXLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.41,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836384,DTCC01349782,1579682,53968
CHEMBL2336363,P08253,,ZGEIJYNGFAYBLZ-MDZDMXLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.44,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836383,DTCC01349783,2092349,53968
CHEMBL2336364,P08253,,KOHQEJQWHDVMAG-MDZDMXLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.46,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836381,DTCC01349784,188049,53968
CHEMBL2336365,P08253,,YFNMOUZZAUENGW-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.57,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836380,DTCC01349785,447220,53968
CHEMBL2336366,P08253,,GMZUXMRGXGHDIM-BQYQJAHWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1524.69,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836379,DTCC01349786,835858,53968
CHEMBL2336779,P08253,,WADSTQPPRBFDRC-RUDMXATFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,4.18,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836378,DTCC01350185,1929606,53968
CHEMBL2336780,P08253,,XSGGJVXCEQZANP-MDZDMXLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.62,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836377,DTCC01350186,674449,53968
CHEMBL2336781,P08253,,SBHIDPHFTJXXDA-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1674.81,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836376,DTCC01350187,1833246,53968
CHEMBL2336782,P08253,,KEKJEZHUSREKBJ-BJMVGYQFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,4.32,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836375,DTCC01350188,932809,53968
CHEMBL2336783,P08253,,JAWRIGQGECSYFZ-MDZDMXLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.73,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836374,DTCC01350189,2092344,53968
CHEMBL2336784,P08253,,IMHFDXPRVKWYLM-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1724.94,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836373,DTCC01350190,997224,53968
CHEMBL2336785,P08253,4-METHYL-(3'-HYDROXY)CINNAMANILIDE,JYPMYOZVAOWZEW-JXMROGBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,4.43,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836372,DTCC01350191,964988,53968
CHEMBL2336786,P08253,,QCDWMGBNZNDWIQ-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.09,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836371,DTCC01350192,1061925,53968
CHEMBL2336787,P08253,,FTPPVEIEMOLRCH-BQYQJAHWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1867.71,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836370,DTCC01350193,771013,53968
CHEMBL2336788,P08253,,LEZHWFABXKSTPU-RUDMXATFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.59,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836369,DTCC01350194,252608,53968
CHEMBL2336789,P08253,,OMUJIZDFZQJYDG-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,9.41,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836368,DTCC01350195,1547464,53968
CHEMBL2337130,P08253,,BEZJPBNIFWANDL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835698,DTCC01350532,56348,53820
CHEMBL2337131,P08253,,AJAHTKZXCRUIAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835696,DTCC01350533,1061928,53820
CHEMBL2337690,P08253,,FGQTUBBIXYISNM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23376997,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948653,DTCT0025094,11842604,DTCC01351073,1527535,53978
CHEMBL2337691,P08253,,ZVJILQAAQQNBOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23376997,IC50,=,3.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948653,DTCT0025094,11842603,DTCC01351074,848343,53978
CHEMBL2337691,P08253,,ZVJILQAAQQNBOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,3.8,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586891,DTCC01351074,868999,55984
CHEMBL2337696,P08253,,UGRPRGWEEBXORM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23376997,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948653,DTCT0025094,11842601,DTCC01351079,1462678,53978
CHEMBL2337697,P08253,,BTMSEVQRJBBBAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23376997,IC50,=,0.43,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948653,DTCT0025094,11842600,DTCC01351080,1559589,53978
CHEMBL2337698,P08253,,CHTZMALPRVCUIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23376997,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro- Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to substrate addition measured every 15 secs for 15 mins by fluorometric analysis,,Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation.,Eur. J. Med. Chem.,2013,62,,"Nuti E, Santamaria S, Casalini F, Yamamoto K, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Marini AM, Salerno S, Taliani S, Da Settimo F, Nagase H, Rossello A",,948653,DTCT0025094,11842598,DTCC01351081,492967,53978
CHEMBL233842,P08253,,LBHPINDOHXBHHL-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169347,DTCC00464769,1135027,23623
CHEMBL233843,P08253,,XDSDBWPXGOPPFL-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169345,DTCC00464771,326448,23623
CHEMBL233844,P08253,,ZASAXMMLZWOHBG-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169344,DTCC00464772,1970813,23623
CHEMBL2338554,P08253,SYMPLOSTATIN 5,KPKJQINJXGFAPS-NBGICTFWSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23350733,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using (5-FAM/QXLTM) FRET peptide substrate assessed as residual activity at 10 uM incubated for 15 mins prior to substrate addition measured for 2 hrs,,Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.,J. Med. Chem.,2013,56,3,"Salvador LA, Taori K, Biggs JS, Jakoncic J, Ostrov DA, Paul VJ, Luesch H",,944689,DTCT0025094,11803600,DTCC01351885,686495,53882
CHEMBL233932,P08253,,ZYKVSIDVBIFMGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,73,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153917,DTCC00461901,1490934,23077
CHEMBL234032,P08253,,IBWSLBQVCNZYSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169343,DTCC00464773,260537,23623
CHEMBL234033,P08253,,UNCGRKPTWVECFJ-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169342,DTCC00464774,1684679,23623
CHEMBL234034,P08253,,NMHJSIJTDAPUMQ-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169341,DTCC00464775,876465,23623
CHEMBL234143,P08253,,DKLKUPISRVEUAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153941,DTCC00461904,1426379,23077
CHEMBL234144,P08253,,KAWCOVYOZMDLKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153940,DTCC00461905,1166190,23077
CHEMBL234145,P08253,,IYSKDTAJMOMROJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153939,DTCC00461906,778732,23077
CHEMBL234199,P08253,,KEGZCMGJDRKBBL-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169349,DTCC00464767,260536,23623
CHEMBL234350,P08253,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14759279,DTCC00461900,2111482,69259
CHEMBL234350,P08253,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14759928,DTCC00461900,2111482,69259
CHEMBL234350,P08253,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153843,DTCC00461900,650170,23077
CHEMBL234351,P08253,,VGMJDHAFWAQDDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153937,DTCC00461908,1198666,23077
CHEMBL234352,P08253,,KVLYVSHQXNTARE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153936,DTCC00461909,1296297,23077
CHEMBL234353,P08253,,WHUGMPJJQOVPAC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,62.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153935,DTCC00461910,1296298,23077
CHEMBL234529,P08253,,QSOYTCHABFMDFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,25.3,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800852,DTCC00463157,1071223,31524
CHEMBL234530,P08253,,HFLSBITWFGZVGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,1.57,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800870,DTCC00111741,1071224,31524
CHEMBL234565,P08253,,VRQPNJFSKYEBCN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,2058,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153934,DTCC00461911,228220,23077
CHEMBL234566,P08253,,GFRCZBUEHADXTC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,176,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153932,DTCC00461913,326357,23077
CHEMBL234567,P08253,,BIGQJQKSDHOEOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,664,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153931,DTCC00461914,1808694,23077
CHEMBL234735,P08253,,LQNSDZTXHZUYKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,16.2,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800861,DTCC00111742,1685708,31524
CHEMBL234737,P08253,,IIOCRGOBAHXAAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,>,100000,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800833,DTCC00463160,392918,31524
CHEMBL234774,P08253,,XAISFEMYYICOMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153929,DTCC00461916,876379,23077
CHEMBL234775,P08253,,JOILTJHUYYDODY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153928,DTCC00461917,488690,23077
CHEMBL234776,P08253,,PRHFUFABVIQNBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153927,DTCC00461918,714342,23077
CHEMBL2347847,P08253,,JFYUPKXGFNQNTK-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453070,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) by FRET method,,A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Ishiguro N, Sogame S, Suenaga Y, Kawanishi M, Suzuki H, Jinno N, Tanaka E, Miyoshi S",,953679,DTCT0025094,11856630,DTCC01353178,156183,54221
CHEMBL2348091,P08253,,FXCKSJPZDBQRLO-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453070,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) by FRET method,,A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Ishiguro N, Sogame S, Suenaga Y, Kawanishi M, Suzuki H, Jinno N, Tanaka E, Miyoshi S",,953679,DTCT0025094,11856629,DTCC01353415,868718,54221
CHEMBL2348091,P08253,,FXCKSJPZDBQRLO-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24316668,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-ProLeuGlyLeuDpaAlaArg-NH2 as substrate after 45 mins by fluorescence plate reader analysis,,Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping.,Eur. J. Med. Chem.,2014,71,,"Sogame S, Suenaga Y, Atobe M, Kawanishi M, Tanaka E, Miyoshi S",,1283988,DTCT0025094,12983854,DTCC01353415,848823,56872
CHEMBL2348094,P08253,,IBACCBWOEGUMMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856714,DTCC01353418,1559615,54223
CHEMBL2348095,P08253,,VNQRWROOTZIALG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856715,DTCC01353419,1942099,54223
CHEMBL2348096,P08253,,ISLWLJVVCYYEPA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856717,DTCC01353420,815494,54223
CHEMBL2348097,P08253,,ZINLDZKMVPOLIJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856718,DTCC01353421,848375,54223
CHEMBL2348098,P08253,,PEHPKJRGFSEUSC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856719,DTCC01353422,103551,54223
CHEMBL2348099,P08253,,YIQHKOLXRWOQMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856721,DTCC01353423,168161,54223
CHEMBL2348100,P08253,,MTZSGZVRTUPRNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856720,DTCC01353424,1009477,54223
CHEMBL2348101,P08253,,YTJOAUCXVDRHRJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856722,DTCC01353425,1074480,54223
CHEMBL2348102,P08253,,ZZLCOSKKPBQVBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11856723,DTCC01353426,428650,54223
CHEMBL2348103,P08253,,FYFCQQWPYIPZHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857943,DTCC01353427,686512,54223
CHEMBL2348104,P08253,,GJJNYDNFTIICIW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857944,DTCC01353428,1495240,54223
CHEMBL2348105,P08253,,IQHVXYQDXZZSGO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,16500,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857945,DTCC01353429,1656745,54223
CHEMBL2348106,P08253,,NPIRNMJJVHZMRB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857947,DTCC01353430,977067,54223
CHEMBL2348107,P08253,,HXWQTAKCJJMCFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857946,DTCC01353431,944941,54223
CHEMBL2348108,P08253,,SYQPMBRDBYNLMZ-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,3900,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857949,DTCC01353432,1688743,54223
CHEMBL2348109,P08253,,PTTQTIUIJMYLNA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857948,DTCC01353433,1398523,54223
CHEMBL2348110,P08253,,STHJDHRCLMKMGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857950,DTCC01353434,396167,54223
CHEMBL2348111,P08253,,JKLPWBPZWDGFPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857951,DTCC01353435,944942,54223
CHEMBL2348112,P08253,,QKSNGQHNRJSIGH-VMPITWQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857952,DTCC01353436,265073,54223
CHEMBL2348113,P08253,,WVVARRFLFPIQLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,1800,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857953,DTCC01353437,557370,54223
CHEMBL2348114,P08253,,LUCYEPUXPXFUTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857954,DTCC01353438,1300729,54223
CHEMBL2348115,P08253,,MCCUBPXKRMEWLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,30,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857956,DTCC01353439,330809,54223
CHEMBL2348116,P08253,,FIWXKDPCZMMNRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,16000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857955,DTCC01353440,1333389,54223
CHEMBL235095,P08253,,BUEVFADAMKTXGD-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204552,DTCC00471862,195973,24059
CHEMBL235318,P08253,,JOIDQCSRISGBOH-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,35000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204551,DTCC00471863,67005,24059
CHEMBL235500,P08253,,XKCXKEBZTDNOFH-HNENSFHCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14716121,DTCC00471242,2100348,67810
CHEMBL235559,P08253,,DYUKSKSACQYNBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,513,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180819,DTCC00470412,1744477,23780
CHEMBL235916,P08253,,WGTWQHQAJDQPEW-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,335,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204567,DTCC00471841,228357,24059
CHEMBL235997,P08253,,UUIVGJHXTSUZJO-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296518,DTCC00464760,1231233,25233
CHEMBL236130,P08253,,VUFJIPWRAIIGQA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,41000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204566,DTCC00471848,1491086,24059
CHEMBL236400,P08253,,IHSDOJRAORURAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180821,DTCC00470410,1005301,23780
CHEMBL236446,P08253,,QROXNPLBULDOSL-QGRTWZNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17512742,IC50,=,123,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447905,DTCT0025094,2176032,DTCC00468601,163984,23716
CHEMBL236565,P08253,,REIYGWGAFRRHED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,207,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204558,DTCC00471856,326506,24059
CHEMBL236572,P08253,,XOBSNYRLSVUYKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180829,DTCC00470402,2003455,23780
CHEMBL236573,P08253,,RXFCFGLSOUOCEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180828,DTCC00470403,909129,23780
CHEMBL236574,P08253,,VYJYRILYFYRPCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180827,DTCC00470404,876482,23780
CHEMBL236770,P08253,,YVCXCHMORKNFGU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204556,DTCC00471858,1716115,24059
CHEMBL236806,P08253,,UFOCAFMHHPCHKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,4181,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180818,DTCC00470413,131505,23780
CHEMBL236974,P08253,,YJBLORWBSQLNFW-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,756,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204562,DTCC00471852,1841312,24059
CHEMBL2369771,P08253,,CUFDUYINQGKMHD-HSTXLCKHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,671560,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093844,DTCC01366465,1640963,45986
CHEMBL2369772,P08253,,ZIRZSMBIXVXUPG-NJDYBWQSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,200630,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093850,DTCC01366466,1926105,45986
CHEMBL237078,P08253,,BBUFBPSZYHVWGA-RSKCKNFOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17512742,IC50,=,78500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447905,DTCT0025094,2176030,DTCC00468626,972772,23716
CHEMBL2370817,P08253,,CDMKWESEIDQQND-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,46,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1259582,DTCC01367461,1468510,12304
CHEMBL2370819,P08253,,JJVBVWAKWZHHLG-QDSKXPNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,83,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1259585,DTCC01367463,1694363,12304
CHEMBL2370820,P08253,,LISPGQPSYLENBK-UXPWSPDFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,12,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1249077,DTCC01367464,1915388,12304
CHEMBL2370821,P08253,,GGFSYPJCMRNMQX-MNEFBYGVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1251402,DTCC01367465,950610,12304
CHEMBL2370822,P08253,,YCFIKRHPDITMJW-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,77,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1276783,DTCC01367466,1851029,12304
CHEMBL237177,P08253,,GYLCNFGXAVLQBI-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,5590,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204560,DTCC00471854,1905591,24059
CHEMBL23725,P08253,,SXCBCJFEHSPGNX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,KI,<,3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104534,DTCT0025094,1057252,DTCC00158057,809227,16063
CHEMBL237370,P08253,CINNAMIC ACID HYDROXAMATE,LHTLDFWBUPYUDR-DUXPYHPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,<,25,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617806,DTCC00467388,428959,56109
CHEMBL237384,P08253,,PMSJHLLBCDOJAE-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204565,DTCC00471849,521031,24059
CHEMBL237466,P08253,,CEVWXUVNZJTNNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,Not Determined,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180825,DTCC00470406,131504,23780
CHEMBL237467,P08253,,CIPRRERRNXDHQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,97,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180824,DTCC00470407,1135053,23780
CHEMBL237468,P08253,,CLSBMSGIRGYRMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,1530,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180823,DTCC00470408,228328,23780
CHEMBL2380314,P08253,,ZXVWNUSVQOQAIY-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429966,DTCC01373961,1256045,54589
CHEMBL2380387,P08253,,WSFQQGCWUCOARG-NMLBUPMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429984,DTCC01373946,1865323,54589
CHEMBL2380388,P08253,,KJNZDUKNEQXTSO-LIONHTAISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429983,DTCC01373947,123665,54589
CHEMBL2380389,P08253,,QDPILJAKSNERSV-YAOOYPAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,8.5,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429982,DTCC01373948,1062010,54589
CHEMBL2380390,P08253,,RYDPXGZLAKQPJB-AUAHOFGGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429981,DTCC01373949,577338,54589
CHEMBL2380391,P08253,,YTQYMJLEQVXIPD-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,810,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429979,DTCC01373950,1995520,54589
CHEMBL2380391,P08253,,YTQYMJLEQVXIPD-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,25000,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429978,DTCC01373950,1995521,54589
CHEMBL2380392,P08253,,YTQYMJLEQVXIPD-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,430,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429977,DTCC01373951,1929711,54589
CHEMBL2380393,P08253,,IVYZHWRIIPQLOI-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,7200,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429976,DTCC01373952,1929712,54589
CHEMBL2380394,P08253,,XBPHJVRPJAQGKS-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429975,DTCC01373953,706586,54589
CHEMBL2380395,P08253,,YTQYMJLEQVXIPD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,4.6,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429973,DTCC01373954,1962830,54589
CHEMBL2380395,P08253,,YTQYMJLEQVXIPD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429974,DTCC01373954,1962829,54589
CHEMBL2380396,P08253,,YTQYMJLEQVXIPD-IAGOWNOFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,67,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429972,DTCC01373955,156243,54589
CHEMBL2380397,P08253,,GPFVSBBSRCFVPP-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429971,DTCC01373956,738899,54589
CHEMBL2380398,P08253,,WOUSJKQGCHWOAQ-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,5700,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429970,DTCC01373957,480801,54589
CHEMBL2380399,P08253,,HMRLQVJTSOHCLV-MOGJOVFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,27,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429969,DTCC01373958,868763,54589
CHEMBL2380399,P08253,,HMRLQVJTSOHCLV-MOGJOVFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,38,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429962,DTCC01373958,868764,54589
CHEMBL2380400,P08253,,UJWXVGWYDPXCST-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,3.9,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429968,DTCC01373959,1579765,54589
CHEMBL2380401,P08253,,BTCYLUBBXQARQV-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,2.3,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429967,DTCC01373960,706587,54589
CHEMBL2380402,P08253,,MUWDEQLPHWVPPA-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,3.8,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429965,DTCC01373962,156244,54589
CHEMBL2380403,P08253,,FHORSTUZHMJGTR-GUTACTQSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,3.1,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429964,DTCC01373963,318346,54589
CHEMBL2380404,P08253,,NCMGDRDFDQYIHA-GUTACTQSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,7000,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429963,DTCC01373964,1962831,54589
CHEMBL2380405,P08253,,HMRLQVJTSOHCLV-QNBGGDODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,49,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429961,DTCC01373965,1736763,54589
CHEMBL2380406,P08253,,IZCZBRLGTKWIIZ-VWTOLEPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23631440,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959637,DTCT0025094,12429985,DTCC01373966,1515507,54589
CHEMBL238081,P08253,,YLRFPZVTHHHQAF-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,56,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180877,DTCC00470415,1620239,23780
CHEMBL2385084,P08253,,GTWOZLUSMOSBEV-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,4.8,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447062,DTCC01376345,1127107,54747
CHEMBL2385441,P08253,,QZZBJIXIULKRDH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447065,DTCC01376342,1962853,54747
CHEMBL2385442,P08253,,MLTDQJFAHZGYPI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,<,1,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447064,DTCC01376343,1223050,54747
CHEMBL2385443,P08253,,MSXPXCLRTNXLCH-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,<,1,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447063,DTCC01376344,1127106,54747
CHEMBL2385444,P08253,,GGDZUSVGHHPSCC-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,<,1,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447061,DTCC01376346,1256066,54747
CHEMBL2385445,P08253,,XCZGTSRWCUGQHZ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,<,1,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447060,DTCC01376347,318372,54747
CHEMBL2385446,P08253,,LABDSZDDNFHLIV-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447059,DTCC01376348,2092443,54747
CHEMBL2385447,P08253,,RYJGACKGNMUBMP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447058,DTCC01376349,1158406,54747
CHEMBL2385448,P08253,,HRNGMFYSJLHLOC-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,141,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447057,DTCC01376350,1418783,54747
CHEMBL2385449,P08253,,CJDLHVDTFICCKV-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447056,DTCC01376351,901017,54747
CHEMBL2385450,P08253,,TZMCLEOCJWIHKF-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,5.8,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447055,DTCC01376352,674549,54747
CHEMBL2385451,P08253,,YYUVVXFBDREZPQ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23688254,IC50,=,3.6,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa(Dnp)-Ala-Arg-NH2 as substrate measured up to 120 mins by fluorescence assay,,"Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.",J. Med. Chem.,2013,56,12,"Selivanova SV, Stellfeld T, Heinrich TK, Müller A, Krämer SD, Schubiger PA, Schibli R, Ametamey SM, Vos B, Meding J, Bauser M, Hütter J, Dinkelborg LM",,960847,DTCT0025094,12447053,DTCC01376353,1929740,54747
CHEMBL2393088,P08253,,PDSXOKWGOMWNSE-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23528299,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP2 (unknown origin) using L-Leu-p-nitroanilide as substrate incubated for 5 mins prior to substrate addition measured after 60 mins by UV-Vis spectrophotometry,,Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent.,Bioorg. Med. Chem. Lett.,2013,23,9,"Su L, Jia Y, Wang X, Zhang L, Fang H, Xu W",,963628,DTCT0025094,12463217,DTCC01380789,447381,54810
CHEMBL240464,P08253,,OTYPWJTWIVTSCQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215340,DTCC00477164,1539491,24158
CHEMBL240465,P08253,,VDNQILFFXZGSAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215323,DTCC00477187,1378237,24158
CHEMBL240648,P08253,,JAJGEGVZSPWXRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215333,DTCC00477171,763015,24158
CHEMBL240652,P08253,,RKUJFFMHPNCFGS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215330,DTCC00477174,1571477,24158
CHEMBL240653,P08253,,NRIFANAMCHKQRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,=,930,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215338,DTCC00477166,1728630,24158
CHEMBL240654,P08253,,NOXUFSHDRYQLKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215336,DTCC00477168,827621,24158
CHEMBL240852,P08253,,WUUXXJBNJKDVJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215335,DTCC00477169,1668635,24158
CHEMBL240854,P08253,,MXSTVAAIMVPNIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,=,2700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215327,DTCC00477177,1760416,24158
CHEMBL240855,P08253,,HLZGHZBDUQUWJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215324,DTCC00477186,310263,24158
CHEMBL240963,P08253,LAWSONE,CSFWPUWCSPOLJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,84,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103958,DTCC00473933,1057327,43205
CHEMBL241048,P08253,,RYFSQVRNVFCETF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215315,DTCC00477159,83180,24158
CHEMBL241051,P08253,,NIJRSBKAMIDLFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215326,DTCC00477179,1247789,24158
CHEMBL241405,P08253,METHYL ROSMARINATE,XHALVRQBZGZHFE-BBOMDTFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,3580,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534763,DTCC00474227,1267308,48665
CHEMBL241405,P08253,METHYL ROSMARINATE,XHALVRQBZGZHFE-BBOMDTFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535480,DTCC00474227,1267308,48665
CHEMBL242073,P08253,,HOAKXOLFZXBTCB-UEUJIKQLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17267227,IC50,=,140000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441978,DTCT0025094,2144958,DTCC00460316,2079532,23207
CHEMBL242074,P08253,,PAWMGXIJYPYCIU-WQMPYENHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17267227,IC50,=,7700,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441978,DTCT0025094,2144957,DTCC00460317,661441,23207
CHEMBL242530,P08253,OBOVATAL,KGHJODCHEIEYBP-HWKANZROSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17428670,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP2 in HT1080 cells at 15 uM by gelatin zymography assay,Active,Inhibitory effect of obovatal on the migration and invasion of HT1080 cells via the inhibition of MMP-2.,Bioorg. Med. Chem.,2007,15,12,"Lee SK, Chun HK, Yang JY, Han DC, Son KH, Kwon BM",,444046,DTCT0025094,2147834,DTCC00460706,714383,23415
CHEMBL242530,P08253,OBOVATAL,KGHJODCHEIEYBP-HWKANZROSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17428670,IC50,=,800,NM,,cell_based,,,,,,,,,,,,Inhibition of MMP2 expressed in insect cells,,Inhibitory effect of obovatal on the migration and invasion of HT1080 cells via the inhibition of MMP-2.,Bioorg. Med. Chem.,2007,15,12,"Lee SK, Chun HK, Yang JY, Han DC, Son KH, Kwon BM",,444045,DTCT0025094,2132755,DTCC00460706,714383,23415
CHEMBL2425930,P08253,,PECBDMOWKLTTSB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577956,DTCC01394954,1780885,55760
CHEMBL2425931,P08253,,ZTOBNNQGIRZHDO-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577955,DTCC01394955,396398,55760
CHEMBL2425932,P08253,,XMVQXBAGOTVZDD-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577954,DTCC01394956,977332,55760
CHEMBL2425933,P08253,,UCWSKTMFEWSSSI-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577953,DTCC01394957,589788,55760
CHEMBL2425934,P08253,,BDPAGEAOFNRCNJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577952,DTCC01394958,1720338,55760
CHEMBL2425935,P08253,,WCHOGKFWHQMHQW-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577951,DTCC01394959,945221,55760
CHEMBL2425936,P08253,,WTEZGXPTIFMTCH-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577950,DTCC01394960,200173,55760
CHEMBL2425937,P08253,,MIKGRMSWGTVOSA-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577949,DTCC01394961,1720339,55760
CHEMBL2425938,P08253,,XJNFMEAYBQFDAS-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,0.4,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577948,DTCC01394962,686766,55760
CHEMBL2425939,P08253,,CMKYCYOBCXIZPF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577947,DTCC01394963,493235,55760
CHEMBL2425940,P08253,,NXCSXUBVRRHHLE-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,9,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577946,DTCC01394964,622205,55760
CHEMBL2425941,P08253,,NTDGKPHATDVYNT-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,0.8,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577945,DTCC01394965,913758,55760
CHEMBL2425942,P08253,,VPDOXKSDXTZFIX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577944,DTCC01394966,428918,55760
CHEMBL2425943,P08253,,ADDYZQRMSCIHFH-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577943,DTCC01394967,1748898,55760
CHEMBL2425944,P08253,,WUGYYDAXBPEKAI-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,0.5,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577942,DTCC01394968,686767,55760
CHEMBL2425946,P08253,,OPJBQWSZZMIIHX-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,0.9,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577961,DTCC01394970,21657,55760
CHEMBL2425947,P08253,,MFOJAATVHNHXKB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,0.7,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577960,DTCC01394971,331061,55760
CHEMBL2425948,P08253,,LTTRJMCJTUBEGF-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577959,DTCC01394972,1430830,55760
CHEMBL2425949,P08253,,ZXGBSFAKYZEOPJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,0.9,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577958,DTCC01394973,525520,55760
CHEMBL2425950,P08253,,SMKRBNFEFJZHAI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of MMP-2 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983462,DTCT0025094,12577957,DTCC01394974,1909986,55760
CHEMBL2430286,P08253,,GMECKBIBYMNMBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23999043,IC50,=,5.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by fluorescence plate reader analysis,,Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.,Bioorg. Med. Chem. Lett.,2013,23,20,"Freskos JN, Asmelash B, Gaston KR, Karwa A, Marzan TA, Nickols MA, Rogers TE, Schoenstein T, Sympson CJ, Vu B",,985896,DTCT0025094,12592016,DTCC01396239,1736958,55953
CHEMBL2430287,P08253,,JASUYRSWGSPWAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23999043,IC50,<,1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by fluorescence plate reader analysis,,Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.,Bioorg. Med. Chem. Lett.,2013,23,20,"Freskos JN, Asmelash B, Gaston KR, Karwa A, Marzan TA, Nickols MA, Rogers TE, Schoenstein T, Sympson CJ, Vu B",,985896,DTCT0025094,12592015,DTCC01396240,2092671,55953
CHEMBL2430288,P08253,,LVPLMOLWCRLVEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23999043,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by fluorescence plate reader analysis,,Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.,Bioorg. Med. Chem. Lett.,2013,23,20,"Freskos JN, Asmelash B, Gaston KR, Karwa A, Marzan TA, Nickols MA, Rogers TE, Schoenstein T, Sympson CJ, Vu B",,985896,DTCT0025094,12592014,DTCC01396241,123894,55953
CHEMBL2430289,P08253,,GWRAQHGIJHUVNF-QNGWXLTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23999043,IC50,<,1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by fluorescence plate reader analysis,,Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.,Bioorg. Med. Chem. Lett.,2013,23,20,"Freskos JN, Asmelash B, Gaston KR, Karwa A, Marzan TA, Nickols MA, Rogers TE, Schoenstein T, Sympson CJ, Vu B",,985896,DTCT0025094,12592012,DTCC01396242,1256256,55953
CHEMBL2431015,P08253,,YGTYRNSBOZPWFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586886,DTCC01396971,803495,55984
CHEMBL2431016,P08253,,IVQNYNVXTUYYFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,7.8,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586885,DTCC01396972,771296,55984
CHEMBL2431017,P08253,,RMRVSLSYZNRHKL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586884,DTCC01396973,1995757,55984
CHEMBL2431018,P08253,,URIKLEJPYMMEBH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,41,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586883,DTCC01396974,57073,55984
CHEMBL2431019,P08253,,GPJRFRUTVIKWFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,670,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586882,DTCC01396975,771297,55984
CHEMBL2431020,P08253,,WVHOOIOSMOLBGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586881,DTCC01396976,1029966,55984
CHEMBL2431021,P08253,,VONWNPCXOBRHMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,1750,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586880,DTCC01396977,220582,55984
CHEMBL2431022,P08253,,JFSQCRNERBWFRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,1870,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586878,DTCC01396978,1483276,55984
CHEMBL2431023,P08253,,QXELZFZRJLTGNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,125000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586877,DTCC01396979,545458,55984
CHEMBL2431024,P08253,,HPKAGMQWGBOAOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,3800,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586876,DTCC01396980,1547767,55984
CHEMBL2431025,P08253,,AACHNFJXJZIPFX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,1045,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586875,DTCC01396981,1158643,55984
CHEMBL2431026,P08253,,TZCXUSWHXSLZNB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,4100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586874,DTCC01396982,803496,55984
CHEMBL2431027,P08253,,HJLAUHYNMNIAAR-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,1440,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586873,DTCC01396983,1191062,55984
CHEMBL2431027,P08253,,HJLAUHYNMNIAAR-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26871660,IC50,=,1440,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 3 hrs by fluorometric assay,,Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.,Eur. J. Med. Chem.,2016,111,,"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.",,1559055,DTCT0025094,101497,DTCC01396983,1162293,66304
CHEMBL2431028,P08253,,QTXVPJOTKLUYMQ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,240,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586872,DTCC01396984,1897905,55984
CHEMBL2431029,P08253,,QPWBTJDQYIYLND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586890,DTCC01396985,1865390,55984
CHEMBL2431030,P08253,,VCASEBIJMMTOBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586889,DTCC01396986,1354063,55984
CHEMBL2431031,P08253,,APPNLLFVKPQJGQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,7.5,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586888,DTCC01396987,1579986,55984
CHEMBL2431032,P08253,,LGTBURVEOHTXLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,48,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586887,DTCC01396988,642634,55984
CHEMBL2431901,P08253,,NNQAQGDSGCGFER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23964961,INH,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform.,J. Med. Chem.,2013,56,18,"Blackburn C, Barrett C, Chin J, Garcia K, Gigstad K, Gould A, Gutierrez J, Harrison S, Hoar K, Lynch C, Rowland RS, Tsu C, Ringeling J, Xu H",,985004,DTCT0025094,12596672,DTCC01397867,1450794,55932
CHEMBL243236,P08253,,NVJUVGMOOGFJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17289381,KI,>,3000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442203,DTCT0025094,2162215,DTCC00463665,110626,23225
CHEMBL243307,P08253,,KSINVMMDBYSEMQ-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22386984,IC50,=,315000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805641,DTCT0025094,7640474,DTCC00455841,1642106,47642
CHEMBL2435340,P08253,,DDIJQZRWMIFTHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,=,80,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617804,DTCC01398381,396438,56109
CHEMBL243664,P08253,ACACETIN,DANYIYRPLHHOCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells at 5 uM by gelatin zymography,Not Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501260,DTCT0025094,14455602,DTCC00459230,1518410,62853
CHEMBL2437163,P08253,,JRAYHZWPXHIVJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044937,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 using NFF-2 as substrate after 90 mins,,Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.,Eur. J. Med. Chem.,2013,69,,"Maingot L, Elbakali J, Dumont J, Bosc D, Cousaert N, Urban A, Deglane G, Villoutreix B, Nagase H, Sperandio O, Leroux F, Deprez B, Deprez-Poulain R",,986684,DTCT0025094,12607850,DTCC01400189,751355,56087
CHEMBL2437163,P08253,,JRAYHZWPXHIVJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044937,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human MMP-2 using NFF-2 as substrate at 10 uM after 90 mins,,Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.,Eur. J. Med. Chem.,2013,69,,"Maingot L, Elbakali J, Dumont J, Bosc D, Cousaert N, Urban A, Deglane G, Villoutreix B, Nagase H, Sperandio O, Leroux F, Deprez B, Deprez-Poulain R",,986805,DTCT0025094,12607877,DTCC01400189,751355,56087
CHEMBL243874,P08253,,IEFFRLNSCQIVBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17289381,KI,=,5700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442203,DTCT0025094,2162331,DTCC00463738,2047468,23225
CHEMBL24398,P08253,,UACUZULRKJKTHE-CZYKHXBRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,6300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1422371,DTCC00158787,1693988,16438
CHEMBL24398,P08253,,UACUZULRKJKTHE-CZYKHXBRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,6300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457506,DTCC00158787,1696785,32556
CHEMBL2440429,P08253,,MDQNHUVXMAEAFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,6400,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629950,DTCC01400793,1158679,56259
CHEMBL2440430,P08253,,GPHBFHLZRQMFLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,2800,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629954,DTCC01400794,1708742,56259
CHEMBL2440431,P08253,,VRCNSKZUURJQAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629953,DTCC01400795,252959,56259
CHEMBL2440432,P08253,,ZSBBJNVNCGRSOS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,2800,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629952,DTCC01400796,1158680,56259
CHEMBL2440433,P08253,"3,4-DICHLOROPHENYLAMINOMETHYLENEBISPHOSPHONIC ACID",ADHSWFUIIRWNHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629958,DTCC01400797,220619,56259
CHEMBL2440434,P08253,,GSMGLRFAXIPFLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629957,DTCC01400798,1062292,56259
CHEMBL2440435,P08253,,SENUMOHBDKDZCG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,20800,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629962,DTCC01400799,1127369,56259
CHEMBL2440436,P08253,,SCLGFWTXZFUITP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,42000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629961,DTCC01400800,1321323,56259
CHEMBL2440437,P08253,,ZEZSYIYQVUYORL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,36000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629965,DTCC01400801,1256310,56259
CHEMBL2440438,P08253,,XQVNOYYFZWUDCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,6600,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629964,DTCC01400802,1095361,56259
CHEMBL2440439,P08253,(P-TOLYLAMINO)METHYLENEDIPHOSPHONIC ACID,FVJHDPVFVSTFKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629967,DTCC01400803,642669,56259
CHEMBL2440440,P08253,,RBHODZPTKHWXDX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629966,DTCC01400804,1062293,56259
CHEMBL2440441,P08253,,AXIAQHKDCQVIKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629969,DTCC01400805,318637,56259
CHEMBL2440578,P08253,,HTWBLJFKBSZUAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629968,DTCC01400943,1938015,56259
CHEMBL2440579,P08253,(4-CHLOROPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,PPOZCMYPJMEBPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629970,DTCC01400944,416940,56259
CHEMBL2440580,P08253,(PHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,XVNZXEWQQDCZSM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629972,DTCC01400945,1515790,56259
CHEMBL2440581,P08253,,CXOBNZQSLVRTMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,28200,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629971,DTCC01400946,383983,56259
CHEMBL2442878,P08253,,KXYWMKRIKCLADT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,550,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640795,DTCC01403249,188424,56235
CHEMBL2442879,P08253,,VFVIUYYQHAEKJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,760,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640794,DTCC01403250,91625,56235
CHEMBL2442880,P08253,,SJWVELZZBPYZRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,690,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640793,DTCC01403251,220656,56235
CHEMBL2442881,P08253,,NPWUBXHYMWVDKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640792,DTCC01403252,351448,56235
CHEMBL2442882,P08253,,XCRZYFVDWZHDQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,440,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640791,DTCC01403253,1547821,56235
CHEMBL2442883,P08253,,IUYSNQXMHWEVJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,560,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640790,DTCC01403254,252989,56235
CHEMBL2442884,P08253,,PXYTTWPKWBWEHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,420,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640789,DTCC01403255,2092731,56235
CHEMBL2442885,P08253,,NKVKCTYTQNQNIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640788,DTCC01403256,1256330,56235
CHEMBL2442886,P08253,,LJRIZWAWUQHHTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,290,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640787,DTCC01403257,1354112,56235
CHEMBL2442887,P08253,,KDYJIWZXMZGJQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,490,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640786,DTCC01403258,2060629,56235
CHEMBL2442888,P08253,,FNTWGXGOCVTLKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,680,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640785,DTCC01403259,1030030,56235
CHEMBL2442889,P08253,,MWMLZWBDIRKPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,160,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640800,DTCC01403260,1450847,56235
CHEMBL2442890,P08253,,JOSPLESHDLLQSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,230,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640799,DTCC01403261,1062314,56235
CHEMBL2442891,P08253,,NDWDLJQCZNKAHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,310,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640798,DTCC01403262,481047,56235
CHEMBL2442892,P08253,,FWECVAAARPJXSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,480,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640797,DTCC01403263,57219,56235
CHEMBL2442893,P08253,,LYYLWOIDTXRRLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24028490,KI,=,390,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using MOCAcPLGLA2pr(Dnp)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,991126,DTCT0025094,12640796,DTCC01403264,1547822,56235
CHEMBL24447,P08253,PHENETHYLCARBAMOYLPHOSPHONIC ACID,GHFCXEYUGIXTHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,20000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1320459,DTCC00158289,2077403,17838
CHEMBL24447,P08253,PHENETHYLCARBAMOYLPHOSPHONIC ACID,GHFCXEYUGIXTHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420865,DTCC00158289,2071713,51419
CHEMBL244645,P08253,,CCXFQMZSQXHYKQ-LICLKQGHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10219762,DTCC00460148,1445247,33038
CHEMBL244883,P08253,METHOTREXATE GAMMA-HYDROXAMIC ACID,YUQBNZUBNMWBAQ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,INHIBITION,=,67,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 100 uM,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441104,DTCT0025094,2148748,DTCC00003032,1308171,23121
CHEMBL24510,P08253,FUSARIC ACID,DGMPVYSXXIOGJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,43,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5096296,DTCC00104041,2055567,43205
CHEMBL245382,P08253,,FXJADKGLMYYRPW-AJTFRIOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221423,DTCC00478075,359103,24252
CHEMBL245383,P08253,,SXQXJOREJVFQQR-ATIYNZHBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221422,DTCC00478076,326532,24252
CHEMBL245384,P08253,,UTQFFMUHRGYGFM-YIXXDRMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221420,DTCC00478078,1744537,24252
CHEMBL245394,P08253,,OYASIRZNJCJRET-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233035,DTCC00477442,634187,24428
CHEMBL245397,P08253,,KLBXZZGMUJWXKZ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,13000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233034,DTCC00477443,1954504,24428
CHEMBL245398,P08253,,PJGCGUOCHAEDBS-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233033,DTCC00477444,1021552,24428
CHEMBL245581,P08253,,BNMNXPAFKBDIBX-WIZGVZBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221419,DTCC00478079,131576,24252
CHEMBL245582,P08253,,CVQRCKDPFUCDTJ-CGHJUBPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221418,DTCC00478080,811250,24252
CHEMBL245713,P08253,,PJGCGUOCHAEDBS-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233031,DTCC00477447,956966,24428
CHEMBL245774,P08253,,GHIFQOQBENAQBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221416,DTCC00478054,228402,24252
CHEMBL245776,P08253,,GHIFQOQBENAQBR-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221437,DTCC00478057,228403,24252
CHEMBL245916,P08253,,COVJQHAKHFTHTI-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233030,DTCC00477448,1280381,24428
CHEMBL245917,P08253,,WGCNWTXUEJFXAN-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,10600,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233027,DTCC00477451,763048,24428
CHEMBL245974,P08253,,XTOUSIOCVVYRQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221434,DTCC00478061,1620304,24252
CHEMBL246122,P08253,,RHYMWYIDOQTOQW-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233026,DTCC00477452,408594,24428
CHEMBL246171,P08253,,LGAMIUMXRWOVGN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221433,DTCC00478062,1263918,24252
CHEMBL246178,P08253,,BIVVTMYKPQBBMU-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233002,DTCC00477427,666352,24428
CHEMBL246179,P08253,,MVGIOBHNULDSLE-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,4400,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233045,DTCC00477428,2020130,24428
CHEMBL246376,P08253,,UEOYACNTKVVWRI-QFQXNSOFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221428,DTCC00478069,8772,24252
CHEMBL246563,P08253,,GHIFQOQBENAQBR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,=,567,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221436,DTCC00477929,1231073,24252
CHEMBL246576,P08253,,SSOHCNKODIJGFS-XHCCPWGMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221427,DTCC00478071,1776382,24252
CHEMBL246577,P08253,,SSOHCNKODIJGFS-UZTOHYMASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221425,DTCC00478072,1361794,24252
CHEMBL246577,P08253,,SSOHCNKODIJGFS-UZTOHYMASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221426,DTCC00478072,1361793,24252
CHEMBL246780,P08253,,TYVSUIISWMVVPD-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233039,DTCC00477436,1760457,24428
CHEMBL246990,P08253,,YYIWXDYDKYLKGP-LIRRHRJNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233044,DTCC00477429,860634,24428
CHEMBL246991,P08253,,HCTDCXATPFTQBT-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,3800,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233043,DTCC00477430,408593,24428
CHEMBL247140,P08253,,BYQIIKCYPGKHOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,=,1598,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240619,DTCC00479011,1987234,24538
CHEMBL247141,P08253,,WUGZBWFREMAISJ-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240616,DTCC00479014,1442482,24538
CHEMBL247188,P08253,,YCQZWQOYMCXJKC-KPHUOKFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,4300,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233042,DTCC00477431,375547,24428
CHEMBL247189,P08253,,RUYSZZSAVKIYSO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233041,DTCC00477432,1889590,24428
CHEMBL247346,P08253,,CXRXRCFYUZTJSR-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240614,DTCC00479016,634208,24538
CHEMBL247347,P08253,,XZCDAPHMYWQDPY-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240612,DTCC00479018,439330,24538
CHEMBL247348,P08253,,MOMCZJRIDPUOBK-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240611,DTCC00479019,1954523,24538
CHEMBL247390,P08253,,DZKLVNPFPXCMHY-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233040,DTCC00477434,1182561,24428
CHEMBL247391,P08253,,JKLMFOXAXAQPLI-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233038,DTCC00477437,1571518,24428
CHEMBL247392,P08253,,ABVYUTNGNIQHHD-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233037,DTCC00477439,1792930,24428
CHEMBL247545,P08253,,IMAXZHZQJLQAFI-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240610,DTCC00479020,1280403,24538
CHEMBL247546,P08253,,DAUHEXDIKFZUFM-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240608,DTCC00479022,1313114,24538
CHEMBL247742,P08253,,HUKXOIMLTBNTPV-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240607,DTCC00479023,1280404,24538
CHEMBL247743,P08253,,QOMQSCJPJZHYPI-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240606,DTCC00479024,892829,24538
CHEMBL247946,P08253,,NBEQYTSXQZAREJ-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240604,DTCC00479026,1442483,24538
CHEMBL247947,P08253,,GQPOMTPZRNEORO-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240603,DTCC00479027,1507443,24538
CHEMBL247966,P08253,,QNXKVQKPSNZLGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215325,DTCC00477185,1539492,24158
CHEMBL247967,P08253,,YYHXOYNNTNFXCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215476,DTCC00477190,634148,24158
CHEMBL248148,P08253,,DXSANODVHPAKSB-UFHPHHKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240602,DTCC00479028,698565,24538
CHEMBL248172,P08253,,CNPXAHGTJQERBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215482,DTCC00477191,244564,24158
CHEMBL248173,P08253,,VXTLHKJGOCNUSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215481,DTCC00477192,1086718,24158
CHEMBL248323,P08253,,MEWQGNPVNKWBSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240622,DTCC00479008,1119298,24538
CHEMBL248523,P08253,,AZDMTLYFRFXZGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240621,DTCC00479009,634207,24538
CHEMBL248524,P08253,,FRIRYAGACGIOFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240620,DTCC00479010,342991,24538
CHEMBL24871,P08253,,DEQRLFQPZJLTBQ-HQMADOEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10021913,KI,=,6.1,NM,,,,,,,,,,,,,,Inhibition of recombinant matrix metalloprotease-2 (MMP-2),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,101930,DTCT0025094,685769,DTCC00160972,969472,3377
CHEMBL249249,P08253,,GAAIGFFCAWTRLA-QPJJXVBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,149000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266499,DTCC00112348,682335,24949
CHEMBL249449,P08253,,FIJLFZRLPPVBHV-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.1,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,843369,DTCC00487070,906446,1379
CHEMBL249847,P08253,PNU-107859,RKWXKADYTDWZIJ-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163188,KI,=,3000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (gelatinase-A),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104408,DTCT0025094,1540255,DTCC00003876,2013186,17850
CHEMBL249859,P08253,HEXYL 6-MERCAPTOPICOLINATE,XQEVBXYFXXEMPD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,85000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266505,DTCC00003789,1103055,24949
CHEMBL249860,P08253,,XRKJHHWDVPLKME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266504,DTCC00112342,359235,24949
CHEMBL249861,P08253,,KHRGNMHSFZBLQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266503,DTCC00112343,228510,24949
CHEMBL249862,P08253,,PEIDAZNWHKOSTB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266501,DTCC00112345,2068225,24949
CHEMBL249863,P08253,,SBUBCHFHLBPIDO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266729,DTCC00112347,1652658,24949
CHEMBL250057,P08253,4-FLUOROBENZYL 6-MERCAPTOPICOLINATE,BLOAUADPJKEVHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,108000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266518,DTCC00003781,1231187,24949
CHEMBL250058,P08253,"2,6-DIFLUOROBENZYL 6-MERCAPTOPICOLINATE",KGUKLAHWSIAZLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,66000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266517,DTCC00003782,585425,24949
CHEMBL250059,P08253,"2,4,5-TRIFLUOROBENZYL 6-MERCAPTOPICOLINATE",LUIWBJOVQPJOKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,90000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266515,DTCC00003784,2068224,24949
CHEMBL250069,P08253,3-PHENOXYBENZYL 6-MERCAPTOPICOLINATE,HWVLDNSMUHAKFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,46000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266508,DTCC00003787,844236,24949
CHEMBL250070,P08253,4-PHENOXYBENZYL 6-MERCAPTOPICOLINATE,UEHKLPHNSUXLCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,93000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266507,DTCC00003788,1329180,24949
CHEMBL250093,P08253,,RZISBFWRHNXABZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,870,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237251,DTCC00480948,1716176,24495
CHEMBL250094,P08253,,PPNXUTAPILQZQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,1630,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237268,DTCC00480949,1684812,24495
CHEMBL250266,P08253,UK-370106,NSMABJUGSNPHMN-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,34200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266848,DTCC00003798,779009,24951
CHEMBL250266,P08253,UK-370106,NSMABJUGSNPHMN-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,34200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457458,DTCC00003798,791164,32556
CHEMBL250297,P08253,,NYRVSWKULSLJMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,2230,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237266,DTCC00480951,1426591,24495
CHEMBL250298,P08253,,UVFPNZAMZZIJLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,840,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237265,DTCC00480952,196054,24495
CHEMBL250299,P08253,,GRFJGGIFOFQTRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,520,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237264,DTCC00480953,1361831,24495
CHEMBL250502,P08253,,SQWKFISUTRRKSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,840,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237262,DTCC00480955,2036345,24495
CHEMBL250503,P08253,,RYUNWXPVOIGBCD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,1620,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237261,DTCC00480956,1620344,24495
CHEMBL250504,P08253,,OAXXNDPRBWJXOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,940,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237259,DTCC00480958,8867,24495
CHEMBL250708,P08253,,YFKTVOCECCSHLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237258,DTCC00480959,714559,24495
CHEMBL250709,P08253,,ZXFJUXBYVRDBQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237257,DTCC00480960,1937696,24495
CHEMBL250710,P08253,,KLUBFNJJJWONQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,1030,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237256,DTCC00480961,1231111,24495
CHEMBL250905,P08253,,CBVWAXQRTCTDDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,2570,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237255,DTCC00480963,844150,24495
CHEMBL250906,P08253,,ZUAUVLUKHSXGGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,1450,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237253,DTCC00480965,326576,24495
CHEMBL250907,P08253,,RZAVXBHMHDOVTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237252,DTCC00480966,1905673,24495
CHEMBL251081,P08253,4-CHLOROBENZYL 6-MERCAPTOPICOLINATE,XZZQGEUTXIQYSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,96000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266514,DTCC00003785,1937772,24949
CHEMBL251423,P08253,,FUQRLLAMBZIBJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,98000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266512,DTCC00112337,1652657,24949
CHEMBL251424,P08253,,KPHDNQTWSWMHLI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266511,DTCC00112338,682334,24949
CHEMBL251425,P08253,,KBKONNUEKRQXBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,110000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266510,DTCC00112339,99413,24949
CHEMBL251426,P08253,,KUFQPJWHPFBJRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,42000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266509,DTCC00112340,1458628,24949
CHEMBL251440,P08253,,SUFSQYXUPYDFHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3.39,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258298,DTCC00486984,294021,24803
CHEMBL251465,P08253,,NRFRJBJLCBPJDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266496,DTCC00112351,1652659,24949
CHEMBL251481,P08253,L-702842,HDGWGGCPTVXRNA-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,210,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,855813,DTCC00003873,647788,1379
CHEMBL251482,P08253,,DUPLBHCXXUUWQN-YGOYIFOWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,844413,DTCC00487068,2065533,1379
CHEMBL251820,P08253,,ZKFYETVHOLUSNG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278072,DTCC00489350,1808991,25102
CHEMBL251821,P08253,,LVBZYMLTLOAXGK-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278552,DTCC00489351,1954617,25112
CHEMBL251823,P08253,,MQRVNMRQQSVHCA-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278060,DTCC00489415,359262,25102
CHEMBL251827,P08253,,VJUDEGHVGRIZAQ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,1318,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278532,DTCC00489422,1571619,25112
CHEMBL251830,P08253,,XWALZJCMHMIYFN-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,1563,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278057,DTCC00489429,1231208,25102
CHEMBL251831,P08253,,QFDKCGXVQVJGKD-SVMVAKDDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278530,DTCC00489430,1280502,25112
CHEMBL251847,P08253,,WKQUYZQZMVHYFW-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,32,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276489,DTCC00488405,1296624,25086
CHEMBL251848,P08253,,NNEYUWWQEQYTDH-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276488,DTCC00488406,1873467,25086
CHEMBL251865,P08253,,GYKATPWJHDSXEC-FQECFTEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,39,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276485,DTCC00488431,1971035,25086
CHEMBL251866,P08253,,CFGDWDJLEQTCJQ-PXDATVDWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,=,302,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282311,DTCC00488432,585456,25163
CHEMBL251867,P08253,,CHOIXTQDKMNYCU-FUHWJXTLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,2128,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282315,DTCC00488437,67193,25163
CHEMBL251868,P08253,,UCCRPMLKYDMJAV-PKOBYXMFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,2128,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282313,DTCC00488439,1394305,25163
CHEMBL251884,P08253,,MHXODSYUSQLZGR-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,13,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276501,DTCC00488364,260755,25086
CHEMBL251901,P08253,,LONXPMRZFFZWDV-VKHMYHEASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163188,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (gelatinase-A),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104408,DTCT0025094,1537942,DTCC00487079,1753701,17850
CHEMBL251916,P08253,,JRIUEEGXFJPYTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,853,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266885,DTCC00486120,1166464,24951
CHEMBL251917,P08253,,YVBOXQAMDNUBQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,529,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266883,DTCC00486122,1296611,24951
CHEMBL251917,P08253,,YVBOXQAMDNUBQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,529,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457468,DTCC00486122,1309117,32556
CHEMBL251918,P08253,,MIINGMFBCOVDAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,188,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266882,DTCC00486123,260740,24951
CHEMBL251937,P08253,,SBJBAOFNJMFNBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,66000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266571,DTCC00112323,1426656,24949
CHEMBL251994,P08253,,AZIJSGUGQIBFMD-LLGBQNBKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18234496,KI,=,1920,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,4,"Ott GR, Asakawa N, Liu RQ, Covington MB, Qian M, Vaddi K, Newton RC, Trzaskos JM, Christ DD, Galya L, Scholz T, Marshall W, Duan JJ",,462319,DTCT0025094,2282168,DTCC00488624,1182678,25158
CHEMBL252020,P08253,,SKTKKGJWKRRVNC-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278550,DTCC00489353,763158,25112
CHEMBL252021,P08253,,YXOSTPQOYPBEJL-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,670,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278549,DTCC00489355,698656,25112
CHEMBL252022,P08253,,HTTNNOVNWHTYRY-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278548,DTCC00489357,43745,25112
CHEMBL252023,P08253,,IMEFZFRDMGAZIZ-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,1999,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278059,DTCC00489419,455619,25102
CHEMBL252024,P08253,,AQXFSOLTNZQWIK-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278058,DTCC00489425,972983,25102
CHEMBL252079,P08253,,IDLHJNPBZBJSDO-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,50,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276499,DTCC00488366,294068,25086
CHEMBL252081,P08253,,CADNLTAFOMUWRR-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,1100,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276498,DTCC00488367,553293,25086
CHEMBL252117,P08253,,ULYBHGVRJILHNJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,534,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266880,DTCC00486125,196148,24951
CHEMBL252246,P08253,,XKPUKZQRNSFQLM-YVZMLIKISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,960,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276477,DTCC00488482,1587813,25086
CHEMBL252246,P08253,,XKPUKZQRNSFQLM-YVZMLIKISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,998,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828317,DTCC00488482,1588619,33677
CHEMBL252246,P08253,,XKPUKZQRNSFQLM-YVZMLIKISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,998,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101293,DTCC00488482,1589121,36106
CHEMBL252278,P08253,,OEHDRCQWQWUTCW-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,433,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276496,DTCC00488369,1070310,25086
CHEMBL252309,P08253,,DCCFCESVXXKHHR-AYQJTBPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3981.07,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258422,DTCC00487024,1555531,24803
CHEMBL252326,P08253,,WIZJUQTZYUHMJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,103000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266533,DTCC00485908,391969,24949
CHEMBL252327,P08253,CYCLOBUTYL 6-MERCAPTOPICOLINATE,OJWQIHGLXWACCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266531,DTCC00003770,2003636,24949
CHEMBL252422,P08253,,BMSDLUUZGPIUGG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,61,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278529,DTCC00489290,1668797,25112
CHEMBL252422,P08253,,BMSDLUUZGPIUGG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,61,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300323,DTCC00489290,1652743,25438
CHEMBL252426,P08253,,ADRWSFRHTJKETB-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278547,DTCC00489366,212331,25112
CHEMBL252442,P08253,,DAWQVDWNIUMYHC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,488,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276474,DTCC00488486,260756,25086
CHEMBL252470,P08253,,FXFZIKOEGYQWSD-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282411,DTCC00488443,650445,25163
CHEMBL252480,P08253,,BYIUYAJXVDVGFA-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282410,DTCC00488444,260774,25163
CHEMBL252481,P08253,,UVQRQVBDZDEEBU-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282409,DTCC00488445,1394306,25163
CHEMBL252522,P08253,PHENETHYL 6-MERCAPTOPICOLINATE,VDMYYWJHHLSXLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,119000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266528,DTCC00003773,1361920,24949
CHEMBL252523,P08253,3-PHENYLPROPYL 6-MERCAPTOPICOLINATE,KVPPTQZVYDXFBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266527,DTCC00003774,488954,24949
CHEMBL252612,P08253,,PWJXCFJUGNPSAZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,546,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278053,DTCC00489489,553296,25102
CHEMBL252627,P08253,,JWVKYLLQNXGDRB-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,135,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278070,DTCC00489371,2003660,25102
CHEMBL252674,P08253,,HJRCGMHZQDXQAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17936631,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.",Bioorg. Med. Chem.,2008,16,1,"Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG, Choi HM, Lee HY, Hong SH, Kim MS, Nam KY, Han G",,461353,DTCT0025094,2274636,DTCC00487740,1442560,25060
CHEMBL252677,P08253,,OHKVFVLOLOFCQJ-ZVUIFXONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282407,DTCC00488447,326700,25163
CHEMBL252678,P08253,,XZAGAORJLXBQCC-VYCPFJESSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,37,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276483,DTCC00488448,1103077,25086
CHEMBL252823,P08253,,YQDBAVJLVOFOMZ-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,262,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278545,DTCC00489369,2084572,25112
CHEMBL252826,P08253,,KCAMDNAUAMLPGX-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,139,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278569,DTCC00489296,1636453,25112
CHEMBL252826,P08253,,KCAMDNAUAMLPGX-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,139,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300307,DTCC00489296,1620497,25438
CHEMBL252827,P08253,,AJNIYVYCXZKNMP-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,9.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278568,DTCC00489298,1954615,25112
CHEMBL252830,P08253,,KNJSKLCAFSSXEZ-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278069,DTCC00489375,164195,25102
CHEMBL252876,P08253,,BEHWVPRIGLRXIG-LPOPLRKUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282404,DTCC00488450,2068258,25163
CHEMBL252877,P08253,,ZOHXHAYMXURWLP-MNNMKWMVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,50,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276482,DTCC00488452,1841474,25086
CHEMBL252912,P08253,,ZUTQIHRPMPHINT-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,<,5,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276490,DTCC00488395,650434,25086
CHEMBL252965,P08253,,ZFKSAPYYGSUEFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,70000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266562,DTCC00485869,131684,24949
CHEMBL253019,P08253,,IKHATIJQVUIUCY-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278052,DTCC00489494,1744699,25102
CHEMBL253020,P08253,,IKHATIJQVUIUCY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278051,DTCC00489495,1264046,25102
CHEMBL253021,P08253,,RMPKUSBLGZHQII-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,1272,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278050,DTCC00489496,1652687,25102
CHEMBL253032,P08253,,YMEMYNPRLJHTGN-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278566,DTCC00489302,1954616,25112
CHEMBL253033,P08253,,NLCRRRBETNPQLX-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278565,DTCC00489303,957069,25112
CHEMBL253035,P08253,,OJSMIPQPXMBSTI-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278068,DTCC00489379,1937788,25102
CHEMBL253075,P08253,,NYOFYADPNAWQIO-ZWKOTPCHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282402,DTCC00488455,9067,25163
CHEMBL253076,P08253,,QCELJPBZUJYPIW-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282401,DTCC00488457,1166497,25163
CHEMBL253172,P08253,,CASVJRHAYOMAAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,110000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266561,DTCC00485870,521173,24949
CHEMBL253188,P08253,,FBXFLSBLYSCCKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,125000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266540,DTCC00485897,1231186,24949
CHEMBL253189,P08253,,XVLGIGXPBDHMCN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,107000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266539,DTCC00485898,1394272,24949
CHEMBL253230,P08253,,RMPKUSBLGZHQII-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,1380,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278049,DTCC00489499,67183,25102
CHEMBL253242,P08253,,YFEKLRQLQCUVPO-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,9.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278563,DTCC00489306,1728790,25112
CHEMBL253256,P08253,,QWCJOBSHHHILCA-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,391,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276487,DTCC00112461,521199,25086
CHEMBL253275,P08253,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282400,DTCC00003908,392011,25163
CHEMBL253275,P08253,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457237,DTCC00003908,404569,32556
CHEMBL253276,P08253,,JADBDFQEPJQPBJ-GOEBONIOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282399,DTCC00488458,1037911,25163
CHEMBL253313,P08253,,LCTLPROJUJRGOK-OYGGHGNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17936631,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.",Bioorg. Med. Chem.,2008,16,1,"Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG, Choi HM, Lee HY, Hong SH, Kim MS, Nam KY, Han G",,461353,DTCT0025094,2274651,DTCC00487736,1954602,25060
CHEMBL253372,P08253,,RZPBUIMYXLDFQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,90000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266559,DTCC00485872,1426657,24949
CHEMBL253373,P08253,,UFTZDZSQVAEJAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,71000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266558,DTCC00485873,1776512,24949
CHEMBL253374,P08253,,QQSFVIDGFAOBIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,71000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266556,DTCC00485875,1198941,24949
CHEMBL253375,P08253,,WAUSDDFKSNPSDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,66000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266555,DTCC00485876,746944,24949
CHEMBL253450,P08253,,BAFXERACAAFQDU-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278562,DTCC00489311,472501,25112
CHEMBL253452,P08253,,CLQLXMUGXKTPBU-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,655,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278065,DTCC00489389,779034,25102
CHEMBL253460,P08253,,GNZQSAUOKCWSHO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,1387,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276486,DTCC00112462,1716239,25086
CHEMBL253489,P08253,,IMWYAYZRQVPCBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17936631,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.",Bioorg. Med. Chem.,2008,16,1,"Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG, Choi HM, Lee HY, Hong SH, Kim MS, Nam KY, Han G",,461353,DTCT0025094,2274650,DTCC00487742,1604159,25060
CHEMBL253605,P08253,,OWGKRTPKHBGQCB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,39000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266552,DTCC00485879,746945,24949
CHEMBL253652,P08253,,NUZIOEFGCJGHAK-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278047,DTCC00489508,488974,25102
CHEMBL253665,P08253,,IVYQYYDKKZBNTO-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,1999,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278064,DTCC00489390,67182,25102
CHEMBL253680,P08253,,LFOGEPKUSWRLCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1312039,DTCC00487204,1035283,16328
CHEMBL253694,P08253,,QBKGBIIDSAFPRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17936631,IC50,=,860,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.",Bioorg. Med. Chem.,2008,16,1,"Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG, Choi HM, Lee HY, Hong SH, Kim MS, Nam KY, Han G",,461353,DTCT0025094,2274648,DTCC00487746,537305,25060
CHEMBL253710,P08253,,HNNDIXHHVAZLIV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17936631,IC50,=,1040,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.",Bioorg. Med. Chem.,2008,16,1,"Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG, Choi HM, Lee HY, Hong SH, Kim MS, Nam KY, Han G",,461353,DTCT0025094,2274682,DTCC00487750,827765,25060
CHEMBL253801,P08253,,WLDFNVXUZOLFLV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,73000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266565,DTCC00112331,746943,24949
CHEMBL253820,P08253,,SENFKJJTAIUEKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,64000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266550,DTCC00485881,714644,24949
CHEMBL253823,P08253,,MBMOJYHUZVXHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266548,DTCC00485885,9012,24949
CHEMBL253835,P08253,,KBHIXHPPONXJSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,33000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266538,DTCC00485900,1905754,24949
CHEMBL253890,P08253,,BTZCYRDTCBYYDO-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278063,DTCC00489394,1005489,25102
CHEMBL253892,P08253,,UBYVBDDXGLCPEF-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,7.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278539,DTCC00489397,1345902,25112
CHEMBL253920,P08253,,KRVYWSXTKLCPHD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,14,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276493,DTCC00488379,9050,25086
CHEMBL254006,P08253,,KHUYGJKVYSCEOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266564,DTCC00112332,228514,24949
CHEMBL254038,P08253,,BQQDHHXBQHXQLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266537,DTCC00485902,1808971,24949
CHEMBL254039,P08253,,YQZDMSWWISKFJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,73000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266536,DTCC00485903,1135256,24949
CHEMBL254238,P08253,,MEULEAFJINXPTC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,69000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266547,DTCC00485887,972955,24949
CHEMBL254239,P08253,,XRTFXZGCGQXDQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,57000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266546,DTCC00485888,585424,24949
CHEMBL254240,P08253,,BNQIAXFYQJNTFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,68000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266544,DTCC00485890,326666,24949
CHEMBL254293,P08253,,JKSLNLNYDBSARV-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278557,DTCC00489326,1313205,25112
CHEMBL254295,P08253,,REAAGXUAXYMPTM-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,126,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278062,DTCC00489402,2003661,25102
CHEMBL254398,P08253,,GYHDAVSEPKRYGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266914,DTCC00486104,876686,24951
CHEMBL254403,P08253,,ZISWMICBHCDCHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266526,DTCC00112333,99412,24949
CHEMBL254404,P08253,,XPTXINZCVRFJFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,98000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266525,DTCC00112334,1103054,24949
CHEMBL254405,P08253,3-(TRIFLUOROMETHYL)BENZYL 6-MERCAPTOPICOLINATE,HQDIBKWVFVAFAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,110000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266524,DTCC00003775,1037867,24949
CHEMBL254406,P08253,3-METHOXYBENZYL 6-MERCAPTOPICOLINATE,QHNITERHCRUTKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,90000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266522,DTCC00003777,67171,24949
CHEMBL254448,P08253,,GGTBYVPJZZRXTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,107000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266543,DTCC00485891,164174,24949
CHEMBL254492,P08253,,CTRWITLGGIGPOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,264,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278056,DTCC00489474,196175,25102
CHEMBL254506,P08253,,RVZZCWYPKFKFQC-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,53,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278555,DTCC00489329,827772,25112
CHEMBL254508,P08253,,ODKWXUUQJAZOOR-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2277985,DTCC00489331,682358,25102
CHEMBL254509,P08253,,NXDUTDHMFGWNPY-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,5.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278537,DTCC00489404,2020187,25112
CHEMBL254510,P08253,,ANOPQMHOFNTJCB-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,315,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278061,DTCC00489406,940969,25102
CHEMBL254604,P08253,,QJRFEWMMQFRQAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266879,DTCC00486108,391972,24951
CHEMBL254605,P08253,,CAEWBIZXRBQXKA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,620,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266896,DTCC00486109,1652661,24951
CHEMBL254606,P08253,,OWAPDZZCMRGQHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,320,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266895,DTCC00486110,1329185,24951
CHEMBL254610,P08253,4-PHENOXYBUTYL 6-MERCAPTOPICOLINATE,JINCVTOAYWQJTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,63000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266520,DTCC00003779,521174,24949
CHEMBL254611,P08253,3-FLUOROBENZYL 6-MERCAPTOPICOLINATE,OHJOCHBVYDYTJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,124000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266519,DTCC00003780,714645,24949
CHEMBL254627,P08253,,WDNYCRKXDHHDIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,72000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266570,DTCC00112324,521172,24949
CHEMBL254657,P08253,,PQCTVEFWWXYXGC-VMPITWQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,90000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266542,DTCC00485895,746946,24949
CHEMBL254715,P08253,,AFJYAUBLMRWZHB-GGYWPGCISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,549,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278074,DTCC00489334,714661,25102
CHEMBL254718,P08253,,GGFOVHADCXFYBC-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,119,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278535,DTCC00489410,1668796,25112
CHEMBL254722,P08253,,XUGIQJJECDDGBH-DOTOQJQBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,2128,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282317,DTCC00488435,1841493,25163
CHEMBL254816,P08253,,URSVZCYOMZVHJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,3080,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266893,DTCC00486112,164177,24951
CHEMBL254817,P08253,,AFLLOSXTZXYSAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,222,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266891,DTCC00486114,940947,24951
CHEMBL254818,P08253,,LMSQNDZFBZDFQV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,1208,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266890,DTCC00486115,1776515,24951
CHEMBL254821,P08253,,IGVYCJWEGFBBOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,111000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266534,DTCC00485907,1808972,24949
CHEMBL254837,P08253,,IGTOOKSKMAGIMJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,70000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266569,DTCC00112325,2068223,24949
CHEMBL254838,P08253,,BYXJDCBFAJLZRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,101000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266568,DTCC00112326,1937770,24949
CHEMBL254929,P08253,,PYBCEKGPALJXJE-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,5.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278534,DTCC00489412,1668799,25112
CHEMBL255029,P08253,,JYHCJUBSWRQINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,998,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266889,DTCC00486116,1005477,24951
CHEMBL255030,P08253,,SKUFTRBSRXIMDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,196,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266888,DTCC00486117,391973,24951
CHEMBL255051,P08253,,HLKJVILSXJCTNG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,69000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266566,DTCC00112329,1394271,24949
CHEMBL255160,P08253,,UWFRWYGMHWPIMQ-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317227,DTCC00499834,1700709,25272
CHEMBL255171,P08253,,HULXBZPKHGNNND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,242,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289282,DTCC00501410,844383,25715
CHEMBL255374,P08253,,ZSZOBVLJWIXXND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469435,DTCT0025094,2289277,DTCC00501413,1905900,25715
CHEMBL255374,P08253,,ZSZOBVLJWIXXND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,IC50,=,9300,NM,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564426,DTCT0025094,2612867,DTCC00501413,1917961,33264
CHEMBL255374,P08253,,ZSZOBVLJWIXXND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21609408,IC50,=,9300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14717814,DTCC00501413,2101220,69102
CHEMBL255375,P08253,,RRZNITDSNPAPBH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289280,DTCC00501414,1296744,25715
CHEMBL255418,P08253,,UCBHULDBBSNWOP-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,=,2933,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317237,DTCC00500049,1442584,25272
CHEMBL255575,P08253,,NAYVOTYJJPROOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,610,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289275,DTCC00501455,1038014,25715
CHEMBL255575,P08253,,NAYVOTYJJPROOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21609408,IC50,=,610,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14717123,DTCC00501455,2100874,69102
CHEMBL255756,P08253,,RYSSHJFPQIVXNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,377,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289031,DTCC00501944,682465,25686
CHEMBL255757,P08253,,JIQWJAWERNKCFL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,59.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289032,DTCC00501945,1776658,25686
CHEMBL255995,P08253,,ROXDKSYNRMRPOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,22.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289293,DTCC00501277,9240,25715
CHEMBL255996,P08253,,LUXNVTGRZAPNHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,41,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289294,DTCC00501279,1937892,25715
CHEMBL256018,P08253,,WUDIIDPVRNKUNH-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,893,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300298,DTCC00500708,1296688,25438
CHEMBL256066,P08253,,LJTOKVQVUWPBDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,72,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289035,DTCC00502029,131836,25686
CHEMBL256067,P08253,,GJWCBBLTUFPHCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,184,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289036,DTCC00502030,682464,25686
CHEMBL256157,P08253,,PRJCFROAJDAXAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.25,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14744864,DTCC00490063,2108850,69259
CHEMBL256157,P08253,,PRJCFROAJDAXAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,<,1.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278124,DTCC00490063,2003662,25102
CHEMBL256187,P08253,,GYCOCSHXBFMYGU-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,2317,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300299,DTCC00500752,1394358,25438
CHEMBL256245,P08253,,XZHJCGLTNPMNLE-XTEPFMGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,=,2633,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296530,DTCC00502063,424775,25233
CHEMBL256438,P08253,,ZCLGRPDLXFVIIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,95.9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289033,DTCC00501989,359381,25686
CHEMBL256598,P08253,,BEMAWHUATSKVDF-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,=,1500,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296531,DTCC00501616,424774,25233
CHEMBL256621,P08253,,NASYCHQKVXYGPX-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296506,DTCC00501980,521230,25233
CHEMBL256642,P08253,,FGVRDWMLTSAQAQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,4591,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289285,DTCC00501078,521328,25715
CHEMBL256681,P08253,,YURFZWNLXFKRFO-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296517,DTCC00501695,1394318,25233
CHEMBL256805,P08253,,TTZQPUPTVJAEIJ-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,=,2733,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296532,DTCC00501618,1296649,25233
CHEMBL256843,P08253,,DIWCYPNWGCAUKU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,108.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289284,DTCC00501079,359397,25715
CHEMBL257070,P08253,,GLZLLWJIHUOGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,10.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289038,DTCC00502071,1620542,25686
CHEMBL257072,P08253,,GWAXDFHSCOMEEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,84.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289039,DTCC00502074,1744803,25686
CHEMBL257086,P08253,,CQAUVGAVNXQLQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,66.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289298,DTCC00501324,1394424,25715
CHEMBL257088,P08253,,HAPYOOOJPQOLHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289027,DTCC00501372,2068349,25686
CHEMBL257088,P08253,,HAPYOOOJPQOLHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289301,DTCC00501372,2068358,25715
CHEMBL257211,P08253,,RWHRRAZIYVBNOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,167.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289034,DTCC00501992,779157,25686
CHEMBL257480,P08253,,ISONEAYXNYSTJQ-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,36.8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289028,DTCC00501865,1873601,25686
CHEMBL257531,P08253,,LSEJNPTVWWYHHK-NGYIFUPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296520,DTCC00501776,521228,25233
CHEMBL257532,P08253,,BVFWOEMSVMBUTK-PIPMEXSNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296521,DTCC00501778,2068269,25233
CHEMBL257672,P08253,,UEFDPQIFYVNTDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,8.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289296,DTCC00501316,585573,25715
CHEMBL257673,P08253,,GVTAXPJFCIKNRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,6.1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289297,DTCC00501320,553416,25715
CHEMBL257724,P08253,,HFAMBBILJIHLFF-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,1262,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300319,DTCC00500537,1841532,25438
CHEMBL257725,P08253,,QMFXBRFSLXUTKY-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,286,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300318,DTCC00500538,1426728,25438
CHEMBL257874,P08253,,QVVWOFJAPGVZJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,66.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289300,DTCC00501369,1426798,25715
CHEMBL258055,P08253,,AXERWECZRIZWCH-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317234,DTCC00499963,2084595,25272
CHEMBL258300,P08253,,SQWGCQTZANCRQT-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,344,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300311,DTCC00500377,1296687,25438
CHEMBL258301,P08253,,MDYILYKXSLZVLM-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,1057,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300310,DTCC00500378,1199026,25438
CHEMBL260091,P08253,CHIR-090,FQYBTYFKOHPWQT-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25408833,INHIBITION,=,12,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) at 30 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432685,DTCT0025094,13976524,DTCC00004087,902363,60283
CHEMBL261932,P08253,TANOMASTAT,JXAGDPXECXQWBC-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104534,DTCT0025094,1077305,DTCC00288849,1035816,16063
CHEMBL261932,P08253,TANOMASTAT,JXAGDPXECXQWBC-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,11,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1568634,DTCC00288849,1035158,16699
CHEMBL262397,P08253,,QTGQZAQZBAEHLR-URZIEALYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15837315,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 in MMPi assay,,A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.,Bioorg. Med. Chem. Lett.,2005,15,9,"Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S, Tuccinardi T, Atkinson SJ, Murphy G, Balsamo A",,305684,DTCT0025094,1841401,DTCC00403446,337522,18987
CHEMBL262676,P08253,,HNXQLWUITFQYPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1606265,DTCC00299222,2045764,15919
CHEMBL262676,P08253,,HNXQLWUITFQYPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,1.51,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258478,DTCC00299222,2036409,24803
CHEMBL262693,P08253,,HJASPQSKQSRTLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,479582,DTCC00260764,1585300,3361
CHEMBL26317,P08253,,XGFZWXKDGNCTSR-QLFBSQMISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,2,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,630882,DTCC00163354,1227613,2586
CHEMBL263717,P08253,,SPOYPAQQYPYRKF-TVZXLZGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,100,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,518230,DTCC00135930,1772722,14548
CHEMBL263750,P08253,,JDKMZILZEJPWTA-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1798740,DTCC00394441,142392,8231
CHEMBL264067,P08253,,HJFONKSERLWIGE-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860324,DTCC00407659,855096,19837
CHEMBL264455,P08253,,DTQSORRPTAWCFK-SMXONETASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.1,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1053126,DTCC00283638,594797,1950
CHEMBL264495,P08253,,SSNRGEULLFASJG-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,19.95,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258303,DTCC00208605,650399,24803
CHEMBL264495,P08253,,SSNRGEULLFASJG-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,20,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,693237,DTCC00208605,647426,2288
CHEMBL264605,P08253,,ACEQKTCZFYDQCP-IXDOHACOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,3,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,628736,DTCC00164377,1902243,2586
CHEMBL264859,P08253,,YALGTTXMUHXKRY-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,355873,DTCC00231877,982005,16308
CHEMBL265075,P08253,,YPULLLFYLVWNFW-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,61,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,536697,DTCC00136006,95662,14548
CHEMBL265342,P08253,,WWRZCSYJKWXOGQ-CKIYMEHHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,150,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,533870,DTCC00135789,905269,14548
CHEMBL265769,P08253,,SQEKFRREQBQUKS-VGSVOMNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9191969,IC50,=,19000,NM,,,,,,,,,,,,,,The concentration required to achieve 50% inhibition against Matrix metalloprotease-2,,Dual inhibition of human leukocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives.,J. Med. Chem.,1997,40,12,"Portevin B, Lonchampt M, Canet E, De Nanteuil G",,104563,DTCT0025094,1256581,DTCC00204634,1805941,14199
CHEMBL266133,P08253,,VVFWIKQAXZHMNQ-WWBASHGMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,30,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,534724,DTCC00135494,969197,14548
CHEMBL266245,P08253,,BDVACXGBIHLFIX-QQSVUBKYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,<,2.8,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1535000,DTCC00135646,1534802,4824
CHEMBL266292,P08253,,SUFSQYXUPYDFHG-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1315159,DTCC00133589,1631533,4760
CHEMBL266294,P08253,,PLLLIPJQFJENRC-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,0,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,538672,DTCC00135942,2032739,14548
CHEMBL266335,P08253,,KRMDDILTPWLCKE-QQSVUBKYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,500,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1525688,DTCC00135561,207327,4824
CHEMBL266367,P08253,,NBOQQJXCMRBQCH-HSALFYBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,1500,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,455290,DTCC00136025,256865,14548
CHEMBL266579,P08253,,SIQAXTKFLDLSOX-AOHZBQACSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,532885,DTCC00135702,1195202,14548
CHEMBL266612,P08253,,ZCERGCHRYHXHNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104545,DTCT0025094,737889,DTCC00143029,256945,6676
CHEMBL266764,P08253,,DTHLOBYXEMQYBV-CERRFVOPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,49,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,540341,DTCC00135671,1648847,14548
CHEMBL267452,P08253,,RQQIQUQRTVOJTM-FULLSBAXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,518233,DTCC00135625,613900,14548
CHEMBL267503,P08253,,UIOBFFKNGCFAHB-UWPQIUOOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,,17,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,519222,DTCC00135943,63200,14548
CHEMBL26753,P08253,,CRJIZTSRHKBTKG-HZSPNIEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,100,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,623309,DTCC00104118,128128,2586
CHEMBL267533,P08253,,ZDFWMZOVILGQKY-HRHHFINDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,25,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,529070,DTCC00135788,905268,14548
CHEMBL267536,P08253,,MFDDFJXXVOMZLW-XFQWPLCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,610100,DTCC00362046,551991,2023
CHEMBL267603,P08253,FOLATE GAMMA-L-PHENYLALANINEHYDROXAMIC ACID,WYBGJFMKGROIBY-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,IC50,=,65000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441088,DTCT0025094,2143972,DTCC00003031,2079521,23121
CHEMBL267603,P08253,FOLATE GAMMA-L-PHENYLALANINEHYDROXAMIC ACID,WYBGJFMKGROIBY-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,RATIO IC50,=,2708,,,,,,,,,,,,,,,Ratio of IC50 of drug to CGS 27023A for human recombinant MMP2,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441100,DTCT0025094,2143993,DTCC00003031,2079521,23121
CHEMBL267722,P08253,,ODAJGMHJQWCVQY-OZNIXHKMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,94,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,542291,DTCC00135622,1772720,14548
CHEMBL267854,P08253,,BGTGOVQBCQMVIR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17936631,IC50,=,1470,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.",Bioorg. Med. Chem.,2008,16,1,"Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG, Choi HM, Lee HY, Hong SH, Kim MS, Nam KY, Han G",,461353,DTCT0025094,2274649,DTCC00487744,180218,25060
CHEMBL267939,P08253,,XDYZXHJJAIXYOR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1312862,DTCC00133464,1275453,4760
CHEMBL268050,P08253,,SBJYHMQPQSBUBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,567,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,938136,DTCC00138716,1177786,16645
CHEMBL268114,P08253,,CNDCCBOSTVCBMM-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,2.7,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1315166,DTCC00133623,2015284,4760
CHEMBL268143,P08253,,WAQUJVIPPSYKJX-DYIKCSJPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,800,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,516070,DTCC00135994,1066391,14548
CHEMBL268377,P08253,,SRBWJOFRJIEWKS-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,5.3,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1322465,DTCC00133440,2015283,4760
CHEMBL268377,P08253,,SRBWJOFRJIEWKS-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,5.25,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258302,DTCC00133440,2003619,24803
CHEMBL268381,P08253,,TVIRTWMMZYUJOB-INOCPDNRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,48,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1535161,DTCC00135495,1275478,4824
CHEMBL268405,P08253,,ZFVODTPAFVMUMK-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,48,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,536694,DTCC00136037,63201,14548
CHEMBL268680,P08253,,YKDJPMMXYREXJX-NIDLKEISSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,1133,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1555854,DTCC00135634,1755762,4824
CHEMBL268882,P08253,,TZHSKYKMJBHKLJ-NIDLKEISSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,27,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1533935,DTCC00135725,855684,4824
CHEMBL268883,P08253,,PHPNJCKHSRLBDB-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,1900,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,529076,DTCC00135899,1740944,14548
CHEMBL268992,P08253,,VGFAMRABAXJUTN-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,2430,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1122413,DTCC00344215,1241524,4691
CHEMBL268992,P08253,,VGFAMRABAXJUTN-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,2454.71,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258364,DTCC00344215,1231166,24803
CHEMBL269019,P08253,,RCXJWFMVFQBLSC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1298433,DTCC00133541,1599275,4760
CHEMBL269019,P08253,,RCXJWFMVFQBLSC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,0.708,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258301,DTCC00133541,1587769,24803
CHEMBL269334,P08253,,ZVCHAVSCMLWXRD-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,16,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,527194,DTCC00135721,1583956,14548
CHEMBL269613,P08253,,ZQJRBAHLNKPYFN-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,517199,DTCC00135528,1967124,14548
CHEMBL269797,P08253,,QOLXVMJRZKRSEE-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,2535,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300306,DTCC00500247,585502,25438
CHEMBL269815,P08253,,NUHXWSDHKIQRIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289030,DTCC00501899,326814,25686
CHEMBL269834,P08253,,ZWPPXQSIUHCIOD-XXBNENTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18835710,KI,=,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496898,DTCT0025094,2456666,DTCC00505033,985373,31825
CHEMBL270010,P08253,,HMCYLAUUSNONFW-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,247,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300309,DTCC00500332,260824,25438
CHEMBL270023,P08253,,QTXVUOFTEGYFFX-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,509,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300316,DTCC00500501,682413,25438
CHEMBL270050,P08253,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18251495,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465546,DTCT0025094,2311301,DTCC00503704,1636500,25409
CHEMBL270050,P08253,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457325,DTCC00503704,1632393,32556
CHEMBL270083,P08253,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18257543,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465795,DTCT0025094,2311837,DTCC00004596,2020286,25428
CHEMBL270083,P08253,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18257543,INHIBITION,=,90,%,,,,,,,,,,,,,,Inhibition of MMP2 activity in reconstituted Matrigel coated membrane assessed as inhibition of tumor cell invasion at 100 uM,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465802,DTCT0025094,2311852,DTCC00004596,2020286,25428
CHEMBL270083,P08253,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457402,DTCC00004596,2016157,32556
CHEMBL270229,P08253,,WPAHDVHPQGUCCP-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,401,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300312,DTCC00500419,553364,25438
CHEMBL270230,P08253,,KWWODZMHQNKZHP-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,582,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300313,DTCC00500421,294141,25438
CHEMBL270296,P08253,TRANS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-PHDIDXHHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18257543,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465795,DTCT0025094,2311845,DTCC00004597,1151799,25428
CHEMBL270372,P08253,,XITKJDIGEPUHLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289044,DTCC00502152,811487,25686
CHEMBL270509,P08253,SUMAFLAVONE,BCTLOSNRPJXRNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029185,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 in UVB irradiated human dermal fibroblasts at <5 uM by zymography,Not Active,Biflavonoids isolated from Selaginella tamariscina regulate the expression of matrix metalloproteinase in human skin fibroblasts.,Bioorg. Med. Chem.,2008,16,2,"Lee CW, Choi HJ, Kim HS, Kim DH, Chang IS, Moon HT, Lee SY, Oh WK, Woo ER",,465413,DTCT0025094,2292671,DTCC00503218,99494,25393
CHEMBL270515,P08253,DELANZOMIB,SJFBTAPEPRWNKH-CCKFTAQKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18247547,INHIBITION,=,-5,%,,,,,,,,,,,,,,Inhibition of human MMP2 at 10 uM,,"Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.",J. Med. Chem.,2008,51,4,"Dorsey BD, Iqbal M, Chatterjee S, Menta E, Bernardini R, Bernareggi A, Cassarà PG, D'Arasmo G, Ferretti E, De Munari S, Oliva A, Pezzoni G, Allievi C, Strepponi I, Ruggeri B, Ator MA, Williams M, Mallamo JP",,464575,DTCT0025094,2308329,DTCC00504722,1442592,25324
CHEMBL270606,P08253,,OYFJDPJIGCMKKI-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296515,DTCC00501659,521229,25233
CHEMBL270800,P08253,,CNSXDPYRIAFYKG-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296511,DTCC00502180,1037923,25233
CHEMBL270817,P08253,,KCBXQUWPZNVZIG-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317224,DTCC00499794,472518,25272
CHEMBL270819,P08253,,SVLPSGKSYVCBRQ-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296516,DTCC00501660,811411,25233
CHEMBL270868,P08253,,BEGMRZSKEXZQQD-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,1233,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300315,DTCC00500499,1971104,25438
CHEMBL271234,P08253,,NTFMFANVPWIUGQ-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296508,DTCC00502100,1198991,25233
CHEMBL271235,P08253,,SIICAQVADMFEDB-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,=,1100,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296509,DTCC00502102,1776559,25233
CHEMBL271347,P08253,"2',8'-BIAPIGENIN",IDXPHFRRYHNPFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029185,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 in UVB irradiated human dermal fibroblasts at <5 uM by zymography,Not Active,Biflavonoids isolated from Selaginella tamariscina regulate the expression of matrix metalloproteinase in human skin fibroblasts.,Bioorg. Med. Chem.,2008,16,2,"Lee CW, Choi HJ, Kim HS, Kim DH, Chang IS, Moon HT, Lee SY, Oh WK, Woo ER",,465413,DTCT0025094,2292826,DTCC00004539,1620491,25393
CHEMBL271450,P08253,,FPQFSGNFLIZLQV-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317228,DTCC00499874,989464,25272
CHEMBL271520,P08253,,WVYUBYOZPPLWTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,104.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289288,DTCC00501173,1841596,25715
CHEMBL271720,P08253,,HVBCQBVRPBCTHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,5.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289286,DTCC00501128,1329332,25715
CHEMBL271736,P08253,,JGESVFFMSKZGDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289290,DTCC00501176,1809117,25715
CHEMBL271866,P08253,,CDYLCTGLLNQEQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,12.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289040,DTCC00502114,1103192,25686
CHEMBL271867,P08253,,WKRVNRRBAKSSCD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,17.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289043,DTCC00502115,1555685,25686
CHEMBL271938,P08253,,JRZMGNCXDSZZAF-LEWJYISDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317231,DTCC00499913,277689,25272
CHEMBL272102,P08253,,DOXOLOXDHNMGLW-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317236,DTCC00500008,1539671,25272
CHEMBL272341,P08253,,QZMMDSUYRAUHCK-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296523,DTCC00501813,617765,25233
CHEMBL272512,P08253,,VCNCKDLZUXUYIX-SIKLNZKXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,=,3300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317235,DTCC00500007,1889728,25272
CHEMBL272528,P08253,,HXQPXYLMOANXKE-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,INHIBITION,=,87,%,,,,,,,,,,,,,,Inhibition of full length MMP2 at 10 uM,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465910,DTCT0025094,2300360,DTCC00500152,1873544,25438
CHEMBL272763,P08253,,RRHRZNYTQKIVLU-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300300,DTCC00500799,359337,25438
CHEMBL272861,P08253,TAIWANIAFLAVONE,IMKDLTDRZZSWPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029185,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 in UVB irradiated human dermal fibroblasts at <5 uM by zymography,Not Active,Biflavonoids isolated from Selaginella tamariscina regulate the expression of matrix metalloproteinase in human skin fibroblasts.,Bioorg. Med. Chem.,2008,16,2,"Lee CW, Choi HJ, Kim HS, Kim DH, Chang IS, Moon HT, Lee SY, Oh WK, Woo ER",,465413,DTCT0025094,2292829,DTCC00503170,1684953,25393
CHEMBL272984,P08253,,MTGNXLIVWGHNAC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,56,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300301,DTCC00500802,9152,25438
CHEMBL274174,P08253,,LFQCQDFQXKNBRD-OCOZRVBESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,87,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,954771,DTCC00138502,952175,16645
CHEMBL274881,P08253,,QJKGJGURDPRKGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,948297,DTCC00138736,855707,16645
CHEMBL274997,P08253,,PSKXAYSNQRZKIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,965334,DTCC00138499,1949639,16645
CHEMBL275014,P08253,,QGOLLUPJBACRFO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104545,DTCT0025094,731381,DTCC00142925,1902040,6676
CHEMBL275130,P08253,,NJHUORLPMNSFLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,26,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,949522,DTCC00138690,305534,16645
CHEMBL275345,P08253,,LRNHIFFROICLCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,1160,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,975197,DTCC00138682,1502499,16645
CHEMBL275362,P08253,,WWYUUQYLTXYLBK-VQHVLOKHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.05,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836402,DTCC00147933,997232,53968
CHEMBL275654,P08253,,YZAPRHDGKDEXIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,12,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1597361,DTCC00230956,1902969,16699
CHEMBL275700,P08253,,ZZBMCFITYYSQSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,939398,DTCC00138634,1437792,16645
CHEMBL275732,P08253,,GPCRWNMOLNNODH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (No data),Not Determined,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104546,DTCT0025094,749049,DTCC00142996,549467,6676
CHEMBL275754,P08253,,ZJBLIILJIFWDHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,380,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,953644,DTCC00138683,596814,16645
CHEMBL27577,P08253,SALICYLAMIDE,SKZKKFZAGNVIMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103076,DTCC00161342,183413,43205
CHEMBL276016,P08253,,TYFXGYABSVUPRB-IDCGIGBZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,969196,DTCC00138586,1437793,16645
CHEMBL276373,P08253,,NCWXRZLEODZYTE-YKILCQELSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,84,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,536691,DTCC00136043,1933918,14548
CHEMBL277792,P08253,,KKRBZYCHOUTMBU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,6,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1083345,DTCC00249127,615165,15258
CHEMBL277972,P08253,,ZPDVGCNXBJNBDB-MRVPVSSYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,75,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1455997,DTCC00197952,949248,17283
CHEMBL279078,P08253,,OBJBBLBMOOBABD-BEVDRBHNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,0.3,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,982758,DTCC00151610,1308397,15116
CHEMBL279438,P08253,,NDXVEINWVXXBKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11934591,INHIBITION,=,55,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 at 50 uM,,Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,8,"Pergament I, Reich R, Srebnik M",,104393,DTCT0025094,471494,DTCC00151685,2064653,5468
CHEMBL279482,P08253,,TUIHSDQRXNNCLL-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10882354,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease -2,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,104549,DTCT0025094,1106731,DTCC00152021,140588,15747
CHEMBL279482,P08253,,TUIHSDQRXNNCLL-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11354379,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,104558,DTCT0025094,703843,DTCC00152021,128005,4814
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,5.1,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,980295,DTCC00151612,919877,15116
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,6,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,643197,DTCC00151612,905592,2586
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,0.85,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1397632,DTCC00151612,907004,2897
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10397503,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101907,DTCT0025094,513406,DTCC00151612,905843,3181
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1478659,DTCC00151612,917406,3373
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,0.75,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,723513,DTCC00151612,906713,3985
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,627891,DTCC00151612,906831,4635
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,0.75,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1673843,DTCC00151612,917130,4449
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,0.75,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1080730,DTCC00151612,917285,4541
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.41,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1580590,DTCC00151612,906350,16699
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12014967,KI,=,0.6,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-2 (MMP-2),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104562,DTCT0025094,789590,DTCC00151612,917001,16740
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,516912,DTCC00151612,917874,13726
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26653735,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of full length human recombinant MMP2 using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552513,DTCT0025094,73303,DTCC00151612,915925,65989
CHEMBL279785,P08253,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,6,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,691920,DTCC00151612,906079,2288
CHEMBL279786,P08253,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,1,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,1014094,DTCC00151611,984634,15116
CHEMBL279786,P08253,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,2.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1372581,DTCC00151611,970785,2897
CHEMBL279786,P08253,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,0.5,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1135160,DTCC00151611,983181,4691
CHEMBL279786,P08253,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12877590,IC50,=,0.73,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 (MMP-2),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104373,DTCT0025094,1526045,DTCC00151611,970901,17445
CHEMBL279786,P08253,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15582436,IC50,=,13,NM,,cell_based,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 expressed in Sf9 insect cells,,"N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.",Bioorg. Med. Chem. Lett.,2005,15,1,"Lee J, Shim JS, Jung SA, Lee ST, Kwon HJ",,306130,DTCT0025094,1757714,DTCC00151611,983688,18428
CHEMBL279786,P08253,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,4,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,665669,DTCC00151611,969961,2288
CHEMBL279964,P08253,,GTBJTISRJIZWKE-HIFRSBDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,42.5,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,999332,DTCC00151073,1114498,15116
CHEMBL280017,P08253,,RSMQCSLXBNSQJJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1683005,DTCC00201392,937808,16216
CHEMBL280998,P08253,CATECHOL,YCIMNLLNPGFGHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103753,DTCC00161195,517323,43205
CHEMBL281371,P08253,,YOZKFIDLBXLPFF-HIFRSBDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,8.4,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,1015393,DTCC00151650,1437901,15116
CHEMBL281392,P08253,,JXIHYPLXDHICJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11934591,INHIBITION,=,50,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 at 50 uM,,Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,8,"Pergament I, Reich R, Srebnik M",,104393,DTCT0025094,698022,DTCC00151747,1455033,5468
CHEMBL281428,P08253,,HMQSTUIDQZFHHO-GRHQJALTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,40,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,637671,DTCC00164311,2033017,2586
CHEMBL281795,P08253,,GCBPAPVOMPJQHK-NQIIRXRSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,101925,DTCT0025094,1449484,DTCC00157778,1049545,1206
CHEMBL281810,P08253,,CHLJPGIRYHWCBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11934591,INHIBITION,=,40,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 at 50 uM,,Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,8,"Pergament I, Reich R, Srebnik M",,104393,DTCT0025094,712959,DTCC00151255,1584135,5468
CHEMBL282146,P08253,,AKWKBACKRMYPRV-NQIIRXRSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,115,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,101929,DTCT0025094,1470039,DTCC00168996,726366,1206
CHEMBL283066,P08253,,NWYFRVGJVQHAJF-DLFZDVPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10021913,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of recombinant matrix metalloprotease-2 (MMP-2),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,101930,DTCT0025094,670652,DTCC00161074,451895,3377
CHEMBL283580,P08253,,NBBPYGNNDFCNNP-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11354379,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,104558,DTCT0025094,696876,DTCC00151925,1066552,4814
CHEMBL284104,P08253,DIPICOLINIC ACID,WJJMNDUMQPNECX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-6,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103767,DTCC00159433,280901,43205
CHEMBL284465,P08253,,DFGIMYUXEBBKPA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,876453,DTCC00171529,1402575,2600
CHEMBL285112,P08253,,YKHOQKKUOWOUDP-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,,,,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2 (not determined)",Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,13,,,101927,DTCT0025094,1476122,DTCC00168915,888195,1206
CHEMBL285296,P08253,,TUACOILKNZYSRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,48,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1447224,DTCC00179359,1692841,4274
CHEMBL285418,P08253,,OONXADPQRATYFL-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.3,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,101929,DTCT0025094,1476116,DTCC00104294,35210,1206
CHEMBL286204,P08253,QUINOLINIC ACID,GJAWHXHKYYXBSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-16,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103688,DTCC00158604,151276,43205
CHEMBL286290,P08253,,AGGJZKIOHQRDLH-HLAWJBBLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,10,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,647670,DTCC00164347,646950,2586
CHEMBL286295,P08253,,ITLCYVVIJXYTPH-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,881647,DTCC00170871,497070,2600
CHEMBL286698,P08253,,YFRJNXOLSKBGTP-QEMZJVQQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,64,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,879018,DTCC00170903,916301,2600
CHEMBL286718,P08253,,QJTVGYXBJXFBOD-YZGWKJHDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,30,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,364954,DTCC00163655,224926,2586
CHEMBL286718,P08253,,QJTVGYXBJXFBOD-YZGWKJHDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,100,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,638829,DTCC00163655,224925,2586
CHEMBL286788,P08253,,NWIDFBAHFQXVFF-QEMZJVQQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,885456,DTCC00171152,28545,2600
CHEMBL286904,P08253,,BQOKFWQTKSZIMZ-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,472,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,101929,DTCT0025094,1473752,DTCC00169030,856017,1206
CHEMBL287556,P08253,KOJIC ACID,BEJNERDRQOWKJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,52,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103727,DTCC00159276,1381648,43205
CHEMBL287899,P08253,"PYRIDINE-2,3-DIOL",GGOZGYRTNQBSSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-18,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5102634,DTCC01739869,1316336,43205
CHEMBL288067,P08253,,MIXVCULNWAELJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,58000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1586511,DTCC00179777,464189,4273
CHEMBL288067,P08253,,MIXVCULNWAELJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,58,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1473900,DTCC00179777,464199,4274
CHEMBL288072,P08253,,NEQBRWOTAUTWCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,708539,DTCC00184795,626230,3810
CHEMBL288099,P08253,,SMWGTYPHHCYQHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11378378,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104559,DTCT0025094,1033063,DTCC00173333,647042,4214
CHEMBL288114,P08253,GALLIC ACID,LNTHITQWFMADLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15081893,IC50,=,200000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14713322,DTCC00180264,2099101,68331
CHEMBL288385,P08253,,RCBZDQNYDDBSAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,89,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1468943,DTCC00179812,236670,4274
CHEMBL288510,P08253,,VKALTFMIUSHHED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,6900,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1564562,DTCC00179844,1239659,4273
CHEMBL288592,P08253,,XJIQVSMHQQCBEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,12000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1558160,DTCC00180002,1499348,4273
CHEMBL288701,P08253,,RLIATYHSAHYWGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,25000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1581310,DTCC00179654,819627,4273
CHEMBL288750,P08253,,VTEHMCYSJRSGPC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,130,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,638515,DTCC00191454,950975,15057
CHEMBL289003,P08253,,MVNUXJNXEWKALY-NPPFBWRTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,66,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,884189,DTCC00170896,334834,2600
CHEMBL289108,P08253,,QMVPXGOXZBWYSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,650000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1560676,DTCC00179279,1046166,4273
CHEMBL289857,P08253,,CKVQEICURFVZKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,723458,DTCC00184401,1628776,3810
CHEMBL290067,P08253,,JAFHGTXCEIJXQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,8000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1570698,DTCC00179842,1946330,4273
CHEMBL290140,P08253,PNU-142372,HZAXNPDJVFUGDS-BYPYZUCNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163188,KI,=,3000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (gelatinase-A),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104408,DTCT0025094,1546260,DTCC01739728,1564727,17850
CHEMBL290377,P08253,,UTSFQPTVPZNJJH-YPJJGMIRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12824028,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104553,DTCT0025094,1488310,DTCC00181446,853101,5648
CHEMBL290457,P08253,,RNHVOKXLHUNLLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,45000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1578727,DTCC00179878,819626,4273
CHEMBL290631,P08253,,CSLQYGQMUXSECS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,728348,DTCC00184264,1881772,3810
CHEMBL290632,P08253,PROCYANIDIN C1,MOJZMWJRUKIQGL-XILRTYJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20053563,IC50,=,31400,NM,,,,,,,,,,,,,,Inhibition of human rheumatoid synovial fibroblasts gelatinase A after 30 mins by fluorescence plate reader,,"Identification of potential and selective collagenase, gelatinase inhibitors from Crataegus pinnatifida.",Bioorg. Med. Chem. Lett.,2010,20,3,"Moon HI, Kim TI, Cho HS, Kim EK",,607930,DTCT0025094,3191708,DTCC00178120,372550,37466
CHEMBL291133,P08253,,UAFDRTNAZWZUDR-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,31,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,903633,DTCC00185834,1046252,15892
CHEMBL291194,P08253,,CZOWYKOQKWYITK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,644114,DTCC00192095,1981306,15057
CHEMBL291194,P08253,,CZOWYKOQKWYITK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,500,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1259770,DTCC00192095,1967745,15166
CHEMBL291213,P08253,,SDUKSXDVVHERIX-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1274783,DTCC00191852,1488014,15166
CHEMBL291884,P08253,,FGGOECPJNJCERE-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,491429,DTCC00211584,1934791,5598
CHEMBL291994,P08253,,AMOCYMNNMVOHOG-IFMALSPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.5,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,669309,DTCC00208351,2000520,2288
CHEMBL292160,P08253,,IKZOIIFNGBJACQ-FYYLOGMGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,90,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,684440,DTCC00208219,1002528,2288
CHEMBL292313,P08253,,GWXMWHCYBJJJND-GDBMZVCRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.7,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,671857,DTCC00208710,452427,2288
CHEMBL292431,P08253,,DCSHLVVGHNRVCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1719465,DTCC00200601,1325927,16216
CHEMBL292546,P08253,,FDOUDYUDNHWREP-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,491414,DTCC00211950,1326086,5598
CHEMBL292657,P08253,,UALGGXUAYUNRBS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,41,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1703173,DTCC00200819,1584625,16216
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15582436,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 expressed in Sf9 insect cells; ND:Not determined,Not Determined,"N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.",Bioorg. Med. Chem. Lett.,2005,15,1,"Lee J, Shim JS, Jung SA, Lee ST, Kwon HJ",,306496,DTCT0025094,1757720,DTCC00165773,109891,18428
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233025,DTCC00165773,115476,24428
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,21960,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542639,DTCC00165773,111636,28603
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,IC50,=,9500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654669,DTCC00165773,99875,30500
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,162000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680415,DTCC00165773,100325,31487
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,40500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622542,DTCC00165773,100165,33114
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,40500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621549,DTCC00165773,100168,33133
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,162000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041666,DTCC00165773,100620,35560
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,162000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155247,DTCC00165773,112398,36679
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,253200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219789,DTCC00165773,112441,37311
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20637634,IC50,=,156980,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.",Bioorg. Med. Chem.,2010,18,16,"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W",,647223,DTCT0025094,3435368,DTCC00165773,101213,40062
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,167000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14721176,DTCC00165773,2102268,67818
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21802307,IC50,=,120400,NM,,,,,,,,,,,,,,Inhibition of human MMP-2 after 30 mins by spectrophotometry,,Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.,Bioorg. Med. Chem.,2011,19,17,"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W",,763989,DTCT0025094,6072850,DTCC00165773,120003,45627
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21911297,IC50,=,163480,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2011,19,20,"Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W",,769837,DTCT0025094,6093860,DTCC00165773,120066,45986
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22607877,IC50,=,156000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP2 using succinylated gelatin as substrate incubated for 10 mins prior to substrate addition measured after 1 hr by UV/VIS spectrophotometry,,"Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2012,20,12,"Su L, Jia Y, Zhang L, Xu Y, Fang H, Xu W",,822742,DTCT0025094,10498257,DTCC00165773,102590,48415
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23528299,IC50,=,156000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP2 (unknown origin) using L-Leu-p-nitroanilide as substrate incubated for 5 mins prior to substrate addition measured after 60 mins by UV-Vis spectrophotometry,,Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent.,Bioorg. Med. Chem. Lett.,2013,23,9,"Su L, Jia Y, Wang X, Zhang L, Fang H, Xu W",,963628,DTCT0025094,12463216,DTCC00165773,123731,54810
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709721,DTCC00165773,124809,58773
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,,,,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,Not Determined,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550515,DTCC00165773,94447,63755
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,Not Determined,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550542,DTCC00165773,94447,63755
CHEMBL29292,P08253,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,276000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP-2 using succinylated gelatin as substrate incubated for 10 mins before addition of substrate measured after 60 mins by UV-Vis spectrophotometric analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,879811,DTCT0025094,11466028,DTCC00165773,122891,51793
CHEMBL293003,P08253,,VCJOCQOXJUMEBE-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,5.9,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1658949,DTCC00215412,1596527,2712
CHEMBL293019,P08253,,NPZDPBHMFYXBRP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1528040,DTCC00209001,1046465,4358
CHEMBL293074,P08253,,NSLCGVDBXCHQFK-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,154,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1458385,DTCC00197745,107804,17283
CHEMBL293305,P08253,,BEKYMPWGANBKBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1694307,DTCC00201393,1741622,16216
CHEMBL293357,P08253,,DYSNZNGQZPYHHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,0.6,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1712504,DTCC00200657,808246,16216
CHEMBL293358,P08253,,WPVBITLNIHHKGY-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,136,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1449973,DTCC00104969,1531968,17283
CHEMBL293382,P08253,,NJCSEXFBNXQBFK-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,15.14,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258321,DTCC00208627,2036410,24803
CHEMBL293382,P08253,,NJCSEXFBNXQBFK-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,15,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,666934,DTCC00208627,2033485,2288
CHEMBL293411,P08253,,XXCBSIYZQACPFC-OBFZPWGMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1555876,DTCC00208643,497500,4358
CHEMBL293479,P08253,,BHTYFFISFVNOLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629955,DTCC00200892,318636,56259
CHEMBL293503,P08253,,GWQRQVFEMGHPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,0.7,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1707060,DTCC00201391,1934658,16216
CHEMBL293503,P08253,,GWQRQVFEMGHPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,0.7,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1618958,DTCC00201391,1947698,15919
CHEMBL293503,P08253,,GWQRQVFEMGHPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,0.692,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258460,DTCC00201391,1937748,24803
CHEMBL293504,P08253,,HOSIVTBRRYYOOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1705679,DTCC00200534,1805904,16216
CHEMBL293528,P08253,,MHGISLAIZQKUNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,0.7,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1696762,DTCC00200538,969875,16216
CHEMBL293774,P08253,,LOYIGNDQOZNJNZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1707065,DTCC00201035,1773398,16216
CHEMBL293774,P08253,,LOYIGNDQOZNJNZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1613757,DTCC00201035,1786101,15919
CHEMBL293774,P08253,,LOYIGNDQOZNJNZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,17.78,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258459,DTCC00201035,1776493,24803
CHEMBL294066,P08253,,SXFDETGXHVKYJE-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,0.603,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258308,DTCC00208644,1070278,24803
CHEMBL294066,P08253,,SXFDETGXHVKYJE-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.6,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,659760,DTCC00208644,1067209,2288
CHEMBL294133,P08253,,YNYAHGDBURIHAM-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,794.33,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258313,DTCC00208774,1808953,24803
CHEMBL294133,P08253,,YNYAHGDBURIHAM-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,800,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,684436,DTCC00208774,1805982,2288
CHEMBL294337,P08253,,FDMDTOXXLRGLMS-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,501.19,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258315,DTCC00208602,1458609,24803
CHEMBL294337,P08253,,FDMDTOXXLRGLMS-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,500,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,693229,DTCC00208602,1455607,2288
CHEMBL294405,P08253,,RUILUWMFIHGOHD-NKFKGCMQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1529265,DTCC00208195,1046467,4358
CHEMBL295058,P08253,,DFMJZEAMRUGHGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,729504,DTCC00184292,1913831,3810
CHEMBL295193,P08253,,ALKGLLLPQJKCRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,723462,DTCC00184934,1628775,3810
CHEMBL295305,P08253,,DLSHWTXXGZXIQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,711808,DTCC00183916,593730,3810
CHEMBL295526,P08253,,QFRQMCKTBBVNQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,707388,DTCC00184779,2044539,3810
CHEMBL295653,P08253,,YXSFWZAMZUKSOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,724632,DTCC00184525,1628777,3810
CHEMBL295660,P08253,,OUYWTARRIITHBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,724702,DTCC00185213,1143665,3810
CHEMBL295710,P08253,,YHQKAILNGYAYKF-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,647,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1476613,DTCC00197946,367845,17283
CHEMBL295798,P08253,,OAXIYDWDKICQCU-PVHODMMVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,91,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101919,DTCT0025094,570498,DTCC00191774,422440,1951
CHEMBL295818,P08253,,SNKXLTDCGDAPHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,700486,DTCC00184369,1370314,3810
CHEMBL295861,P08253,,IOHLXUUXBXQFBO-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,4.7,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1276994,DTCC00191853,679383,15166
CHEMBL295871,P08253,,JUPHQCOZPHPYPF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,927042,DTCC00186639,1402750,15892
CHEMBL295950,P08253,,WGYOZKBKTQRASH-IERDGZPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12729664,IC50,=,540,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.,Bioorg. Med. Chem. Lett.,2003,13,10,"Augé F, Hornebeck W, Decarme M, Laronze JY",,104364,DTCT0025094,1071217,DTCC00195039,1499513,5548
CHEMBL296196,P08253,,PTONAIKVYGVBIS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,909624,DTCC00186419,236755,15892
CHEMBL296196,P08253,,PTONAIKVYGVBIS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,11,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061981,DTCC00186419,228138,22402
CHEMBL296327,P08253,,CLEKQCRHVLOQSA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,0.65,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1264677,DTCC00191728,743752,15166
CHEMBL296487,P08253,,UBTDNVISINZMMM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,730608,DTCC00184259,1881771,3810
CHEMBL296761,P08253,,IQVPRIHMNPAIMY-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10397503,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101907,DTCT0025094,525491,DTCC00188542,1713326,3181
CHEMBL296817,P08253,,OELFZOQYHXDMPS-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1276992,DTCC00192054,452237,15166
CHEMBL296911,P08253,,TWQZYQBXMVVVCY-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10397503,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101907,DTCT0025094,526384,DTCC00188240,2796,3181
CHEMBL297453,P08253,EPIGALOCATECHIN GALLATE,WMBWREPUVVBILR-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15081893,IC50,=,3700,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14715092,DTCC00187987,2099956,68331
CHEMBL297453,P08253,EPIGALOCATECHIN GALLATE,WMBWREPUVVBILR-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,9600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894216,DTCC00187987,985698,35073
CHEMBL297488,P08253,,UOHZYJYLFKMPMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1698014,DTCC00200864,1034802,16216
CHEMBL29758,P08253,,JIJHAAWHZJGATL-ZCFHBRKKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,30,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,633212,DTCC00164378,873272,2586
CHEMBL297749,P08253,,GZQRNXJPJXICJZ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,918811,DTCC00186610,658584,15892
CHEMBL297792,P08253,,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,620753,DTCC00192123,1436535,15057
CHEMBL297792,P08253,,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1281545,DTCC00192123,1423555,15166
CHEMBL297793,P08253,,YOMOCOIGEKGJBP-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,33,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1250454,DTCC00192124,1741517,15166
CHEMBL297959,P08253,,AVYWYSFUVCHTCM-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,94,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1475516,DTCC00198067,236870,17283
CHEMBL298167,P08253,,PMVTXYIJWIAFKQ-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9599226,KI,=,238,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104564,DTCT0025094,1357165,DTCC00193648,323312,14640
CHEMBL298258,P08253,,XHVNEGKHXFCMFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,723454,DTCC00184331,367692,3810
CHEMBL298327,P08253,,JXUYPFWFQKLOLF-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1251569,DTCC00191944,225230,15166
CHEMBL298606,P08253,,MMCVYPKEJGVLMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1680253,DTCC00200915,743833,16216
CHEMBL298635,P08253,,BNTJDVFEUJBXMT-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1464530,DTCC00198090,2044693,17283
CHEMBL298699,P08253,,MAMDBBMJAYDZQJ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,53,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,625211,DTCC00192025,1080566,15057
CHEMBL298699,P08253,,MAMDBBMJAYDZQJ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,5.9,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1264679,DTCC00192025,1067003,15166
CHEMBL298822,P08253,,JMWYGNIQHYKDCH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1688124,DTCC00201439,1520406,16216
CHEMBL298884,P08253,,MGPQYGIRNDXSAA-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,<,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1471725,DTCC00198128,1817550,17283
CHEMBL299023,P08253,,CRKJGMQLKRTZPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1689350,DTCC00201420,1293406,16216
CHEMBL299091,P08253,,QFPRVWUEWDLNPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,25,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1715032,DTCC00200999,1325931,16216
CHEMBL299141,P08253,,QJCXYCVUFZIPQG-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,32,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1445052,DTCC00197459,1628926,17283
CHEMBL29934,P08253,,PQOSFDCYBJNHGK-JALIKCBVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,5,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,626567,DTCC00163623,1649145,2586
CHEMBL299600,P08253,,NJSAPXUDAYVTFL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1713859,DTCC00200869,1934657,16216
CHEMBL29976,P08253,,QXLMMZHXXOWCDY-OWCLPIDISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,3,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,634406,DTCC00163718,905593,2586
CHEMBL29977,P08253,,PWLHPFHFBANNHA-KWXGJIJISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,9,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,639903,DTCC00163719,1681272,2586
CHEMBL299796,P08253,,SZWRRABFHREDHM-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,75,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1460708,DTCC00197890,2076718,17283
CHEMBL299883,P08253,,AWUFNEOCKCVYDD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,2518,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1463402,DTCC00198065,1046359,17283
CHEMBL299997,P08253,,CZUPUFGAPNROGT-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,1376,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1482842,DTCC00197584,400627,17283
CHEMBL300362,P08253,,YRUNEWMUGNJMAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1718072,DTCC00200830,1805905,16216
CHEMBL300375,P08253,,YHTDLXCRQOJRHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1538616,DTCC00209051,367960,4358
CHEMBL300394,P08253,,OQWWHTLOLOTDPO-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,52,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1457145,DTCC00198186,1174914,17283
CHEMBL300707,P08253,,FWIXCOHQTREFPI-SSDOTTSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,312,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1466931,DTCC00197956,1337897,17283
CHEMBL300771,P08253,,BTZXQMHZPVTFBL-YITPRAEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,0.6,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1526919,DTCC00209002,819930,4358
CHEMBL300807,P08253,,DMOIDCGAIGWXGJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1699213,DTCC00201437,711540,16216
CHEMBL300902,P08253,,OORGRLDXMMAWSI-OQHSHRKDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12729664,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.,Bioorg. Med. Chem. Lett.,2003,13,10,"Augé F, Hornebeck W, Decarme M, Laronze JY",,104364,DTCT0025094,1081822,DTCC00195008,29084,5548
CHEMBL301085,P08253,,NOYXCNRQZBBVGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,2.8,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1693209,DTCC00200557,1520405,16216
CHEMBL301157,P08253,,KJGJYHSHMUFLOA-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1468117,DTCC00197887,1849634,17283
CHEMBL301177,P08253,,YDCLZJDJJGSFJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1720811,DTCC00200792,96315,16216
CHEMBL301303,P08253,,KQVRGIRNMDCIEB-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1448753,DTCC00197897,236869,17283
CHEMBL301469,P08253,,IODSZLVGIASSTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,70000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1612439,DTCC00201002,1435961,15919
CHEMBL301786,P08253,,MZISFPSOTJFTTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1719460,DTCC00200965,257620,16216
CHEMBL301977,P08253,,ATNNMKHWMHMLHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1720800,DTCC00201068,1358752,16216
CHEMBL302002,P08253,,LZYMCZBJTXXZLJ-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,491419,DTCC00211783,1520528,5598
CHEMBL302227,P08253,,BJOZETKUSDMMAN-QRVBRYPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1671239,DTCC00215866,433131,2712
CHEMBL302311,P08253,,LUZFASJCLDTWLF-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,1.9,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1385045,DTCC00225565,1207413,14854
CHEMBL302368,P08253,,BWPZARSJOUWFCK-XXBNENTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,2,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1385041,DTCC00225594,108075,14854
CHEMBL302455,P08253,,OWZWNKSSYNZLEH-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,=,435,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,475045,DTCC00212166,1520529,5598
CHEMBL302954,P08253,,FWNRCECLAVXIOV-GKBBYZSKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,13,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1383742,DTCC00224712,29663,14854
CHEMBL303155,P08253,,URVVMIUWONGKFU-IAGOWNOFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,1.3,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1376173,DTCC00225316,1629208,14854
CHEMBL303286,P08253,,ZYWQCDFNGKDOSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,15,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1530485,DTCC00209007,529586,4358
CHEMBL303298,P08253,,HEPINVNDBLHRTM-BDTNDASRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1676099,DTCC00215881,1046551,2712
CHEMBL303352,P08253,2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID,FNLNSQHJKVQCBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723961,SELECTIVITY,,,,,,,,,,,,,,,,,Selectivity for zinc metalloprotease over matrix metalloprotease 2(MMP-2) for >=50% inhibition,,Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.,J. Med. Chem.,2003,46,10,"Majer P, Jackson PF, Delahanty G, Grella BS, Ko YS, Li W, Liu Q, Maclin KM, Poláková J, Shaffer KA, Stoermer D, Vitharana D, Wang EY, Zakrzewski A, Rojas C, Slusher BS, Wozniak KM, Burak E, Limsakun T, Tsukamoto T",,231455,DTCT0025094,926014,DTCC01740607,290990,17301
CHEMBL303352,P08253,2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID,FNLNSQHJKVQCBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723961,SELECTIVITY,,,,,,,,,,,,,,,,,Selectivity for zinc metalloprotease over matrix metalloprotease 2(MMP-2) for >=50% stimulation,,Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.,J. Med. Chem.,2003,46,10,"Majer P, Jackson PF, Delahanty G, Grella BS, Ko YS, Li W, Liu Q, Maclin KM, Poláková J, Shaffer KA, Stoermer D, Vitharana D, Wang EY, Zakrzewski A, Rojas C, Slusher BS, Wozniak KM, Burak E, Limsakun T, Tsukamoto T",,231456,DTCT0025094,926007,DTCC01740607,290990,17301
CHEMBL303370,P08253,,LKSPKYMQSGHZEA-GGAORHGYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,502422,DTCC00212263,388848,5598
CHEMBL303510,P08253,,QFBSFEVNNJBNOX-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,506226,DTCC00211539,1100109,5598
CHEMBL303756,P08253,,JPKRVTXRYYGNMK-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,3,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,669305,DTCC00208704,323476,2288
CHEMBL3037894,P08253,,MTYCIOUNOCYLSE-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,1.9,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1572596,DTCC01404950,1391779,16699
CHEMBL303918,P08253,,YZDALJROFHNCEI-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,170,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1393652,DTCC00226034,237156,14854
CHEMBL303983,P08253,,LJHSZEIWFDSULF-VWNXMTODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,=,324,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,480899,DTCC00211481,1870378,5598
CHEMBL304045,P08253,,NITYDPDXAAFEIT-CXAGYDPISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,1800,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1399880,DTCC00225519,658972,14854
CHEMBL304221,P08253,,RTSLKKUJJKXEJT-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1672487,DTCC00215898,237057,2712
CHEMBL304243,P08253,,CIQJGNDHWOIZCK-ZNZIZOMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1662665,DTCC00216001,1144015,2712
CHEMBL304281,P08253,,UTERPWJSMDDIGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,2.9,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1636609,DTCC00227332,562772,15919
CHEMBL304281,P08253,,UTERPWJSMDDIGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,2.88,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258458,DTCC00227332,553250,24803
CHEMBL304617,P08253,,UKNOMEZXDWRZAF-GMQRUSHYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,7.5,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1379723,DTCC00225488,237157,14854
CHEMBL305069,P08253,2-ACETYLCYCLOPENTANONE,OSWDNIFICGLKEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103817,DTCC00223385,1283746,43205
CHEMBL305160,P08253,,CPDXTLZUFAYJLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1524587,DTCC00208701,140369,4358
CHEMBL305163,P08253,,OUOMLZAHOSXYHR-GYCJOSAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,491424,DTCC00211566,711664,5598
CHEMBL305222,P08253,,MOPRTFSMCQNUCT-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.7,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1368293,DTCC00225617,1079123,14854
CHEMBL305373,P08253,,FYOBGEVGGRZAKF-DHIUTWEWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,480894,DTCC00212468,743974,5598
CHEMBL305780,P08253,,VZUMDYFAZYINJW-NHCUHLMSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,4,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1373608,DTCC00226109,1596639,14854
CHEMBL306033,P08253,,DGXRLXMZJHBYOU-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,575319,DTCC00232233,29797,16308
CHEMBL306050,P08253,,FATWEDBJJYSZOL-JUPPYLHDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,1.9,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1579246,DTCC00231235,906349,16699
CHEMBL306090,P08253,PKF-241-466,KNCYWVRUUBOHGE-RRFJBIMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12014967,KI,=,0.3,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-2 (MMP-2),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104562,DTCT0025094,778400,DTCC01741052,497698,16740
CHEMBL306177,P08253,,KLIVJDFDIVVAGE-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,3.82,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,575313,DTCC00231343,1693401,16308
CHEMBL306177,P08253,,KLIVJDFDIVVAGE-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.82,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1687727,DTCC00231343,1693671,1013
CHEMBL306189,P08253,,SLZZXDGACSPBLI-UTKZUKDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.66,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1395898,DTCC00225534,368141,14854
CHEMBL306224,P08253,,VKWHTWCAMYPFQG-KUHUBIRLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.88,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1373612,DTCC00225609,1240175,14854
CHEMBL306256,P08253,,LDNUXKXHGIVDIF-PXJZQJOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.59,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,558997,DTCC00232234,1722974,16308
CHEMBL306276,P08253,,HUVXWBYSMDRXQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.42,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1558641,DTCC00231003,1870576,16699
CHEMBL306276,P08253,,HUVXWBYSMDRXQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.42,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,,MedChemComm,2012,3,11,,,1327984,DTCT0025094,13570929,DTCC00231003,1898555,40045
CHEMBL306301,P08253,,GPQULZGUYNODGJ-FUKCDUGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,1.5,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1583276,DTCC00231212,193360,16699
CHEMBL306470,P08253,,AOPYXKATLYBNDC-IERDGZPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,2.6,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1373616,DTCC00225336,1629209,14854
CHEMBL306524,P08253,,SMZZZWJJIWYSNC-DVECYGJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.52,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1386178,DTCC00225147,1785317,14854
CHEMBL306585,P08253,,RYHIQCQLOAVPLG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,2.6,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1572592,DTCC00230592,873917,16699
CHEMBL306608,P08253,,NGMNLVMLTVTIKU-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.02,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,567362,DTCC00232411,1532297,16308
CHEMBL306724,P08253,,FBSRGDLMHOPCIT-ANYOKISRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,5300,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104565,DTCT0025094,1560602,DTCC00232318,335548,2242
CHEMBL306726,P08253,,YXXIQAWIZFAIOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,0.8,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1629133,DTCC00227196,1818654,15919
CHEMBL306726,P08253,,YXXIQAWIZFAIOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,0.794,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258457,DTCC00227196,1808951,24803
CHEMBL306779,P08253,,PENUYKDCGZXPRG-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,812,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,573159,DTCC00232195,1785381,16308
CHEMBL306779,P08253,,PENUYKDCGZXPRG-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,812,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1710781,DTCC00232195,1785645,1013
CHEMBL306871,P08253,,HYGHKRXESWZJHZ-JPYJTQIMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.73,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1366976,DTCC00225125,1403136,14854
CHEMBL306912,P08253,,CBYPWAIEESKRSM-CZUORRHYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.44,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1366980,DTCC00224800,1207412,14854
CHEMBL306947,P08253,,LHIMKPOFOYDWFM-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,575322,DTCC00231928,335551,16308
CHEMBL306985,P08253,,DJHMSJLOZQFJKZ-LYKKTTPLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,620,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104565,DTCT0025094,1577130,DTCC00232648,433292,2242
CHEMBL307027,P08253,,RGTVFBJQARSWHO-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,10.3,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,550666,DTCC00231992,400996,16308
CHEMBL307027,P08253,,RGTVFBJQARSWHO-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,10.3,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1709254,DTCC00231992,401263,1013
CHEMBL307090,P08253,,YUPQCEGDWHZIJW-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,1.3,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1373621,DTCC00225129,1435145,14854
CHEMBL307207,P08253,,DAMUFYPHDRVCNP-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,123,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,580741,DTCC00232255,1785380,16308
CHEMBL307207,P08253,,DAMUFYPHDRVCNP-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,123,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1682590,DTCC00232255,1785644,1013
CHEMBL307211,P08253,,WFOYCJYFLJCILB-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,46.5,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,559000,DTCC00232825,1370823,16308
CHEMBL307211,P08253,,WFOYCJYFLJCILB-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,46.5,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1698783,DTCC00232825,1371102,1013
CHEMBL307365,P08253,,QQHGONNRQYLVKQ-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,1,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,574110,DTCC00232701,885379,16308
CHEMBL307365,P08253,,QQHGONNRQYLVKQ-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1720309,DTCC00232701,885636,1013
CHEMBL307372,P08253,,IBBWGNRWVQJYIM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.91,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1586959,DTCC00231528,1002773,16699
CHEMBL307413,P08253,,VWWHTVYUWIWLPA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.35,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1562526,DTCC00230955,1359109,16699
CHEMBL30782,P08253,,KSSHTSOSCFKFRS-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,,,,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2 (not determined)",Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,13,,,101927,DTCT0025094,1467652,DTCC00168888,436167,1206
CHEMBL307915,P08253,,GXQXFRYCUXQDFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,7.4,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1590936,DTCC00231253,906351,16699
CHEMBL308012,P08253,,MYGNBBVBBNZVCZ-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,6.9,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1369570,DTCC00224756,204695,14854
CHEMBL308032,P08253,,BAYJYFFPKRGRAF-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,71000,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1397429,DTCC00225465,1849940,14854
CHEMBL30804,P08253,,UDNLRUDZHBXCON-OFSOJUDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,14,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,101931,DTCT0025094,1455541,DTCC00168891,597107,1206
CHEMBL308228,P08253,,DRZSKJBSLSLPQN-IOMROCGXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,1.9,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1403420,DTCC00225486,658973,14854
CHEMBL308264,P08253,,YJNJISQXBXDEOV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.34,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1585804,DTCC00231092,906352,16699
CHEMBL308277,P08253,,VGXYGECPCDQSNI-DINWUYGQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12824028,IC50,=,6.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104553,DTCT0025094,1510776,DTCC00232492,1532289,5648
CHEMBL308333,P08253,ACTINONIN,XJLATMLVMSFZBN-VYDXJSESSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11551755,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.,Bioorg. Med. Chem. Lett.,2001,11,19,"Pratt LM, Beckett RP, Davies SJ, Launchbury SB, Miller A, Spavold ZM, Todd RS, Whittaker M",,104547,DTCT0025094,1088118,DTCC00231518,1968387,4468
CHEMBL308397,P08253,,BAIUIZQDBMFOMK-AOYPEHQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,8.1,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1399733,DTCC00224637,497653,14854
CHEMBL308429,P08253,,GBFCSIJILLHVFK-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,6.3,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1388715,DTCC00225516,1499818,14854
CHEMBL3084965,P08253,,FWZHHLOLYIUTJO-LBXVMSDZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11266157,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,104385,DTCT0025094,646731,DTCC01407937,487523,4704
CHEMBL3084966,P08253,,RMJFXTVVOBTABN-RWWKDMOOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11266157,IC50,=,251,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,104385,DTCT0025094,618641,DTCC01407938,1165043,4704
CHEMBL308511,P08253,,XQSIQJLWCRJICL-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.06,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,549319,DTCC00232151,497732,16308
CHEMBL308511,P08253,,XQSIQJLWCRJICL-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.06,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1010697,DTCC00232151,486430,1012
CHEMBL308533,P08253,,ZAYGCPGBYLINSH-VWNXMTODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,555576,DTCC00232259,1979922,16308
CHEMBL308598,P08253,,NGIYDDHHYYPZFT-UTKZUKDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,19,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1368298,DTCC00225496,755586,14854
CHEMBL308799,P08253,,WLKRWBCBYSPLIM-ZBFHGGJFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,860,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104565,DTCT0025094,1578661,DTCC00232649,1946971,2242
CHEMBL309053,P08253,,WCYAWVVNZFAEIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,1.3,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1559921,DTCC00231209,161499,16699
CHEMBL309067,P08253,,JWBVNSRNJDQUGY-NAKRPHOHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,1.83,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,571955,DTCC00232218,1499897,16308
CHEMBL309067,P08253,,JWBVNSRNJDQUGY-NAKRPHOHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1.83,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1701366,DTCC00232218,1500150,1013
CHEMBL3092080,P08253,,YIVUZDIRWOBHSX-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,2776,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952031,DTCC01411694,1366481,56672
CHEMBL3092081,P08253,,HRYADIHXUSIUPC-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,834.9,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952030,DTCC01411695,493387,56672
CHEMBL3092082,P08253,,YRSOGVBDTBBBQY-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,28190,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952029,DTCC01411696,1203199,56672
CHEMBL3092083,P08253,,NOFPFSLLPFXERN-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,9480,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952028,DTCC01411697,1975465,56672
CHEMBL3092084,P08253,,LFMYVGWTTJIYGD-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,878,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952027,DTCC01411698,168553,56672
CHEMBL3092085,P08253,,WTNQTGOWRZYDSO-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,77930,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952026,DTCC01411699,1009884,56672
CHEMBL3092086,P08253,,UCYNPYUXDVYBAB-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,3093,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952025,DTCC01411700,1910128,56672
CHEMBL3092087,P08253,,PSDDPRAVOZCMAH-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,7480,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952024,DTCC01411701,200307,56672
CHEMBL3092088,P08253,,SHSWUYNKOPITQJ-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,678,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952023,DTCC01411702,1430944,56672
CHEMBL3092089,P08253,,BGGQTTOJIJRRBX-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,786,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952022,DTCC01411703,881160,56672
CHEMBL3092090,P08253,,HHLZOIRRBIWPTC-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,877,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952021,DTCC01411704,719190,56672
CHEMBL3092091,P08253,,DJTDHZMIOZWZFT-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,516,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952020,DTCC01411705,1430945,56672
CHEMBL3092092,P08253,,KKDAXBNRYRMJPP-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,428990,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952019,DTCC01411706,913901,56672
CHEMBL3092092,P08253,,KKDAXBNRYRMJPP-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,430270,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121051,DTCC01411706,904959,66411
CHEMBL3092093,P08253,,YNWORMHDVSJLIM-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,20620,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952018,DTCC01411707,1366482,56672
CHEMBL3092094,P08253,,XBSLXUBPHTVZGN-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,6559,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952017,DTCC01411708,1942507,56672
CHEMBL3092095,P08253,,PJGHPVVRPMTJQE-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,10800,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952016,DTCC01411709,881161,56672
CHEMBL3092096,P08253,,ZQEYYXXMEKKBFO-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,679,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952015,DTCC01411710,1074885,56672
CHEMBL3092097,P08253,,PRHFZBDCPUXSTK-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,1802,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952014,DTCC01411711,2008279,56672
CHEMBL3092098,P08253,,HAKSIJTYQIRFDS-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,5438,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952013,DTCC01411712,1910129,56672
CHEMBL3092099,P08253,,YZYDDFAJNFXHQH-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,386,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952012,DTCC01411713,1527960,56672
CHEMBL3092100,P08253,,XAPPLBYKNPAEFC-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,530,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952011,DTCC01411714,396538,56672
CHEMBL3092101,P08253,,PYIYKSHMSGEAOE-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,325,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952010,DTCC01411715,1845697,56672
CHEMBL3092102,P08253,,MSAUGAMHNLJIHG-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,678.1,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952009,DTCC01411716,1877961,56672
CHEMBL3092103,P08253,,QXPIJDJNYNLQPO-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,325,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952008,DTCC01411717,460270,56672
CHEMBL3092104,P08253,,AKOSAZUQCGCWJD-SOFGYWHQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24247003,IC50,=,1021,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins by spectrophotometry,,"Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.",Bioorg. Med. Chem.,2013,21,24,"Shi L, Wang Q, Wang H, Zhou H, Li Y, Li X",,1280036,DTCT0025094,12952007,DTCC01411718,71577,56672
CHEMBL309247,P08253,,CZQAIUBHMIDFAY-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,71,%,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) at 1 uM,,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101910,DTCT0025094,840916,DTCC00238505,1617748,1379
CHEMBL309329,P08253,,LEFXWKHWSSYLEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.44,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1577826,DTCC00230831,1617664,16699
CHEMBL309329,P08253,,LEFXWKHWSSYLEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.44,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,,MedChemComm,2012,3,11,,,1327984,DTCT0025094,13570926,DTCC00230831,1645491,40045
CHEMBL309465,P08253,,SMUHFCXUZGSRMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,3.3,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,725805,DTCC00240431,1392082,3985
CHEMBL309465,P08253,,SMUHFCXUZGSRMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,3.3,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1647346,DTCC00240431,1403313,4449
CHEMBL309539,P08253,,QTBRRNPXGRIPDP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,0.3,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1670298,DTCC00106130,659143,4449
CHEMBL309794,P08253,,IONSTZXMLPCJLY-LYKKTTPLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104565,DTCT0025094,1564489,DTCC00232570,497728,2242
CHEMBL30980,P08253,,IZYWROOEWSDARX-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,101929,DTCT0025094,1450648,DTCC00168927,338478,1206
CHEMBL310008,P08253,,QZURMXFXKAPVRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,2,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,713036,DTCC00241016,1714093,3985
CHEMBL310008,P08253,,QZURMXFXKAPVRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,2.2,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1664145,DTCC00241016,1723056,4449
CHEMBL310008,P08253,,QZURMXFXKAPVRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835700,DTCC00241016,1736689,53820
CHEMBL310037,P08253,,AAMWPNSLYMJRGM-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.06,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,558994,DTCC00232110,2045038,16308
CHEMBL310037,P08253,,AAMWPNSLYMJRGM-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.06,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1004550,DTCC00232110,2034010,1012
CHEMBL310060,P08253,,SWDPDYNSAGSRKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,0.8,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1641463,DTCC00241070,1338357,4449
CHEMBL310073,P08253,,MTFCRDDKUHOORR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1434201,DTCC00241701,1326421,6359
CHEMBL310118,P08253,,KCVCZNALVNWOCE-QDSKXPNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,25,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,853338,DTCC00238946,1488530,1379
CHEMBL310249,P08253,,HJPHCDCNWWBUEA-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.6,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1378545,DTCC00224949,1596641,14854
CHEMBL310388,P08253,,JVWFOTNQRDMUFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,2.4,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1675047,DTCC00106119,1403312,4449
CHEMBL310438,P08253,,PXKAFPXSNMQDMU-YGOYIFOWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,827236,DTCC00239113,1552857,1379
CHEMBL3104658,P08253,,VVXZPLQFCWCGBS-MDWZMJQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24316668,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-ProLeuGlyLeuDpaAlaArg-NH2 as substrate after 45 mins by fluorescence plate reader analysis,,Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping.,Eur. J. Med. Chem.,2014,71,,"Sogame S, Suenaga Y, Atobe M, Kawanishi M, Tanaka E, Miyoshi S",,1283988,DTCT0025094,12983853,DTCC01417897,783634,56872
CHEMBL310545,P08253,,PDGCWNNXCULGFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1.1,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1642638,DTCC00240810,2045133,4449
CHEMBL310555,P08253,OXYQUINOLINE,MCJGNVYPOGVAJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,130000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096318,DTCC00239255,1090149,43205
CHEMBL310555,P08253,OXYQUINOLINE,MCJGNVYPOGVAJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,94,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104033,DTCC00239255,1090149,43205
CHEMBL310587,P08253,,CAZNRDJXNQISBA-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,818390,DTCC00238991,711955,1379
CHEMBL310767,P08253,,WUSMUBXGTIYNCE-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,220,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,848437,DTCC00238959,1552858,1379
CHEMBL310823,P08253,,KDXMWIZHCFDNIO-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,71,%,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) at 1 uM,,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101910,DTCT0025094,854581,DTCC00239467,356533,1379
CHEMBL310834,P08253,,ZKTSRBGPYOEYPS-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) at 1 uM,,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101910,DTCT0025094,838573,DTCC00238972,647789,1379
CHEMBL311004,P08253,,FNURWSLLBXZLRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1291617,DTCC00242427,582684,16328
CHEMBL3110281,P08253,,QQYCFXUASOHQCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24304348,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay,Not Active,Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.,J. Med. Chem.,2013,56,24,"Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK",,1286651,DTCT0025094,12997871,DTCC01420618,1107623,57022
CHEMBL3110287,P08253,,YYRBBLSWPCHZTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24304348,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay,Not Active,Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.,J. Med. Chem.,2013,56,24,"Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK",,1286651,DTCT0025094,12997872,DTCC01420624,945416,57022
CHEMBL311097,P08253,,SBYCYYMPCYJMTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1305048,DTCC00242342,193495,16328
CHEMBL311141,P08253,,ORLPHOALLZATDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.098,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1573743,DTCC00231182,841379,16699
CHEMBL311266,P08253,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1307401,DTCC00242099,744290,16328
CHEMBL311266,P08253,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1319104,DTCC00242099,744289,16328
CHEMBL311324,P08253,,MAOGCCYMZYSJDX-NYMACZPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,6100,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,843258,DTCC00239089,1585027,1379
CHEMBL311336,P08253,,ZGSTVUAZFACDLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1603752,DTCC00243756,820899,15919
CHEMBL311336,P08253,,ZGSTVUAZFACDLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,10.96,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258469,DTCC00243756,811346,24803
CHEMBL311393,P08253,,ASDFSRLSQAJCEU-ZVAWYAOSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104565,DTCT0025094,1591645,DTCC00232297,1175294,2242
CHEMBL311397,P08253,,OHBYAEPYMITRJA-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.03,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,550669,DTCC00231917,204782,16308
CHEMBL311397,P08253,,OHBYAEPYMITRJA-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.03,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,978304,DTCC00231917,193641,1012
CHEMBL311618,P08253,,RZTCAABKSWEFOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.93,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1583272,DTCC00230830,291224,16699
CHEMBL31164,P08253,,WATNMHGSJFUVDX-JOMNFKBKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,300,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil gelatinase, matrix metalloprotease-2",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,219181,DTCT0025094,1467646,DTCC00168840,1725862,1206
CHEMBL311932,P08253,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3286010,DTCC00243867,598684,38228
CHEMBL311932,P08253,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22967811,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP2 using BML-P125-9090 as substrate after 30 mins by microplate reader analysis,,"Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.",Bioorg. Med. Chem.,2012,20,19,"Cheng XC, Wang RL, Dong ZK, Li J, Li YY, Li RR",,850398,DTCT0025094,11344227,DTCC00243867,608711,50678
CHEMBL311932,P08253,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835707,DTCC00243867,609579,53820
CHEMBL311932,P08253,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550514,DTCC00243867,580433,63755
CHEMBL311932,P08253,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550541,DTCC00243867,580433,63755
CHEMBL312076,P08253,,AHLWGTUBPHXANM-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.08,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,546995,DTCC00231894,1175299,16308
CHEMBL312076,P08253,,AHLWGTUBPHXANM-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.08,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1014513,DTCC00231894,1163947,1012
CHEMBL312100,P08253,,IOANZCGEYMTXEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,0.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1301285,DTCC00242298,1773867,16328
CHEMBL312218,P08253,,HBPRCALADDGDIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23134659,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of para-amino phenylmercuric acetate-activated MMP2 using Mca-P-L-G-L-Dap(Dnp)-A-R-NH2 as substrate after 1 hr by fluorescence assay,,Design and synthesis of procollagen C-proteinase inhibitors.,Bioorg. Med. Chem. Lett.,2012,22,24,"Turtle E, Chow N, Yang C, Sosa S, Bauer U, Brenner M, Solow-Cordero D, Ho WB",,886677,DTCT0025094,11488693,DTCC00242814,1676008,52120
CHEMBL312649,P08253,,NDPOIVUWKQUMRL-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,57,%,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) at 1 uM,,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101910,DTCT0025094,818387,DTCC00238529,291321,1379
CHEMBL312800,P08253,,CKAKIHRIUBAWGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1431427,DTCC00241699,1552893,6359
CHEMBL312944,P08253,,JXPHXPUEWNVYDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1409577,DTCC00242436,1742068,6359
CHEMBL313340,P08253,,IMQVPVWXNJYVAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,24.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1297509,DTCC00242488,577853,16328
CHEMBL313360,P08253,,UFJUEKAJZPTZED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,11,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1078551,DTCC00249036,1424200,15258
CHEMBL313386,P08253,,XYZHDRSTLPUTBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,330,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1084513,DTCC00249347,291450,15258
CHEMBL313472,P08253,,RFNUTMXSNZMOSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,10,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1059539,DTCC00249282,1002960,15258
CHEMBL313896,P08253,,NFDNOGJHVSTSMJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,19,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1085847,DTCC00249106,422043,15258
CHEMBL314199,P08253,,GKNHTZOPKGQBHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of MMP-2 gelatinase-A at 2 uM,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104392,DTCT0025094,1084520,DTCC00249345,291449,15258
CHEMBL31422,P08253,MALTOL,XPCTZQVDEJYUGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103291,DTCC00167287,604861,43205
CHEMBL3142588,P08253,,NMJSZUFFJMVVTC-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,18000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1045736,DTCC01434962,776475,5080
CHEMBL3142589,P08253,,LBXQNROQWCXYOR-JSGCOSHPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,15000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1048214,DTCC01434963,4100,5080
CHEMBL3142590,P08253,,CPXWXSPXARFAMY-UGSOOPFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,8000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1032053,DTCC01434964,1359339,5080
CHEMBL3142591,P08253,,KXEOBTKKJDNBQP-YWZLYKJASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,33000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1025915,DTCC01434965,938350,5080
CHEMBL3142592,P08253,,YPHZPHWJIIIDPD-WPRPVWTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,6000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1054598,DTCC01434966,776476,5080
CHEMBL3142593,P08253,,BUTLOPCSKDMNBW-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,17000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1042210,DTCC01434967,1870833,5080
CHEMBL3142594,P08253,,FBWGSUGKKLTDRD-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,5000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1020953,DTCC01434968,1682213,5080
CHEMBL3142596,P08253,,NUHCNKSHBIFLOX-HOCLYGCPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,8000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1045741,DTCC01434970,1035400,5080
CHEMBL3142598,P08253,,OLEDPIQVUZOZBZ-WMZOPIPTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,24000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1028475,DTCC01434972,486381,5080
CHEMBL3142599,P08253,,GHEPWMPGSKBGIP-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,36000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1019731,DTCC01434973,938351,5080
CHEMBL3142600,P08253,,HBSLPEMCEWWBRI-NHYWBVRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,10000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1040945,DTCC01434974,4099,5080
CHEMBL3142601,P08253,,OMBKWZNZMXWHMG-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,11000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1040940,DTCC01434975,1035401,5080
CHEMBL3142602,P08253,,CLSZSRWILIUAGI-GUYCJALGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,18000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1054603,DTCC01434976,841609,5080
CHEMBL3142605,P08253,,KXLQATQMHVLQBR-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,7000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1047027,DTCC01434979,1132658,5080
CHEMBL3142606,P08253,,QULPHXDROMVDLR-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,4000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1050770,DTCC01434980,615188,5080
CHEMBL3142607,P08253,,IKFXTEOZLBAELL-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1020958,DTCC01434981,970460,5080
CHEMBL3142608,P08253,,QJVFJOYLFWWFDX-JXFKEZNVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,40000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1040953,DTCC01434982,1968441,5080
CHEMBL3142610,P08253,,CRCHRLLZPJQYMX-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,12000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1032048,DTCC01434984,529938,5080
CHEMBL3142611,P08253,,YBPBIDCTKSJPFD-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,13000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1022250,DTCC01434985,1682214,5080
CHEMBL3142612,P08253,,RRKJXTGNGHGKTN-QYTXMFFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,35000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1027168,DTCC01434986,906605,5080
CHEMBL3142613,P08253,,PNEADTFJKOWMPK-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,41000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1022255,DTCC01434987,1585216,5080
CHEMBL3142614,P08253,,WXEFGNPPQHTRDV-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,12000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1029600,DTCC01434988,1935200,5080
CHEMBL3142615,P08253,,DNTCJTLVTZKQNR-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,20000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1040935,DTCC01434989,1002989,5080
CHEMBL3142618,P08253,,LOGSBACCMCSGPF-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,16000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1032043,DTCC01434992,1935201,5080
CHEMBL3142625,P08253,,BXPQIAVWFZXLFI-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,16000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1018321,DTCC01434999,1935199,5080
CHEMBL3142626,P08253,,NQPVYHWCSWOQOG-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,15000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1053296,DTCC01435000,129099,5080
CHEMBL3142627,P08253,,XRDWNRBIEZYTNT-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,17000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1020944,DTCC01435001,1456061,5080
CHEMBL314327,P08253,,ZWSBOQGJEGJBLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,43000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,508516,DTCC00261681,1359447,3361
CHEMBL314565,P08253,,YQEMFOGNUTYMTJ-URCIPWINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of MMP-2 gelatinase-A at 2 uM,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104392,DTCT0025094,1059532,DTCC00248816,2065651,15258
CHEMBL315046,P08253,,JPTZDOYPNCQOTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,100,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1092140,DTCC00249105,291444,15258
CHEMBL315114,P08253,,IIBGHLQTRXDEKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,0.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1297516,DTCC00106157,1838801,16328
CHEMBL315843,P08253,,WYBFHVSAXDKMJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,9,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1073912,DTCC00248711,1326511,15258
CHEMBL315900,P08253,,KSMVGBPYLIRIKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP-2 gelatinase-A at 2 uM,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104392,DTCT0025094,1062032,DTCC00249774,1100495,15258
CHEMBL315901,P08253,,LHVGXRIIQBVWQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,275,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1062039,DTCC00249775,1035362,15258
CHEMBL316169,P08253,,JRCGNOYYZQLNTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1616260,DTCC00243846,1723666,15919
CHEMBL316169,P08253,,JRCGNOYYZQLNTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,15.14,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258473,DTCC00243846,1716218,24803
CHEMBL316200,P08253,,MERYKHOGOUEPIA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,26,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1063244,DTCC00248814,582756,15258
CHEMBL316725,P08253,,SMNQMEVQCDUWFV-CEUYOYMZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,833923,DTCC00265591,776604,4579
CHEMBL316884,P08253,,QIBKFCGQDQXRPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,52000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,478442,DTCC00261761,453058,3361
CHEMBL316892,P08253,8-HYDROXY QUINALDINE,NBYLBWHHTUWMER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103720,DTCC00262976,508351,43205
CHEMBL316954,P08253,,OHZMUNMVWGUMMY-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,80,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1466335,DTCC00264378,1723295,3373
CHEMBL316954,P08253,,OHZMUNMVWGUMMY-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,79.43,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258339,DTCC00264378,1716220,24803
CHEMBL316978,P08253,,KCKFHONGIZWYTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1381865,DTCC00273603,530282,16392
CHEMBL316997,P08253,(CYCLOPENTYLAMINO)CARBONYLPHOSPHONIC ACID,CYCCYWRSDZSMIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,80,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1297663,DTCC00261231,303295,17838
CHEMBL316997,P08253,(CYCLOPENTYLAMINO)CARBONYLPHOSPHONIC ACID,CYCCYWRSDZSMIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,80,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420869,DTCC00261231,297596,51419
CHEMBL317132,P08253,,VGAPHGIXAQRVAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,649002,DTCC00269579,1067913,4635
CHEMBL317508,P08253,,ITDDXQSXMTUIFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,625724,DTCC00269558,1067912,4635
CHEMBL317764,P08253,,GIVHLLLIKQPKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,40000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,485356,DTCC00261644,679873,3361
CHEMBL318005,P08253,,WFARRRAQEGQWNJ-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,819645,DTCC00265443,1067868,4579
CHEMBL318005,P08253,,WFARRRAQEGQWNJ-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258430,DTCC00265443,1070277,24803
CHEMBL318023,P08253,,ARFFCGXUOISSHZ-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1464020,DTCC00264599,1371183,3373
CHEMBL318023,P08253,,ARFFCGXUOISSHZ-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3019.95,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258331,DTCC00264599,1361901,24803
CHEMBL318122,P08253,,LCHJXWBHDASHHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,200000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,498668,DTCC00260694,1774078,3361
CHEMBL318190,P08253,,MVEPSFJZKBVDHV-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1478671,DTCC00264484,949983,3373
CHEMBL318190,P08253,,MVEPSFJZKBVDHV-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,602.56,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258340,DTCC00264484,940926,24803
CHEMBL318252,P08253,,ODPDWLUYVWCNHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1378635,DTCC00265469,917418,6400
CHEMBL318252,P08253,,ODPDWLUYVWCNHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2456481,DTCC00265469,920644,32556
CHEMBL318455,P08253,,VWOQXPBXOWHZCH-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1457852,DTCC00263986,1240611,3373
CHEMBL318455,P08253,,VWOQXPBXOWHZCH-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,7079.46,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258329,DTCC00263986,1231164,24803
CHEMBL318484,P08253,,YTRMRJDVKQXSIU-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,0.048,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,828676,DTCC00265594,1714167,4579
CHEMBL318664,P08253,PENTAN-3-YLCARBAMOYLPHOSPHONIC ACID,NBDIMGROXSSYHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,3000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1319235,DTCC01741840,723827,17838
CHEMBL318664,P08253,PENTAN-3-YLCARBAMOYLPHOSPHONIC ACID,NBDIMGROXSSYHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420870,DTCC01741840,718217,51419
CHEMBL318716,P08253,,LRVIJTRFTUQDKW-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1477304,DTCC00264594,335905,3373
CHEMBL318716,P08253,,LRVIJTRFTUQDKW-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,501.19,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258325,DTCC00264594,326644,24803
CHEMBL318795,P08253,,QYMKPTMAFMKKTC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,82,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,633443,DTCC00269560,1871037,4635
CHEMBL318860,P08253,,NMAKKNGSMZZSBP-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,0.26,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,830035,DTCC00265430,453103,4579
CHEMBL318860,P08253,,NMAKKNGSMZZSBP-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,0.257,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258432,DTCC00265430,455572,24803
CHEMBL318902,P08253,,CQDYUDMWSWIZOK-MXHVWWQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14611841,IC50,=,5.97,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104382,DTCT0025094,868728,DTCC00263292,291593,5741
CHEMBL319040,P08253,,MVTUAPMXVXQWFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,4.1,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1404224,DTCC00273183,1980402,16392
CHEMBL319055,P08253,,YTDQNSGULXQVKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,148,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,707418,DTCC00260695,1774074,3985
CHEMBL319075,P08253,,LLVLFZAKVKFNSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,655346,DTCC00269143,1935390,18131
CHEMBL319782,P08253,,QBIHWFSRXVWUDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1398529,DTCC00265485,1338612,6400
CHEMBL320045,P08253,,FXEYKJYOHRTUNG-VWPQPMDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,7.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1375232,DTCC00282878,97233,2897
CHEMBL320402,P08253,,TWQZYQBXMVVVCY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1182603,DTCC00273854,1521206,16385
CHEMBL320442,P08253,,NQHPVFGLBXTGFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,3.2,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1381860,DTCC00273104,627204,16392
CHEMBL320782,P08253,,DZVQTAQHEPKNSI-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1391490,DTCC00283117,324379,2897
CHEMBL320908,P08253,,QQIWYSRJJVUKEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,114000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,490041,DTCC00261682,1132728,3361
CHEMBL320968,P08253,,CIARJCUCRKNXEE-PPTMTGTBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,7.3,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1035341,DTCC00284042,659574,1950
CHEMBL321005,P08253,,SJVNLZPBUGMURM-VEEOACQBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,26,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1047957,DTCC00284069,1047272,1950
CHEMBL321006,P08253,,DYGUFLUIGDJMDE-VJGNERBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2300,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,559672,DTCC00285615,583160,1951
CHEMBL321055,P08253,,QDICWLMZEKDVEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,370830,DTCC00269070,1392183,18131
CHEMBL321087,P08253,,WWORPQDFFFNCBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,501001,DTCC00261688,744473,3361
CHEMBL321088,P08253,,YTDLONOVKJHSJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,150000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,476029,DTCC00261435,938440,3361
CHEMBL321180,P08253,,QVHQLFLTQMCYLJ-MDASCCDHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,0.38,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1364851,DTCC00282747,193949,2897
CHEMBL321213,P08253,,UVGAWIJNBYCHSP-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,300,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1681719,DTCC00282582,874479,16424
CHEMBL321556,P08253,,DQDPBMDGDOPPLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17289381,KI,=,27,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442203,DTCT0025094,2162332,DTCC00259627,564440,23225
CHEMBL321602,P08253,,QESYNYYOSNECPA-VJGNERBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,91,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1375236,DTCC00283008,615511,2897
CHEMBL321613,P08253,,OJHBBJNOLVTWJS-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1016976,DTCC00284172,465379,1950
CHEMBL321633,P08253,,REZSPXZZCJTZIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15177439,IC50,=,0.26,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,104555,DTCT0025094,1495039,DTCC00288306,1915036,6475
CHEMBL321633,P08253,,REZSPXZZCJTZIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317309,DTCC00288306,1901888,67557
CHEMBL321633,P08253,,REZSPXZZCJTZIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317106,DTCC00288306,1901888,67557
CHEMBL3221177,P08253,,VZDQUYBTCHUAJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.53,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,,MedChemComm,2012,3,11,,,1327984,DTCT0025094,13570925,DTCC01468106,1801936,40045
CHEMBL3221178,P08253,,QYMSAHRHXPUNSA-MUMRKEEXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.61,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,,MedChemComm,2012,3,11,,,1327984,DTCT0025094,13570927,DTCC01468107,1645492,40045
CHEMBL3221179,P08253,,GPQULZGUYNODGJ-FUBQLUNQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,,MedChemComm,2012,3,11,,,1327984,DTCT0025094,13570932,DTCC01468108,1030666,40045
CHEMBL322142,P08253,,IXVVVBIIUONGJK-MVSFAKPFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,73,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1050538,DTCC00284125,401604,1950
CHEMBL3221863,P08253,,BJIOETDXHXZDRQ-LEAFIULHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1167,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328282,DTCT0025094,13572206,DTCC01468798,1845949,39059
CHEMBL3221864,P08253,,OKHKINWJYOOKOF-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1088,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328282,DTCT0025094,13572207,DTCC01468799,396851,39059
CHEMBL322412,P08253,,ZAVWWISQYKVWCT-GFOWMXPYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1194618,DTCC00273571,615409,16385
CHEMBL322433,P08253,,NVAYQDCPVGCOHV-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,659118,DTCC00269212,1839095,18131
CHEMBL322540,P08253,,DHOAHVLHKCBDJS-BHYZAODMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,86,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1034080,DTCC00107039,1818473,1950
CHEMBL322619,P08253,,FCHACJJPJSMUHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,8.82,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1404217,DTCC00273331,820634,16392
CHEMBL322795,P08253,,LEDMBBYIVRLZAS-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,340,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1707158,DTCC00282335,389662,16424
CHEMBL32285,P08253,,RMDCZACTUKUROI-GLDPYIMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,6.2,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,860970,DTCC00171277,1078543,2600
CHEMBL322888,P08253,,VOEOVKSVTSGALB-ZGTCLIOFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,143,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1183565,DTCC00273544,583007,16385
CHEMBL323090,P08253,,ZUICQLWFCKUDMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1393106,DTCC00273716,627205,16392
CHEMBL323148,P08253,,YUYXLIRWRFFNDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,640133,DTCC00269613,615363,4635
CHEMBL323371,P08253,,PRCRNUDMWULKSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,640139,DTCC00269593,389494,4635
CHEMBL323575,P08253,,WNQMYJZKTYVQPU-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1180465,DTCC00273545,1742428,16385
CHEMBL3235911,P08253,,RNBZJLOFSRJJMQ-RUPCYPOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505519,DTCT0025094,14475908,DTCC01474946,235426,63066
CHEMBL3235911,P08253,,RNBZJLOFSRJJMQ-RUPCYPOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505523,DTCT0025094,14475884,DTCC01474946,235426,63066
CHEMBL3235912,P08253,,ILECMSXDFSLYHA-XOXLXNDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505519,DTCT0025094,14475905,DTCC01474947,1433423,63066
CHEMBL3235912,P08253,,ILECMSXDFSLYHA-XOXLXNDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505523,DTCT0025094,14475956,DTCC01474947,1433423,63066
CHEMBL323612,P08253,CP-471474,QCOQJYRPDUMCNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using (7-amino-4-methyl-coumarin)-Pro-Leu-Gly-Leu-(dinitrophenylamine)-Ala-Arg- NH2 as substrate by fluorimetric analysis,,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944580,DTCT0025094,11835663,DTCC01742415,1450499,53820
CHEMBL323874,P08253,,LGRKPVBTQGGKSY-CRAIPNDOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,31600,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1411255,DTCC00287105,820749,16438
CHEMBL323885,P08253,,NRVATKFKFLOMDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14711305,KI,=,200000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,104396,DTCT0025094,1265941,DTCC00287362,1079825,17924
CHEMBL323917,P08253,,GQBXEDCNLAXENR-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,559675,DTCC00285308,1068100,1951
CHEMBL323929,P08253,,FQRGCXYNQQKTLK-ARNLJNQMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,=,450,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1285152,DTCC00287903,1047307,16439
CHEMBL324004,P08253,,BXMNIXOHCAIUBA-BHYZAODMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,96,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1032850,DTCC00283938,788374,1950
CHEMBL324549,P08253,,KNGLZBYFVBOFMQ-IARZGTGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1285146,DTCC00287206,1723526,16439
CHEMBL324550,P08253,,USDVPRSOSNTZAZ-IARZGTGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1304876,DTCC00287207,1468156,16439
CHEMBL324664,P08253,,JMYNELQJPYBCPZ-ZVDOUQERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,1.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1395130,DTCC00283009,193947,2897
CHEMBL324691,P08253,,LMJBKCLEHMNEQJ-ZFCSCTFJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,4.8,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1031818,DTCC00283882,788375,1950
CHEMBL324874,P08253,,QQWABDFFKSDQLH-XFAFFCHDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,6.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1401309,DTCC00283022,129476,2897
CHEMBL324891,P08253,,YDDMVPLLJTZTQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14711305,KI,=,30000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,104396,DTCT0025094,1257646,DTCC00287325,30861,17924
CHEMBL325006,P08253,,PFJMJBQWTLBHRB-JBOQNHBVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,50,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 1 uM.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101932,DTCT0025094,570495,DTCC00285574,1424573,1951
CHEMBL325007,P08253,,CWZUIJLHNLMGLG-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,770,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,546660,DTCC00285575,938754,1951
CHEMBL325041,P08253,BORTEZOMIB,GXJABQQUPOEUTA-RDJZCZTQSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18247547,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human MMP2 at 10 uM,,"Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.",J. Med. Chem.,2008,51,4,"Dorsey BD, Iqbal M, Chatterjee S, Menta E, Bernardini R, Bernareggi A, Cassarà PG, D'Arasmo G, Ferretti E, De Munari S, Oliva A, Pezzoni G, Allievi C, Strepponi I, Ruggeri B, Ator MA, Williams M, Mallamo JP",,464575,DTCT0025094,2308367,DTCC00287769,1539678,25324
CHEMBL325048,P08253,,ZYIMYAJZHPOFQU-XPKDYRNWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,73,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1422366,DTCC00287138,1597338,16438
CHEMBL325163,P08253,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1311919,DTCC00287408,1500490,16439
CHEMBL325163,P08253,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,486627,DTCC00287408,1489451,6009
CHEMBL325163,P08253,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457316,DTCC00287408,1503285,32556
CHEMBL3251694,P08253,,BIYDZHKIVFQYDX-BQBZGAKWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,364200,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14721096,DTCC01484845,2102224,67818
CHEMBL325421,P08253,,QMTWRDGSYLQRRX-IARZGTGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1293737,DTCC00286953,1079821,16439
CHEMBL325552,P08253,,JQYSJWITJMOASO-VXNXHJTFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,9.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1371305,DTCC00282905,2001376,2897
CHEMBL325574,P08253,,DPHTYOHAIZCUCJ-RSXGOPAZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,90,%,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2) at a concentration of 1 uM,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101911,DTCT0025094,1031821,DTCC00284041,1371399,1950
CHEMBL325749,P08253,,GQNHFEIKUYMXAQ-DHZHZOJOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.37,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836363,DTCC00289313,545134,53968
CHEMBL325835,P08253,,AYKWMGZBLRUSIJ-BHYZAODMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,130,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1046817,DTCC00284043,691755,1950
CHEMBL325940,P08253,,ZAXDLNVDZOYNCA-GVAUOCQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,5.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1371311,DTCC00282935,1228897,2897
CHEMBL326018,P08253,,HLTKMJZXSYKWCY-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,570,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1053123,DTCC00284143,1047273,1950
CHEMBL3261742,P08253,,YELZSDDYAFGMGX-SQRKDXEHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,7430,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709696,DTCC01487182,1419842,58773
CHEMBL3261743,P08253,,IJFJIVCTPXRADP-SAJNASKISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,5760,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709697,DTCC01487183,319468,58773
CHEMBL3261744,P08253,,WPGWFCORHXGZOQ-GEUPQXMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,1520,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709698,DTCC01487184,578448,58773
CHEMBL3261745,P08253,,MHBROIMTYJQWFE-NIJUGZMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,5210,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709699,DTCC01487185,221470,58773
CHEMBL3261746,P08253,,RLTGTHWSHLNDLY-HDHUNYPFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,2070,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709700,DTCC01487186,448379,58773
CHEMBL3261747,P08253,,GOQYPYXGXLIDNM-XJPBFQKESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,2320,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709701,DTCC01487187,902087,58773
CHEMBL3261748,P08253,,ZUIJZQXOFUSPPJ-RGESYUBESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,4360,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709702,DTCC01487188,578449,58773
CHEMBL3261749,P08253,,WAELIFAGZVFDLQ-FWBJMGQWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,2950,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709703,DTCC01487189,221471,58773
CHEMBL3261750,P08253,,VYBGLOQAJNUSCH-BDURURIASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,870,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709704,DTCC01487190,1096148,58773
CHEMBL3261750,P08253,,VYBGLOQAJNUSCH-BDURURIASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,38320,NM,,,,,,,,,,,,,,Inhibition of MMP2 in human SKOV3 cell suspension using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1347847,DTCT0025094,13709790,DTCC01487190,1096148,58773
CHEMBL3261751,P08253,,QVRJGTLBQPBIAT-OYDMLLMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,2050,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709705,DTCC01487191,998455,58773
CHEMBL3261752,P08253,,RRFJPUAEZOZHTG-QEXYDYNRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,980,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709706,DTCC01487192,384786,58773
CHEMBL3261753,P08253,,DHHHDKINBVBFKW-GEUPQXMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,1030,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709707,DTCC01487193,1580809,58773
CHEMBL3261754,P08253,,TZNXAKPMELJCFF-UWSFXBGYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,4190,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709708,DTCC01487194,92444,58773
CHEMBL3261755,P08253,,GVZNEMPPZFIWSX-JPZWBZILSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,2710,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709709,DTCC01487195,546315,58773
CHEMBL3261756,P08253,,LHTBQWWRIIBNDM-MGMDSTOOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,520,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709710,DTCC01487196,1930781,58773
CHEMBL3261756,P08253,,LHTBQWWRIIBNDM-MGMDSTOOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,29670,NM,,,,,,,,,,,,,,Inhibition of MMP2 in human SKOV3 cell suspension using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1347847,DTCT0025094,13709791,DTCC01487196,1930781,58773
CHEMBL3261757,P08253,,YZAQMRAOVIUMBE-WRXRWIBPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,1940,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709711,DTCC01487197,643449,58773
CHEMBL3261758,P08253,,JCAKOIZWQPRZTF-BOKRKPFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,720,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709712,DTCC01487198,675626,58773
CHEMBL3261758,P08253,,JCAKOIZWQPRZTF-BOKRKPFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,31540,NM,,,,,,,,,,,,,,Inhibition of MMP2 in human SKOV3 cell suspension using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1347847,DTCT0025094,13709792,DTCC01487198,675626,58773
CHEMBL3261759,P08253,,RMYZEOWLVWLIPJ-VMESOOAKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,760,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709713,DTCC01487199,675627,58773
CHEMBL3261759,P08253,,RMYZEOWLVWLIPJ-VMESOOAKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,35860,NM,,,,,,,,,,,,,,Inhibition of MMP2 in human SKOV3 cell suspension using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1347847,DTCT0025094,13709793,DTCC01487199,675627,58773
CHEMBL3261760,P08253,,ZQDKTTXSHCQNMC-FGRQNRTPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,3360,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709714,DTCC01487200,2029529,58773
CHEMBL3261761,P08253,,BKMMQEKCFHRNPR-SAJNASKISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,1810,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709715,DTCC01487201,2093445,58773
CHEMBL3261762,P08253,,GXSCUJTUGROEHG-GEUPQXMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,270,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709716,DTCC01487202,157301,58773
CHEMBL3261762,P08253,,GXSCUJTUGROEHG-GEUPQXMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,18420,NM,,,,,,,,,,,,,,Inhibition of MMP2 in human SKOV3 cell suspension using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1347847,DTCT0025094,13709794,DTCC01487202,157301,58773
CHEMBL3261763,P08253,,VJDGTIOZKHBKCP-NZUKPGGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,1280,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709717,DTCC01487203,253783,58773
CHEMBL3261764,P08253,,NBOWPBKPMMPMSS-HDHUNYPFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,430,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709718,DTCC01487204,998456,58773
CHEMBL3261764,P08253,,NBOWPBKPMMPMSS-HDHUNYPFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,24730,NM,,,,,,,,,,,,,,Inhibition of MMP2 in human SKOV3 cell suspension using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1347847,DTCT0025094,13709795,DTCC01487204,998456,58773
CHEMBL3261765,P08253,,JZRSOQPDBXCRJZ-XJPBFQKESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,460,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709719,DTCC01487205,1834403,58773
CHEMBL3261765,P08253,,JZRSOQPDBXCRJZ-XJPBFQKESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,26180,NM,,,,,,,,,,,,,,Inhibition of MMP2 in human SKOV3 cell suspension using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1347847,DTCT0025094,13709796,DTCC01487205,1834403,58773
CHEMBL326212,P08253,,FIAWMYOFRLETPB-DSPMFFIESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,49,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 1 uM.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101932,DTCT0025094,566869,DTCC00285129,1359737,1951
CHEMBL326489,P08253,,MDNBGABATBOAOY-YCLCTBJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12877590,IC50,=,750,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 (MMP-2),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104373,DTCT0025094,1547323,DTCC00293235,258687,17445
CHEMBL326586,P08253,,TUHPBCNODYNMRM-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,41,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 1 uM.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101913,DTCT0025094,576099,DTCC00285572,2034326,1951
CHEMBL326795,P08253,,KULPQNMXJAAJOM-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,565727,DTCC00285692,1650454,1951
CHEMBL32685,P08253,,GITBBJRHJIWPLI-JBOQNHBVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Not determined),Not Determined,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101921,DTCT0025094,572711,DTCC00285372,615548,1951
CHEMBL327108,P08253,,ONKQNWHNBOMBCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14711305,KI,=,4650,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,104396,DTCT0025094,1256339,DTCC00287264,917661,17924
CHEMBL327159,P08253,,PGCZNTNNZCKKFG-SABQHFGXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,370,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,816740,DTCC00258586,1456123,11463
CHEMBL32730,P08253,,JBRUCLKAHIYELE-IMJJTQAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,894521,DTCC00171308,1849304,2600
CHEMBL327402,P08253,,IMBONAKHRALLLQ-YZGWKJHDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,19000,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,796946,DTCC00257962,679837,11463
CHEMBL327472,P08253,,RTQWWGKTAVZDQB-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.05,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,987688,DTCC00256826,1132702,1012
CHEMBL327617,P08253,,COMOZYQMQPSLMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,31,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1056157,DTCC00249769,1806421,15258
CHEMBL327641,P08253,,DVBWYFQJLIUTJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,145,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1059525,DTCC00249776,776445,15258
CHEMBL327780,P08253,,HADCYVFNVGINJC-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1900,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1004544,DTCC00256802,1617950,1012
CHEMBL328005,P08253,,VFZUGYPXLGNLTO-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,6.9,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,989967,DTCC00256487,1488726,1012
CHEMBL328045,P08253,,DUUHMNHPMFRVFH-PTOPELDVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,670,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,809547,DTCC00257772,453027,11463
CHEMBL328092,P08253,,VGTPSCHBTJBJOQ-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1014516,DTCC00256938,291523,1012
CHEMBL328162,P08253,,IRBWGGQXMBAYQL-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,60,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1453241,DTCC00264512,1014649,3373
CHEMBL328162,P08253,,IRBWGGQXMBAYQL-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,60.26,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258335,DTCC00264512,1005460,24803
CHEMBL328199,P08253,,GZISYEQJJGPWOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,33000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1365846,DTCC00265331,1047084,6400
CHEMBL328346,P08253,,UPPWLWGJBCEKOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1073543,DTCC00255283,108412,4541
CHEMBL328346,P08253,,UPPWLWGJBCEKOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317093,DTCC00255283,95556,67557
CHEMBL328346,P08253,,UPPWLWGJBCEKOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317296,DTCC00255283,95556,67557
CHEMBL328381,P08253,,NFRICHJLQIOONF-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1478666,DTCC00264486,1693757,3373
CHEMBL32839,P08253,,FOCKEUBBGLJYBX-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,858518,DTCC00171309,269235,2600
CHEMBL328472,P08253,,BSROGOBTKDPHJQ-FBCDUXLGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,796950,DTCC00257771,1163957,11463
CHEMBL328477,P08253,,JPXVSGRVNQTELH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,100000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,498667,DTCC00261645,1067812,3361
CHEMBL328607,P08253,,TVPDWLZUMDRQKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,230000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,501000,DTCC00261641,226034,3361
CHEMBL328645,P08253,,HAKDXLDJTCFTIE-HFTWOUSFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,22000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1386232,DTCC00265462,982320,6400
CHEMBL328886,P08253,,YQEMFOGNUTYMTJ-BUAFSUBRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,20,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1085840,DTCC00249311,1326512,15258
CHEMBL328910,P08253,"2,4-DIHYDROXYBENZOIC ACID",UIAFKZKHHVMJGS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-7,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103686,DTCC00254453,1828599,43205
CHEMBL329043,P08253,,WEJRAOYHTAOVFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,=,667,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,693859,DTCC00269044,1633413,18131
CHEMBL3291000,P08253,,HVGLTRLVWUDEJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,15800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754121,DTCC01502007,1010481,59385
CHEMBL3291001,P08253,,JLXXIHBBQZRECY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,9500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754122,DTCC01502008,849343,59385
CHEMBL3291002,P08253,,QKVWIEXPHPPFNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,4800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754123,DTCC01502009,1334413,59385
CHEMBL3291003,P08253,,DZEUVTPRJSYTQV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754124,DTCC01502010,816431,59385
CHEMBL3291004,P08253,,UVNARDNPHQIFFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,52000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754125,DTCC01502011,266086,59385
CHEMBL3291005,P08253,,ZHULBIHONRXGPO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,18000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754126,DTCC01502012,881733,59385
CHEMBL3291006,P08253,,JPGBTOAGOAJLCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,19000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754127,DTCC01502013,1334414,59385
CHEMBL3291007,P08253,,YWLUKEMIKYQFFX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,4900,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754128,DTCC01502014,526233,59385
CHEMBL3291008,P08253,,NYHZYLUEWGHESJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,16000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754129,DTCC01502015,622906,59385
CHEMBL3291009,P08253,,SZOCMHFDKYEXMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754130,DTCC01502016,1171525,59385
CHEMBL3291010,P08253,,PGZULCLASVMFOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754131,DTCC01502017,460899,59385
CHEMBL3291011,P08253,,GGXPSOYEDIWMFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754132,DTCC01502018,23433,59385
CHEMBL3291012,P08253,,QVQWZOSZWYYZDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754133,DTCC01502019,136817,59385
CHEMBL3291013,P08253,,OYDJNQORFHAAEZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,192,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754134,DTCC01502020,752048,59385
CHEMBL329232,P08253,,HKZHDTJNCBXYPY-ULNSLHSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,831472,DTCC00265667,1228695,4579
CHEMBL329232,P08253,,HKZHDTJNCBXYPY-ULNSLHSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3388.44,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258424,DTCC00265667,1231167,24803
CHEMBL329287,P08253,,PTYZKNZXNKWTEF-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1476064,DTCC00264543,465152,3373
CHEMBL329287,P08253,,PTYZKNZXNKWTEF-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3019.95,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258332,DTCC00264543,455575,24803
CHEMBL329298,P08253,,GWEITLSXCOXESW-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,95,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1444451,DTCC00264987,205150,3373
CHEMBL329298,P08253,,GWEITLSXCOXESW-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,95.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258323,DTCC00264987,196121,24803
CHEMBL329302,P08253,,IXAIGCQWYVKFMN-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,852200,DTCC00265445,1650202,4579
CHEMBL329302,P08253,,IXAIGCQWYVKFMN-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,2187.76,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258421,DTCC00265445,1652639,24803
CHEMBL329313,P08253,,OKYUILRERWOFCH-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1457857,DTCC00265034,853467,3373
CHEMBL329313,P08253,,OKYUILRERWOFCH-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258327,DTCC00265034,844215,24803
CHEMBL329617,P08253,,LSAOZCAKUIANSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,50000,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,971599,DTCC00256444,1981571,4784
CHEMBL329651,P08253,,BRKOQUQULDVEDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,250,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1084506,DTCC00249770,1903191,15258
CHEMBL329659,P08253,,JSZJOMOAWAHHBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,540,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1071320,DTCC00255273,76163,4541
CHEMBL329659,P08253,,JSZJOMOAWAHHBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,539.51,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317302,DTCC00255273,63118,67557
CHEMBL329659,P08253,,JSZJOMOAWAHHBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,540,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317099,DTCC00255273,63118,67557
CHEMBL329696,P08253,,JRPWDHSHTBNCJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,150000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,500998,DTCC00260924,324093,3361
CHEMBL329784,P08253,(CYCLOHEXYLAMINO)CARBONYLPHOSPHONIC ACID,QQRCALUVCOFAOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,3000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1291830,DTCC00261567,401327,17838
CHEMBL329784,P08253,(CYCLOHEXYLAMINO)CARBONYLPHOSPHONIC ACID,QQRCALUVCOFAOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420868,DTCC00261567,395589,51419
CHEMBL329967,P08253,,BVQJLICESKJIJB-IADYIPOJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,8000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1388720,DTCC00265510,659401,6400
CHEMBL330028,P08253,,BGKNBDGHNBOSGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104401,DTCT0025094,1040969,DTCC00252259,1132659,5080
CHEMBL330028,P08253,,BGKNBDGHNBOSGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,0.04,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835706,DTCC00252259,1158307,53820
CHEMBL330078,P08253,,LGHHCGQENBRXEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,1800,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,701666,DTCC00260404,648007,3985
CHEMBL330731,P08253,,ZRMAXAMITMCTTB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,250,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1083338,DTCC00249768,1713982,15258
CHEMBL330857,P08253,,VLTOUUSTKONGKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,2.4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1625322,DTCC00299273,31105,15919
CHEMBL330857,P08253,,VLTOUUSTKONGKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258471,DTCC00299273,8954,24803
CHEMBL330950,P08253,,GJCGJVYGHHRTHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,>,100000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1605178,DTCC00298620,627501,15919
CHEMBL331114,P08253,,UTOKQYCFEAMQLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,14000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1631628,DTCC00299140,950357,15919
CHEMBL331308,P08253,,RFJAQRMGTCPTHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,>,100000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1601069,DTCC00298795,303681,15919
CHEMBL331311,P08253,,CDVYEYANHXGLCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,1.9,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1631604,DTCC00298873,433997,15919
CHEMBL331311,P08253,,CDVYEYANHXGLCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,1.91,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258467,DTCC00298873,424705,24803
CHEMBL331342,P08253,,VKUYLANQOAKALN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1620359,DTCC00299210,1818652,15919
CHEMBL331342,P08253,,VKUYLANQOAKALN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258465,DTCC00299210,1808950,24803
CHEMBL331364,P08253,,RYSYGNANNWCOSN-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,70,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,555096,DTCC00285281,1164283,1951
CHEMBL331598,P08253,,WPWKYFZHRKLCAD-DSPMFFIESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 1 uM.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101932,DTCT0025094,550245,DTCC00285309,615547,1951
CHEMBL331669,P08253,,AUIKJLRMPLDORG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,40,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1617674,DTCC00299154,1468302,15919
CHEMBL331669,P08253,,AUIKJLRMPLDORG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258476,DTCC00299154,1458608,24803
CHEMBL332120,P08253,,HLJHTDAQDAFOFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1627937,DTCC00299400,108901,15919
CHEMBL332120,P08253,,HLJHTDAQDAFOFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,15.14,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258453,DTCC00299400,99390,24803
CHEMBL332145,P08253,,BLBYFZDCNCBJTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,72000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1602494,DTCC00298760,1597482,15919
CHEMBL332362,P08253,,ZQFMPAUDTOJXIB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,120,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1629141,DTCC00298575,141317,15919
CHEMBL332406,P08253,,VSJBIWYXNLUPIE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,41,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1636602,DTCC00299016,1818653,15919
CHEMBL332406,P08253,,VSJBIWYXNLUPIE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,40.74,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258472,DTCC00299016,1808949,24803
CHEMBL332429,P08253,,CSAFQHHGNGUQOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,69,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1607479,DTCC00299120,498462,15919
CHEMBL332429,P08253,,CSAFQHHGNGUQOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,69.18,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258438,DTCC00299120,488944,24803
CHEMBL332439,P08253,,KTJYZIRNJPDNBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,19000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1602486,DTCC00298787,1338994,15919
CHEMBL332755,P08253,,XFNJKSWXHKYCFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,0.8,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1631596,DTCC00299302,917813,15919
CHEMBL332755,P08253,,XFNJKSWXHKYCFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,0.794,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258470,DTCC00299302,909278,24803
CHEMBL332858,P08253,,HJAQLIVSMXUHPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,75,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1599867,DTCC00299089,530553,15919
CHEMBL332858,P08253,,HJAQLIVSMXUHPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,75.86,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258441,DTCC00299089,521152,24803
CHEMBL33306,P08253,,LFRIKIYAMSRRPD-KSMMKXTCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,2.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,877763,DTCC00170902,819525,2600
CHEMBL333122,P08253,,AUBKGBIPPZSEKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,73000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1616276,DTCC00298761,950354,15919
CHEMBL333248,P08253,,JCUTWTFOYUXMPS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,66,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1618950,DTCC00299397,1629815,15919
CHEMBL333248,P08253,,JCUTWTFOYUXMPS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,66.07,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258436,DTCC00299397,1620392,24803
CHEMBL333532,P08253,2-HYDROXYSULFAMOYL-BENZOIC ACID,USQRZPGPLTUIHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,90,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1603760,DTCC01742806,950356,15919
CHEMBL3337869,P08253,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25192810,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442062,DTCT0025094,13992240,DTCC01523362,1322384,59837
CHEMBL3337869,P08253,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25264600,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431420,DTCT0025094,13989104,DTCC01523362,1302071,60036
CHEMBL3337894,P08253,,CDQRIIUMNLMHRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25192810,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442062,DTCT0025094,13992241,DTCC01523387,966370,59837
CHEMBL333831,P08253,,FYBKBNVRCAQIIE-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,87,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 1 uM.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101932,DTCT0025094,544479,DTCC00285470,1682595,1951
CHEMBL333896,P08253,,VOESHNWTIDIZCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,87,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1617682,DTCC00299583,238021,15919
CHEMBL333896,P08253,,VOESHNWTIDIZCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,87.1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258437,DTCC00299583,228499,24803
CHEMBL333973,P08253,2-METHOXYBENZENETHIOL,DSCJETUEDFKYGN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103212,DTCC01742611,734155,43205
CHEMBL33418,P08253,,JKTJOHWXAHGOJM-WCYRKSIYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,873939,DTCC00171287,1046075,2600
CHEMBL334446,P08253,,SAHHDJPYSWCBQK-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,,1079,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,479729,DTCC00318326,1294786,6009
CHEMBL334468,P08253,,WXBITLRZKLGBHW-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,502443,DTCC00318770,874890,6009
CHEMBL334909,P08253,,RMKNDVDQYWXAON-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1399352,DTCC00325503,2078085,15412
CHEMBL3350758,P08253,,OLQSPMWFVKDWRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23999043,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by fluorescence plate reader analysis,,Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.,Bioorg. Med. Chem. Lett.,2013,23,20,"Freskos JN, Asmelash B, Gaston KR, Karwa A, Marzan TA, Nickols MA, Rogers TE, Schoenstein T, Sympson CJ, Vu B",,985896,DTCT0025094,12592011,DTCC01529950,803489,55953
CHEMBL335177,P08253,,RSQQVXDXQWIKTP-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,498812,DTCC00318329,1262287,6009
CHEMBL3355722,P08253,,VGWZAHYVUANFST-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25438884,IC50,=,7.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 fluorogenic substrate,,"A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹8F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.",Bioorg. Med. Chem.,2015,23,1,"Matusiak N, Castelli R, Tuin AW, Overkleeft HS, Wisastra R, Dekker FJ, Prély LM, Bischoff RP, van Waarde A, Dierckx RA, Elsinga PH",,1441827,DTCT0025094,14004872,DTCC01533159,137038,60339
CHEMBL3355723,P08253,,CHCWPXOCMTZBSY-VJTSUQJLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25438884,IC50,=,12.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 fluorogenic substrate,,"A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹8F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.",Bioorg. Med. Chem.,2015,23,1,"Matusiak N, Castelli R, Tuin AW, Overkleeft HS, Wisastra R, Dekker FJ, Prély LM, Bischoff RP, van Waarde A, Dierckx RA, Elsinga PH",,1441827,DTCT0025094,14004871,DTCC01533160,1269485,60339
CHEMBL3355724,P08253,,KFGQNXFUJFZCKJ-RDAHNBDFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25438884,IC50,=,1449,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 fluorogenic substrate,,"A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹8F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.",Bioorg. Med. Chem.,2015,23,1,"Matusiak N, Castelli R, Tuin AW, Overkleeft HS, Wisastra R, Dekker FJ, Prély LM, Bischoff RP, van Waarde A, Dierckx RA, Elsinga PH",,1441827,DTCT0025094,14004870,DTCC01533161,623136,60339
CHEMBL3356186,P08253,,PMNRYCFAWDUYAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25408833,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) at 10 uM,Not Determined,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432686,DTCT0025094,13976519,DTCC01533621,1355240,60283
CHEMBL3356187,P08253,,RGQLOHCHGMQBNF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25408833,INHIBITION,=,94,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) at 10 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432686,DTCT0025094,13976520,DTCC01533622,59603,60283
CHEMBL3356196,P08253,,IOCDLEZNUKXAIV-SZPZYZBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25408833,INHIBITION,=,92,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) at 10 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432686,DTCT0025094,13976521,DTCC01533631,1322421,60283
CHEMBL3356583,P08253,,KRFHCIPQISWSHQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25408833,INHIBITION,=,93,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) at 10 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432686,DTCT0025094,13976522,DTCC01534021,59641,60283
CHEMBL3356586,P08253,,NUBIFODTFFUFEI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25408833,INHIBITION,=,97,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) at 10 uM,,"Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.",ACS Med. Chem. Lett.,2014,5,11,"Murphy-Benenato KE, Olivier N, Choy A, Ross PL, Miller MD, Thresher J, Gao N, Hale MR",,1432686,DTCT0025094,13976523,DTCC01534024,221846,60283
CHEMBL3358151,P08253,,LNIRXDCIYOBRPL-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,=,24000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000051,DTCC01535600,2061710,60298
CHEMBL3358152,P08253,,GPHYVVDMOPSOAK-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,Not Determined,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000052,DTCC01535601,1769989,60298
CHEMBL3358153,P08253,,KDEHHSHGVKUYEZ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000053,DTCC01535602,1063499,60298
CHEMBL3358154,P08253,,WIKRDIGSYVQGTH-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,=,6100,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000054,DTCC01535603,1996998,60298
CHEMBL3358155,P08253,,LBVBVIKJOWWVJX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000055,DTCC01535604,385128,60298
CHEMBL3358156,P08253,,NPWGFJCNOCYDSO-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,=,7500,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000056,DTCC01535605,1387876,60298
CHEMBL3358157,P08253,,SZDCEHDWAAZEPH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,=,7100,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000057,DTCC01535606,676013,60298
CHEMBL3358158,P08253,,PDBQNZHFRVAZBC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25415648,IC50,=,11000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435761,DTCT0025094,14000058,DTCC01535607,1128498,60298
CHEMBL3359091,P08253,,YNHGVYGMFAREOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25264600,IC50,=,5300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431420,DTCT0025094,13989103,DTCC01536542,1108444,60036
CHEMBL3359462,P08253,,XIWMYPMMJBLNNV-YRNVUSSQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25467291,INHIBITION,=,56.29,%,,cell_based,,,,,,,,,,,,Inhibition of MMP2 activity in human H1299 cells at 5 uM after 24 hrs by gelatin zymography,,Discovery of 2-[2-(5-nitrofuran-2-yl)vinyl]quinoline derivatives as a novel type of antimetastatic agents.,Bioorg. Med. Chem.,2015,23,1,"Tseng CH, Tzeng CC, Chiu CC, Hsu CY, Chou CK, Chen YL",,1443728,DTCT0025094,13849370,DTCC01536916,998876,60525
CHEMBL3359462,P08253,,XIWMYPMMJBLNNV-YRNVUSSQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25467291,INHIBITION,=,63.69,%,,cell_based,,,,,,,,,,,,Inhibition of MMP2 activity in human H1299 cells at 2 uM after 24 hrs by gelatin zymography,,Discovery of 2-[2-(5-nitrofuran-2-yl)vinyl]quinoline derivatives as a novel type of antimetastatic agents.,Bioorg. Med. Chem.,2015,23,1,"Tseng CH, Tzeng CC, Chiu CC, Hsu CY, Chou CK, Chen YL",,1443727,DTCT0025094,13849369,DTCC01536916,998876,60525
CHEMBL3359462,P08253,,XIWMYPMMJBLNNV-YRNVUSSQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25467291,INHIBITION,=,75.47,%,,cell_based,,,,,,,,,,,,Inhibition of MMP2 activity in human H1299 cells at 1 uM after 24 hrs by gelatin zymography,,Discovery of 2-[2-(5-nitrofuran-2-yl)vinyl]quinoline derivatives as a novel type of antimetastatic agents.,Bioorg. Med. Chem.,2015,23,1,"Tseng CH, Tzeng CC, Chiu CC, Hsu CY, Chou CK, Chen YL",,1443726,DTCT0025094,13849368,DTCC01536916,998876,60525
CHEMBL3359462,P08253,,XIWMYPMMJBLNNV-YRNVUSSQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25467291,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP2 activity in human H1299 cells after 24 hrs by gelatin zymography,Dose-dependent effect,Discovery of 2-[2-(5-nitrofuran-2-yl)vinyl]quinoline derivatives as a novel type of antimetastatic agents.,Bioorg. Med. Chem.,2015,23,1,"Tseng CH, Tzeng CC, Chiu CC, Hsu CY, Chou CK, Chen YL",,1443593,DTCT0025094,13849363,DTCC01536916,998876,60525
CHEMBL3359657,P08253,,DFSJOYHCSMRYOD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25265401,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433220,DTCT0025094,13993812,DTCC01537099,364793,60040
CHEMBL3359658,P08253,,SKWAAHKOPIVFIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25265401,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433220,DTCT0025094,13993813,DTCC01537100,882038,60040
CHEMBL336832,P08253,,XORDSICOUVZNCB-AHWVRZQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1054554,DTCC00318198,1915389,6011
CHEMBL336900,P08253,,VLXGWLLECQNRLI-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,,675,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,497523,DTCC00318807,258980,6009
CHEMBL337309,P08253,TAXIFOLIN,CXQWRCVTCMQVQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,22620,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534775,DTCC00321631,912570,48665
CHEMBL337309,P08253,TAXIFOLIN,CXQWRCVTCMQVQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535491,DTCC00321631,912570,48665
CHEMBL337594,P08253,,XXOLBMKULOJKQR-WUJWULDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,1.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1399357,DTCC00325473,1274023,15412
CHEMBL337849,P08253,,ODDGTPKMNMBICU-UPVQGACJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1042140,DTCC00318200,336563,6011
CHEMBL337946,P08253,,DAAIDRXNEKWJIQ-LQGLAIQGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,522116,DTCC00304579,1436012,13726
CHEMBL337986,P08253,,FSFVECJWHSGENK-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,76,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,543943,DTCC00304730,724287,13726
CHEMBL338877,P08253,,QOOGIVWLICWQOB-HARLFGEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,533627,DTCC00304546,1629864,13726
CHEMBL339137,P08253,,IDKKXCKXGPPWMS-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,106,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,521063,DTCC00304581,76740,13726
CHEMBL33915,P08253,,SCDTVKKBOXTTSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11378378,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104559,DTCT0025094,1023410,DTCC00173329,743590,4214
CHEMBL339315,P08253,,CJLBNTMKOCAXSY-GKCIPKSASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,542950,DTCC00304908,1533087,13726
CHEMBL339380,P08253,,DWPJTZNVLPANSJ-FPOVZHCZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1040888,DTCC00318291,854059,6011
CHEMBL3394285,P08253,,ABKAFUZUCJSIKV-ZZXKWVIFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26753813,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP1 expressed in yeast using (5-FAM/QXLTM) FRET peptide as substrate,,Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.,Bioorg. Med. Chem.,2016,24,4,"Ai T, Qiu L, Xie J, Geraghty RJ, Chen L.",,1547670,DTCT0025094,50482,DTCC01541321,1869229,65891
CHEMBL339588,P08253,,QKYPFBUZQDJQHX-DQMJNTIXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,743,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,539248,DTCC00304182,1915219,13726
CHEMBL339610,P08253,,FWGPCZGIMGDSOM-APTRMMRNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,14,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,521075,DTCC00304804,1339064,13726
CHEMBL33977,P08253,,FDJBYAHLPYLRKD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11378378,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104559,DTCT0025094,1035538,DTCC00173295,1805633,4214
CHEMBL340345,P08253,,JIIMVBXHLBKVOM-SNRMKQJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,130,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,523133,DTCC00304892,336391,13726
CHEMBL340455,P08253,,AXIUEWMOHLWPSR-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,73,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,541131,DTCC00304315,917875,13726
CHEMBL340461,P08253,,RAPHEYPJGISJNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,0.8,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1607487,DTCC00298841,1371597,15919
CHEMBL340461,P08253,,RAPHEYPJGISJNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,0.794,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258466,DTCC00298841,1361900,24803
CHEMBL340771,P08253,,HIYYLOFJQXHPRU-OPXMRZJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,526005,DTCC00304552,1786179,13726
CHEMBL341249,P08253,,IFCFGMLOBSUCSN-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,83,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,530754,DTCC00304771,627569,13726
CHEMBL341380,P08253,,JNLVNYQWIZOKGL-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1030757,DTCC00318209,821146,6011
CHEMBL341570,P08253,,AHBFOOOWLVWQFO-MFKMUULPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,5.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1375737,DTCC00325536,1404317,15412
CHEMBL341702,P08253,,JKNLEZFIFUXSHW-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,,585,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,350184,DTCC00319027,1424916,6009
CHEMBL3417742,P08253,,GHWPTWVNZOSEBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472746,DTCT0025094,14104016,DTCC01554158,1140955,61965
CHEMBL3417745,P08253,,PJTIDEQBVYCKIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472746,DTCT0025094,14104015,DTCC01554161,1561095,61965
CHEMBL3417751,P08253,,ZUZGJCNWNOCKEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472746,DTCT0025094,14105235,DTCC01554167,946456,61965
CHEMBL3417763,P08253,,MKCKIGOKGYMJOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472746,DTCT0025094,14105238,DTCC01554179,1976632,61965
CHEMBL3417764,P08253,,ZQKGUWOTJVDTGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472746,DTCT0025094,14105237,DTCC01554180,1943630,61965
CHEMBL341817,P08253,,DENDBTOOZOCPQJ-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1050700,DTCC00319355,2078018,6011
CHEMBL34206,P08253,,SYAAEFMNVNGONW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11378378,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104559,DTCT0025094,1018305,DTCC00173335,290571,4214
CHEMBL342172,P08253,,IBRCQOLHLBIVAH-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,3.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1383315,DTCC00325535,205840,15412
CHEMBL342210,P08253,,CQRAUIRVDKNRIO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,7.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1367830,DTCC00325532,238281,15412
CHEMBL342248,P08253,,RRETZYBLLSHELY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1384554,DTCC00326418,854146,15412
CHEMBL342570,P08253,,BGDARAHTNRWTGV-FXAWDEMLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,2.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1613765,DTCC00333307,1904159,16049
CHEMBL3426196,P08253,,VNXONCMUSHASMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25835200,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 in human MDA-MB-231 cells at 1 to 7.5 uM after 24 hrs by gelatin zymographic method,Active,Synthesis of ß-Carboline-Based N-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells.,J. Med. Chem.,2015,58,8,"Dighe SU, Khan S, Soni I, Jain P, Shukla S, Yadav R, Sen P, Meeran SM, Batra S",,1476321,DTCT0025094,14131311,DTCC01556764,201600,62217
CHEMBL3426201,P08253,,RPBXFJFZRHCIJS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25835200,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 in human MDA-MB-231 cells at 1 to 5 uM after 24 hrs by gelatin zymographic method,Active,Synthesis of ß-Carboline-Based N-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells.,J. Med. Chem.,2015,58,8,"Dighe SU, Khan S, Soni I, Jain P, Shukla S, Yadav R, Sen P, Meeran SM, Batra S",,1476322,DTCT0025094,14131313,DTCC01556769,882247,62217
CHEMBL3426203,P08253,,LIJFKOIJICPMRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25835200,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 in human MDA-MB-231 cells at 1 to 7.5 uM after 24 hrs by gelatin zymographic method,Active,Synthesis of ß-Carboline-Based N-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells.,J. Med. Chem.,2015,58,8,"Dighe SU, Khan S, Soni I, Jain P, Shukla S, Yadav R, Sen P, Meeran SM, Batra S",,1476321,DTCT0025094,14131312,DTCC01556771,1561123,62217
CHEMBL342687,P08253,,LDBLVRGRVILSTH-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1049477,DTCC00318959,1015227,6011
CHEMBL342713,P08253,,ZISSKBQNAGMCRC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,475102,DTCC00319026,162462,6009
CHEMBL342870,P08253,,TZGDIJWAFCVLEH-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,2454,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1052048,DTCC00318936,303902,6011
CHEMBL343082,P08253,,SEQZHNNPDSVBRC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,,,,,,,,,,,,,,,,,Inhibition of gelatinase-A (Matrix metalloprotease-2) (Not determined),Not Determined,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106806,DTCT0025094,1388157,DTCC00325373,1274022,15412
CHEMBL343216,P08253,,BRSYUNJNYYWNHY-SZNDQCEHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,38,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,710075,DTCC00333624,1371990,17028
CHEMBL343378,P08253,,SQLYTESBAWLCTR-IDERCBEYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,87,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1266753,DTCC00318922,1947941,12304
CHEMBL34353,P08253,,LQNNJMYUCBDMHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11378378,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104559,DTCT0025094,1015889,DTCC00173334,1520107,4214
CHEMBL343548,P08253,,FGMZHMTZHZNKCA-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,1011,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1036683,DTCC00318906,1404241,6011
CHEMBL343721,P08253,,IKJVWZDFWJUWCD-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643312,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104560,DTCT0025094,479723,DTCC00318771,519366,6009
CHEMBL343911,P08253,,NXRASPQMAAGLPZ-DFCKQENNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,0.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1624046,DTCC00333891,2034900,16049
CHEMBL344633,P08253,,TUSYEXLVYIINDP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1381936,DTCC00325573,1306625,15412
CHEMBL344634,P08253,,VCUJZXCWHYPIIH-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,1.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1369145,DTCC00325533,1176355,15412
CHEMBL344828,P08253,,XGJAXXYDMLECBQ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,11.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1394378,DTCC00325372,1404315,15412
CHEMBL344843,P08253,,SXUMCLTUZSYGJQ-FPOVZHCZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1019664,DTCC00317789,1533259,6011
CHEMBL344999,P08253,,PDYICDUZWJCQQF-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1636637,DTCC00333620,616105,16049
CHEMBL345200,P08253,,ISNHZTGWQYYHNX-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,646291,DTCC00350698,1145547,15057
CHEMBL345238,P08253,,QWWYGFMPRICJFQ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,629624,DTCC00350851,1501237,15057
CHEMBL345305,P08253,,MDHGHVZOCBQJRL-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,52000,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,562259,DTCC00344460,141852,4692
CHEMBL345306,P08253,,PCGCWQHPTVXXQZ-JZTDYHMVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,1700,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,559906,DTCC00344461,1724206,4692
CHEMBL345445,P08253,,GBABKPSGHJLCTJ-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,6.4,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1112969,DTCC00344216,402313,4691
CHEMBL345445,P08253,,GBABKPSGHJLCTJ-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,6.46,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258375,DTCC00344216,391950,24803
CHEMBL345447,P08253,,FKSBYESEMYJJHL-KXUYPQTPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,34,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,572890,DTCC00344326,1208729,4692
CHEMBL345597,P08253,,NLABJQQLMHAJIL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,631635,DTCC00350721,1274348,15057
CHEMBL345768,P08253,THIOURACIL,ZEMGGZBWXRYJHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,47,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103795,DTCC00337992,1283745,43205
CHEMBL345818,P08253,,WQVQASAGIHVFJO-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,280,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1110318,DTCC00344057,1565527,4691
CHEMBL345818,P08253,,WQVQASAGIHVFJO-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,281.84,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258365,DTCC00344057,1555530,24803
CHEMBL346118,P08253,,UPCAIRKRFXQRRM-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,17,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,641835,DTCC00350479,1436534,15057
CHEMBL346265,P08253,,JSUMSNXSMOEZBZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,8.3,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,632931,DTCC00350909,1339620,15057
CHEMBL346442,P08253,,YBRVBUDXSMPLGQ-YPFLROGLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,490550,DTCC00340681,1145418,15546
CHEMBL346624,P08253,,QRDYOYPORKWZCP-YDRQLGOLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,477742,DTCC00340174,1786615,15546
CHEMBL347138,P08253,,YKCFIBZBJVGNQA-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,645180,DTCC00350933,2046332,15057
CHEMBL347594,P08253,,FYHSMVNHGKEDAV-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,3500,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1133926,DTCC00344077,109424,4691
CHEMBL347594,P08253,,FYHSMVNHGKEDAV-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,3467.37,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258366,DTCC00344077,99394,24803
CHEMBL347595,P08253,,ITYFHVLIAPNWSK-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,0.2,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1133923,DTCC00343820,109422,4691
CHEMBL347595,P08253,,ITYFHVLIAPNWSK-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258390,DTCC00343820,99392,24803
CHEMBL347612,P08253,,HAEIZFMEOGTXJF-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,654240,DTCC00350594,2078400,15057
CHEMBL347658,P08253,,VTULZRYBMWMKHT-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,110,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,636344,DTCC00350889,304323,15057
CHEMBL347673,P08253,,MSDABIFBXLTNAU-KIFXHHALSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,100,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,555343,DTCC00344372,2078318,4692
CHEMBL347847,P08253,,VZUNCTCGDYWBLP-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,280,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,638517,DTCC00350409,854434,15057
CHEMBL348088,P08253,,LIECXDHTIYQPFE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,<,200,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,643001,DTCC00350458,1948342,15057
CHEMBL348129,P08253,,CFINSGSIDZSUDX-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,<,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,635277,DTCC00350736,141921,15057
CHEMBL348210,P08253,,AJUUQAWYLUYLDD-SBXXRYSUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,476535,DTCC00340474,563217,15546
CHEMBL348335,P08253,,MDWFJTBWOFNAQX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,<,100,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,646300,DTCC00351046,1662620,15057
CHEMBL348878,P08253,,ZFQPFNFJKNLTIW-KFACBJOOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,210,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,547925,DTCC00344327,1565535,4692
CHEMBL348878,P08253,,ZFQPFNFJKNLTIW-KFACBJOOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,RATIO,=,8.1,,,,,,,,,,,,,,,Selectivity for Matrix metalloprotease-2,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,229582,DTCT0025094,547926,DTCC00344327,1565535,4692
CHEMBL349099,P08253,,YXFLQXXMKGQVQR-BPUDTRNYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,50,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1124754,DTCC00344070,1630285,4691
CHEMBL349099,P08253,,YXFLQXXMKGQVQR-BPUDTRNYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1584.89,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258370,DTCC00344070,1620399,24803
CHEMBL349124,P08253,,NXKGLSOWQLOKML-FPNNDXFKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,270,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1095575,DTCC00343873,466084,4691
CHEMBL349397,P08253,,HQKHAIXFILRCNW-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,594951,DTCC00362577,2066954,2023
CHEMBL349798,P08253,,IAOGVQLLIKLDLH-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,631643,DTCC00350723,141922,15057
CHEMBL350231,P08253,,OFJQHDDSKOHCOJ-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,1.6,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1121176,DTCC00343896,271244,4691
CHEMBL350231,P08253,,OFJQHDDSKOHCOJ-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1.58,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258389,DTCC00343896,260721,24803
CHEMBL350674,P08253,,DIYSOYKZARVATO-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,84,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,637385,DTCC00350578,1080567,15057
CHEMBL351110,P08253,,WLJNZEMUQWWHSY-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,641838,DTCC00350823,466181,15057
CHEMBL351363,P08253,,DAGYTGGBYWXSKA-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,53,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,629621,DTCC00350521,918437,15057
CHEMBL351806,P08253,,JBYHBQIDTNHWJF-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,IC50,=,240,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay,,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987741,DTCT0025094,12617815,DTCC00350520,1235642,56109
CHEMBL351806,P08253,,JBYHBQIDTNHWJF-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,Active,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617805,DTCC00350520,1235642,56109
CHEMBL352609,P08253,,NKDAHLSBYWSQCA-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,220,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,598604,DTCC00362073,2002344,2023
CHEMBL35348,P08253,,MVNUXJNXEWKALY-SPEDKVCISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,4.2,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,871400,DTCC00171501,1881622,2600
CHEMBL35476,P08253,,CTGVDIGFCHCCJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11378378,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104559,DTCT0025094,1042177,DTCC00173371,1002127,4214
CHEMBL355752,P08253,,GPPXSZZXGYMBHW-QKFKETGDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9888835,IC50,,,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease 2 (Not determined),Not Determined,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104381,DTCT0025094,1144686,DTCC00372315,854716,15162
CHEMBL356011,P08253,,CYBDDZKSRZPTQR-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,510231,DTCC00340538,1851292,15546
CHEMBL35602,P08253,,GKHRDWHFKKUYAX-KURKYZTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,867408,DTCC00171530,2044385,2600
CHEMBL356124,P08253,,ZJOQXNGTEXFLLO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,724,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,880002,DTCC00334202,173919,6330
CHEMBL356413,P08253,,BQKZRXTUCVWMIN-AUSIDOKSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,86,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,547928,DTCC00344506,1786666,4692
CHEMBL356471,P08253,,RYMINZKMUZXTLF-CDCQXCROSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,512672,DTCC00340433,1339485,15546
CHEMBL356504,P08253,,WUVSVKLVNMIEJM-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1606317,DTCC00333828,292453,16049
CHEMBL356837,P08253,,KTYADSSNJMMACA-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,560,NM,,,,,,,,,,,,,,Inhibition of human gelatinase A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,101922,DTCT0025094,994992,DTCC00340622,1036386,1529
CHEMBL356975,P08253,,GDUSADXUOJTTQS-YGRLFVJLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,108,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,727536,DTCC00333540,1404419,17028
CHEMBL357050,P08253,,OECFBMNWNGPPFC-RQNDZEIBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,0.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,506541,DTCC00340841,756859,15546
CHEMBL357675,P08253,,BDLXCRNZHKNUCS-VFNWGFHPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,19,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,711171,DTCC00333595,1501022,17028
CHEMBL357728,P08253,,BUOKQWSUTKFXOW-NLKUQUHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,476529,DTCC00340744,402280,15546
CHEMBL357796,P08253,,AKTPDJLIUXRMDA-SBXXRYSUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,491839,DTCC00340775,660245,15546
CHEMBL357934,P08253,,GWZMHEYDUOAMNJ-AFDUHFSSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,495550,DTCC00340680,1113106,15546
CHEMBL358064,P08253,,ULDXUWXTVRRUND-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1624036,DTCC00333936,1229583,16049
CHEMBL358182,P08253,,NIUQIJFMBOIHLA-WPZCJLIBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,502899,DTCC00340840,1786616,15546
CHEMBL358405,P08253,,RQEBSVZFRXVOLZ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,496678,DTCC00340792,1241485,15546
CHEMBL358539,P08253,,OVUDWXYTKUKYAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,880012,DTCC00334156,1565409,6330
CHEMBL3585670,P08253,,LDXFMYDMYKZDCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells at 10 uM by gelatin zymography,Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501254,DTCT0025094,14455624,DTCC01648638,709522,62853
CHEMBL3585671,P08253,,LQIRFLYUTCRGAT-FLFKKZLDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells at 10 uM by gelatin zymography,Not Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501254,DTCT0025094,14455623,DTCC01648639,1868283,62853
CHEMBL3585672,P08253,,IULHPNNAVFLEJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells by gelatin zymography,Not Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501256,DTCT0025094,14455616,DTCC01648640,1389372,62853
CHEMBL3585673,P08253,,NWIQXDRMJSLWLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells by gelatin zymography,Not Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501256,DTCT0025094,14455615,DTCC01648641,1421696,62853
CHEMBL3585674,P08253,,UZJOXJSGSOVPMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells by gelatin zymography,Not Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501256,DTCT0025094,14455614,DTCC01648642,516013,62853
CHEMBL3585675,P08253,,UCJISPPCLJRDKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells by gelatin zymography,Not Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501256,DTCT0025094,14455613,DTCC01648643,483754,62853
CHEMBL3585676,P08253,,IOHWFKJACXNPSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells at 10 uM by gelatin zymography,Not Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501254,DTCT0025094,14455622,DTCC01648644,1518409,62853
CHEMBL3585677,P08253,,JWBGDCUQPYSWKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells at 10 uM by gelatin zymography,Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501254,DTCT0025094,14455621,DTCC01648645,612576,62853
CHEMBL3585678,P08253,,DMOBTVZLAWXNMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,=,60,%,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells at 5 uM by gelatin zymography,,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501260,DTCT0025094,14455601,DTCC01648646,1771397,62853
CHEMBL3585678,P08253,,DMOBTVZLAWXNMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,=,90,%,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells at 10 uM by gelatin zymography,,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501254,DTCT0025094,14455620,DTCC01648646,1771397,62853
CHEMBL3585678,P08253,,DMOBTVZLAWXNMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells by gelatin zymography,Dose-dependent effect,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501256,DTCT0025094,14455611,DTCC01648646,1771397,62853
CHEMBL3585759,P08253,,FAOKYLWYCBQYDT-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,10300,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456743,DTCC01648728,753888,62860
CHEMBL3585760,P08253,,FAOKYLWYCBQYDT-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456744,DTCC01648729,1238347,62860
CHEMBL3585761,P08253,,UOJWLSDRILDSBX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456745,DTCC01648730,2043261,62860
CHEMBL3585762,P08253,,UOJWLSDRILDSBX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,1400,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456746,DTCC01648731,138718,62860
CHEMBL3585763,P08253,,ZZNYWQSQHHAWBQ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456747,DTCC01648732,1142243,62860
CHEMBL3585764,P08253,,ZZNYWQSQHHAWBQ-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,34700,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456748,DTCC01648733,202839,62860
CHEMBL3585765,P08253,,VKRNXLAHYIGGFO-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,6.4,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456749,DTCC01648734,657216,62860
CHEMBL3585766,P08253,,VKRNXLAHYIGGFO-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,32.8,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456750,DTCC01648735,786014,62860
CHEMBL3585767,P08253,,FFXVPKULVPXOFT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,2100,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456751,DTCC01648736,1433392,62860
CHEMBL3585768,P08253,,FFXVPKULVPXOFT-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456753,DTCC01648737,1401376,62860
CHEMBL3585769,P08253,,ZJBBKJOUNAIIJA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,3.9,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456754,DTCC01648738,1912533,62860
CHEMBL3585770,P08253,,ZJBBKJOUNAIIJA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,6.3,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456755,DTCC01648739,268028,62860
CHEMBL3585771,P08253,,OLYCJZWCGNXHMV-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,35700,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456756,DTCC01648740,1271106,62860
CHEMBL3585772,P08253,,OLYCJZWCGNXHMV-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456757,DTCC01648741,1783523,62860
CHEMBL3585773,P08253,,FWGLYVKGDMYORU-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,9.3,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456758,DTCC01648742,1401377,62860
CHEMBL3585774,P08253,,FWGLYVKGDMYORU-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,IC50,=,7.2,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456759,DTCC01648743,235396,62860
CHEMBL359251,P08253,,GOWUYJZGNHYGEC-SZNDQCEHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,11,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,706629,DTCC00333183,1339394,17028
CHEMBL3593549,P08253,,DFINJLCZWBDBQX-KDNYSNCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505519,DTCT0025094,14475911,DTCC01651896,333622,63066
CHEMBL3593549,P08253,,DFINJLCZWBDBQX-KDNYSNCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505523,DTCT0025094,14475885,DTCC01651896,333622,63066
CHEMBL3593550,P08253,,SWCOKZUOBSVFCL-NROLRVEYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,Not Determined,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505519,DTCT0025094,14475909,DTCC01651897,2010871,63066
CHEMBL3593551,P08253,,ZEPWGRQYGKUKNA-KFIZHRIMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505519,DTCT0025094,14475906,DTCC01651898,818354,63066
CHEMBL3593551,P08253,,ZEPWGRQYGKUKNA-KFIZHRIMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505523,DTCT0025094,14475955,DTCC01651898,818354,63066
CHEMBL3593552,P08253,,QABDTPJMJYQBCF-KQQMQGIYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505519,DTCT0025094,14475904,DTCC01651899,980185,63066
CHEMBL3593552,P08253,,QABDTPJMJYQBCF-KQQMQGIYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505523,DTCT0025094,14475957,DTCC01651899,980185,63066
CHEMBL359424,P08253,,MJJPSHCMTYJCDM-PXAZEXFGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,14,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,694965,DTCC00333516,854231,17028
CHEMBL359569,P08253,,QNVRWDPZVVAENF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,=,2167,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768725,DTCC00387628,271775,18194
CHEMBL359625,P08253,,UJCQVXJYOKSWGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1767157,DTCC00387768,304744,18194
CHEMBL359716,P08253,,RAGDORVOHODYFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15686921,KI,=,4.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302479,DTCT0025094,1744792,DTCC00381579,1586741,18787
CHEMBL359770,P08253,,NVNDKOXSOGFACQ-HKBQPEDESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,62,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1799860,DTCC00394674,2046793,8231
CHEMBL360193,P08253,,ZWTFDOKRWKJVER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800218,DTCC00398283,358362,16433
CHEMBL360509,P08253,,WXVPWVLIIPQGLY-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,>,2000000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2,,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,302309,DTCT0025094,1771845,DTCC00389512,369983,17054
CHEMBL360609,P08253,,YKSIUQZREKHXCH-AEFFLSMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307790,DTCT0025094,1789967,DTCC00392956,616784,19089
CHEMBL360609,P08253,,YKSIUQZREKHXCH-AEFFLSMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,55,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307795,DTCT0025094,1789968,DTCC00392956,616784,19089
CHEMBL360860,P08253,,IZFSBROZVUFQDL-BQBZGAKWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1771456,DTCC00389413,142339,17054
CHEMBL360868,P08253,,ALWUFFCDYONNPP-JSGCOSHPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770687,DTCC00389493,1048477,17054
CHEMBL361034,P08253,,IKZDCRKJMJCCPS-ONGXEEELSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770673,DTCC00389435,1883974,17054
CHEMBL361376,P08253,,JTEXDSSTTHRJGK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769264,DTCC00387599,1015992,18194
CHEMBL361449,P08253,,NKJYIBRDRYQXFN-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307790,DTCT0025094,1791013,DTCC00392763,1295652,19089
CHEMBL361449,P08253,,NKJYIBRDRYQXFN-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307795,DTCT0025094,1791014,DTCC00392763,1295652,19089
CHEMBL361527,P08253,,QBWALRVIJDSECI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15686921,KI,=,0.4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302479,DTCT0025094,1745330,DTCC00381643,1360847,18787
CHEMBL361527,P08253,,QBWALRVIJDSECI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15686921,KI,=,1.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302479,DTCT0025094,1745336,DTCC00381643,1360848,18787
CHEMBL3617400,P08253,,NUFBSNVYZRUJSW-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518237,DTCT0025094,14545608,DTCC01663485,1291518,63632
CHEMBL3617401,P08253,,KUDQLMASLRCXLF-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518237,DTCT0025094,14545607,DTCC01663486,839147,63632
CHEMBL3617402,P08253,,QHHHTEGVVKPDKH-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,IC50,=,0.33,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518237,DTCT0025094,14545606,DTCC01663487,126658,63632
CHEMBL3617402,P08253,,QHHHTEGVVKPDKH-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,RATIO IC50,=,2,,,,,,,,,,,,,,,Ratio of ARP101 IC50 to compound IC50 for recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518242,DTCT0025094,14545649,DTCC01663487,126658,63632
CHEMBL3617403,P08253,,NJZUERVIVLYZMO-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518237,DTCT0025094,14545605,DTCC01663488,94439,63632
CHEMBL3617404,P08253,,UJKKQEHHLXCTJE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,IC50,=,0.13,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518237,DTCT0025094,14545604,DTCC01663489,1161438,63632
CHEMBL3617404,P08253,,UJKKQEHHLXCTJE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 gelatinase activity in human HUVEC by gel zymography,Dose-dependent effect,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518252,DTCT0025094,14545669,DTCC01663489,1161438,63632
CHEMBL3617404,P08253,,UJKKQEHHLXCTJE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 gelatinase activity in human HUVEC at 0.1 uM by gel zymography,Active,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518256,DTCT0025094,14545675,DTCC01663489,1161438,63632
CHEMBL3617404,P08253,,UJKKQEHHLXCTJE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,RATIO IC50,=,6,,,,,,,,,,,,,,,Ratio of ARP101 IC50 to compound IC50 for recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518242,DTCT0025094,14545650,DTCC01663489,1161438,63632
CHEMBL3617405,P08253,,WVPKYEATTXWJLC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,IC50,=,0.37,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518237,DTCT0025094,14545603,DTCC01663490,1739733,63632
CHEMBL3617406,P08253,,RAYJCTCOKFKWEF-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,IC50,=,590,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518237,DTCT0025094,14545602,DTCC01663491,871801,63632
CHEMBL3617406,P08253,,RAYJCTCOKFKWEF-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 gelatinase activity in human HUVEC at 0.001 to 10 uM by gel zymography,Not Active,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518258,DTCT0025094,14545677,DTCC01663491,871801,63632
CHEMBL3617407,P08253,,WQCXDERWRJMJQA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,IC50,=,0.67,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518237,DTCT0025094,14545601,DTCC01663492,2063303,63632
CHEMBL3617407,P08253,,WQCXDERWRJMJQA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 gelatinase activity in human HUVEC by gel zymography,Dose-dependent effect,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518252,DTCT0025094,14545670,DTCC01663492,2063303,63632
CHEMBL3617407,P08253,,WQCXDERWRJMJQA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 gelatinase activity in human HUVEC at 0.001 uM by gel zymography,Active,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518254,DTCT0025094,14545673,DTCC01663492,2063303,63632
CHEMBL3617407,P08253,,WQCXDERWRJMJQA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 in HUVEC assessed as suppression of protein release at 10 uM after 24 hrs by Western blot analysis,Active,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518360,DTCT0025094,14545679,DTCC01663492,2063303,63632
CHEMBL3617407,P08253,,WQCXDERWRJMJQA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26263024,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 in HUVEC assessed as suppression of protein production at 10 uM after 24 hrs by Western blot analysis,Active,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518362,DTCT0025094,14545681,DTCC01663492,2063303,63632
CHEMBL3618461,P08253,,FOCZQHBXIUOIJR-UQKRIMTDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,=,235.2,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550507,DTCC01664557,288988,63755
CHEMBL3618461,P08253,,FOCZQHBXIUOIJR-UQKRIMTDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,97.7,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550531,DTCC01664557,288988,63755
CHEMBL3618462,P08253,,FOCZQHBXIUOIJR-PFEQFJNWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,=,144.6,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550508,DTCC01664558,935907,63755
CHEMBL3618462,P08253,,FOCZQHBXIUOIJR-PFEQFJNWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550532,DTCC01664558,935907,63755
CHEMBL3618463,P08253,,QNKSDDQPRLWOEC-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,=,256.2,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550510,DTCC01664559,580432,63755
CHEMBL3618463,P08253,,QNKSDDQPRLWOEC-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,92.6,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550534,DTCC01664559,580432,63755
CHEMBL3618464,P08253,,QNKSDDQPRLWOEC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,=,299.2,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550511,DTCC01664560,709675,63755
CHEMBL3618464,P08253,,QNKSDDQPRLWOEC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550535,DTCC01664560,709675,63755
CHEMBL3618465,P08253,,WWTIQZDEOKXNTE-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,,,,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,Not Determined,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550108,DTCC01664561,2096295,63755
CHEMBL3618465,P08253,,WWTIQZDEOKXNTE-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,,,,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,Not Determined,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550513,DTCC01664561,2096289,63755
CHEMBL3618465,P08253,,WWTIQZDEOKXNTE-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,7.9,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550538,DTCC01664561,2096295,63755
CHEMBL3618465,P08253,,WWTIQZDEOKXNTE-HJPURHCSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,30.7,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550537,DTCC01664561,2096289,63755
CHEMBL3618466,P08253,,WWTIQZDEOKXNTE-MWTRTKDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,,,,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,Not Determined,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550158,DTCC01664562,288989,63755
CHEMBL3618466,P08253,,WWTIQZDEOKXNTE-MWTRTKDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,,,,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,Not Determined,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550308,DTCC01664562,288990,63755
CHEMBL3618466,P08253,,WWTIQZDEOKXNTE-MWTRTKDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,12.9,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550539,DTCC01664562,288989,63755
CHEMBL3618466,P08253,,WWTIQZDEOKXNTE-MWTRTKDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,14.1,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550540,DTCC01664562,288990,63755
CHEMBL362099,P08253,,SHTFVFWWLRULMZ-JQWIXIFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,=,88000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2,,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,302309,DTCT0025094,1770682,DTCC00389390,1851836,17054
CHEMBL362100,P08253,,HTTGXWWZNURROV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1766620,DTCC00387621,337380,18194
CHEMBL3621216,P08253,,ARAZNEJIUPWBGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,8511.38,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571625,DTCC01665642,560370,63889
CHEMBL3621216,P08253,,ARAZNEJIUPWBGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,8630,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571533,DTCC01665642,560370,63889
CHEMBL3622219,P08253,,CQSZJPKSXWNIRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,7920,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571531,DTCC01665640,1848258,63889
CHEMBL3622219,P08253,,CQSZJPKSXWNIRM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,7943.28,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571623,DTCC01665640,1848258,63889
CHEMBL3622220,P08253,,LIWWLVIGWDNERW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,2884.03,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571624,DTCC01665641,1173522,63889
CHEMBL3622220,P08253,,LIWWLVIGWDNERW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,2910,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571532,DTCC01665641,1173522,63889
CHEMBL3622221,P08253,,JMFFPPYXIAJJHS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,3235.94,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571626,DTCC01665643,1238494,63889
CHEMBL3622221,P08253,,JMFFPPYXIAJJHS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,3240,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571534,DTCC01665643,1238494,63889
CHEMBL3622222,P08253,,PSLZAPBDBBDPPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,4786.3,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571627,DTCC01665644,1594970,63889
CHEMBL3622222,P08253,,PSLZAPBDBBDPPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,4830,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571535,DTCC01665644,1594970,63889
CHEMBL3622223,P08253,,IRKAGORJCMYCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,11220.18,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571628,DTCC01665645,1978148,63889
CHEMBL3622223,P08253,,IRKAGORJCMYCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,11360,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571536,DTCC01665645,1978148,63889
CHEMBL3622224,P08253,,JOXOSYLMICYIJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,9332.54,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571629,DTCC01665646,1945161,63889
CHEMBL3622224,P08253,,JOXOSYLMICYIJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,9430,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571537,DTCC01665646,1945161,63889
CHEMBL3622225,P08253,,BRRWKZSRWJEFEJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,6760.83,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571630,DTCC01665647,1303819,63889
CHEMBL3622225,P08253,,BRRWKZSRWJEFEJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,6810,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571538,DTCC01665647,1303819,63889
CHEMBL3622226,P08253,,GKUKGTPBNZYOOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,208.93,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571631,DTCC01665648,786190,63889
CHEMBL3622226,P08253,,GKUKGTPBNZYOOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,210,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571539,DTCC01665648,786190,63889
CHEMBL3622784,P08253,,DLFXYHXMQWTTSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,4168.69,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571632,DTCC01666211,1880629,63889
CHEMBL3622784,P08253,,DLFXYHXMQWTTSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,4270,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571540,DTCC01666211,1880629,63889
CHEMBL3622785,P08253,,UQLGCIRFNNFGKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,794.33,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571633,DTCC01666212,1465764,63889
CHEMBL3622785,P08253,,UQLGCIRFNNFGKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,810,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571542,DTCC01666212,1465764,63889
CHEMBL3622786,P08253,,HSEFAXKXEWSOGH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,2691.53,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571634,DTCC01666213,947920,63889
CHEMBL3622786,P08253,,HSEFAXKXEWSOGH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571543,DTCC01666213,947920,63889
CHEMBL3622787,P08253,,WHZFAJYEXJWWSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,12589.25,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571635,DTCC01666214,947921,63889
CHEMBL3622787,P08253,,WHZFAJYEXJWWSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,12630,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571544,DTCC01666214,947921,63889
CHEMBL3622788,P08253,,DTOSICPIIPECKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,11440,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571545,DTCC01666215,657353,63889
CHEMBL3622788,P08253,,DTOSICPIIPECKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,11481.54,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571636,DTCC01666215,657353,63889
CHEMBL3622789,P08253,,BIAVIKBVTJZJOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,14791.08,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571637,DTCC01666216,851413,63889
CHEMBL3622789,P08253,,BIAVIKBVTJZJOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,14830,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571546,DTCC01666216,851413,63889
CHEMBL3622790,P08253,,XMVTYJNGLRSMOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,2089.3,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571638,DTCC01666217,689555,63889
CHEMBL3622790,P08253,,XMVTYJNGLRSMOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,3860,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571547,DTCC01666217,689555,63889
CHEMBL3622791,P08253,,QBDCDXFJSXBXGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,2150,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571548,DTCC01666218,1498228,63889
CHEMBL3622791,P08253,,QBDCDXFJSXBXGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,3801.89,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571639,DTCC01666218,1498228,63889
CHEMBL3622792,P08253,,GXTKOOYKFOIAAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,23820,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571549,DTCC01666219,1205820,63889
CHEMBL3622792,P08253,,GXTKOOYKFOIAAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,23988.33,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571640,DTCC01666219,1205820,63889
CHEMBL3622793,P08253,,CYWCRGAEIMKYTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,17782.79,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571641,DTCC01666220,1562492,63889
CHEMBL3622793,P08253,,CYWCRGAEIMKYTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,17820,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571550,DTCC01666220,1562492,63889
CHEMBL3622794,P08253,,RLILVSDCEHRYOZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,15488.17,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571642,DTCC01666221,1945168,63889
CHEMBL3622794,P08253,,RLILVSDCEHRYOZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,15670,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571551,DTCC01666221,1945168,63889
CHEMBL3622795,P08253,,XJWLMPXBCDULME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,2810,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571552,DTCC01666222,560374,63889
CHEMBL3622795,P08253,,XJWLMPXBCDULME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,2818.38,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571643,DTCC01666222,560374,63889
CHEMBL3622796,P08253,,SOQUQUULZBJGPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,9900,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571553,DTCC01666223,1659674,63889
CHEMBL3622796,P08253,,SOQUQUULZBJGPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571644,DTCC01666223,1659674,63889
CHEMBL3622797,P08253,,WEUFMBNLGSJUJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,14791.08,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571645,DTCC01666224,1369102,63889
CHEMBL3622797,P08253,,WEUFMBNLGSJUJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,14940,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571554,DTCC01666224,1369102,63889
CHEMBL3622798,P08253,,QUGGOMITCPEQQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,16840,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571555,DTCC01666225,1336527,63889
CHEMBL3622798,P08253,,QUGGOMITCPEQQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,16982.44,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571646,DTCC01666225,1336527,63889
CHEMBL3622799,P08253,,BDBAYMZOFMAWRY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,3600,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571556,DTCC01666226,851414,63889
CHEMBL3622799,P08253,,BDBAYMZOFMAWRY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,3630.78,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571647,DTCC01666226,851414,63889
CHEMBL3622800,P08253,,SRPCXEFYFVDUFQ-KBKZQPOHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26346367,IC50,=,1260,NM,,,,,,,,,,,,,,Inhibition of APMA-activated human recombinant MMP2 incubated for 5 mins using 4-nitrophenylacetate substrate by esterase assay,,"Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.",Bioorg. Med. Chem. Lett.,2015,25,20,"Yan XQ, Wang ZC, Li Z, Wang PF, Qiu HY, Chen LW, Lu XY, Lv PC, Zhu HL",,1519998,DTCT0025094,14571557,DTCC01666227,333771,63889
CHEMBL362522,P08253,,GSLFAMACMHMDQE-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,4,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1799565,DTCC00394652,563809,8231
CHEMBL362651,P08253,,PKVXJRTWUNPBJP-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15713379,IC50,=,0.41,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305733,DTCT0025094,1747894,DTCC00381850,1936708,18841
CHEMBL362651,P08253,,PKVXJRTWUNPBJP-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15837315,IC50,=,0.41,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 in MMPi assay,,A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.,Bioorg. Med. Chem. Lett.,2005,15,9,"Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S, Tuccinardi T, Atkinson SJ, Murphy G, Balsamo A",,305684,DTCT0025094,1841415,DTCC00381850,1948929,18987
CHEMBL362678,P08253,,DGZZVIWCMGVHGV-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15713379,IC50,=,10.3,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305733,DTCT0025094,1747887,DTCC00381819,1969977,18841
CHEMBL362791,P08253,,CXYSWVJGECIJOF-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,16,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1799434,DTCC00394612,206650,8231
CHEMBL362791,P08253,,CXYSWVJGECIJOF-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,16,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860287,DTCC00394612,206771,19837
CHEMBL362912,P08253,,URXHOHGQEBFJOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,7.21,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828759,DTCC00399798,1755052,19718
CHEMBL363261,P08253,,SGKYEMLYQFTLEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768296,DTCC00387635,32986,18194
CHEMBL3633817,P08253,,ZQYRDNFYQHYIPA-SCLBCKFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527165,DTCT0025094,14586893,DTCC01670821,1550629,64111
CHEMBL3633817,P08253,,ZQYRDNFYQHYIPA-SCLBCKFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586875,DTCC01670821,1550629,64111
CHEMBL3633818,P08253,,WIGAWQAOMBSMTI-VGOFRKELSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527165,DTCT0025094,14586894,DTCC01670822,1932749,64111
CHEMBL3633818,P08253,,WIGAWQAOMBSMTI-VGOFRKELSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,Not Active,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586876,DTCC01670822,1932749,64111
CHEMBL3633819,P08253,,WIGAWQAOMBSMTI-HTAPYJJXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527165,DTCT0025094,14586895,DTCC01670823,1900808,64111
CHEMBL3633819,P08253,,WIGAWQAOMBSMTI-HTAPYJJXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,74,%,,,,,,,,,,,,,,Inhibition MMP-2 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate at 5 uM preincubated for 5 mins followed by substrate addition measured for 30 mins by fluorometric assay,,,MedChemComm,2015,6,2,,,1527163,DTCT0025094,14586877,DTCC01670823,1900808,64111
CHEMBL363451,P08253,,IGCXXFVEWDCCKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1766907,DTCC00387667,1598534,18194
CHEMBL363675,P08253,,ASAPWKWJXIHFER-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,340157,DTCC00389348,109933,17054
CHEMBL363719,P08253,,VIJGBSAWWJKQHY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800094,DTCC00398373,488094,16433
CHEMBL363732,P08253,,YDTKUAMJIYPIGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769250,DTCC00387578,725267,18194
CHEMBL363953,P08253,,MEFLBZIMEXKFFU-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770694,DTCC00389451,1948789,17054
CHEMBL363968,P08253,,VACPECYZKUSTIV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1766900,DTCC00387733,304743,18194
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,18,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650860,DTCC01703280,1130506,64498
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,59,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650755,DTCC01703280,1130506,64498
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,85,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646222,DTCC01703280,1130506,64498
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,86,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247368,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,181908,DTCC01703280,1130506,64498
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,86,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641799,DTCC01703280,1130506,64498
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,93,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650651,DTCC01703280,1130506,64498
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,649,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646326,DTCC01703280,1130506,64498
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646430,DTCC01703280,1130506,64498
CHEMBL3639695,P08253,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655440,DTCC01703280,1130506,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,37,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650789,DTCC01708180,1615862,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,233,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646360,DTCC01708180,1615862,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,896,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247402,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,183550,DTCC01708180,1615862,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,896,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641833,DTCC01708180,1615862,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650582,DTCC01708180,1615862,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650685,DTCC01708180,1615862,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655370,DTCC01708180,1615862,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646256,DTCC01708180,1615862,64498
CHEMBL3639744,P08253,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655474,DTCC01708180,1615862,64498
CHEMBL364185,P08253,,MAGGVGMLDUAYRI-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,12.1,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1798986,DTCC00394788,1113706,8231
CHEMBL364212,P08253,,HVCMNEIPCJLAQO-IXLVIVEVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,>,100000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2,,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,302309,DTCT0025094,1770190,DTCC00389323,1469364,17054
CHEMBL364589,P08253,,TUZYRFJHUHCUNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768170,DTCC00387692,1501650,18194
CHEMBL364775,P08253,,HGHDQFUGOIJFTI-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,>,100000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2,,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,302309,DTCT0025094,1771978,DTCC00389612,725294,17054
CHEMBL364783,P08253,,UGLZDULKIKNNBG-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1770182,DTCC00389369,789574,17054
CHEMBL364875,P08253,,MCBALNMZVCCHAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,=,2566,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769394,DTCC00387548,1724710,18194
CHEMBL364979,P08253,,NUMGTAZEZUDGNC-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307790,DTCT0025094,1790894,DTCC00392916,98440,19089
CHEMBL364979,P08253,,NUMGTAZEZUDGNC-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,15,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307795,DTCT0025094,1790895,DTCC00392916,98440,19089
CHEMBL365031,P08253,,NGBXKQSVMZPDNE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1769654,DTCC00387577,499471,18194
CHEMBL365167,P08253,,NPIWTBAYANSBHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800393,DTCC00398407,1037012,16433
CHEMBL365259,P08253,,OUCZIEVBEJQBJK-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,14,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1798876,DTCC00394615,1948844,8231
CHEMBL365386,P08253,,MUEJBYPIDLKGKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800405,DTCC00398433,1425801,16433
CHEMBL365632,P08253,,PGPCNXNVLLYCGR-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,73,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307790,DTCT0025094,1789955,DTCC00392926,908338,19089
CHEMBL365632,P08253,,PGPCNXNVLLYCGR-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307795,DTCT0025094,1789956,DTCC00392926,908338,19089
CHEMBL365905,P08253,,UXWAVVXCMUJGHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,=,1400,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768162,DTCC00387755,499472,18194
CHEMBL365910,P08253,,RANUWAUPDVMUKD-NHCUHLMSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307790,DTCT0025094,1790762,DTCC00392611,908333,19089
CHEMBL365910,P08253,,RANUWAUPDVMUKD-NHCUHLMSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307795,DTCT0025094,1790763,DTCC00392611,908333,19089
CHEMBL365923,P08253,,ZRKRXBQAESAFIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,2,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1799002,DTCC00394734,1663112,8231
CHEMBL365947,P08253,,WXPUJRINFGPEGC-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,522,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860381,DTCC00407674,1695368,19837
CHEMBL365990,P08253,,KLUMXQDRHKUFQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,3700,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828746,DTCC00399922,271890,19718
CHEMBL366060,P08253,,HYJDMXKMWHHPTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,=,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800076,DTCC00398339,130820,16433
CHEMBL366111,P08253,,WJULIBHPWZXMJA-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15324896,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease 2,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305042,DTCT0025094,1768934,DTCC00388400,142333,18227
CHEMBL36615,P08253,,MJDJFIONJBJENE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,400,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1577253,DTCC00180255,1913767,4273
CHEMBL366956,P08253,,DKXJVAHFRHPDKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,>,50000,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,958519,DTCC00372967,206471,4784
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,11.8,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650749,DTCC01703274,839513,64498
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,46,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650854,DTCC01703274,839513,64498
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,90,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247362,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,168289,DTCC01703274,839513,64498
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,90,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641793,DTCC01703274,839513,64498
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,118,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646216,DTCC01703274,839513,64498
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,119,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646320,DTCC01703274,839513,64498
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,120,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646424,DTCC01703274,839513,64498
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,122,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650645,DTCC01703274,839513,64498
CHEMBL3670691,P08253,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655434,DTCC01703274,839513,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,8.9,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650750,DTCC01703275,127019,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,44,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650646,DTCC01703275,127019,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,53,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650855,DTCC01703275,127019,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,112,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247363,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,161703,DTCC01703275,127019,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,112,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641794,DTCC01703275,127019,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,240,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646217,DTCC01703275,127019,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,552,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646321,DTCC01703275,127019,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646425,DTCC01703275,127019,64498
CHEMBL3670692,P08253,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655435,DTCC01703275,127019,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,235,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650856,DTCC01703276,1098405,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,401,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650751,DTCC01703276,1098405,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,403,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247364,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,175024,DTCC01703276,1098405,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,403,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641795,DTCC01703276,1098405,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,489,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650647,DTCC01703276,1098405,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646218,DTCC01703276,1098405,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646322,DTCC01703276,1098405,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646426,DTCC01703276,1098405,64498
CHEMBL3670693,P08253,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655436,DTCC01703276,1098405,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,111,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650648,DTCC01703277,289306,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,114,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650857,DTCC01703277,289306,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,268,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650752,DTCC01703277,289306,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,538,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247365,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,158791,DTCC01703277,289306,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,538,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641796,DTCC01703277,289306,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,897,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646219,DTCC01703277,289306,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646323,DTCC01703277,289306,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646427,DTCC01703277,289306,64498
CHEMBL3670694,P08253,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655437,DTCC01703277,289306,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,11,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650753,DTCC01703278,2031908,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,30,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650858,DTCC01703278,2031908,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,35,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650649,DTCC01703278,2031908,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,112,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247366,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,156820,DTCC01703278,2031908,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,112,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641797,DTCC01703278,2031908,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,243,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646220,DTCC01703278,2031908,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,556,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646324,DTCC01703278,2031908,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646428,DTCC01703278,2031908,64498
CHEMBL3670695,P08253,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655438,DTCC01703278,2031908,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,35,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650859,DTCC01703279,1518861,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,64,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650754,DTCC01703279,1518861,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,91,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247367,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,173526,DTCC01703279,1518861,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,91,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641798,DTCC01703279,1518861,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,381,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646221,DTCC01703279,1518861,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,520,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650650,DTCC01703279,1518861,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,899,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646325,DTCC01703279,1518861,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646429,DTCC01703279,1518861,64498
CHEMBL3670696,P08253,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655439,DTCC01703279,1518861,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,191,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650861,DTCC01703281,1357220,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,254,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650756,DTCC01703281,1357220,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,302,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646223,DTCC01703281,1357220,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,556,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650652,DTCC01703281,1357220,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247369,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,181984,DTCC01703281,1357220,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641800,DTCC01703281,1357220,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646327,DTCC01703281,1357220,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646431,DTCC01703281,1357220,64498
CHEMBL3670697,P08253,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655441,DTCC01703281,1357220,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,8.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650757,DTCC01703282,1711859,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,51,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650653,DTCC01703282,1711859,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,52,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650862,DTCC01703282,1711859,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,129,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646224,DTCC01703282,1711859,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,150,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247370,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,163338,DTCC01703282,1711859,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,150,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641801,DTCC01703282,1711859,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,452,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646328,DTCC01703282,1711859,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646432,DTCC01703282,1711859,64498
CHEMBL3670698,P08253,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655442,DTCC01703282,1711859,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,91,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650863,DTCC01703283,774361,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,348,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650758,DTCC01703283,774361,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,553,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655443,DTCC01703283,774361,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,575,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646225,DTCC01703283,774361,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,605,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646433,DTCC01703283,774361,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,638,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646329,DTCC01703283,774361,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247371,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,174997,DTCC01703283,774361,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641802,DTCC01703283,774361,64498
CHEMBL3670699,P08253,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650654,DTCC01703283,774361,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,114,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646331,DTCC01703284,1583049,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,398,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650760,DTCC01703284,1583049,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,762,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247373,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,177098,DTCC01703284,1583049,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,762,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641804,DTCC01703284,1583049,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646435,DTCC01703284,1583049,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650865,DTCC01703284,1583049,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655445,DTCC01703284,1583049,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650656,DTCC01703284,1583049,64498
CHEMBL3670700,P08253,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646227,DTCC01703284,1583049,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.4,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650761,DTCC01703285,904397,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,60,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650866,DTCC01703285,904397,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,78,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646228,DTCC01703285,904397,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,83,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247374,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,177290,DTCC01703285,904397,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,83,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641805,DTCC01703285,904397,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,114,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650657,DTCC01703285,904397,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,383,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646332,DTCC01703285,904397,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646436,DTCC01703285,904397,64498
CHEMBL3670701,P08253,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655446,DTCC01703285,904397,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,36,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650867,DTCC01703286,1357221,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,53,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650762,DTCC01703286,1357221,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,65,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247375,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,181646,DTCC01703286,1357221,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,65,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641806,DTCC01703286,1357221,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,699,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646229,DTCC01703286,1357221,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646333,DTCC01703286,1357221,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646437,DTCC01703286,1357221,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650658,DTCC01703286,1357221,64498
CHEMBL3670702,P08253,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655447,DTCC01703286,1357221,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,8,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650763,DTCC01703287,580739,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,30,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650868,DTCC01703287,580739,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,93,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247376,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,184579,DTCC01703287,580739,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,93,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641807,DTCC01703287,580739,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,196,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650659,DTCC01703287,580739,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,440,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646230,DTCC01703287,580739,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,832,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646334,DTCC01703287,580739,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646438,DTCC01703287,580739,64498
CHEMBL3670703,P08253,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655448,DTCC01703287,580739,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,24,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650869,DTCC01703288,1680152,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,52,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247377,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,157052,DTCC01703288,1680152,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,52,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641808,DTCC01703288,1680152,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,54,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650764,DTCC01703288,1680152,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,527,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650660,DTCC01703288,1680152,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,750,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646231,DTCC01703288,1680152,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646335,DTCC01703288,1680152,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646439,DTCC01703288,1680152,64498
CHEMBL3670704,P08253,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655449,DTCC01703288,1680152,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,234,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650870,DTCC01703289,1389860,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,412,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650765,DTCC01703289,1389860,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,834,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247378,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,158573,DTCC01703289,1389860,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,834,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641809,DTCC01703289,1389860,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646232,DTCC01703289,1389860,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646336,DTCC01703289,1389860,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646440,DTCC01703289,1389860,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650661,DTCC01703289,1389860,64498
CHEMBL3670705,P08253,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655450,DTCC01703289,1389860,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,5.4,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650766,DTCC01703290,1836770,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,39.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247379,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,168219,DTCC01703290,1836770,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,39.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641810,DTCC01703290,1836770,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,49,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650871,DTCC01703290,1836770,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,105,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646233,DTCC01703290,1836770,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,256,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650662,DTCC01703290,1836770,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,261,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646337,DTCC01703290,1836770,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646441,DTCC01703290,1836770,64498
CHEMBL3670706,P08253,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655451,DTCC01703290,1836770,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,436,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650872,DTCC01703291,1259462,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,830,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650767,DTCC01703291,1259462,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247380,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,159258,DTCC01703291,1259462,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641811,DTCC01703291,1259462,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646338,DTCC01703291,1259462,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646442,DTCC01703291,1259462,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646234,DTCC01703291,1259462,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650663,DTCC01703291,1259462,64498
CHEMBL3670707,P08253,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655452,DTCC01703291,1259462,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,11.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650768,DTCC01703292,1291821,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,78,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247381,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,163660,DTCC01703292,1291821,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,78,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641812,DTCC01703292,1291821,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,80,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650873,DTCC01703292,1291821,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,276,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650664,DTCC01703292,1291821,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,351,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646339,DTCC01703292,1291821,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,460,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646235,DTCC01703292,1291821,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646443,DTCC01703292,1291821,64498
CHEMBL3670708,P08253,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655453,DTCC01703292,1291821,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646236,DTCC01703293,1647965,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646340,DTCC01703293,1647965,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646444,DTCC01703293,1647965,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650665,DTCC01703293,1647965,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650769,DTCC01703293,1647965,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247382,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,164507,DTCC01703293,1647965,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641813,DTCC01703293,1647965,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650874,DTCC01703293,1647965,64498
CHEMBL3670709,P08253,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655454,DTCC01703293,1647965,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,160,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650770,DTCC01703294,1065482,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,332,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646341,DTCC01703294,1065482,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,550,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650875,DTCC01703294,1065482,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247383,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,177593,DTCC01703294,1065482,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641814,DTCC01703294,1065482,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650666,DTCC01703294,1065482,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655455,DTCC01703294,1065482,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646237,DTCC01703294,1065482,64498
CHEMBL3670710,P08253,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646445,DTCC01703294,1065482,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646446,DTCC01703295,1771871,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650771,DTCC01703295,1771871,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650876,DTCC01703295,1771871,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247384,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,172787,DTCC01703295,1771871,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641815,DTCC01703295,1771871,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646238,DTCC01703295,1771871,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646342,DTCC01703295,1771871,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650667,DTCC01703295,1771871,64498
CHEMBL3670711,P08253,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655456,DTCC01703295,1771871,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,900,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655353,DTCC01703296,420053,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247385,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,178107,DTCC01703296,420053,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641816,DTCC01703296,420053,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646239,DTCC01703296,420053,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646343,DTCC01703296,420053,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646447,DTCC01703296,420053,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650668,DTCC01703296,420053,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650772,DTCC01703296,420053,64498
CHEMBL3670712,P08253,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655457,DTCC01703296,420053,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,309,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655354,DTCC01703297,839514,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,856,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650773,DTCC01703297,839514,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247386,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,174280,DTCC01703297,839514,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641817,DTCC01703297,839514,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646344,DTCC01703297,839514,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650669,DTCC01703297,839514,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655458,DTCC01703297,839514,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646240,DTCC01703297,839514,64498
CHEMBL3670713,P08253,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646448,DTCC01703297,839514,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,117,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655355,DTCC01703298,548550,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,469,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650774,DTCC01703298,548550,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247387,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,171969,DTCC01703298,548550,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641818,DTCC01703298,548550,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646345,DTCC01703298,548550,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646449,DTCC01703298,548550,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650670,DTCC01703298,548550,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655459,DTCC01703298,548550,64498
CHEMBL3670714,P08253,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646241,DTCC01703298,548550,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,154,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650775,DTCC01703299,1998926,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,235,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646450,DTCC01703299,1998926,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,598,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655356,DTCC01703299,1998926,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,818,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646346,DTCC01703299,1998926,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247388,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,163740,DTCC01703299,1998926,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641819,DTCC01703299,1998926,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646242,DTCC01703299,1998926,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650671,DTCC01703299,1998926,64498
CHEMBL3670715,P08253,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655460,DTCC01703299,1998926,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,155,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650776,DTCC01703300,1550906,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,839,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646347,DTCC01703300,1550906,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247389,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,158345,DTCC01703300,1550906,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641820,DTCC01703300,1550906,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646451,DTCC01703300,1550906,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650672,DTCC01703300,1550906,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655357,DTCC01703300,1550906,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655461,DTCC01703300,1550906,64498
CHEMBL3670716,P08253,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646243,DTCC01703300,1550906,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,641,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655358,DTCC01703301,1771872,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,969,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650777,DTCC01703301,1771872,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646244,DTCC01703301,1771872,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646348,DTCC01703301,1771872,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646452,DTCC01703301,1771872,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655462,DTCC01703301,1771872,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247390,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,168405,DTCC01703301,1771872,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641821,DTCC01703301,1771872,64498
CHEMBL3670717,P08253,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650673,DTCC01703301,1771872,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,518,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655359,DTCC01703302,710012,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,797,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650778,DTCC01703302,710012,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247391,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,172801,DTCC01703302,710012,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641822,DTCC01703302,710012,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646349,DTCC01703302,710012,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646453,DTCC01703302,710012,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655463,DTCC01703302,710012,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646245,DTCC01703302,710012,64498
CHEMBL3670718,P08253,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650674,DTCC01703302,710012,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,887,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650779,DTCC01703303,968343,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646246,DTCC01703303,968343,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646350,DTCC01703303,968343,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650675,DTCC01703303,968343,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655360,DTCC01703303,968343,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655464,DTCC01703303,968343,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247392,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,164312,DTCC01703303,968343,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641823,DTCC01703303,968343,64498
CHEMBL3670719,P08253,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646454,DTCC01703303,968343,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,158,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650780,DTCC01703304,1226403,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,199,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650573,DTCC01703304,1226403,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,212,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655361,DTCC01703304,1226403,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,231,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646351,DTCC01703304,1226403,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,281,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646247,DTCC01703304,1226403,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,438,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655465,DTCC01703304,1226403,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,442,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247393,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,159417,DTCC01703304,1226403,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,442,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641824,DTCC01703304,1226403,64498
CHEMBL3670720,P08253,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,679,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650676,DTCC01703304,1226403,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,59,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650781,DTCC01703305,1291822,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,373,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646352,DTCC01703305,1291822,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247394,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,160644,DTCC01703305,1291822,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641825,DTCC01703305,1291822,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646248,DTCC01703305,1291822,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650574,DTCC01703305,1291822,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650677,DTCC01703305,1291822,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655362,DTCC01703305,1291822,64498
CHEMBL3670721,P08253,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655466,DTCC01703305,1291822,64498
CHEMBL367524,P08253,,XWZIZWWEAJZAMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327602,IC50,=,898,NM,,,,,,,,,,,,,,"Inhibition of Gelatinase A, matrix metalloprotease-2",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,71650,DTCT0025094,971604,DTCC00374233,174399,4784
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,240,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655363,DTCC01708173,1615861,64498
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,369,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650782,DTCC01708173,1615861,64498
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,657,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247395,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,166953,DTCC01708173,1615861,64498
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,657,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641826,DTCC01708173,1615861,64498
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646353,DTCC01708173,1615861,64498
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650575,DTCC01708173,1615861,64498
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650678,DTCC01708173,1615861,64498
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655467,DTCC01708173,1615861,64498
CHEMBL3675541,P08253,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646249,DTCC01708173,1615861,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,12,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650783,DTCC01708174,613076,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,52,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646354,DTCC01708174,613076,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,141,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650576,DTCC01708174,613076,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,225,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247396,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,176918,DTCC01708174,613076,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,225,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641827,DTCC01708174,613076,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,337,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646250,DTCC01708174,613076,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,410,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655468,DTCC01708174,613076,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,446,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650679,DTCC01708174,613076,64498
CHEMBL3675542,P08253,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,532,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655364,DTCC01708174,613076,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650784,DTCC01708175,742365,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,88,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646251,DTCC01708175,742365,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,99,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650680,DTCC01708175,742365,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,134,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655365,DTCC01708175,742365,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,146,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646355,DTCC01708175,742365,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,151,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247397,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,169076,DTCC01708175,742365,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,151,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641828,DTCC01708175,742365,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,547,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655469,DTCC01708175,742365,64498
CHEMBL3675543,P08253,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,618,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650577,DTCC01708175,742365,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,18.6,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650785,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,226,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646356,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,445,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247398,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,180433,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,445,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641829,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,689,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655366,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650578,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650681,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646252,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655470,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655551,DTCC01708176,1324414,64498
CHEMBL3675544,P08253,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,100000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655539,DTCC01708176,1324414,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,48,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650786,DTCC01708177,645830,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,285,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646357,DTCC01708177,645830,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,448,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247399,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,183622,DTCC01708177,645830,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,448,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641830,DTCC01708177,645830,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,884,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655367,DTCC01708177,645830,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650579,DTCC01708177,645830,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650682,DTCC01708177,645830,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655471,DTCC01708177,645830,64498
CHEMBL3675545,P08253,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646253,DTCC01708177,645830,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,259,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655368,DTCC01708178,2031940,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,306,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650787,DTCC01708178,2031940,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,319,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247400,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,175982,DTCC01708178,2031940,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,319,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641831,DTCC01708178,2031940,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,657,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646358,DTCC01708178,2031940,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646254,DTCC01708178,2031940,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650580,DTCC01708178,2031940,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650683,DTCC01708178,2031940,64498
CHEMBL3675546,P08253,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655472,DTCC01708178,2031940,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,119,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650788,DTCC01708179,1194373,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,414,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646359,DTCC01708179,1194373,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247401,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,164870,DTCC01708179,1194373,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641832,DTCC01708179,1194373,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655369,DTCC01708179,1194373,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650581,DTCC01708179,1194373,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650684,DTCC01708179,1194373,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655473,DTCC01708179,1194373,64498
CHEMBL3675547,P08253,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646255,DTCC01708179,1194373,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,52,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650790,DTCC01708181,548584,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,270,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646361,DTCC01708181,548584,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,632,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247403,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,181314,DTCC01708181,548584,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,632,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14641834,DTCC01708181,548584,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650583,DTCC01708181,548584,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650686,DTCC01708181,548584,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655371,DTCC01708181,548584,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655475,DTCC01708181,548584,64498
CHEMBL3675548,P08253,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646257,DTCC01708181,548584,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,58,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650791,DTCC01708182,968371,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,311,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646362,DTCC01708182,968371,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247404,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,185224,DTCC01708182,968371,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646155,DTCC01708182,968371,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650584,DTCC01708182,968371,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650687,DTCC01708182,968371,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655372,DTCC01708182,968371,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655476,DTCC01708182,968371,64498
CHEMBL3675549,P08253,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646258,DTCC01708182,968371,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,75,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650792,DTCC01708183,450759,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,339,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646363,DTCC01708183,450759,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,847,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247405,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,180793,DTCC01708183,450759,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,847,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646156,DTCC01708183,450759,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650688,DTCC01708183,450759,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655373,DTCC01708183,450759,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650585,DTCC01708183,450759,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646259,DTCC01708183,450759,64498
CHEMBL3675550,P08253,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655477,DTCC01708183,450759,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,41,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650793,DTCC01708184,2031941,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,204,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646364,DTCC01708184,2031941,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,790,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247406,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,180630,DTCC01708184,2031941,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,790,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646157,DTCC01708184,2031941,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650586,DTCC01708184,2031941,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650689,DTCC01708184,2031941,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655374,DTCC01708184,2031941,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655478,DTCC01708184,2031941,64498
CHEMBL3675551,P08253,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646260,DTCC01708184,2031941,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,76,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650794,DTCC01708185,321876,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,364,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646365,DTCC01708185,321876,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247407,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,160691,DTCC01708185,321876,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646158,DTCC01708185,321876,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655375,DTCC01708185,321876,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650587,DTCC01708185,321876,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650690,DTCC01708185,321876,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655479,DTCC01708185,321876,64498
CHEMBL3675552,P08253,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,50000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646261,DTCC01708185,321876,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,259,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650795,DTCC01708186,904423,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,929,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646366,DTCC01708186,904423,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247408,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,160111,DTCC01708186,904423,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646159,DTCC01708186,904423,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650588,DTCC01708186,904423,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655376,DTCC01708186,904423,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655480,DTCC01708186,904423,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646262,DTCC01708186,904423,64498
CHEMBL3675553,P08253,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650691,DTCC01708186,904423,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,12.7,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650796,DTCC01708187,1259488,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,63,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646367,DTCC01708187,1259488,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,433,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650692,DTCC01708187,1259488,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,546,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247409,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,177994,DTCC01708187,1259488,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,546,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646160,DTCC01708187,1259488,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650589,DTCC01708187,1259488,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655377,DTCC01708187,1259488,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655481,DTCC01708187,1259488,64498
CHEMBL3675554,P08253,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646263,DTCC01708187,1259488,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,190,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650797,DTCC01708188,127053,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247410,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,177172,DTCC01708188,127053,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646161,DTCC01708188,127053,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646264,DTCC01708188,127053,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646368,DTCC01708188,127053,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650590,DTCC01708188,127053,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650693,DTCC01708188,127053,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655378,DTCC01708188,127053,64498
CHEMBL3675555,P08253,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655482,DTCC01708188,127053,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,176,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650798,DTCC01708189,1966318,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646369,DTCC01708189,1966318,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650591,DTCC01708189,1966318,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650694,DTCC01708189,1966318,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247411,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,180435,DTCC01708189,1966318,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646162,DTCC01708189,1966318,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646265,DTCC01708189,1966318,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655379,DTCC01708189,1966318,64498
CHEMBL3675556,P08253,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655483,DTCC01708189,1966318,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,73,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650799,DTCC01708190,127054,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,436,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655380,DTCC01708190,127054,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,685,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650592,DTCC01708190,127054,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,878,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646266,DTCC01708190,127054,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247412,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,169887,DTCC01708190,127054,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646163,DTCC01708190,127054,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646370,DTCC01708190,127054,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650695,DTCC01708190,127054,64498
CHEMBL3675557,P08253,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655484,DTCC01708190,127054,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,91,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650800,DTCC01708191,872152,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646371,DTCC01708191,872152,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650593,DTCC01708191,872152,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247413,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,166235,DTCC01708191,872152,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646164,DTCC01708191,872152,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655381,DTCC01708191,872152,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646267,DTCC01708191,872152,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650696,DTCC01708191,872152,64498
CHEMBL3675558,P08253,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655485,DTCC01708191,872152,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,57,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650801,DTCC01708192,1098436,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247414,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,163115,DTCC01708192,1098436,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646165,DTCC01708192,1098436,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646372,DTCC01708192,1098436,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650594,DTCC01708192,1098436,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650697,DTCC01708192,1098436,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655382,DTCC01708192,1098436,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646268,DTCC01708192,1098436,64498
CHEMBL3675559,P08253,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655486,DTCC01708192,1098436,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,56,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650802,DTCC01708193,1194374,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,391,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650217,DTCC01708193,1194374,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247415,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,159750,DTCC01708193,1194374,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646166,DTCC01708193,1194374,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646269,DTCC01708193,1194374,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650698,DTCC01708193,1194374,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655383,DTCC01708193,1194374,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655487,DTCC01708193,1194374,64498
CHEMBL3675560,P08253,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646373,DTCC01708193,1194374,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,35,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650803,DTCC01708194,1804477,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646374,DTCC01708194,1804477,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650699,DTCC01708194,1804477,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247416,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,176817,DTCC01708194,1804477,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646167,DTCC01708194,1804477,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650595,DTCC01708194,1804477,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655384,DTCC01708194,1804477,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646270,DTCC01708194,1804477,64498
CHEMBL3675561,P08253,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655488,DTCC01708194,1804477,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,52,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650804,DTCC01708195,1550939,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,809,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646375,DTCC01708195,1550939,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247417,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,170778,DTCC01708195,1550939,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646168,DTCC01708195,1550939,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650596,DTCC01708195,1550939,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650700,DTCC01708195,1550939,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655385,DTCC01708195,1550939,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646271,DTCC01708195,1550939,64498
CHEMBL3675562,P08253,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655489,DTCC01708195,1550939,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1.63,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650805,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655386,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,53,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247418,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,172537,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,53,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646169,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,64,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646283,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,74,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646272,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,76,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650701,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,132,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646376,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,134,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650816,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,180,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655397,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,386,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247429,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,184853,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,386,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646180,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,502,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655552,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646387,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650597,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650712,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655490,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650608,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655501,DTCC01708196,645831,64498
CHEMBL3675563,P08253,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655540,DTCC01708196,645831,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,5.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650806,DTCC01708197,806748,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655387,DTCC01708197,806748,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,45,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247419,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,175234,DTCC01708197,806748,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,45,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646170,DTCC01708197,806748,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,102,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650702,DTCC01708197,806748,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,244,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646273,DTCC01708197,806748,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,452,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646377,DTCC01708197,806748,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650598,DTCC01708197,806748,64498
CHEMBL3675564,P08253,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655491,DTCC01708197,806748,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,14.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650807,DTCC01708198,1389896,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,55,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655388,DTCC01708198,1389896,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247420,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,180624,DTCC01708198,1389896,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646171,DTCC01708198,1389896,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,447,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650703,DTCC01708198,1389896,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,621,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646378,DTCC01708198,1389896,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646274,DTCC01708198,1389896,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650599,DTCC01708198,1389896,64498
CHEMBL3675565,P08253,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655492,DTCC01708198,1389896,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650808,DTCC01708199,1130545,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,23,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655389,DTCC01708199,1130545,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,35,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650704,DTCC01708199,1130545,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,55,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247421,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,172751,DTCC01708199,1130545,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,55,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646172,DTCC01708199,1130545,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,168,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646275,DTCC01708199,1130545,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,287,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646379,DTCC01708199,1130545,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650600,DTCC01708199,1130545,64498
CHEMBL3675566,P08253,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655493,DTCC01708199,1130545,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,6.6,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650809,DTCC01708200,1065520,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,33,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655390,DTCC01708200,1065520,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,73,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247422,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,160071,DTCC01708200,1065520,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,73,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646173,DTCC01708200,1065520,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,119,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650705,DTCC01708200,1065520,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,620,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646276,DTCC01708200,1065520,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,793,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646380,DTCC01708200,1065520,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650601,DTCC01708200,1065520,64498
CHEMBL3675567,P08253,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655494,DTCC01708200,1065520,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650810,DTCC01708201,321877,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,16.4,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655391,DTCC01708201,321877,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,49,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247423,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,162551,DTCC01708201,321877,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,49,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646174,DTCC01708201,321877,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,130,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650706,DTCC01708201,321877,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,238,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646277,DTCC01708201,321877,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,532,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646381,DTCC01708201,321877,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650602,DTCC01708201,321877,64498
CHEMBL3675568,P08253,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655495,DTCC01708201,321877,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,10.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650811,DTCC01708202,1550940,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,36,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655392,DTCC01708202,1550940,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,68,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247424,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,164635,DTCC01708202,1550940,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,68,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646175,DTCC01708202,1550940,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,168,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650707,DTCC01708202,1550940,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,337,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646278,DTCC01708202,1550940,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,526,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646382,DTCC01708202,1550940,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650603,DTCC01708202,1550940,64498
CHEMBL3675569,P08253,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655496,DTCC01708202,1550940,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.5,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650812,DTCC01708203,211,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,16.6,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655393,DTCC01708203,211,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,31,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247425,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,172978,DTCC01708203,211,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,31,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646176,DTCC01708203,211,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,71,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650708,DTCC01708203,211,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,108,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646279,DTCC01708203,211,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,227,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646383,DTCC01708203,211,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650604,DTCC01708203,211,64498
CHEMBL3675570,P08253,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655497,DTCC01708203,211,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,7.8,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650813,DTCC01708204,839552,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,81,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655394,DTCC01708204,839552,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,258,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646280,DTCC01708204,839552,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,332,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247426,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,183405,DTCC01708204,839552,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,332,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646177,DTCC01708204,839552,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,382,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650709,DTCC01708204,839552,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,567,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646384,DTCC01708204,839552,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650605,DTCC01708204,839552,64498
CHEMBL3675571,P08253,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655498,DTCC01708204,839552,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,4.7,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650814,DTCC01708205,2063689,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,12,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247427,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,169008,DTCC01708205,2063689,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,12,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646178,DTCC01708205,2063689,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,17,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655395,DTCC01708205,2063689,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,105,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646385,DTCC01708205,2063689,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,231,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646281,DTCC01708205,2063689,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,421,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650710,DTCC01708205,2063689,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655499,DTCC01708205,2063689,64498
CHEMBL3675572,P08253,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650606,DTCC01708205,2063689,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1.05,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650815,DTCC01708206,1000927,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,7.7,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650711,DTCC01708206,1000927,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,10.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655396,DTCC01708206,1000927,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,18.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247428,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,173702,DTCC01708206,1000927,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,18.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646179,DTCC01708206,1000927,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,34,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646282,DTCC01708206,1000927,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,99,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646386,DTCC01708206,1000927,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,645,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650607,DTCC01708206,1000927,64498
CHEMBL3675573,P08253,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,696,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655500,DTCC01708206,1000927,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,97,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655398,DTCC01708207,1518882,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,254,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650817,DTCC01708207,1518882,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,300,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646284,DTCC01708207,1518882,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,541,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247430,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,159730,DTCC01708207,1518882,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,541,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646181,DTCC01708207,1518882,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646388,DTCC01708207,1518882,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650713,DTCC01708207,1518882,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650609,DTCC01708207,1518882,64498
CHEMBL3675574,P08253,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655502,DTCC01708207,1518882,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,10.5,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650818,DTCC01708208,1161801,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,13.5,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655399,DTCC01708208,1161801,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,16,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646285,DTCC01708208,1161801,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,39,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247431,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,164179,DTCC01708208,1161801,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,39,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646182,DTCC01708208,1161801,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,430,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650714,DTCC01708208,1161801,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,865,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646389,DTCC01708208,1161801,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650610,DTCC01708208,1161801,64498
CHEMBL3675575,P08253,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655503,DTCC01708208,1161801,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,122,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650819,DTCC01708209,516548,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,232,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655400,DTCC01708209,516548,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,252,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646286,DTCC01708209,516548,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247432,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,171529,DTCC01708209,516548,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646183,DTCC01708209,516548,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650715,DTCC01708209,516548,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646390,DTCC01708209,516548,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650611,DTCC01708209,516548,64498
CHEMBL3675576,P08253,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655504,DTCC01708209,516548,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,142,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646287,DTCC01708210,321878,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,251,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650820,DTCC01708210,321878,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,427,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655401,DTCC01708210,321878,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,854,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247433,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,178812,DTCC01708210,321878,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,854,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646184,DTCC01708210,321878,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646391,DTCC01708210,321878,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650612,DTCC01708210,321878,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655505,DTCC01708210,321878,64498
CHEMBL3675577,P08253,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650716,DTCC01708210,321878,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,234,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650821,DTCC01708211,2063690,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,377,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655402,DTCC01708211,2063690,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247434,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,182181,DTCC01708211,2063690,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646185,DTCC01708211,2063690,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646288,DTCC01708211,2063690,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646392,DTCC01708211,2063690,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650717,DTCC01708211,2063690,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655506,DTCC01708211,2063690,64498
CHEMBL3675578,P08253,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,50000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650613,DTCC01708211,2063690,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,116,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646289,DTCC01708212,1771918,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,206,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650822,DTCC01708212,1771918,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,367,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655403,DTCC01708212,1771918,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,729,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247435,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,180482,DTCC01708212,1771918,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,729,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14645854,DTCC01708212,1771918,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646393,DTCC01708212,1771918,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655507,DTCC01708212,1771918,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650614,DTCC01708212,1771918,64498
CHEMBL3675579,P08253,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650718,DTCC01708212,1771918,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,203,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646290,DTCC01708213,1194375,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,443,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655404,DTCC01708213,1194375,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247436,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,167455,DTCC01708213,1194375,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646186,DTCC01708213,1194375,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646394,DTCC01708213,1194375,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650719,DTCC01708213,1194375,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650823,DTCC01708213,1194375,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655508,DTCC01708213,1194375,64498
CHEMBL3675580,P08253,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,100000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650615,DTCC01708213,1194375,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,8.6,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650824,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,40,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646395,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,142,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247437,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,179044,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,142,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646187,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,321,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655405,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,373,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650720,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646291,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650616,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655509,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655553,DTCC01708214,212,64498
CHEMBL3675581,P08253,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,100000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655541,DTCC01708214,212,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,18.6,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650825,DTCC01708215,1033284,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,48,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646396,DTCC01708215,1033284,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,204,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247438,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,160494,DTCC01708215,1033284,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,204,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646188,DTCC01708215,1033284,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,651,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650721,DTCC01708215,1033284,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,801,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655406,DTCC01708215,1033284,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650617,DTCC01708215,1033284,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655510,DTCC01708215,1033284,64498
CHEMBL3675582,P08253,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646292,DTCC01708215,1033284,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,44,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650826,DTCC01708216,1486575,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,73,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646397,DTCC01708216,1486575,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,234,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247439,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,163071,DTCC01708216,1486575,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,234,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646189,DTCC01708216,1486575,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650618,DTCC01708216,1486575,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650722,DTCC01708216,1486575,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655407,DTCC01708216,1486575,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655511,DTCC01708216,1486575,64498
CHEMBL3675583,P08253,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646293,DTCC01708216,1486575,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,14.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650828,DTCC01708217,1901139,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,49,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646398,DTCC01708217,1901139,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,334,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247440,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,165468,DTCC01708217,1901139,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,334,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646190,DTCC01708217,1901139,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,435,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650723,DTCC01708217,1901139,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650619,DTCC01708217,1901139,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655408,DTCC01708217,1901139,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655512,DTCC01708217,1901139,64498
CHEMBL3675584,P08253,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646294,DTCC01708217,1901139,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,20.9,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650829,DTCC01708218,1804478,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,41,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646399,DTCC01708218,1804478,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,140,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247441,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,181611,DTCC01708218,1804478,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,140,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646191,DTCC01708218,1804478,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,514,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650724,DTCC01708218,1804478,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,584,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655409,DTCC01708218,1804478,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,859,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650620,DTCC01708218,1804478,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655513,DTCC01708218,1804478,64498
CHEMBL3675585,P08253,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646295,DTCC01708218,1804478,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,25.6,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650830,DTCC01708219,62372,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,62,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646400,DTCC01708219,62372,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,348,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247442,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,180374,DTCC01708219,62372,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,348,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646192,DTCC01708219,62372,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,835,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650725,DTCC01708219,62372,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655410,DTCC01708219,62372,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655514,DTCC01708219,62372,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650621,DTCC01708219,62372,64498
CHEMBL3675586,P08253,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646296,DTCC01708219,62372,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,34,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650831,DTCC01708220,1486576,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,63,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646401,DTCC01708220,1486576,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,371,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247443,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,177102,DTCC01708220,1486576,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,371,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646193,DTCC01708220,1486576,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650622,DTCC01708220,1486576,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650726,DTCC01708220,1486576,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655411,DTCC01708220,1486576,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655515,DTCC01708220,1486576,64498
CHEMBL3675587,P08253,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646297,DTCC01708220,1486576,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,16.4,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650832,DTCC01708221,677985,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,47,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646402,DTCC01708221,677985,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,147,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247444,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,183864,DTCC01708221,677985,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,147,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646194,DTCC01708221,677985,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,742,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650727,DTCC01708221,677985,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650623,DTCC01708221,677985,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655412,DTCC01708221,677985,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655516,DTCC01708221,677985,64498
CHEMBL3675588,P08253,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646298,DTCC01708221,677985,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,32,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650833,DTCC01708222,904424,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,73,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646403,DTCC01708222,904424,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,298,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247445,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,173532,DTCC01708222,904424,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,298,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646195,DTCC01708222,904424,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650624,DTCC01708222,904424,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650728,DTCC01708222,904424,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655413,DTCC01708222,904424,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655517,DTCC01708222,904424,64498
CHEMBL3675589,P08253,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646299,DTCC01708222,904424,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,94,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646404,DTCC01708223,1000928,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,124,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650834,DTCC01708223,1000928,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,484,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247446,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,158471,DTCC01708223,1000928,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,484,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646196,DTCC01708223,1000928,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650625,DTCC01708223,1000928,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655414,DTCC01708223,1000928,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655518,DTCC01708223,1000928,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650729,DTCC01708223,1000928,64498
CHEMBL3675590,P08253,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,100000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646300,DTCC01708223,1000928,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,8,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650835,DTCC01708224,839553,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,18,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646405,DTCC01708224,839553,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,116,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247447,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,164288,DTCC01708224,839553,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,116,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646197,DTCC01708224,839553,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,143,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650730,DTCC01708224,839553,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,284,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650626,DTCC01708224,839553,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,366,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655415,DTCC01708224,839553,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,430,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655519,DTCC01708224,839553,64498
CHEMBL3675591,P08253,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646301,DTCC01708224,839553,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1.84,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650836,DTCC01708225,968372,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,10.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646406,DTCC01708225,968372,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,97,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247448,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,176913,DTCC01708225,968372,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,97,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646198,DTCC01708225,968372,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,242,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650627,DTCC01708225,968372,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,353,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650731,DTCC01708225,968372,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,564,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655416,DTCC01708225,968372,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646302,DTCC01708225,968372,64498
CHEMBL3675592,P08253,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655520,DTCC01708225,968372,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.58,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650837,DTCC01708226,936273,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,108,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646303,DTCC01708226,936273,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,156,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650732,DTCC01708226,936273,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,200,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655417,DTCC01708226,936273,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,279,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247449,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,166954,DTCC01708226,936273,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,279,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646199,DTCC01708226,936273,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,381,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646407,DTCC01708226,936273,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,874,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650628,DTCC01708226,936273,64498
CHEMBL3675593,P08253,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655521,DTCC01708226,936273,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,17,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650838,DTCC01708227,1740101,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,33,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655418,DTCC01708227,1740101,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,38.8,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650733,DTCC01708227,1740101,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,307,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646408,DTCC01708227,1740101,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247450,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,171730,DTCC01708227,1740101,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646200,DTCC01708227,1740101,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646304,DTCC01708227,1740101,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650629,DTCC01708227,1740101,64498
CHEMBL3675594,P08253,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655522,DTCC01708227,1740101,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,22,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650839,DTCC01708228,645832,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,233,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646409,DTCC01708228,645832,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,868,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247451,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,184027,DTCC01708228,645832,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,868,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646201,DTCC01708228,645832,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646305,DTCC01708228,645832,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650630,DTCC01708228,645832,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650734,DTCC01708228,645832,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655419,DTCC01708228,645832,64498
CHEMBL3675595,P08253,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655523,DTCC01708228,645832,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,317,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650843,DTCC01708229,904425,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655423,DTCC01708229,904425,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247455,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,160414,DTCC01708229,904425,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646205,DTCC01708229,904425,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650634,DTCC01708229,904425,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646309,DTCC01708229,904425,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646413,DTCC01708229,904425,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650738,DTCC01708229,904425,64498
CHEMBL3675596,P08253,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655527,DTCC01708229,904425,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,5.4,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650844,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,522,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655424,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247456,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,179775,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646206,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646414,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650739,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655528,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650635,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646310,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655544,DTCC01708230,420085,64498
CHEMBL3675597,P08253,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655556,DTCC01708230,420085,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,15.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650845,DTCC01708231,1740102,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,559,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646415,DTCC01708231,1740102,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,559,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655425,DTCC01708231,1740102,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,862,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247457,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,168399,DTCC01708231,1740102,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,862,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646207,DTCC01708231,1740102,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646311,DTCC01708231,1740102,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650636,DTCC01708231,1740102,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650740,DTCC01708231,1740102,64498
CHEMBL3675598,P08253,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655529,DTCC01708231,1740102,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.56,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650846,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,379,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646416,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,571,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650741,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,933,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655426,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247458,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,180326,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646208,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655530,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646312,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650637,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,100000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655545,DTCC01708232,904426,64498
CHEMBL3675599,P08253,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,100000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655557,DTCC01708232,904426,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,56,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650847,DTCC01708233,1259489,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,635,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655427,DTCC01708233,1259489,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247459,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,173284,DTCC01708233,1259489,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646209,DTCC01708233,1259489,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646417,DTCC01708233,1259489,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650638,DTCC01708233,1259489,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650742,DTCC01708233,1259489,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646313,DTCC01708233,1259489,64498
CHEMBL3675600,P08253,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655531,DTCC01708233,1259489,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.9,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650848,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,563,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655428,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,656,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646418,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,845,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650743,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247460,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,161491,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646210,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655532,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646314,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650639,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655558,DTCC01708234,645833,64498
CHEMBL3675601,P08253,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655546,DTCC01708234,645833,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,40,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650849,DTCC01708235,580782,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646419,DTCC01708235,580782,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655429,DTCC01708235,580782,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247461,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,176549,DTCC01708235,580782,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646211,DTCC01708235,580782,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650640,DTCC01708235,580782,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650744,DTCC01708235,580782,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655533,DTCC01708235,580782,64498
CHEMBL3675602,P08253,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646315,DTCC01708235,580782,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,4.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650851,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,132,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655431,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,318,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650746,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,339,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247463,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,171031,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,339,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646213,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,396,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650642,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,675,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646421,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,791,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646317,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655535,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655548,DTCC01708236,159656,64498
CHEMBL3675603,P08253,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655560,DTCC01708236,159656,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,84,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650852,DTCC01708237,159657,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,766,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646422,DTCC01708237,159657,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247464,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,182370,DTCC01708237,159657,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646214,DTCC01708237,159657,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650747,DTCC01708237,159657,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655432,DTCC01708237,159657,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655536,DTCC01708237,159657,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646318,DTCC01708237,159657,64498
CHEMBL3675604,P08253,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650643,DTCC01708237,159657,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655568,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,80,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655567,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,118,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655570,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,198,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655569,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,401,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248218,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,173188,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,401,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655562,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,520,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655565,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,579,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655563,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655561,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655564,DTCC01708238,256074,64498
CHEMBL3675605,P08253,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655566,DTCC01708238,256074,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20817735,KI,=,1060,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14747519,DTCC01708239,2106911,69686
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14739086,DTCC01708239,2106910,68703
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.7,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650842,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,693,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650737,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,694,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646412,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,714,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655422,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247454,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,158379,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646204,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655526,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646308,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650633,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655555,DTCC01708239,1901140,64498
CHEMBL3675606,P08253,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,100000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655543,DTCC01708239,1901140,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,KI,=,377,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14759263,DTCC01708240,2111479,68703
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,KI,=,377,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14759912,DTCC01708240,2111479,68703
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.65,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650850,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,203,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646420,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,377,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247462,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,179822,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,377,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646212,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,603,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655430,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14646316,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650641,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14650745,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655534,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655547,DTCC01708240,289344,64498
CHEMBL3675607,P08253,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,,Pseudodipeptides as MMP inhibitors,,2014,,,,,1527654,DTCT0025094,14655559,DTCC01708240,289344,64498
CHEMBL368347,P08253,(+)-SECOISOLARICIRESINOL,PUETUDUXMCLALY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534777,DTCC00371311,1812173,48665
CHEMBL369317,P08253,,ODABXNMRQKCARG-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15713379,IC50,=,935,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305733,DTCT0025094,1745776,DTCC00381878,6892,18841
CHEMBL369536,P08253,,QQULKIIBIKMAGK-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15341955,KI,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2; NA denotes no activity upto solubility limit,No Activity,Synthesis and evaluation of novel oxazoline MMP inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,19,"Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S",,303049,DTCT0025094,1715736,DTCC00389511,1209229,17054
CHEMBL370333,P08253,,HOXYEQZQHOZJQN-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860429,DTCC00407680,370185,19837
CHEMBL370351,P08253,,GXOXVMQTJCQLGA-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1050,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860308,DTCC00407629,660937,19837
CHEMBL370351,P08253,,GXOXVMQTJCQLGA-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,1050,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904473,DTCC00407629,651474,35265
CHEMBL370631,P08253,,RPOIZUWTBLHTNU-YTTGMZPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,4340,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860426,DTCC00407679,1566231,19837
CHEMBL370662,P08253,(3-BROMOPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,SYHPXVAOJHTCRU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,37400,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629960,DTCC00001220,2060610,56259
CHEMBL370667,P08253,,LUACGTLZVKVKKY-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1770,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860318,DTCC00407650,1534242,19837
CHEMBL370685,P08253,,GIJHNOWTLZLFTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,26,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828773,DTCC00400047,271894,19718
CHEMBL371199,P08253,,CKPNTYRTTDOFLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800411,DTCC00398230,843308,16433
CHEMBL371600,P08253,,IUOUVCOHELGZDO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828777,DTCC00400451,531691,19718
CHEMBL371781,P08253,,WZUCVDGGDSHNQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800224,DTCC00398284,1361040,16433
CHEMBL372188,P08253,"5-[4-(4-BROMO-PHENOXY)-PHENYL]-5-[4-(3-TRIBUTYLSTANNANYL-BENZOYL)-PIPERAZIN-1-YL]-PYRIMIDINE-2,4,6-TRIONE",,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,,,,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2; n.d.=not determined,Not Determined,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305978,DTCT0025094,1828960,DTCC00399923,174648,19718
CHEMBL372263,P08253,,OCXZZMWHJAJWII-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,1500,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828945,DTCC00399894,77779,19718
CHEMBL372405,P08253,,CNVJYZPKUZXAML-MUUNZHRXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16275085,IC50,=,28,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,2,"Xiang JS, Hu Y, Rush TS, Thomason JR, Ipek M, Sum PE, Abrous L, Sabatini JJ, Georgiadis K, Reifenberg E, Majumdar M, Morris EA, Tam S",,327743,DTCT0025094,1878758,DTCC00411555,1490519,19995
CHEMBL372659,P08253,,CPNHPERKWKQFHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,>,3330,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800082,DTCC00398190,130821,16433
CHEMBL372705,P08253,,KTPFSPDDZUMWHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828953,DTCC00400020,596115,19718
CHEMBL372914,P08253,,IJXPNMMIIHZGBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,86,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828956,DTCC00399924,2014659,19718
CHEMBL373154,P08253,,WOGNSQDLIXXYFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,=,3100,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800236,DTCC00398286,1715489,16433
CHEMBL373217,P08253,,GXFNBOPPVZGKBI-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,81,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860311,DTCC00407636,1598757,19837
CHEMBL373275,P08253,,JJPRJMIBECZYNN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,3070,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1886065,DTCC00110065,66437,20234
CHEMBL373311,P08253,,LAHYEFDNWASMJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15908214,KI,=,600,NM,,,,,,,,,,,,,,In vitro binding affinity against matrix metalloprotease 2,,"Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.",Bioorg. Med. Chem. Lett.,2005,15,12,"Duan JJ, Lu Z, Wasserman ZR, Liu RQ, Covington MB, Decicco CP",,302346,DTCT0025094,1800070,DTCC00398032,2035576,16433
CHEMBL373532,P08253,,SCOVLRMEIYKGOU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019767,DTCC00438874,467214,21880
CHEMBL373532,P08253,,SCOVLRMEIYKGOU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,5,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276503,DTCC00438874,455616,25086
CHEMBL373532,P08253,,SCOVLRMEIYKGOU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,<,5,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101217,DTCC00438874,456978,36106
CHEMBL373721,P08253,,WZGKUAJQZGCNHS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,1500,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079342,DTCC00449740,358851,22603
CHEMBL373853,P08253,,CDQQKPZINNWUDS-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019762,DTCC00438907,790106,21880
CHEMBL374377,P08253,,VWKXFDZWHLCIIU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,20,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061757,DTCC00447804,1684492,22402
CHEMBL374840,P08253,,IRAYKKMZUQCZJL-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,=,80000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113935,DTCC00452791,358915,23023
CHEMBL374840,P08253,,IRAYKKMZUQCZJL-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,=,80000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710439,DTCC00452791,371428,32223
CHEMBL3751971,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59795,DTCC00071689,1162219,65811
CHEMBL3751997,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26810711,IC50,=,6.5,NM,,,,,,,,,,,,,,"Inhibition of human MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549575,DTCT0025094,50622,DTCC00072284,355028,65936
CHEMBL3752374,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,9000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59796,DTCC00071690,1259964,65811
CHEMBL3752419,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26810711,IC50,=,791,NM,,,,,,,,,,,,,,"Inhibition of human MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549575,DTCT0025094,50623,DTCC00072285,1804884,65936
CHEMBL3752513,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59799,DTCC00071692,1837252,65811
CHEMBL3752564,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26810711,IC50,=,9.25,NM,,,,,,,,,,,,,,"Inhibition of human MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549575,DTCT0025094,50616,DTCC00072278,95261,65936
CHEMBL3752747,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26810711,IC50,=,628,NM,,,,,,,,,,,,,,"Inhibition of human MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549575,DTCT0025094,50618,DTCC00072280,1324856,65936
CHEMBL3752826,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26810711,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of human MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549575,DTCT0025094,50619,DTCC00072281,1933521,65936
CHEMBL37537,P08253,PROTOCATECHUIC ACID,YQUVCSBJEUQKSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-8,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103102,DTCC00174549,313612,43205
CHEMBL3753984,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59810,DTCC00071688,1901590,65811
CHEMBL3754094,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59811,DTCC00071687,516993,65811
CHEMBL3754100,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59797,DTCC00071691,840004,65811
CHEMBL375418,P08253,,ZCDHAHOTIYZFKF-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019759,DTCC00438915,1566520,21880
CHEMBL375418,P08253,,ZCDHAHOTIYZFKF-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,13,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276475,DTCC00438915,1555575,25086
CHEMBL3754243,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26810711,IC50,=,11.66,NM,,,,,,,,,,,,,,"Inhibition of human MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549575,DTCT0025094,50617,DTCC00072279,1869235,65936
CHEMBL3754302,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26810711,IC50,=,56.3,NM,,,,,,,,,,,,,,"Inhibition of human MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549575,DTCT0025094,50620,DTCC00072282,840009,65936
CHEMBL3754314,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26810711,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of human MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549575,DTCT0025094,50621,DTCC00072283,62801,65936
CHEMBL376316,P08253,P-DODECYLAMINOPHENOL,UFCRKZJPBDDMSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23953690,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP2 activity in human HT1080 cells at 1 uM after 24 hrs,Not Active,Inhibitory effects of p-dodecylaminophenol on the invasiveness of human fibrosarcoma cell line HT1080.,Bioorg. Med. Chem.,2013,21,19,"Takahashi N, Takeda K, Imai M",,980576,DTCT0025094,12548205,DTCC00002586,783399,55644
CHEMBL376557,P08253,,BUKCBCDGRPOFJP-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,8.7,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061756,DTCC00447810,1005132,22402
CHEMBL376841,P08253,,NXFJEQASTSQSQQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,9600,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079344,DTCC00449738,778662,22603
CHEMBL3770688,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26871660,IC50,=,370,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 3 hrs by fluorometric assay,,Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.,Eur. J. Med. Chem.,2016,111,,"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.",,1559055,DTCT0025094,101496,DTCC00079604,62862,66304
CHEMBL3770935,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26871660,IC50,=,5400,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 3 hrs by fluorometric assay,,Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.,Eur. J. Med. Chem.,2016,111,,"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.",,1559055,DTCT0025094,101495,DTCC00079605,678496,66304
CHEMBL377112,P08253,,SKLSVPSTTVFNGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936990,DTCC00423371,1775948,20885
CHEMBL377272,P08253,,LIJQQAFTSYEDRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969700,DTCC00428526,1004972,21111
CHEMBL377317,P08253,,SFHMNFHDIRPFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969647,DTCC00428531,778474,21111
CHEMBL377317,P08253,,SFHMNFHDIRPFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2154022,DTCC00428531,778734,23077
CHEMBL3774477,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,13220,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121036,DTCC00081096,160180,66411
CHEMBL3774479,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,5520,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121054,DTCC00081113,355110,66411
CHEMBL3774559,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121029,DTCC00081090,1616390,66411
CHEMBL3774656,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,81010,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121045,DTCC00081105,1098976,66411
CHEMBL3774714,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,28520,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121053,DTCC00081112,1292368,66411
CHEMBL3774803,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,36790,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121052,DTCC00081111,1357775,66411
CHEMBL3774826,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,74910,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121048,DTCC00081108,1131056,66411
CHEMBL3774841,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,7170,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121047,DTCC00081107,1260047,66411
CHEMBL3774916,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,640,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121056,DTCC00081115,192017,66411
CHEMBL3775011,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,34790,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121032,DTCC00081093,1422708,66411
CHEMBL3775115,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,36040,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121042,DTCC00081102,1292366,66411
CHEMBL3775142,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,38650,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121043,DTCC00081103,387665,66411
CHEMBL3775206,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,1050,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121059,DTCC00081118,1390419,66411
CHEMBL3775221,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,28760,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121049,DTCC00081109,322371,66411
CHEMBL3775319,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,159390,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121031,DTCC00081092,1648537,66411
CHEMBL3775356,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,90810,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121037,DTCC00081097,160181,66411
CHEMBL3775412,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,112260,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121038,DTCC00081098,1357774,66411
CHEMBL3775422,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,240,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121058,DTCC00081117,1131057,66411
CHEMBL3775428,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,1890,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121055,DTCC00081114,1804962,66411
CHEMBL3775452,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,67010,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121041,DTCC00081101,840095,66411
CHEMBL3775460,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,17170,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121040,DTCC00081100,840094,66411
CHEMBL3775542,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,566890,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121039,DTCC00081099,710550,66411
CHEMBL3775574,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,58220,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121033,DTCC00081094,872681,66411
CHEMBL3775617,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,64300,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121044,DTCC00081104,1648538,66411
CHEMBL3775698,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,9390,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121035,DTCC00081095,1583642,66411
CHEMBL3775708,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,246260,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121046,DTCC00081106,742923,66411
CHEMBL3775713,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,187410,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121030,DTCC00081091,1390418,66411
CHEMBL3775720,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,210410,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121060,DTCC00081119,355111,66411
CHEMBL3775799,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,98020,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121028,DTCC00081089,894,66411
CHEMBL3775945,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,410,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121057,DTCC00081116,1551441,66411
CHEMBL3775970,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,223370,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121050,DTCC00081110,1292367,66411
CHEMBL377700,P08253,,QDDDNZKRPVNLGQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,3430,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1885372,DTCC00412723,1102373,20234
CHEMBL377862,P08253,,KRGBAILWDVNOCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,111,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969632,DTCC00428540,649907,21111
CHEMBL378740,P08253,,JGNJABZIGHTRNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,792,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936986,DTCC00423304,843579,20885
CHEMBL378878,P08253,,CQLFBASNQPHDMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937003,DTCC00423316,293432,20885
CHEMBL379220,P08253,,PFPAVZNBPUOGBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1936994,DTCC00423128,1263448,20885
CHEMBL379247,P08253,,VFGCXHQYVYXXSU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16420030,IC50,=,1120,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.,J. Med. Chem.,2006,49,2,"Ma D, Jiang Y, Chen F, Gong LK, Ding K, Xu Y, Wang R, Ge A, Ren J, Li J, Li J, Ye Q",,330167,DTCT0025094,1885350,DTCC00412626,584720,20234
CHEMBL379271,P08253,,FHIQJWGHFZCTKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,145,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937012,DTCC00423344,843580,20885
CHEMBL3792842,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220684,DTCC00088746,236375,66798
CHEMBL379287,P08253,,RBTIHKNARDNLNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,345,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969583,DTCC00428563,617188,21111
CHEMBL3792916,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,=,0.19,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220664,DTCC00088745,1402350,66798
CHEMBL3792940,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,=,2.05,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220702,DTCC00088752,1402351,66798
CHEMBL3793231,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220687,DTCC00088747,1692542,66798
CHEMBL3793480,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,=,21.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220696,DTCC00088750,1946023,66798
CHEMBL3794076,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220693,DTCC00088749,496860,66798
CHEMBL3794468,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220690,DTCC00088748,2011853,66798
CHEMBL3794512,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27038494,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorimetric analysis,,Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.,Bioorg. Med. Chem. Lett.,2016,26,9,"Song J, Peng P, Chang J, Liu MM, Yu JM, Zhou L, Sun X.",,1572537,DTCT0025094,220699,DTCC00088751,819325,66798
CHEMBL379469,P08253,,IGMJBXNPPIZSAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16289878,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Conversion of potent MMP inhibitors into selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,4,"Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJ, Decicco CP",,334535,DTCT0025094,469047,DTCC00415423,1242357,20373
CHEMBL379653,P08253,,XSFJTFAYDHIPHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937010,DTCC00422941,1619807,20885
CHEMBL379763,P08253,,MXMCYIBSFFNNTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,44,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969598,DTCC00428552,131113,21111
CHEMBL38,P08253,TRETINOIN,SHGAZHPCJJPHSC-YCNIQYBTSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23953690,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP2 activity in human HT1080 cells at 1 uM after 24 hrs,Not Active,Inhibitory effects of p-dodecylaminophenol on the invasiveness of human fibrosarcoma cell line HT1080.,Bioorg. Med. Chem.,2013,21,19,"Takahashi N, Takeda K, Imai M",,980576,DTCT0025094,12548203,DTCC00134063,21562,55644
CHEMBL380049,P08253,,NPWNPFHGYNOBOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,341,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969718,DTCC00428568,1393760,21111
CHEMBL380049,P08253,,NPWNPFHGYNOBOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,341,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832586,DTCC00428568,1406775,33699
CHEMBL380895,P08253,,YVFLHFYMDLEMFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926498,DTCC00110328,520521,20786
CHEMBL381173,P08253,,SFSKPKLATIXRLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926484,DTCC00421728,1165867,20786
CHEMBL381189,P08253,,NSZHVJWSFHBPMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16392792,KI,=,8100,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329820,DTCT0025094,1880237,DTCC00411959,391231,20214
CHEMBL381953,P08253,,QRWVORUSUQDRRN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926485,DTCC00421715,7598,20786
CHEMBL382201,P08253,,BZVYQWLRCHLAGK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16451058,KI,=,1200,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330545,DTCT0025094,1887710,DTCC00413190,563987,20245
CHEMBL382201,P08253,,BZVYQWLRCHLAGK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,1100,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061735,DTCC00413190,552885,22402
CHEMBL382227,P08253,,VYVUMCRZVGOXEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,0.62,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937013,DTCC00423333,1134601,20885
CHEMBL382352,P08253,,MJYOLQLJRBLLML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926488,DTCC00421659,227888,20786
CHEMBL3826991,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,472,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317030,DTCC00102286,517273,67557
CHEMBL3827012,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,27.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317285,DTCC00102339,1325152,67557
CHEMBL3827012,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317082,DTCC00102339,1325152,67557
CHEMBL3827024,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,263,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317037,DTCC00102293,1422907,67557
CHEMBL3827071,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317101,DTCC00102433,1099206,67557
CHEMBL3827071,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6.607,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317304,DTCC00102433,1099206,67557
CHEMBL3827073,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325956,DTCC00102284,1869506,67557
CHEMBL3827107,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317080,DTCC00102337,581505,67557
CHEMBL3827107,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1300.17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317283,DTCC00102337,581505,67557
CHEMBL3827117,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,53.95,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317256,DTCC00102310,160392,67557
CHEMBL3827117,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317053,DTCC00102310,160392,67557
CHEMBL3827119,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,330,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,318175,DTCC00102307,905181,67557
CHEMBL3827119,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,5105.05,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317253,DTCC00102307,905181,67557
CHEMBL3827120,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,29.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317247,DTCC00102301,1001636,67557
CHEMBL3827120,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317045,DTCC00102301,1001636,67557
CHEMBL3827160,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317050,DTCC00102306,2064416,67557
CHEMBL3827160,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1581.25,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317252,DTCC00102306,2064416,67557
CHEMBL3827162,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,41,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325960,DTCC00102280,1422905,67557
CHEMBL3827185,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,779.83,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317259,DTCC00102313,646586,67557
CHEMBL3827185,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,780,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317056,DTCC00102313,646586,67557
CHEMBL3827196,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,419,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317032,DTCC00102288,192237,67557
CHEMBL3827212,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1698.24,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317271,DTCC00102325,1740860,67557
CHEMBL3827212,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317068,DTCC00102325,1740860,67557
CHEMBL3827224,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,>,500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317033,DTCC00102289,63116,67557
CHEMBL3827238,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,38,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317046,DTCC00102302,1408,67557
CHEMBL3827238,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,38.02,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317248,DTCC00102302,1408,67557
CHEMBL3827243,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317038,DTCC00102294,192238,67557
CHEMBL3827249,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,33.96,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317269,DTCC00102323,1034083,67557
CHEMBL3827249,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,34,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317066,DTCC00102323,1034083,67557
CHEMBL3827250,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,44.65,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325963,DTCC00102277,1162527,67557
CHEMBL3827306,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,177,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325965,DTCC00102275,646584,67557
CHEMBL3827321,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317057,DTCC00102314,1195121,67557
CHEMBL3827321,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317260,DTCC00102314,1195121,67557
CHEMBL3827377,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317063,DTCC00102320,2032672,67557
CHEMBL3827377,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,60.95,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317266,DTCC00102320,2032672,67557
CHEMBL3827433,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,2430,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317047,DTCC00102303,1409,67557
CHEMBL3827433,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,2432.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317249,DTCC00102303,1409,67557
CHEMBL3827444,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317086,DTCC00102341,1487337,67557
CHEMBL3827444,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,4.603,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317289,DTCC00102341,1487337,67557
CHEMBL3827453,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,103,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325959,DTCC00102281,646585,67557
CHEMBL3827454,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,672,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317031,DTCC00102287,2032670,67557
CHEMBL3827514,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,59,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317083,DTCC00102340,1099204,67557
CHEMBL3827514,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,59.02,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317286,DTCC00102340,1099204,67557
CHEMBL3827521,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317049,DTCC00102305,127768,67557
CHEMBL3827521,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317251,DTCC00102305,127768,67557
CHEMBL3827566,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317060,DTCC00102317,613819,67557
CHEMBL3827566,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317263,DTCC00102317,613819,67557
CHEMBL3827615,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325958,DTCC00102282,1099203,67557
CHEMBL3827627,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,5.794,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317250,DTCC00102304,1805195,67557
CHEMBL3827627,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,5.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317048,DTCC00102304,1805195,67557
CHEMBL3827640,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,98,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325962,DTCC00102278,160391,67557
CHEMBL3827680,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,51,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317036,DTCC00102292,1454773,67557
CHEMBL3827694,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1790,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317067,DTCC00102324,1616608,67557
CHEMBL3827694,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1790.61,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317270,DTCC00102324,1616608,67557
CHEMBL3827703,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,10.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317280,DTCC00102334,160393,67557
CHEMBL3827703,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317077,DTCC00102334,160393,67557
CHEMBL3827735,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,79,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325957,DTCC00102283,1227213,67557
CHEMBL3827759,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,3500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317042,DTCC00102298,1680907,67557
CHEMBL3827759,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6194.41,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317244,DTCC00102298,1680907,67557
CHEMBL3827764,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6800,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317073,DTCC00102330,95554,67557
CHEMBL3827764,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6807.69,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317276,DTCC00102330,95554,67557
CHEMBL3827768,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,3.396,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317257,DTCC00102311,1162528,67557
CHEMBL3827768,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317054,DTCC00102311,1162528,67557
CHEMBL3827781,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,208,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325964,DTCC00102276,1066313,67557
CHEMBL382781,P08253,,WAYKDGBJSUBARX-NCRNUEESSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15837315,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 in MMPi assay,,A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.,Bioorg. Med. Chem. Lett.,2005,15,9,"Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S, Tuccinardi T, Atkinson SJ, Murphy G, Balsamo A",,305684,DTCT0025094,1841407,DTCC00403447,110078,18987
CHEMBL3827831,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317059,DTCC00102316,1357989,67557
CHEMBL3827831,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,199.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317262,DTCC00102316,1357989,67557
CHEMBL3827869,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,885,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325968,DTCC00102272,1099202,67557
CHEMBL3827934,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317076,DTCC00102333,1422908,67557
CHEMBL3827934,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317279,DTCC00102333,1422908,67557
CHEMBL3827937,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317105,DTCC00102437,1740861,67557
CHEMBL3827937,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6.607,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317308,DTCC00102437,1740861,67557
CHEMBL3827994,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,11.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,318170,DTCC00102438,420800,67557
CHEMBL3827994,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317108,DTCC00102438,420800,67557
CHEMBL3828007,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317072,DTCC00102329,1551654,67557
CHEMBL3828007,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317275,DTCC00102329,1551654,67557
CHEMBL3828041,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,209.89,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317277,DTCC00102331,1999714,67557
CHEMBL3828041,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,210,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317074,DTCC00102331,1999714,67557
CHEMBL3828051,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,123,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325955,DTCC00102285,840318,67557
CHEMBL3828059,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,414,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317069,DTCC00102326,1195122,67557
CHEMBL3828059,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,414,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317272,DTCC00102326,1195122,67557
CHEMBL3828068,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,34197.94,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,318172,DTCC00102440,451536,67557
CHEMBL3828068,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,34200.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317110,DTCC00102440,451536,67557
CHEMBL3828077,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,83.95,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317254,DTCC00102308,2032671,67557
CHEMBL3828077,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,84,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317051,DTCC00102308,2032671,67557
CHEMBL3828088,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,843,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325967,DTCC00102273,872904,67557
CHEMBL3828216,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,334.97,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317281,DTCC00102335,840320,67557
CHEMBL3828216,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,335,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317078,DTCC00102335,840320,67557
CHEMBL3828219,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,5.998,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,318173,DTCC00102441,1227215,67557
CHEMBL3828219,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317111,DTCC00102441,1227215,67557
CHEMBL3828226,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,76,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317039,DTCC00102295,1805194,67557
CHEMBL3828270,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,193,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317040,DTCC00102296,840319,67557
CHEMBL3828305,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,920,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317079,DTCC00102336,646587,67557
CHEMBL3828305,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,920.45,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317282,DTCC00102336,646587,67557
CHEMBL3828314,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,309.74,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317268,DTCC00102322,1680908,67557
CHEMBL3828314,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,310,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317065,DTCC00102322,1680908,67557
CHEMBL3828315,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,203,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325966,DTCC00102274,256786,67557
CHEMBL3828318,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,291,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317041,DTCC00102297,290061,67557
CHEMBL3828325,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317102,DTCC00102434,95557,67557
CHEMBL3828325,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317305,DTCC00102434,95557,67557
CHEMBL3828338,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,38.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,318171,DTCC00102439,1325155,67557
CHEMBL3828338,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317109,DTCC00102439,1325155,67557
CHEMBL3828359,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,109.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317307,DTCC00102436,678723,67557
CHEMBL3828359,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317104,DTCC00102436,678723,67557
CHEMBL3828382,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,749.89,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,318174,DTCC00102442,1869510,67557
CHEMBL3828382,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,750,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317112,DTCC00102442,1869510,67557
CHEMBL3828398,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,10.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317255,DTCC00102309,1648750,67557
CHEMBL3828398,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317052,DTCC00102309,1648750,67557
CHEMBL3828437,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,85.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317278,DTCC00102332,1583854,67557
CHEMBL3828437,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,86,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317075,DTCC00102332,1583854,67557
CHEMBL3828446,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,806,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317035,DTCC00102291,969100,67557
CHEMBL3828455,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.3802,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317284,DTCC00102338,1034084,67557
CHEMBL3828455,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317081,DTCC00102338,1034084,67557
CHEMBL3828457,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,279.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317246,DTCC00102300,872905,67557
CHEMBL3828457,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317044,DTCC00102300,872905,67557
CHEMBL3828459,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317043,DTCC00102299,451535,67557
CHEMBL3828459,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,61.94,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317245,DTCC00102299,451535,67557
CHEMBL3828460,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,>,500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317034,DTCC00102290,1422906,67557
CHEMBL3828521,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317061,DTCC00102318,1648751,67557
CHEMBL3828521,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317264,DTCC00102318,1648751,67557
CHEMBL3828527,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,186,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,325961,DTCC00102279,1967037,67557
CHEMBL3828531,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317091,DTCC00102432,224564,67557
CHEMBL3828531,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.7499,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317294,DTCC00102432,224564,67557
CHEMBL3828556,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317103,DTCC00102435,1583857,67557
CHEMBL3828556,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317306,DTCC00102435,1583857,67557
CHEMBL3828566,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,41,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317071,DTCC00102328,387896,67557
CHEMBL3828566,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,41.02,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317274,DTCC00102328,387896,67557
CHEMBL3828568,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317055,DTCC00102312,678722,67557
CHEMBL3828568,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,254.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317258,DTCC00102312,678722,67557
CHEMBL3828582,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,51999.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317070,DTCC00102327,355327,67557
CHEMBL3828582,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,51999.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317273,DTCC00102327,355327,67557
CHEMBL3828697,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,269.77,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317267,DTCC00102321,290062,67557
CHEMBL3828697,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,270,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317064,DTCC00102321,290062,67557
CHEMBL3828712,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6.397,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317261,DTCC00102315,1616607,67557
CHEMBL3828712,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,6.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317058,DTCC00102315,1616607,67557
CHEMBL3828753,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317062,DTCC00102319,743136,67557
CHEMBL3828753,P08253,,,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317265,DTCC00102319,743136,67557
CHEMBL38299,P08253,,XCGVYWMKRYFDJR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,61,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1473904,DTCC00180080,236671,4274
CHEMBL383193,P08253,,UHEMMICIPFAOHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,0.98,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937004,DTCC00423262,1004917,20885
CHEMBL384759,P08253,,QGWNDRXFNXRZMB-UUOKFMHZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15081893,IC50,=,200000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14713964,DTCC00431480,2099437,68331
CHEMBL385821,P08253,,HTEPICDCVMJOSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,1590,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832583,DTCC00428534,1535724,33699
CHEMBL387079,P08253,,XIQNNSMTTLQUTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,77,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969730,DTCC00428561,1970456,21111
CHEMBL387079,P08253,,XIQNNSMTTLQUTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,77,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2154017,DTCC00428561,1970726,23077
CHEMBL38717,P08253,,MSWYFTOHLLVIHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,37000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1581306,DTCC00179305,1046165,4273
CHEMBL387202,P08253,,NJCBPLQYZDLBCA-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019758,DTCC00438921,1663624,21880
CHEMBL387202,P08253,,NJCBPLQYZDLBCA-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828322,DTCC00438921,1653468,33677
CHEMBL388124,P08253,,FABNMTMBXQFDAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101563,DTCC00455482,1146629,22885
CHEMBL388309,P08253,,SUZRJMQBDIHWSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,81800,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079331,DTCC00449751,1970663,22603
CHEMBL388453,P08253,,XALJTPOAALNLJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,2230,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800845,DTCC00463155,425575,31524
CHEMBL38851,P08253,,XZWFHJUEAVOHHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,49,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,643365,DTCC00180222,1261750,4635
CHEMBL38851,P08253,,XZWFHJUEAVOHHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,32,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1586508,DTCC00180222,1272449,4273
CHEMBL388671,P08253,,YTJNSUHDNZWJPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,5120,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800839,DTCC00463156,683291,31524
CHEMBL38868,P08253,,DDXMPPFUPDTKNK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1454486,DTCC00179381,367638,4274
CHEMBL388878,P08253,,RDZUJKVCOZNTDE-MZQXSQAVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,INHIBITION,=,58,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 100 uM,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441104,DTCT0025094,2148749,DTCC00460186,1599235,23121
CHEMBL388879,P08253,,UYVVHTPVCDOQRA-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 100 uM,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441104,DTCT0025094,2148747,DTCC00460189,2015254,23121
CHEMBL388982,P08253,,UZLNTZNPSMNCRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,730,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079336,DTCC00449746,163842,22603
CHEMBL389020,P08253,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113784,DTCC00452712,195826,23023
CHEMBL389020,P08253,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440144,DTCT0025094,2113814,DTCC00452712,195826,23023
CHEMBL389020,P08253,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440150,DTCT0025094,2113842,DTCC00452712,195826,23023
CHEMBL389020,P08253,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440156,DTCT0025094,2113871,DTCC00452712,195826,23023
CHEMBL389020,P08253,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457528,DTCC00452712,208200,32556
CHEMBL389594,P08253,,BLIQFUCBRCDFAI-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17289381,KI,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442203,DTCT0025094,2162210,DTCC00463661,564439,23225
CHEMBL389691,P08253,,SBINJYYFUVHVNU-UPVQGACJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17368021,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438528,DTCT0025094,2101559,DTCC00455488,952027,22885
CHEMBL389898,P08253,,HTKNWYDCBWYORK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,Not Determined,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061988,DTCC00447846,1555210,22402
CHEMBL39035,P08253,,BXGFONUNBZSLOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,480000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1591707,DTCC00179902,1849414,4273
CHEMBL391288,P08253,,VDZXMXGMCNRNLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215479,DTCC00477194,1313064,24158
CHEMBL391362,P08253,,SXQXJOREJVFQQR-BKMJKUGQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221421,DTCC00478077,99287,24252
CHEMBL391376,P08253,,BIMPKRWFMWVAKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215477,DTCC00477196,310264,24158
CHEMBL391388,P08253,,CYAPFFVOYRXNFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240595,DTCC00479007,83226,24538
CHEMBL391509,P08253,,FNYMWMSAYUTPPB-IJULCPIYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17512742,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447905,DTCT0025094,2176029,DTCC00468628,909116,23716
CHEMBL391676,P08253,,LNLWALQGRPVSTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153926,DTCC00461919,424415,23077
CHEMBL391880,P08253,,GGDBCZZATDMWMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153921,DTCC00461923,1070028,23077
CHEMBL391881,P08253,,IDHBZDJZPPEMGC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,183,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2154020,DTCC00461928,1166191,23077
CHEMBL392088,P08253,,BXSPGECKGKAUCR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,992,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204563,DTCC00471851,714474,24059
CHEMBL392172,P08253,,PFPQINANHHJKFH-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221432,DTCC00478065,1620305,24252
CHEMBL392231,P08253,,ONXPGSKZKJFIFD-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240609,DTCC00479021,472421,24538
CHEMBL392232,P08253,,HOQRRVLBMMILPN-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240605,DTCC00479025,1921648,24538
CHEMBL392294,P08253,,LYGIRBLDUCXHDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,82,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153943,DTCC00461902,650171,23077
CHEMBL392295,P08253,,RCCBHNFHHCGOQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,58,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153942,DTCC00461903,1037559,23077
CHEMBL392308,P08253,,KJOVWWTWOVUHSB-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204559,DTCC00471855,1873303,24059
CHEMBL392312,P08253,,VMWZNZVYBAZMKQ-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169350,DTCC00464766,260535,23623
CHEMBL392505,P08253,,HQGORWGMKQFFGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,161,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153938,DTCC00461907,682040,23077
CHEMBL392571,P08253,,PUBARVPHTAEUJQ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204557,DTCC00471857,1905592,24059
CHEMBL392572,P08253,,DFWYBNIMFAUWSX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204554,DTCC00471860,99252,24059
CHEMBL392837,P08253,,XDKBCKDIDNIGIV-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240617,DTCC00479013,795216,24538
CHEMBL392867,P08253,,AJLMUTLJMXTHCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215480,DTCC00477193,2020086,24158
CHEMBL392974,P08253,,UEVLLYXFWPWEDN-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,9110,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204553,DTCC00471861,293894,24059
CHEMBL393443,P08253,,JCIVWVZJOHHYOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240618,DTCC00479012,1668694,24538
CHEMBL393444,P08253,,UEOYACNTKVVWRI-HFZDXXHNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,=,307,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221429,DTCC00478068,424602,24252
CHEMBL393445,P08253,,SSOHCNKODIJGFS-WINIVTDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221424,DTCC00478074,424603,24252
CHEMBL393550,P08253,,XWVXWDVYQZEQBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153933,DTCC00461912,1587505,23077
CHEMBL39358,P08253,,PTWLELXABRMCEI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,160000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1580076,DTCC00179315,1434636,4273
CHEMBL393750,P08253,,UHWQCCAGEXNQTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,99.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153930,DTCC00461915,1970725,23077
CHEMBL393793,P08253,,NKCMINBLFYGDJZ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204564,DTCC00471850,1329038,24059
CHEMBL393828,P08253,,FGEXLQKMIJWUIY-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,239,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204569,DTCC00471838,1361759,24059
CHEMBL393829,P08253,,NVEOTSPQRXNTEA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,4350,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204568,DTCC00471839,1491085,24059
CHEMBL393863,P08253,,MKDLVNDURLPYMP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221435,DTCC00477930,1296486,24252
CHEMBL393944,P08253,,MCRBDLJEZXPESB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215328,DTCC00477176,277532,24158
CHEMBL394003,P08253,,SVFGAFGHEBEAJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,>,1666,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180817,DTCC00470414,228329,23780
CHEMBL394084,P08253,,FREFRJYSKQLKFN-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240615,DTCC00479015,730895,24538
CHEMBL394294,P08253,,DRAXUTSANKJHDR-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17576061,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456575,DTCT0025094,2240613,DTCC00479017,537223,24538
CHEMBL395121,P08253,,HLFJGIDGAGVBPC-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233036,DTCC00477441,1182562,24428
CHEMBL395354,P08253,,CXQMMCABJANHHZ-YNKQFZHNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233032,DTCC00477445,1247825,24428
CHEMBL39553,P08253,,WFELCPTZICREII-QMMMGPOBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163188,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (gelatinase-A),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104408,DTCT0025094,1539083,DTCC00177963,1914835,17850
CHEMBL39566,P08253,,BMCMQADGLVGIMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1476239,DTCC00179438,1402673,4274
CHEMBL395877,P08253,,ZRAQZYQKZITEAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215332,DTCC00477172,1857247,24158
CHEMBL395878,P08253,,WFZMQTYFKFRTGC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215331,DTCC00477173,1987169,24158
CHEMBL395880,P08253,,FMMBVZGWJZFRLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,=,2170,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215322,DTCC00477188,730829,24158
CHEMBL395880,P08253,,FMMBVZGWJZFRLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,2170,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2456519,DTCC00477188,726868,32556
CHEMBL39601,P08253,,FQCGONNCIXUVIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,26,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1461835,DTCC00179350,626174,4274
CHEMBL396294,P08253,FOLATE GAMMA-HYDROXAMIC ACID,TZBJIYPNYFAUQG-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,INHIBITION,=,66,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 100 uM,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441104,DTCT0025094,2143981,DTCC00003030,143060,23121
CHEMBL396296,P08253,METHOTREXATE GAMMA-L-PHENYLALANINEHYDROXAMIC ACID,QHQOEZXEZMHMER-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441088,DTCT0025094,2143973,DTCC00003033,952076,23121
CHEMBL396296,P08253,METHOTREXATE GAMMA-L-PHENYLALANINEHYDROXAMIC ACID,QHQOEZXEZMHMER-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,RATIO IC50,=,2500,,,,,,,,,,,,,,,Ratio of IC50 of drug to CGS 27023A for human recombinant MMP2,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441100,DTCT0025094,2144004,DTCC00003033,952076,23121
CHEMBL397396,P08253,,NGZKBBDWDWWOBY-LAJNKCICSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,15600,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233029,DTCC00477449,148031,24428
CHEMBL398265,P08253,,VJUDEGHVGRIZAQ-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278531,DTCC00489424,1987318,25112
CHEMBL398331,P08253,,JZEPJLQIDIDDKA-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278570,DTCC00489294,860749,25112
CHEMBL398331,P08253,,JZEPJLQIDIDDKA-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300308,DTCC00489294,844317,25438
CHEMBL398350,P08253,,YMEMYNPRLJHTGN-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,178,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278567,DTCC00489300,569480,25112
CHEMBL398351,P08253,,AIVGSEYFSRMFJB-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278564,DTCC00489304,569481,25112
CHEMBL398405,P08253,,SFWRCXWXHAIKBP-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204550,DTCC00471864,2036268,24059
CHEMBL398450,P08253,,HKAAGCIEBUZLMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,86000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266551,DTCC00485880,1776513,24949
CHEMBL398602,P08253,,SAQZCMSCRMAPLW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,6120,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204549,DTCC00471865,1684738,24059
CHEMBL398639,P08253,,XRBRLEUPIULYDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,4380,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266894,DTCC00486111,650417,24951
CHEMBL398640,P08253,,GIXYBRZLOBPOLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,173,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266887,DTCC00486118,779010,24951
CHEMBL398641,P08253,,XMVZJCLXRBLZHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,262,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266884,DTCC00486121,1523447,24951
CHEMBL398644,P08253,,BHIHZVBFDJREPF-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,5.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278538,DTCC00489400,83309,25112
CHEMBL398662,P08253,4-(TRIFLUOROMETHYL)BENZYL 6-MERCAPTOPICOLINATE,UXTIYMFTTMKCDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,125000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266523,DTCC00003776,1458627,24949
CHEMBL398743,P08253,,NUZIOEFGCJGHAK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278046,DTCC00489510,391998,25102
CHEMBL398838,P08253,,NZJFWCGEQFWBKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,65000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266535,DTCC00485905,1394273,24949
CHEMBL398892,P08253,,RQUBDDXSSKDSJC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,70000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266557,DTCC00485874,972954,24949
CHEMBL399029,P08253,,OOPDBSPAOGDGKV-MRUHUIDDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,5.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278543,DTCC00489376,375660,25112
CHEMBL399070,P08253,,ZQZVJUAJNUFNDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,65000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266567,DTCC00112327,1458626,24949
CHEMBL399096,P08253,,AGMWQNDXCWDRDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,960,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237267,DTCC00480950,876605,24495
CHEMBL399096,P08253,,AGMWQNDXCWDRDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,960,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2456486,DTCC00480950,888688,32556
CHEMBL399097,P08253,,JQJWNYAMOJOHCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,1110,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237263,DTCC00480954,844149,24495
CHEMBL399098,P08253,,LEMMSOIQHPOJRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,760,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237260,DTCC00480957,1744582,24495
CHEMBL39921,P08253,,QQFFLMZJIVBXJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,1300,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1473902,DTCC00179491,204169,4274
CHEMBL399304,P08253,,LHAPHQLKKIRONO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,70000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266554,DTCC00485877,1426658,24949
CHEMBL399351,P08253,,JGSJEYLQTZAQRG-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278073,DTCC00489339,1744698,25102
CHEMBL399400,P08253,,HPBWNXRDTAWPAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,334,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180826,DTCC00470405,876483,23780
CHEMBL399401,P08253,,HGILVKJBXAXGDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,216,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180822,DTCC00470409,2003456,23780
CHEMBL399504,P08253,,NQYVTZONPGFIAQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,109000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266541,DTCC00485896,1005476,24949
CHEMBL399565,P08253,,OOMMMKWDYHOZLE-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,64,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278556,DTCC00489328,1571618,25112
CHEMBL399566,P08253,,ROZSKUGTEUMAMI-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278554,DTCC00489332,1119400,25112
CHEMBL399684,P08253,,KNRYOABLFLVDOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,69000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266553,DTCC00485878,1905753,24949
CHEMBL399685,P08253,,GBDUKEUKPOMNDD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,69000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266549,DTCC00485883,359234,24949
CHEMBL399908,P08253,4-METHOXYBENZYL 6-MERCAPTOPICOLINATE,YSTUWPYBTHJZLL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,91000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266521,DTCC00003778,1587794,24949
CHEMBL399997,P08253,2-BROMOBENZYL 6-MERCAPTOPICOLINATE,BYAIZTJWUFLESC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,108000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266513,DTCC00003786,1841459,24949
CHEMBL399998,P08253,,KKLDLTCISAWVLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,48000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266498,DTCC00112349,359236,24949
CHEMBL399999,P08253,,JXNVCUFWCAJVAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,77000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266506,DTCC00112341,909304,24949
CHEMBL400083,P08253,,SBUWCTGSDDXCCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,196,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266881,DTCC00486124,1841460,24951
CHEMBL400163,P08253,,IROSASOHPXXTQE-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,6.1,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,827239,DTCC00487071,841464,1379
CHEMBL400192,P08253,,SETBBCAYVFZDCA-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,83,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278561,DTCC00489312,1313204,25112
CHEMBL400193,P08253,,SJARSEBFYXSCRJ-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,202,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278560,DTCC00489314,1247936,25112
CHEMBL400206,P08253,,BUDIJDXJWOVXRJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17064892,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440761,DTCT0025094,2153844,DTCC00461899,972679,23077
CHEMBL400285,P08253,,USBYYTHGWSZFCH-MRUHUIDDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,2.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278533,DTCC00489417,1086857,25112
CHEMBL400314,P08253,,YZJVCXDOAAOGHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163188,KI,>,100000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (gelatinase-A),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104408,DTCT0025094,1540257,DTCC00487074,1785836,17850
CHEMBL40034,P08253,,LUPLBSDRRWYFTC-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163188,KI,=,226000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (gelatinase-A),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104408,DTCT0025094,1527414,DTCC00177713,1403699,17850
CHEMBL400357,P08253,,HWCTXADEOSNKAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266497,DTCC00112350,650414,24949
CHEMBL400358,P08253,,JKVLJXIAJUKATA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266495,DTCC00485909,1905755,24949
CHEMBL400430,P08253,,CBEZXYHTYKUDTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17606376,IC50,=,1312,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,2007,15,18,"Huang A, Joseph-McCarthy D, Lovering F, Sun L, Wang W, Xu W, Zhu Y, Cui J, Zhang Y, Levin JI",,448559,DTCT0025094,2180820,DTCC00470411,424535,23780
CHEMBL400445,P08253,,XTJBWIGVMWHTBK-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,281,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278546,DTCC00489368,1475076,25112
CHEMBL400449,P08253,"2,5-DIFLUOROBENZYL 6-MERCAPTOPICOLINATE",WZHYWMHDTQCLHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,79000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266516,DTCC00003783,1937771,24949
CHEMBL400528,P08253,,GHULRYOEOZAXEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278048,DTCC00489502,1555579,25102
CHEMBL400641,P08253,,HMSHXTUFXMZOJG-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,9.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278544,DTCC00489373,1668798,25112
CHEMBL400784,P08253,,DMFDGAVDVQNWSQ-DVECYGJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278559,DTCC00489321,763157,25112
CHEMBL400785,P08253,,DMFDGAVDVQNWSQ-CYFREDJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278558,DTCC00489324,244700,25112
CHEMBL400850,P08253,,DYVOQIGOSGKBQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266502,DTCC00112344,1394274,24949
CHEMBL400851,P08253,,FFKBKVNEQNIDAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266500,DTCC00112346,260739,24949
CHEMBL401263,P08253,,KRGIXMSVPSMLII-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,=,2800,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296529,DTCC00488619,1361969,25233
CHEMBL401263,P08253,,KRGIXMSVPSMLII-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18234496,KI,=,2800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,4,"Ott GR, Asakawa N, Liu RQ, Covington MB, Qian M, Vaddi K, Newton RC, Trzaskos JM, Christ DD, Galya L, Scholz T, Marshall W, Duan JJ",,462319,DTCT0025094,2282167,DTCC00488619,1378406,25158
CHEMBL401404,P08253,,MXIFPAKFUUYAMN-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,27,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278553,DTCC00489349,1857409,25112
CHEMBL40143,P08253,ABT-770,IIHFBHZWJNGWRC-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1450792,DTCC01739757,464200,4274
CHEMBL40143,P08253,ABT-770,IIHFBHZWJNGWRC-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457394,DTCC01739757,468359,32556
CHEMBL401445,P08253,,RTWRPNRMLWESPM-VLBBBODESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17512742,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447905,DTCT0025094,2176031,DTCC00468604,1808775,23716
CHEMBL401453,P08253,,JRRSWIJDZJXIAR-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169346,DTCC00464770,1328990,23623
CHEMBL401454,P08253,,CKGRNUKOQHVJOB-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169340,DTCC00464776,617508,23623
CHEMBL401471,P08253,,AZIJSGUGQIBFMD-CAKYRVLISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18234496,KI,=,1357,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,4,"Ott GR, Asakawa N, Liu RQ, Covington MB, Qian M, Vaddi K, Newton RC, Trzaskos JM, Christ DD, Galya L, Scholz T, Marshall W, Duan JJ",,462319,DTCT0025094,2282169,DTCC00488623,1182677,25158
CHEMBL40151,P08253,,GTNUMHYGLZBCGR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1455634,DTCC00179317,2044489,4274
CHEMBL401821,P08253,,VAYOACRDUZWWKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300322,DTCC00500630,1296686,25438
CHEMBL401824,P08253,,CYLJDKJSOJVUOS-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296519,DTCC00112994,1070343,25233
CHEMBL401870,P08253,,RAJATBMMJHSJNJ-FQECFTEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,53,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276481,DTCC00488459,294069,25086
CHEMBL401979,P08253,,DIZGMOHGYCJEBO-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,=,1700,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296533,DTCC00501693,67201,25233
CHEMBL402118,P08253,,YJSYFCHNFUBPQY-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317232,DTCC00499916,1857435,25272
CHEMBL402309,P08253,,AIMZNBMNWSVLMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,16.7,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289041,DTCC00502113,9220,25686
CHEMBL402310,P08253,,SCABKVASOUSOGA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,=,468,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289042,DTCC00502116,1937886,25686
CHEMBL402393,P08253,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317223,DTCC00499750,957099,25272
CHEMBL402393,P08253,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457220,DTCC00499750,952985,32556
CHEMBL402436,P08253,,SDNMPMDMJTYOAW-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,2128,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282312,DTCC00488433,1873486,25163
CHEMBL402554,P08253,,OMPYFSXSVDORIO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,6.1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289291,DTCC00501225,260890,25715
CHEMBL402636,P08253,,HDDGWKVPDOMYLP-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,=,1367,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317233,DTCC00499961,1728809,25272
CHEMBL402639,P08253,,PDLSPVLGWRRTFM-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,2382,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300314,DTCC00500457,1523522,25438
CHEMBL402720,P08253,BENZYL 6-MERCAPTOPICOLINATE,VZXSYHPSVIVBDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,85000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266529,DTCC00003772,391970,24949
CHEMBL402745,P08253,,LFOGEPKUSWRLCL-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,7.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1316690,DTCC00487205,808682,16328
CHEMBL402746,P08253,,OXTQTRNMDRGLGO-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296419,DTCC00487834,1744721,25233
CHEMBL402747,P08253,,CARKQNSZFCLNKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18054488,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones.",Bioorg. Med. Chem. Lett.,2008,18,1,"Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Rao BG",,461727,DTCT0025094,2277148,DTCC00487839,196172,25093
CHEMBL402747,P08253,,CARKQNSZFCLNKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2456473,DTCC00487839,208204,32556
CHEMBL402750,P08253,,UNYQRNBJIKAMKU-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,2917,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300297,DTCC00500628,1744760,25438
CHEMBL402954,P08253,,MAXWOEDRRCSRHI-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,21,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276500,DTCC00488365,553292,25086
CHEMBL402990,P08253,,JUDXBTMVZVWJNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17936631,IC50,=,590,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,"Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.",Bioorg. Med. Chem.,2008,16,1,"Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG, Choi HM, Lee HY, Hong SH, Kim MS, Nam KY, Han G",,461353,DTCT0025094,2274647,DTCC00487747,1760569,25060
CHEMBL402991,P08253,,OMHMZZGGFHEFEP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17936631,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,Not Determined,"Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.",Bioorg. Med. Chem.,2008,16,1,"Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG, Choi HM, Lee HY, Hong SH, Kim MS, Nam KY, Han G",,461353,DTCT0025094,2274646,DTCC00487748,1475065,25060
CHEMBL403022,P08253,,IKZZUHATDHDZKR-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,4999,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276492,DTCC00488380,1361941,25086
CHEMBL403089,P08253,,BNMLMEDMDSOEPR-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,102,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300321,DTCC00112969,1587883,25438
CHEMBL403110,P08253,,UHKFCKGWGNVWOQ-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300302,DTCC00500149,455682,25438
CHEMBL403161,P08253,,UCFPOZCPIVOGIJ-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,24,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276497,DTCC00488368,488971,25086
CHEMBL403169,P08253,,VOASHVXIDJYPJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,73,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300326,DTCC00500714,553363,25438
CHEMBL403185,P08253,,PEAOAVRAGQRJEO-AKQSQHNNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,35,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276484,DTCC00488434,909316,25086
CHEMBL403186,P08253,,WMWPLQAXVKBJIC-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,2128,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282316,DTCC00488436,260773,25163
CHEMBL40335,P08253,,ZFNITODUSPHELT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,130,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1470179,DTCC00180028,1946344,4274
CHEMBL403380,P08253,,JLFCWOIZNQXZMP-ICSRJNTNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,159,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276494,DTCC00488376,972978,25086
CHEMBL403401,P08253,,GIYCAHCPFIZYMQ-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296513,DTCC00501582,1809018,25233
CHEMBL403412,P08253,,NZHYOLNTGNGMON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289295,DTCC00501278,1135414,25715
CHEMBL403539,P08253,,FLPIBFXJTDQPCO-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317225,DTCC00499796,343119,25272
CHEMBL403620,P08253,,SMWUMKAFRZUPSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289037,DTCC00502069,1873600,25686
CHEMBL403777,P08253,,MMRITKOLOPLQTB-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317229,DTCC00499875,343118,25272
CHEMBL403778,P08253,,YXKKEOGFLPKGED-ZWKOTPCHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317230,DTCC00499877,666501,25272
CHEMBL404010,P08253,,IYGKJIOIZXNZOC-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282403,DTCC00488451,1037910,25163
CHEMBL404019,P08253,,PVXFXCXPVPZDJJ-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317188,DTCC00500052,1054123,25272
CHEMBL404093,P08253,,VDWUMLKWSKKGLE-BSOSBYQFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276476,DTCC00488484,521200,25086
CHEMBL404132,P08253,,KAJHXHOIEARPHN-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,63,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276491,DTCC00488393,844255,25086
CHEMBL404162,P08253,,JJARNQDLIPGYKD-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296510,DTCC00502141,1103112,25233
CHEMBL404170,P08253,,WIQCNJLTNFUAEJ-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,2500,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276495,DTCC00488370,714659,25086
CHEMBL404205,P08253,ISOPROPYL 6-MERCAPTOPICOLINATE,QJUDBPJUUNCMKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266532,DTCC00003769,2003635,24949
CHEMBL404270,P08253,,HSRYNFLYAOMHLV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,147,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300273,DTCC00500756,1103147,25438
CHEMBL404382,P08253,,JFELXNYVJCRVPT-ZVUIFXONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282408,DTCC00488446,99450,25163
CHEMBL404409,P08253,,IDSXRTDVRWTZOK-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278071,DTCC00489354,1296629,25102
CHEMBL404673,P08253,,XNUPVUIWOKTWNU-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282398,DTCC00488441,1166496,25163
CHEMBL404752,P08253,,QRKISYORPUCMMH-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of full length MMP2 at 10 uM,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465910,DTCT0025094,2300358,DTCC00500588,392066,25438
CHEMBL404882,P08253,,JZMCRZFBCUTVMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,61,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300325,DTCC00500711,2003722,25438
CHEMBL404893,P08253,,BNMLMEDMDSOEPR-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300320,DTCC00500586,99499,25438
CHEMBL405600,P08253,,CTEBTZSRXSZTCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1709811,DTCC00105079,63907,16216
CHEMBL405651,P08253,,WUXSSALNWBMRKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,30,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1072667,DTCC00106276,291445,15258
CHEMBL40613,P08253,,WCKLNALJHKEBOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,85,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1466494,DTCC00180030,2044488,4274
CHEMBL407176,P08253,,DPCOBXCUZAXERT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17980583,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469150,DTCT0025094,2289029,DTCC00501896,585562,25686
CHEMBL407443,P08253,,PONKMSIAUNHYAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,1.6,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1373015,DTCC00273294,1723389,16392
CHEMBL40746,P08253,,MACBSAQGLFHSQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,0.8,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,706272,DTCC00184695,1531824,3810
CHEMBL407540,P08253,,AMUGNOPZMAZKFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,80,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1056150,DTCC00249365,356662,15258
CHEMBL407640,P08253,,WTVDGWPQROHFND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,,,,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,Not Determined,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,950840,DTCC00138732,239822,16645
CHEMBL408366,P08253,,WIAJGSYMEDWMGP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,5.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289287,DTCC00501132,1971170,25715
CHEMBL408720,P08253,,IXVZBDKTAIRGPK-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,23.3,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1796044,DTCC00393966,33080,8231
CHEMBL408906,P08253,,GBUFCNZUHLSHNE-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,297,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300305,DTCC00500248,650497,25438
CHEMBL409536,P08253,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17623656,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507872,DTCT0025094,2388607,DTCC00503784,1950627,29282
CHEMBL409536,P08253,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18251495,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465546,DTCT0025094,2311306,DTCC00503784,1954666,25409
CHEMBL409536,P08253,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497427,DTCT0025094,2457341,DTCC00503784,1950505,32556
CHEMBL409536,P08253,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25265401,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433220,DTCT0025094,13993814,DTCC00503784,1943413,60040
CHEMBL41067,P08253,,FQLYLGDLLIEWGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,76000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1559347,DTCC00179875,1206900,4273
CHEMBL41100,P08253,,JXKUSYFOHKHALF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,8200,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1593042,DTCC00179908,755084,4273
CHEMBL41102,P08253,,UZBOAJFAUCURIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,7800,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1582785,DTCC00179969,1206901,4273
CHEMBL41102,P08253,,UZBOAJFAUCURIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1461832,DTCC00179969,1206909,4274
CHEMBL41150,P08253,,ADMHVXMYTVXKSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1478838,DTCC00179852,1660716,4274
CHEMBL411519,P08253,,KATLUBNAFTZQRL-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,142,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300317,DTCC00500503,1103148,25438
CHEMBL411851,P08253,,LXWSFODDORIHFJ-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,2.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1369998,DTCC00282992,1682565,2897
CHEMBL41324,P08253,,KLPXBGLTDZNLHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1444607,DTCC00179839,1143594,4274
CHEMBL41408,P08253,,NOJIQYLBNRETQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1471292,DTCC00179966,1370254,4274
CHEMBL414626,P08253,,QZATUGXXMHCJRV-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,330,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1126155,DTCC00344067,1851326,4691
CHEMBL414626,P08253,,QZATUGXXMHCJRV-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,5128.61,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258368,DTCC00344067,1841438,24803
CHEMBL41485,P08253,,VRDVYZAEYHXMTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,260000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1561985,DTCC00179243,819628,4273
CHEMBL415074,P08253,,UBPYMHQGZFVTLG-WDYNHAJCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.1,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,548188,DTCC00232756,29798,16308
CHEMBL415074,P08253,,UBPYMHQGZFVTLG-WDYNHAJCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.1,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,984194,DTCC00232756,4194,1012
CHEMBL415482,P08253,,GETQXLAMYOMSJS-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,0.68,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1311758,DTCC00133489,1725495,4760
CHEMBL415872,P08253,,DRMZKUIIQMVRSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,3400,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1580081,DTCC00179304,432757,4273
CHEMBL415879,P08253,PHENANTHROLINE,DGEZNRSVGBDHLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5104007,DTCC00177236,247838,43205
CHEMBL415949,P08253,,KZZUIFPIPUBRFP-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,690,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1464524,DTCC00198130,1239887,17283
CHEMBL416304,P08253,,SILYLRSFWCVUFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1706974,DTCC00200716,1034801,16216
CHEMBL416306,P08253,,DNEUAPIVDBXPFN-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,391,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1458391,DTCC00197460,1046360,17283
CHEMBL416421,P08253,,ZLPOIHFXRODFHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1478840,DTCC00179379,1013741,4274
CHEMBL416510,P08253,,LBNTZOSDPQSCQC-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,602.56,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258317,DTCC00209043,488942,24803
CHEMBL416510,P08253,,LBNTZOSDPQSCQC-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,600,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,673015,DTCC00209043,485907,2288
CHEMBL417061,P08253,,BLYOONREWFOUNV-FIYSCABWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,2033,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1529221,DTCC00103480,564494,4824
CHEMBL417200,P08253,,HSJPSXSXQYYJSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1700489,DTCC00200548,421498,16216
CHEMBL417212,P08253,,RGHQIKPHUVHVFH-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,305,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,504952,DTCC00212058,1067263,5598
CHEMBL417411,P08253,,JTEKRZIXTMGGJR-GJZUVCINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,488915,DTCC00211599,1741749,5598
CHEMBL417749,P08253,,IHPUTEIJIZVYPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,33,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1699208,DTCC00201248,679478,16216
CHEMBL417757,P08253,,MXZLDTSVPDTTAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,16,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1690795,DTCC00201006,1358751,16216
CHEMBL417977,P08253,,SCKGCOPJBBAWME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11297453,IC50,=,2391,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104376,DTCT0025094,956219,DTCC00138723,1340877,16645
CHEMBL418028,P08253,,HCAGVHGQPPXQPY-IXDOHACOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,10,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,625538,DTCC00164379,840691,2586
CHEMBL418291,P08253,,RGQWTGAVFAYQEF-NXCFDTQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,0.1,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1641185,DTCC00215868,497564,2712
CHEMBL418292,P08253,,BJOZETKUSDMMAN-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,2.2,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1645903,DTCC00215765,1693218,2712
CHEMBL418292,P08253,,BJOZETKUSDMMAN-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,5.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1380025,DTCC00215765,1682566,2897
CHEMBL418437,P08253,,OTHBKTUWXHXMSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1463038,DTCC00179967,1111361,4274
CHEMBL418442,P08253,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,39,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,904792,DTCC00186442,1046249,15892
CHEMBL418442,P08253,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17088065,IC50,=,39,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432503,DTCT0025094,2061970,DTCC00186442,1037472,22402
CHEMBL418443,P08253,,GSXKMMPZFVRZAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,730616,DTCC00184906,236734,3810
CHEMBL418472,P08253,,DGZARDVMPOFZHA-GDBMZVCRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,900,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,671853,DTCC00208586,841134,2288
CHEMBL418476,P08253,,JTEKRZIXTMGGJR-NVQXNPDNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,492745,DTCC00211543,743973,5598
CHEMBL418521,P08253,,YKOGGKVKSNWIHK-MBDJBHLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,810,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,543143,DTCC00136024,678810,14548
CHEMBL418639,P08253,,KHCVBQLHKXPRJT-GMLYINLCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1543373,DTCC00208671,691009,4358
CHEMBL418715,P08253,,ZAMDOHCMZRPYMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104545,DTCT0025094,741880,DTCC00142952,1648931,6676
CHEMBL418779,P08253,,JJAIMBOXMQASFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,125000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,485354,DTCC00261754,1424301,3361
CHEMBL41892,P08253,,ZOQRCAUTYNYRRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,5900,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1560673,DTCC00180196,2044483,4273
CHEMBL419011,P08253,,LPRBYIANGHPFSM-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,6.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1393902,DTCC00282939,648278,2897
CHEMBL41923,P08253,,ADLXGSBFAAQQTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,19000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1567003,DTCC00179933,1206902,4273
CHEMBL41928,P08253,,YBEJDLYIFZAISG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1559344,DTCC00179962,1272450,4273
CHEMBL41928,P08253,,YBEJDLYIFZAISG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16242329,IC50,>,120000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327978,DTCT0025094,1875147,DTCC00179962,1263318,20151
CHEMBL419292,P08253,,FNZTUGDYJXXGEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1408366,DTCC00241886,1742067,6359
CHEMBL419315,P08253,,AWEAPFWTHDDCFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,184,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1073621,DTCC00255150,335810,4541
CHEMBL419315,P08253,,AWEAPFWTHDDCFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,184,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317084,DTCC00255150,322613,67557
CHEMBL419315,P08253,,AWEAPFWTHDDCFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,184.08,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317287,DTCC00255150,322613,67557
CHEMBL41943,P08253,,IIHFBHZWJNGWRC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,180,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1472600,DTCC00179722,172253,4274
CHEMBL419750,P08253,,VTRJTXRAOIMSTL-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,520,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1719485,DTCC00282282,258562,16424
CHEMBL419751,P08253,,CHAFUQVXOKHDCA-APWZRJJASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,4.3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1429717,DTCC00287233,205368,16438
CHEMBL419896,P08253,,KBRVEWFSDCONMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1403499,DTCC00265483,1047085,6400
CHEMBL420259,P08253,,ZJYOUKFITJWMLH-FOWTUZBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14611841,IC50,=,5.73,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104382,DTCT0025094,879102,DTCC00263309,1003086,5741
CHEMBL420376,P08253,,LMZDADMPZWYRMS-SQHAQQRYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,1.03,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,569688,DTCC00232219,1914378,16308
CHEMBL420376,P08253,,LMZDADMPZWYRMS-SQHAQQRYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1.03,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1707995,DTCC00232219,1914648,1013
CHEMBL42040,P08253,,RZEIFKHIQYQVQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,715185,DTCC00185207,1370312,3810
CHEMBL420424,P08253,,GSCKLBZEPMMUCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104401,DTCT0025094,1024677,DTCC00251601,161731,5080
CHEMBL420447,P08253,,OHBUDNXYSLNZHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,54000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,477278,DTCC00261003,1617996,3361
CHEMBL420487,P08253,,QDCHOZJXLIIHRT-BJZITVGISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,408,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1418547,DTCC00286603,885959,16438
CHEMBL420656,P08253,,WHTRIFCXCJYQKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,2.3,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1400612,DTCC00273612,2013184,16392
CHEMBL420657,P08253,,ZPNXAVJYHSAOKF-YSSMNDQQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543676,IC50,=,2.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104375,DTCT0025094,1176096,DTCC00273546,1424440,16385
CHEMBL42067,P08253,,UKLIIGXGTPSYBF-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,530,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,901106,DTCC00186535,658583,15892
CHEMBL420674,P08253,,NWYFRVGJVQHAJF-JOMNFKBKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101917,DTCT0025094,1031815,DTCC00284346,1914967,1950
CHEMBL420932,P08253,,JBXOGQUSYPCSQK-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.44,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1394809,DTCC00225652,75833,14854
CHEMBL421009,P08253,,LUOBAMXDTNOZAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,430,NM,,,,,,,,,,,,,,Inhibition against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,101935,DTCT0025094,819649,DTCC00265197,1196559,4579
CHEMBL421029,P08253,,UGEYJONPMBOKNN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11543675,IC50,=,1.2,NM,,,,,,,,,,,,,,In vitro inhibition of human matrix metalloprotease-2,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104365,DTCT0025094,1404220,DTCC00273395,562502,16392
CHEMBL42104,P08253,,OHZWWRAGTGIQOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,730612,DTCC00184247,1692908,3810
CHEMBL42114,P08253,,LKVAANCBUJLQIE-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,36,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,901099,DTCC00186439,1046251,15892
CHEMBL421188,P08253,,QBERFMAYWTXPQT-MXHVWWQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14611841,IC50,,,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 (inactive),Not Active,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104383,DTCT0025094,861048,DTCC00262787,1774097,5741
CHEMBL421295,P08253,,REGRZFZFPDDXIW-SOFGYWHQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,5.09,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836399,DTCC00220986,1736684,53968
CHEMBL421372,P08253,,MNSCIDWEUDHWNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,,,,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (Not Determined),Not Determined,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104387,DTCT0025094,705205,DTCC00261183,1100607,3985
CHEMBL42152,P08253,,LZZFXVQBLDVWTK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,696805,DTCC00184315,1499405,3810
CHEMBL421530,P08253,,NBKLHSQMSJZFJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1.4,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1642644,DTCC00240809,1014403,4449
CHEMBL421699,P08253,,XFKRGURHEZYQDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835704,DTCC00237568,1126998,53820
CHEMBL421882,P08253,,GJOCABIDMCKCEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104401,DTCT0025094,1053305,DTCC00252532,1132660,5080
CHEMBL421882,P08253,,GJOCABIDMCKCEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,0.004,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835705,DTCC00252532,1158308,53820
CHEMBL421932,P08253,,ZHLANTZRDCBWFM-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,,,,,,,,,,,,,,,,,Inhibition of gelatinase-A (Matrix metalloprotease-2) (Not determined),Not Determined,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106806,DTCT0025094,337830,DTCC00325502,238280,15412
CHEMBL421966,P08253,,KXEGEKRSCUZQMH-OJSPLJLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,495544,DTCC00340473,1724168,15546
CHEMBL421985,P08253,,URGYPDKRIKINRO-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,3.3,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1123573,DTCC00343843,1819208,4691
CHEMBL421985,P08253,,URGYPDKRIKINRO-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,61.66,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258383,DTCC00343843,1808954,24803
CHEMBL422058,P08253,,BUFVDSAQIYWDGD-UHSQPCAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.03,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,569694,DTCC00231929,1946978,16308
CHEMBL422250,P08253,,IIABJCHWKFZJBK-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,240,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1708541,DTCC00281784,389664,16424
CHEMBL422251,P08253,,JOKZNFFZUNYVMR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11563922,KI,=,850,NM,,,,,,,,,,,,,,In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,104405,DTCT0025094,1719501,DTCC00282610,906992,16424
CHEMBL422266,P08253,,RFUWBCJNXALDEH-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of human fibroblast gelatinase A at pH 7.5,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71652,DTCT0025094,1254807,DTCC00318566,1145155,12304
CHEMBL422266,P08253,,RFUWBCJNXALDEH-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,KI,=,410,NM,,,,,,,,,,,,,,Inhibition of rabbit fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71653,DTCT0025094,1254810,DTCC00318566,1145155,12304
CHEMBL422799,P08253,,ITAGUEQBTLVHLX-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,68,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1271311,DTCC00318920,821145,12304
CHEMBL422821,P08253,,JOHYDRPBWMKVTC-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,=,1537,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1038172,DTCC00318980,1468511,6011
CHEMBL422948,P08253,,YIEJUKBUYFONED-XXBNENTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.71,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1377320,DTCC00224757,853033,14854
CHEMBL423015,P08253,,QGTWMCXPSZIGIN-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -2 (gelatinase-A),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104368,DTCT0025094,1626771,DTCC00333068,1229582,16049
CHEMBL423686,P08253,,JUASDDPTEREPES-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1100,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,546656,DTCC00285160,615546,1951
CHEMBL42378,P08253,,PYGGWLWYZUEZDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,701646,DTCC00184370,1174762,3810
CHEMBL423906,P08253,,WWXZQIVISJRIMS-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,=,656,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1028409,DTCC00319004,238219,6011
CHEMBL424,P08253,SALICYLIC ACID,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,12,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103005,DTCC00133347,47753,43205
CHEMBL424130,P08253,,QMIAXILIKVOPKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14684295,IC50,=,853,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,1,"Ma D, Wu W, Yang G, Li J, Li J, Ye Q",,104556,DTCT0025094,878643,DTCC00334179,109304,6330
CHEMBL42420,P08253,PD-169469,GJOCABIDMCKCEG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,927054,DTCC01739891,1272542,15892
CHEMBL42420,P08253,PD-169469,GJOCABIDMCKCEG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16451058,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330545,DTCT0025094,1887715,DTCC01739891,1274997,20245
CHEMBL42449,P08253,,QXMYNGZVAQOGPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,724636,DTCC00184949,1466985,3810
CHEMBL424646,P08253,,WKMOUFIFYFASPS-MDZRGWNJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8277511,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibition of human 72 kDa fibroblast gelatinase A,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,71651,DTCT0025094,1254813,DTCC00318539,886345,12304
CHEMBL42481,P08253,,VUAHLIXSRRYNJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,717526,DTCC00185613,949109,3810
CHEMBL425020,P08253,,PYNQNWZHEDOQHX-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1610,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860370,DTCC00407673,1177224,19837
CHEMBL42521,P08253,,FCCDGLDMUDUABZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10052961,KI,=,30,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-2 (MMP-2), gelatinase-A",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104394,DTCT0025094,857521,DTCC00185111,1436408,15577
CHEMBL42521,P08253,,FCCDGLDMUDUABZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,43,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,728410,DTCC00185111,1434702,3810
CHEMBL42537,P08253,,SZVMBGCUMABOMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,270,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,699327,DTCC00184757,1563731,3810
CHEMBL425415,P08253,,PACKAWWLZSBYDP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926491,DTCC00422057,98764,20786
CHEMBL425783,P08253,,KSOLTKWEALJMDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16723229,IC50,=,302,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,15,"Park K, Aplasca A, Du MT, Sun L, Zhu Y, Zhang Y, Levin JI",,377986,DTCT0025094,1969679,DTCC00428619,1296018,21111
CHEMBL426319,P08253,,VBMFIGJMAPMVAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,3060,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937009,DTCC00110338,1808389,20885
CHEMBL426388,P08253,,RINLHBFSMHCDCB-ZWBSKUQPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,350,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019761,DTCC00438908,1114131,21880
CHEMBL426434,P08253,,YCBSBKZAEBKTSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1766629,DTCC00387570,1274763,18194
CHEMBL426833,P08253,,QMJIUHKQZQSTQO-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,259,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860313,DTCC00407639,1598758,19837
CHEMBL427366,P08253,,USIMDPVZFWUXPH-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16153831,IC50,=,1760,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321185,DTCT0025094,1860414,DTCC00407677,1113845,19837
CHEMBL42739,P08253,,PLJQSRJZKINNOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,728342,DTCC00184758,2012229,3810
CHEMBL427616,P08253,,KKVTZTBYJGHGCO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1284939,DTCC00133624,2079565,4760
CHEMBL42771,P08253,,ZLXAYIGZHIXCJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,27,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,711915,DTCC00185141,1466984,3810
CHEMBL427717,P08253,,XDUWIWKZACXXFQ-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278067,DTCC00489384,1873472,25102
CHEMBL427861,P08253,,CLZKGFRECSRANT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215337,DTCC00477167,1792876,24158
CHEMBL428212,P08253,,QQRACKPWBYRJJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215329,DTCC00477175,1954457,24158
CHEMBL428554,P08253,,SZTBUYMVXLGMJO-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204555,DTCC00471859,488834,24059
CHEMBL428591,P08253,,WHHTZGVOGIKLTQ-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278536,DTCC00489407,957068,25112
CHEMBL42862,P08253,,YGUKHRAGYHDVCC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,950000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1572091,DTCC00179905,884814,4273
CHEMBL428762,P08253,,AGNZRJUBGONHIU-WEVVVXLNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266494,DTCC00485910,164175,24949
CHEMBL428767,P08253,,DRNABTKZDYWZBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,776,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266892,DTCC00486113,1523446,24951
CHEMBL429107,P08253,,ATCZHZRQAQJGGH-YFIOFSHDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221417,DTCC00478081,1555435,24252
CHEMBL429112,P08253,,IANBHIHXRLTEEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215478,DTCC00477195,1889544,24158
CHEMBL429123,P08253,,UUKCYLIDEZGIBS-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,4.8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278540,DTCC00489392,1857410,25112
CHEMBL42938,P08253,,AGRDSOUIPBKOKQ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,930630,DTCC00185902,1531845,15892
CHEMBL429431,P08253,,GJFWRLSCEYCXSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,4.9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289289,DTCC00501172,650548,25715
CHEMBL429444,P08253,,VKZVNFAGQVZFTI-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276676,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447083,DTCT0025094,2169326,DTCC00464765,1135026,23623
CHEMBL429486,P08253,,SKGCSJBALNLNLA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,9.9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278542,DTCC00489377,505178,25112
CHEMBL429571,P08253,,VPPPUOKULYHXCC-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,283,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300304,DTCC00500246,1458715,25438
CHEMBL42958,P08253,,KDMOASCHWTZIML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,715085,DTCC00184796,464257,3810
CHEMBL429589,P08253,,MUYREESVDCFSSL-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296514,DTCC00501584,1135311,25233
CHEMBL429669,P08253,,ZMPZOWIAKRPTEQ-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,106,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276479,DTCC00112467,585443,25086
CHEMBL429674,P08253,,ITVUSPVMUHFUQB-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18282708,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463861,DTCT0025094,2317226,DTCC00499830,43779,25272
CHEMBL42970,P08253,,BBUKTIVKWOIGTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1471294,DTCC00179851,140006,4274
CHEMBL429800,P08253,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204561,DTCC00471853,876522,24059
CHEMBL429800,P08253,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563907,DTCC00471853,899521,48958
CHEMBL429800,P08253,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983459,DTCT0025094,12575113,DTCC00471853,881014,55760
CHEMBL429927,P08253,,BMSDLUUZGPIUGG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,=,67,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300324,DTCC00500665,1070386,25438
CHEMBL430010,P08253,,YYBIEDBGDCCHID-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17433673,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 30 mins,,"Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,10,"Li Q, Fang H, Xu W",,455438,DTCT0025094,2233028,DTCC00477450,537205,24428
CHEMBL43011,P08253,,JNJHUFNAFHUGBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,88,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,727176,DTCC00185140,1143663,3810
CHEMBL430210,P08253,,ZJGVSDUUDCVLEO-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18083558,IC50,=,8.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461906,DTCT0025094,2278541,DTCC00489381,860750,25112
CHEMBL43026,P08253,,GMIPYLIWDLRSEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,35000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104389,DTCT0025094,1572088,DTCC00179841,1817345,4273
CHEMBL43050,P08253,,YIASDUXALBOMQY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,728416,DTCC00185003,172321,3810
CHEMBL430524,P08253,,BZTWELLPCHJZLB-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,7.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1396271,DTCC00282956,258568,2897
CHEMBL430524,P08253,,BZTWELLPCHJZLB-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18053726,IC50,=,7.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.,Bioorg. Med. Chem.,2008,16,4,"Maryanoff BE, Costanzo MJ",,469279,DTCT0025094,2295124,DTCC00282956,260885,25694
CHEMBL430612,P08253,,IVFPKTAJBISJDW-YKSBVNFPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,11,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1395987,DTCC00226002,853032,14854
CHEMBL43063,P08253,,NZVNFHULUBKMQI-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,904822,DTCC00186612,755163,15892
CHEMBL43065,P08253,OXYRESVERATROL,PDHAOJSHSJQANO-OWOJBTEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,27600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10535382,DTCC00185244,1169674,48665
CHEMBL43065,P08253,OXYRESVERATROL,PDHAOJSHSJQANO-OWOJBTEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535493,DTCC00185244,1169674,48665
CHEMBL43113,P08253,,MZIZOOUSSMSGAV-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,908481,DTCC00186443,1979397,15892
CHEMBL431130,P08253,,LZROMIIQKWLGFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,703821,DTCC00184915,2076585,3810
CHEMBL431210,P08253,BB-3497,AVDLWYHBABSSHC-CHWSQXEVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11551755,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.,Bioorg. Med. Chem. Lett.,2001,11,19,"Pratt LM, Beckett RP, Davies SJ, Launchbury SB, Miller A, Spavold ZM, Todd RS, Whittaker M",,104547,DTCT0025094,1068922,DTCC01741522,1968386,4468
CHEMBL431226,P08253,,IDKUTWZTCGVYET-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1381119,DTCC00265456,982319,6400
CHEMBL43147,P08253,,BGKNBDGHNBOSGD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,40,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,904780,DTCC00186340,787356,15892
CHEMBL43147,P08253,,BGKNBDGHNBOSGD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23453072,INH,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953885,DTCT0025094,11857957,DTCC00186340,783143,54223
CHEMBL43148,P08253,,PSHCHUIVTMBGMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,725765,DTCC00184297,1628774,3810
CHEMBL43152,P08253,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,915392,DTCC01739899,2012246,15892
CHEMBL43152,P08253,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16451058,IC50,=,4,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330545,DTCT0025094,1887720,DTCC01739899,2014806,20245
CHEMBL43152,P08253,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835710,DTCC01739899,2028335,53820
CHEMBL431680,P08253,,DQLDJYJWPVFOFC-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,=,700,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1294909,DTCC00286954,336147,16439
CHEMBL431926,P08253,,JRXNWTIRACLYGX-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,<,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1471719,DTCC00197857,852749,17283
CHEMBL43206,P08253,,NEOOWKPSCAQYPI-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,535,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,931894,DTCC00186341,1111450,15892
CHEMBL432079,P08253,BB-1101,GKHRDWHFKKUYAX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873367,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104363,DTCT0025094,865991,DTCC01739584,497069,2600
CHEMBL432079,P08253,BB-1101,GKHRDWHFKKUYAX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,1.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1378802,DTCC01739584,486746,2897
CHEMBL432223,P08253,,VDDKIBQLKXMKIW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1617690,DTCC00298906,595003,15919
CHEMBL432223,P08253,,VDDKIBQLKXMKIW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,1.51,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258451,DTCC00298906,585406,24803
CHEMBL432299,P08253,,WDJVSROJMOYUQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10052961,KI,>,10000,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-2 (MMP-2), gelatinase-A",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104394,DTCT0025094,869056,DTCC00184942,304185,15577
CHEMBL432299,P08253,,WDJVSROJMOYUQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,716314,DTCC00184942,302452,3810
CHEMBL432307,P08253,,UJVIDDIDLMDARE-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,911870,DTCC00186526,1467007,15892
CHEMBL432333,P08253,,VOKDMWUXBXSQQZ-VWNXMTODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,=,1244,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,488910,DTCC00212057,1455649,5598
CHEMBL432346,P08253,,CXBAZJDTLXTASG-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,6.4,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,561308,DTCC00232874,302963,16308
CHEMBL432346,P08253,,CXBAZJDTLXTASG-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,6.4,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1688987,DTCC00232874,303238,1013
CHEMBL432397,P08253,,IOTJDDOXTYOJJN-JZWVFAODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,0.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1377680,DTCC00283116,1806814,2897
CHEMBL43256,P08253,,OFWLISQOQVGMBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,706238,DTCC00184278,819686,3810
CHEMBL432642,P08253,,ONJATSAJIVHMLQ-GVAUOCQISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1100,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,564677,DTCC00285218,1164281,1951
CHEMBL43276,P08253,,GSCKLBZEPMMUCA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,19,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,906084,DTCC00185835,658585,15892
CHEMBL432770,P08253,,QUIDRRLYQSJQMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,75,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1056165,DTCC00249346,161690,15258
CHEMBL432842,P08253,,YPHZFHQBHSELGO-QUCCMNQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,3.2,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,980290,DTCC00151632,1725664,15116
CHEMBL432882,P08253,,NQPIHEUUYRAYII-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,653065,DTCC00186511,2046333,15057
CHEMBL432882,P08253,,NQPIHEUUYRAYII-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,917730,DTCC00186511,2044570,15892
CHEMBL432882,P08253,,NQPIHEUUYRAYII-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16451058,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330545,DTCT0025094,1887717,DTCC00186511,2047007,20245
CHEMBL432990,P08253,,NMVSNTFENGJBJY-XFAFFCHDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,=,0.64,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1304869,DTCC00287734,1273601,16439
CHEMBL432991,P08253,,PJKWYBIJVPNFJI-FBLLAGFSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,1.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1390292,DTCC00283278,648277,2897
CHEMBL433063,P08253,,LJNWPYWHBAYDNO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1536363,DTCC00209041,949376,4358
CHEMBL433171,P08253,,IXBLAZNLURBEMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1089330,DTCC00255274,401245,4541
CHEMBL433171,P08253,,IXBLAZNLURBEMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317094,DTCC00255274,387897,67557
CHEMBL433171,P08253,,IXBLAZNLURBEMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317297,DTCC00255274,387897,67557
CHEMBL433250,P08253,,UTTKOYMMTNAAJL-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,14000,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1671243,DTCC00215896,691090,2712
CHEMBL433262,P08253,,VHCRBJFCQRNNFG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,934327,DTCC00185901,1660789,15892
CHEMBL433262,P08253,,VHCRBJFCQRNNFG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16451058,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330545,DTCT0025094,1887719,DTCC00185901,1663324,20245
CHEMBL433314,P08253,,MOODLLAARDEUNJ-GRYCIOLGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12014967,KI,=,0.3,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-2 (MMP-2),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104562,DTCT0025094,792662,DTCC00229842,1532258,16740
CHEMBL43338,P08253,,FGYNRNOOSHCFPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,713014,DTCC00184933,1013798,3810
CHEMBL433415,P08253,,XZLXJYHIADSFPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,1000,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,717478,DTCC00260366,808880,3985
CHEMBL433426,P08253,,GJLVFYXHGPXLCC-QUCCMNQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9548812,IC50,=,1.6,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-2 (MMP-2).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,106804,DTCT0025094,998140,DTCC00151649,1081960,15116
CHEMBL433934,P08253,,QZATUGXXMHCJRV-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,5100,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1122410,DTCC00344103,304230,4691
CHEMBL433934,P08253,,QZATUGXXMHCJRV-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,331.13,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258369,DTCC00344103,294023,24803
CHEMBL43411,P08253,,IIHFBHZWJNGWRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412980,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease-2.,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104388,DTCT0025094,1445928,DTCC00179724,1174701,4274
CHEMBL434201,P08253,,QUCIMBXHIZZKDW-HZSPNIEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9871766,ACTIVITY,=,1,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (Gel.A),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,106801,DTCT0025094,637665,DTCC00164279,1616972,2586
CHEMBL434204,P08253,,ZVOOITOWQYKKKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11412979,IC50,=,5200,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,101908,DTCT0025094,1587716,DTCC00179314,916394,4273
CHEMBL434348,P08253,,HUNBFLZYPNPINY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15357971,KI,>,3300,NM,,,,,,,,,,,,,,inhibition of Matrix metalloprotease-2 (MMP-2),,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,17,"Xue CB, Chen XT, He X, Roderick J, Corbett RL, Ghavimi B, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Trzaskos J, Newton RC, Duan JJ, Decicco CP",,302675,DTCT0025094,1768806,DTCC00387612,77658,18194
CHEMBL43447,P08253,,ZIHRXQGOGSXZRF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,30,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,724708,DTCC00184756,1979378,3810
CHEMBL434567,P08253,,CKZHFOKQZRZCPF-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17256836,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425539,DTCT0025094,2019756,DTCC00438928,33872,21880
CHEMBL434567,P08253,,CKZHFOKQZRZCPF-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457492,DTCC00438928,36639,32556
CHEMBL43479,P08253,,UKLIIGXGTPSYBF-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,910700,DTCC00186429,107667,15892
CHEMBL434902,P08253,,WOYRNWQVZJJWTK-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,2.14,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1796431,DTCC00394750,693066,8231
CHEMBL435399,P08253,,HWWUSFMLISZBRB-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14643313,KI,>,3333,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2),,"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization.",Bioorg. Med. Chem. Lett.,2003,13,24,"Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Qian M, Ribadeneira MD, Vaddi K, Christ DD, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP",,104561,DTCT0025094,1042135,DTCC00318376,1980922,6011
CHEMBL435690,P08253,,QGNGZCPBWQOYKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828769,DTCC00399828,855009,19718
CHEMBL43587,P08253,,HTLIQNNZGMWTCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,713018,DTCC00184798,1979379,3810
CHEMBL436205,P08253,,NOXYNXIAEWTFQX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,1.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1370528,DTCC00325471,1754229,15412
CHEMBL436230,P08253,,HMXIGWYKQCGDNX-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,414,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1112974,DTCC00344112,1565528,4691
CHEMBL436230,P08253,,HMXIGWYKQCGDNX-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,414,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,553019,DTCC00344112,1565536,4692
CHEMBL436230,P08253,,HMXIGWYKQCGDNX-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,416.87,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258379,DTCC00344112,1555529,24803
CHEMBL436326,P08253,,YDMULAZNHVGCAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15857146,IC50,=,30,NM,,,,,,,,,,,,,,In vitro inhibition of human Matrix metalloprotease 2,,C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.,J. Med. Chem.,2005,48,9,"Breyholz HJ, Schäfers M, Wagner S, Höltke C, Faust A, Rabeneck H, Levkau B, Schober O, Kopka K",,305379,DTCT0025094,1828762,DTCC00400024,1340194,19718
CHEMBL43644,P08253,,VHCRBJFCQRNNFG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,450,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,904832,DTCC00186536,172340,15892
CHEMBL43644,P08253,,VHCRBJFCQRNNFG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16451058,IC50,=,450,NM,,,,,,,,,,,,,,Inhibitory activity against MMP2,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330545,DTCT0025094,1887718,DTCC00186536,174787,20245
CHEMBL43667,P08253,,MTRUAHVPTPWCQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,696904,DTCC00185139,916461,3810
CHEMBL436950,P08253,,ISGKPJSIGMKCEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16516466,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354460,DTCT0025094,1926500,DTCC00421635,908661,20786
CHEMBL43704,P08253,,NATAMMXFTCDJKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,715179,DTCC00184727,1143664,3810
CHEMBL437407,P08253,,HTUGJHMFYMFUPL-IKCVQBBRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282406,DTCC00488449,260775,25163
CHEMBL437488,P08253,,RVWAKNLWMSGWFK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113786,DTCC00452694,1230897,23023
CHEMBL437488,P08253,,RVWAKNLWMSGWFK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440144,DTCT0025094,2113816,DTCC00452694,1230897,23023
CHEMBL437488,P08253,,RVWAKNLWMSGWFK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440150,DTCT0025094,2113844,DTCC00452694,1230897,23023
CHEMBL437488,P08253,,RVWAKNLWMSGWFK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440156,DTCT0025094,2113873,DTCC00452694,1230897,23023
CHEMBL43806,P08253,,URQYGZHYLQIBIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,719759,DTCC00184977,626231,3810
CHEMBL438125,P08253,,FLELGRFHQSJQFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,>,3330,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215334,DTCC00477170,147992,24158
CHEMBL438519,P08253,,MXFDANXBAJYGHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,>,150,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266560,DTCC00485871,1005475,24949
CHEMBL438528,P08253,,BVFWOEMSVMBUTK-RBDMOPTHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296522,DTCC00501777,1135310,25233
CHEMBL43854,P08253,,CPQOAVVNIOSBCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,702810,DTCC00184371,529330,3810
CHEMBL439012,P08253,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,IC50,=,92000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440138,DTCT0025094,2113782,DTCC00452723,1715977,23023
CHEMBL439012,P08253,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440144,DTCT0025094,2113812,DTCC00452723,1715977,23023
CHEMBL439012,P08253,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440150,DTCT0025094,2113840,DTCC00452723,1715977,23023
CHEMBL439012,P08253,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP2 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440156,DTCT0025094,2113869,DTCC00452723,1715977,23023
CHEMBL439066,P08253,,LBCLZTXMMZKWOQ-AZGAKELHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296507,DTCC00502017,973006,25233
CHEMBL439405,P08253,,VVHOXHYIVMZQIO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,574,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278055,DTCC00489477,228533,25102
CHEMBL439668,P08253,,LBBPJNWJEYJGRW-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16005220,IC50,=,8.4,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-2,,Identification of potent and selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,18,"Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE",,304620,DTCT0025094,1793973,DTCC00394152,757489,8231
CHEMBL439931,P08253,,UGBFTDFVLBACAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,0.6,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1712499,DTCC00201013,1132089,16216
CHEMBL440048,P08253,,ZVQXOBXYAOIXSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,=,370,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215339,DTCC00477165,1214780,24158
CHEMBL440178,P08253,,UBBBKPVDKLDZNE-AXVPLRHPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,506547,DTCC00340689,1047919,15546
CHEMBL440355,P08253,,XJMLKUIRAXOATH-YZYPPFLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10639284,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104366,DTCT0025094,484624,DTCC00340443,1598008,15546
CHEMBL440398,P08253,,SIMKLZXUJGLRHO-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18086526,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of full length MMP2,,"beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.",Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV",,465909,DTCT0025094,2300303,DTCC00500201,294142,25438
CHEMBL44045,P08253,,XNBVIEGDQYIRRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,31,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,699333,DTCC00184665,1881770,3810
CHEMBL440498,P08253,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,KI,=,0.22,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104534,DTCT0025094,1060823,DTCC01741261,583202,16063
CHEMBL440498,P08253,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,0.4,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,699283,DTCC01741261,582874,3985
CHEMBL440498,P08253,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,0.4,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1642626,DTCC01741261,594329,4449
CHEMBL440498,P08253,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15686921,KI,=,0.22,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302479,DTCT0025094,1744918,DTCC01741261,584379,18787
CHEMBL440498,P08253,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14741471,DTCC01741261,2107724,69259
CHEMBL440498,P08253,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19422229,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500582,DTCT0025094,2824172,DTCC01741261,585998,33635
CHEMBL440498,P08253,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25192810,IC50,=,0.029,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442062,DTCT0025094,13992242,DTCC01741261,611029,59837
CHEMBL440498,P08253,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25264600,IC50,=,0.029,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431420,DTCT0025094,13989102,DTCC01741261,590804,60036
CHEMBL44062,P08253,,QVNUOLHHXUUNEH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,927029,DTCC00104684,367719,15892
CHEMBL440714,P08253,,QTXKDSNGGLBSKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1616268,DTCC00298905,465562,15919
CHEMBL440714,P08253,,QTXKDSNGGLBSKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,12.02,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258450,DTCC00298905,455571,24803
CHEMBL440921,P08253,,JDHBSANRAFEDMI-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,23,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,629626,DTCC00351020,1436536,15057
CHEMBL441084,P08253,,GBQQHIUTXSUOPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,3.9,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1627921,DTCC00299221,1144920,15919
CHEMBL441084,P08253,,GBQQHIUTXSUOPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,3.89,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258479,DTCC00299221,1135235,24803
CHEMBL44138,P08253,,IOOPRDTXOWLHHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,711804,DTCC00184718,2012228,3810
CHEMBL441502,P08253,,GXQYQFOZGUYSTC-HZPDHXFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307790,DTCT0025094,1789822,DTCC00392620,1360974,19089
CHEMBL441502,P08253,,GXQYQFOZGUYSTC-HZPDHXFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15369398,INHIBITION,=,8,%,,,,,,,,,,,,,,Inhibition of MMP-2 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307795,DTCT0025094,1789823,DTCC00392620,1360974,19089
CHEMBL441662,P08253,,AKNDZTHCJLFZCF-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,2.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1367838,DTCC00326356,1565298,15412
CHEMBL441901,P08253,,QFAVBCHJZGCQGB-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18061445,KI,>,3333,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463236,DTCT0025094,2296512,DTCC00502182,131739,25233
CHEMBL442057,P08253,,BBUAWDNXWDAMGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,660,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079337,DTCC00449745,1905404,22603
CHEMBL44225,P08253,,JXKHWYPWBNGVBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10052961,KI,=,50,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-2 (MMP-2), gelatinase-A",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104394,DTCT0025094,875642,DTCC00185170,1915625,15577
CHEMBL44225,P08253,,JXKHWYPWBNGVBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,44,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,701709,DTCC00185170,1913830,3810
CHEMBL442286,P08253,CYCLOHEXYL 6-MERCAPTOPICOLINATE,FHNKYBYJCSINOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,73000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266530,DTCC00003771,779008,24949
CHEMBL442291,P08253,,QVJFNCBRJKNUCE-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278066,DTCC00489386,2068244,25102
CHEMBL442421,P08253,,RWKNBRIIHLUCGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17188863,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,5,"Sheppeck JE, Gilmore JL, Yang A, Chen XT, Xue CB, Roderick J, Liu RQ, Covington MB, Decicco CP, Duan JJ",,453870,DTCT0025094,2221430,DTCC00478066,488866,24252
CHEMBL442423,P08253,,ODDQJXJHWIBVKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17027261,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452971,DTCT0025094,2215475,DTCC00477189,147993,24158
CHEMBL442432,P08253,,JRYQAIVHIZIBOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18068976,IC50,=,537,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461864,DTCT0025094,2278054,DTCC00489485,196176,25102
CHEMBL442443,P08253,,YQLRSUQLXQKLGB-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,472,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276480,DTCC00488471,1103078,25086
CHEMBL442445,P08253,,DMYSRZBLJSUUJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029177,IC50,=,457,NM,,,,,,,,,,,,,,Inhibition of MMP2,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459992,DTCT0025094,2266886,DTCC00486119,553270,24951
CHEMBL442449,P08253,,WVXZZGALNSGPLY-XNTDXEJSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215439,DTCC00491577,1346512,33038
CHEMBL44250,P08253,,UDXFDWQRRZOFEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10052961,KI,=,20,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-2 (MMP-2), gelatinase-A",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104394,DTCT0025094,876855,DTCC00185109,238493,15577
CHEMBL44250,P08253,,UDXFDWQRRZOFEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,472123,DTCC00185109,236733,3810
CHEMBL442587,P08253,,NLBBUNXLZBVJIF-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,11200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680393,DTCC00562846,1685712,31487
CHEMBL443202,P08253,,IRTFYDKSRVRHKT-MAUPQMMJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654641,DTCC00114751,2004130,30500
CHEMBL443759,P08253,,FLQJJGGFZOAADY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,476027,DTCC00261434,808884,3361
CHEMBL443759,P08253,,FLQJJGGFZOAADY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,480781,DTCC00261434,808886,3361
CHEMBL443818,P08253,,ZWHGWUJFPYMQHK-QTQRRKOQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229774,IC50,=,41,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-2 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,106807,DTCT0025094,578280,DTCC00344563,1533562,4692
CHEMBL44383,P08253,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,920969,DTCC00186509,593751,15892
CHEMBL44383,P08253,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,6.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1297397,DTCC00186509,582683,16328
CHEMBL44383,P08253,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12798337,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,104384,DTCT0025094,1398931,DTCC00186509,594169,5629
CHEMBL44415,P08253,,MMVAAAGUQUNADB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,694493,DTCC00184266,755131,3810
CHEMBL444279,P08253,,XFIGJGXIKVKUNO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,662,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289299,DTCC00501370,294200,25715
CHEMBL444522,P08253,,ZDPCJJXVDVOFRD-BZRAAQBKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,96.9,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586312,DTCC00565052,1821475,32055
CHEMBL44455,P08253,,PLCPLXITTDSMSK-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,61,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,923304,DTCC00186527,626251,15892
CHEMBL444664,P08253,,JTRIMPIOJZGKFB-XWRHLKSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,97.1,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586315,DTCC00565049,371783,32055
CHEMBL445717,P08253,,KMMSPMPORWBMTE-QBDLAISOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,1277,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828318,DTCC00554189,164925,33677
CHEMBL445758,P08253,,WSOOLVHGCDJMDF-LOWQCSRCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,328500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680408,DTCC00562886,1588726,31487
CHEMBL445939,P08253,,NMJHXOZWEMYWQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029173,IC50,=,67000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and evaluation of novel heterocyclic MMP inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,24,"Hayashi R, Jin X, Cook GR",,459969,DTCT0025094,2266413,DTCC00112322,424730,24949
CHEMBL445971,P08253,,PHMPGOJWLISPFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457374,DTCC00115941,371585,32556
CHEMBL445994,P08253,,MYTAFXBNPKBRNX-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510904,DTCT0025094,2438467,DTCC00512741,1809282,30977
CHEMBL446456,P08253,,UAIMSPBCAMKARB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17531482,IC50,=,1230,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,15,"Lombart HG, Feyfant E, Joseph-McCarthy D, Huang A, Lovering F, Sun L, Zhu Y, Zeng C, Zhang Y, Levin J",,456209,DTCT0025094,2237254,DTCC00480964,1102977,24495
CHEMBL446457,P08253,,YZXVQIOBIKCYRB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18036818,IC50,=,86,NM,,,,,,,,,,,,,,Binding affinity to MMP2,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461665,DTCT0025094,2276478,DTCC00488479,99430,25086
CHEMBL446702,P08253,,CLASZRHZKWOEPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16632358,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361726,DTCT0025094,1937006,DTCC00423119,584849,20885
CHEMBL446709,P08253,,FUBZFCWMCGQOOE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) at 37.32 uM after 16 hr by gelatin zymographic analysis,Active,,Med Chem Res,2011,20,7,,,912852,DTCT0025094,11590502,DTCC00444686,1611744,36632
CHEMBL447211,P08253,,VRUANMLASZOUAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,24,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612814,DTCC00117301,2016407,33264
CHEMBL447275,P08253,,AAVVXYJNWGIBPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,145,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832596,DTCC00554162,1821394,33699
CHEMBL447457,P08253,,YDDMVPLLJTZTQL-LAABSITASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,30,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457433,DTCC00115970,79316,32556
CHEMBL447787,P08253,,HWRTYSUSQVJAGF-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18242982,KI,>,2128,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462362,DTCT0025094,2282314,DTCC00488438,1684915,25163
CHEMBL448207,P08253,,ZDPCJJXVDVOFRD-MZNXXXKPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,99.1,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586313,DTCC00565051,791347,32055
CHEMBL448246,P08253,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,0,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708837,DTCC00516462,2047968,32215
CHEMBL448246,P08253,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518904,DTCT0025094,2708988,DTCC00516462,2047969,32218
CHEMBL448399,P08253,HYDROXYTOLUIC ACID,WHSXTWFYRGOBGO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103272,DTCC00565293,1703863,43205
CHEMBL448717,P08253,,DYBBHRRDRJTRSU-RYUDHWBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708945,DTCC00515627,650755,32216
CHEMBL448755,P08253,,PUZANBQLKMKNQY-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,99700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680395,DTCC00562847,68075,31487
CHEMBL44898,P08253,,YWAPUIQWVUXRRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,902226,DTCC00104686,1046250,15892
CHEMBL44931,P08253,,YFSKDXWVNPXSTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,699239,DTCC00184984,75408,3810
CHEMBL449526,P08253,,MSYDJEJTQXSRBR-BQBZGAKWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708927,DTCC00516467,1264392,32216
CHEMBL449790,P08253,,HVFMCOZNQUGGRT-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680406,DTCC00562885,1395191,31487
CHEMBL450327,P08253,,XVUIGVGFVWRFJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1635497,DTCC00227650,1338995,15919
CHEMBL450327,P08253,,XVUIGVGFVWRFJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,12.88,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258456,DTCC00227650,1329166,24803
CHEMBL45035,P08253,,ILHVRYPRZRUQCQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,702862,DTCC00185002,2076584,3810
CHEMBL45040,P08253,,AGRDSOUIPBKOKQ-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,33,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,930618,DTCC00186467,1467008,15892
CHEMBL450431,P08253,,NRHSKONRJVZHAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,45,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103898,DTCC00571871,896234,43205
CHEMBL450479,P08253,,PCUZNOWAYFCVHZ-IRPSRAIASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791138,DTCC00514877,489273,31586
CHEMBL450721,P08253,,SBTMZMWGVVORIF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,145,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800816,DTCC00562380,973846,31524
CHEMBL450923,P08253,,GCPYOJSLSJRNKG-ZDWAKIIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,99.3,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586309,DTCC00565055,501249,32055
CHEMBL450938,P08253,(3-NITROPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,VPXZTOOBAWPNGR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,15500,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629963,DTCC00406538,156505,56259
CHEMBL451393,P08253,,KZGHOBSGUMPHLC-WLQAAXPGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,340800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621583,DTCC00551967,1524166,33133
CHEMBL451473,P08253,,GJILTQLZCZTCIV-FMQWLBJXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,211300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680399,DTCC00562882,747896,31487
CHEMBL45162,P08253,,CQIQKDQFHVTTKM-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10397503,IC50,=,49,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101907,DTCT0025094,528387,DTCC00188800,1099852,3181
CHEMBL45208,P08253,,LBHXVNIHKACCKG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,38,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,724696,DTCC00185114,1174761,3810
CHEMBL452082,P08253,,RMPMGGGCHRCWIU-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510904,DTCT0025094,2438443,DTCC00512738,9768,30977
CHEMBL452083,P08253,,MOPRTFSMCQNUCT-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17719700,IC50,=,170,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510904,DTCT0025094,2438455,DTCC00512739,1841747,30977
CHEMBL452584,P08253,,MXMAVZMWYSUCJZ-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510904,DTCT0025094,2438462,DTCC00512740,261085,30977
CHEMBL452947,P08253,,JUTPCQYEVUKCAU-MNNSJKJDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,45,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791149,DTCC00514936,392324,31586
CHEMBL45357,P08253,,FCYBWLNLMVDLRH-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10397503,IC50,=,53,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101907,DTCT0025094,539685,DTCC00188708,808145,3181
CHEMBL453956,P08253,,GCPYOJSLSJRNKG-BCJWCAIOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,98.7,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586308,DTCC00565056,1535855,32055
CHEMBL454808,P08253,"2,6-DIHYDROXYBENZOIC ACID",AKEUNCKRJATALU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-6,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5102653,DTCC00005081,86519,43205
CHEMBL45483,P08253,SC-44463,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,<,1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1416203,DTCC01740008,401646,16438
CHEMBL45483,P08253,SC-44463,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12877590,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2 (MMP-2),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104373,DTCT0025094,1541415,DTCC01740008,389797,17445
CHEMBL45483,P08253,SC-44463,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,<,10,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104565,DTCT0025094,1585244,DTCC01740008,400992,2242
CHEMBL455409,P08253,,LCTLPROJUJRGOK-FOZCRLHDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19095454,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Current perspective of TACE inhibitors: a review.,Bioorg. Med. Chem.,2009,17,2,"DasGupta S, Murumkar PR, Giridhar R, Yadav MR",,495049,DTCT0025094,2595473,DTCC00517016,1470653,32093
CHEMBL45631,P08253,,USEJKZYMWYHGSP-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1651074,DTCC00192340,1403047,2712
CHEMBL456774,P08253,,LKJAZJMUPQPJNA-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,24.7,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800821,DTCC00562381,1809896,31524
CHEMBL456911,P08253,RO-28-2653,NJKTYSXXGARILV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22118188,IC50,=,23,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800773,DTCT0025094,7619122,DTCC00007863,866231,47195
CHEMBL457427,P08253,,WPWVRWGCQTWXNA-OLZOCXBDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,151400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680376,DTCC00562777,1038750,31487
CHEMBL457447,P08253,,JQRQBHODFDAKHX-DSITVLBTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,182900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680410,DTCC00117032,1330117,31487
CHEMBL457448,P08253,,LUAXIZMRCSGLOX-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,100700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680413,DTCC00117033,1809903,31487
CHEMBL457648,P08253,,AAKBPHIFCIAJDJ-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,99700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680378,DTCC00562778,425583,31487
CHEMBL457649,P08253,,AGXSAOAFQICGHJ-OLZOCXBDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,112100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680380,DTCC00562779,1167378,31487
CHEMBL457656,P08253,,DJVFLDPPUKKEPD-OLZOCXBDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,219400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680384,DTCC00562842,877596,31487
CHEMBL457657,P08253,,UOIHWOBJIFVAIQ-GXSJLCMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,771900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680386,DTCC00562843,1427538,31487
CHEMBL457658,P08253,,CCSXUQWAOZZWCG-NEPJUHHUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,802300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680388,DTCC00562844,132697,31487
CHEMBL457867,P08253,,COOIZJRWICLAGD-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,78800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680390,DTCC00562845,910241,31487
CHEMBL458083,P08253,,BDKFXCQTCZZQLZ-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,201900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680382,DTCC00562841,1459531,31487
CHEMBL45906,P08253,,LPSDGPPONMJJGK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,81,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1281547,DTCC00192096,1902533,15166
CHEMBL459540,P08253,,DFKJKWMLWWFZHX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,546800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680397,DTCC00562848,197025,31487
CHEMBL459757,P08253,,MFTCXYWCFRCMIY-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,221000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680404,DTCC00562884,2069160,31487
CHEMBL460725,P08253,,QHDIXGPUTSAIJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19173605,IC50,>,2500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494617,DTCT0025094,2596034,DTCC00517113,715017,32135
CHEMBL460899,P08253,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19173605,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494617,DTCT0025094,2596043,DTCC00114032,1166828,32135
CHEMBL460899,P08253,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,IC50,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14718579,DTCC00114032,2101638,68703
CHEMBL460899,P08253,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25265401,IC50,>,2500,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433220,DTCT0025094,13993816,DTCC00114032,1171843,60040
CHEMBL461004,P08253,,CHMKPIIZEKXJIC-RITPCOANSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,7100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560815,DTCC00529213,36487,28832
CHEMBL461004,P08253,,CHMKPIIZEKXJIC-RITPCOANSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,7100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582690,DTCC00529213,10376,31732
CHEMBL461220,P08253,,ZVRPHGZPZLMEPV-PIKZIKFNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18835710,KI,=,2267000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496898,DTCT0025094,2456665,DTCC00529493,111525,31825
CHEMBL46183,P08253,,ZKUXVTKGURJPOW-YESZJQIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9599226,KI,=,2400,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104564,DTCT0025094,1347399,DTCC00193499,969802,14640
CHEMBL462627,P08253,,MNYLANCSXOSQBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,19,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708832,DTCC00516390,758694,32215
CHEMBL462628,P08253,,ITQDPSGUKJGOJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,17,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708833,DTCC00516392,565008,32215
CHEMBL462629,P08253,,XEXZOINHSIFHFY-XFXZXTDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708834,DTCC00516393,175688,32215
CHEMBL462863,P08253,SODIUM 1-(12-HYDROXY)OCTADECANYL SULFATE,OHZIQDFMQOONPF-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12502345,IC50,=,9,UG.ML-1,,,,,,,,,,,,,,Inhibition of recombinant MMP2,,"Sodium 1-(12-hydroxy)octadecanyl sulfate, an MMP2 inhibitor, isolated from a tunicate of the family Polyclinidae.",J. Nat. Prod.,2002,65,12,"Fujita M, Nakao Y, Matsunaga S, Nishikawa T, Fusetani N",,505291,DTCT0025094,2400697,DTCC00006204,650854,28120
CHEMBL463395,P08253,,OPSGGAROSGLASJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19410464,IC50,=,3270,NM,,,,,,,,,,,,,,Inhibition of MMP2 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545898,DTCT0025094,2499017,DTCC00571420,1104052,33915
CHEMBL466059,P08253,,GYETWAWIKBOMPE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19422229,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500582,DTCT0025094,2824173,DTCC00536373,164710,33635
CHEMBL466118,P08253,,OJALZWLVBUFAQK-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329309,IC50,=,6.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500226,DTCT0025094,2723474,DTCC00536890,1983077,34185
CHEMBL467891,P08253,,CYVZQRKPMGDNKM-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329309,IC50,=,5.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500226,DTCT0025094,2723472,DTCC00536758,1950368,34185
CHEMBL46804,P08253,,KRFIIEPIJNLUBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,696809,DTCC00184869,2044540,3810
CHEMBL46818,P08253,,UWHPJOBPMXNVII-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,931900,DTCC00185806,464278,15892
CHEMBL46830,P08253,,ZGWIOFHKEXLJPC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,924607,DTCC00186466,1979398,15892
CHEMBL468722,P08253,,ZHXMXRVBOZWQPF-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329309,IC50,=,3.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500226,DTCT0025094,2723471,DTCC00536694,1243566,34185
CHEMBL468900,P08253,,NHPBWKYFMTXWAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497427,DTCT0025094,2457351,DTCC00530186,2016158,32556
CHEMBL46915,P08253,,HBDOUVSVVYQJQQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,700490,DTCC00185271,1370313,3810
CHEMBL46963,P08253,,YFKWYMMUDUFOOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,KI,=,36,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-2.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104541,DTCT0025094,714017,DTCC00185138,1692907,3810
CHEMBL469990,P08253,,WVAADEFBDRAILG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,IC50,=,37700,NM,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564426,DTCT0025094,2612859,DTCC00569626,37404,33264
CHEMBL469990,P08253,,WVAADEFBDRAILG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,63,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612812,DTCC00569626,37404,33264
CHEMBL470415,P08253,,MOSNISIZWMRDTO-BQBZGAKWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708923,DTCC00516465,715005,32216
CHEMBL47076,P08253,,WLJUNQUGIMIQDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,924613,DTCC00104690,1467009,15892
CHEMBL470830,P08253,,ABYNUYKRSMWNED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,IC50,=,19000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564426,DTCT0025094,2612854,DTCC00570503,1697035,33264
CHEMBL470830,P08253,,ABYNUYKRSMWNED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,94,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612827,DTCC00570503,1697035,33264
CHEMBL470831,P08253,,FDGGHYRGDJKCPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,26,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612826,DTCC00570504,1211020,33264
CHEMBL47133,P08253,,RDXNYSSQQZEEJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-2,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104391,DTCT0025094,730604,DTCC00184985,1206979,3810
CHEMBL471536,P08253,,WDSISXXPBLTCID-ZHRRBRCNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791131,DTCC00514801,682698,31586
CHEMBL471537,P08253,,GSWRTFGMHRKLKT-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,0.35,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800879,DTCC00514690,489269,31524
CHEMBL47254,P08253,,HXNNABWLGZRTMD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,904810,DTCC00186592,1596218,15892
CHEMBL472704,P08253,,AHTVSMWLENJGJF-VIEJVQOZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708957,DTCC00515697,521503,32216
CHEMBL472727,P08253,,MOFHEJYRFDDJMD-RNUUNTDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708921,DTCC00516464,1005810,32216
CHEMBL472833,P08253,,OXILFLCUDLSQBZ-WHECAKDPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,100.9,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586316,DTCC00565048,1726541,32055
CHEMBL472899,P08253,,ZRAUMSIZBNBIFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,1.2,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800897,DTCC00514692,1296946,31524
CHEMBL472905,P08253,,LBXMPUXEDBNURB-RYUDHWBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708959,DTCC00515698,521504,32216
CHEMBL472906,P08253,,LZVWNHAIDYLKHC-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708961,DTCC00515699,941299,32216
CHEMBL472915,P08253,,AKOSAZUQCGCWJD-IWDGFTLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708973,DTCC00516585,359612,32216
CHEMBL472915,P08253,,AKOSAZUQCGCWJD-IWDGFTLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560799,DTCC00516585,371518,28832
CHEMBL472915,P08253,,AKOSAZUQCGCWJD-IWDGFTLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582668,DTCC00516585,359744,31732
CHEMBL472915,P08253,,AKOSAZUQCGCWJD-IWDGFTLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,5600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183620,DTCC00516585,360736,37037
CHEMBL472915,P08253,,AKOSAZUQCGCWJD-IWDGFTLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,950,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709720,DTCC00516585,384787,58773
CHEMBL472915,P08253,,AKOSAZUQCGCWJD-IWDGFTLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,=,43750,NM,,,,,,,,,,,,,,Inhibition of MMP2 in human SKOV3 cell suspension using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1347847,DTCT0025094,13709797,DTCC00516585,384787,58773
CHEMBL472915,P08253,,AKOSAZUQCGCWJD-IWDGFTLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27039251,IC50,=,5640,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (unknown origin) after 30 mins using succinylated gelatin as substrate,,"Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.",Bioorg. Med. Chem.,2016,24,9,"Yang L, Wang P, Wu JF, Yang LM, Wang RR, Pang W, Li YG, Shen YM, Zheng YT, Li X.",,1560520,DTCT0025094,121034,DTCC00516585,355109,66411
CHEMBL473107,P08253,,YNKDEHKXKOAEBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708839,DTCC00515624,984986,32215
CHEMBL473314,P08253,,DIPCWZOATLQURP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,73,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708840,DTCC00515689,305973,32215
CHEMBL473314,P08253,,DIPCWZOATLQURP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211227,DTCC00515689,314252,33038
CHEMBL473318,P08253,,VUVYONMDCKIQRI-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708933,DTCC00516523,1264393,32216
CHEMBL473319,P08253,,NAMIVVVXZIEDQD-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,4200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708935,DTCC00516524,1231533,32216
CHEMBL473326,P08253,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Not Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518904,DTCT0025094,2708986,DTCC00516458,694221,32218
CHEMBL473326,P08253,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22018790,ACTIVITY,=,83,%,,,,,,,,,,,,,,Inhibition of human MMP2 assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799330,DTCT0025094,7596127,DTCC00516458,704135,47025
CHEMBL473326,P08253,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22018790,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human MMP2 using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799263,DTCT0025094,7596105,DTCC00516458,704135,47025
CHEMBL473326,P08253,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25330343,INHIBITION,>,10,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using GRIGFL substrate up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435005,DTCT0025094,13947405,DTCC00516458,687799,60192
CHEMBL473327,P08253,,ZHNBFYMZDUSWSL-OWBHPGMISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,80,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708835,DTCC00516459,597255,32215
CHEMBL473521,P08253,,FBMGHEDUGHGPQZ-ONGXEEELSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708947,DTCC00515628,2003994,32216
CHEMBL473522,P08253,,GWMUMTFKARYGPQ-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,5200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708939,DTCC00516526,1523758,32216
CHEMBL473523,P08253,,CWNWOKPLGFDZMG-RYUDHWBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708943,DTCC00516528,1394616,32216
CHEMBL473524,P08253,,ZXIFZTOARITQIS-SWICKSTGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708963,DTCC00516529,1166815,32216
CHEMBL473731,P08253,,XOPFIARROALHID-UNERYHBUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708967,DTCC00516531,2004006,32216
CHEMBL473732,P08253,,VOISKJXADUZZFZ-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,109,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708971,DTCC00516533,164489,32216
CHEMBL474325,P08253,,WXWCEHFFHYJWIF-JOVKLMRISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708917,DTCC00515693,1362261,32216
CHEMBL474326,P08253,,KCONJLWEYUCWTH-OCCSQVGLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708919,DTCC00515694,973301,32216
CHEMBL474327,P08253,,KTJDKDVTYIKQCS-AZGCOUAMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708953,DTCC00515695,650756,32216
CHEMBL474523,P08253,,OUDOQEURKMFZDS-DVECYGJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791132,DTCC00514802,844569,31586
CHEMBL474723,P08253,,QJTQSHPLYJZWCK-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791133,DTCC00514803,1426981,31586
CHEMBL474924,P08253,,IFXKVYOUWYXBAE-KOSHJBKYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791127,DTCC00514742,682696,31586
CHEMBL474925,P08253,,JEXGMFUVEIZKRF-MWTRTKDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791128,DTCC00514743,1103405,31586
CHEMBL475343,P08253,,QPFMXZZJEFJTTA-YTDWTQRBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708925,DTCC00516466,425051,32216
CHEMBL475344,P08253,,DXYYQAQGIUPDKU-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708931,DTCC00516469,941302,32216
CHEMBL475540,P08253,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,7,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708829,DTCC00515616,1178193,32215
CHEMBL475540,P08253,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518904,DTCT0025094,2708989,DTCC00515616,1178199,32218
CHEMBL475742,P08253,,RLJYCZREXIWYAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,49,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708830,DTCC00515618,2015780,32215
CHEMBL476466,P08253,,BUQMNSXLQZDEDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,659600,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622540,DTCC00551622,327472,33114
CHEMBL476637,P08253,,KYGMQKOVZLAUNI-PFWMLDTASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,116300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621569,DTCC00551655,1071063,33133
CHEMBL476638,P08253,,NTWBLXIKHNDWTO-YRYLYKBFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,71400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621561,DTCC00551656,941674,33133
CHEMBL476639,P08253,,UGRLXBNVYASYNP-YRYLYKBFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,64300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621558,DTCC00551657,1491962,33133
CHEMBL476657,P08253,,ZSUBNFVJGMRAEZ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,76100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622539,DTCC00551479,1491958,33114
CHEMBL476868,P08253,,HSLSHFAHKZFSOL-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,501500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622541,DTCC00551623,1653437,33114
CHEMBL477251,P08253,,VSRQAGFMXSCXSN-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,287300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622536,DTCC00551420,779759,33114
CHEMBL47728,P08253,,XXNCZTSFXIANIO-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10397503,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101907,DTCT0025094,531208,DTCC00188668,1584488,3181
CHEMBL477449,P08253,,BXJNUUXUWSKOHW-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,76800,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622537,DTCC00551421,1971790,33114
CHEMBL477652,P08253,,NRHWNPMAXZZLFZ-JEJOPICUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,120800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621570,DTCC00551658,2069017,33133
CHEMBL477656,P08253,,WXSBCFUNXZCXIL-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,107200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622535,DTCC00551419,100163,33114
CHEMBL478053,P08253,,GCPYOJSLSJRNKG-AOPVIXITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,96.5,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586311,DTCC00565053,1050257,32055
CHEMBL478078,P08253,,LIAOTEQQTPWSMG-NUCSPZLJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,37800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621547,DTCC00551438,132526,33133
CHEMBL478079,P08253,,IGGAUACBPJXFHC-ITHMCKDVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,47600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621551,DTCC00551439,747730,33133
CHEMBL47971,P08253,,JWTZXWCNQFZKDO-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1251571,DTCC00191978,647232,15166
CHEMBL480191,P08253,,RSGVORYAIGQYKC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710443,DTCC00532931,240442,32223
CHEMBL480192,P08253,,BVHVBQPFFANDCW-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,Not Determined,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710451,DTCC00532932,888537,32223
CHEMBL480351,P08253,,GIAVIYZYXMFIGR-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,=,74900,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710438,DTCC00532933,1821152,32223
CHEMBL480757,P08253,,GAXJSGLKTKGDQV-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710442,DTCC00532819,629992,32223
CHEMBL480758,P08253,,IXUAWIOCMPIPOM-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,Not Determined,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710450,DTCC00532821,629993,32223
CHEMBL481532,P08253,,QXJLSBOOUJWBFB-YQJFHSMKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654631,DTCC00526186,1716668,30500
CHEMBL481533,P08253,,UKKOTZUVQBTYJI-YQJFHSMKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654630,DTCC00114702,585895,30500
CHEMBL481704,P08253,,HHZNDOJXEPMOON-YQJFHSMKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,IC50,=,297300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654668,DTCC00114703,1070774,30500
CHEMBL481711,P08253,,OIXMXOATOMTGIL-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710445,DTCC00532758,111345,32223
CHEMBL481712,P08253,,IALSBWBRIDYNGC-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,=,21700,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710436,DTCC00532759,985182,32223
CHEMBL482118,P08253,,CSOPRORDYFJSBJ-YGLIYXGISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654628,DTCC00526402,228979,30500
CHEMBL482319,P08253,,JRIDLXYLYGFXAV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,=,81800,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710440,DTCC00533006,1178399,32223
CHEMBL482341,P08253,,OFLBRKJKSKQKCC-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,=,50500,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710437,DTCC00532687,1821145,32223
CHEMBL48256,P08253,,DOXXSEYJDIFFAY-KMDXXIMOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9599226,KI,=,249,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104564,DTCT0025094,1359473,DTCC00193645,1099889,14640
CHEMBL482569,P08253,,XBFXJMMYLBDNIS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,24,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612816,DTCC00569554,1406957,33264
CHEMBL482570,P08253,,DSVOZVDBZXHCJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,15,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612813,DTCC00117302,501285,33264
CHEMBL482633,P08253,,KSPRROVOPCKOKA-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,628000,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622522,DTCC00552211,618490,33114
CHEMBL482716,P08253,,CMVYRAWWEOBLGF-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,3140,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542598,DTCC00559815,111630,28603
CHEMBL482917,P08253,,AQCVVGWXCDKQLI-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,12700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542597,DTCC00559816,694722,28603
CHEMBL482961,P08253,,JDHGPTDYDICLJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564426,DTCT0025094,2612858,DTCC00569552,1983467,33264
CHEMBL482961,P08253,,JDHGPTDYDICLJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,69,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612818,DTCC00569552,1983467,33264
CHEMBL482962,P08253,,IVGSTMMMIBMQSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,33,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612817,DTCC00569553,2016406,33264
CHEMBL48310,P08253,HINOKITIOL,FUWUEFKEXZQKKA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,90,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103134,DTCC00192828,1763870,43205
CHEMBL483113,P08253,,RWIMUDZHMABXDA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,8760,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542578,DTCC00559764,1374419,28603
CHEMBL483114,P08253,,PFKRXUAGNJCQHE-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,2930,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542600,DTCC00559765,533310,28603
CHEMBL483123,P08253,,CVDKJHCVSLFIMB-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,17800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542596,DTCC00559817,533312,28603
CHEMBL483320,P08253,,ICZZYDCHOPJQOS-JWHUVLAVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,50500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542595,DTCC00559818,1756690,28603
CHEMBL48368,P08253,,SHIWHCHRVQEPMU-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1251567,DTCC00191757,1870153,15166
CHEMBL483857,P08253,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,13.9,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457380,DTCC00007664,1756562,32556
CHEMBL483857,P08253,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19807733,KI,=,64,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14736731,DTCC00007664,2106063,69319
CHEMBL483857,P08253,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19807733,KI,=,320,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14736732,DTCC00007664,2106063,69319
CHEMBL483857,P08253,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,0,%,,,,,,,,,,,,,,Inhibition of human MMP2 using fluorogenic substrate assessed as activity remaining at 30 uM by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831085,DTCT0025094,10566565,DTCC00007664,1767161,48923
CHEMBL483857,P08253,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,1.1,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702123,DTCT0025094,5064901,DTCC00007664,1746732,42713
CHEMBL483857,P08253,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,=,1.8,10'-3/M/S,,,,,,,,,,,,,,Inhibition of MMP2 assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702126,DTCT0025094,5066029,DTCC00007664,1746732,42713
CHEMBL483857,P08253,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,13.9,NM,,,,,,,,,,,,,,Inhibition of MMP2 by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702132,DTCT0025094,5066062,DTCC00007664,1746732,42713
CHEMBL483857,P08253,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,13.9,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP2 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831070,DTCT0025094,10566503,DTCC00007664,1767161,48923
CHEMBL484119,P08253,,ZFHBIVUDCQWJCX-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18474428,IC50,=,24,/UM,,,,,,,,,,,,,,Inhibition of human bowes melanoma cell MMP2,,"Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.",Bioorg. Med. Chem.,2008,16,11,"Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H",,556818,DTCT0025094,2543653,DTCC00559410,1885708,28901
CHEMBL484121,P08253,TX-2030,QEVLNRMSPRSJQH-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18474428,IC50,=,49,/UM,,,,,,,,,,,,,,Inhibition of human bowes melanoma cell MMP2,,"Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.",Bioorg. Med. Chem.,2008,16,11,"Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H",,556818,DTCT0025094,2543660,DTCC00008578,1696932,28901
CHEMBL484123,P08253,TX-2045,JGCODPNHLJNTMW-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18474428,IC50,>,240,/UM,,,,,,,,,,,,,,Inhibition of human bowes melanoma cell MMP2,,"Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.",Bioorg. Med. Chem.,2008,16,11,"Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H",,556818,DTCT0025094,2543656,DTCC00008586,1950642,28901
CHEMBL484262,P08253,,BBCCMNOZBPHYAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,664,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2456497,DTCC00546798,1470988,32556
CHEMBL484302,P08253,TX-2046,JGCODPNHLJNTMW-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18474428,IC50,>,240,/UM,,,,,,,,,,,,,,Inhibition of human bowes melanoma cell MMP2,,"Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.",Bioorg. Med. Chem.,2008,16,11,"Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H",,556818,DTCT0025094,2543655,DTCC00008591,371710,28901
CHEMBL484316,P08253,TX-2044,ZFHBIVUDCQWJCX-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18474428,IC50,,,,,,,,,,,,,,,,,Inhibition of human bowes melanoma cell MMP2,Not Determined,"Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.",Bioorg. Med. Chem.,2008,16,11,"Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H",,556818,DTCT0025094,2543661,DTCC00008577,2016299,28901
CHEMBL484321,P08253,TX-2031,QEVLNRMSPRSJQH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18474428,IC50,=,50,/UM,,,,,,,,,,,,,,Inhibition of human bowes melanoma cell MMP2,,"Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.",Bioorg. Med. Chem.,2008,16,11,"Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H",,556818,DTCT0025094,2543659,DTCC00008583,111629,28901
CHEMBL485492,P08253,,QNKSDDQPRLWOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457367,DTCC00115942,306350,32556
CHEMBL485492,P08253,,QNKSDDQPRLWOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21866961,KI,=,110000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771288,DTCT0025094,6116349,DTCC00115942,296761,46049
CHEMBL485492,P08253,,QNKSDDQPRLWOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,=,170,NM,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550512,DTCC00115942,288987,63755
CHEMBL485492,P08253,,QNKSDDQPRLWOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550536,DTCC00115942,288987,63755
CHEMBL486063,P08253,,ZANUNWQWTQAZRE-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,55300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622521,DTCC00552210,425446,33114
CHEMBL486368,P08253,,LDSFSKFATNBTBV-GUBZILKMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,0.4,%,,,,,,,,,,,,,,Inhibition of MMP2 at 1.3 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495832,DTCT0025094,2586298,DTCC00117134,501251,32055
CHEMBL48786,P08253,,WMVFFTPYCGKWCT-PCCBWWKXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9599226,KI,=,1533,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104564,DTCT0025094,1355637,DTCC00193466,1934553,14640
CHEMBL488617,P08253,,YQOYDTYUPFCPKG-AMGIVPHBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791141,DTCC00514928,650740,31586
CHEMBL488734,P08253,,MJFCTCXSBZQDJC-ILHLOOHCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621594,DTCC00551966,586215,33133
CHEMBL488992,P08253,,SOONHHZPGHUUEI-UHNVWZDZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582669,DTCC00528550,1556024,31732
CHEMBL489026,P08253,,VUDJWDOZBXAVEB-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,71200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622531,DTCC00552383,1136063,33114
CHEMBL489100,P08253,BMS-561392,QVNZBDLTUKCPGJ-SHQCIBLASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,482,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328282,DTCT0025094,13572208,DTCC00005548,590183,39059
CHEMBL489231,P08253,,ALDGZQPIINGCCY-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,86300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622532,DTCC00552384,586218,33114
CHEMBL489232,P08253,,GXWPPLPNXVAZIT-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,108700,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622533,DTCC00552385,845042,33114
CHEMBL489237,P08253,,HLOMNYUFQZGWNQ-LWMHEAGWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,397600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621586,DTCC00551847,11154,33133
CHEMBL489238,P08253,,ZGQPFAJZXXEWHK-BDQBNCQGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,368100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621584,DTCC00551848,1297361,33133
CHEMBL489414,P08253,,LSAVDSMWTYAIPK-LJLILKBBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,79600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621564,DTCC00551786,845035,33133
CHEMBL489415,P08253,,OQRMZSLHTNQGLS-DDQVESBOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,83200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621566,DTCC00551787,425440,33133
CHEMBL489603,P08253,,HDDDAEIHJFNBGK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457389,DTCC00546721,1821316,32556
CHEMBL489603,P08253,,HDDDAEIHJFNBGK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21609408,IC50,=,50000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14717067,DTCC00546721,2100842,69102
CHEMBL489826,P08253,,YAULWGVMRBKLGL-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,52300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622527,DTCC00552325,1071071,33114
CHEMBL490028,P08253,,LKTUJNRKRYBTTH-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,Not Active,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622529,DTCC00552327,100176,33114
CHEMBL490266,P08253,TX-2036,NUMKSDJRUKJUOU-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18474428,IC50,=,77,/UM,,,,,,,,,,,,,,Inhibition of human bowes melanoma cell MMP2,,"Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.",Bioorg. Med. Chem.,2008,16,11,"Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H",,556818,DTCT0025094,2543658,DTCC00008584,1017781,28901
CHEMBL490267,P08253,TX-2037,NUMKSDJRUKJUOU-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18474428,IC50,=,183,/UM,,,,,,,,,,,,,,Inhibition of human bowes melanoma cell MMP2,,"Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.",Bioorg. Med. Chem.,2008,16,11,"Uto Y, Nagasawa H, Jin CZ, Nakayama S, Tanaka A, Kiyoi S, Nakashima H, Shimamura M, Inayama S, Fujiwara T, Takeuchi Y, Uehara Y, Kirk KL, Nakata E, Hori H",,556818,DTCT0025094,2543657,DTCC00008585,953116,28901
CHEMBL490355,P08253,SULFURETIN,RGNXWPVNPFAADO-NSIKDUERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215380,DTCC00521793,148619,33038
CHEMBL490438,P08253,,RWVOFTDDGHBAIO-PPYMECGQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,256100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621580,DTCC00551731,521906,33133
CHEMBL490452,P08253,,KWIVGXIHOSWTAL-BDQBNCQGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,470600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621589,DTCC00551905,327474,33133
CHEMBL490453,P08253,,WWXOVCOSDZIFSL-BDQBNCQGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621592,DTCC00551906,877448,33133
CHEMBL490647,P08253,,FEXUIUKARXGGHJ-UXZSZYKQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,470700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621590,DTCC00551907,489671,33133
CHEMBL490844,P08253,,SWPKEZXSKUURJJ-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,169400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622524,DTCC00552270,1777325,33114
CHEMBL491050,P08253,,AASDOETWBYSNMM-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,26100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622526,DTCC00552272,1971802,33114
CHEMBL491450,P08253,,RYGCMELOLBEZLU-PEKVBPLLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,235800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621578,DTCC00551727,1777320,33133
CHEMBL491451,P08253,,ACLSNQXZQOGBCS-ZCRIDZFUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,159100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621572,DTCC00551728,973719,33133
CHEMBL491643,P08253,,AQXFSOLTNZQWIK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457501,DTCC00546723,306348,32556
CHEMBL491650,P08253,,CJCPMVSIORKIRD-PPGNKHEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,211400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621576,DTCC00551729,164887,33133
CHEMBL491651,P08253,,KPRNDHLGDTYXNC-MRZGDXHCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,283600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621581,DTCC00551730,521905,33133
CHEMBL491656,P08253,,OYGDFGMYQAEBEV-FCFXZMEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,76800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621563,DTCC00551788,554035,33133
CHEMBL49185,P08253,,YYNNRJWNBXEQTP-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,7100,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1272556,DTCC00191572,1649407,15166
CHEMBL491854,P08253,,KEWNWQHFWSYINJ-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,369400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622523,DTCC00552269,618491,33114
CHEMBL49186,P08253,,VFURABQMPHTDQE-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1271492,DTCC00191573,1067002,15166
CHEMBL492065,P08253,,KTTUJUXDBHAOOL-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,33600,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622530,DTCC00552328,1685580,33114
CHEMBL492239,P08253,,HPXPYPPJQGRHJK-KBVBDRTLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654636,DTCC00527205,1938248,30500
CHEMBL492436,P08253,,KZDWKJGPXRPGSC-WEKMIXOTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654635,DTCC00527206,132222,30500
CHEMBL492461,P08253,,OGHSZTARJCMZOC-AEFFLSMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,3200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2562203,DTCC00528196,1745144,31732
CHEMBL492462,P08253,,ORJLDRHITJOHCX-AEFFLSMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582689,DTCC00528197,1070805,31732
CHEMBL492599,P08253,,ZVFYVGRNAIMTAR-UTKZUKDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,320,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791137,DTCC00514876,1296949,31586
CHEMBL492843,P08253,,NQDVSFMRGWMBTO-CNELAYHGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654640,DTCC00114752,618181,30500
CHEMBL492859,P08253,,UYJOQDJNVXQEPP-NYQNCTAXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582678,DTCC00528492,1809475,31732
CHEMBL492881,P08253,,JLQIQGSTZQRJFN-QKFVEJEJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582684,DTCC00528260,618200,31732
CHEMBL493191,P08253,,MMLAOCAVJAJQBK-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560810,DTCC00540914,952912,28832
CHEMBL493192,P08253,,XWMMIVHGOFCADZ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560809,DTCC00540915,1147576,28832
CHEMBL493193,P08253,,CWDULFACOYCVBO-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560808,DTCC00540916,759009,28832
CHEMBL49411,P08253,,JBYHBQIDTNHWJF-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,=,310,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,637387,DTCC00191340,466182,15057
CHEMBL49413,P08253,,ZDCLAWKUXDCGDW-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,4.8,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1257467,DTCC00192052,1967744,15166
CHEMBL494297,P08253,,OJGRQQLKVKUHGN-VRZZLATASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582672,DTCC00528547,973449,31732
CHEMBL494467,P08253,,UPOJREPCRCPRAE-NRMKIYEFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654642,DTCC00527073,553750,30500
CHEMBL494522,P08253,,KJSDVSGSFRRLSV-WBVHZDCISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582682,DTCC00528405,779472,31732
CHEMBL494523,P08253,,BPAHUPZKRPSBLZ-QAPCUYQASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582681,DTCC00528406,99906,31732
CHEMBL494524,P08253,,FJLFUVJPVRWTDL-PWSUYJOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582679,DTCC00528408,2068699,31732
CHEMBL494642,P08253,,BBFVUFQMJUEVEV-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560800,DTCC00540980,1535578,28832
CHEMBL494805,P08253,,QLHFEEXZYDBHBZ-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560803,DTCC00540977,823519,28832
CHEMBL494919,P08253,,RTWOQKUHGFRHFX-QAPCUYQASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582686,DTCC00528199,1556021,31732
CHEMBL494920,P08253,,XDGPYCILXATFIO-YPMHNXCESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582685,DTCC00528200,909796,31732
CHEMBL494975,P08253,,PEWQDXCIGJCUHE-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560802,DTCC00540978,1276249,28832
CHEMBL494976,P08253,,BMWSCLBVMGXTRY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560801,DTCC00540979,1243623,28832
CHEMBL49499,P08253,,PBUVCYINXCCIRF-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1251573,DTCC00191428,2065049,15166
CHEMBL495109,P08253,,OQMZPGBWBMCCID-YPMHNXCESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582675,DTCC00528495,392495,31732
CHEMBL495234,P08253,,JMCBIKYQULEIOX-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560814,DTCC00540706,36488,28832
CHEMBL495295,P08253,,CZSOBXXKATVOEA-KBVBDRTLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654639,DTCC00114753,1038337,30500
CHEMBL495296,P08253,,IRDFIZUWBFSIIF-KBVBDRTLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654637,DTCC00527133,553751,30500
CHEMBL495382,P08253,,CDDWJAOPANZSOZ-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560806,DTCC00540918,1756498,28832
CHEMBL495490,P08253,,ZZERRWNAUFCPHV-BWODNOAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654667,DTCC00114748,489402,30500
CHEMBL495491,P08253,,IRMRRFYGYFNNAM-BWODNOAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654644,DTCC00527071,747439,30500
CHEMBL495502,P08253,,OBBSDCUMPDPHQF-BEEZEEGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,3000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457267,DTCC00547246,1983210,32556
CHEMBL495555,P08253,,OKNJOSGDEWUQIH-RNAHPLFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496898,DTCT0025094,2456667,DTCC00548438,694598,31825
CHEMBL495596,P08253,,JUKNHBAVDHQUJP-LMBAYHJBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828321,DTCC00554191,1038654,33677
CHEMBL495621,P08253,,OVRNSWPIJUFVHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,>,15000,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832582,DTCC00553772,1178656,33699
CHEMBL495795,P08253,,BWCDPDUCUGVEMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,15099,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832594,DTCC00554044,2080564,33699
CHEMBL495797,P08253,,VXPAAABROXRBQT-XHXISMBCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,1662,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828319,DTCC00554190,715467,33677
CHEMBL495831,P08253,,DVAPUVGZYOTZOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,1401,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832584,DTCC00553832,2048412,33699
CHEMBL496018,P08253,,HOYBUULCSXDSPC-KAOUJKNGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,92,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828323,DTCC00554257,1716981,33677
CHEMBL496211,P08253,,VOGZLMQCZGOADJ-FLJXZVEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,81,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828324,DTCC00554258,521952,33677
CHEMBL496212,P08253,,UMKOSVICWGLVQX-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828325,DTCC00554259,779793,33677
CHEMBL496309,P08253,,QCSQWZYXJSYMSJ-DJUQAAIZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496898,DTCT0025094,2456664,DTCC00547689,111517,31825
CHEMBL496423,P08253,,JRSOKCXTAIQJPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,2140,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832598,DTCC00554165,856607,33699
CHEMBL496527,P08253,IM-491,RJSKOAOWDAMMHR-FYYLOGMGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,3333,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457285,DTCC00007697,436647,32556
CHEMBL496619,P08253,,CXZHJWRHSTZNHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,1743,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832597,DTCC00554164,1374334,33699
CHEMBL496628,P08253,,SPGSQKKTHWOODB-BVSLBCMMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828332,DTCC00554399,1971829,33677
CHEMBL496629,P08253,,SPGSQKKTHWOODB-HJNYFJLDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,1090,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828333,DTCC00554400,1809802,33677
CHEMBL49671,P08253,,HWLNAJHPYNDARJ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase A (matrix metalloprotease-2 MMP2),,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104372,DTCT0025094,634042,DTCC00191760,1981305,15057
CHEMBL496825,P08253,,DSPHOALBCOPTJE-LLQWEQGGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,236,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828330,DTCC00554326,554059,33677
CHEMBL496829,P08253,,ZABUEZYWKJKVJI-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828334,DTCC00554401,1167262,33677
CHEMBL496909,P08253,,OUGLYRIZWKQCPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,14,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612823,DTCC00570592,727134,33264
CHEMBL496910,P08253,,LEYALAQCHLCNCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,85,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612822,DTCC00570593,2080760,33264
CHEMBL496942,P08253,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17623656,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507872,DTCT0025094,2388621,DTCC00547183,1983321,29282
CHEMBL496942,P08253,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497427,DTCT0025094,2457333,DTCC00547183,1983207,32556
CHEMBL496942,P08253,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25265401,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433220,DTCT0025094,13993815,DTCC00547183,1976454,60040
CHEMBL497012,P08253,,XQTUJUSPSCMEOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,3614,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832592,DTCC00554042,1178661,33699
CHEMBL497026,P08253,,SPGSQKKTHWOODB-GFUWAVFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,321,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828328,DTCC00554324,779794,33677
CHEMBL497032,P08253,,FXUWJFZELUGOAQ-YPHDSLMMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,156,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828331,DTCC00554398,1038657,33677
CHEMBL497222,P08253,,AVCGYVHCLDMOAW-GFUWAVFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,68,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828329,DTCC00554325,1874229,33677
CHEMBL497645,P08253,,ZABUEZYWKJKVJI-NYMACZPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828335,DTCC00554465,877479,33677
CHEMBL497769,P08253,,PIRLKANLMCDQSE-UFHPHHKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496898,DTCT0025094,2456661,DTCC00547750,1917719,31825
CHEMBL497772,P08253,,KQIFSUSWYMDFOC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,135,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457441,DTCC00547182,823604,32556
CHEMBL497810,P08253,,YOOJSKRBENNWQY-BWKNWUBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18835710,KI,=,7000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496898,DTCT0025094,2456668,DTCC00548337,1983227,31825
CHEMBL497838,P08253,,LJJFKNOMQHHBEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,1241,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832587,DTCC00116270,726959,33699
CHEMBL497908,P08253,,QBMRYLHKTSDMJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19410464,IC50,=,1270,NM,,,,,,,,,,,,,,Inhibition of MMP2 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545898,DTCT0025094,2499014,DTCC00117363,1809997,33915
CHEMBL497985,P08253,,HJNKYGBTSGQBDU-HOCLYGCPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2456450,DTCC00547304,630170,32556
CHEMBL498032,P08253,,VOYWXVODQDUTJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,6958,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832585,DTCC00553833,953057,33699
CHEMBL498272,P08253,,NSHZQFVEIUWJLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,IC50,=,23000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564426,DTCT0025094,2612857,DTCC00570595,791396,33264
CHEMBL498272,P08253,,NSHZQFVEIUWJLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,94,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612820,DTCC00570595,791396,33264
CHEMBL498274,P08253,,UHPIIBXLPOMYFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,11,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612821,DTCC00570594,985625,33264
CHEMBL498915,P08253,,NIPJJOWPCLBDGS-CLOONOSVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,79,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791142,DTCC00514929,67486,31586
CHEMBL499313,P08253,,IBMUIXAPDBZOLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,2674,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832591,DTCC00553988,1341791,33699
CHEMBL499426,P08253,,XGMBBGDQKHEJGS-NJHZRGNWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791134,DTCC00514804,1070634,31586
CHEMBL499539,P08253,,RRXCEVZGPPDCGR-RQJHMYQMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708915,DTCC00515692,1971389,32216
CHEMBL499854,P08253,,GKURRRNPHZGWQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,96,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832593,DTCC00554043,759132,33699
CHEMBL499905,P08253,,JUSNXCIZGYMOPC-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19410464,IC50,=,1440,NM,,,,,,,,,,,,,,Inhibition of MMP2 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545898,DTCT0025094,2499015,DTCC00570829,812391,33915
CHEMBL50,P08253,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,6680,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534770,DTCC00135230,18482,48665
CHEMBL50,P08253,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535486,DTCC00135230,18482,48665
CHEMBL500351,P08253,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,47,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708836,DTCC00516461,984995,32215
CHEMBL500351,P08253,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Not Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518904,DTCT0025094,2708987,DTCC00516461,984998,32218
CHEMBL500911,P08253,,FIAIOOXBOSIPBY-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,170000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542585,DTCC00559945,1885714,28603
CHEMBL500939,P08253,,SYCXYHUSJAGOAG-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,8080,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542589,DTCC00559887,533313,28603
CHEMBL501043,P08253,,KYBRPVZTHIQEEP-NJGSGMGMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,94.5,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586314,DTCC00565050,371784,32055
CHEMBL501081,P08253,,OTXIXYSFGHUGEN-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,23500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680372,DTCC00562775,973850,31487
CHEMBL501715,P08253,,RMPMGGGCHRCWIU-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17719700,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510904,DTCT0025094,2438437,DTCC00560261,100290,30977
CHEMBL501757,P08253,,JTEZZZAMYIVVNR-SCZZXKLOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582670,DTCC00528549,392497,31732
CHEMBL502079,P08253,,MQVHPUMPNXPCIB-CPBHLAHYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791139,DTCC00514878,1588157,31586
CHEMBL50209,P08253,,YZDALJROFHNCEI-FWJOYPJLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12729664,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.,Bioorg. Med. Chem. Lett.,2003,13,10,"Augé F, Hornebeck W, Decarme M, Laronze JY",,104364,DTCT0025094,1086770,DTCC00195010,1272636,5548
CHEMBL502256,P08253,,IPUAYBJYRVGGOE-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,12600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542587,DTCC00559944,727041,28603
CHEMBL502260,P08253,,MKRVPSJJQDWWOP-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,11700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542583,DTCC00560003,1600270,28603
CHEMBL50228,P08253,,NSZHVJWSFHBPMB-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9599226,KI,=,8100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104564,DTCT0025094,1349978,DTCC00193676,969803,14640
CHEMBL50228,P08253,,NSZHVJWSFHBPMB-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,8100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457446,DTCC00193676,985350,32556
CHEMBL502281,P08253,,OYBUNFYJJOKUDR-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,19200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542593,DTCC00559883,79438,28603
CHEMBL502282,P08253,,RLNUXKIELANPPG-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,25500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542591,DTCC00559885,1309272,28603
CHEMBL502620,P08253,ACLARUBICIN,USZYSDMBJDPRIF-SVEJIMAYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,9900,NM,,,,,,,,,,,,,,Concentration inhibiting Clostridium histolyticum collagenase.,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49492,DTCT0025094,795387,DTCC00522599,1359408,11463
CHEMBL502674,P08253,,MLPPJTCCWGPRTB-MYVCOICNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,247,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791148,DTCC00514935,877015,31586
CHEMBL502796,P08253,,VNIVLVJMMLQGNQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,516,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832588,DTCC00116271,2016238,33699
CHEMBL502913,P08253,,WBUKRDOSNJTSTC-YTDWTQRBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,Not Determined,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708929,DTCC00516468,1809323,32216
CHEMBL503052,P08253,,GCPYOJSLSJRNKG-YNJWEERUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19007202,ACTIVITY,=,96.2,%,,,,,,,,,,,,,,Inhibition of MMP2 at 10 uM by fluorimetric assay,,Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.,J. Med. Chem.,2008,51,23,"Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N",,495830,DTCT0025094,2586310,DTCC00565054,436832,32055
CHEMBL503067,P08253,,RPWIXTPWMSUQKW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,1093,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832590,DTCC00553987,2016240,33699
CHEMBL503231,P08253,,NFPKLGKUZSGXBR-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,750,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457451,DTCC00547118,888687,32556
CHEMBL503470,P08253,,HLLDDDNIWYZZJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708838,DTCC00516463,1082310,32215
CHEMBL503651,P08253,,ZBCPKTFDPDVKFC-ABFWBJRFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,1813,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791144,DTCC00514931,714988,31586
CHEMBL50437,P08253,,OGKMZGGDXJSOLE-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1259772,DTCC00191942,1870152,15166
CHEMBL50445,P08253,,CBAVXLBMIZUDPK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10346925,IC50,=,5.4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2 (concentration required for 50% inhibition of enzyme activity),,Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.,J. Med. Chem.,1999,42,10,"Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M",,104552,DTCT0025094,1248123,DTCC00192022,1649408,15166
CHEMBL504873,P08253,ISOACTEOSIDE,FNMHEHXNBNCPCI-QEOJJFGVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,IC50,=,8960,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827434,DTCT0025094,10534769,DTCC00506630,1169673,48665
CHEMBL504873,P08253,ISOACTEOSIDE,FNMHEHXNBNCPCI-QEOJJFGVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827440,DTCT0025094,10535485,DTCC00506630,1169673,48665
CHEMBL505141,P08253,,QTAWCJGFQMZWFT-LURJTMIESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,9500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560812,DTCC00540708,1600043,28832
CHEMBL505724,P08253,,KATQZGNGQJYXSJ-KOLCDFICSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560816,DTCC00529212,79245,28832
CHEMBL505724,P08253,,KATQZGNGQJYXSJ-KOLCDFICSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582691,DTCC00529212,67651,31732
CHEMBL505762,P08253,,FLHDBGONVWRFKB-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,170200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680374,DTCC00562776,1745529,31487
CHEMBL506057,P08253,,PHCNKOHEKZYJCZ-OYRZRQNVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496898,DTCT0025094,2456662,DTCC00547690,111518,31825
CHEMBL506570,P08253,,WSVIQCQIJLDTEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,65,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103971,DTCC00571870,1381649,43205
CHEMBL507420,P08253,,PTUCPHGSAFOJAU-MGONOCMRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,192,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457426,DTCC00115971,1788790,32556
CHEMBL508335,P08253,,ODFXJYBYTABKHA-BTYSJIOQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,9.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791143,DTCC00514930,877014,31586
CHEMBL508335,P08253,,ODFXJYBYTABKHA-BTYSJIOQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,KI,=,8.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791219,DTCC00514930,877014,31586
CHEMBL508461,P08253,,VMTJQZUZINLEKC-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457357,DTCC00115944,1950497,32556
CHEMBL508517,P08253,,JZHCWZUFJUJXAM-NEPJUHHUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582676,DTCC00528494,1005959,31732
CHEMBL509027,P08253,,WRHZVMBBRYBTKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103759,DTCC00541055,669654,43205
CHEMBL509270,P08253,,HDFXAYMYXQRRFT-ATRWTNPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,1273,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791146,DTCC00514933,132052,31586
CHEMBL509346,P08253,,QEEFWEXKMRZIRZ-RTYIMRNCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791147,DTCC00514934,1588158,31586
CHEMBL510082,P08253,,MYTAFXBNPKBRNX-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510904,DTCT0025094,2438471,DTCC00512742,1971363,30977
CHEMBL510287,P08253,,XUMMBVXGIOJOPC-PWSUYJOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560797,DTCC00529211,2048282,28832
CHEMBL510287,P08253,,XUMMBVXGIOJOPC-PWSUYJOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582666,DTCC00529211,2036930,31732
CHEMBL510694,P08253,,LCLWTUJSVDCASO-JLSHBGBKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,310,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791145,DTCC00514932,1716557,31586
CHEMBL511203,P08253,,JGTIIKHYSZFICL-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329309,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,9,"Hopper DW, Vera MD, How D, Sabatini J, Xiang JS, Ipek M, Thomason J, Hu Y, Feyfant E, Wang Q, Georgiadis KE, Reifenberg E, Sheldon RT, Keohan CC, Majumdar MK, Morris EA, Skotnicki J, Sum PE",,500226,DTCT0025094,2723473,DTCC00536888,1115037,34185
CHEMBL511865,P08253,,OIVPJRDHCQNRMJ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18996018,IC50,=,632400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).",Bioorg. Med. Chem.,2008,16,23,"Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W",,537039,DTCT0025094,2680401,DTCC00562883,1071227,31487
CHEMBL512856,P08253,,WBXZBHWAMZPHQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612825,DTCC00570505,1821575,33264
CHEMBL513597,P08253,,ZAAJQVMPSOBCJC-JJGXFYADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 10 nM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494402,DTCT0025094,2595851,DTCC00517385,99765,32132
CHEMBL513597,P08253,,ZAAJQVMPSOBCJC-JJGXFYADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 100 nM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494404,DTCT0025094,2595855,DTCC00517385,99765,32132
CHEMBL513597,P08253,,ZAAJQVMPSOBCJC-JJGXFYADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in HUVEC assessed as increase in enzyme activity at 1 uM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494406,DTCT0025094,2595859,DTCC00517385,99765,32132
CHEMBL513597,P08253,,ZAAJQVMPSOBCJC-JJGXFYADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 10 nM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494408,DTCT0025094,2595863,DTCC00517385,99765,32132
CHEMBL513597,P08253,,ZAAJQVMPSOBCJC-JJGXFYADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 100 nM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494410,DTCT0025094,2595867,DTCC00517385,99765,32132
CHEMBL513597,P08253,,ZAAJQVMPSOBCJC-JJGXFYADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity at 1 uM relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494412,DTCT0025094,2595871,DTCC00517385,99765,32132
CHEMBL513597,P08253,,ZAAJQVMPSOBCJC-JJGXFYADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19161308,ACTIVITY,,,,,,,,,,,,,,,,,Stimulation of MMP2 activity in CB1 receptor knockout HUVEC assessed as increase in enzyme activity in presence of 1 uM anandamide receptor antagonist O-1918 relative to control,Not Active,Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.,J. Med. Chem.,2009,52,4,"Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S",,494599,DTCT0025094,2595875,DTCC00517385,99765,32132
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9258358,KI,=,20,NM,,,,,,,,,,,,,,"Inhibition of recombinant human 72 kDa gelatinase A, Matrix metalloprotease-2 (MMP-2)",,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104540,DTCT0025094,1289479,DTCC00514693,1228441,14264
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9888835,IC50,=,9.1,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease 2,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104380,DTCT0025094,1170610,DTCC00514693,1241881,15162
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9888835,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease 2,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,101926,DTCT0025094,1170611,DTCC00514693,1241881,15162
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10450979,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease 2,,Synthesis of an array of potential matrix metalloproteinase inhibitors using a sequence of polymer-supported reagents.,Bioorg. Med. Chem. Lett.,1999,9,14,"Caldarelli M, Habermann J, Ley SV",,101936,DTCT0025094,1560598,DTCC00514693,1228109,3238
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,=,9.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1395520,DTCC00514693,1241292,15412
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (Matrix metalloprotease-2),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104403,DTCT0025094,1395521,DTCC00514693,1241292,15412
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104534,DTCT0025094,1083289,DTCC00514693,1228978,16063
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,9.1,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1321327,DTCC00514693,1242834,4760
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,4.6,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1071324,DTCC00514693,1240485,4541
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,526000,DTCC00514693,1241045,13726
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14980648,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,5,"Delbecq F, Cordonnier G, Pommery N, Barbry D, Hénichart JP",,104545,DTCT0025094,741878,DTCC00514693,1227362,6676
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16338135,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP2,,The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.,Bioorg. Med. Chem. Lett.,2006,16,4,"Xiong Y, Wiltsie J, Woods A, Guo J, Pivnichny JV, Tang W, Bansal A, Cummings RT, Cunningham BR, Friedlander AM, Douglas CM, Salowe SP, Zaller DM, Scolnick EM, Schmatz DM, Bartizal K, Hermes JD, MacCoss M, Chapman KT",,334084,DTCT0025094,1895870,DTCC00514693,1242354,20352
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17127067,IC50,=,24,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.,Bioorg. Med. Chem.,2007,15,3,"Santos MA, Enyedy EA, Nuti E, Rossello A, Krupenko NI, Krupenko SA",,441088,DTCT0025094,2146214,DTCC00514693,1242789,23121
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17276072,IC50,=,25,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in mouse myeloma cells,,Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.,Bioorg. Med. Chem.,2007,15,6,"Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT",,435727,DTCT0025094,2079328,DTCC00514693,1230837,22603
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17956082,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451365,DTCT0025094,2204545,DTCC00514693,1231041,24059
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,24.8,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800904,DTCC00514693,1231512,31524
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3286041,DTCC00514693,1244871,38228
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21514700,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753767,DTCT0025094,6000258,DTCC00514693,1252235,44948
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21937229,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.,Bioorg. Med. Chem. Lett.,2011,21,21,"Tommasi RA, Weiler S, McQuire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Melton R, Springer C, Walker M, Zhang J, Zhu L, Shultz M",,788432,DTCT0025094,7527184,DTCC00514693,1253389,46372
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563905,DTCC00514693,1254588,48958
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944589,DTCT0025094,11835715,DTCC00514693,1255984,53820
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,=,95,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617803,DTCC00514693,1235643,56109
CHEMBL514138,P08253,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,KI,=,20,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456742,DTCC00514693,1238346,62860
CHEMBL514307,P08253,,BPUSUNXICFCCSU-JJGIJDNGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708949,DTCC00515629,1362260,32216
CHEMBL514308,P08253,,OUMSFTNGCOEURQ-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708941,DTCC00516527,715007,32216
CHEMBL514309,P08253,,KITOUJSPQKANAY-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708965,DTCC00516530,1231534,32216
CHEMBL514336,P08253,,MWVPZMFYJCIIFS-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,740,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791135,DTCC00514805,1523731,31586
CHEMBL514357,P08253,,OCOIMWKYFQPVIV-ITHMCKDVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,71200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621560,DTCC00551492,812155,33133
CHEMBL514379,P08253,,CHEGCBAIFIIJMZ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,52800,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622538,DTCC00551422,1556313,33114
CHEMBL514495,P08253,,PTRVCICYKILIEH-SQFISAMPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18358729,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition recombinant MMP2 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518659,DTCT0025094,2708831,DTCC00515685,78922,32215
CHEMBL515083,P08253,,QVAVQQVTOJMLHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,193,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800890,DTCC00514691,521492,31524
CHEMBL515085,P08253,,PJARMVPVJAFMPZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,2200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708955,DTCC00515696,294403,32216
CHEMBL515390,P08253,,MCVFKNHXPZRVBQ-VLIAUNLRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12408705,KI,=,82,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-2 (MMP-2),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104397,DTCT0025094,726185,DTCC00516662,627883,17028
CHEMBL515400,P08253,,BXZPATRZAYGZQD-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,6100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708937,DTCC00516525,1166814,32216
CHEMBL51557,P08253,,TXFHRXOVMCSUEC-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,231,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1462199,DTCC00104960,1752916,17283
CHEMBL515766,P08253,,KGKJMMZCNMIUBO-ODYMAQSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708951,DTCC00515630,132060,32216
CHEMBL515913,P08253,,VPPUEHXKTJJTPC-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791130,DTCC00514744,1938097,31586
CHEMBL515980,P08253,,KBZNOZAJAJRTII-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19053764,IC50,=,0.5,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MMP2 transfected in mouse melanoma cells,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561986,DTCT0025094,2800826,DTCC00562382,2004561,31524
CHEMBL516042,P08253,,SMSVBYMJAZEGBX-RYUDHWBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18362041,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,"Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Eur. J. Med. Chem.,2008,43,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,518899,DTCT0025094,2708969,DTCC00516532,359611,32216
CHEMBL516281,P08253,,RKBGHASJAPIGMP-ITHMCKDVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,59900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621556,DTCC00551440,327470,33133
CHEMBL51658,P08253,,APCYYZKHCZUJGB-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,491,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1449979,DTCC00104979,1563910,17283
CHEMBL51735,P08253,,ZZFYPMWQKLOJIR-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,<,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1446412,DTCC00198124,916618,17283
CHEMBL517970,P08253,,RWKHWCXMRSXBCY-LVZGIILASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19375915,ACTIVITY,,,,,,,,,,,,,,,,,Reduction of gelatinolytic activity of MMP2 in phorbol myristate acetate-stimulated human HT1080 cells at 40 and 60 ug/ml,Active,The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.,Bioorg. Med. Chem. Lett.,2009,19,10,"Mendis E, Kim MM, Rajapakse N, Kim SK",,578118,DTCT0025094,2884680,DTCC00544866,306697,34969
CHEMBL517970,P08253,,RWKHWCXMRSXBCY-LVZGIILASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19375915,FC,=,3,,,,,,,,,,,,,,,Inhibition of MMP2 gene promoter activity in phorbol myristate acetate-stimulated human HT1080 cells at 60 ug/ml by luciferase reporter gene assay relative to control,,The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.,Bioorg. Med. Chem. Lett.,2009,19,10,"Mendis E, Kim MM, Rajapakse N, Kim SK",,578124,DTCT0025094,2884688,DTCC00544866,306697,34969
CHEMBL517970,P08253,,RWKHWCXMRSXBCY-LVZGIILASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19375915,INHIBITION,=,62,%,,,,,,,,,,,,,,Inhibition of MMP2 gelatinolytic activity in phorbol myristate acetate-stimulated human HT1080 cells at 60 ug/ml by gelatin zymography relative to control,,The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.,Bioorg. Med. Chem. Lett.,2009,19,10,"Mendis E, Kim MM, Rajapakse N, Kim SK",,578120,DTCT0025094,2884685,DTCC00544866,306697,34969
CHEMBL517970,P08253,,RWKHWCXMRSXBCY-LVZGIILASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19375915,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 in phorbol myristate acetate-stimulated human HT1080 cells by gelatin zymography relative to control,Active,The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.,Bioorg. Med. Chem. Lett.,2009,19,10,"Mendis E, Kim MM, Rajapakse N, Kim SK",,578116,DTCT0025094,2884682,DTCC00544866,306697,34969
CHEMBL517970,P08253,,RWKHWCXMRSXBCY-LVZGIILASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19375915,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 gene promoter activity in phorbol myristate acetate-stimulated human HT1080 cells by luciferase reporter gene assay,Dose-dependent effect,The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.,Bioorg. Med. Chem. Lett.,2009,19,10,"Mendis E, Kim MM, Rajapakse N, Kim SK",,578122,DTCT0025094,2884690,DTCC00544866,306697,34969
CHEMBL517970,P08253,,RWKHWCXMRSXBCY-LVZGIILASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19375915,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP2 gelatinolytic activity in human HT1080 cells at upto 60 ug/ml by gelatin zymography relative to control,Not Active,The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.,Bioorg. Med. Chem. Lett.,2009,19,10,"Mendis E, Kim MM, Rajapakse N, Kim SK",,578143,DTCT0025094,2884708,DTCC00544866,306697,34969
CHEMBL518467,P08253,,QYMZESBXBCDLLC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710447,DTCC00532930,952798,32223
CHEMBL51862,P08253,,DBYYJEGRUPLGLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1681667,DTCC00201061,1261010,16216
CHEMBL518974,P08253,,ZAIPXKUDIXPSIL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,18,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612815,DTCC00569555,2048582,33264
CHEMBL519293,P08253,,RAZVWQXLABWRGV-XETPBLJFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654629,DTCC00526251,228976,30500
CHEMBL519318,P08253,,QFDZSKGCCKALKW-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,8490,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542599,DTCC00559766,1178736,28603
CHEMBL51966,P08253,,YNTPPOZAYYWSFD-SSDOTTSWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,<,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1466935,DTCC00197921,1693042,17283
CHEMBL519941,P08253,,BWVMAAWEEKUCNA-YQJFHSMKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654632,DTCC00526185,1297088,30500
CHEMBL51996,P08253,,UQQMFHHUUGVIPE-FWJOYPJLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12729664,IC50,=,550,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.,Bioorg. Med. Chem. Lett.,2003,13,10,"Augé F, Hornebeck W, Decarme M, Laronze JY",,104364,DTCT0025094,1077042,DTCC00195353,1596312,5548
CHEMBL520087,P08253,,SJSLPFGXTJRLHN-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710446,DTCC00532820,1243529,32223
CHEMBL520785,P08253,,VALKNOMNTXYCBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,=,46,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457363,DTCC00115943,1535639,32556
CHEMBL520972,P08253,,NNQRFJGGVDWZPR-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,7480,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542594,DTCC00559819,630318,28603
CHEMBL52107,P08253,,OUDOQEURKMFZDS-PHSANKKPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12729664,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.,Bioorg. Med. Chem. Lett.,2003,13,10,"Augé F, Hornebeck W, Decarme M, Laronze JY",,104364,DTCT0025094,1090569,DTCC00194480,561671,5548
CHEMBL52116,P08253,,QKGIVFXXAJEIST-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12729664,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.,Bioorg. Med. Chem. Lett.,2003,13,10,"Augé F, Hornebeck W, Decarme M, Laronze JY",,104364,DTCT0025094,1084105,DTCC00195351,658674,5548
CHEMBL52129,P08253,,WSGAVYSGAQDOGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,1915,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1462195,DTCC00198187,75557,17283
CHEMBL521410,P08253,,ARJCBSRIPGJMAD-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,Not Determined,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710449,DTCC00532757,175872,32223
CHEMBL521443,P08253,,ZHPLZQUODUBTCW-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,Not Determined,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710453,DTCC00533005,952800,32223
CHEMBL521530,P08253,,WBQPBSUHTUBCDU-KBVBDRTLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654638,DTCC00527132,682845,30500
CHEMBL521626,P08253,,RDANSEYYLHZNAT-JODIQZLPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,101500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621568,DTCC00551789,1777321,33133
CHEMBL521693,P08253,,BIVYXAUUGLCTSW-PWSUYJOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582674,DTCC00528496,392496,31732
CHEMBL521719,P08253,,ZFHJWQWVJPMAIW-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,106,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828326,DTCC00554260,1427426,33677
CHEMBL521853,P08253,,FUMDVFPNMVYFGP-PBHICJAKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582680,DTCC00528407,392494,31732
CHEMBL521861,P08253,,ICILFGNGVHEIRZ-APWZRJJASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582688,DTCC00528198,1166949,31732
CHEMBL521950,P08253,,CCPBOVXKCCEIBZ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,114900,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622525,DTCC00552271,11166,33114
CHEMBL521980,P08253,,GHPSOSQWKAIEPE-YQJFHSMKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654634,DTCC00527207,489404,30500
CHEMBL52209,P08253,,QUKDWRYJPHUXQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103122,DTCC00193427,1024887,43205
CHEMBL522422,P08253,,JOBBURWSJZOPNT-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,92,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791140,DTCC00514879,196493,31586
CHEMBL522494,P08253,,NRJRPHNKSXXZCS-NEPJUHHUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,5200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582677,DTCC00528493,1620891,31732
CHEMBL523008,P08253,,KZZLCEDWRLUBTD-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560807,DTCC00540917,1983142,28832
CHEMBL523034,P08253,,MKAIHDAGQJQAHA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19725580,IC50,=,60,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579098,DTCT0025094,2894855,DTCC00534180,683489,34869
CHEMBL523056,P08253,,YHXFISLYIQPKQL-BWODNOAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654645,DTCC00114749,1809459,30500
CHEMBL523076,P08253,,JQTQTEMWCRRECT-LLQWEQGGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19457660,IC50,=,271,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523764,DTCT0025094,2828327,DTCC00554323,1264840,33677
CHEMBL523218,P08253,,LDLLYKAZPLGUFZ-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560813,DTCC00540707,1600042,28832
CHEMBL523223,P08253,,XIGAJUVEUZPGFO-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560805,DTCC00540919,2080423,28832
CHEMBL523279,P08253,,DINOOIKKECMSCC-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,54400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622528,DTCC00552326,747737,33114
CHEMBL523373,P08253,,MYSOONWMJUSWRF-BWODNOAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654643,DTCC00527072,1556000,30500
CHEMBL523446,P08253,,RXEANXJETHDITQ-VDAFUPJJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19339187,IC50,=,76500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W",,563682,DTCT0025094,2621562,DTCC00551846,1038621,33133
CHEMBL523537,P08253,,OJQDLSAUBHRZRU-JWAFFJSPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654633,DTCC00527208,553753,30500
CHEMBL523828,P08253,,SJCLHSFAQZIWIL-WBVHZDCISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,3500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582683,DTCC00528404,1135749,31732
CHEMBL523871,P08253,,YESMHTZZRUQNPZ-KOLCDFICSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582671,DTCC00528548,811882,31732
CHEMBL523915,P08253,,FBFLGERGLQVEPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,IC50,=,14400,NM,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564426,DTCT0025094,2612856,DTCC00570591,985624,33264
CHEMBL523915,P08253,,FBFLGERGLQVEPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612824,DTCC00570591,985624,33264
CHEMBL523936,P08253,,DZJHUUQQLCRPFJ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19329328,IC50,=,122400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).,Bioorg. Med. Chem.,2009,17,8,"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W",,563473,DTCT0025094,2622534,DTCC00552386,294827,33114
CHEMBL523956,P08253,,YGNQFXKRHBOPDC-CZYKHXBRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,KI,>,3000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457511,DTCC00546724,1243693,32556
CHEMBL523999,P08253,,DPSWSNHGVDSGPZ-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18782669,IC50,=,310,NM,,,,,,,,,,,,,,Inhibition of human recombinant pro-MMP2 by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557953,DTCT0025094,2791136,DTCC00514875,9816,31586
CHEMBL524056,P08253,,BRUVFGNZSIDHKS-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560811,DTCC00540772,1341652,28832
CHEMBL524197,P08253,,XKGCWMLEFHEHGA-XTZCOPOCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18571419,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,"Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.",Bioorg. Med. Chem.,2008,16,14,"Tu G, Li S, Huang H, Li G, Xiong F, Mai X, Zhu H, Kuang B, Xu WF",,487545,DTCT0025094,2654627,DTCC00527020,1362386,30500
CHEMBL52423,P08253,,KFIXLPNCOAUSPO-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,<,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1475510,DTCC00198085,2044694,17283
CHEMBL524523,P08253,,JKZWSHFLGLXDEO-JWHUVLAVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,3540,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542584,DTCC00559946,727042,28603
CHEMBL524533,P08253,,WRDNQNGMPREKKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19464885,IC50,=,855,NM,,,,,,,,,,,,,,inhibition of human recombinant MMP2 catalytic domain,,Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.,Bioorg. Med. Chem. Lett.,2009,19,13,"Zhang C, Lovering F, Behnke M, Zask A, Sandanayaka V, Sun L, Zhu Y, Xu W, Zhang Y, Levin JI",,523795,DTCT0025094,2832595,DTCC00554161,1632468,33699
CHEMBL525215,P08253,,HLMFJGVJQBEIED-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18945617,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP2 by fluorescence assay,Not Determined,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518958,DTCT0025094,2710452,DTCC00532934,1470831,32223
CHEMBL525225,P08253,,RGQFCXUQAZZQQE-RQJHMYQMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18718763,IC50,=,8900,NM,,,,,,,,,,,,,,Inhibition of MMP2 by microtiter plate fluorimetric assay,,Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2008,16,17,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,511263,DTCT0025094,2582673,DTCC00528497,1523895,31732
CHEMBL525245,P08253,,LEIKEYFUUHMEJK-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,14300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542590,DTCC00559886,1950646,28603
CHEMBL52531,P08253,,WEACEEZKOJLZFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1716532,DTCC00200795,161166,16216
CHEMBL52532,P08253,,ONOMIQQPBDQZDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,25,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1686727,DTCC00200796,1423651,16216
CHEMBL525733,P08253,,SQICDVOXCYHCFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19261472,INHIBITION,=,21,%,,,,,,,,,,,,,,Inhibition of human MMP2 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564423,DTCT0025094,2612819,DTCC00570596,1050319,33264
CHEMBL526329,P08253,,HITGUJDZSMUCGR-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18440232,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Cheng XC, Wang Q, Fang H, Tang W, Xu WF",,552206,DTCT0025094,2560804,DTCC00540976,240529,28832
CHEMBL526346,P08253,,ZOARFGHSZGZXEA-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,9940,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542581,DTCC00560005,2048481,28603
CHEMBL526556,P08253,,TUJUERHPOXOKCW-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,8000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542588,DTCC00559943,111635,28603
CHEMBL526558,P08253,,GZJCQGRTERPORI-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,32000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542582,DTCC00560004,1885715,28603
CHEMBL52659,P08253,,HEHZCMROVKSJTK-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,85,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1471731,DTCC00197898,29140,17283
CHEMBL526926,P08253,,NMDSITQGUBFCRH-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18467109,IC50,=,13100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2008,16,10,"Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W",,556437,DTCT0025094,2542592,DTCC00559884,1821465,28603
CHEMBL527018,P08253,,SFVPXERGVLDWIS-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19410464,IC50,=,270,NM,,,,,,,,,,,,,,Inhibition of MMP2 by FLIPR assay,,Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem.,2009,17,11,"Park K, Gopalsamy A, Aplasca A, Ellingboe JW, Xu W, Zhang Y, Levin JI",,545898,DTCT0025094,2499013,DTCC00117362,132799,33915
CHEMBL52808,P08253,,FEFNNGHDRQMMNY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,332,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1452490,DTCC00198221,852750,17283
CHEMBL52815,P08253,,KDIMQQWECGDHDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,1497,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1472983,DTCC00197982,690878,17283
CHEMBL52893,P08253,,WIOHNTSOYPKJIX-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,49,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1470453,DTCC00198181,497394,17283
CHEMBL52994,P08253,,NJSIDFBPVWKNNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1689345,DTCC00201450,808248,16216
CHEMBL53009,P08253,,RTBPRRSADWSXAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1720806,DTCC00200715,1773397,16216
CHEMBL53044,P08253,,WPXAJFJACNOICK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1715027,DTCC00200878,1681643,16216
CHEMBL53051,P08253,,KOFNJKLYWDTWHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1681677,DTCC00200549,614602,16216
CHEMBL53055,P08253,,RNWFVTPNHGOAMY-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,361,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1472987,DTCC00198278,981637,17283
CHEMBL53091,P08253,,YTZCQIFAVXLXHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1717904,DTCC00200970,1293404,16216
CHEMBL53094,P08253,,WYVILPRSBDCCKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1712490,DTCC00201456,1423652,16216
CHEMBL53116,P08253,,JGJZJJQMNAKKDG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1711288,DTCC00201046,485829,16216
CHEMBL53123,P08253,,YGLAUESDHXXPSW-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,1595,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1446406,DTCC00198248,593879,17283
CHEMBL53233,P08253,,DXGJDBTUJCUBRD-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,23,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1476619,DTCC00198100,1913977,17283
CHEMBL53250,P08253,,HTAGYDAMQNRLDD-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,960,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1463396,DTCC00198196,1305245,17283
CHEMBL53457,P08253,,AQKDLUIAUGFUEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1711273,DTCC00201027,647325,16216
CHEMBL53463,P08253,DOXORUBICIN,AOJJSUZBOXZQNB-TZSSRYMLSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,809551,DTCC00196573,4222,11463
CHEMBL53643,P08253,,PFUFYTLQYUUPMX-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,<,2.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1475521,DTCC00198125,1239888,17283
CHEMBL538453,P08253,,YWWJREBSMRNZGO-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904482,DTCC00594705,910479,35265
CHEMBL53847,P08253,,SKADGQGCAOBKKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1696772,DTCC00200740,582202,16216
CHEMBL538881,P08253,,PLLAWDNBRCNJGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19359184,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human MMP2 up to 100 uM by fluorescence peptide cleavage assay,Not Active,Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,Bioorg. Med. Chem.,2009,17,9,"Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M",,575333,DTCT0025094,2877488,DTCC00584492,1363011,34590
CHEMBL53949,P08253,,FTUOECQUSPMQQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1707055,DTCC00200918,1325929,16216
CHEMBL539683,P08253,,WJFKRCVNGHZYFA-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10649971,IC50,=,49,NM,,,,,,,,,,,,,,In vitro inhibition of matrix metalloprotease-2 (MMP-2),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104367,DTCT0025094,904804,DTCC00186441,400504,15892
CHEMBL539930,P08253,,LNJYGNLGJFKFCM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17981034,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469430,DTCT0025094,2289292,DTCC00501228,1841595,25715
CHEMBL54021,P08253,,WBMFTZHBDMFDSO-MRVPVSSYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1482838,DTCC00197953,593878,17283
CHEMBL54049,P08253,,XGAYQDWZIPRBPF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103838,DTCC00200085,1445792,43205
CHEMBL54054,P08253,,FEWWJFPIJXNCFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1718067,DTCC00201389,96316,16216
CHEMBL540723,P08253,,KDBQSPNKNKKPEM-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,1630,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904500,DTCC00589981,100586,35265
CHEMBL540952,P08253,(CYCLOPROPYLAMINO)CARBONYLPHOSPHONIC ACID,XNEFJXZBPPJDHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,500,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1298909,DTCC00261593,1305900,17838
CHEMBL541218,P08253,,FECFHXJGVVXRMZ-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,2060,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904527,DTCC00588393,1006580,35265
CHEMBL541447,P08253,,DMMXGBRKSOTFSC-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,6200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904479,DTCC00586761,1330358,35265
CHEMBL541456,P08253,,YXFLQXXMKGQVQR-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11229773,IC50,=,1580,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-2 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,106803,DTCT0025094,1119575,DTCC00344053,1113146,4691
CHEMBL541456,P08253,,YXFLQXXMKGQVQR-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258371,DTCC00344053,1103037,24803
CHEMBL541703,P08253,,JENVXNLJMJTTNA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,3650,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904524,DTCC00586807,2069376,35265
CHEMBL542088,P08253,,YHLIANIUQRLCCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11378378,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104559,DTCT0025094,1042182,DTCC00573690,1099676,4214
CHEMBL54292,P08253,,WJPORLWHPJGLSC-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,3001,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1459476,DTCC00198035,916619,17283
CHEMBL54406,P08253,,UTVAYVOWTJFEEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1711293,DTCC00200736,1488101,16216
CHEMBL54436,P08253,,RCGPSTRFXVIUQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1712494,DTCC00201253,1391445,16216
CHEMBL54483,P08253,,CNZGQRARNYMASL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,0.8,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1704474,DTCC00200539,518045,16216
CHEMBL54501,P08253,,HHSADBHNZPOTTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,35,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1698024,DTCC00200582,1132088,16216
CHEMBL54535,P08253,,VURZBHKGMIEEFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1691940,DTCC00201047,969874,16216
CHEMBL54566,P08253,,IYEVXJPUTMBOTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1696757,DTCC00200735,808247,16216
CHEMBL54617,P08253,,DFPDFXUEOXPMIV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1689356,DTCC00200815,1067099,16216
CHEMBL54621,P08253,,ACSSJLXQNWFMSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1711283,DTCC00201400,1902622,16216
CHEMBL54663,P08253,,MAPLEBZZVBOXKC-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12723945,KI,=,75,NM,,,,,,,,,,,,,,In vitro inhibitory activity against broad spectrum matrix metalloprotease-2 (MMP-2),,"Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.",J. Med. Chem.,2003,46,10,"Cherney RJ, Duan JJ, Voss ME, Chen L, Wang L, Meyer DT, Wasserman ZR, Hardman KD, Liu RQ, Covington MB, Qian M, Mandlekar S, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104404,DTCT0025094,1468122,DTCC00198092,1913978,17283
CHEMBL54697,P08253,,SESYXDSEOCRODR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1680258,DTCC00201436,193005,16216
CHEMBL54904,P08253,,GHHVNOZFZMDYFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,0.9,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1688119,DTCC00200547,1163303,16216
CHEMBL54915,P08253,,PCQHVURJJBFBQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1691935,DTCC00200608,711539,16216
CHEMBL54965,P08253,,HVHBPSLGXXXKOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1708467,DTCC00200812,969876,16216
CHEMBL54981,P08253,,YMYDSTVSNKTLJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1681672,DTCC00200987,1293405,16216
CHEMBL549854,P08253,,ZAQHFZCMMMYWLV-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,3590,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904476,DTCC00589964,618893,35265
CHEMBL549884,P08253,,FXHXSGLQLDHFTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19359184,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human MMP2 up to 100 uM by fluorescence peptide cleavage assay,Not Active,Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,Bioorg. Med. Chem.,2009,17,9,"Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M",,575333,DTCT0025094,2877492,DTCC00590661,1745708,34590
CHEMBL550038,P08253,,FWPVXLYOKAOERT-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19725580,IC50,=,66,NM,,,,,,,,,,,,,,Inhibition of human MMP2,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579116,DTCT0025094,2894761,DTCC00589403,941987,34869
CHEMBL550081,P08253,,RPWGPXSVYLHGRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859435,DTCC00590514,489960,34421
CHEMBL550148,P08253,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859434,DTCC00592085,1588878,34421
CHEMBL550148,P08253,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3285998,DTCC00592085,1601175,38228
CHEMBL550350,P08253,,DKTYDWAJILHINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859438,DTCC00592090,1653714,34421
CHEMBL550350,P08253,,DKTYDWAJILHINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,KI,=,25,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859550,DTCC00592090,1653714,34421
CHEMBL550548,P08253,,UTCUOTDVVXFCLJ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,9.6,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859445,DTCC00592094,327760,34421
CHEMBL550548,P08253,,UTCUOTDVVXFCLJ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,KI,=,54,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859548,DTCC00592094,327760,34421
CHEMBL550628,P08253,,FRFSAUPOCJTACG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859441,DTCC00589012,1038878,34421
CHEMBL550961,P08253,DIAZEPINOMICIN,SALVHVNECODMJP-GNUCVDFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20056543,IC50,=,0.46,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP2,,Anti-invasive and anti-angiogenic activities of naturally occurring dibenzodiazepine BU-4664L and its derivatives.,Bioorg. Med. Chem. Lett.,2010,20,3,"Miyanaga S, Sakurai H, Saiki I, Onaka H, Igarashi Y",,608222,DTCT0025094,3195700,DTCC00592150,501978,37479
CHEMBL55107,P08253,,OPYOHFRGHGDNSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,36,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1716527,DTCC00201049,614603,16216
CHEMBL55110,P08253,,UGMRVUAZVAXFHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1693204,DTCC00201048,323389,16216
CHEMBL55110,P08253,,UGMRVUAZVAXFHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1627929,DTCC00201048,336295,15919
CHEMBL55110,P08253,,UGMRVUAZVAXFHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,1.51,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258461,DTCC00201048,326643,24803
CHEMBL551312,P08253,,WVRDOLPMKOCJRJ-KNQAVFIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,5400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894232,DTCC00590911,791478,35073
CHEMBL551313,P08253,,BMJHAAZDURGGSC-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,19000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894235,DTCC00590912,1017954,35073
CHEMBL55154,P08253,,HIWQTXDWQYKMGH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1686722,DTCC00200813,1805903,16216
CHEMBL551611,P08253,,QAEKGVKCHDBGEN-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,886,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904488,DTCC00588364,456817,35265
CHEMBL552213,P08253,,QXMXXJUEHWZLCA-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,4410,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904509,DTCC00588380,715781,35265
CHEMBL55236,P08253,,UJKQHAYQMMMAEL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,39,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1699203,DTCC00201249,1227975,16216
CHEMBL55310,P08253,N-HYDROXY-BENZENESULFONAMIDE,BRMDATNYMUMZLN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,70000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1626741,DTCC01740306,31107,15919
CHEMBL553109,P08253,,OQBQWDSSUDLMTA-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,39,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,539522,DTCC00135874,451627,14548
CHEMBL55371,P08253,,IXFMBXNLOHKCPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629951,DTCC00200900,383980,56259
CHEMBL554269,P08253,,OBHHLEXVYGNCHI-INFYBVPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19093877,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to MMP2 assessed as enzyme mediated cleavage of compound by measuring increase in fluorescence after 16 hrs by HPLC-MS,Not Active,Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.,J. Med. Chem.,2009,52,2,"Lo PC, Chen J, Stefflova K, Warren MS, Navab R, Bandarchi B, Mullins S, Tsao M, Cheng JD, Zheng G",,495043,DTCT0025094,2594660,DTCC00582506,1049706,32091
CHEMBL554512,P08253,,VKMIOAOQXFVGMB-YKHFMZSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,2470,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904554,DTCC00591520,1006583,35265
CHEMBL55521,P08253,,MOHDKNTXJIGORP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,1.6,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1698029,DTCC00200537,290900,16216
CHEMBL55522,P08253,,HGCCQMHYESJBML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1715037,DTCC00200741,1741621,16216
CHEMBL55561,P08253,,RGDPJPMKLABBRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1699218,DTCC00200776,1325928,16216
CHEMBL555957,P08253,,HIEBUDJHJYAXFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19359184,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human MMP2 up to 100 uM by fluorescence peptide cleavage assay,Not Active,Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,Bioorg. Med. Chem.,2009,17,9,"Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M",,575333,DTCT0025094,2877491,DTCC00587576,68229,34590
CHEMBL556,P08253,DEFEROXAMINE,UBQYURCVBFRUQT-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,Active,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617802,DTCC00145488,1657032,56109
CHEMBL556277,P08253,,XGTBMCGGGJLOPS-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,28000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894238,DTCC00594139,1148018,35073
CHEMBL556645,P08253,,KNWGEVZOUCQOLE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,581,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904515,DTCC00593100,651477,35265
CHEMBL556692,P08253,,BXDRTHBTGNNTEW-LEWJYISDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,22000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894241,DTCC00594148,1471297,35073
CHEMBL55744,P08253,,BITXXJKMASUYME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1690790,DTCC00200914,1805906,16216
CHEMBL558100,P08253,,KOTPGHDHHVOARW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19359184,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human MMP2 up to 100 uM by fluorescence peptide cleavage assay,Not Active,Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,Bioorg. Med. Chem.,2009,17,9,"Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M",,575333,DTCT0025094,2877493,DTCC00593863,327781,34590
CHEMBL558549,P08253,BRARTEMICIN,UZVUYEBJQAEAGM-SHSJKSAASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19358565,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Evaluated,"Brartemicin, an inhibitor of tumor cell invasion from the actinomycete Nonomuraea sp.",J. Nat. Prod.,2009,72,5,"Igarashi Y, Mogi T, Yanase S, Miyanaga S, Fujita T, Sakurai H, Saiki I, Ohsaki A",,576353,DTCT0025094,2861035,DTCC00585890,1726653,34693
CHEMBL55907,P08253,,JVBPIOHSXSYBRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,17,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1711268,DTCC00201010,225329,16216
CHEMBL559250,P08253,,TVMGXYGVVFPAHO-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,3810,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904494,DTCC00593087,1265207,35265
CHEMBL559294,P08253,,BMJHAAZDURGGSC-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,18700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894222,DTCC00594129,1789127,35073
CHEMBL559413,P08253,,HESIRWKKCVPIEN-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904512,DTCC00586799,1556705,35265
CHEMBL559804,P08253,,PXHGETTXNHZYEU-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904521,DTCC00586806,1556707,35265
CHEMBL559805,P08253,,XDMVXFHJJTUNSB-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,2840,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904548,DTCC00586808,1685937,35265
CHEMBL55984,P08253,,XCCIACQOXSWRJQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,1.8,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1712510,DTCC00200742,937807,16216
CHEMBL560137,P08253,,RVBSKRBWGPIJIS-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,379,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904470,DTCC00585249,715778,35265
CHEMBL560224,P08253,,MLMHMIQLMFUEPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19359184,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human MMP2 up to 100 uM by fluorescence peptide cleavage assay,Not Active,Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,Bioorg. Med. Chem.,2009,17,9,"Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M",,575333,DTCT0025094,2877495,DTCC00587567,2004713,34590
CHEMBL56025,P08253,,ULPVLGUDYQAPPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1707070,DTCC00201417,1488102,16216
CHEMBL56065,P08253,,NEUXHEKNAOUEQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1698019,DTCC00200847,1681642,16216
CHEMBL560837,P08253,,LBKCSOUMADYGHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,4.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859436,DTCC00122971,1717205,34421
CHEMBL560837,P08253,,LBKCSOUMADYGHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,KI,=,3.8,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859549,DTCC00122971,1717205,34421
CHEMBL561036,P08253,,HZTQDRLCDGHQSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,5.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859437,DTCC00122972,748051,34421
CHEMBL561038,P08253,,WVAIZSKMOMDPIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859440,DTCC00122975,910381,34421
CHEMBL561039,P08253,,KJDPTHLLJDQIMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,56,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859443,DTCC00122976,715703,34421
CHEMBL561625,P08253,,PZJJOMPTIHBGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859433,DTCC00587403,1492221,34421
CHEMBL561625,P08253,,PZJJOMPTIHBGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3285992,DTCC00587403,1504395,38228
CHEMBL561630,P08253,,JSQUVSOHRBZSNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859444,DTCC00587413,489961,34421
CHEMBL561963,P08253,,UMEYNLZNXJZVAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,KI,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859552,DTCC00585821,1104090,34421
CHEMBL562003,P08253,,FSIUHCOQNBURSE-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,2150,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904497,DTCC00586782,1071452,35265
CHEMBL562338,P08253,,SBXVFSKKCXNEDY-AQJFCTLQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,8990,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904557,DTCC00585300,1685939,35265
CHEMBL562607,P08253,,WXFYHQKQOWMEDX-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,7500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904551,DTCC00593117,845403,35265
CHEMBL562716,P08253,,WVRDOLPMKOCJRJ-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19524436,IC50,=,8700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay,,Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.,Bioorg. Med. Chem. Lett.,2009,19,15,"Aihara Y, Yoshida A, Furuta T, Wakimoto T, Akizawa T, Konishi M, Kan T",,579666,DTCT0025094,2894219,DTCC00590907,1789126,35073
CHEMBL563026,P08253,,MRYXWLVKWYVRPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,310,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859442,DTCC00584342,327759,34421
CHEMBL563679,P08253,,ZQBRASLBYJYZLM-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19606871,IC50,=,74,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571082,DTCT0025094,2859439,DTCC00587409,425709,34421
CHEMBL563896,P08253,,YBWPRDKPAFCNSF-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,1410,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904506,DTCC00591496,1717288,35265
CHEMBL564232,P08253,,NSOWFDNMRUSVGR-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,5110,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904491,DTCC00588365,2004802,35265
CHEMBL564564,P08253,,UAKRFNIIOJOWLK-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,1150,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904503,DTCC00591495,1297731,35265
CHEMBL56498,P08253,,CSPDSJARPZQPMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,1.2,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1696767,DTCC00200743,1584624,16216
CHEMBL564998,P08253,,RVXGDNRYPJLPKA-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,323,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904485,DTCC00586762,1167626,35265
CHEMBL565103,P08253,,JWILGVWCZHAXFQ-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19625186,IC50,=,595,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.",Bioorg. Med. Chem. Lett.,2009,19,16,"Li W, Hu Y, Li J, Thomason JR, DeVincentis D, Du X, Wu J, Hotchandani R, Rush TS, Skotnicki JS, Tam S, Chockalingam PS, Morris EA, Levin JI",,581467,DTCT0025094,2904518,DTCC00593106,1556706,35265
CHEMBL56542,P08253,AG-528,MYKCTDWWIWGLHW-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215477,DTCC01740436,1924106,33038
CHEMBL566233,P08253,,YLTJCMLZAIRVFF-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101225,DTCC00607716,1745918,36106
CHEMBL56731,P08253,AG-494,HKHOVJYOELRGMV-XYOKQWHBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10211225,DTCC01740445,765557,33038
CHEMBL567893,P08253,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19715320,ACTIVITY,=,97,%,,,,,,,,,,,,,,Inhibition of MMP2 assessed as residual activity at 10 uM after 10 to 15 mins by fluorescence assay relative to control,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,599415,DTCT0025094,3096282,DTCC00604795,1039098,36236
CHEMBL567893,P08253,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19715320,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP2 after 10 to 15 mins by fluorescence assay,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600071,DTCT0025094,3096339,DTCC00604795,1039098,36236
CHEMBL567939,P08253,,OKGOBXODUWTHAJ-RNLLHNEJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,502,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101215,DTCC00607745,1874743,36106
CHEMBL567940,P08253,,VPNMZNYQFRFELQ-BZSNNMDCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,730,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101231,DTCC00607747,1907035,36106
CHEMBL568346,P08253,,JRJYBZYDJRBFTK-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,235,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101226,DTCC00607719,780275,36106
CHEMBL568356,P08253,,QQKFJAPYPOIWRW-JBZVSFTFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,1662,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101292,DTCC00607732,1874742,36106
CHEMBL569166,P08253,,RTBFVYBTGAGBSP-FYQYPFLCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,<,5,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101218,DTCC00607670,1071609,36106
CHEMBL569369,P08253,,VLHQDFRXDXPKGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19359184,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human MMP2 up to 100 uM by fluorescence peptide cleavage assay,Not Active,Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,Bioorg. Med. Chem.,2009,17,9,"Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M",,575333,DTCT0025094,2877494,DTCC00589175,554301,34590
CHEMBL569370,P08253,,FHAKHNFPYWASFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19359184,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human MMP2 up to 100 uM by fluorescence peptide cleavage assay,Not Active,Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,Bioorg. Med. Chem.,2009,17,9,"Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M",,575333,DTCT0025094,2877490,DTCC00589178,2069298,34590
CHEMBL569388,P08253,,YDJAXPJDHWQNLF-YPJRHXLCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,102,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101220,DTCC00607671,1524734,36106
CHEMBL569389,P08253,,JOTYZMGPCUSZKL-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101234,DTCC00607672,1104343,36106
CHEMBL56951,P08253,,PFPVZWIKTNGHGO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10794702,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease 2 (MMP-2),,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,104538,DTCT0025094,1711278,DTCC00201024,1325930,16216
CHEMBL569853,P08253,,VVWOQMJGNBQWHG-YPJRHXLCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101221,DTCC00607681,522475,36106
CHEMBL570760,P08253,,FQUKTXLABCFONX-KXNJDZORSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101222,DTCC00607682,2004978,36106
CHEMBL572045,P08253,,MIUJFEWUCGLALV-VABKMULXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,1475,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101237,DTCC00607708,1363250,36106
CHEMBL572091,P08253,,FQSNZGGDFVIKEV-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,581,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101233,DTCC00607644,490182,36106
CHEMBL572301,P08253,,VLUAXQQDRZDFOF-YPJRHXLCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,<,5,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101223,DTCC00607696,1686085,36106
CHEMBL572302,P08253,,PFMDDCHUGSRIJN-FKBYEOEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,843,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101236,DTCC00607698,229826,36106
CHEMBL572780,P08253,,ZCRWOWSOWBMWGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044395,DTCC00597333,618949,35647
CHEMBL572982,P08253,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19703773,IC50,=,4520,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592277,DTCT0025094,3044566,DTCC00598166,824313,35947
CHEMBL572982,P08253,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19703773,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,Not Determined,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592277,DTCT0025094,3044564,DTCC00598166,824314,35947
CHEMBL572982,P08253,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19703773,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP2,Not Determined,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592277,DTCT0025094,3044565,DTCC00598166,824315,35947
CHEMBL573130,P08253,,PSBQUBXJKCPLEY-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,2067200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041609,DTCC00595487,877836,35560
CHEMBL573304,P08253,,BUPWURBQJPMAIX-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,623100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041621,DTCC00595494,100615,35560
CHEMBL573367,P08253,,FQILLAQMOCATFH-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,1642900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041594,DTCC00595496,651504,35560
CHEMBL573580,P08253,,OBNAZEHHQGYILT-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,237600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041627,DTCC00596148,12415,35560
CHEMBL573583,P08253,,MKAODEMEQAWQSZ-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,193600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041642,DTCC00596151,1363129,35560
CHEMBL573714,P08253,,ITWGWXCEGHFMHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044427,DTCC00597369,1427807,35647
CHEMBL573714,P08253,,ITWGWXCEGHFMHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26638045,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP2 after 2 hrs using FS-6 as substrate by fluorometry,,"Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.",Eur. J. Med. Chem.,2016,108,,"Sjli S, Nuti E, Camodeca C, Bilto I, Rossello A, Winberg JO, Sylte I, Adekoya OA.",,1550088,DTCT0025094,59809,DTCC00597369,1422628,65811
CHEMBL573715,P08253,,YOMXWXIANUYIMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044389,DTCC00597370,1297783,35647
CHEMBL573934,P08253,,OREDIHYKGISTDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044417,DTCC00597353,327896,35647
CHEMBL573935,P08253,,HGICQEUHJFERNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,510,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044444,DTCC00597354,393223,35647
CHEMBL573936,P08253,,FIPYOKGRSDJCAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044404,DTCC00597355,1427806,35647
CHEMBL574,P08253,P-TOLUENESULFONAMIDE,LMYRWZFENFIFIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103837,DTCC00146038,508352,43205
CHEMBL574056,P08253,,UENCUNWFGNLXJO-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,322500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041636,DTCC00596138,100619,35560
CHEMBL574057,P08253,,DHBBMPKEHGHOCP-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,348500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041639,DTCC00596139,165326,35560
CHEMBL574273,P08253,,JCXXZCMREHBFLC-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,345500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041651,DTCC00596128,261973,35560
CHEMBL574274,P08253,,BOEKKMGYMMMJAF-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,41100,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041654,DTCC00596129,1395468,35560
CHEMBL574370,P08253,,YYBFXMXFWMJGLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,38,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044403,DTCC00597263,12430,35647
CHEMBL574589,P08253,,WQRJSSRVHCJAKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044468,DTCC00597341,1071501,35647
CHEMBL574605,P08253,,CPUBMGYGVNFLPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,73,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044409,DTCC00597298,327895,35647
CHEMBL574756,P08253,,IEJUAGSJJDOOMV-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,149600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041603,DTCC00595483,261967,35560
CHEMBL574757,P08253,,FNMVBIGRXKCAGO-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,176000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041606,DTCC00595484,2004838,35560
CHEMBL575397,P08253,,VRKWHWQMOJOXPS-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,100400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041660,DTCC00123567,1038990,35560
CHEMBL575400,P08253,,BOQPMGFVMSFISW-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,28900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041663,DTCC00596137,1745807,35560
CHEMBL575431,P08253,,BNQZAXKADGKQEB-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,89200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041615,DTCC00595492,845431,35560
CHEMBL575628,P08253,,AOVTZCHFEAXBMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,23,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163433,DTCC00609613,241430,36845
CHEMBL575628,P08253,,AOVTZCHFEAXBMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,53,%,,,,,,,,,,,,,,Inhibition of MMP2 at 50 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603498,DTCT0025094,3163425,DTCC00609613,241430,36845
CHEMBL575654,P08253,,SWANMPQFABUFGF-BCPZQOPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,36700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041597,DTCC00595497,715825,35560
CHEMBL575800,P08253,,RPBMUZJLIZEHEZ-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,203600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041633,DTCC00596134,554409,35560
CHEMBL575881,P08253,,ABXUEPSHNXWTBZ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044557,DTCC00597225,1653861,35647
CHEMBL575895,P08253,,QPFIKHZWPMXTRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,35000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044520,DTCC00597330,1427805,35647
CHEMBL575896,P08253,,MYZHQACPXTZCJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044461,DTCC00597331,554423,35647
CHEMBL575945,P08253,,VDQPKRPHLSTBEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163440,DTCC00609550,209098,36845
CHEMBL575945,P08253,,VDQPKRPHLSTBEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,26,%,,,,,,,,,,,,,,Inhibition of MMP2 at 50 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603498,DTCT0025094,3163431,DTCC00609550,209098,36845
CHEMBL575945,P08253,,VDQPKRPHLSTBEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21413800,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg- NH2 as substrate at 20 ug/ml preincubated for 10 mins measured after 3 hrs by fluorescence assay,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853830,DTCT0025094,11368669,DTCC00609550,219391,50935
CHEMBL576061,P08253,,GMXIFCSQVFGFBC-ZRTMLZEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,365,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101213,DTCC00607744,974260,36106
CHEMBL576762,P08253,,RPBGCJQDVJCGSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,9900,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044504,DTCC00597340,1265255,35647
CHEMBL576973,P08253,,XVDZEYZSVKHSDM-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,253200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041612,DTCC00595488,1232381,35560
CHEMBL576974,P08253,,PVJVPKMFOHVNJM-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,150800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041624,DTCC00595495,651503,35560
CHEMBL578858,P08253,,MJPPDKQQAFNBDZ-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,483600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041630,DTCC00596131,1972178,35560
CHEMBL578859,P08253,,IJFGERLKSYMSLO-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,236300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041645,DTCC00596152,1906910,35560
CHEMBL579028,P08253,GNF-PF-1656,VCOYGGNDFXYZQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,>,100000,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay. (Class of assay: confirmatory) ,inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,809419,DTCT0025094,10215407,DTCC00026028,1505224,33038
CHEMBL579067,P08253,,YMAXKJGQKQACFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,710,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044449,DTCC00597343,812562,35647
CHEMBL579068,P08253,,HSMGGAWDRKACFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044479,DTCC00597380,1842555,35647
CHEMBL58235,P08253,,KFQYZMVFFVTGGQ-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258318,DTCC00105346,778987,24803
CHEMBL58235,P08253,,KFQYZMVFFVTGGQ-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,200,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,663381,DTCC00105346,775995,2288
CHEMBL582839,P08253,,DHENBWAOBADTQO-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,85500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041648,DTCC00596154,522338,35560
CHEMBL583058,P08253,,VYYNJCCRLSCUBZ-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,692800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041600,DTCC00595498,2004839,35560
CHEMBL583183,P08253,,LZXYFLYJYUISDI-ZETCQYMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,226400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041657,DTCC00596135,942075,35560
CHEMBL58361,P08253,,DGYOAFGUADSYMB-IFMALSPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,50,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,683290,DTCC00208220,1713530,2288
CHEMBL584116,P08253,,PDNKMRBXZXHUFT-ACRUOGEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,344,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101235,DTCC00607673,360595,36106
CHEMBL584120,P08253,,XLCDJKIIBWOGQT-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,102,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101224,DTCC00607697,262112,36106
CHEMBL584122,P08253,,OAJUMLCSJOEUON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044467,DTCC00597332,715843,35647
CHEMBL584147,P08253,,XORCBTCEBZUVES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,190,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044423,DTCC00597381,2037631,35647
CHEMBL584334,P08253,,KSBCPHOBEZMZNM-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,432,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101232,DTCC00607643,1686084,36106
CHEMBL584358,P08253,,OARHWELPMDWQQF-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,8700,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041591,DTCC00595491,1972171,35560
CHEMBL584365,P08253,,DJZNIZCARKSSDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,9.7,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044396,DTCC00597271,165336,35647
CHEMBL584601,P08253,,LFVUEMWOKAKPTH-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19454370,IC50,=,101600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2009,17,13,"Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W",,588448,DTCT0025094,3041618,DTCC00595493,1745797,35560
CHEMBL584960,P08253,,XYYDUHNDMZDPKL-UZVDJONISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,210,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101216,DTCC00607635,1907034,36106
CHEMBL585299,P08253,,YYMXPNNILUETLE-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,471,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101229,DTCC00607737,619058,36106
CHEMBL585304,P08253,,YDJAXPJDHWQNLF-AABGKKOBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,<,5,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101291,DTCC00607748,2037740,36106
CHEMBL585376,P08253,,BZWDHUMJSSLVCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19775099,IC50,=,58000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591602,DTCT0025094,3044525,DTCC00597342,100632,35647
CHEMBL58553,P08253,,WKYNDNVMBNENDU-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1542342,DTCC00208405,1629045,4358
CHEMBL585886,P08253,,KMMXFFDNBCQBEI-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,=,613,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101230,DTCC00607746,1842659,36106
CHEMBL586042,P08253,,QHTFXHUNNOAYME-BSOSBYQFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19635666,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP-2,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598555,DTCT0025094,3101228,DTCC00607731,1972305,36106
CHEMBL58834,P08253,,RMIHUCKIXBQQLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1530490,DTCC00208196,1175034,4358
CHEMBL58945,P08253,,OPPSVVRCTWTXLK-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258311,DTCC00105355,1296588,24803
CHEMBL58945,P08253,,OPPSVVRCTWTXLK-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,10,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,659756,DTCC00105355,1293496,2288
CHEMBL589640,P08253,,COAZAKWFQRXOIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163439,DTCC00609551,1375138,36845
CHEMBL589641,P08253,,PSUIDWCIHHZLNA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of MMP2 at 50 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603498,DTCT0025094,3163430,DTCC00609552,663126,36845
CHEMBL589641,P08253,,PSUIDWCIHHZLNA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163438,DTCC00609552,663126,36845
CHEMBL589642,P08253,,ZTFUNGNMDXRNQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibition of MMP2 at 50 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603498,DTCT0025094,3163429,DTCC00609553,1822168,36845
CHEMBL589642,P08253,,ZTFUNGNMDXRNQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163437,DTCC00609553,1822168,36845
CHEMBL589679,P08253,,QZHTVRKTPPIILZ-ICNOJOBBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,<,1,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180441,DTCC00620082,748432,37498
CHEMBL589710,P08253,,FIGGEGWDYUINOK-ULKIPEBDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,24,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180435,DTCC00620088,1395728,37498
CHEMBL589760,P08253,,QLPKUSVWQWRECK-LLRGJTHUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,18,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180440,DTCC00620083,1654132,37498
CHEMBL589761,P08253,,YVQBEOXREDVQBP-VTBTYGGHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,88,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180437,DTCC00620086,1039311,37498
CHEMBL589762,P08253,,WHZAMGQVPGHHBH-HKPJPKSRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,116,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180431,DTCC00620092,1200301,37498
CHEMBL589763,P08253,,CQUQBNMIEIDWPI-LDNUBHSTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,31,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180428,DTCC00620095,1136717,37498
CHEMBL589764,P08253,,UEBHASPTCLODRO-FNYWWBFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,40,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180422,DTCC00620101,1778015,37498
CHEMBL589880,P08253,,LRLOXBPLQAPNIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,28,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163435,DTCC00609555,1600948,36845
CHEMBL589880,P08253,,LRLOXBPLQAPNIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,52,%,,,,,,,,,,,,,,Inhibition of MMP2 at 50 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603498,DTCT0025094,3163427,DTCC00609555,1600948,36845
CHEMBL589881,P08253,,IXDAHUUSJCCCFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,27,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163432,DTCC00609614,1697606,36845
CHEMBL589881,P08253,,IXDAHUUSJCCCFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,54,%,,,,,,,,,,,,,,Inhibition of MMP2 at 50 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603498,DTCT0025094,3163424,DTCC00609614,1697606,36845
CHEMBL589886,P08253,,CWUJMCRFVRZWMX-BASHDASISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,59,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180416,DTCC00620107,1492589,37498
CHEMBL58997,P08253,,GDWAEOPDOGIQAU-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,100,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,691924,DTCC00208194,841133,2288
CHEMBL589996,P08253,,QDIKAYSONRRSHM-FXWROETPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180421,DTCC00620102,1460098,37498
CHEMBL589997,P08253,,AKDGBIXCKDWCJO-WJCZHFNKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,47,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180419,DTCC00620104,586915,37498
CHEMBL59023,P08253,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.31,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,656027,DTCC00208380,452428,2288
CHEMBL590343,P08253,,LIKQSFURRNSUMR-UKKPGEIXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20022498,KI,=,33000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608475,DTCT0025094,3182373,DTCC00617046,100864,37349
CHEMBL590393,P08253,,LMQOLPSUIMIYSE-RYUDHWBXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,5684600,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3221952,DTCC00617679,1536574,37311
CHEMBL590394,P08253,,RRKBVNNLIRANCO-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,1935500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3221953,DTCC00617680,1179508,37311
CHEMBL59104,P08253,,HZWSSUJZEMEIID-YABDQXBESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1532803,DTCC00208267,819932,4358
CHEMBL591300,P08253,,ZFDHLFVZKFPILO-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,3464200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3221951,DTCC00617627,38683,37311
CHEMBL591441,P08253,,FZLIURRYFXUDQW-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,407400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219771,DTCC00617748,1504241,37311
CHEMBL591674,P08253,,LLTAKNRYOCZNSJ-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,4515200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219773,DTCC00617805,1568501,37311
CHEMBL591675,P08253,,SZTDEGLEPPXNFT-UWVGGRQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,3630200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219775,DTCC00617807,695524,37311
CHEMBL591774,P08253,,LRRAUDSVXJEODP-VTVVEXCCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20022498,KI,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608475,DTCT0025094,3182374,DTCC00617111,1330626,37349
CHEMBL59185,P08253,,MYFICVJSVBCBLS-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258319,DTCC00208609,778986,24803
CHEMBL59185,P08253,,MYFICVJSVBCBLS-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,10000,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,681923,DTCC00208609,775994,2288
CHEMBL592228,P08253,,SXEONTJNLWOUBB-MYXCDZCHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20053563,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of human rheumatoid synovial fibroblasts gelatinase A after 30 mins by fluorescence plate reader,,"Identification of potential and selective collagenase, gelatinase inhibitors from Crataegus pinnatifida.",Bioorg. Med. Chem. Lett.,2010,20,3,"Moon HI, Kim TI, Cho HS, Kim EK",,607930,DTCT0025094,3191712,DTCC00619790,1568517,37466
CHEMBL592329,P08253,,PBYRKMXDROOXMU-KCXYZFMFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20053563,IC50,=,12400,NM,,,,,,,,,,,,,,Inhibition of human rheumatoid synovial fibroblasts gelatinase A after 30 mins by fluorescence plate reader,,"Identification of potential and selective collagenase, gelatinase inhibitors from Crataegus pinnatifida.",Bioorg. Med. Chem. Lett.,2010,20,3,"Moon HI, Kim TI, Cho HS, Kim EK",,607930,DTCT0025094,3191710,DTCC00619789,307315,37466
CHEMBL592373,P08253,,QRFZGLTZLZZHCM-NWYMYRDLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20053563,IC50,=,43200,NM,,,,,,,,,,,,,,Inhibition of human rheumatoid synovial fibroblasts gelatinase A after 30 mins by fluorescence plate reader,,"Identification of potential and selective collagenase, gelatinase inhibitors from Crataegus pinnatifida.",Bioorg. Med. Chem. Lett.,2010,20,3,"Moon HI, Kim TI, Cho HS, Kim EK",,607930,DTCT0025094,3191714,DTCC00619791,1697703,37466
CHEMBL59248,P08253,,VOHTXZWPKONFAR-ISKFKSNPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.6,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,666938,DTCC00208352,937889,2288
CHEMBL592538,P08253,,BHVJSFZBDMFOLF-IUCAKERBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,5308900,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3221955,DTCC00617682,501962,37311
CHEMBL592539,P08253,,CTBIUPZNGPOIFP-IUCAKERBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,4204200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219767,DTCC00617683,921621,37311
CHEMBL59337,P08253,,KLFOAKCPAGOTNG-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,47,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1541001,DTCC00208349,1753036,4358
CHEMBL59338,P08253,,AZODBPSQRNONKH-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,<,0.15,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,685715,DTCC00208350,3213,2288
CHEMBL593542,P08253,,MJPAIGFBKXBHSC-MMQHEFTJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,131000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155264,DTCC00614649,2049240,36679
CHEMBL593543,P08253,,LWUABVIGSHEPDU-HKUPYCBJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155295,DTCC00614650,80219,36679
CHEMBL593562,P08253,,QVVDZRGUBTVPBX-ZNFPLGDCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155234,DTCC00124082,1471854,36679
CHEMBL59361,P08253,,WGIKYFGWOYVGQU-ISKFKSNPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,30,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,669301,DTCC00208218,388791,2288
CHEMBL593782,P08253,,GQHRMMOCCGLLAS-FBRRREGBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155296,DTCC00614651,534053,36679
CHEMBL593793,P08253,,PRQRXLGGRFSZQY-HKUPYCBJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155236,DTCC00124095,534055,36679
CHEMBL593794,P08253,,UUYPAUYUBZWJQH-SIFUEBAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155235,DTCC00614668,1148547,36679
CHEMBL593795,P08253,,WHGBWNHYWFWEGU-MMQHEFTJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,166600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155261,DTCC00614669,921578,36679
CHEMBL593811,P08253,,WNTWFQPDGSSCIF-CRGRJFMMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155291,DTCC00614690,921580,36679
CHEMBL59472,P08253,,DHMHJSLNCAYKRH-QOMWVZHYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1554466,DTCC00208237,2044788,4358
CHEMBL594848,P08253,,TYVAVCSSCPJBHI-KAUXGEHWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,285900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155257,DTCC00614689,1211687,36679
CHEMBL594936,P08253,,UDUDMUCZVMGCCP-LPQFERQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,324400,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155271,DTCC00614630,1471856,36679
CHEMBL594937,P08253,,IYFMHLNXJQTJNM-ZNFPLGDCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155294,DTCC00614631,1665597,36679
CHEMBL594941,P08253,,NSIFOTSSIDBAJI-CRGRJFMMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,176500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155269,DTCC00614647,824585,36679
CHEMBL594961,P08253,,ZISAOCXNPSAHAU-FMQWLBJXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,447200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155258,DTCC00124087,986254,36679
CHEMBL594969,P08253,,AUMPNGJVHLRSII-AUECHBEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155239,DTCC00614615,2081408,36679
CHEMBL595209,P08253,,AOIMNHYQILMKAB-LPQFERQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,178600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155277,DTCC00614685,501923,36679
CHEMBL595446,P08253,,DJCZWKGQNYOQDG-SIFUEBAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155292,DTCC00614562,1886505,36679
CHEMBL595672,P08253,,OZQKBKFOIDAGQH-ZNFPLGDCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155293,DTCC00614563,1886506,36679
CHEMBL595870,P08253,,KQZGKRFTZIJIGA-MMQHEFTJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155240,DTCC00614576,1439436,36679
CHEMBL595871,P08253,,HAIXPFDNCCQBJW-ATWMFIQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,594300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155251,DTCC00614577,1600990,36679
CHEMBL595881,P08253,,PYYHYACWZHNHRI-HKUPYCBJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,196600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155274,DTCC00614723,1375172,36679
CHEMBL596097,P08253,,BKUMDLZTLUZSJJ-ZNFPLGDCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155232,DTCC00614638,1439437,36679
CHEMBL596098,P08253,,SLNVARNRAMAWOO-HKUPYCBJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155231,DTCC00614639,1310021,36679
CHEMBL596553,P08253,,INBRHSSIAXLSEI-ATWMFIQVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,232500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155275,DTCC00614670,598502,36679
CHEMBL596560,P08253,,GEWJSTSZXRZGCY-AUECHBEKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,196500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155262,DTCC00614684,1179471,36679
CHEMBL59684,P08253,,SMIPFSAKTAQFJC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1526925,DTCC00208656,1175033,4358
CHEMBL596897,P08253,,AVQMYZHDLJWDEW-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,1362800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183611,DTCC00124351,2069664,37037
CHEMBL597106,P08253,,NBGHQRKTVFJIOP-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,2976200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219768,DTCC00617745,307296,37311
CHEMBL597107,P08253,,QMMRNNSLRQXSAE-IHRRRGAJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,2895800,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219769,DTCC00617746,1697680,37311
CHEMBL597128,P08253,,WNQOMXRKQKUNBB-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,1538500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219786,DTCC00617976,1984157,37311
CHEMBL59722,P08253,,KCPCRNOCKZPKFZ-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258305,DTCC00208604,585408,24803
CHEMBL59722,P08253,,KCPCRNOCKZPKFZ-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,685711,DTCC00208604,582292,2288
CHEMBL597331,P08253,,QZVYFTYMHSJCNF-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,1649500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219787,DTCC00617977,241517,37311
CHEMBL597332,P08253,,NZIVDBVRAKALAB-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,8135500,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219788,DTCC00617978,760039,37311
CHEMBL597736,P08253,,QHCIIJUTJLVXGC-GWCFXTLKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,8967100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219782,DTCC00617928,792068,37311
CHEMBL597935,P08253,,BFONLFXAGOPXCU-UFBFGSQYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,1755200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219783,DTCC00617929,1407640,37311
CHEMBL597936,P08253,,JIQLEEAXRQLCRD-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,1776200,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219784,DTCC00617930,986296,37311
CHEMBL598119,P08253,,LSXWIQFJOMCJEJ-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,106000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183613,DTCC00620355,393502,37037
CHEMBL598137,P08253,,XWTJFHFTZVAERF-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,630300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219785,DTCC00124210,501965,37311
CHEMBL598322,P08253,,PVXRFKDGDHSVFG-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,9426500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183615,DTCC00620357,1810459,37037
CHEMBL598323,P08253,,PLKLKUFJAPIKNT-ZMFCMNQTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,1750000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183616,DTCC00620358,12986,37037
CHEMBL598542,P08253,,PFWSZJRJWNFSTP-KKUMJFAQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,8364400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219774,DTCC00617806,1018547,37311
CHEMBL598554,P08253,,VAIXJDVUSNCVHE-ULQDDVLXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,513600,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219778,DTCC00617870,760036,37311
CHEMBL598761,P08253,,ZMCGGHHKSIJWIL-JYJNAYRXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,7586400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219780,DTCC00617872,1439484,37311
CHEMBL598929,P08253,,MQVJYOYJHJYYIV-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,6460800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183605,DTCC00620215,1686242,37037
CHEMBL598942,P08253,,WSTPQYKTYRBMIY-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,2000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183608,DTCC00620218,1330664,37037
CHEMBL599311,P08253,,NPEMIVWBFYPYFR-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,624480,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183607,DTCC00620217,1686244,37037
CHEMBL599329,P08253,,AEDGYXKKAFYKPL-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,24180,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183609,DTCC00620282,910788,37037
CHEMBL599356,P08253,,DNXCHRLNZMLSBE-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,446900,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219770,DTCC00617747,1727071,37311
CHEMBL59968,P08253,,VQXXXMXDXGETFY-DWXRJYCRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,=,433,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,504957,DTCC00211655,2065284,5598
CHEMBL599733,P08253,,URNYTFMHOBGYHV-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,105300,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183614,DTCC00620356,262269,37037
CHEMBL599783,P08253,,BWUASXBEWIUMRX-JYJNAYRXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,3160100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219777,DTCC00617869,1116184,37311
CHEMBL600067,P08253,,CEUNNLWAKWOBCW-YUMQZZPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,428300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3221954,DTCC00617681,241513,37311
CHEMBL600618,P08253,,FYQQYLSRRUUUHM-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,11520000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183618,DTCC00620422,1200308,37037
CHEMBL600619,P08253,,MXDNYOKZHHFFIN-AJZOCDQUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,1920500,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183619,DTCC00620423,197565,37037
CHEMBL601266,P08253,,MPPBYRPSQFFWRI-KSEVBTLESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,69,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180420,DTCC00620103,586914,37498
CHEMBL601442,P08253,,RAZYUXHSAABPKZ-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,2757800,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183617,DTCC00620421,295515,37037
CHEMBL601474,P08253,,GCPDHEUDCRIVRM-DHLBNNOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,30,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180418,DTCC00620105,1039313,37498
CHEMBL601475,P08253,,KETPAISALUWJRR-OAVYBYCVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,37,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180417,DTCC00620106,554715,37498
CHEMBL60179,P08253,,HVGJVSYGPSRPHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1519821,DTCC00208217,1207239,4358
CHEMBL60196,P08253,,GJIKNAOMJVWUCN-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,30.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258304,DTCC00208625,1744656,24803
CHEMBL60196,P08253,,GJIKNAOMJVWUCN-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,30,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,663385,DTCC00208625,1741705,2288
CHEMBL602301,P08253,,FHIUBRXIZJRTHF-FBVZUCIOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,<,1,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180439,DTCC00620084,1717573,37498
CHEMBL602302,P08253,,KTAORHMSVCAETQ-UUXDBVTOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,6,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180438,DTCC00620085,910784,37498
CHEMBL602303,P08253,,IUOZLSPXKIQNGM-YGSUAAAGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180436,DTCC00620087,1039312,37498
CHEMBL602505,P08253,,KAYRZBPWJXJHQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163436,DTCC00609554,759946,36845
CHEMBL602505,P08253,,KAYRZBPWJXJHQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,40,%,,,,,,,,,,,,,,Inhibition of MMP2 at 50 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603498,DTCT0025094,3163428,DTCC00609554,759946,36845
CHEMBL602508,P08253,,YHPSBACDAFARBS-OMYDOWJBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,11,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180433,DTCC00620090,1746071,37498
CHEMBL602509,P08253,,LPZYDQQHEPEWGM-ZMLVVKDOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,>,120,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180432,DTCC00620091,1265490,37498
CHEMBL602510,P08253,,BHGGSEGLXWNHKI-IQVHGFSNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,21,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180430,DTCC00620093,878120,37498
CHEMBL602511,P08253,,UQIFQWMHIQGZOA-IJGIEEHNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,55,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180429,DTCC00620094,2037891,37498
CHEMBL602512,P08253,,QUFHCGIQHWBHRW-HFMZJWALSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,25,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180426,DTCC00620097,1460097,37498
CHEMBL602513,P08253,,QLSQTUSZZCKABS-MBEKMZCTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,21,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180424,DTCC00620099,165568,37498
CHEMBL602700,P08253,,PBFATXRYSNBSSV-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,30050,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183601,DTCC00621243,974418,37037
CHEMBL602701,P08253,,ZVCGDPBRLICPPH-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,10490,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183602,DTCC00621244,1104502,37037
CHEMBL602708,P08253,,LITXUKDGYSQFSD-FNYWWBFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,31,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180423,DTCC00620100,619221,37498
CHEMBL602902,P08253,,XEMUADJVHGUZBQ-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,37290,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183603,DTCC00621245,1104503,37037
CHEMBL602949,P08253,,YYPITAAWUASTAE-OPWSDZRHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20022498,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608475,DTCT0025094,3182375,DTCC00617171,683777,37349
CHEMBL603241,P08253,,MERBYHIQINGLJP-SRVKXCTJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,8611400,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219781,DTCC00617927,339932,37311
CHEMBL603308,P08253,,FEBYOUNMPSRCSF-JZBCIKKISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,7,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180434,DTCC00620089,1428086,37498
CHEMBL603309,P08253,,OVISQYITSPXJSG-QQJJXHBYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,20,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180427,DTCC00620096,910785,37498
CHEMBL603310,P08253,,PPJQVOJWNQJPRU-SWJJWXSQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,29,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180425,DTCC00620098,12972,37498
CHEMBL603452,P08253,,GJXOTLMPBXLRJB-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,56600,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183612,DTCC00124352,1686246,37037
CHEMBL603656,P08253,,KOTGODCEORJYIF-QAQDUYKDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20005097,KI,>,25000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605226,DTCT0025094,3176037,DTCC00610540,534004,36915
CHEMBL60373,P08253,,SBXPRGGYMRGODQ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,=,482,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,475050,DTCC00211747,906130,5598
CHEMBL604328,P08253,,NIDUKJJGNGSXIT-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,58140,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183600,DTCC00621242,1039322,37037
CHEMBL604365,P08253,,CNPHGGDFYWHAFF-SEBRQYJASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20060717,RATIO,=,114,,,,,,,,,,,,,,,Ratio Kcat to Ki for MMP2,,Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.,Bioorg. Med. Chem. Lett.,2010,20,3,"Hu Z, Jiang X, Albright CF, Graciani N, Yue E, Zhang M, Zhang SY, Bruckner R, Diamond M, Dowling R, Rafalski M, Yeleswaram S, Trainor GL, Seitz SP, Han W",,609253,DTCT0025094,3180415,DTCC00620108,393496,37498
CHEMBL604376,P08253,,MINRXUILZMVZAT-FBRRREGBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155290,DTCC00614648,1504205,36679
CHEMBL604737,P08253,,QVEXZGOTIARLFX-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,124320,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183606,DTCC00620216,1686243,37037
CHEMBL604872,P08253,,HWNUMHPIOXMCTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,27,%,,,,,,,,,,,,,,Inhibition of MMP2 at 5 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603497,DTCT0025094,3163434,DTCC00609556,2017051,36845
CHEMBL604872,P08253,,HWNUMHPIOXMCTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19948404,INHIBITION,=,60,%,,,,,,,,,,,,,,Inhibition of MMP2 at 50 uM,,Synthesis and anticancer activities of ageladine A and structural analogs.,Bioorg. Med. Chem. Lett.,2010,20,1,"Ma Y, Nam S, Jove R, Yakushijin K, Horne DA",,603498,DTCT0025094,3163426,DTCC00609556,2017051,36845
CHEMBL605144,P08253,,UVAUHFHRTCJRKU-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20097082,IC50,=,26170,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).,Bioorg. Med. Chem.,2010,18,4,"Li Y, Zhang J, Xu W, Zhu H, Li X",,609021,DTCT0025094,3183610,DTCC00620283,1842811,37037
CHEMBL605201,P08253,,XDBOLPFDJWTESQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20005097,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605226,DTCT0025094,3176016,DTCC00610415,953811,36915
CHEMBL60546,P08253,,CNVCLEPNZAFTKK-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258306,DTCC00208623,1231163,24803
CHEMBL60546,P08253,,CNVCLEPNZAFTKK-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,2,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,662090,DTCC00208623,1228054,2288
CHEMBL605558,P08253,,AJUANUGNKYWBDO-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,7903100,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219772,DTCC00617804,1375213,37311
CHEMBL60567,P08253,,KVUZGLYOUHGFEF-SLXFGWRHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1557076,DTCC00208591,302724,4358
CHEMBL605764,P08253,,AZEKZZSSVLIPCQ-QZTJIDSGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20022498,KI,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608475,DTCT0025094,3182372,DTCC00617773,1232601,37349
CHEMBL605765,P08253,,JVHRFYWPHZOPRF-JYJNAYRXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,8047300,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219779,DTCC00617871,1601021,37311
CHEMBL60674,P08253,,MYJDKITWUNFHCY-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258316,DTCC00208705,521150,24803
CHEMBL60674,P08253,,MYJDKITWUNFHCY-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1000,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,679422,DTCC00208705,518138,2288
CHEMBL606759,P08253,GLUCOSAMINE,MSWZFWKMSRAUBD-UKFBFLRUSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19375915,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2 gelatinolytic activity in phorbol myristate acetate-stimulated human HT1080 cells at 60 ug/ml by gelatin zymography relative to control,Not Active,The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.,Bioorg. Med. Chem. Lett.,2009,19,10,"Mendis E, Kim MM, Rajapakse N, Kim SK",,578120,DTCT0025094,2884686,DTCC00626110,759418,34969
CHEMBL607828,P08253,,HROOIHUIQVRMKZ-FMQWLBJXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,=,999000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155255,DTCC00614595,1244664,36679
CHEMBL607850,P08253,,AFXMMYGEBHALBB-DCAQKATOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19969464,IC50,=,1710600,NM,,,,,,,,,,,,,,Inhibition of MMP2 by spectrophotometry,,"Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.",Bioorg. Med. Chem.,2010,18,2,"Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W",,607645,DTCT0025094,3219776,DTCC00617808,1439482,37311
CHEMBL607980,P08253,,NGZUALIVDSVRKP-KAUXGEHWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155237,DTCC00614646,1633300,36679
CHEMBL608562,P08253,,JIICDBTUKQTVGF-LPQFERQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155233,DTCC00614629,437533,36679
CHEMBL608563,P08253,,NRLBWIYZCCOVDV-LPQFERQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155238,DTCC00614616,921576,36679
CHEMBL61017,P08253,,KVNBSMBKXVJFRN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1530479,DTCC00105357,1046466,4358
CHEMBL610755,P08253,,STBDFWKKHLAONS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19914829,RATIO,<,33,,,,,,,,,,,,,,,Ratio of Kinact to Ki for MMP2,,Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase.,Bioorg. Med. Chem. Lett.,2010,20,1,"Capková K, Hixon MS, Pellett S, Barbieri JT, Johnson EA, Janda KD",,606601,DTCT0025094,3171719,DTCC00613871,2049236,36801
CHEMBL611643,P08253,,GDSOVCVPAMBEPJ-MMQHEFTJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19782572,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,"Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.",Bioorg. Med. Chem.,2009,17,20,"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W",,604357,DTCT0025094,3155241,DTCC00614739,759990,36679
CHEMBL61354,P08253,,MALRHJHVJCYQHD-PUUKEUDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1529259,DTCC00208378,107904,4358
CHEMBL61517,P08253,,CFKXSBQQOQUGFI-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258314,DTCC00105363,682317,24803
CHEMBL61517,P08253,,CFKXSBQQOQUGFI-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,200,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,659752,DTCC00105363,679551,2288
CHEMBL61538,P08253,,FLPUCLSORYCSPS-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258312,DTCC00208773,1329167,24803
CHEMBL61538,P08253,,FLPUCLSORYCSPS-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,50,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,673019,DTCC00208773,1326032,2288
CHEMBL61577,P08253,,CYDOQDKDFWIELG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1557082,DTCC00209511,787579,4358
CHEMBL61873,P08253,,VWVNHRHZTZJGIS-IFMALSPDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.8,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,670578,DTCC00208702,1326033,2288
CHEMBL62007,P08253,,LBZOGBFXCHOCBC-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,2.3,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1642447,DTCC00215441,75752,2712
CHEMBL62007,P08253,,LBZOGBFXCHOCBC-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873712,IC50,=,2.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease 2 isolated from human HT1080 fibrosarcoma cells induced with TNF,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102121,DTCT0025094,1403759,DTCC00215441,64880,2897
CHEMBL62056,P08253,,XTNDKIPXZCROEY-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258307,DTCC00105359,1970997,24803
CHEMBL62056,P08253,,XTNDKIPXZCROEY-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,676963,DTCC00105359,1967947,2288
CHEMBL62089,P08253,,DVNVXZQJDUVWTB-RWWKDMOOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11454461,IC50,=,41,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-2,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104370,DTCT0025094,1541006,DTCC00208658,1946674,4358
CHEMBL6216,P08253,,BAOZVZLVHANZCO-PYPSMOBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,16,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,524339,DTCC00135887,1292693,14548
CHEMBL62186,P08253,,GGPADGTYHCKBRV-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,39810.72,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258320,DTCC00208387,455573,24803
CHEMBL62186,P08253,,GGPADGTYHCKBRV-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,40000,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,660913,DTCC00208387,452429,2288
CHEMBL62245,P08253,,QICZKEXYEUFFTG-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258309,DTCC00208645,455574,24803
CHEMBL62245,P08253,,QICZKEXYEUFFTG-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,1,NM,,,,,,,,,,,,,,Compound concentration for 50% inhibition of human recombinant gelatinase A (MMP-2).,,,Bioorg. Med. Chem. Lett.,1997,7,2,,,71648,DTCT0025094,693233,DTCC00208645,452426,2288
CHEMBL62455,P08253,,VJDIWGRVXNTKIX-HNAYVOBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,567,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,496309,DTCC00211980,1552577,5598
CHEMBL62740,P08253,,DHZSRYYUAYXLLX-OXQOHEQNSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,509819,DTCC00212466,1681779,5598
CHEMBL62964,P08253,,CHRGPXOYOHYPAP-GGAORHGYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,=,194,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,349032,DTCC00212261,711665,5598
CHEMBL63272,P08253,,DHZSRYYUAYXLLX-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,1267,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,497500,DTCC00211493,257750,5598
CHEMBL63354,P08253,AMENTOFLAVONE,YUSWMAULDXZHPY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029185,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 in UVB irradiated human dermal fibroblasts at <5 uM by zymography,Not Active,Biflavonoids isolated from Selaginella tamariscina regulate the expression of matrix metalloproteinase in human skin fibroblasts.,Bioorg. Med. Chem.,2008,16,2,"Lee CW, Choi HJ, Kim HS, Kim DH, Chang IS, Moon HT, Lee SY, Oh WK, Woo ER",,465413,DTCT0025094,2292828,DTCC00216407,1555640,25393
CHEMBL63677,P08253,ROBUSTAFLAVONE,BORWSEZUWHQTOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18029185,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP2 in UVB irradiated human dermal fibroblasts at <5 uM by zymography,Not Active,Biflavonoids isolated from Selaginella tamariscina regulate the expression of matrix metalloproteinase in human skin fibroblasts.,Bioorg. Med. Chem.,2008,16,2,"Lee CW, Choi HJ, Kim HS, Kim DH, Chang IS, Moon HT, Lee SY, Oh WK, Woo ER",,465413,DTCT0025094,2292827,DTCC00215991,1587879,25393
CHEMBL64013,P08253,,YKYLOHCKSMYHPL-DSITVLBTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,0.8,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1673595,DTCC00216008,949443,2712
CHEMBL64262,P08253,,YYHIIRGQRSUJIF-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,=,805,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,501112,DTCC00212056,1806024,5598
CHEMBL64281,P08253,,QTGLVPVEYPPUEP-LAUBAEHRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,478565,DTCC00211507,388847,5598
CHEMBL64586,P08253,,DCPYFXNPRQTWHH-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,=,446,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,488905,DTCC00211948,128647,5598
CHEMBL64739,P08253,,FTQUTXYBANDKFP-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12781190,KI,>,3000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-2,,Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Duan JJ, Lu Z, Xue CB, He X, Seng JL, Roderick JJ, Wasserman ZR, Liu RQ, Covington MB, Magolda RL, Newton RC, Trzaskos JM, Decicco CP",,104399,DTCT0025094,348651,DTCC00212434,388849,5598
CHEMBL65159,P08253,,XEONYLBJVDXPRB-BDTNDASRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1643633,DTCC00215885,658870,2712
CHEMBL6572,P08253,,QPEZTCMCOIDQRV-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1316350,DTCC00133465,34547,4760
CHEMBL66134,P08253,,QPPXLNJKZJGLRN-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,3.8,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1649892,DTCC00215883,75751,2712
CHEMBL66532,P08253,,ANFAAJVPGXQKBB-NXCFDTQHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9873491,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of fibroblast gelatinase A (MMP-2),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101906,DTCT0025094,1654871,DTCC00215598,29480,2712
CHEMBL67291,P08253,,JBDQTGJGXFAHIQ-VQHVLOKHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.22,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836401,DTCC00220573,964993,53968
CHEMBL67498,P08253,CAFFEIC ACID PHENETHYL AMIDE,QOWABIXYAFJMQE-VQHVLOKHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,8.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836400,DTCC00220542,447224,53968
CHEMBL67830,P08253,,SVJNLPDHJMHQCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25907368,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP-2 activity in human HT1080 cells by gelatin zymography,Not Active,"Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.",Bioorg. Med. Chem.,2015,23,13,"Nanjan P, Nambiar J, Nair BG, Banerji A",,1501256,DTCT0025094,14455612,DTCC00216955,1739582,62853
CHEMBL68049,P08253,,ZRSUANFPMBWMDZ-YKSBVNFPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,55,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1399737,DTCC00224780,1661211,14854
CHEMBL68149,P08253,,IWLYSDNBOSWMRQ-JWQCQUIFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,3,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1398508,DTCC00224685,1817827,14854
CHEMBL68427,P08253,,TUCRGTOIEKYIRD-FNORWQNLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,1587.17,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836398,DTCC00220988,1418674,53968
CHEMBL68890,P08253,,NDJSPXLINRRDIS-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.57,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1387373,DTCC00224920,2012678,14854
CHEMBL69072,P08253,,MXPPQWXYSRGIMR-UZLBHIALSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,20,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1383738,DTCC00224774,2012677,14854
CHEMBL6973,P08253,,DRWHINQPSIPRHF-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,8.8,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1301007,DTCC00133507,110647,4760
CHEMBL6973,P08253,,DRWHINQPSIPRHF-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,8.71,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258297,DTCC00133507,99391,24803
CHEMBL69803,P08253,,QEFITTUAKPOZPK-KRXBUXKQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23375794,IC50,=,3.28,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,5,"Shi ZH, Li NG, Shi QP, Tang H, Tang YP, Li W, Yin L, Yang JP, Duan JA",,948151,DTCT0025094,11836397,DTCC00220717,91234,53968
CHEMBL70049,P08253,,VWIDRIAWTQJPLN-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,19,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1393596,DTCC00225610,1435144,14854
CHEMBL70110,P08253,,LCWFIBYPSAWVLI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,16,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103198,DTCC00224425,1349087,43205
CHEMBL70315,P08253,,KXYFKTLZKSANJT-SJLPKXTDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1381112,DTCC00226033,29662,14854
CHEMBL70354,P08253,,CVRRBTAXFZBMPH-KAYWLYCHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,6.7,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1380996,DTCC00225598,1914295,14854
CHEMBL70398,P08253,,OKGPERFMUXABQD-UTUOFQBUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.47,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1386229,DTCC00225984,1403135,14854
CHEMBL70406,P08253,,OUMHWPMKRPJGKY-XDAJTCOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,25,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1382344,DTCC00224975,1693318,14854
CHEMBL70417,P08253,,BOHIPQBVCFMFFK-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.52,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1382340,DTCC00225271,433223,14854
CHEMBL70426,P08253,,SBOCVCYAEHVMEA-UZLBHIALSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,3.5,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1368302,DTCC00225464,1564220,14854
CHEMBL70430,P08253,,UMZQUWRHZNAVMN-ILBGXUMGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.59,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1365751,DTCC00225049,1596640,14854
CHEMBL70492,P08253,,FYGGOGPIPBSHEF-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.42,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1393600,DTCC00224896,335444,14854
CHEMBL70570,P08253,,CJQLPOBRKZCBHK-VXGBXAGGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,1.1,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1368419,DTCC00225946,335443,14854
CHEMBL70571,P08253,,JHRIMEDFWCLALJ-PVAVHDDUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.89,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1395991,DTCC00225947,204694,14854
CHEMBL70639,P08253,,UHJDYMMCTFTTSW-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,42,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1388631,DTCC00225490,1111858,14854
CHEMBL70953,P08253,,UKNOMEZXDWRZAF-GSMMQLOJSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,46,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1372219,DTCC00225487,1079125,14854
CHEMBL70965,P08253,,FNRRTPCWYWKARV-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.54,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1372224,DTCC00225239,140536,14854
CHEMBL71014,P08253,,XQEHCUFTCDJVSN-ZWKOTPCHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,43,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1383746,DTCC00225460,820108,14854
CHEMBL71071,P08253,,QUSCQVGYLGWIJY-NRYAXDJKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.64,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1379727,DTCC00225563,1079124,14854
CHEMBL7108,P08253,,VAQNHYAKIUNIKM-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1286292,DTCC00133441,1209922,4760
CHEMBL7108,P08253,,VAQNHYAKIUNIKM-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258300,DTCC00133441,1198919,24803
CHEMBL71468,P08253,,GPKYERMOQBHGRC-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,17,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1368314,DTCC00224782,1046648,14854
CHEMBL71482,P08253,,YSZLQAVPFNEECF-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.21,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1402231,DTCC00225535,1014237,14854
CHEMBL71618,P08253,,USFNQSYWKLKGHX-RTBURBONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.7,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1381000,DTCC00224917,787755,14854
CHEMBL71630,P08253,,DEDGVHPWRWYTIC-IXCJQBJRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,8.1,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1368310,DTCC00224922,981927,14854
CHEMBL71713,P08253,,OFIZOTOQCJTVRO-UTKZUKDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,4.6,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1391195,DTCC00225339,1753206,14854
CHEMBL71801,P08253,,NITYDPDXAAFEIT-GUYCJALGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,300,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1392424,DTCC00225088,949541,14854
CHEMBL72337,P08253,,PJVJLPSYNZOOCE-JWQCQUIFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,18,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1368306,DTCC00225298,302884,14854
CHEMBL72457,P08253,,XIYFEESCIBNMIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103364,DTCC00224003,1185922,43205
CHEMBL72511,P08253,PKF-242-484,IOLRUMINDIUCLJ-RRFJBIMHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12014967,KI,=,0.5,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-2 (MMP-2),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104562,DTCT0025094,800970,DTCC01741036,853076,16740
CHEMBL72628,P08253,2-PICOLINIC ACID,SIOXPEMLGUPBBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103025,DTCC00227813,1251244,43205
CHEMBL72743,P08253,,QZRDSGNFNCBFPU-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,7.3,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1395894,DTCC00225158,1564219,14854
CHEMBL72788,P08253,,GNHMOHGVWISYSN-IERDGZPVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.92,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1390044,DTCC00225656,755585,14854
CHEMBL7301,P08253,FENRETINIDE,AKJHMTWEGVYYSE-FXILSDISSA-N,3,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23953690,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of MMP2 activity in human HT1080 cells at 1 uM after 24 hrs,Not Active,Inhibitory effects of p-dodecylaminophenol on the invasiveness of human fibrosarcoma cell line HT1080.,Bioorg. Med. Chem.,2013,21,19,"Takahashi N, Takeda K, Imai M",,980576,DTCT0025094,12548204,DTCC00132924,1942336,55644
CHEMBL73173,P08253,2-CARBOXYPYRIDINE 1-OXIDE,FHYMLBVGNFVFBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103214,DTCC01740992,1510695,43205
CHEMBL734,P08253,ACETOHYDROXAMIC ACID,RRUDCFGSUDOHDG-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,IC50,=,15000000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715236,DTCT0025094,5096334,DTCC00163357,637574,43205
CHEMBL734,P08253,ACETOHYDROXAMIC ACID,RRUDCFGSUDOHDG-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103211,DTCC00163357,637574,43205
CHEMBL73652,P08253,,ZAGFXXPMKXEROI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,1.4,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1597358,DTCC00230720,614971,16699
CHEMBL73803,P08253,,ZWZXXDZMSDNWNF-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.254,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,561305,DTCC00232109,1338270,16308
CHEMBL73803,P08253,,ZWZXXDZMSDNWNF-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.254,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,992461,DTCC00232109,1326608,1012
CHEMBL73866,P08253,,DFIPAYGHEIHLSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,2.4,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1584591,DTCC00230832,1806225,16699
CHEMBL7390,P08253,,SUSMVCKSLVPRCL-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1310676,DTCC00133540,693701,4760
CHEMBL7390,P08253,,SUSMVCKSLVPRCL-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258299,DTCC00133540,682316,24803
CHEMBL73928,P08253,,YHQIGEQPWJUUHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,1.7,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1565048,DTCC00231252,711867,16699
CHEMBL74040,P08253,,RJDSAKRTODCGAU-DGPALRBDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,567365,DTCC00232410,335552,16308
CHEMBL74151,P08253,,SZXOIWIFZQPGPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,3.6,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1563885,DTCC00231065,614972,16699
CHEMBL74175,P08253,,LICFKTFLYQYXDH-ZIAGYGMSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9457244,KI,=,0.96,NM,,,,,,,,,,,,,,Binding affinity towards 72 kDa gelatinase (Matrix metalloprotease-2),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,104542,DTCT0025094,1385037,DTCC00225651,1499819,14854
CHEMBL74308,P08253,,ARCVMPXMLFTEBX-PXJZQJOASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.03,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,569691,DTCC00232232,1499898,16308
CHEMBL74365,P08253,,ANRXCWSBJHOAED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,62,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1559926,DTCC00231119,518390,16699
CHEMBL74812,P08253,,ZBQMJMAWFWQVBB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,9.5,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1571240,DTCC00230567,1681988,16699
CHEMBL74977,P08253,,OXBBHJALLZTSBF-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,18.9,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,579680,DTCC00232759,2077057,16308
CHEMBL74977,P08253,,OXBBHJALLZTSBF-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,18.9,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1693931,DTCC00232759,2077345,1013
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against gelatinase-A (matrix metalloprotease-2).,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,106805,DTCT0025094,1369134,DTCC00231104,336627,15412
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10579818,KI,=,0.083,NM,,,,,,,,,,,,,,Inhibition of gelatinase-A (Matrix metalloprotease-2),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104403,DTCT0025094,1369135,DTCC00231104,336627,15412
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10669559,KI,=,0.083,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104534,DTCT0025094,1072598,DTCC00231104,324460,16063
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,0.3,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,698093,DTCC00231104,324088,3985
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11212095,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104377,DTCT0025094,628948,DTCC00231104,324195,4635
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,0.3,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1673837,DTCC00231104,335657,4449
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.048,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1565052,DTCC00231104,323739,16699
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,0.08,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104400,DTCT0025094,1019724,DTCC00231104,323997,5080
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12930146,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP2),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104390,DTCT0025094,532645,DTCC00231104,336390,13726
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14711305,KI,=,0.05,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,104396,DTCT0025094,1264841,DTCC00231104,336154,17924
CHEMBL75094,P08253,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15713379,IC50,=,0.09,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305733,DTCT0025094,1745890,DTCC00231104,325586,18841
CHEMBL75114,P08253,,QYMSAHRHXPUNSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.61,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1572588,DTCC00230626,1391780,16699
CHEMBL75139,P08253,,SBVGWUXDJBPGDG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.72,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1592229,DTCC00231254,614970,16699
CHEMBL75148,P08253,,GOFLUZCVSLWGBX-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,1.17,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,578434,DTCC00231346,433296,16308
CHEMBL75148,P08253,,GOFLUZCVSLWGBX-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,1.17,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1710778,DTCC00231346,433550,1013
CHEMBL75154,P08253,,BYBOLCACCXBYNF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.45,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1576459,DTCC00231570,193361,16699
CHEMBL75164,P08253,,UWWZSLPTPKEDCJ-ZYMOGRSISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.36,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1592239,DTCC00231183,711866,16699
CHEMBL75164,P08253,,UWWZSLPTPKEDCJ-ZYMOGRSISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,IC50,=,0.36,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,,MedChemComm,2012,3,11,,,1327984,DTCT0025094,13570928,DTCC00231183,739815,40045
CHEMBL75189,P08253,,ZOYPENCXBQHGNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.57,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1561137,DTCC00230630,356450,16699
CHEMBL75302,P08253,,LSWGUPLJLWZCIM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.32,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1588317,DTCC00230776,518391,16699
CHEMBL75403,P08253,,FMRZZWFHPADOAW-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.062,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,556719,DTCC00231895,1914379,16308
CHEMBL75403,P08253,,FMRZZWFHPADOAW-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.06,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1696340,DTCC00231895,1914647,1013
CHEMBL75403,P08253,,FMRZZWFHPADOAW-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.062,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1004547,DTCC00231895,1903268,1012
CHEMBL75419,P08253,,SXXYGGYNEUHILZ-ANYOKISRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,550,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104565,DTCT0025094,1569303,DTCC00232298,1240250,2242
CHEMBL75437,P08253,,ZIOWEXJTMJYIOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,3.7,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1572583,DTCC00231652,128855,16699
CHEMBL75464,P08253,,PIPNMGRIVITFEC-VQCQRNETSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,20,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1566230,DTCC00230825,808541,16699
CHEMBL75487,P08253,,IAPIGLKJGZQTIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.35,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1568630,DTCC00231094,1261335,16699
CHEMBL75529,P08253,,OFKCKYMJSALCIS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.39,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1563889,DTCC00231180,1326294,16699
CHEMBL75567,P08253,,YUAGFRRWRZNRHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,1.3,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1562521,DTCC00230957,1067475,16699
CHEMBL75618,P08253,,NATAXQWJZDVABL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,2.4,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1565045,DTCC00231568,744168,16699
CHEMBL76043,P08253,,JGARQZXVQXLEJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.86,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1569940,DTCC00231566,1617665,16699
CHEMBL76158,P08253,,JJZXSGSWLVQWHL-GGAORHGYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,575316,DTCC00232031,1403221,16308
CHEMBL76222,P08253,REBIMASTAT,GTXSRFUZSLTDFX-HRCADAONSA-N,2,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,41,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1562530,DTCC00231103,1326293,16699
CHEMBL76297,P08253,,GKLAUAGSCYZMQP-BFHYXJOUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12014967,KI,=,4.8,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-2 (MMP-2),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104562,DTCT0025094,809398,DTCC00229222,981970,16740
CHEMBL76519,P08253,,YGJCNDHMYMIUBJ-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.3,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,565128,DTCC00232260,659058,16308
CHEMBL76519,P08253,,YGJCNDHMYMIUBJ-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.3,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,991079,DTCC00232260,647971,1012
CHEMBL76757,P08253,,MMRISAVXAFHOJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.67,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1569944,DTCC00231621,1870575,16699
CHEMBL76869,P08253,,PNOAVGXEWQIVLB-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,555579,DTCC00232376,853104,16308
CHEMBL76869,P08253,,PNOAVGXEWQIVLB-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.5,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1705330,DTCC00232376,853377,1013
CHEMBL76869,P08253,,PNOAVGXEWQIVLB-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,366,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1717667,DTCC00232376,853376,1013
CHEMBL77013,P08253,,IJQHRVZFTGGUJN-ZVAWYAOSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,430,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104565,DTCT0025094,1581198,DTCC00232677,400993,2242
CHEMBL77057,P08253,,DKPQMSLWGNDZTO-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.02,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,578440,DTCC00232820,626727,16308
CHEMBL77163,P08253,,VAQVSMUJBPTVIS-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12824028,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104553,DTCT0025094,1491831,DTCC00232704,1403218,5648
CHEMBL77461,P08253,,ZKISXIXLRWGPKA-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,571958,DTCC00231878,497734,16308
CHEMBL77461,P08253,,ZKISXIXLRWGPKA-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,10,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1700076,DTCC00231878,497988,1013
CHEMBL7756,P08253,,HTNLSTWGHBHDPS-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11327577,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104379,DTCT0025094,1292485,DTCC00133590,207299,4760
CHEMBL77659,P08253,,QCHJWCBHICZTTP-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.05,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,580744,DTCC00232152,1661284,16308
CHEMBL77663,P08253,,RHQDIPUHXQNFIY-IHLOFXLRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.02,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,578437,DTCC00232153,1596726,16308
CHEMBL77754,P08253,,ABTPKZSVAHUDFA-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.33,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,562552,DTCC00231863,755644,16308
CHEMBL77754,P08253,,ABTPKZSVAHUDFA-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.33,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,989964,DTCC00231863,744425,1012
CHEMBL77808,P08253,,FCKWIYZMPDIGLV-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,2.24,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,554316,DTCC00232150,1946977,16308
CHEMBL77808,P08253,,FCKWIYZMPDIGLV-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,2.24,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,996268,DTCC00232150,1935248,1012
CHEMBL77874,P08253,,WGXKBOQJZAHOOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,2.8,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1592234,DTCC00230728,225702,16699
CHEMBL77907,P08253,,WASBGWNGXLFKPA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,1.8,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1593477,DTCC00230747,1261334,16699
CHEMBL77956,P08253,,WVBSAEZXOPOUJB-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,3.06,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,576404,DTCC00232618,497733,16308
CHEMBL77956,P08253,,WVBSAEZXOPOUJB-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.06,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1679721,DTCC00232618,497987,1013
CHEMBL77995,P08253,,WFQFQAQNCYHBTC-FUJFQHJFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12824028,IC50,=,6.6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104553,DTCT0025094,1497636,DTCC00232836,820189,5648
CHEMBL78047,P08253,,VEAMBOBAFHZNKJ-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,6,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,569697,DTCC00232544,2012756,16308
CHEMBL78047,P08253,,VEAMBOBAFHZNKJ-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,6,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1706608,DTCC00232544,2013004,1013
CHEMBL78052,P08253,,GSMKHTZLWUPIAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.33,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1586963,DTCC00231005,1455853,16699
CHEMBL78081,P08253,,ATHLMNGFZTVPSA-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,77,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,852068,DTCC00238990,841463,1379
CHEMBL78145,P08253,,MJYMJQBCXIIWTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,0.53,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1571243,DTCC00231530,1902970,16699
CHEMBL78213,P08253,,CATBJIHGLQLCIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11754593,IC50,=,34,NM,,,,,,,,,,,,,,In vitro selective inhibition against matrix metalloprotease-2 (MMP-2) using fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104551,DTCT0025094,1566227,DTCC00231510,744167,16699
CHEMBL78233,P08253,,ROFAQOFULLWONA-FOIFJWKZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12824028,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104553,DTCT0025094,1501942,DTCC00232527,335546,5648
CHEMBL78335,P08253,,OUOSIGGTYBFYMF-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,0.9,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,568552,DTCC00232757,1273033,16308
CHEMBL78335,P08253,,OUOSIGGTYBFYMF-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.9,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1679724,DTCC00232757,1273287,1013
CHEMBL78598,P08253,,RRMMAIAIQQHWEX-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,820701,DTCC00238555,970296,1379
CHEMBL78826,P08253,,QCBWOUQUDIILOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835702,DTCC00237661,868683,53820
CHEMBL78919,P08253,,OGYHNTDCEFBNGN-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,24,%,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) at 1 uM,,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101910,DTCT0025094,831369,DTCC00238554,2065532,1379
CHEMBL790,P08253,CHLORHEXIDINE,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20053563,IC50,=,7630,NM,,,,,,,,,,,,,,Inhibition of human rheumatoid synovial fibroblasts gelatinase A after 30 mins by fluorescence plate reader,,"Identification of potential and selective collagenase, gelatinase inhibitors from Crataegus pinnatifida.",Bioorg. Med. Chem. Lett.,2010,20,3,"Moon HI, Kim TI, Cho HS, Kim EK",,607930,DTCT0025094,3191716,DTCC00172379,1918621,37466
CHEMBL79267,P08253,,UYFGGWJRPCRSHW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,3.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1322792,DTCC00242002,1163761,16328
CHEMBL79433,P08253,,IMKDKHQDFFLOKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,104548,DTCT0025094,494318,DTCC00235743,75938,17340
CHEMBL79438,P08253,,NICYWIBCSYQDRP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,12,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1647340,DTCC00241069,75995,4449
CHEMBL79450,P08253,,RFLCSJBVTOHUGE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1.1,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1668899,DTCC00241094,1144285,4449
CHEMBL79619,P08253,,DOCKNIJXKGCWQV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1661467,DTCC00240866,723611,4449
CHEMBL79636,P08253,,VECQGWFFKYPCMA-OWCLPIDISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant gelatinase-A (MMP-2) at 10e-4 M (No significant activity),Not Active,,Bioorg. Med. Chem. Lett.,1997,7,19,,,101732,DTCT0025094,1500921,DTCC00241234,1838786,2263
CHEMBL79712,P08253,,NNDUTDPDZHXRRE-QDSKXPNFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,4840,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,845578,DTCC00239094,1585028,1379
CHEMBL79837,P08253,,ZJECTIJIWXIEHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,3,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1643894,DTCC00240945,755723,4449
CHEMBL79857,P08253,,VEYIMQVTPXPUHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103186,DTCC00238936,701896,43205
CHEMBL79906,P08253,,QPSBVVFMTSFAJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,53,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1313201,DTCC00242125,1903109,16328
CHEMBL79948,P08253,,DTEROUBEWKRJFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1411847,DTCC00242133,1455980,6359
CHEMBL80102,P08253,,UVCYZCWBCCZIRY-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,42,%,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) at 1 uM,,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101910,DTCT0025094,831372,DTCC00238002,421915,1379
CHEMBL81014,P08253,,IYAKGTQGDHUISZ-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,,,,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) (Not tested),Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101915,DTCT0025094,843364,DTCC00238976,161583,1379
CHEMBL81113,P08253,,BDCJZZXWIQJYLP-FIWHBWSRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835703,DTCC00237078,1800998,53820
CHEMBL81264,P08253,,XXOYKWAQHGQSOT-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,130,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,846963,DTCC00106070,970297,1379
CHEMBL81270,P08253,,XZCOTKRLQZVHTR-NYMACZPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,833848,DTCC00239051,1293829,1379
CHEMBL81333,P08253,,DGOJEEWMDRDFIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1652653,DTCC00240433,1403314,4449
CHEMBL81398,P08253,,SNUSZUYTMHKCPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,39,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103188,DTCC00239383,927980,43205
CHEMBL81672,P08253,,YCCKHBLGJUKATM-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) at 1 uM,,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101910,DTCT0025094,849691,DTCC00238504,1682060,1379
CHEMBL82092,P08253,,JXCJPSURORGUCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1.1,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1647352,DTCC00240841,1112008,4449
CHEMBL82113,P08253,,PYGZWPVJQNBFNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,58.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1290349,DTCC00242452,1773868,16328
CHEMBL82115,P08253,,FJAZVXUPZQSZKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1410583,DTCC00241670,1163766,6359
CHEMBL82169,P08253,,LFOGEPKUSWRLCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,0.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1298764,DTCC00241974,550551,16328
CHEMBL82217,P08253,,VSSBMKQTJZCDML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,21,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1645102,DTCC00240811,108262,4449
CHEMBL82499,P08253,,DLQDIVPCTCJXSZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1.8,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1642632,DTCC00240910,594330,4449
CHEMBL8256,P08253,,UXFNMUGVMKCZTP-NZJKTDFXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,310,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,614805,DTCC00135765,1101820,2023
CHEMBL82597,P08253,,YHUAHVPZGNXPMS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,32,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5102658,DTCC00238679,1892887,43205
CHEMBL82744,P08253,,RZAFOWVSSSTSEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1406076,DTCC00242671,776374,6359
CHEMBL8282,P08253,,RQBUQSJYJPOWOP-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,580,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,530949,DTCC00135761,1869584,14548
CHEMBL82842,P08253,,AYFOFUUKQJIUFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,330,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1648729,DTCC00240868,1370912,4449
CHEMBL82868,P08253,,QCLOBJCDRHHNCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1613740,DTCC00243186,950353,15919
CHEMBL82868,P08253,,QCLOBJCDRHHNCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,18.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258477,DTCC00243186,940924,24803
CHEMBL83209,P08253,,URNFYSXQOHQAJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,1.3,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,728379,DTCC00240463,1968542,3985
CHEMBL83209,P08253,,URNFYSXQOHQAJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1.2,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1650142,DTCC00240463,1980028,4449
CHEMBL83209,P08253,,URNFYSXQOHQAJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23287054,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944583,DTCT0025094,11835699,DTCC00240463,1995454,53820
CHEMBL83282,P08253,,ICFOTHUAZLHTNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,1.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1292786,DTCC00242039,1585074,16328
CHEMBL83368,P08253,,HGCZRPPCNXJXAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,<,0.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1287852,DTCC00242344,323868,16328
CHEMBL83508,P08253,,WLZISXXOYYGJNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,=,110,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1612430,DTCC00243572,238020,15919
CHEMBL83508,P08253,,WLZISXXOYYGJNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,KI,=,109.65,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258439,DTCC00243572,228498,24803
CHEMBL83508,P08253,,WLZISXXOYYGJNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20180536,IC50,=,32,NM,,,,,,,,,,,,,,Inhibition of MMP2 by fluorometric assay,,Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.,J. Med. Chem.,2010,53,6,"Nuti E, Casalini F, Avramova SI, Santamaria S, Fabbi M, Ferrini S, Marinelli L, La Pietra V, Limongelli V, Novellino E, Cercignani G, Orlandini E, Nencetti S, Rossello A",,624093,DTCT0025094,3286016,DTCC00243572,241678,38228
CHEMBL83616,P08253,,JXAGDPXECXQWBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,91.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1310933,DTCC00242500,1773869,16328
CHEMBL83955,P08253,,ILTCMGUVAAYHSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1316681,DTCC00242203,1067615,16328
CHEMBL84031,P08253,,HQGDKMFOWKNNOV-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,INHIBITION,=,14,%,,,,,,,,,,,,,,Inhibition of human gelatinase-A (MMP-2) at 1 uM,,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101910,DTCT0025094,829879,DTCC00239000,1742025,1379
CHEMBL84103,P08253,,JKJGTZQYWJTZFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1439323,DTCC00241700,3883,6359
CHEMBL8432,P08253,,MJTVUROZTDIMFT-MZEQIWSPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,43,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1528010,DTCC00135333,239783,4824
CHEMBL84401,P08253,,DISLBCKXFDUIBD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1409587,DTCC00242647,193501,6359
CHEMBL84416,P08253,,VECQGWFFKYPCMA-HRCADAONSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant gelatinase-A (MMP-2) at 10e-4 M (No significant activity),Not Active,,Bioorg. Med. Chem. Lett.,1997,7,19,,,101732,DTCT0025094,1490651,DTCC00241209,128959,2263
CHEMBL84417,P08253,,CLKBXQUHUHIIKD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1416893,DTCC00241851,193500,6359
CHEMBL8447,P08253,,KFCGJOUPNCPHDL-NOOIUNMQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,39,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1552005,DTCC00135696,1340847,4824
CHEMBL84492,P08253,,DDIURNOVEIWZCF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1431437,DTCC00242646,1649958,6359
CHEMBL8451,P08253,,XMKDGSRADZHPTC-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,3000,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,518240,DTCC00135663,224640,14548
CHEMBL84543,P08253,,NPXKPNYJEQAEFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15109641,IC50,,,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 at 100 uM (inactive),Not Active,Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.,Bioorg. Med. Chem. Lett.,2004,14,10,"Ishida K, Simizu S, Teruya T, Wierzba MK, Osada H",,104544,DTCT0025094,1439175,DTCC00242074,1649959,6359
CHEMBL8466,P08253,,DLHFXODLXJAOSF-XRODADMRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,2.8,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1539820,DTCC00135786,272550,4824
CHEMBL8474,P08253,,DFHTYEKEXQDADI-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.5,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,825673,DTCC00135731,3815,1379
CHEMBL8474,P08253,,DFHTYEKEXQDADI-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,3.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,606779,DTCC00135731,6489,2023
CHEMBL8494,P08253,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,200,NM,,,,,,,,,,,,,,Inhibitory activity against human gelatinase-A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101914,DTCT0025094,840913,DTCC00135604,1163711,1379
CHEMBL8494,P08253,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of human gelatinase A (MMP-2),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,101922,DTCT0025094,1008209,DTCC00135604,1164916,1529
CHEMBL8494,P08253,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP-2.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101920,DTCT0025094,566866,DTCC00135604,1164280,1951
CHEMBL8494,P08253,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2 (MMP-2),,,Bioorg. Med. Chem. Lett.,1996,6,7,,,101928,DTCT0025094,617197,DTCC00135604,1165200,2023
CHEMBL8496,P08253,,KLPLOGXKUWGLSE-XRODADMRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,<,2.8,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1529229,DTCC00135818,370756,4824
CHEMBL84969,P08253,BB-3554,AVDLWYHBABSSHC-ZGTCLIOFSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11551755,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-2,,Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.,Bioorg. Med. Chem. Lett.,2001,11,19,"Pratt LM, Beckett RP, Davies SJ, Launchbury SB, Miller A, Spavold ZM, Todd RS, Whittaker M",,104547,DTCT0025094,1077160,DTCC01741523,1617853,4468
CHEMBL85026,P08253,,IRVGVLJCCVMVAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,549,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1286649,DTCC00242319,421955,16328
CHEMBL85030,P08253,CGS-25966,ZGSTVUAZFACDLH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22540974,KI,=,11,NM,,,,,,,,,,,,,,"Inhibition of MMP2 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832930,DTCT0025094,10563906,DTCC01741458,543755,48958
CHEMBL85030,P08253,CGS-25966,ZGSTVUAZFACDLH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,23899323,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of MMP-2 (unknown origin),,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983459,DTCT0025094,12575118,DTCC01741458,525519,55760
CHEMBL85030,P08253,CGS-25966,ZGSTVUAZFACDLH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25921268,KI,=,11,NM,,,,,,,,,,,,,,"Inhibition of human active MMP2 using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 fluorogenic substrate assessed as fluorescent product release",,New matrix metalloproteinase inhibitors based on ¿-fluorinated a-aminocarboxylic and a-aminohydroxamic acids.,Bioorg. Med. Chem.,2015,23,13,"Behrends M, Wagner S, Kopka K, Schober O, Schäfers M, Kumbhar S, Waller M, Haufe G",,1501467,DTCT0025094,14456762,DTCC01741458,527978,62860
CHEMBL85255,P08253,,LGSJACYKGMNZKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11549451,ACTIVITY,=,1.9,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,"Selective, orally active MMP inhibitors with an aryl backbone.",Bioorg. Med. Chem. Lett.,2001,11,18,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Mehta P, Munie GE, Villamil CI",,106802,DTCT0025094,1653844,DTCC00240904,1370909,4449
CHEMBL85374,P08253,,BLYHHTXBRXLLOI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472202,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-2,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104369,DTCT0025094,1320326,DTCC00242381,1455978,16328
CHEMBL8539,P08253,,VYRNNIARONKBRB-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,2400,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,515084,DTCC00135734,1901970,14548
CHEMBL8553,P08253,,RDDJLUVPXZTDCT-QQSVUBKYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,<,2.8,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1529225,DTCC00135425,1146741,4824
CHEMBL85744,P08253,,ZGTPJERIIBYCFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,202,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1093442,DTCC00248613,1002961,15258
CHEMBL8578,P08253,,JHLCBEICWMJALX-ULNYTKQRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,760,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,514087,DTCC00135683,1551747,14548
CHEMBL8580,P08253,,JJIIYULDEGYNEW-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,210,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,537720,DTCC00135771,1292694,14548
CHEMBL8634,P08253,,NFMRFQNSUWXJSA-XPWALMASSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,47,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,541398,DTCC00135606,937105,14548
CHEMBL86390,P08253,,HCCYYUWFQWPMDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,85,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1072660,DTCC00248612,452924,15258
CHEMBL8655,P08253,,FPXJIRSUGPCTBC-QQSVUBKYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,31,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1535165,DTCC00135623,143114,4824
CHEMBL8702,P08253,,WHHWDHNQTWOJFL-PFATUAPWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,<,1,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1526880,DTCC00135672,1852611,4824
CHEMBL87159,P08253,,SFORRVNMTYAPLQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,8,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1065670,DTCC00248280,291448,15258
CHEMBL8718,P08253,,HKGUEYWZKLSNKN-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,14,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,540338,DTCC00135639,1837647,14548
CHEMBL87300,P08253,,BVONHINTCXADCU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,17,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1056171,DTCC00248279,291447,15258
CHEMBL8745,P08253,,IVVIGKFVPVPXEY-OZNIXHKMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,380,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,543140,DTCC00103481,95661,14548
CHEMBL8753,P08253,,VFGGQXYFBRUJJO-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,530955,DTCC00136027,1740945,14548
CHEMBL8761,P08253,,QQSPWJZNPRUUJQ-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,543137,DTCC00135481,322699,14548
CHEMBL87786,P08253,,UERCGTJUVRFNRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,260,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1084527,DTCC00248815,1456037,15258
CHEMBL88187,P08253,,BVNHOVTUHKATJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,30,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1082197,DTCC00249128,323966,15258
CHEMBL88188,P08253,,LWTYDGJEOHWGQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,40,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1092147,DTCC00249129,582755,15258
CHEMBL8828,P08253,,RTPXKIITNMOTOD-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,351790,DTCC00135854,290150,14548
CHEMBL8833,P08253,,DKCIEOMWEADZSJ-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,80,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,540335,DTCC00136055,646656,14548
CHEMBL8847,P08253,,LGJQFTJRPHIEEF-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,38,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,530952,DTCC00135967,549407,14548
CHEMBL88520,P08253,,HFAGTNGCAZYYLZ-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472217,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104535,DTCT0025094,1674080,DTCC00251150,291473,16346
CHEMBL8868,P08253,,MGIJXUJXJHNWQP-OZNIXHKMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,518237,DTCC00136056,1740946,14548
CHEMBL8888,P08253,,OGCXCGPUOHWTTK-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,32,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,518136,DTCC00135897,1325239,14548
CHEMBL88896,P08253,,JBYHBQIDTNHWJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104401,DTCT0025094,1024676,DTCC00251602,970461,5080
CHEMBL88972,P08253,"PYRIDINE-2,5-DICARBOXYLIC ACID",LVPMIMZXDYBCDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,-5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103130,DTCC00250420,2087684,43205
CHEMBL89057,P08253,,RIOJMNDNYHZZFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,24,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1082204,DTCC00249245,1838879,15258
CHEMBL8914,P08253,,FWCQVBZMZSRSKB-HRHHFINDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,6900,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,529073,DTCC00135633,937104,14548
CHEMBL8917,P08253,,SAJIBYZMJURFDN-TVZXLZGTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,1600,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,544207,DTCC00135888,743214,14548
CHEMBL8930,P08253,,DZJGNVNCJWKZRX-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,34,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,514084,DTCC00136057,2064484,14548
CHEMBL8943,P08253,,VXDKQRWTOJFQKH-BJZITVGISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585439,KI,=,1507,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,104536,DTCT0025094,1409057,DTCC00135827,1468155,16438
CHEMBL8943,P08253,,VXDKQRWTOJFQKH-BJZITVGISA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,1507,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1519785,DTCC00135827,1470173,4824
CHEMBL8961,P08253,,RZFXBBCSOPZCEJ-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,25,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,351692,DTCC00135756,1740947,14548
CHEMBL8984,P08253,,UZLLJEIQEDPUMV-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,1800,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,517202,DTCC00135752,127844,14548
CHEMBL90211,P08253,,IYMQHQXCXLDREF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1082011,DTCC00255143,1850277,4541
CHEMBL90211,P08253,,IYMQHQXCXLDREF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317097,DTCC00255143,1837566,67557
CHEMBL90211,P08253,,IYMQHQXCXLDREF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317300,DTCC00255143,1837566,67557
CHEMBL9028,P08253,,YQJZTTJHPABLHV-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,22,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,522317,DTCC00136040,1772721,14548
CHEMBL90377,P08253,,LBHKXKMLUPCKIQ-RLXSEPNVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,8064799,KI,=,90,NM,,,,,,,,,,,,,,Binding constant containing a pseudophenylalanine residue,,Cyclic peptides with a phosphinic bond as potent inhibitors of a zinc bacterial collagenase.,J. Med. Chem.,1994,37,17,"Yiotakis A, Lecoq A, Vassiliou S, Raynal I, Cuniasse P, Dive V",,49495,DTCT0025094,941561,DTCC00255667,917282,12611
CHEMBL90487,P08253,,WGRMVARLTSCXRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,80,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1059267,DTCC00255302,1818149,4541
CHEMBL90487,P08253,,WGRMVARLTSCXRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,79.98,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317301,DTCC00255302,1805198,67557
CHEMBL90487,P08253,,WGRMVARLTSCXRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,80,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317098,DTCC00255302,1805198,67557
CHEMBL90622,P08253,,RZDDQWJXBRPPTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10411481,KI,=,14,NM,,,,,,,,,,,,,,Binding affinity against matrix metalloprotease-2 (gelatinase-A).,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,104402,DTCT0025094,1090998,DTCC00249364,1742142,15258
CHEMBL9074,P08253,,FAJSWDUTNDYTOS-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,544210,DTCC00135945,1837648,14548
CHEMBL90743,P08253,,YQELKCVHKSQHTN-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.59,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1004553,DTCC00257144,1553043,1012
CHEMBL90762,P08253,,HXBXLCOXHVGSLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,3.2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1055871,DTCC00255151,1629523,4541
CHEMBL90762,P08253,,HXBXLCOXHVGSLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,3.199,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317298,DTCC00255151,1616609,67557
CHEMBL90762,P08253,,HXBXLCOXHVGSLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,3.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317095,DTCC00255151,1616609,67557
CHEMBL9086,P08253,,LNOUSIQMHQJZBP-WIOYSNFSSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11738583,KI,=,4.5,NM,,,,,,,,,,,,,,Binding affinity for human gelatinase A (MMP-2),,Potent P1' biphenylmethyl substituted aggrecanase inhibitors.,Bioorg. Med. Chem. Lett.,2002,12,1,"Yao W, Chao M, Wasserman ZR, Liu RQ, Covington MB, Newton R, Christ D, Wexler RR, Decicco CP",,104395,DTCT0025094,1522342,DTCC00135631,629319,4824
CHEMBL90923,P08253,,PTONAIKVYGVBIS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104401,DTCT0025094,1036755,DTCC00252258,1585215,5080
CHEMBL9102,P08253,,PMABCPFRGPPVJY-CKIYMEHHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,280,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,541395,DTCC00135904,1616679,14548
CHEMBL9105,P08253,,GJWCMELEZPWLGX-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,9083493,KI,=,3600,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104543,DTCT0025094,542288,DTCC00135896,387990,14548
CHEMBL91054,P08253,,NEPPMULRSZAPIH-JSOSNVBQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,157,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1713422,DTCC00256413,1661532,1013
CHEMBL91055,P08253,,ZKISXIXLRWGPKA-SVBPBHIXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11428927,KI,=,210,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-2,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104539,DTCT0025094,548191,DTCC00256517,269931,16308
CHEMBL91055,P08253,,ZKISXIXLRWGPKA-SVBPBHIXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,210,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Gelatinase-A enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101924,DTCT0025094,1697631,DTCC00256517,270192,1013
CHEMBL91124,P08253,,UDYKJHQVNSKFHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1057006,DTCC00255250,1882477,4541
CHEMBL91124,P08253,,UDYKJHQVNSKFHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317089,DTCC00255250,1869508,67557
CHEMBL91124,P08253,,UDYKJHQVNSKFHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317292,DTCC00255250,1869508,67557
CHEMBL91434,P08253,,XIOQDQAMCAXVAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1055776,DTCC00255252,1785626,4541
CHEMBL91434,P08253,,XIOQDQAMCAXVAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.5998,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317293,DTCC00255252,1772640,67557
CHEMBL91434,P08253,,XIOQDQAMCAXVAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317090,DTCC00255252,1772640,67557
CHEMBL91636,P08253,,DONMTDNLNMLOIC-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11472217,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104535,DTCT0025094,1647506,DTCC00251443,1261581,16346
CHEMBL91636,P08253,,DONMTDNLNMLOIC-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11585440,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104537,DTCT0025094,1304863,DTCC00251443,1273600,16439
CHEMBL91655,P08253,,RMDYHDHTWWNFHG-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,977166,DTCC00256713,1456109,1012
CHEMBL91767,P08253,,TXFOUFDGVNFIGH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,12217351,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104401,DTCT0025094,1017140,DTCC00251617,647933,5080
CHEMBL91905,P08253,,OJKKCGQMPIPJOV-VJWYXCESSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,808102,DTCC00257803,1774049,11463
CHEMBL92283,P08253,,YOKGGTHIDPCFBA-SENIWNHXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,17000,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,812297,DTCC00257963,518680,11463
CHEMBL92295,P08253,,FLSKAQHICLBKFX-XWXSEMISSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,791355,DTCC00257964,1521016,11463
CHEMBL92327,P08253,,TWTZRHWHKRIAHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,40,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1078290,DTCC00255226,820444,4541
CHEMBL92327,P08253,,TWTZRHWHKRIAHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,39.99,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317295,DTCC00255226,807502,67557
CHEMBL92327,P08253,,TWTZRHWHKRIAHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317092,DTCC00255226,807502,67557
CHEMBL924,P08253,ZOLEDRONIC ACID,XRASPMIURGNCCH-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24071448,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990170,DTCT0025094,12629973,DTCC00200651,1095364,56259
CHEMBL924,P08253,ZOLEDRONIC ACID,XRASPMIURGNCCH-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24813742,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 pretreated for 30 mins measured 2 to 4 hrs after Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate addition by fluorescence analysis,,Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.,Bioorg. Med. Chem. Lett.,2014,24,12,"Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P",,1362451,DTCT0025094,13754120,DTCC00200651,1075470,59385
CHEMBL92453,P08253,,WYEWOIOFHXNSNW-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,979476,DTCC00256945,324032,1012
CHEMBL92581,P08253,,PGCZNTNNZCKKFG-YZSUGWMWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,778628,DTCC00257138,1228610,11463
CHEMBL92600,P08253,,NLAVZJASCRYXPN-SQHAQQRYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.03,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1012027,DTCC00257096,1617949,1012
CHEMBL92778,P08253,,MHIFGXNSNUWQOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1093221,DTCC00255197,1882476,4541
CHEMBL92778,P08253,,MHIFGXNSNUWQOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.3999,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317290,DTCC00255197,1869507,67557
CHEMBL92778,P08253,,MHIFGXNSNUWQOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317087,DTCC00255197,1869507,67557
CHEMBL92828,P08253,,IURHJAMYHLDNBR-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,988762,DTCC00256909,1935247,1012
CHEMBL92899,P08253,,BHBGOKVZFAQJAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,<,0.1,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1064250,DTCC00255132,562291,4541
CHEMBL92899,P08253,,BHBGOKVZFAQJAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1074862,DTCC00255132,562292,4541
CHEMBL92899,P08253,,BHBGOKVZFAQJAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,19.3,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1086892,DTCC00255132,562290,4541
CHEMBL92899,P08253,,BHBGOKVZFAQJAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,19.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317085,DTCC00255132,549311,67557
CHEMBL92899,P08253,,BHBGOKVZFAQJAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,19.32,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317288,DTCC00255132,549311,67557
CHEMBL92923,P08253,,DSBXKNRWNDALKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1060603,DTCC00255196,1785625,4541
CHEMBL92923,P08253,,DSBXKNRWNDALKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317100,DTCC00255196,1772641,67557
CHEMBL92923,P08253,,DSBXKNRWNDALKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317303,DTCC00255196,1772641,67557
CHEMBL93,P08253,ZILEUTON,MWLSOWXNZPKENC-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,Active,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617808,DTCC00139913,21742,56109
CHEMBL93231,P08253,,HDTLIPGODNAYEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1065405,DTCC00255209,1818148,4541
CHEMBL93231,P08253,,HDTLIPGODNAYEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317088,DTCC00255209,1805196,67557
CHEMBL93231,P08253,,HDTLIPGODNAYEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317291,DTCC00255209,1805196,67557
CHEMBL93235,P08253,,VQWLMWWSSYJPOW-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.02,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,996271,DTCC00256946,1870880,1012
CHEMBL93395,P08253,,VGJHUMMWUOOYIO-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,989970,DTCC00257301,1520993,1012
CHEMBL93583,P08253,,CWNLQOSKBPEJOV-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1008302,DTCC00257037,647972,1012
CHEMBL93695,P08253,,MWWSEQIBKWJTDA-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.03,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,1003463,DTCC00256937,64539,1012
CHEMBL93768,P08253,,BAHYQLXNOCVJNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,370000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,507363,DTCC00261671,1903310,3361
CHEMBL93791,P08253,,FWRANZUQAGPBMV-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.02,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,992464,DTCC00256947,486431,1012
CHEMBL93890,P08253,,HLSQLCOADIMQBK-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,33,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,991082,DTCC00257036,96909,1012
CHEMBL93959,P08253,,ZJSZPCRXLCONMI-GFSCODLRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,220,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,785805,DTCC00257139,679838,11463
CHEMBL94114,P08253,,UVOFCKSSQUNXIZ-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,,KI,=,0.02,NM,,,,,,,,,,,,,,Inhibition of the gelatinase-A enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,101923,DTCT0025094,987685,DTCC00256654,96910,1012
CHEMBL94248,P08253,,HYJOVEQOBWVFPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11591510,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibitory activity against human Matrix metalloprotease-2,,alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2001,11,20,"Becker DP, DeCrescenzo G, Freskos J, Getman DP, Hockerman SL, Li M, Mehta P, Munie GE, Swearingen C",,104378,DTCT0025094,1059262,DTCC00254882,594477,4541
CHEMBL94248,P08253,,HYJOVEQOBWVFPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317096,DTCC00254882,581507,67557
CHEMBL94248,P08253,,HYJOVEQOBWVFPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,27452283,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589851,DTCT0025094,317299,DTCC00254882,581507,67557
CHEMBL94268,P08253,,UDHGDEUNZHLECB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,160000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,479581,DTCC00260964,129188,3361
CHEMBL94324,P08253,,YOZFGFQUBUJIAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,3500,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,724658,DTCC00261065,129182,3985
CHEMBL94346,P08253,(PROPYLAMINO)CARBONYLPHOSPHONIC ACID,KMYNAIWKMORGAF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,300,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1288010,DTCC00260739,1850377,17838
CHEMBL94348,P08253,(ETHYLAMINO)CARBONYLPHOSPHONIC ACID,IZWWUWVUAGTWGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,5000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1319227,DTCC00260740,949944,17838
CHEMBL94382,P08253,,GGHBTRSJMHGOFQ-OBTYFGFYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,1322986,IC50,=,420,NM,,,,,,,,,,,,,,Inhibitory concentration against Clostridium histolyticum Collagenase,,Inhibition of collagenase by aranciamycin and aranciamycin derivatives.,J. Med. Chem.,1992,35,15,"Bols M, Binderup L, Hansen J, Rasmussen P",,49491,DTCT0025094,784432,DTCC00257965,1228609,11463
CHEMBL94467,P08253,,RMDGEXDQWGEALM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,35,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,699279,DTCC00260727,1003058,3985
CHEMBL94715,P08253,,XRLMAIWPTHLVKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24044434,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of recombinant human MMP-2 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 4 hrs measured every 15 secs for 20 mins by fluorimetric assay,,Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.,J. Med. Chem.,2013,56,20,"Nuti E, Casalini F, Santamaria S, Fabbi M, Carbotti G, Ferrini S, Marinelli L, La Pietra V, Novellino E, Camodeca C, Orlandini E, Nencetti S, Rossello A",,984238,DTCT0025094,12586879,DTCC00260052,1612575,55984
CHEMBL94796,P08253,,ZNNSGWVSEZETLO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,155000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,496164,DTCC00261001,64581,3361
CHEMBL94828,P08253,,UNYWJVNGOZMHAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,,,,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-2 (Not Determined),Not Determined,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104387,DTCT0025094,715144,DTCC00261092,161812,3985
CHEMBL94872,P08253,,RGHANNJVNFHOMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,70,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,723510,DTCC00261093,1968541,3985
CHEMBL94873,P08253,,BNUZEMYRPYPLIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,503619,DTCC00260925,1806549,3361
CHEMBL94887,P08253,,ILSJMXQCMMFBCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,23000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,481859,DTCC00260729,1935295,3361
CHEMBL94887,P08253,,ILSJMXQCMMFBCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,100000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,488801,DTCC00260729,1935296,3361
CHEMBL95004,P08253,,HMBQNWFTVVKUNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,72000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,496163,DTCC00260965,938439,3361
CHEMBL95068,P08253,PIPERIDIN-1-YLCARBONYLPHOSPHONIC ACID,LPCNDTNDDXIPDM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,1000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1290504,DTCC01741836,820511,17838
CHEMBL95143,P08253,,GTJPTRZNILSWIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,90000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,484125,DTCC00260259,291570,3361
CHEMBL95187,P08253,,RFVDXPXDUMYMOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,110000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,497391,DTCC00261793,1968550,3361
CHEMBL95237,P08253,,IHERVMJHCHNTKO-YJJOXIQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,14611841,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-2,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104382,DTCT0025094,874026,DTCC00263307,518732,5741
CHEMBL95237,P08253,,IHERVMJHCHNTKO-YJJOXIQCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17512742,IC50,=,9.2,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447905,DTCT0025094,2176028,DTCC00263307,520985,23716
CHEMBL95305,P08253,,DCDJWNFOPNVBIM-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,101935,DTCT0025094,838667,DTCC00265381,874273,4579
CHEMBL95414,P08253,,FUYGKZYSHSZHFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1401122,DTCC00264967,1079590,6400
CHEMBL95483,P08253,,DYYRCQAVWNBEBP-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1457842,DTCC00264377,917407,3373
CHEMBL95560,P08253,,WZGXNKZZGHCVJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,51000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,476028,DTCC00261797,226033,3361
CHEMBL95614,P08253,,QHRUJPVXLYJUEM-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1451869,DTCC00264573,205149,3373
CHEMBL95614,P08253,,QHRUJPVXLYJUEM-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1995.26,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258330,DTCC00264573,196120,24803
CHEMBL95679,P08253,,XMSYMMKQCALYGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,492610,DTCC00261800,1100611,3361
CHEMBL95718,P08253,,XSFCSVRJCFLQJI-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,110,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,830043,DTCC00265442,1488828,4579
CHEMBL95718,P08253,,XSFCSVRJCFLQJI-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,109.65,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258428,DTCC00265442,1491218,24803
CHEMBL95763,P08253,(CYCLOBUTYLAMINO)CARBONYLPHOSPHONIC ACID,UILNVWQPBYOCJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,150,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1286793,DTCC00261232,788164,17838
CHEMBL95781,P08253,,HHWUIFVBNRTZLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,498666,DTCC00261708,1035488,3361
CHEMBL96438,P08253,(DIBUTYLAMINO)CARBONYLPHOSPHONIC ACID,NEQAQLUTBGWNLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,50000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1307517,DTCC00261385,465117,17838
CHEMBL96443,P08253,,UTLBTKPJHMYSDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,493733,DTCC00261436,1100610,3361
CHEMBL96447,P08253,,IZRBMZAYLCRHAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,491308,DTCC00260955,808885,3361
CHEMBL97034,P08253,(ISOPROPYLAMINO)CARBONYLPHOSPHONIC ACID,ZBIIKTYRXGHZSP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,1000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1307509,DTCC00261507,335874,17838
CHEMBL97034,P08253,(ISOPROPYLAMINO)CARBONYLPHOSPHONIC ACID,ZBIIKTYRXGHZSP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420872,DTCC00261507,330232,51419
CHEMBL97057,P08253,(DIETHYLAMINO)CARBONYLPHOSPHONIC ACID,DCJBWQGCBUBISK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,1000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1296410,DTCC00261591,1240575,17838
CHEMBL97175,P08253,,YQIVJUKRUOXAHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,507362,DTCC00261825,1585301,3361
CHEMBL97293,P08253,,AMAQUKTXJPWLRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,150000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,504846,DTCC00261669,356776,3361
CHEMBL97382,P08253,,ZNTBEHZFMMNDRG-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1448188,DTCC00264485,433638,3373
CHEMBL97382,P08253,,ZNTBEHZFMMNDRG-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1995.26,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258341,DTCC00264485,424706,24803
CHEMBL97388,P08253,(METHYLAMINO)CARBONYLPHOSPHONIC ACID,DKRGQDKOWKPDBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1314462,DTCC00261329,659364,17838
CHEMBL97389,P08253,SODIUM HYDROGEN (BUTYLAMINO)CARBONYLPHOSPHONATE,XZWWCSRZYGUJCH-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,2000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1318098,DTCC00261330,368532,17838
CHEMBL97408,P08253,,CQWGNGOLUOZZBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,500999,DTCC00261838,1359446,3361
CHEMBL97454,P08253,,WEJATSORFYGFCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,50000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,485355,DTCC00261837,258284,3361
CHEMBL97478,P08253,,SCJDSSFAEYTLGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11133099,IC50,=,2300,NM,,,,,,,,,,,,,,50 percent inhibition of human Matrix metalloprotease-2 by the cleavage of fluorogenic peptide MCA-Pro-Leu-Gly-Leu-Dpa-ala-Arg-NH2,,Synthesis and activity of selective MMP inhibitors with an aryl backbone.,Bioorg. Med. Chem. Lett.,2000,10,24,"Barta TE, Becker DP, Bedell LJ, De Crescenzo GA, McDonald JJ, Munie GE, Rao S, Shieh HS, Stegeman R, Stevens AM, Villamil CI",,104386,DTCT0025094,710857,DTCC00261094,1359441,3985
CHEMBL97510,P08253,(SEC-BUTYLAMINO)CARBONYLPHOSPHONIC ACID,FRMUISNHCCQMGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,3000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1305205,DTCC01741841,1273346,17838
CHEMBL97513,P08253,,UFTKNLSTJLMVEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,510932,DTCC00261755,486475,3361
CHEMBL97513,P08253,,UFTKNLSTJLMVEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,900,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,496166,DTCC00261755,486476,3361
CHEMBL97552,P08253,,PNGANVOKQWUCHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,496165,DTCC00261346,550756,3361
CHEMBL97614,P08253,(CYCLOHEPTYLAMINO)CARBONYLPHOSPHONIC ACID,PZCAQCXIXVTXSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,4000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1313340,DTCC00261524,1753576,17838
CHEMBL97709,P08253,(CYCLOOCTYLAMINO)CARBONYLPHOSPHONIC ACID,RDECIIJACWTCQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,1000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1309954,DTCC00261479,917368,17838
CHEMBL97709,P08253,(CYCLOOCTYLAMINO)CARBONYLPHOSPHONIC ACID,RDECIIJACWTCQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420866,DTCC00261479,912870,51419
CHEMBL97838,P08253,MORPHOLIN-4-YLCARBONYLPHOSPHONIC ACID,XUDXDIFMUCLQQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1313348,DTCC01741839,1564617,17838
CHEMBL97936,P08253,,FCGVXISUYVDDPU-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1457847,DTCC00264930,401357,3373
CHEMBL97936,P08253,,FCGVXISUYVDDPU-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258333,DTCC00264930,391949,24803
CHEMBL97951,P08253,CYCLOHEXYLMETHYLCARBAMOYLPHOSPHONIC ACID,XBMRQHZMWARLEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15139760,IC50,=,200,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-2 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104550,DTCT0025094,1320467,DTCC00106572,1273345,17838
CHEMBL97951,P08253,CYCLOHEXYLMETHYLCARBAMOYLPHOSPHONIC ACID,XBMRQHZMWARLEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22894736,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.,J. Med. Chem.,2012,55,17,"Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, Breuer E",,861930,DTCT0025094,11420867,DTCC00106572,1267647,51419
CHEMBL98,P08253,VORINOSTAT,WAEXFXRVDQXREF-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21714538,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP2,Not Active,Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.,J. Med. Chem.,2011,54,15,"Zhang Y, Fang H, Feng J, Jia Y, Wang X, Xu W",,768035,DTCT0025094,6100959,DTCC00141645,1040480,45885
CHEMBL98,P08253,VORINOSTAT,WAEXFXRVDQXREF-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24074025,INHIBITION,<,25,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate at 10 uM preincubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay relative to control,,Investigating the selectivity of metalloenzyme inhibitors.,J. Med. Chem.,2013,56,20,"Day JA, Cohen SM",,987736,DTCT0025094,12617809,DTCC00141645,1042274,56109
CHEMBL98,P08253,VORINOSTAT,WAEXFXRVDQXREF-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,24755524,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP2 (unknown origin) using succinylated gelatin as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometry,Not Determined,"Design, synthesis and preliminary evaluation of a-sulfonyl ¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem.,2014,22,11,"Zhang J, Li X, Jiang Y, Feng J, Li X, Zhang Y, Xu W",,1350982,DTCT0025094,13709722,DTCC00141645,1063099,58773
CHEMBL98,P08253,VORINOSTAT,WAEXFXRVDQXREF-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,IC50,,,,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis,Not Determined,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518634,DTCT0025094,14550516,DTCC00141645,1032901,63755
CHEMBL98,P08253,VORINOSTAT,WAEXFXRVDQXREF-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26386821,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human full length MMP2 using Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate at 10 uM incubated for 2 hrs prior to testing measured for 15 mins by fluorometric analysis relative to control,Not Determined,"Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.",Bioorg. Med. Chem.,2015,23,20,"Yan Y, Chen X, Yang X, Zhang J, Xu W, Zhang Y",,1518637,DTCT0025094,14550543,DTCC00141645,1032901,63755
CHEMBL98017,P08253,,OEPLGUBYTRYCJX-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1451874,DTCC00264988,2013090,3373
CHEMBL98017,P08253,,OEPLGUBYTRYCJX-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,398.11,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258324,DTCC00264988,2003620,24803
CHEMBL98044,P08253,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1474975,DTCC00264954,76259,3373
CHEMBL98044,P08253,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,891.25,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258337,DTCC00264954,67153,24803
CHEMBL98044,P08253,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18790648,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497403,DTCT0025094,2457482,DTCC00264954,79308,32556
CHEMBL98186,P08253,,JDAADLBCXSWLIJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522699,IC50,=,120000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2).,,"Design, combinatorial chemical synthesis and in vitro characterization of novel urea based gelatinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,19,"Zhang Y, Li D, Houtman JC, Witiak DT, Seltzer J, Bertics PJ, Lauhon CT",,101934,DTCT0025094,479580,DTCC00260922,161816,3361
CHEMBL98202,P08253,,KQXZHGMAVQYCLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,55000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1386238,DTCC00265444,401371,6400
CHEMBL98304,P08253,,IGKZHEJCICMYIH-ULNSLHSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,230,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,848556,DTCC00265592,129248,4579
CHEMBL98304,P08253,,IGKZHEJCICMYIH-ULNSLHSMSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,229.09,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258426,DTCC00265592,131663,24803
CHEMBL98328,P08253,N-HYDROXY-METHANESULFONAMIDE,YKSVNSKYIUPAKW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11020282,KI,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-2,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,104407,DTCT0025094,1622872,DTCC01741913,1014996,15919
CHEMBL98390,P08253,,AYWKRESAZCSENH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1403505,DTCC00265682,691581,6400
CHEMBL98770,P08253,,HFKQCTSECBMUHK-ZNZIZOMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,0.79,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,827366,DTCC00265384,906778,4579
CHEMBL98770,P08253,,HFKQCTSECBMUHK-ZNZIZOMTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,0.794,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258431,DTCC00265384,909280,24803
CHEMBL98852,P08253,,VDOSRWCTGZRCFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,41000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1364695,DTCC00265511,949990,6400
CHEMBL98917,P08253,,OVICMAJBKGLSNC-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1472416,DTCC00264408,755981,3373
CHEMBL98917,P08253,,OVICMAJBKGLSNC-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258342,DTCC00264408,746928,24803
CHEMBL99045,P08253,,QSRYPQMSBYPAQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1382454,DTCC00264808,1403621,6400
CHEMBL99103,P08253,,KAJAADJOOYZIPJ-PKTNWEFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,0.23,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,854720,DTCC00265669,648071,4579
CHEMBL99109,P08253,,TZTMRGAOGRZNKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibition against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,101935,DTCT0025094,820862,DTCC00265198,1839056,4579
CHEMBL99120,P08253,,LBQUSUPCYKIDFL-DSITVLBTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,13,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,830039,DTCC00265383,356818,4579
CHEMBL99120,P08253,,LBQUSUPCYKIDFL-DSITVLBTSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,12.88,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258429,DTCC00265383,359206,24803
CHEMBL99148,P08253,,ZVAKMIZOMSWYGQ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1450624,DTCC00264513,788198,3373
CHEMBL99148,P08253,,ZVAKMIZOMSWYGQ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,602.56,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258336,DTCC00264513,778988,24803
CHEMBL99189,P08253,,YLYMDJMYRSEUOA-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1466340,DTCC00265032,1532650,3373
CHEMBL99189,P08253,,YLYMDJMYRSEUOA-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,302,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258326,DTCC00265032,1523430,24803
CHEMBL99283,P08253,,YINOLIYDTHQXKP-PKTNWEFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,96,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,844513,DTCC00265076,389445,4579
CHEMBL99283,P08253,,YINOLIYDTHQXKP-PKTNWEFCSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,95.5,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258425,DTCC00265076,391951,24803
CHEMBL99318,P08253,,NUWGCPAPIJNAPL-AYQJTBPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,840987,DTCC00265593,518757,4579
CHEMBL99318,P08253,,NUWGCPAPIJNAPL-AYQJTBPPSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258423,DTCC00265593,521151,24803
CHEMBL99365,P08253,,YFYQFPIGOKJLFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1394860,DTCC00265479,562406,6400
CHEMBL99547,P08253,,GIGQELYOVAVUIF-NGDRWEMDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,11677124,IC50,=,11,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-2,,Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.,Bioorg. Med. Chem. Lett.,2001,11,22,"Holms J, Mast K, Marcotte P, Elmore I, Li J, Pease L, Glaser K, Morgan D, Michaelides M, Davidsen S",,104557,DTCT0025094,828672,DTCC00265668,161880,4579
CHEMBL99547,P08253,,GIGQELYOVAVUIF-NGDRWEMDSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,10.96,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258427,DTCC00265668,164157,24803
CHEMBL99733,P08253,,PIZFUXJESIVHOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15163180,KI,=,433,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-2,,Sultam hydroxamates as novel matrix metalloproteinase inhibitors.,J. Med. Chem.,2004,47,12,"Cherney RJ, Mo R, Meyer DT, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,104406,DTCT0025094,671273,DTCC00269145,582953,18131
CHEMBL99932,P08253,8-AMINOQUINOLINE,WREVVZMUNPAPOV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21189019,INHIBITION,=,51,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715231,DTCT0025094,5103184,DTCC00265364,540480,43205
CHEMBL99981,P08253,,ZBTKKYFIZQHNDQ-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,10522712,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Gel-A MMP-2,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101909,DTCT0025094,1456611,DTCC00265035,173185,3373
CHEMBL99981,P08253,,ZBTKKYFIZQHNDQ-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,17275314,IC50,=,398.11,NM,,,,,,,,,,,,,,Inhibition of MMP2,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458931,DTCT0025094,2258328,DTCC00265035,164159,24803
CHEMBL99995,P08253,,CDDCBQKBUFNWAE-NTBLAEGASA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,15125955,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-2,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104554,DTCT0025094,1383850,DTCC00265558,853474,6400
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14745309,DTCC01744004,2108945,69259
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,2.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14751474,DTCC01744004,2108945,69259
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,6620,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14722936,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14720693,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14720769,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,18000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14726561,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,19200,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14707425,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,25000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14708296,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,39400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14719602,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,46900,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14725270,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,47100,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14705282,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,50600,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14712366,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14704739,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14705093,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14705287,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14706201,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14707496,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14707674,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14709352,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14711740,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14722310,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14722966,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14723197,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14723404,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14725609,DTCC01744004,2096566,67810
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19807733,KI,=,0.53,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14749713,DTCC01744004,2103688,69319
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19807733,KI,=,1400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14749864,DTCC01744004,2103688,69319
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19807733,KI,=,2100,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14747996,DTCC01744004,2103688,69319
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,19807733,KI,=,40000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14728712,DTCC01744004,2103688,69319
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20817735,KI,=,192,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14753291,DTCC01744004,2110394,69686
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,115000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14704750,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,125600,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14705998,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,203400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14706536,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,225400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14722097,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,236600,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14725513,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,328500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14707717,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,333700,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14721902,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,681700,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14706928,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,710300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14726404,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,1000000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14710699,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,21770859,IC50,=,1000000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14723537,DTCC01744004,2096574,67818
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,IC50,=,66,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14725238,DTCC01744004,2098141,68703
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,KI,=,47,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14751477,DTCC01744004,2098141,68703
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,KI,=,57,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14745586,DTCC01744004,2098141,68703
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,KI,=,100,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14753290,DTCC01744004,2098141,68703
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,KI,=,127,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14746899,DTCC01744004,2098141,68703
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,22689580,KI,=,583,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14749092,DTCC01744004,2098141,68703
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25418204,IC50,=,1800,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14704913,DTCC01744004,2096668,67910
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25418204,IC50,=,8000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14721792,DTCC01744004,2096668,67910
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25418204,IC50,=,13700,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14724888,DTCC01744004,2096668,67910
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25418204,IC50,=,19200,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14710988,DTCC01744004,2096668,67910
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,25418204,IC50,=,60300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14723904,DTCC01744004,2096668,67910
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,330,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14726571,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,1810,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14722929,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,1830,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14709632,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,2130,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14706659,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,3230,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14708535,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,3840,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14725096,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,4620,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14719477,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,4650,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14704802,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,8730,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14706282,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,8830,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14704745,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,9830,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14712211,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,11300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14724210,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,11500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14719554,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,12800,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14720044,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,12900,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14726837,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,13500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14723265,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,15000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14725373,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,15800,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14719953,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,16200,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14719070,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,16400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14719146,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,16500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14724125,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,18800,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14726691,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,18900,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14724449,DTCC01744004,2096570,67814
,P08253,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,24700,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14722942,DTCC01744004,2096570,67814
,P08253,AC1NSUQX,PFEOKQKYEJFZNV-WZUFQYTHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14721994,DTCC01745046,2102476,67810
,P08253,AC1NZN6N,WYRWIZUSWGLKCX-ZCXUNETKSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,18221310,IC50,=,25000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14712856,DTCC01744726,2098847,67810
,P08253,AGN-PC-00A9Z8,WRQYAPDRSRSBNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14733960,DTCC01745945,2105094,69259
,P08253,AGN-PC-00AW7I,ZBOSPOSQGJWURE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.9,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14746241,DTCC01746086,2109118,69259
,P08253,AGN-PC-00B1B8,QVHYJMPAZNGFHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14727757,DTCC01745743,2103471,69259
,P08253,AGN-PC-00B1IZ,BEQXRWLSEUIFKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14747797,DTCC01746160,2109488,69259
,P08253,AGN-PC-00B6KS,FQPCVUZCOHLRGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.15,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14750739,DTCC01746416,2109959,69259
,P08253,AGN-PC-00BMEK,QYCUMAKSYBUWER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.13,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14753763,DTCC01746699,2110472,69259
,P08253,AGN-PC-00C7AZ,SWYRTBQMGJFWDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14729794,DTCC01745814,2103978,69259
,P08253,AGN-PC-00COJ9,WDPVPUZANMBBLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14732734,DTCC01745926,2104739,69259
,P08253,AGN-PC-00D2VZ,NKHJMAWHLPBSOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14752273,DTCC01746561,2110229,69259
,P08253,AGN-PC-00E2QR,JQESDCUCXWEIBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14753811,DTCC01746703,2110478,69259
,P08253,AGN-PC-00ERPQ,YLRBOIVJMWEGGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14745122,DTCC01745987,2108904,69259
,P08253,ALPHA-SULFONE 13,VFZUVETVSPJFEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,2.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14755249,DTCC01746812,2110672,69259
,P08253,ALPHA-SULFONE 17,DZCKADUBMZPQDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14748820,DTCC01746261,2109668,69259
,P08253,ALPHA-SULFONE 27A,FAOIZSVKMZLOCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14750210,DTCC01746370,2109869,69259
,P08253,ALPHA-SULFONE 27B,LFIZWBFUWVSLOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.22,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14755207,DTCC01746809,2110669,69259
,P08253,ALPHA-SULFONE 27H,IBMBDMBDQPRIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14750599,DTCC01746401,2109934,69259
,P08253,ALPHA-SULFONE 27I,NWFAIXPOXVQZQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14757531,DTCC01746901,2111161,69259
,P08253,ALPHA-SULFONE 35G,KLWUGXOQJJWEBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14754581,DTCC01746770,2110582,69259
,P08253,ALPHA-SULFONE 35H,XJMDDZUUIUEEJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14746924,DTCC01746132,2109290,69259
,P08253,BETA-SULFONE 7A,XXKPJSZGWAMVSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,16220987,KI,=,0.2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14745408,DTCC01746015,2108961,69259
,P08253,BI-102C8,SSQUTXCOTMRKGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20308072,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14710173,DTCC01744594,2098163,68371
,P08253,BI-92G11,NUSZCZOBSDRJEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,20308072,IC50,=,1900,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14707325,DTCC01744374,2097426,68371
,P08253,CAPZIMIN,MYNGHZGMRXNEEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,28244987,IC50,=,50000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14706949,DTCC01744314,2097333,68306
,P08253,DDA-TETRACYCLINE,XCCHQGIGHCRZOS-KBKZQPOHSA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,1130,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14718946,DTCC01744737,2101807,67814
,P08253,ZINC05006470,YMAMXDTXKWPGGB-UHFFFAOYNA-N,0,MATRIX METALLOPROTEINASE-2,MMP2,Enzyme,,,26061284,IC50,=,17300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0025094,14719662,DTCC01744821,2101926,67814
